View
213
Download
0
Category
Preview:
Citation preview
135
Creator Gaelen Adam
Organization Brown University
TitleDescriptionContributorsMethodologyNotesFunding AgencyExtraction Form
12345678
Study ID:EF ID Creator Create Date PMID6304:194 admin Aug 18, 2013 Sep 5, 2014 185059676305:194 admin Aug 18, 2013 Sep 5, 2014 110758746306:194 admin Aug 18, 2013 Sep 5, 2014 126632776307:194 admin Aug 18, 2013 Sep 5, 2014 78928826308:194 admin Aug 18, 2013 Sep 5, 2014 162804276309:194 admin Aug 18, 2013 Sep 5, 2014 182086366311:194 admin Aug 18, 2013 Sep 5, 2014 13303606312:194 admin Aug 18, 2013 Sep 5, 2014 86211986313:194 admin Aug 18, 2013 Sep 5, 2014 97435116314:194 admin Aug 18, 2013 Sep 5, 2014 157673346315:194 admin Aug 18, 2013 Sep 5, 2014 161034506316:194 admin Aug 18, 2013 Sep 5, 2014 179650376317:194 admin Aug 18, 2013 Sep 5, 2014 186895596318:194 admin Aug 18, 2013 Sep 5, 2014 175359856319:194 admin Aug 18, 2013 Sep 5, 2014 181983946320:194 admin Aug 18, 2013 Sep 5, 2014 172438666321:194 admin Aug 18, 2013 Sep 5, 2014 188427716322:194 admin Aug 18, 2013 Sep 5, 2014 83334126323:194 admin Aug 18, 2013 Sep 5, 2014 99219606324:194 admin Aug 18, 2013 Sep 5, 2014 3298936325:194 admin Aug 18, 2013 Sep 5, 2014 76128036326:194 admin Aug 18, 2013 Sep 5, 2014 187553196327:194 admin Aug 18, 2013 Sep 5, 2014 167979036328:194 admin Aug 18, 2013 Sep 5, 2014 176564206329:194 admin Aug 18, 2013 Sep 5, 2014 175025306330:194 admin Aug 18, 2013 Sep 5, 2014 115666566331:194 admin Aug 18, 2013 Sep 5, 2014 19001601
Project ID (SRDR)
The Relationships of Vitamin D and Calcium Background: Since the 1997 Dietary Reference Mei Chung, MPH Ethan M Balk, MD, MPH Michael Search terms that were used to identify outcomes For access to the full report available on the The Office of Dietary Supplements/National Vitamin D and Calcium RelationshipsKey Questions
for this Quality of Interventional StudiesQuality of Cohort or Nested Case-control What is the effect of exposures on functional or What is the effect of exposures on indicators of What is the effect of indicators of exposure or What is the effect of exposures on indicators of What is the effect of indicators of exposure or What is the effect of intermediate indicators of
Last Updated
6333:194 admin Aug 18, 2013 Sep 5, 2014 162804476334:194 admin Aug 18, 2013 Sep 5, 2014 152130386335:194 admin Aug 18, 2013 Sep 5, 2014 82200926336:194 admin Aug 18, 2013 Sep 5, 2014 86824536337:194 admin Aug 18, 2013 Sep 5, 2014 88906616338:194 admin Aug 18, 2013 Sep 5, 2014 171895526339:194 admin Aug 18, 2013 Sep 5, 2014 162782626340:194 admin Aug 18, 2013 Sep 5, 2014 80781156341:194 admin Aug 18, 2013 Sep 5, 2014 153424526342:194 admin Aug 18, 2013 Sep 5, 2014 156684856343:194 admin Aug 18, 2013 Nov 6, 2013 19376626344:194 admin Aug 18, 2013 Sep 5, 2014 173720316345:194 admin Aug 18, 2013 Sep 5, 2014 188386236346:194 admin Aug 18, 2013 Sep 5, 2014 179715266347:194 admin Aug 18, 2013 Sep 5, 2014 183814726348:194 admin Aug 18, 2013 Sep 5, 2014 90612756349:194 admin Aug 18, 2013 Sep 5, 2014 173110576350:194 admin Aug 18, 2013 Sep 5, 2014 88502736351:194 admin Aug 18, 2013 Sep 5, 2014 28573646352:194 admin Aug 18, 2013 Sep 5, 2014 25729006353:194 admin Aug 18, 2013 Sep 5, 2014 74936596356:194 admin Aug 18, 2013 Sep 5, 2014 146522386357:194 admin Aug 18, 2013 Sep 5, 2014 172279966358:194 admin Aug 18, 2013 Sep 5, 2014 105113296359:194 admin Aug 18, 2013 Sep 5, 2014 156712226360:194 admin Aug 18, 2013 Sep 5, 2014 162865196361:194 admin Aug 18, 2013 Sep 5, 2014 145539576362:194 admin Aug 18, 2013 Sep 5, 2014 124993436363:194 admin Aug 18, 2013 Sep 5, 2014 94050296364:194 admin Aug 18, 2013 Sep 5, 2014 39462956367:194 admin Aug 18, 2013 Nov 6, 2013 104714226368:194 admin Aug 18, 2013 Nov 6, 2013 104714226369:194 admin Aug 18, 2013 Sep 5, 2014 152258336370:194 admin Aug 18, 2013 Sep 5, 2014 116417506371:194 admin Aug 18, 2013 Sep 5, 2014 174421306372:194 admin Aug 18, 2013 Sep 5, 2014 82014446373:194 admin Aug 18, 2013 Sep 5, 2014 175528806374:194 admin Aug 18, 2013 Sep 5, 2014 82055386375:194 admin Aug 18, 2013 Sep 5, 2014 93438376376:194 admin Aug 18, 2013 Sep 5, 2014 86107046377:194 admin Aug 18, 2013 Sep 5, 2014 158805326378:194 admin Aug 18, 2013 Sep 5, 2014 175361916379:194 admin Aug 18, 2013 Sep 5, 2014 171064376380:194 admin Aug 18, 2013 Sep 5, 2014 183980336381:194 admin Aug 18, 2013 Sep 5, 2014 192211906382:194 admin Aug 18, 2013 Sep 5, 2014 153541506383:194 admin Aug 18, 2013 Sep 5, 2014 175566976384:194 admin Aug 18, 2013 Sep 5, 2014 18433305
6385:194 admin Aug 18, 2013 Sep 5, 2014 165229156386:194 admin Aug 18, 2013 Sep 5, 2014 165229156387:194 admin Aug 18, 2013 Sep 5, 2014 183322896388:194 admin Aug 18, 2013 Sep 5, 2014 190565696389:194 admin Aug 18, 2013 Sep 5, 2014 173886676390:194 admin Aug 18, 2013 Sep 5, 2014 85579656391:194 admin Aug 18, 2013 Sep 5, 2014 158002686392:194 admin Aug 18, 2013 Sep 5, 2014 175332086393:194 admin Aug 18, 2013 Sep 5, 2014 164000446394:194 admin Aug 18, 2013 Sep 5, 2014 174739116395:194 admin Aug 18, 2013 Sep 5, 2014 172091776396:194 admin Aug 18, 2013 Sep 5, 2014 37555176397:194 admin Aug 18, 2013 Sep 5, 2014 188246626398:194 admin Aug 18, 2013 Sep 5, 2014 159554676399:194 admin Aug 18, 2013 Sep 5, 2014 120201026401:194 admin Aug 18, 2013 Sep 5, 2014 36232606402:194 admin Aug 18, 2013 Sep 5, 2014 32436096403:194 admin Aug 18, 2013 Sep 5, 2014 163915876404:194 admin Aug 18, 2013 Sep 5, 2014 67930586405:194 admin Aug 18, 2013 Sep 5, 2014 127087196406:194 admin Aug 18, 2013 Sep 5, 2014 163650076407:194 admin Aug 18, 2013 Sep 5, 2014 186950766408:194 admin Aug 18, 2013 Sep 5, 2014 188278116409:194 admin Aug 18, 2013 Sep 5, 2014 171064376410:194 admin Aug 18, 2013 Sep 5, 2014 163526846411:194 admin Aug 18, 2013 Sep 5, 2014 112624666412:194 admin Aug 18, 2013 Sep 5, 2014 171818906413:194 admin Aug 18, 2013 Sep 5, 2014 191257566414:194 admin Aug 18, 2013 Sep 5, 2014 191582266415:194 admin Aug 18, 2013 Sep 5, 2014 97941756416:194 admin Aug 18, 2013 Sep 5, 2014 173796166417:194 admin Aug 18, 2013 Sep 5, 2014 175219216418:194 admin Aug 18, 2013 Sep 5, 2014 176222446419:194 admin Aug 18, 2013 Sep 5, 2014 172153806420:194 admin Aug 18, 2013 Sep 5, 2014 180000206421:194 admin Aug 18, 2013 Sep 5, 2014 179252836422:194 admin Aug 18, 2013 Sep 5, 2014 192377246423:194 admin Aug 18, 2013 Sep 5, 2014 112975966424:194 admin Aug 18, 2013 Sep 5, 2014 105306086425:194 admin Aug 18, 2013 Sep 5, 2014 110457886428:194 admin Aug 18, 2013 Sep 5, 2014 158271036429:194 admin Aug 18, 2013 Sep 5, 2014 128693976430:194 admin Aug 18, 2013 Sep 5, 2014 173153196431:194 admin Aug 18, 2013 Sep 5, 2014 92364166432:194 admin Aug 18, 2013 Sep 5, 2014 155315006433:194 admin Aug 18, 2013 Sep 5, 2014 103621256434:194 admin Aug 18, 2013 Sep 5, 2014 74981006435:194 admin Aug 18, 2013 Sep 5, 2014 12208895
6436:194 admin Aug 18, 2013 Sep 5, 2014 170197166437:194 admin Aug 18, 2013 Sep 5, 2014 169850316438:194 admin Aug 18, 2013 Sep 5, 2014 84781446439:194 admin Aug 18, 2013 Sep 5, 2014 190569006440:194 admin Aug 18, 2013 Sep 5, 2014 23114616441:194 admin Aug 18, 2013 Sep 5, 2014 192088426442:194 admin Aug 18, 2013 Sep 5, 2014 170470876443:194 admin Aug 18, 2013 Sep 5, 2014 92424786444:194 admin Aug 18, 2013 Nov 6, 2013 124671336445:194 admin Aug 18, 2013 Sep 5, 2014 33073076446:194 admin Aug 18, 2013 Sep 5, 2014 126099406447:194 admin Aug 18, 2013 Sep 5, 2014 158834416450:194 admin Aug 18, 2013 Sep 5, 2014 163394766451:194 admin Aug 18, 2013 Sep 5, 2014 186358556452:194 admin Aug 18, 2013 Sep 5, 2014 37888356453:194 admin Aug 18, 2013 Sep 5, 2014 180655926454:194 admin Aug 18, 2013 Sep 5, 2014 15447556455:194 admin Aug 18, 2013 Sep 5, 2014 169601776456:194 admin Aug 18, 2013 Sep 5, 2014 164816366457:194 admin Aug 18, 2013 Sep 5, 2014 176615656458:194 admin Aug 18, 2013 Nov 6, 2013 182590076459:194 admin Aug 18, 2013 Sep 5, 2014 181803956460:194 admin Aug 18, 2013 Sep 5, 2014 86750936461:194 admin Aug 18, 2013 Sep 5, 2014 189889096462:194 admin Aug 18, 2013 Sep 5, 2014 90225616463:194 admin Aug 18, 2013 Sep 5, 2014 36203146464:194 admin Aug 18, 2013 Sep 5, 2014 119043166465:194 admin Aug 18, 2013 Sep 5, 2014 176238016466:194 admin Aug 18, 2013 Sep 5, 2014 77958376467:194 admin Aug 18, 2013 Sep 5, 2014 95214376468:194 admin Aug 18, 2013 Sep 5, 2014 180897016469:194 admin Aug 18, 2013 Sep 5, 2014 18410225
Alt ID(s) Title Year Author2008200020031995200520081992199619982005200520082008200720082007200819931999-- Not Found --1995200820062007200720012008
Quality [* Serum vitamin D
concentration and Ahn J., Peters U., Albanes D., Purdue MP., Abnet CC., Prostate cancer risk and
prediagnostic serum 25-Ahonen MH., Tenkanen L., Teppo L., Hakama M., A prospective study of
calcium intake from diet Al-Delaimy WK., Rimm E., Willett WC., Stampfer MJ., The influence of
menopause and hormonal Aloia JF., Vaswani A., Russo L., Sheehan M., Low-fat dairy consumption
and reduced risk of Alonso A., Beunza JJ., Delgado-Rodríguez M., Effect of vitamin D
supplementation on bone Andersen R., Mølgaard C., Skovgaard LT., Brot C., A prospective study of
nutritional factors and Ascherio A., Rimm EB., Giovannucci EL., Colditz Prospective study of
nutritional factors, blood Ascherio A., Hennekens C., Willett WC., Sacks F., Intake of potassium,
magnesium, calcium, and Ascherio A., Rimm EB., Hernán MA., Giovannucci Risk of prostate cancer in
a randomized clinical trial Baron JA., Beach M., Wallace K., Grau MV., Plasma 25-hydroxyvitamin
D and 1,25-Bertone-Johnson ER., Chen WY., Holick MF., Hollis BW., Vitamin D
supplementation has Björkman M., Sorva A., Risteli J., Tilvis R.Body size and serum 25
hydroxy vitamin D Blum M., Dallal GE., Dawson-Hughes B.Maternal vitamin D
deficiency increases the Bodnar LM., Catov JM., Simhan HN., Holick MF., Vascular events in healthy
older women receiving Bolland MJ., Barber PA., Doughty RN., Mason B., Two-year randomized
controlled trial of vitamin Bolton-Smith C., McMurdo ME., Paterson CR., Mole Dairy calcium
supplementation in Bortolotti M., Rudelle S., Schneiter P., Vidal H., Relation of calcium,
vitamin D, and dairy food Bostick RM., Potter JD., Sellers TA., McKenzie DR., Relation of calcium,
vitamin D, and dairy food Bostick RM., Kushi LH., Wu Y., Meyer KA., Sellers TA., Cinematics of fibroblast
spreading. I. Analysis of a Bliokh ZhL., Smolianinov VV.Prostate cancer and
prediagnostic levels of Braun MM., Helzlsouer KJ., Hollis BW., Comstock GW.Calcium, vitamin D
supplementation, and Brunner RL., Cochrane B., Jackson RD., Larson J., Effects of vitamin D
supplementation and Bunout D., Barrera G., Leiva L., Gattas V., de la Does vitamin D stop
inpatients falling? A Burleigh E., McColl J., Potter J.Calcium plus vitamin D
supplementation and the Caan B., Neuhouser M., Aragaki A., Lewis CB., Dairy products, calcium,
and prostate cancer risk in Chan JM., Stampfer MJ., Ma J., Gann PH., Gaziano JM., Calcium plus vitamin D
supplementation and the Chlebowski RT., Johnson KC., Kooperberg C.,
20052004-- Not Found ---- Not Found --1996200620061994200420051991 Ford ES., Cooper RS.2007200820072008199620081996198519891995200320071999200520052003200319971986199919992004200120071994200819941997199620052007200620082009200420072008
Effects of calcium, dairy product, and vitamin D
Cheng S., Lyytikäinen A., Kröger H., Lamberg-Allardt Weight loss and calcium
intake influence calcium Cifuentes M., Riedt CS., Brolin RE., Field MP., Vitamin D and prostate
cancer: a prediagnostic Corder EH., Guess HA., Hulka BS., Friedman GD., Calcium chemoprevention
in colorectal cancer.Duris I., Hruby D., Pekarkova B., Huorka M., Dietary calcium, alcohol,
and incidence of treated Dwyer JH., Li L., Dwyer KM., Curtin LR., Feinleib M.Effect of 1-year dairy
product intervention on fat Eagan MS., Lyle RM., Gunther CW., Peacock M., Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J., Seasonal and geographical
variations in the growth Feliciano ES., Ho ML., Specker BL., Falciglia G., Plasma vitamin D
metabolites and risk of Feskanich D., Ma J., Fuchs CS., Kirkner GJ., Hankinson Calcium from diet and
supplements is associated Flood A., Peters U., Chatterjee N., Lacey JV., Risk factors for
hypertension in a national Plasma 25-hydroxyvitamin D levels and risk of
Forman JP., Giovannucci E., Holmes MD., Bischoff-Plasma 25-hydroxyvitamin
D levels and risk of Forman JP., Curhan GC., Taylor EN.Prospective study of
serum vitamin D and Freedman DM., Looker AC., Chang SC., Graubard Serum levels of vitamin D
metabolites and breast Freedman DM., Chang SC., Falk RT., Purdue MP., Dietary factors and risk of
colon cancer: a Gaard M., Tretli S., Løken EB.Maternal vitamin D status
during pregnancy and Gale CR., Robinson SM., Harvey NC., Javaid MK., Circulating vitamin D
metabolites in relation to Gann PH., Ma J., Hennekens CH., Hollis Dietary vitamin D and
calcium and risk of Garland C., Shekelle RB., Barrett-Connor E., Criqui Serum 25-hydroxyvitamin
D and colon cancer: eight-Garland CF., Comstock GW., Garland FC., Helsing The influence of dairy
products on plasma uric Ghadirian P., Shatenstein B., Verdy M., Hamet P.Vitamin D, calcium
supplementation, and Grau MV., Baron JA., Sandler RS., Haile RW., Prolonged effect of
calcium supplementation Grau MV., Baron JA., Sandler RS., Wallace K., Plasma 25-hydroxyvitamin
D responses of younger Harris SS., Dawson-Hughes B., Perrone GA.The association of calcium
and vitamin D with risk of Hartman TJ., Albert PS., Snyder K., Slattery ML., The impact of calcium and
dairy product consumption Harvey-Berino J., Gold BC., Lauber R., Starinski A.Gestational calcium
supplementation and Hatton DC., Harrison-Hohner J., Coste S., Reller Human serum 25-
hydroxycholecalciferol Heaney RP., Davies KM., Chen TC., Holick MF., Long-term vitamin D3
supplementation may Heikkinen AM., Tuppurainen MT., Colon cancer and dietary
fat, phosphorus, and Heilbrun LK., Hankin JH., Nomura AM., Prospective study of
calcium, potassium, and Iso H., Stampfer MJ., Manson JE., Rexrode K., Prospective study of
calcium, potassium, and Iso H., Stampfer MJ., Manson JE., Rexrode K., Plasma levels of 25-
hydroxyvitamin D, 1,25-Jacobs ET., Giuliano AR., Martínez ME., Hollis BW., Prospective study on milk
products, calcium and Järvinen R., Knekt P., Hakulinen T., Aromaa A.Nutritional status and
subsequent all-cause Jia X., Aucott LS., McNeill G.Dietary intakes,
anthropometric Johnson AA., Knight EM., Edwards CH., Oyemade Calcium intake and the
outcome of short-term Kabrnová-Hlavatá K., Hainer V., Gojová M., Fermented dairy products,
calcium, and colorectal Kampman E., Goldbohm RA., van den Brandt PA., Prospective study of diet
and female colorectal Kato I., Akhmedkhanov A., Koenig K., Toniolo PG., Calcium, vitamin D, and
dairy foods and the Kearney J., Giovannucci E., Rimm EB., Ascherio A., Dietary calcium,
phosphorus, vitamin D, Kesse E., Boutron-Ruault MC., Norat T., Riboli E., Dairy products, calcium
and the risk of breast Kesse-Guyot E., Bertrais S., Duperray B., Arnault N., Dairy products, calcium
and prostate cancer risk.Koh KA., Sesso HD., Paffenbarger RS., Lee IM.Dairy product, saturated
fatty acid, and calcium Kurahashi N., Inoue M., Iwasaki M., Sasazuki S., Calcium plus vitamin D
supplementation and LaCroix AZ., Kotchen J., Anderson G., Brzyski R., Girls on a high-calcium
diet gain weight at the Lappe JM., Rafferty KA., Davies KM., Lypaczewski Vitamin D and calcium
supplementation reduces Lappe JM., Travers-Gustafson D., Davies KM., Calcium and vitamin d
supplementation Lappe J., Cullen D., Haynatzki G., Recker R.,
200620062008200920071995 Lijnen P., Petrov V.200520072006200720071986200820052002198719882006198120032005200820082006200620012006 Moschonis G., Manios Y.200920091998200720072007200720072007200920011999200020052003200719972004199919952002
Calcium and dairy food intakes are inversely
Larsson SC., Bergkvist L., Rutegård J., Giovannucci Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci Magnesium, calcium,
potassium, and sodium Larsson SC., Virtanen MJ., Mars M., Männistö S., Long-term dietary calcium
intake and breast cancer Larsson SC., Bergkvist L., Wolk A.A prospective study of
plasma vitamin D Li H., Stampfer MJ., Hollis JB., Mucci LA., Gaziano JM., Dietary calcium, blood
pressure and cell Intakes of calcium and vitamin D and risk of
Lin J., Zhang SM., Cook NR., Manson JE., Lee IM., Intakes of calcium and
vitamin D and breast Lin J., Manson JE., Lee IM., Cook NR., Buring JE., Calcium supplementation
for 1 y does not reduce Lorenzen JK., Mølgaard C., Michaelsen KF., Astrup A.Preventing fractures
among older people living Lyons RA., Johansen A., Brophy S., Newcombe RG., Supplementation with
calcium + vitamin D Major GC., Alarie F., Doré J., Phouttama S., Tremblay Vitamin D
supplementation in Mallet E., Gügi B., Brunelle P., Hénocq A., Basuyau JP., Effect of calcium and
vitamin D supplementation Margolis KL., Ray RM., Van Horn L., Manson JE., Allison Dietary and serum
vitamins and minerals as Marniemi J., Alanen E., Impivaara O., Seppänen Calcium, vitamin D, and
risk of adenoma Martínez ME., Marshall JR., Sampliner R., Wilkinson J., Effect of calcium and
vitamin D supplementation Marya RK., Rathee S., Manrow M.Effect of vitamin D
supplementation during Marya RK., Rathee S., Dua V., Sangwan K.Vitamin D2 dose required
to rapidly increase 25OHD Mastaglia SR., Mautalen CA., Parisi MS., Oliveri B.Vitamin D supplements
enhance weight gain and Maxwell JD., Ang L., Brooke OG., Brown IR.Calcium, vitamin D, dairy
products, and risk of McCullough ML., Robertson AS., Rodriguez Dairy, calcium, and
vitamin D intake and McCullough ML., Rodriguez C., Diver WR., Feigelson 25-hydroxyvitamin D
levels and the risk of Melamed ML., Michos ED., Post W., Astor B.Dietary calcium and
vitamin D intakes in Mishra G., McCormack V., Kuh D., Hardy R., Stephen Dairy products, calcium
and prostate cancer risk.Koh KA., Sesso HD., Paffenbarger RS., Lee IM.Maternal 25-
hydroxyvitamin D and Morley R., Carlin JB., Pasco JA., Wark JD.Nutrient intake and
hypertensive disorders of Morris CD., Jacobson SL., Anand R., Ewell MG., Skeletal site-dependent
response of bone mineral A double-blind, randomized, placebo-
Nagpal J., Pande JN., Bhartia A.Supplements of 20
microg/d cholecalciferol Nelson ML., Blum JM., Hollis BW., Rosen C., Serum vitamin D
metabolite levels and the Nomura AM., Stemmermann GN., Lee J., Calcium and vitamin D
intakes in relation to risk Oh K., Willett WC., Wu K., Fuchs CS., Giovannucci EL.Diet during pregnancy and
risk of preeclampsia or Oken E., Ning Y., Rifas-Shiman SL., Rich-Edwards Plasma vitamin D and risk
of colorectal cancer: the Otani T., Iwasaki M., Sasazuki S., Inoue M., Calcium and vitamin D
intake and risk of Park SY., Murphy SP., Wilkens LR., Nomura AM., Calcium, dairy foods, and
risk of incident and fatal Park Y., Mitrou PN., Kipnis V., Hollenbeck A., Calcium, vitamin D, and
dairy product intake and Park SY., Murphy SP., Wilkens LR., Stram DO., Dairy food, calcium, and
risk of cancer in the NIH-Park Y., Leitzmann MF., Subar AF., Hollenbeck A., Effects of a short-term
vitamin D(3) and calcium Pfeifer M., Begerow B., Minne HW., Nachtigall D., Diet and risk of colorectal
cancer in a cohort of Pietinen P., Malila N., Virtanen M., Hartman TJ., Plasma 1,25-dihydroxy-
and 25-hydroxyvitamin D Platz EA., Hankinson SE., Hollis BW., Colditz GA., Effects of calcium
supplementation on body Reid IR., Horne A., Mason B., Ames R., Bava U., Calcium, dairy products,
and risk of prostate cancer Rodriguez C., McCullough ML., Mondul AM., Jacobs Meat and dairy
consumption and Rohrmann S., Platz EA., Kavanaugh CJ., Thuita L., Prospective evaluation of
dietary and other Ross RK., Yuan JM., Henderson BE., Park J., Serum parathyroid
hormone is associated Sambrook PN., Chen JS., March LM., Cameron ID., Animal products, calcium
and protein and prostate Schuurman AG., van den Brandt PA., Dorant E., Effect of winter oral
vitamin D3 Scragg R., Khaw KT., Murphy S.Intake of dairy products,
calcium, and vitamin d and Shin MH., Holmes MD., Hankinson SE., Wu K.,
20062006199320081990200920061997200219872003200520062008198620071992200620062006200820081996200819971987200220071995199820082008
Dietary intake of calcium, fiber and other
Shin A., Li H., Shu XO., Yang G., Gao YT., Zheng Vitamin D intake and the
risk for pancreatic cancer Skinner HG., Michaud DS., Giovannucci E., Willett Calcium intake and 28-
year gastro-intestinal Slob IC., Lambregts JL., Schuit AJ., Kok FJ.Supplementation with
cholecalciferol does not Sneve M., Figenschau Y., Jorde R.The influence of dairy and
nondairy calcium on Stemmermann GN., Nomura A., Chyou PH.Serum vitamin D and risk
of pancreatic cancer in the Stolzenberg-Solomon RZ., Hayes RB., Horst RL., A prospective nested case-
control study of vitamin D Stolzenberg-Solomon RZ., Vieth R., Azad A., Pietinen Serum levels of vitamin D
metabolites and the Tangrea J., Helzlsouer K., Pietinen P., Taylor P., Hollis Dietary calcium and
vitamin D intake and risk Terry P., Baron JA., Bergkvist L., Holmberg L., Dietary calcium intake and
blood pressure in Thomsen K., Nilas L., Christiansen C.Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.Dairy, calcium, and
vitamin D intakes and Tseng M., Breslow RA., Graubard BI., Ziegler RG.Dietary intake of calcium
in relation to mortality Umesawa M., Iso H., Date C., Yamamoto A., Dietary calcium intake and
risks of stroke, its Umesawa M., Iso H., Ishihara J., Saito I., Kokubo Oral calcium and blood
pressure: a controlled van Beresteyn EC., Schaafsma G., de Waard Childhood dairy intake and
adult cancer risk: 65-y van der Pols JC., Bain C., Gunnell D., Smith GD., Calcium intake and 28-
year cardiovascular and Van der Vijver LP., van der Waal MA., Weterings KG., Low serum concentrations
of 25-hydroxyvitamin D in Visser M., Deeg DJ., Puts MT., Seidell JC., Lips P.Calcium plus vitamin D
supplementation and the Wactawski-Wende J., Kotchen JM., Anderson GL., High-dose vitamin D3
supplementation in a Wagner CL., Hulsey TC., Fanning D., Ebeling M., Dietary intake of dairy
products, calcium, and Wang L., Manson JE., Buring JE., Lee IM., Sesso Vitamin D deficiency and
risk of cardiovascular Wang TJ., Pencina MJ., Booth SL., Jacques PF., Effect of longterm placebo
controlled calcium Weisgerber UM., Boeing H., Owen RW., Waldherr Is ischemic stroke risk
related to folate status or Weng LC., Yeh WT., Bai CH., Chen HJ., Chuang SY., Efficacy of
nonpharmacologic Whelton PK., Kumanyika SK., Cook NR., Cutler JA., Alcohol, physical activity
and other risk factors for Wu AH., Paganini-Hill A., Ross RK., Henderson BE.Calcium intake and risk of
colon cancer in women Wu K., Willett WC., Fuchs CS., Colditz GA., A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis Lack of blood pressure
effect with calcium and Yamamoto ME., Applegate WB., Klag MJ., Borhani NO., A prospective cohort study
of intake of calcium, Zheng W., Anderson KE., Kushi LH., Sellers TA., Effects of calcium and
vitamin D supplementation Zhu K., Devine A., Dick IM., Wilson SG., Prince RL.Randomized controlled
trial of the effects of Zhu K., Bruce D., Austin N., Devine A., Ebeling PR.,
Status NotesResults needs to
Men, Women
Name Emailleadlead Mei Chunglead nira hadarlead Ethan Balkleadleadlead Jens Japleadleadlead
User Role SRDR
Administrasrdr@ahrq.hhs.govmei_chun.chung@tuftnhadar@tuftsmedicalcebalk@tuftsmedicalceMeghan
Ingerickmeghan_ingerick@broAneesa
Motalaamotala@rand.orgjens_jap@brown.eduGaelen
Adamgaelen_adam@brown.Bryant
Smithsmith.bryantt@gmail.Sydne
Newberrysydnen@rand.org
Study ID:EF ID Creator Create Date PMID6304:194 admin Aug 18, 2013 Sep 5, 2014 185059676305:194 admin Aug 18, 2013 Sep 5, 2014 110758746306:194 admin Aug 18, 2013 Sep 5, 2014 126632776307:194 admin Aug 18, 2013 Sep 5, 2014 78928826308:194 admin Aug 18, 2013 Sep 5, 2014 162804276309:194 admin Aug 18, 2013 Sep 5, 2014 182086366313:194 admin Aug 18, 2013 Sep 5, 2014 97435116314:194 admin Aug 18, 2013 Sep 5, 2014 157673346315:194 admin Aug 18, 2013 Sep 5, 2014 161034506316:194 admin Aug 18, 2013 Sep 5, 2014 179650376317:194 admin Aug 18, 2013 Sep 5, 2014 186895596318:194 admin Aug 18, 2013 Sep 5, 2014 175359856319:194 admin Aug 18, 2013 Sep 5, 2014 181983946320:194 admin Aug 18, 2013 Sep 5, 2014 172438666321:194 admin Aug 18, 2013 Sep 5, 2014 188427716322:194 admin Aug 18, 2013 Sep 5, 2014 83334126323:194 admin Aug 18, 2013 Sep 5, 2014 99219606325:194 admin Aug 18, 2013 Sep 5, 2014 76128036326:194 admin Aug 18, 2013 Sep 5, 2014 187553196327:194 admin Aug 18, 2013 Sep 5, 2014 167979036328:194 admin Aug 18, 2013 Sep 5, 2014 176564206329:194 admin Aug 18, 2013 Sep 5, 2014 175025306330:194 admin Aug 18, 2013 Sep 5, 2014 115666566331:194 admin Aug 18, 2013 Sep 5, 2014 190016016333:194 admin Aug 18, 2013 Sep 5, 2014 162804476334:194 admin Aug 18, 2013 Sep 5, 2014 152130386335:194 admin Aug 18, 2013 Sep 5, 2014 82200926336:194 admin Aug 18, 2013 Sep 5, 2014 86824536337:194 admin Aug 18, 2013 Sep 5, 2014 88906616338:194 admin Aug 18, 2013 Sep 5, 2014 171895526339:194 admin Aug 18, 2013 Sep 5, 2014 162782626340:194 admin Aug 18, 2013 Sep 5, 2014 80781156341:194 admin Aug 18, 2013 Sep 5, 2014 153424526342:194 admin Aug 18, 2013 Sep 5, 2014 156684856344:194 admin Aug 18, 2013 Sep 5, 2014 173720316345:194 admin Aug 18, 2013 Sep 5, 2014 188386236346:194 admin Aug 18, 2013 Sep 5, 2014 179715266347:194 admin Aug 18, 2013 Sep 5, 2014 183814726348:194 admin Aug 18, 2013 Sep 5, 2014 90612756349:194 admin Aug 18, 2013 Sep 5, 2014 173110576350:194 admin Aug 18, 2013 Sep 5, 2014 88502736351:194 admin Aug 18, 2013 Sep 5, 2014 28573646352:194 admin Aug 18, 2013 Sep 5, 2014 25729006353:194 admin Aug 18, 2013 Sep 5, 2014 74936596356:194 admin Aug 18, 2013 Sep 5, 2014 146522386357:194 admin Aug 18, 2013 Sep 5, 2014 172279966358:194 admin Aug 18, 2013 Sep 5, 2014 10511329
Last Updated
6359:194 admin Aug 18, 2013 Sep 5, 2014 156712226360:194 admin Aug 18, 2013 Sep 5, 2014 162865196361:194 admin Aug 18, 2013 Sep 5, 2014 145539576362:194 admin Aug 18, 2013 Sep 5, 2014 124993436363:194 admin Aug 18, 2013 Sep 5, 2014 94050296364:194 admin Aug 18, 2013 Sep 5, 2014 39462956369:194 admin Aug 18, 2013 Sep 5, 2014 152258336370:194 admin Aug 18, 2013 Sep 5, 2014 116417506371:194 admin Aug 18, 2013 Sep 5, 2014 174421306372:194 admin Aug 18, 2013 Sep 5, 2014 82014446373:194 admin Aug 18, 2013 Sep 5, 2014 175528806374:194 admin Aug 18, 2013 Sep 5, 2014 82055386375:194 admin Aug 18, 2013 Sep 5, 2014 93438376376:194 admin Aug 18, 2013 Sep 5, 2014 86107046377:194 admin Aug 18, 2013 Sep 5, 2014 158805326378:194 admin Aug 18, 2013 Sep 5, 2014 175361916379:194 admin Aug 18, 2013 Sep 5, 2014 171064376380:194 admin Aug 18, 2013 Sep 5, 2014 183980336381:194 admin Aug 18, 2013 Sep 5, 2014 192211906382:194 admin Aug 18, 2013 Sep 5, 2014 153541506383:194 admin Aug 18, 2013 Sep 5, 2014 175566976384:194 admin Aug 18, 2013 Sep 5, 2014 184333056385:194 admin Aug 18, 2013 Sep 5, 2014 165229156386:194 admin Aug 18, 2013 Sep 5, 2014 165229156387:194 admin Aug 18, 2013 Sep 5, 2014 183322896388:194 admin Aug 18, 2013 Sep 5, 2014 190565696389:194 admin Aug 18, 2013 Sep 5, 2014 173886676390:194 admin Aug 18, 2013 Sep 5, 2014 85579656391:194 admin Aug 18, 2013 Sep 5, 2014 158002686392:194 admin Aug 18, 2013 Sep 5, 2014 175332086393:194 admin Aug 18, 2013 Sep 5, 2014 164000446394:194 admin Aug 18, 2013 Sep 5, 2014 174739116395:194 admin Aug 18, 2013 Sep 5, 2014 172091776396:194 admin Aug 18, 2013 Sep 5, 2014 37555176397:194 admin Aug 18, 2013 Sep 5, 2014 188246626398:194 admin Aug 18, 2013 Sep 5, 2014 159554676399:194 admin Aug 18, 2013 Sep 5, 2014 120201026401:194 admin Aug 18, 2013 Sep 5, 2014 36232606402:194 admin Aug 18, 2013 Sep 5, 2014 32436096403:194 admin Aug 18, 2013 Sep 5, 2014 163915876404:194 admin Aug 18, 2013 Sep 5, 2014 67930586405:194 admin Aug 18, 2013 Sep 5, 2014 127087196406:194 admin Aug 18, 2013 Sep 5, 2014 163650076407:194 admin Aug 18, 2013 Sep 5, 2014 186950766408:194 admin Aug 18, 2013 Sep 5, 2014 188278116409:194 admin Aug 18, 2013 Sep 5, 2014 171064376410:194 admin Aug 18, 2013 Sep 5, 2014 163526846411:194 admin Aug 18, 2013 Sep 5, 2014 11262466
6412:194 admin Aug 18, 2013 Sep 5, 2014 171818906413:194 admin Aug 18, 2013 Sep 5, 2014 191257566414:194 admin Aug 18, 2013 Sep 5, 2014 191582266415:194 admin Aug 18, 2013 Sep 5, 2014 97941756416:194 admin Aug 18, 2013 Sep 5, 2014 173796166417:194 admin Aug 18, 2013 Sep 5, 2014 175219216418:194 admin Aug 18, 2013 Sep 5, 2014 176222446419:194 admin Aug 18, 2013 Sep 5, 2014 172153806420:194 admin Aug 18, 2013 Sep 5, 2014 180000206421:194 admin Aug 18, 2013 Sep 5, 2014 179252836422:194 admin Aug 18, 2013 Sep 5, 2014 192377246423:194 admin Aug 18, 2013 Sep 5, 2014 112975966424:194 admin Aug 18, 2013 Sep 5, 2014 105306086425:194 admin Aug 18, 2013 Sep 5, 2014 110457886428:194 admin Aug 18, 2013 Sep 5, 2014 158271036429:194 admin Aug 18, 2013 Sep 5, 2014 128693976430:194 admin Aug 18, 2013 Sep 5, 2014 173153196431:194 admin Aug 18, 2013 Sep 5, 2014 92364166432:194 admin Aug 18, 2013 Sep 5, 2014 155315006433:194 admin Aug 18, 2013 Sep 5, 2014 103621256434:194 admin Aug 18, 2013 Sep 5, 2014 74981006435:194 admin Aug 18, 2013 Sep 5, 2014 122088956436:194 admin Aug 18, 2013 Sep 5, 2014 170197166437:194 admin Aug 18, 2013 Sep 5, 2014 169850316438:194 admin Aug 18, 2013 Sep 5, 2014 84781446439:194 admin Aug 18, 2013 Sep 5, 2014 190569006441:194 admin Aug 18, 2013 Sep 5, 2014 192088426442:194 admin Aug 18, 2013 Sep 5, 2014 170470876443:194 admin Aug 18, 2013 Sep 5, 2014 92424786444:194 admin Aug 18, 2013 Nov 6, 2013 124671336445:194 admin Aug 18, 2013 Sep 5, 2014 33073076446:194 admin Aug 18, 2013 Sep 5, 2014 126099406447:194 admin Aug 18, 2013 Sep 5, 2014 158834416450:194 admin Aug 18, 2013 Sep 5, 2014 163394766451:194 admin Aug 18, 2013 Sep 5, 2014 186358556452:194 admin Aug 18, 2013 Sep 5, 2014 37888356453:194 admin Aug 18, 2013 Sep 5, 2014 180655926455:194 admin Aug 18, 2013 Sep 5, 2014 169601776456:194 admin Aug 18, 2013 Sep 5, 2014 164816366457:194 admin Aug 18, 2013 Sep 5, 2014 176615656459:194 admin Aug 18, 2013 Sep 5, 2014 181803956460:194 admin Aug 18, 2013 Sep 5, 2014 86750936461:194 admin Aug 18, 2013 Sep 5, 2014 189889096462:194 admin Aug 18, 2013 Sep 5, 2014 90225616463:194 admin Aug 18, 2013 Sep 5, 2014 36203146464:194 admin Aug 18, 2013 Sep 5, 2014 119043166465:194 admin Aug 18, 2013 Sep 5, 2014 176238016466:194 admin Aug 18, 2013 Sep 5, 2014 7795837
6467:194 admin Aug 18, 2013 Sep 5, 2014 95214376468:194 admin Aug 18, 2013 Sep 5, 2014 180897016469:194 admin Aug 18, 2013 Sep 5, 2014 18410225
Alt ID(s) Title Year Author20082000200319952005200819982005200520082008200720082007200819931999199520082006200720072001200820052004-- Not Found ---- Not Found --1996200620061994200420052007200820072008199620081996198519891995200320071999
Serum vitamin D concentration and
Ahn J., Peters U., Albanes D., Purdue MP., Abnet CC., Prostate cancer risk and
prediagnostic serum 25-Ahonen MH., Tenkanen L., Teppo L., Hakama M., A prospective study of
calcium intake from diet Al-Delaimy WK., Rimm E., Willett WC., Stampfer MJ., The influence of
menopause and hormonal Aloia JF., Vaswani A., Russo L., Sheehan M., Low-fat dairy consumption
and reduced risk of Alonso A., Beunza JJ., Delgado-Rodríguez M., Effect of vitamin D
supplementation on bone Andersen R., Mølgaard C., Skovgaard LT., Brot C., Intake of potassium,
magnesium, calcium, and Ascherio A., Rimm EB., Hernán MA., Giovannucci Risk of prostate cancer in
a randomized clinical trial Baron JA., Beach M., Wallace K., Grau MV., Plasma 25-hydroxyvitamin
D and 1,25-Bertone-Johnson ER., Chen WY., Holick MF., Hollis BW., Vitamin D
supplementation has Björkman M., Sorva A., Risteli J., Tilvis R.Body size and serum 25
hydroxy vitamin D Blum M., Dallal GE., Dawson-Hughes B.Maternal vitamin D
deficiency increases the Bodnar LM., Catov JM., Simhan HN., Holick MF., Vascular events in healthy
older women receiving Bolland MJ., Barber PA., Doughty RN., Mason B., Two-year randomized
controlled trial of vitamin Bolton-Smith C., McMurdo ME., Paterson CR., Mole Dairy calcium
supplementation in Bortolotti M., Rudelle S., Schneiter P., Vidal H., Relation of calcium,
vitamin D, and dairy food Bostick RM., Potter JD., Sellers TA., McKenzie DR., Relation of calcium,
vitamin D, and dairy food Bostick RM., Kushi LH., Wu Y., Meyer KA., Sellers TA., Prostate cancer and
prediagnostic levels of Braun MM., Helzlsouer KJ., Hollis BW., Comstock GW.Calcium, vitamin D
supplementation, and Brunner RL., Cochrane B., Jackson RD., Larson J., Effects of vitamin D
supplementation and Bunout D., Barrera G., Leiva L., Gattas V., de la Does vitamin D stop
inpatients falling? A Burleigh E., McColl J., Potter J.Calcium plus vitamin D
supplementation and the Caan B., Neuhouser M., Aragaki A., Lewis CB., Dairy products, calcium,
and prostate cancer risk in Chan JM., Stampfer MJ., Ma J., Gann PH., Gaziano JM., Calcium plus vitamin D
supplementation and the Chlebowski RT., Johnson KC., Kooperberg C., Effects of calcium, dairy
product, and vitamin D Cheng S., Lyytikäinen A., Kröger H., Lamberg-Allardt Weight loss and calcium
intake influence calcium Cifuentes M., Riedt CS., Brolin RE., Field MP., Vitamin D and prostate
cancer: a prediagnostic Corder EH., Guess HA., Hulka BS., Friedman GD., Calcium chemoprevention
in colorectal cancer.Duris I., Hruby D., Pekarkova B., Huorka M., Dietary calcium, alcohol,
and incidence of treated Dwyer JH., Li L., Dwyer KM., Curtin LR., Feinleib M.Effect of 1-year dairy
product intervention on fat Eagan MS., Lyle RM., Gunther CW., Peacock M., Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J., Seasonal and geographical
variations in the growth Feliciano ES., Ho ML., Specker BL., Falciglia G., Plasma vitamin D
metabolites and risk of Feskanich D., Ma J., Fuchs CS., Kirkner GJ., Hankinson Calcium from diet and
supplements is associated Flood A., Peters U., Chatterjee N., Lacey JV., Plasma 25-hydroxyvitamin
D levels and risk of Forman JP., Giovannucci E., Holmes MD., Bischoff-Plasma 25-hydroxyvitamin
D levels and risk of Forman JP., Curhan GC., Taylor EN.Prospective study of
serum vitamin D and Freedman DM., Looker AC., Chang SC., Graubard Serum levels of vitamin D
metabolites and breast Freedman DM., Chang SC., Falk RT., Purdue MP., Dietary factors and risk of
colon cancer: a Gaard M., Tretli S., Løken EB.Maternal vitamin D status
during pregnancy and Gale CR., Robinson SM., Harvey NC., Javaid MK., Circulating vitamin D
metabolites in relation to Gann PH., Ma J., Hennekens CH., Hollis Dietary vitamin D and
calcium and risk of Garland C., Shekelle RB., Barrett-Connor E., Criqui Serum 25-hydroxyvitamin
D and colon cancer: eight-Garland CF., Comstock GW., Garland FC., Helsing The influence of dairy
products on plasma uric Ghadirian P., Shatenstein B., Verdy M., Hamet P.Vitamin D, calcium
supplementation, and Grau MV., Baron JA., Sandler RS., Haile RW., Prolonged effect of
calcium supplementation Grau MV., Baron JA., Sandler RS., Wallace K., Plasma 25-hydroxyvitamin
D responses of younger Harris SS., Dawson-Hughes B., Perrone GA.
2005200520032003199719862004200120071994200819941997199620052007200620082009200420072008200620062008200920071995 Lijnen P., Petrov V.20052007200620072007198620082005200219871988200619812003200520082008200620062001
The association of calcium and vitamin D with risk of
Hartman TJ., Albert PS., Snyder K., Slattery ML., The impact of calcium and
dairy product consumption Harvey-Berino J., Gold BC., Lauber R., Starinski A.Gestational calcium
supplementation and Hatton DC., Harrison-Hohner J., Coste S., Reller Human serum 25-
hydroxycholecalciferol Heaney RP., Davies KM., Chen TC., Holick MF., Long-term vitamin D3
supplementation may Heikkinen AM., Tuppurainen MT., Colon cancer and dietary
fat, phosphorus, and Heilbrun LK., Hankin JH., Nomura AM., Plasma levels of 25-
hydroxyvitamin D, 1,25-Jacobs ET., Giuliano AR., Martínez ME., Hollis BW., Prospective study on milk
products, calcium and Järvinen R., Knekt P., Hakulinen T., Aromaa A.Nutritional status and
subsequent all-cause Jia X., Aucott LS., McNeill G.Dietary intakes,
anthropometric Johnson AA., Knight EM., Edwards CH., Oyemade Calcium intake and the
outcome of short-term Kabrnová-Hlavatá K., Hainer V., Gojová M., Fermented dairy products,
calcium, and colorectal Kampman E., Goldbohm RA., van den Brandt PA., Prospective study of diet
and female colorectal Kato I., Akhmedkhanov A., Koenig K., Toniolo PG., Calcium, vitamin D, and
dairy foods and the Kearney J., Giovannucci E., Rimm EB., Ascherio A., Dietary calcium,
phosphorus, vitamin D, Kesse E., Boutron-Ruault MC., Norat T., Riboli E., Dairy products, calcium
and the risk of breast Kesse-Guyot E., Bertrais S., Duperray B., Arnault N., Dairy products, calcium
and prostate cancer risk.Koh KA., Sesso HD., Paffenbarger RS., Lee IM.Dairy product, saturated
fatty acid, and calcium Kurahashi N., Inoue M., Iwasaki M., Sasazuki S., Calcium plus vitamin D
supplementation and LaCroix AZ., Kotchen J., Anderson G., Brzyski R., Girls on a high-calcium
diet gain weight at the Lappe JM., Rafferty KA., Davies KM., Lypaczewski Vitamin D and calcium
supplementation reduces Lappe JM., Travers-Gustafson D., Davies KM., Calcium and vitamin d
supplementation Lappe J., Cullen D., Haynatzki G., Recker R., Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci Magnesium, calcium,
potassium, and sodium Larsson SC., Virtanen MJ., Mars M., Männistö S., Long-term dietary calcium
intake and breast cancer Larsson SC., Bergkvist L., Wolk A.A prospective study of
plasma vitamin D Li H., Stampfer MJ., Hollis JB., Mucci LA., Gaziano JM., Dietary calcium, blood
pressure and cell Intakes of calcium and vitamin D and risk of
Lin J., Zhang SM., Cook NR., Manson JE., Lee IM., Intakes of calcium and
vitamin D and breast Lin J., Manson JE., Lee IM., Cook NR., Buring JE., Calcium supplementation
for 1 y does not reduce Lorenzen JK., Mølgaard C., Michaelsen KF., Astrup A.Preventing fractures
among older people living Lyons RA., Johansen A., Brophy S., Newcombe RG., Supplementation with
calcium + vitamin D Major GC., Alarie F., Doré J., Phouttama S., Tremblay Vitamin D
supplementation in Mallet E., Gügi B., Brunelle P., Hénocq A., Basuyau JP., Effect of calcium and
vitamin D supplementation Margolis KL., Ray RM., Van Horn L., Manson JE., Allison Dietary and serum
vitamins and minerals as Marniemi J., Alanen E., Impivaara O., Seppänen Calcium, vitamin D, and
risk of adenoma Martínez ME., Marshall JR., Sampliner R., Wilkinson J., Effect of calcium and
vitamin D supplementation Marya RK., Rathee S., Manrow M.Effect of vitamin D
supplementation during Marya RK., Rathee S., Dua V., Sangwan K.Vitamin D2 dose required
to rapidly increase 25OHD Mastaglia SR., Mautalen CA., Parisi MS., Oliveri B.Vitamin D supplements
enhance weight gain and Maxwell JD., Ang L., Brooke OG., Brown IR.Calcium, vitamin D, dairy
products, and risk of McCullough ML., Robertson AS., Rodriguez Dairy, calcium, and
vitamin D intake and McCullough ML., Rodriguez C., Diver WR., Feigelson 25-hydroxyvitamin D
levels and the risk of Melamed ML., Michos ED., Post W., Astor B.Dietary calcium and
vitamin D intakes in Mishra G., McCormack V., Kuh D., Hardy R., Stephen Dairy products, calcium
and prostate cancer risk.Koh KA., Sesso HD., Paffenbarger RS., Lee IM.Maternal 25-
hydroxyvitamin D and Morley R., Carlin JB., Pasco JA., Wark JD.Nutrient intake and
hypertensive disorders of Morris CD., Jacobson SL., Anand R., Ewell MG.,
2006 Moschonis G., Manios Y.20092009199820072007200720072007200720092001199920002005200320071997200419991995200220062006199320082009200619972002198720032005200620081986200720062006200620081996200819971987200220071995
Skeletal site-dependent response of bone mineral A double-blind, randomized, placebo-
Nagpal J., Pande JN., Bhartia A.Supplements of 20
microg/d cholecalciferol Nelson ML., Blum JM., Hollis BW., Rosen C., Serum vitamin D
metabolite levels and the Nomura AM., Stemmermann GN., Lee J., Calcium and vitamin D
intakes in relation to risk Oh K., Willett WC., Wu K., Fuchs CS., Giovannucci EL.Diet during pregnancy and
risk of preeclampsia or Oken E., Ning Y., Rifas-Shiman SL., Rich-Edwards Plasma vitamin D and risk
of colorectal cancer: the Otani T., Iwasaki M., Sasazuki S., Inoue M., Calcium and vitamin D
intake and risk of Park SY., Murphy SP., Wilkens LR., Nomura AM., Calcium, dairy foods, and
risk of incident and fatal Park Y., Mitrou PN., Kipnis V., Hollenbeck A., Calcium, vitamin D, and
dairy product intake and Park SY., Murphy SP., Wilkens LR., Stram DO., Dairy food, calcium, and
risk of cancer in the NIH-Park Y., Leitzmann MF., Subar AF., Hollenbeck A., Effects of a short-term
vitamin D(3) and calcium Pfeifer M., Begerow B., Minne HW., Nachtigall D., Diet and risk of colorectal
cancer in a cohort of Pietinen P., Malila N., Virtanen M., Hartman TJ., Plasma 1,25-dihydroxy-
and 25-hydroxyvitamin D Platz EA., Hankinson SE., Hollis BW., Colditz GA., Effects of calcium
supplementation on body Reid IR., Horne A., Mason B., Ames R., Bava U., Calcium, dairy products,
and risk of prostate cancer Rodriguez C., McCullough ML., Mondul AM., Jacobs Meat and dairy
consumption and Rohrmann S., Platz EA., Kavanaugh CJ., Thuita L., Prospective evaluation of
dietary and other Ross RK., Yuan JM., Henderson BE., Park J., Serum parathyroid
hormone is associated Sambrook PN., Chen JS., March LM., Cameron ID., Animal products, calcium
and protein and prostate Schuurman AG., van den Brandt PA., Dorant E., Effect of winter oral
vitamin D3 Scragg R., Khaw KT., Murphy S.Intake of dairy products,
calcium, and vitamin d and Shin MH., Holmes MD., Hankinson SE., Wu K., Dietary intake of calcium,
fiber and other Shin A., Li H., Shu XO., Yang G., Gao YT., Zheng Vitamin D intake and the
risk for pancreatic cancer Skinner HG., Michaud DS., Giovannucci E., Willett Calcium intake and 28-
year gastro-intestinal Slob IC., Lambregts JL., Schuit AJ., Kok FJ.Supplementation with
cholecalciferol does not Sneve M., Figenschau Y., Jorde R.Serum vitamin D and risk
of pancreatic cancer in the Stolzenberg-Solomon RZ., Hayes RB., Horst RL., A prospective nested case-
control study of vitamin D Stolzenberg-Solomon RZ., Vieth R., Azad A., Pietinen Serum levels of vitamin D
metabolites and the Tangrea J., Helzlsouer K., Pietinen P., Taylor P., Hollis Dietary calcium and
vitamin D intake and risk Terry P., Baron JA., Bergkvist L., Holmberg L., Dietary calcium intake and
blood pressure in Thomsen K., Nilas L., Christiansen C.Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.Dairy, calcium, and
vitamin D intakes and Tseng M., Breslow RA., Graubard BI., Ziegler RG.Dietary intake of calcium
in relation to mortality Umesawa M., Iso H., Date C., Yamamoto A., Dietary calcium intake and
risks of stroke, its Umesawa M., Iso H., Ishihara J., Saito I., Kokubo Oral calcium and blood
pressure: a controlled van Beresteyn EC., Schaafsma G., de Waard Childhood dairy intake and
adult cancer risk: 65-y van der Pols JC., Bain C., Gunnell D., Smith GD., Low serum concentrations
of 25-hydroxyvitamin D in Visser M., Deeg DJ., Puts MT., Seidell JC., Lips P.Calcium plus vitamin D
supplementation and the Wactawski-Wende J., Kotchen JM., Anderson GL., High-dose vitamin D3
supplementation in a Wagner CL., Hulsey TC., Fanning D., Ebeling M., Vitamin D deficiency and
risk of cardiovascular Wang TJ., Pencina MJ., Booth SL., Jacques PF., Effect of longterm placebo
controlled calcium Weisgerber UM., Boeing H., Owen RW., Waldherr Is ischemic stroke risk
related to folate status or Weng LC., Yeh WT., Bai CH., Chen HJ., Chuang SY., Efficacy of
nonpharmacologic Whelton PK., Kumanyika SK., Cook NR., Cutler JA., Alcohol, physical activity
and other risk factors for Wu AH., Paganini-Hill A., Ross RK., Henderson BE.Calcium intake and risk of
colon cancer in women Wu K., Willett WC., Fuchs CS., Colditz GA., A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis Lack of blood pressure
effect with calcium and Yamamoto ME., Applegate WB., Klag MJ., Borhani NO.,
199820082008
A prospective cohort study of intake of calcium,
Zheng W., Anderson KE., Kushi LH., Sellers TA., Effects of calcium and
vitamin D supplementation Zhu K., Devine A., Dick IM., Wilson SG., Prince RL.Randomized controlled
trial of the effects of Zhu K., Bruce D., Austin N., Devine A., Ebeling PR.,
Inclusion Exclusion
1986 SUBVALUE()RCT SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() NIH SUBVALUE()
RCT SUBVALUE() nd SUBVALUE() nd SUBVALUE()1986 SUBVALUE()
nd SUBVALUE()Gov SUBVALUE()
RCT SUBVALUE() nd SUBVALUE()nd SUBVALUE() nd SUBVALUE() NIH SUBVALUE()
nd SUBVALUE() NIH SUBVALUE()RCT SUBVALUE()RCT SUBVALUE() nd SUBVALUE() nd SUBVALUE()RCT SUBVALUE() nd SUBVALUE() nd SUBVALUE()
1986 SUBVALUE() NCI SUBVALUE()1986 SUBVALUE() NCI SUBVALUE()1974 SUBVALUE()
nd SUBVALUE() WHI SUBVALUE()RCT SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()RCT SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()RCT SUBVALUE() none SUBVALUE() WHI SUBVALUE() Govt SUBVALUE()
nd SUBVALUE() 1995 SUBVALUE()WHI SUBVALUE() Gov SUBVALUE()
RCT SUBVALUE() nd SUBVALUE() nd SUBVALUE()RCT SUBVALUE() nd SUBVALUE() NIH SUBVALUE()
nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()nd SUBVALUE()
nd SUBVALUE() nd SUBVALUE()RCT SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()RCT SUBVALUE() - SUBVALUE()
1976 SUBVALUE() nd SUBVALUE()
AHA SUBVALUE()nd SUBVALUE() 1989 SUBVALUE()
NIH SUBVALUE()NHSS SUBVALUE() nd SUBVALUE()
nd SUBVALUE() - SUBVALUE()nd SUBVALUE() NIH SUBVALUE()
nd SUBVALUE()RCT SUBVALUE() 1994 SUBVALUE() none SUBVALUE()
nd SUBVALUE() 1988 SUBVALUE() nd SUBVALUE()RCT SUBVALUE()RCT SUBVALUE() nd SUBVALUE() - SUBVALUE() USDA SUBVALUE()
Study Design
Enrollment Years
Trial or Cohort
Funding SourceCase-cohort study
SUBVALUE()Non-Hispanic white males, at
No prior history of prostate cancer
1993-2001 SUBVALUE()
Prostate, Lung, Colorectal, and
NIH: National Cancer Institute, Case-cohort study
SUBVALUE()Employees in two Finnish
Previously clinically detected
1981-1982 SUBVALUE()
Helsinki Heart Study SUBVALUE()
Finnish Cancer Foundation, Yrjo Cohort Study
SUBVALUE()Men, 40-75 y, health
Kcal intake outside 800-4200
Health Professionals
Gov t SUBVALUE()Healthy white
women between 6 Cohort Study SUBVALUE()
University graduates or
History of CVD, cancer, DM,
12/99-1/2002 SUBVALUE()
U Navarra Follow-up Study
Govt, University SUBVALUE()General Pakistani
immigrants Medications known to affect
Jan 2002 to Nov 2002 SUBVALUE()Cohort study
SUBVALUE()Male health professionals, 40-
Calorie intake <800 or
Health Professionals
Gov t SUBVALUE()RCT-post hoc (Ca
suppl) Cohort Men Details were referred to original
1988 (mentioned) 1992 (inferred)
From Baron NEJM 1999 paper:
NCI and GlaxoSmithKlein Case-cohort study
SUBVALUE()43 to 69 years old female registered
Those who had cancer before
Original cohort 1976 Study cohort
Nurses health study SUBVALUE()Age 65 years,
chronically Markedly elevated creatinine levels
September to December 2005
A special governmental 2 /subgroup
analysis of an healthy 65 y; subgroup from a
conditions/medications Nested case-
control study nulliparity; no preexisting
1997-2001 SUBVALUE()
Pregnancy Exposures & Postmenopausal
>5 yr, age 55 y, Osteoporosis treatment, Ca
~2000 SUBVALUE()
Same as Reid 2005 SUBVALUE()
Govt (suppl supplied by Healthy women
60 years of age Clinical osteoporosis or
UK Food Standards Agency BMI > 27, Ca
intakes < 800 BMI < 27, high intake of Ca
Nestec SA, Switzerland Cohort study
SUBVALUE()Women aged 55-69 Resided in
Hx of cancer (excl. skin cancer)
Iowa Women s Health Study Cohort study
SUBVALUE()Women 55-69 y, post-menstrual
Ischemic heart disease,
Iowa Women s Health Study Case-cohort study
SUBVALUE()Resident of Washington
None (implied) SUBVALUE()
(Washington County)
nd Corresponding/leaRCT-post hoc**
SUBVALUE()Postmenopausal women (50 to 79
1993-1998 SUBVALUE()
NIH, National Heart, Lung and Subjects with a
serum vitamin D Patients were aged 65 years or
Subjects with hypercalcemica, Women 50-79 y,
postmenopausal 1994-1999 SUBVALUE()Cohort
SUBVALUE()Male physicians, subjects who
Physician s Health Study
The CaP Cure Young Investigator RCT Case-cohort
study SUBVALUE()Post menopausal enrolled in WHI
Women with h/o hypercalcemia,
Until March 2005 SUBVALUE()10-12 y old girls;
Tanner 1 to 2; serious medical conditions;
government and industry Weight-stable,
overweight, post-Women with disease states,
2000-2003 SUBVALUE()Case-cohort study
SUBVALUE()Ambulatory, generally healthy
Orientals excluded (for
Vit D screening 1964-71 Cancer
(Kaiser Permanente)
NCI National MS Society Other intervention
study SUBVALUE()Patients with adenomatous
Group with polyps: nd Patients with Cohort study
SUBVALUE()NHANES I 25-74 yo White or black.
HTN at baseline SUBVALUE()
1971-75 SUBVALUE()
NHANES I SUBVALUE()RCT-post hoc**
SUBVALUE()Calcium intakes <800mg/d and
> 20% overweight or 15%
Dairy Management, Inc. 10-17yr girls in
four schools from 2001-2002 SUBVALUE()37 wk gestation
SUBVALUE()gastrointestinal disease;
Fall 1986; Spring 1987 SUBVALUE()
non-profit SUBVALUE()Case-cohort study
SUBVALUE()Ongoing cohort study with
Previous non-cutaneous cancer
Nurses Health Study SUBVALUE()Cohort study
SUBVALUE()Women found to or not to have
Failed to complete dietary
1973-1980 SUBVALUE()
The Breast Cancer Detection
NCI and American Cancer Society Cohort study
SUBVALUE()-participant of HPFS or NHS who
-Cases from case-control studies
NHS: 1990 1998 HPFS: 1994 - 2002
Health Professionals Case-cohort study
SUBVALUE()Fasting for 8 hours; no
Nurses Health Study 2
American Heart Association & Cohort study
SUBVALUE()Noninstitutionalized US population,
No 25(OH)D measurement
1988-1994 SUBVALUE()
NHANES III SUBVALUE()
NIH/NCI, USPHS/DHHS Case-cohort study
SUBVALUE()Cases: All participants of
History of one of the four PLCO
November 1993 and July 2001
Prostate, Lung, Colorectal, and Cohort study
SUBVALUE()Attended NHSS health screening
Previous cancer (n=617)
1977-1983 SUBVALUE()Cohort study
SUBVALUE()Caucasian women 16 y; singleton
1991-92 SUBVALUE()
non-profit SUBVALUE()Case-cohort study
SUBVALUE()US male physicians
Prior history of MI, stroke, TIA,
Physicians Health Study Cohort study
SUBVALUE()Randomly selected from the
Age at first examination less
1957-1958 SUBVALUE()
Western Electric Health Study
American heart association Case-cohort study
SUBVALUE()Community volunteer cohort
Cases: Non-white cases Previous
1974 (Sep-Nov) SUBVALUE()
NCI, The Dairy Bureau of Canada, Post-menopausal
nuns 50 y Acute illness, medical
Dairy Bureau SUBVALUE()Post hoc analysis
of an existing RCT Subjects had at least one
Calcium Polyp Prevention Study Subjects had at
least one Subjects diet during Calcium
1988-1992 SUBVALUE()
Calcium Polyp Prevention Study
National Institute of Health men 20-35 y or
60-75 y travel to southern areas in last
nd SUBVALUE()RCT SUBVALUE() nd SUBVALUE() nd SUBVALUE()RCT SUBVALUE() 1996 SUBVALUE()RCT SUBVALUE() nd SUBVALUE() - SUBVALUE()RCT SUBVALUE()
nd SUBVALUE()nd SUBVALUE()nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()
nd SUBVALUE() nd SUBVALUE()nd SUBVALUE() nd SUBVALUE()nd SUBVALUE() none SUBVALUE()1986 SUBVALUE()
NCI SUBVALUE()1986 SUBVALUE()1990 SUBVALUE()
Gov SUBVALUE()
WHI SUBVALUE()nd SUBVALUE() - SUBVALUE()
RCT SUBVALUE() nd SUBVALUE() none SUBVALUE() nd SUBVALUE()RCT SUBVALUE() nd SUBVALUE() nd SUBVALUE()
RCT SUBVALUE() none SUBVALUE() None SUBVALUE()
RCT SUBVALUE() nd SUBVALUE() nd SUBVALUE() - SUBVALUE()RCT SUBVALUE() nd SUBVALUE()RCT SUBVALUE() nd SUBVALUE() none SUBVALUE()RCT SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()RCT SUBVALUE() WHI SUBVALUE() NIH SUBVALUE()
nd SUBVALUE()nd SUBVALUE() NCI SUBVALUE()
RCT SUBVALUE() nd SUBVALUE() nd SUBVALUE() - SUBVALUE() nd SUBVALUE()RCT SUBVALUE() nd SUBVALUE() - SUBVALUE() nd SUBVALUE()RCT SUBVALUE() - SUBVALUE()RCT SUBVALUE() nd SUBVALUE() nd SUBVALUE() - SUBVALUE()
nd SUBVALUE()nd SUBVALUE()
Gov SUBVALUE()NIH SUBVALUE()
- SUBVALUE()nd SUBVALUE() nd SUBVALUE()
Cohort study Participants are
Subjects 35 yr with 1 or more
Subjects must not have had resected
1991-1994 SUBVALUE()
The Polyp Prevention Trial Age 18 to 60
years, BMI History of major medical or
National Dairy Council, Northeast Completed CPEP
trial protocol; in CKD, calciuria, hematuria,
Calcium for Prevention of
GSK NIH SUBVALUE()men in good
general health, vitamin supplement
Health Future Foundation 47-56 yo women,
Last menstrual Contraindications for HRT
>=1989 SUBVALUE()
Kuopio Osteoporosis Risk
Schering, Professional Case-cohort study
SUBVALUE()Japanese men living on the Oahu
Food intake determined by a
1965-1968 SUBVALUE()
NCI/NIH SUBVALUE()Case-cohort study
SUBVALUE()Caucasian, male SUBVALUE()
1983, 1989 SUBVALUE()
Nutritional Prevention of
National Cancer Institute Cohort study
SUBVALUE()Participant of a large-scale health
1966-1972 SUBVALUE()Cohort study
SUBVALUE()75 y or older SUBVALUE()
Terminal illness Severe dementia
1999-2000 SUBVALUE()Cohort study
SUBVALUE()African American women; 16-35 y;
DM, sickle cell, thalassemia, Hb C
NICHD SUBVALUE()Other intervention
study SUBVALUE()-overweight or obese -female
-diabetes -uncompensated
Supported by grants IGA Cohort study
SUBVALUE()Age 55 to 69 participant of
History of cancer (excluding skin
Netherlands Cohort Study on
Netherlands Digestive Cohort study
SUBVALUE()Women breast exam participants
Prior colorectal cancer (n=58) 8
1985-1991 SUBVALUE()
New York Univ. Women s Health Cohort study
SUBVALUE()Male health professionals Age
Implausibly high (4200-)/low (-800)
The Health Professionals
American Cancer Society, NIH, Cohort study
SUBVALUE()Women living in France, aged 40 to
Subjects who had reported a cancer
Etude Epid miologique aupr s
French League against Cancer, RCT-post hoc
(cohort follow-up 12741 subjects enrolled in the
Subjects with a recent cancer
1994-1995 SUBVALUE()
SU.VI.MAX trial SUBVALUE()Cohort study
SUBVALUE()Harvard male undergraduates
baseline cancer or no data on dairy
1960 s SUBVALUE()
Harvard Alumni Health Study
government SUBVALUE()Cohort study
SUBVALUE()Male Japanese residents age 40-
History of prostate cancer, extreme
Cohort I launched in 1990, Cohort II
Japan Public Health Center-
Japanese Ministry of Health RCT-post hoc**
Case-cohort study Postmenopausal women aged 50-
A predicted survival of less
1993-1998 SUBVALUE()
National Heart, Lung and Blood RCT-post hoc
SUBVALUE()girl scouts SUBVALUE()
significant health problems (see list
Natl Institute of Nursing >55 y women; no
cancer; mentally More detailed inclusion criteria Women entered
basic training at May 2001 to march 2006
Department of Defense Bone Cohort study
SUBVALUE()Men aged 45-79 Resides in
Missing/erroneous registration #
1997 (Autumn) SUBVALUE()
The Cohort of Swedish Men
the Swedish Cancer Cohort study
SUBVALUE()Men aged 45-79 Resides in
Missing/erroneous registration #
1997 (Autumn) SUBVALUE()
The Cohort of Swedish Men
the Swedish Cancer Cohort Study
SUBVALUE()Male smokers, 50-69 y SUBVALUE()
Nonmelanoma cancer, other
1985-1988 SUBVALUE()
ATBC study SUBVALUE()
Gov t SUBVALUE()Cohort study
SUBVALUE()-Women born between 1917 and
-erroneous or missing national
1987-1990 SUBVALUE()
Swedish Mammography
Swedish Cancer Foundation, Case-cohort study
SUBVALUE()Male physicians SUBVALUE()
Hx of MI, stroke, hx of TIA, unstable
1982 - 2000 SUBVALUE()
Physicians Health Study
NIH, US Army Medical Research Male, Normal
Normotensive (not <1994 SUBVALUE()
nd Supplements provided by Cohort study
Participants are US female professionals aged
Excluded (n=2900) did not
1993 (RCT) SUBVALUE()
The Women s Health Study (a
NCI and National Heart, Lung, and Cohort study of
subjects enrolled 39 876 women 45 years or older who
8389 who provided
During 1993 and 1995 SUBVALUE()
Women s Health Study SUBVALUE()
Gov t SUBVALUE()12y 6 mo old
girls with Danish academic and industry All residents living
in care homes People already receiving 400 IU
December 2000 and January 2003
The Wales Office of Research and Women with low
Ca intake (800 mg Ca supplementation
Wyeth, professional term pregnancy,
white, lived in Women aged 50 to 79 years
Women with < 3years of
1993-1998 SUBVALUE()Cohort study
SUBVALUE()65-99 in 1986-87. Around Turku,
Men<75 in NH Women<70 in NH
1986-87 SUBVALUE()
(Turku, Finland) SUBVALUE()Cohort study
Participants are Men and women 40-80 years of age
Individuals with a personal history of
Wheat Bran Fiber (WBF) trial pregnancy
SUBVALUE()pregnancy SUBVALUE()
preeclampsia, antepartum 50-70 y women;
menopause 1 y; vit D or meds that affect mineral
winter, spring 2002 SUBVALUE()
non-profit and industry pregnant Asians
SUBVALUE()government SUBVALUE()Cohort study
SUBVALUE()Members of CPS II who resided in 21
Men and women lost to follow (until
1992-1993 SUBVALUE()
Cancer Prevention Study (CPS) II Cohort study
SUBVALUE()Women from the CPS II Nutrition
Women who were lost to follow-up
1992- 1993 SUBVALUE()
CPS II Nutrition Cohort Cohort study
SUBVALUE()Adults 20 years or older who had a
Did not have complete data on
Oct 1988-Oct 1994 SUBVALUE()
NHANES III SUBVALUE()
NIH; PJ Schafer CVD Research Cohort study
SUBVALUE()Women from the Medical MRC
Men from the cohort
Since 1946 at birth ages 53 y
Medical MRC NSHD, UK Cohort study
SUBVALUE()male smokers ( 5 cigarettes/d); 50-
previous history of cancer (except for
1985-1988 SUBVALUE()
Alpha-Tocopherol, Beta-Carotene Cohort study
SUBVALUE()Pregnant <16 wk gestation
multiple pregnancies;
2002-2003 SUBVALUE()
government SUBVALUE()Cohort study
SUBVALUE()pregnant women SUBVALUE()
Calcium for Preeclampsia
NICHHD SUBVALUE()
RCT SUBVALUE() 2004 SUBVALUE() nd SUBVALUE()RCT SUBVALUE() nd SUBVALUE()RCT SUBVALUE() 2005 SUBVALUE() nd SUBVALUE() nd SUBVALUE()
nd SUBVALUE() 1976 SUBVALUE()
NCI SUBVALUE()
RCT SUBVALUE() 1997 SUBVALUE() - SUBVALUE()nd SUBVALUE()1976 SUBVALUE() NIH SUBVALUE()
RCT SUBVALUE()nd SUBVALUE()
1989 SUBVALUE()None SUBVALUE() NCI SUBVALUE()
1999 SUBVALUE() nd SUBVALUE()-male SUBVALUE()
RCT SUBVALUE() None SUBVALUE() nd SUBVALUE()nd SUBVALUE() 1980 SUBVALUE()
NIH SUBVALUE()
nd SUBVALUE() nd SUBVALUE()RCT SUBVALUE() nd SUBVALUE()
PLCO SUBVALUE() NIH SUBVALUE()NIH SUBVALUE()nd SUBVALUE()
RCT SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()RCT SUBVALUE() nd SUBVALUE()
nd SUBVALUE()
1990 SUBVALUE()RCT SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()
1996 SUBVALUE()
RCT SUBVALUE() nd SUBVALUE() - SUBVALUE()nd SUBVALUE()
RCT SUBVALUE() nd SUBVALUE() nd SUBVALUE()
RCT SUBVALUE() TOHP SUBVALUE() nd SUBVALUE()1982 SUBVALUE() nd SUBVALUE() nd SUBVALUE()
nd SUBVALUE() 1986 SUBVALUE()RCT SUBVALUE() nd SUBVALUE()
Greek postmenopausal
Women diagnosed having a T-score
Friesland Foods Hellas Male, apparently
healthy , Fasting plasma glucose > 7.0
2006-2007 SUBVALUE()
Indian Council of Medical Research, Women aged 19-
35 y, living in the Pregnant women, Women planned Case-cohort study
SUBVALUE()men with available blood
baseline prostate cancer;
1967-1970 SUBVALUE()
Honolulu Heart Program
government SUBVALUE()Cohort study
SUBVALUE()Registered nurses 30-55y in the
The Nurses Health Study
National Institute of Health Cohort study
SUBVALUE()pregnancy SUBVALUE()
no outpatient medical records;
1999-2002 SUBVALUE()
Project Viva SUBVALUE()
NIH and others SUBVALUE()Case-cohort study
SUBVALUE()Residents living in several
Cases: Non-adenocarcinoma
1990 (Cohort 1) 1993 (Cohort 2)
The Japan Public Health Centre-
Ministry of Health, Labour, and Cohort study
SUBVALUE()Adults aged 45-75 years from five
Participants who are not in one of
1993-1996 SUBVALUE()
Multiethnic Cohort Study SUBVALUE()
National Cancer Institute Cohort study
SUBVALUE()AARP members (50-71);
questionnaires completed by
1995-1996 SUBVALUE()
(NIH)-AARP Diet & Health Study Cohort study
SUBVALUE()Male adults aged 45-75 years from
Not in one of the specified ethnic
1993-1996 SUBVALUE()
Multiethnic Cohort Study SUBVALUE()
National Cancer Institute Cohort study
SUBVALUE()AARP members in 6 specific states
GENERAL***** Provided duplicate
1995-1996 SUBVALUE()
NIH-AARP Diet and Health Study (NIH-
NIH (US) SUBVALUE()25(OH)D < 50
nmol/L -Hypercalcemia or 1
Strathmann, Inc., which markets vit Cohort study
Based on data Male smokers, 50-69 years of age at
History of cancer or other serious
Alpha-Tocopherol, Beta-Carotene
US NCI SUBVALUE()Case-cohort study
SUBVALUE()Participants of NHS (i.e., female
Cases: hyperplastic and
Nurses health study SUBVALUE()5 y post-
menopausal, age Osteoporosis therapy, Ca
~2000 SUBVALUE()
Same as Bolland 2008 SUBVALUE()
Govt (suppl supplied by Cohort study
SUBVALUE()-residing in one of 21 states with
-men with a history of cancer -
1992-1993 SUBVALUE()
Cancer Prevention Study II Nutrition Cohort study
SUBVALUE()men; completed FFQ SUBVALUE()
<35 y in 1989; baseline cancer;
CLUE II study SUBVALUE()
government SUBVALUE()Case-cohort study
SUBVALUE()Men 45-64 yo at screening Cases:
History of cancer SUBVALUE()
1986-89 SUBVALUE()Cohort study
SUBVALUE()65 y; resides in nursing homes or
bedridden; bilateral
Fracture Risk Epidemiology in Case-cohort study
SUBVALUE()-Hx of cancer (except skin
1986-1992 SUBVALUE()
Netherlands Cohort Study
Dutch Cancer Society -Subjects
recruited from -vit D medication/supple
Dec. 1991 Jan. 1992 SUBVALUE()Cohort study
SUBVALUE()Registered nurses from 11 states in
Nurses Health Study SUBVALUE()
National cancer institute, national Cohort study
SUBVALUE()Women between the ages of 40 and
Subjects who had a previous history
March 1997 to May 2000
Shanghai Women s Health Study Cohort study
SUBVALUE()Nurses Healthy Study (NHS):
Prior cancers, except
NHS: 1984 HPFS: 1986 SUBVALUE()
1. NHS 2. HPFS SUBVALUE()
NIH and NHS s grant SUBVALUE()Cohort study
SUBVALUE()All civil servants in Amsterdam, aged
Subjects without information on
1953-1954 SUBVALUE()-men and women -
21-70 yrs old -BMI - diabetes, hx of MI, angina
2005-2007 SUBVALUE()
The Northern Norway Regional Case-cohort study
SUBVALUE()Men and women, aged 55 to 74 y,
A personal history of one of the 4
November 1993 July 2001 Case-cohort study
SUBVALUE()All cases of pancreatic cancer
1) history of malignancy other
Trial enroll: 1985 1988 Cases
Alpha-Tocopherol, Beta-Carotene Post-hoc Case-
cohort study on a Participants of ATBC study Male
No serum controls (2 controls for 2
1985-1993 SUBVALUE()
ATBC study SUBVALUE()Cohort study
SUBVALUE()Women born between 1914-
Women > 76 years old; women
1987-1990 SUBVALUE()
Swedish Mammography
Swedish Cancer Society and Early post-
menopausal Men & women*** 65-85 years***
Already Vit D supplements
06/96-03/97 SUBVALUE()
Medical Research Council, UK Cohort study
SUBVALUE()Diagnosis of prostate cancer at
1982-1984 SUBVALUE()
National Health and Nutrition
NIH, American Cancer Society, Cohort study
SUBVALUE()40-79 y SUBVALUE()
Stroke, CHD, cancer, valid FFQ
1988-1990 SUBVALUE()
Japan Collaborative
Gov t SUBVALUE()Cohort Study
SUBVALUE()40-59 y SUBVALUE()
MI, angina, stroke, cancer at baseline
Japan Public Health Center
Gov t SUBVALUE()Female dietetic
students 20-23 yrs Netherlands Institute for Dairy Cohort study
SUBVALUE()Residence in England and
Subjects could not identified through
1937-1939 SUBVALUE()
The Boyd Orr cohort
The World Cancer Research Fund, Cohort study
(posthoc) representative Dutch older
not living independently; no
Longitudinal Aging Study Amsterdam
government SUBVALUE()1. RCT (for
supplement part RCT part: Postmenopausal
RCT part: Predicted survival
1993-1998 (after 1-year run-in
1. Women s Health Initiative
NHLBI, DHHS SUBVALUE()Fully lactating
mothers within 1 DM; HTN; parathyroid
academic; NIH SUBVALUE()Cohort study
SUBVALUE()Framingham Offspring 25(OH)D
Prevalent CVD or CKD SUBVALUE()
1996-2000 (originally 1971)
Framingham Offspring Newly diagnosed
adenomatous Conditions predisposing to
Europe Against Cancer, Sandoz Cohort study
SUBVALUE()> 40 yrs old (n=3282) Total
Hx of cancer, stroke which may
1989-2002 SUBVALUE()
CVD-FACTS SUBVALUE()
National Health Research Healthy, 30-54 yo
DBP 80-89 mm Hg Treatment with antihypertensive
1987-88 SUBVALUE()Cohort study
SUBVALUE()Residents who moved into the
Pre-existing CRC were excluded Cohort study 1:
HPFS Cohort HPFS: male dentists,
HPFS: men who failed to fill in the
HPFS: 1986 NHS: 1980 SUBVALUE()
HPFS: Health Professionals
HPFS: NCI NHS: NCI SUBVALUE()Case-cohort study
SUBVALUE()Male US health professionals
Health Professionals
National Cancer Institute, National -high-normal DBP
(80 to 90 mm Hg) -preexisting cardiovascular or
Trials of Hypertension
NHLBI NIH SUBVALUE()
1986 SUBVALUE()nd SUBVALUE() 1998 SUBVALUE()
RCT SUBVALUE() nd SUBVALUE()
Cohort study SUBVALUE()
Women 55-69 years old who
Baseline history of cancer, including
Iowa Women s Health Study
US NCI SUBVALUE()RCT-post hoc
SUBVALUE()Substudy of the larger Calcium
Substudy of Calcium Intake
Healthway Health Promotion Women between
70 and 90 yr of Current vitamin D consumption,
April 2003 and October 2004
government SUBVALUE()
ExtractorKP/SI SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()KP/SI SUBVALUE() nd SUBVALUE()EB SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()KP SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()EB SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()Mc SUBVALUE() nd SUBVALUE()EB SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()MC SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()GR SUBVALUE() RIA SUBVALUE() No SUBVALUE() nd SUBVALUE() nd SUBVALUE()MC SUBVALUE() HPLC SUBVALUE() nd SUBVALUE() nd SUBVALUE()SI SUBVALUE() CPBA SUBVALUE() No SUBVALUE() No SUBVALUE()SI SUBVALUE() ELISA SUBVALUE() nd SUBVALUE() nd SUBVALUE()EB SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()MC SUBVALUE() No SUBVALUE() nd SUBVALUE()MB SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()TTe SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()EB SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()EB SUBVALUE() nd SUBVALUE()JHL SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()JHL SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()JHL SUBVALUE() No SUBVALUE() nd SUBVALUE() nd SUBVALUE()EB SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()JHL/SI SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()GR SUBVALUE() nd SUBVALUE() nd SUBVALUE()SI SUBVALUE() nd SUBVALUE()KP SUBVALUE() RIA SUBVALUE() No SUBVALUE() nd SUBVALUE()EB SUBVALUE() No SUBVALUE() nd SUBVALUE()AT SUBVALUE()EB SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()JHL SUBVALUE() No SUBVALUE() nd SUBVALUE() nd SUBVALUE()JHL SUBVALUE() nd SUBVALUE() nd SUBVALUE()SI SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()
RIA SUBVALUE() nd SUBVALUE()TTE SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()MB SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()JHL SUBVALUE() nd SUBVALUE() nd SUBVALUE()TTe SUBVALUE() nd SUBVALUE()GR SUBVALUE() RIA SUBVALUE() ~5y SUBVALUE() nd SUBVALUE()TTE SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()SI SUBVALUE() RIA SUBVALUE() 5 y SUBVALUE()KP/SI SUBVALUE() nd SUBVALUE() nd SUBVALUE()JHL SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()
nd SUBVALUE()EB SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()
nd SUBVALUE() nd SUBVALUE()JHL SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()SI SUBVALUE() HPLC SUBVALUE() 3 wks SUBVALUE()
Background Diet
Background Diet
Background Diet
Background Diet
Background Diet 25(OH)D
determined by y, coefficient of variation in subset Radioimmunoassa
y (Incstar Intra-assay coefficient of
Same day SUBVALUE()
Jan-Feb; March-May; September
HPLC using a diode array
Yes Interassay CV=6.3% and
All seasons (blood were drawn three
See baseline variables
Competitive protein-binding
Interbatch Pearson r for ~3-10 y
SUBVALUE()Within assay CV=5.6% at 21.6
23 (ranged 9-60) nmol/l subjects grouped
by season of Mean Vit D 189 IU/d SUBVALUE()y; interassay CV
10.3% 5-9 years SUBVALUE()
Radioimmunoassay (RIA kit,
Winter (baseline measure only); nd
Vit D+Ca: 25.0 ug/L Placebo: 22.8
25D: RIA (125I) (Hollis 1993)
25D: CV 11.1% interset; 22.0%
~18-20 yr SUBVALUE()
(Late) August through
Using the Nicholas Advantage
25(OH)D 22.0 nmol/L
DiaSorin Liason Chemiluminescent
Y 11.8% SUBVALUE()
Equal % of subjects in both enzyme
immunoassay y; intra and interassay CV:
baseline: Dec to Feb SUBVALUE()
vit D 2.5 g/d SUBVALUE()April and October
SUBVALUE()25(OH)D Nl Ca/Wt maint: 84.1 Competitive
protein binding Mean 11.5 years to diagnosis
25(OH)D: 15-80 ng/ml Not Applicable
SUBVALUE()Not Applicable SUBVALUE()
Not Applicable SUBVALUE()
Not Applicable SUBVALUE()
Not Applicable SUBVALUE()
Immunosorbent assay (Dia-Sorin,
25(OH)D 24.5 ng/mL 25(OH)D -
Competitive Y, intra- and interassay CVs
25(OH)D - 14.0 ng/ml SUBVALUE()86% infant breastfed until 5-6 JHL/TTe
SUBVALUE()Intraset coefficient of variation (CV)
~10 y or 13 y SUBVALUE()
Total Vit D intake: 9.3 g/d, 25(OH)D
25(OH)D measured in
Yes coeff of variation ranged Enzyme
immunoassay Y, coefficient variation=3.2%
26.6 ng/mL SUBVALUE()RIA kit
SUBVALUE()The mean coefficient of
Nd (~7 to ~13 y) (follow-up of the
Vit D intake: 4.7 mcg/d Coeff variation
8.2% for 25(OH)D FFQ for Ca and vit D SUBVALUE()
y; intra and interassay CV
not explicitly reported
UV-B exposure from 2974 RIA for 25-D,
radioreceptor Y; CV = 8.1% for 25-D, 7.9% for
66.4% collected in fall SUBVALUE()
JHL/TTE SUBVALUE()
HPLC and UV absorbance
Inter-assay coefficient of
At least ~9 y (assuming last dx)
Aug-Nov SUBVALUE()
JHL/TTe SUBVALUE()
Radioimmunoassay kit from Nicholas
Y, inter-batch Pearson
11-15y (1988-1992 to ~2003)
inter- and intraassay CV:
February SUBVALUE()
vit D intake Young: 51 IU/d
JHL SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()KP SUBVALUE()EB SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()SI SUBVALUE() nd SUBVALUE() nd SUBVALUE()KP SUBVALUE()TTE SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()KP/SI SUBVALUE() RIA SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()TTE SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()TTe SUBVALUE() RIA SUBVALUE() No SUBVALUE() nd SUBVALUE()SI SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()MB SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()TTE SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()TTe SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()TTe SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()JHL SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()GR SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()SI SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()KP/SI SUBVALUE()JHL SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()SI SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()SI SUBVALUE() RIA SUBVALUE() No SUBVALUE() nd SUBVALUE() nd SUBVALUE()MC SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()TTe SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()TTe SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()EB SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()KP SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()KP/SI SUBVALUE() RIA SUBVALUE() nd SUBVALUE() nd SUBVALUE()EB SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()TTe SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()GR SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()SI SUBVALUE() RIA SUBVALUE() No SUBVALUE() nd SUBVALUE() nd SUBVALUE()JHL SUBVALUE() No SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()EB SUBVALUE() None SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()SI SUBVALUE() nd SUBVALUE()JHL SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()EB SUBVALUE() No SUBVALUE() nd SUBVALUE() nd SUBVALUE()AT SUBVALUE()SI SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()SI SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()SI SUBVALUE() nd SUBVALUE()SI SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()AT SUBVALUE()GR SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()MC SUBVALUE() nd SUBVALUE()GR SUBVALUE() No SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()SI SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()SI SUBVALUE() RIA SUBVALUE() nd SUBVALUE()SI SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()
VitD 4.4 2.4 g/d SUBVALUE()Not Applicable
SUBVALUE()Not Applicable SUBVALUE()
Not Applicable SUBVALUE()
Not Applicable SUBVALUE()
Not Applicable SUBVALUE()
Nichols method (Nichols Institute
October to March, 2 successive years
est. <5 g/d intake of vit D Not Applicable
SUBVALUE()Not Applicable SUBVALUE()
Not Applicable SUBVALUE()
Not Applicable SUBVALUE()
Not Applicable SUBVALUE()
Y, coefficient of variation for
Nd (~6 to ~7 y) (Median f/u of the
April 1999 and March 2000#
Vit D ( g) 2.61 1.28*****
Not Applicable SUBVALUE()
Not Applicable SUBVALUE()
Not Applicable SUBVALUE()
Not Applicable SUBVALUE()
Not Applicable SUBVALUE()DiaSorin Liaison
chemiluminescent dietary vit D 4.5 g/d SUBVALUE()baseline 25(OH)D 71.8 20.3 nmol/L Very little cutaneous
Yes: mean intra-pair coefficients of
Spring or winter: 24.1% of cases
No, Only correlation
Calculated from diet and 25(OH)D: 34.5 mmol/L 25(OH)D
DiaSorin
Competitive protein binding
y; reproducibility at 20 nmol/L 6%
winter, Feb/Mar SUBVALUE()
45% were outside <1 h/d Diasorin Liaison
chemiluminescent 25(OH)D nmol/L <34.4 25.0%, RIA (Incstar)
SUBVALUE()Frozen. Unclear. 10 y SUBVALUE()Not Applicable
SUBVALUE()Not Applicable SUBVALUE()
Not Applicable SUBVALUE()
Not Applicable SUBVALUE()
Not Applicable SUBVALUE()diet: vit D 40 IU/d SUBVALUE()vit D 35 IU/d (diet?) RIA (DIASORIN)
SUBVALUE()y; interassay and intraassay CV
winter, spring SUBVALUE()
25(OH)D level 42 nmol/L (median, 25(OH)D level at 28-32 wk: 20.1 Not Applicable
SUBVALUE()Not Applicable SUBVALUE()
Not Applicable SUBVALUE()
Not Applicable SUBVALUE()
Not Applicable SUBVALUE()Total vitamin D (IU/d) included Diasorin
radioimmunoassaCV from quality control samples,
Winter, Jan-Mar: 25% Spring, Apr-
See results SUBVALUE()
y; CV 10.2% SUBVALUE()
winter and summer
25(OH)D in winter: 48.3 nmol/L;
nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()MB SUBVALUE() RIA SUBVALUE() nd SUBVALUE() nd SUBVALUE()JHL SUBVALUE() RIA SUBVALUE()SI SUBVALUE() 23 y SUBVALUE() nd SUBVALUE()JHL SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()SI SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()
nd SUBVALUE()JHL SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()SI SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()KP/SI SUBVALUE() nd SUBVALUE()TTe SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()MB SUBVALUE() nd SUBVALUE() nd SUBVALUE()AT SUBVALUE()
RIA SUBVALUE()EB SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()KP/SI SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()SI SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()EB SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()SI SUBVALUE() nd SUBVALUE() nd SUBVALUE()MB/SI SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()MB SUBVALUE() nd SUBVALUE() nd SUBVALUE()JHL SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()AT SUBVALUE()MC SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()JHL SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()MB SUBVALUE() nd SUBVALUE() nd SUBVALUE()MC SUBVALUE()GR SUBVALUE() RIA SUBVALUE() nd SUBVALUE()TTe SUBVALUE() nd SUBVALUE()AT SUBVALUE()KP SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()TTe SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()KP/SI SUBVALUE()EB SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()EB SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()KP SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()JHL SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()SI SUBVALUE() 1-2 y SUBVALUE() nd SUBVALUE() nd SUBVALUE()
RIA SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()SI SUBVALUE() RIA SUBVALUE() No SUBVALUE() nd SUBVALUE() nd SUBVALUE()EB SUBVALUE() 3 yr SUBVALUE() nd SUBVALUE() nd SUBVALUE()TTe SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()MB SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()EB SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()MC SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()AT SUBVALUE()
RIA SUBVALUE()MB SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE() nd SUBVALUE()
JHL MC SUBVALUE()
VitD intake 0.59 g/d SUBVALUE()Yes: 5% of
samples re-run for Mean (nmol/L) SD in Y, intra-assay and
inter-assay CV, 1 month SUBVALUE()
September and February
Serum 25(OH)D 62.0nmol/L protein-binding
SUBVALUE()Intra-assay CV 5 to 10%
all subjects live in Hawaii
JHL/TTe SUBVALUE()
Competitive protein-binding
Intra-assay coefficient of
Inferring 9-14 y (cohort 2) or 12-
VitD intake ( g/d) Men: 6.6 Women: VitD intake 335 IU (men) 340 IU
Not Applicable SUBVALUE()
Not Applicable SUBVALUE()
Not Applicable SUBVALUE()
Not Applicable SUBVALUE()
25(OH)D and 1,25(OH)D via RIA
Coeffs of variation for ALL assays
Serum 25(OH)D = 25 13 nmol/mL. Not Applicable
SUBVALUE()Not Applicable SUBVALUE()
Not Applicable SUBVALUE()
Not Applicable SUBVALUE()
Not Applicable SUBVALUE()JHL/TTe
SUBVALUE()Intrapair coefficient of
Nd ~6-~11 y(earliest should
Nd (but stratified analyses based on
1,25(OH)2D=31.9 pg/ml
-Intake <700 mg/day of
Diasorin radioimmunoassa
Intra-assay CV=7.6%; Inter-
Mean (SD) = 25 (18-37) nM vit D
25(OH)D competitive
Y, intra-assay coefficient of
At baseline: Tx group mean = Total Vit D intake 306.7 IU/d Not Applicable
SUBVALUE()Not Applicable SUBVALUE()
Not Applicable SUBVALUE()
Not Applicable SUBVALUE()
Not Applicable SUBVALUE()
electrochemiluminescence
Yes: according to producer, the
Vit D intake (mcg/day)=8.9(6.RIA (Heartland
Assays lab) Yes Overall CV = 4.7% SUBVALUE()
Within 2 hr SUBVALUE()
calendar date of blood draw in 2-
Residential sum exposure at study Y intrabatch and
interbatch The interval between serum
Energy Kcal 2700 Fish 33g Eggs 47 RIA with I125
[25(OH)D] Intraset Coeff of Va: 9.5%
nd~9 to ~12 y inferred)
Vit D intake: 5.3 g/d (4% Not Applicable
SUBVALUE()Not Applicable SUBVALUE()
Not Applicable SUBVALUE()
Not Applicable SUBVALUE()
Not Applicable SUBVALUE()
53.4 nmol/L SUBVALUE()Not Applicable
SUBVALUE()Not Applicable SUBVALUE()
Not Applicable SUBVALUE()
Not Applicable SUBVALUE()
Vitamin D dietary intake 172(101)
Competitive protein-binding
Y interassay CV <15% JHL/TTe
SUBVALUE()Y, interassay coefficient of dietary vit D 273
IU/d SUBVALUE()RIA (DiaSorin) SUBVALUE()
Yes CoV 8.5% (intraassay); Vit D: 4 (microg/d)
SUBVALUE()
Not Applicable SUBVALUE()
Not Applicable SUBVALUE()
Not Applicable SUBVALUE()
Not Applicable SUBVALUE()
Not Applicable SUBVALUE()JHL/TTe
SUBVALUE()Intrapair coefficient of
~7 to 14 y (based on blood
Winter: 28% Spring/Fall: 21%
455.7 IU/d SUBVALUE()
AT SUBVALUE()No SUBVALUE() nd SUBVALUE()
MC SUBVALUE() No SUBVALUE() nd SUBVALUE() nd SUBVALUE()
Not Applicable SUBVALUE()
Not Applicable SUBVALUE()
Not Applicable SUBVALUE()
Not Applicable SUBVALUE()
Not Applicable SUBVALUE()JHL MC
SUBVALUE()25(OH)D - competitive
September 1998 (end of winter in
68.0 (28.7) nmol/liter RIA (DiaSorin,
Stillwater, MN, Mean 25(OH)D = 44.3 (12.9) nM;
FFQ No nd No ndnd nd nd nd nd ndFFQ nd nd ndnd nd nd nd nd ndFFQ Not Applicable Not Applicable Not ApplicableFFQ No No nd ndFFQ nd Not Applicable Not Applicable Not ApplicableFFQ (Block, 1986) No nd nd ndnd nd nd nd nd ndnd nd No nd nd ndnd nd nd nd nd ndnd nd nd nd nd ndnd nd nd nd No nd
nd nd nd nd ndnd nd nd Ca balance No nd
Not Applicable Not Applicable ndFFQ nd Not Applicable Not Applicable Not Applicablend nd nd nd nd ndnd nd nd nd nd ndnd nd nd nd nd ndnd nd nd nd nd nd
(see other article) nd nd ndnd nd nd nd
nd No Not Applicable Not Applicable ndFFQ x 3 d nd No Not Applicable Not Applicable nd
nd No nd nd ndnd nd nd nd nd ndnd nd nd nd nd nd24 hour recall nd nd Not Applicable Not Applicable Not Applicable3-day food records No nd nd ndnd nd nd nd nd ndnd nd nd nd nd ndFFQ nd nd nd nd nd
USDA nd nd ndnd nd nd nd nd ndnd nd nd nd nd nd24HR nd nd ndnd nd nd nd nd ndFFQ Not Applicable Not Applicable ndnd nd nd nd nd ndnd nd nd nd nd nd
nd nd nd ndnd nd nd nd nd ndFFQ & 24 hr recall No Not Applicable Not Applicable ndSFFQ nd nd nd nd nd
nd nd nd nd ndnd nd nd nd nd nd
Background Diet
Background Diet
Background Diet
Background Diet
Background Diet
Background Diet US Department of
Agriculture
USDA, release 10, 1995 + other
Yes Random sample of 127
Spanish food composition
(Previously validated in Spain)General Intake
Estimation System Yes Correlation Ca 0.53nd (need to refer
to NEJM 1999
FFQ, designed for studies of
FFQ (Harvard FFQ by Willet)
USDA Nutrient Database
Yes: reported in Munger et al. Yes Reliability coefficients 0.57-
WHI adaptation of Block FFQ
Yes (not reported here)Short self-
administered Database from the prospective Health Modified block
FFQ
3 day diet record (at baseline and
Food and Nutrient Database 28
62-item National Cancer Institute/
Y (cited two original Block
USDA food composition
Ca intake: 811.8 mg/d
The Norwegian Food Composition
Yes acceptable (reported
28-day diet histories
Food composition table (Ref 2)
Canadian Nutrient File
Semiquantitative food frequency
FFQ USDA nd nd nd7-day food record No Not Applicable Not Applicable Not Applicablenone Not Applicable Not Applicable none Not Applicable ndnd nd nd nd nd ndNot Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable24HR Nd/n Not Applicable Not Applicable ndnd nd nd nd nd nd
Not Applicable Not Applicable ndnd nd nd nd nd ndFFQ USDA No nd nd ndnd nd nd nd nd nd150 item-FFQ nd No nd nd nd
nd nd nd ndnd nd nd
FFQ nd nd ndnd nd nd nd ndUSDA No nd nd nd
FFQ nd nd ndnd nd nd nd nd nd3-d food records nd No nd nd ndnd nd nd nd nd nd
nd No nd nd ndFFQ nd nd ndFFQ Not Applicable Not Applicable ndFFQ nd nd nd ndFFQ nd nd ndnd nd nd nd nd ndNone Not Applicable Not Applicable nd nd ndFFQ nd nd ndWillet method nd nd nd
nd No nd nd ndnd nd nd nd nd nd
No nd nd ndnd nd nd nd nd nd
nd nd nd nd ndInterview (nd) No nd nd nd
nd nd ndnd nd No nd nd ndnd nd nd nd nd ndnd nd nd nd nd ndnd nd nd nd nd nd
USDA nd nd ndnd nd nd
nd nd nd nd nd nd5-day food diaries nd Not Applicable No No
nd nd ndnd nd nd nd nd nd24 h recall nd No nd nd nd
Y (4 day food records from a Other (Food
Processor, version
USDA Handbook #8/supplement,
Diet history Dietary survey
Finnish food composition table
Y (interclass correlation
70-item FFQ slightly modified
Only n=267 assessed; Short FFQ (Rim et al.
1992)USDA and others (Rim et al. 1992)
Correlation of coefficient (energy Conversion of
foods into Y, correlation coefficient for Computerized
questionnaires23 items FFQ (Willett 1985, Standard Tables of
Food Composition Yes, correlation coefficient for
Risk factor questionnaire (no Swedish Food
Administration Yes: by 24HR and correlation Swedish Food
Administration Yes: by 24HR and correlation evaluated previouslySwedish National
Food Y- Pearson correlation
USDA + data from manufacturers
Correlation coefficients (FFQ USDA Nutrient
DatabaseYes, as references to Nurses Health FFQ (88
questions)
3 d dietary record (Tremblay 1983)
Canadian Nutrient File
Food frequency questionnaire Nutrica database
at the Social 113-item Arizona Food Frequency
United States Department of
y assessment of its validity and
68-item semi-quantitative FFQ
y Validated using 4 random 24h FFQ modified from
Questionnaire Diet Analysis System version
Yes. validated using four random
McCance and Widdowson's food 276 item FFQ past
12 modatabase of the Natl Public Health
Yes, intraclass correlation of FFQ
24hr recall nd nd nd ndnd nd nd nd nd nd3-d food records nd No nd nd ndnd nd nd nd nd ndFFQ USDA nd nd nd
No nd nd ndnd nd nd nd nd
nd nd ndUSDA nd nd nd
nd nd ndFFQ (NCI-DHQ) USDA 1994-1996 nd nd ndnd nd nd nd nd ndFFQ nd nd ndSFFQ nd nd nd nd ndnd nd nd nd nd nd
nd nd nd60 item Block FFQ nd No nd nd ndFFQ nd nd nd ndnd nd nd nd nd nd
No nd nd ndnd nd nd nd nd nd
nd nd ndFFQ nd nd ndFFQ (Willet, 1990) nd nd nd
Dutch food tables No nd nd ndFFQ nd nd nd nd
nd nd N/A nd ndnd nd nd nd nd ndFFQ nd nd nd nd nd
nd nd ndnd nd nd nd nd ndnd nd nd Not Applicable Not Applicable ndFFQ No nd nd ndFFQ nd nd ndFFQ nd nd nd nd
No nd nd ndnd nd nd nd
nd nd nd nd nd ndnd nd nd nd nd ndBlock 1998.2 FFQ nd No nd nd ndnd nd nd nd nd ndnd nd nd nd nd ndFFQ nd No nd ndnone Not Applicable Not Applicable nd nd nd
USDA No nd nd ndnd nd nd
FFQ nd nd nd nd ndnd No nd nd nd
Database for Greek food and
Yes, correlation coefficient btw semi-quantitative
FFQHarvard (based on USDA)FFQ (Tsubono et
al, 2003), 44 items Food frequency questionnaire
Data base developed at the
Y, quantitative food frequency 124 item FFQ past
12 moFFQ validated by two 24 h recalls in Self-administered
quantitative FFQFood composition table developed
Y: calibration study comparing Yes (in 1953 participants
Food composition database at the
y Validation study of the dietary
FFQ (modified Block)
Diet Analysis System version
Y, energy-adjusted correlation
Chinese Food Composition
SFFQ (given at baseline to
Dutch food composition table
(1980) 61 item FFQ, (1984, 1986,
USDA Nutrient data base
Y (see other article, Willett et The Chinese Food
Composition Table y Intake levels of major nutrients Harvard University
Food Composition Pearson r between FFQ and 4 1-week FFQ (one-week
recall) Serum Ca was measured at 137 item FFQ
(Deeb, 2007)
Self administered FFQ
Swedish National Food
y Validity evaluated for 129
No specific information, but Japan Food Table v4
No (data from other study Yes Spearman rank correlation Specially
developed Dutch computerized food 7-d household
inventory methodDiet in, data-out program (DIDO
N (but authors state that the FFQ
FFQ 56 foods and coffeeHPFS: FFQ NHS: FFQ
HPFS: USDA and others (REF 33-36)
y (REF 33-36) HPFS: Pearson
24-hr diet recall, FFQ
nd nd ndnd nd nd nd nd
FFQ NUTTAB 90 No No nd nd
Semiquantitative FFQ (by Willet)
USDA Nutrient Database
y For validity and reliability see Semiquantitative
food frequency
ndndndndnd
nd910 mgnd500 mg/dayCa 721 mg/dnd
ndndndndnd
nd
ndndndnd
ndnd
ndndndndnd
ndnd
nd776 mg/dnd876mgnd
Background Diet
Median Ca intake (mg/d) -
Dietary calcium 857 mg/dVit D+Ca: 1078 mg/day Placebo: Ca intake mg/d (SEM) = 586 (137)Total Ca=1118.3 mg/d
See previous table Total Ca 1150
the % of subjects in the placebo arm dietary calcium: 670 mg/d
Total Ca 723.5 mg/d
Total Ca intake: 1049.2 mg/day
907 mg/d (M); 637 mg/d (F)
mg/1000kcal Cancer: 316.7 No
981 435 mg/dNot ApplicablendndNot ApplicableCa: 575 mg/dnd1414 mg/dnd
nd
ndCa=947.0 mg/d
ndnd
nd
ndndnd
nd
nd
ndnd
ndndnd
ndnd
nd
Calcium 933.4 51.8 (SE) mg/d
Ca=1286 mg/d (energy-adjusted
Calcium (mg) 1014.15 Evaluated were calcium, dairy
Daily total calcium, mg CaD dietary intake calcium: 819 mg/d
Mean dairy servings/wk = 6 Ca=809-1665 mg/dCa=809-1665 mg/d
Low Ca diet run-in882 mg/d (median)Calcium dietary intake: Dairy dietary calcium: 957 mg/d
Ca+D: 708.0 (119) mg/d Placebo:
Total Ca intake mg/d <600 19.7%,
diet: calcium 500 mg/dcalcium 429 mg/d (diet?)
68-item food frequency
dietary calcium=1513
dietary calcium pre-intervention:
Ca 679.7 mg/d
nd
ndnd984.5mg/d
Nd 6547130
ndndndnd
ndSee results
ndCa=1.3 g/dndnd
ndndndCa 547.82 mg/dnd
nd
ndnonendNot Applicable939 mg/dCa 970mg/d
Serum Ca (mmol/L) SD = Ca intake 908.2 mg/d
Ca Quintile 1; 510mg Quintile 3: calcium (dietary & supplement): Ca intake (mg/d) Men: 455.7 Ca 960mg (men) 1066mg (women)calcium from non-dairy food (346-7% took calcium supplements Total calcium intake (10th to
Dietary calcium 857 mg/d
25% used calcium supplements
Total Ca intake 773.7 mg/d
Men 929 415mg/d Women Ca intake (mg/day)=940(39Median (IQR) total calcium intake
Mean total Ca intake at 4 year Calcium 730(347) mg/d
Ca (supplements+diecalcium intake: 1125 mg/d
Calcium: 928 (mg/d) by FFQ
1010 mg/dCa mg/d < 800.8 (n=56), 800.8-
Mean calcium intake = 1097
Study ID:EF ID Creator Create Date PMID6304:194 admin Aug 18, 2013 Sep 5, 2014 185059676305:194 admin Aug 18, 2013 Sep 5, 2014 110758746306:194 admin Aug 18, 2013 Sep 5, 2014 126632776307:194 admin Aug 18, 2013 Sep 5, 2014 78928826308:194 admin Aug 18, 2013 Sep 5, 2014 162804276309:194 admin Aug 18, 2013 Sep 5, 2014 182086366311:194 admin Aug 18, 2013 Sep 5, 2014 13303606312:194 admin Aug 18, 2013 Sep 5, 2014 86211986313:194 admin Aug 18, 2013 Sep 5, 2014 97435116314:194 admin Aug 18, 2013 Sep 5, 2014 157673346315:194 admin Aug 18, 2013 Sep 5, 2014 161034506316:194 admin Aug 18, 2013 Sep 5, 2014 179650376317:194 admin Aug 18, 2013 Sep 5, 2014 186895596318:194 admin Aug 18, 2013 Sep 5, 2014 175359856319:194 admin Aug 18, 2013 Sep 5, 2014 181983946320:194 admin Aug 18, 2013 Sep 5, 2014 172438666321:194 admin Aug 18, 2013 Sep 5, 2014 188427716322:194 admin Aug 18, 2013 Sep 5, 2014 83334126323:194 admin Aug 18, 2013 Sep 5, 2014 99219606325:194 admin Aug 18, 2013 Sep 5, 2014 76128036326:194 admin Aug 18, 2013 Sep 5, 2014 187553196327:194 admin Aug 18, 2013 Sep 5, 2014 167979036328:194 admin Aug 18, 2013 Sep 5, 2014 176564206329:194 admin Aug 18, 2013 Sep 5, 2014 175025306330:194 admin Aug 18, 2013 Sep 5, 2014 115666566331:194 admin Aug 18, 2013 Sep 5, 2014 190016016333:194 admin Aug 18, 2013 Sep 5, 2014 162804476334:194 admin Aug 18, 2013 Sep 5, 2014 152130386335:194 admin Aug 18, 2013 Sep 5, 2014 82200926336:194 admin Aug 18, 2013 Sep 5, 2014 86824536337:194 admin Aug 18, 2013 Sep 5, 2014 88906616338:194 admin Aug 18, 2013 Sep 5, 2014 171895526339:194 admin Aug 18, 2013 Sep 5, 2014 162782626340:194 admin Aug 18, 2013 Sep 5, 2014 80781156341:194 admin Aug 18, 2013 Sep 5, 2014 153424526342:194 admin Aug 18, 2013 Sep 5, 2014 156684856343:194 admin Aug 18, 2013 Nov 6, 2013 19376626344:194 admin Aug 18, 2013 Sep 5, 2014 173720316345:194 admin Aug 18, 2013 Sep 5, 2014 188386236346:194 admin Aug 18, 2013 Sep 5, 2014 179715266347:194 admin Aug 18, 2013 Sep 5, 2014 183814726348:194 admin Aug 18, 2013 Sep 5, 2014 90612756349:194 admin Aug 18, 2013 Sep 5, 2014 173110576350:194 admin Aug 18, 2013 Sep 5, 2014 88502736351:194 admin Aug 18, 2013 Sep 5, 2014 28573646352:194 admin Aug 18, 2013 Sep 5, 2014 25729006353:194 admin Aug 18, 2013 Sep 5, 2014 7493659
Last Updated
6356:194 admin Aug 18, 2013 Sep 5, 2014 146522386357:194 admin Aug 18, 2013 Sep 5, 2014 172279966358:194 admin Aug 18, 2013 Sep 5, 2014 105113296359:194 admin Aug 18, 2013 Sep 5, 2014 156712226360:194 admin Aug 18, 2013 Sep 5, 2014 162865196361:194 admin Aug 18, 2013 Sep 5, 2014 145539576362:194 admin Aug 18, 2013 Sep 5, 2014 124993436363:194 admin Aug 18, 2013 Sep 5, 2014 94050296364:194 admin Aug 18, 2013 Sep 5, 2014 39462956367:194 admin Aug 18, 2013 Nov 6, 2013 104714226368:194 admin Aug 18, 2013 Nov 6, 2013 104714226369:194 admin Aug 18, 2013 Sep 5, 2014 152258336370:194 admin Aug 18, 2013 Sep 5, 2014 116417506371:194 admin Aug 18, 2013 Sep 5, 2014 174421306372:194 admin Aug 18, 2013 Sep 5, 2014 82014446373:194 admin Aug 18, 2013 Sep 5, 2014 175528806374:194 admin Aug 18, 2013 Sep 5, 2014 82055386375:194 admin Aug 18, 2013 Sep 5, 2014 93438376376:194 admin Aug 18, 2013 Sep 5, 2014 86107046377:194 admin Aug 18, 2013 Sep 5, 2014 158805326378:194 admin Aug 18, 2013 Sep 5, 2014 175361916379:194 admin Aug 18, 2013 Sep 5, 2014 171064376380:194 admin Aug 18, 2013 Sep 5, 2014 183980336381:194 admin Aug 18, 2013 Sep 5, 2014 192211906382:194 admin Aug 18, 2013 Sep 5, 2014 153541506383:194 admin Aug 18, 2013 Sep 5, 2014 175566976384:194 admin Aug 18, 2013 Sep 5, 2014 184333056385:194 admin Aug 18, 2013 Sep 5, 2014 165229156386:194 admin Aug 18, 2013 Sep 5, 2014 165229156387:194 admin Aug 18, 2013 Sep 5, 2014 183322896388:194 admin Aug 18, 2013 Sep 5, 2014 190565696389:194 admin Aug 18, 2013 Sep 5, 2014 173886676390:194 admin Aug 18, 2013 Sep 5, 2014 85579656391:194 admin Aug 18, 2013 Sep 5, 2014 158002686392:194 admin Aug 18, 2013 Sep 5, 2014 175332086393:194 admin Aug 18, 2013 Sep 5, 2014 164000446394:194 admin Aug 18, 2013 Sep 5, 2014 174739116395:194 admin Aug 18, 2013 Sep 5, 2014 172091776396:194 admin Aug 18, 2013 Sep 5, 2014 37555176397:194 admin Aug 18, 2013 Sep 5, 2014 188246626398:194 admin Aug 18, 2013 Sep 5, 2014 159554676399:194 admin Aug 18, 2013 Sep 5, 2014 120201026401:194 admin Aug 18, 2013 Sep 5, 2014 36232606402:194 admin Aug 18, 2013 Sep 5, 2014 32436096403:194 admin Aug 18, 2013 Sep 5, 2014 163915876404:194 admin Aug 18, 2013 Sep 5, 2014 67930586405:194 admin Aug 18, 2013 Sep 5, 2014 127087196406:194 admin Aug 18, 2013 Sep 5, 2014 16365007
6407:194 admin Aug 18, 2013 Sep 5, 2014 186950766408:194 admin Aug 18, 2013 Sep 5, 2014 188278116409:194 admin Aug 18, 2013 Sep 5, 2014 171064376410:194 admin Aug 18, 2013 Sep 5, 2014 163526846411:194 admin Aug 18, 2013 Sep 5, 2014 112624666412:194 admin Aug 18, 2013 Sep 5, 2014 171818906413:194 admin Aug 18, 2013 Sep 5, 2014 191257566414:194 admin Aug 18, 2013 Sep 5, 2014 191582266415:194 admin Aug 18, 2013 Sep 5, 2014 97941756416:194 admin Aug 18, 2013 Sep 5, 2014 173796166417:194 admin Aug 18, 2013 Sep 5, 2014 175219216418:194 admin Aug 18, 2013 Sep 5, 2014 176222446419:194 admin Aug 18, 2013 Sep 5, 2014 172153806420:194 admin Aug 18, 2013 Sep 5, 2014 180000206421:194 admin Aug 18, 2013 Sep 5, 2014 179252836422:194 admin Aug 18, 2013 Sep 5, 2014 192377246423:194 admin Aug 18, 2013 Sep 5, 2014 112975966424:194 admin Aug 18, 2013 Sep 5, 2014 105306086425:194 admin Aug 18, 2013 Sep 5, 2014 110457886428:194 admin Aug 18, 2013 Sep 5, 2014 158271036429:194 admin Aug 18, 2013 Sep 5, 2014 128693976430:194 admin Aug 18, 2013 Sep 5, 2014 173153196431:194 admin Aug 18, 2013 Sep 5, 2014 92364166432:194 admin Aug 18, 2013 Sep 5, 2014 155315006433:194 admin Aug 18, 2013 Sep 5, 2014 103621256434:194 admin Aug 18, 2013 Sep 5, 2014 74981006435:194 admin Aug 18, 2013 Sep 5, 2014 122088956436:194 admin Aug 18, 2013 Sep 5, 2014 170197166437:194 admin Aug 18, 2013 Sep 5, 2014 169850316438:194 admin Aug 18, 2013 Sep 5, 2014 84781446439:194 admin Aug 18, 2013 Sep 5, 2014 190569006441:194 admin Aug 18, 2013 Sep 5, 2014 192088426442:194 admin Aug 18, 2013 Sep 5, 2014 170470876443:194 admin Aug 18, 2013 Sep 5, 2014 92424786444:194 admin Aug 18, 2013 Nov 6, 2013 124671336445:194 admin Aug 18, 2013 Sep 5, 2014 33073076446:194 admin Aug 18, 2013 Sep 5, 2014 126099406447:194 admin Aug 18, 2013 Sep 5, 2014 158834416450:194 admin Aug 18, 2013 Sep 5, 2014 163394766451:194 admin Aug 18, 2013 Sep 5, 2014 186358556452:194 admin Aug 18, 2013 Sep 5, 2014 37888356453:194 admin Aug 18, 2013 Sep 5, 2014 180655926455:194 admin Aug 18, 2013 Sep 5, 2014 169601776456:194 admin Aug 18, 2013 Sep 5, 2014 164816366457:194 admin Aug 18, 2013 Sep 5, 2014 176615656458:194 admin Aug 18, 2013 Nov 6, 2013 182590076459:194 admin Aug 18, 2013 Sep 5, 2014 181803956460:194 admin Aug 18, 2013 Sep 5, 2014 8675093
6461:194 admin Aug 18, 2013 Sep 5, 2014 189889096462:194 admin Aug 18, 2013 Sep 5, 2014 90225616463:194 admin Aug 18, 2013 Sep 5, 2014 36203146464:194 admin Aug 18, 2013 Sep 5, 2014 119043166465:194 admin Aug 18, 2013 Sep 5, 2014 176238016466:194 admin Aug 18, 2013 Sep 5, 2014 77958376467:194 admin Aug 18, 2013 Sep 5, 2014 95214376468:194 admin Aug 18, 2013 Sep 5, 2014 180897016469:194 admin Aug 18, 2013 Sep 5, 2014 18410225
Alt ID(s) Title Year Author2008200020031995200520081992199619982005200520082008200720082007200819931999199520082006200720072001200820052004-- Not Found ---- Not Found --1996200620061994200420051991 Ford ES., Cooper RS.2007200820072008199620081996198519891995
Serum vitamin D concentration and
Ahn J., Peters U., Albanes D., Purdue MP., Abnet CC., Prostate cancer risk and
prediagnostic serum 25-Ahonen MH., Tenkanen L., Teppo L., Hakama M., A prospective study of
calcium intake from diet Al-Delaimy WK., Rimm E., Willett WC., Stampfer MJ., The influence of
menopause and hormonal Aloia JF., Vaswani A., Russo L., Sheehan M., Low-fat dairy consumption
and reduced risk of Alonso A., Beunza JJ., Delgado-Rodríguez M., Effect of vitamin D
supplementation on bone Andersen R., Mølgaard C., Skovgaard LT., Brot C., A prospective study of
nutritional factors and Ascherio A., Rimm EB., Giovannucci EL., Colditz Prospective study of
nutritional factors, blood Ascherio A., Hennekens C., Willett WC., Sacks F., Intake of potassium,
magnesium, calcium, and Ascherio A., Rimm EB., Hernán MA., Giovannucci Risk of prostate cancer in
a randomized clinical trial Baron JA., Beach M., Wallace K., Grau MV., Plasma 25-hydroxyvitamin
D and 1,25-Bertone-Johnson ER., Chen WY., Holick MF., Hollis BW., Vitamin D
supplementation has Björkman M., Sorva A., Risteli J., Tilvis R.Body size and serum 25
hydroxy vitamin D Blum M., Dallal GE., Dawson-Hughes B.Maternal vitamin D
deficiency increases the Bodnar LM., Catov JM., Simhan HN., Holick MF., Vascular events in healthy
older women receiving Bolland MJ., Barber PA., Doughty RN., Mason B., Two-year randomized
controlled trial of vitamin Bolton-Smith C., McMurdo ME., Paterson CR., Mole Dairy calcium
supplementation in Bortolotti M., Rudelle S., Schneiter P., Vidal H., Relation of calcium,
vitamin D, and dairy food Bostick RM., Potter JD., Sellers TA., McKenzie DR., Relation of calcium,
vitamin D, and dairy food Bostick RM., Kushi LH., Wu Y., Meyer KA., Sellers TA., Prostate cancer and
prediagnostic levels of Braun MM., Helzlsouer KJ., Hollis BW., Comstock GW.Calcium, vitamin D
supplementation, and Brunner RL., Cochrane B., Jackson RD., Larson J., Effects of vitamin D
supplementation and Bunout D., Barrera G., Leiva L., Gattas V., de la Does vitamin D stop
inpatients falling? A Burleigh E., McColl J., Potter J.Calcium plus vitamin D
supplementation and the Caan B., Neuhouser M., Aragaki A., Lewis CB., Dairy products, calcium,
and prostate cancer risk in Chan JM., Stampfer MJ., Ma J., Gann PH., Gaziano JM., Calcium plus vitamin D
supplementation and the Chlebowski RT., Johnson KC., Kooperberg C., Effects of calcium, dairy
product, and vitamin D Cheng S., Lyytikäinen A., Kröger H., Lamberg-Allardt Weight loss and calcium
intake influence calcium Cifuentes M., Riedt CS., Brolin RE., Field MP., Vitamin D and prostate
cancer: a prediagnostic Corder EH., Guess HA., Hulka BS., Friedman GD., Calcium chemoprevention
in colorectal cancer.Duris I., Hruby D., Pekarkova B., Huorka M., Dietary calcium, alcohol,
and incidence of treated Dwyer JH., Li L., Dwyer KM., Curtin LR., Feinleib M.Effect of 1-year dairy
product intervention on fat Eagan MS., Lyle RM., Gunther CW., Peacock M., Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J., Seasonal and geographical
variations in the growth Feliciano ES., Ho ML., Specker BL., Falciglia G., Plasma vitamin D
metabolites and risk of Feskanich D., Ma J., Fuchs CS., Kirkner GJ., Hankinson Calcium from diet and
supplements is associated Flood A., Peters U., Chatterjee N., Lacey JV., Risk factors for
hypertension in a national Plasma 25-hydroxyvitamin D levels and risk of
Forman JP., Giovannucci E., Holmes MD., Bischoff-Plasma 25-hydroxyvitamin
D levels and risk of Forman JP., Curhan GC., Taylor EN.Prospective study of
serum vitamin D and Freedman DM., Looker AC., Chang SC., Graubard Serum levels of vitamin D
metabolites and breast Freedman DM., Chang SC., Falk RT., Purdue MP., Dietary factors and risk of
colon cancer: a Gaard M., Tretli S., Løken EB.Maternal vitamin D status
during pregnancy and Gale CR., Robinson SM., Harvey NC., Javaid MK., Circulating vitamin D
metabolites in relation to Gann PH., Ma J., Hennekens CH., Hollis Dietary vitamin D and
calcium and risk of Garland C., Shekelle RB., Barrett-Connor E., Criqui Serum 25-hydroxyvitamin
D and colon cancer: eight-Garland CF., Comstock GW., Garland FC., Helsing The influence of dairy
products on plasma uric Ghadirian P., Shatenstein B., Verdy M., Hamet P.
200320071999200520052003200319971986199919992004200120071994200819941997199620052007200620082009200420072008200620062008200920071995 Lijnen P., Petrov V.200520072006200720071986200820052002198719882006198120032005
Vitamin D, calcium supplementation, and
Grau MV., Baron JA., Sandler RS., Haile RW., Prolonged effect of
calcium supplementation Grau MV., Baron JA., Sandler RS., Wallace K., Plasma 25-hydroxyvitamin
D responses of younger Harris SS., Dawson-Hughes B., Perrone GA.The association of calcium
and vitamin D with risk of Hartman TJ., Albert PS., Snyder K., Slattery ML., The impact of calcium and
dairy product consumption Harvey-Berino J., Gold BC., Lauber R., Starinski A.Gestational calcium
supplementation and Hatton DC., Harrison-Hohner J., Coste S., Reller Human serum 25-
hydroxycholecalciferol Heaney RP., Davies KM., Chen TC., Holick MF., Long-term vitamin D3
supplementation may Heikkinen AM., Tuppurainen MT., Colon cancer and dietary
fat, phosphorus, and Heilbrun LK., Hankin JH., Nomura AM., Prospective study of
calcium, potassium, and Iso H., Stampfer MJ., Manson JE., Rexrode K., Prospective study of
calcium, potassium, and Iso H., Stampfer MJ., Manson JE., Rexrode K., Plasma levels of 25-
hydroxyvitamin D, 1,25-Jacobs ET., Giuliano AR., Martínez ME., Hollis BW., Prospective study on milk
products, calcium and Järvinen R., Knekt P., Hakulinen T., Aromaa A.Nutritional status and
subsequent all-cause Jia X., Aucott LS., McNeill G.Dietary intakes,
anthropometric Johnson AA., Knight EM., Edwards CH., Oyemade Calcium intake and the
outcome of short-term Kabrnová-Hlavatá K., Hainer V., Gojová M., Fermented dairy products,
calcium, and colorectal Kampman E., Goldbohm RA., van den Brandt PA., Prospective study of diet
and female colorectal Kato I., Akhmedkhanov A., Koenig K., Toniolo PG., Calcium, vitamin D, and
dairy foods and the Kearney J., Giovannucci E., Rimm EB., Ascherio A., Dietary calcium,
phosphorus, vitamin D, Kesse E., Boutron-Ruault MC., Norat T., Riboli E., Dairy products, calcium
and the risk of breast Kesse-Guyot E., Bertrais S., Duperray B., Arnault N., Dairy products, calcium
and prostate cancer risk.Koh KA., Sesso HD., Paffenbarger RS., Lee IM.Dairy product, saturated
fatty acid, and calcium Kurahashi N., Inoue M., Iwasaki M., Sasazuki S., Calcium plus vitamin D
supplementation and LaCroix AZ., Kotchen J., Anderson G., Brzyski R., Girls on a high-calcium
diet gain weight at the Lappe JM., Rafferty KA., Davies KM., Lypaczewski Vitamin D and calcium
supplementation reduces Lappe JM., Travers-Gustafson D., Davies KM., Calcium and vitamin d
supplementation Lappe J., Cullen D., Haynatzki G., Recker R., Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci Magnesium, calcium,
potassium, and sodium Larsson SC., Virtanen MJ., Mars M., Männistö S., Long-term dietary calcium
intake and breast cancer Larsson SC., Bergkvist L., Wolk A.A prospective study of
plasma vitamin D Li H., Stampfer MJ., Hollis JB., Mucci LA., Gaziano JM., Dietary calcium, blood
pressure and cell Intakes of calcium and vitamin D and risk of
Lin J., Zhang SM., Cook NR., Manson JE., Lee IM., Intakes of calcium and
vitamin D and breast Lin J., Manson JE., Lee IM., Cook NR., Buring JE., Calcium supplementation
for 1 y does not reduce Lorenzen JK., Mølgaard C., Michaelsen KF., Astrup A.Preventing fractures
among older people living Lyons RA., Johansen A., Brophy S., Newcombe RG., Supplementation with
calcium + vitamin D Major GC., Alarie F., Doré J., Phouttama S., Tremblay Vitamin D
supplementation in Mallet E., Gügi B., Brunelle P., Hénocq A., Basuyau JP., Effect of calcium and
vitamin D supplementation Margolis KL., Ray RM., Van Horn L., Manson JE., Allison Dietary and serum
vitamins and minerals as Marniemi J., Alanen E., Impivaara O., Seppänen Calcium, vitamin D, and
risk of adenoma Martínez ME., Marshall JR., Sampliner R., Wilkinson J., Effect of calcium and
vitamin D supplementation Marya RK., Rathee S., Manrow M.Effect of vitamin D
supplementation during Marya RK., Rathee S., Dua V., Sangwan K.Vitamin D2 dose required
to rapidly increase 25OHD Mastaglia SR., Mautalen CA., Parisi MS., Oliveri B.Vitamin D supplements
enhance weight gain and Maxwell JD., Ang L., Brooke OG., Brown IR.Calcium, vitamin D, dairy
products, and risk of McCullough ML., Robertson AS., Rodriguez Dairy, calcium, and
vitamin D intake and McCullough ML., Rodriguez C., Diver WR., Feigelson
200820082006200620012006 Moschonis G., Manios Y.200920091998200720072007200720072007200920011999200020052003200719972004199919952002200620061993200820092006199720021987200320052006200819862007200620062006200820081996
25-hydroxyvitamin D levels and the risk of
Melamed ML., Michos ED., Post W., Astor B.Dietary calcium and
vitamin D intakes in Mishra G., McCormack V., Kuh D., Hardy R., Stephen Dairy products, calcium
and prostate cancer risk.Koh KA., Sesso HD., Paffenbarger RS., Lee IM.Maternal 25-
hydroxyvitamin D and Morley R., Carlin JB., Pasco JA., Wark JD.Nutrient intake and
hypertensive disorders of Morris CD., Jacobson SL., Anand R., Ewell MG., Skeletal site-dependent
response of bone mineral A double-blind, randomized, placebo-
Nagpal J., Pande JN., Bhartia A.Supplements of 20
microg/d cholecalciferol Nelson ML., Blum JM., Hollis BW., Rosen C., Serum vitamin D
metabolite levels and the Nomura AM., Stemmermann GN., Lee J., Calcium and vitamin D
intakes in relation to risk Oh K., Willett WC., Wu K., Fuchs CS., Giovannucci EL.Diet during pregnancy and
risk of preeclampsia or Oken E., Ning Y., Rifas-Shiman SL., Rich-Edwards Plasma vitamin D and risk
of colorectal cancer: the Otani T., Iwasaki M., Sasazuki S., Inoue M., Calcium and vitamin D
intake and risk of Park SY., Murphy SP., Wilkens LR., Nomura AM., Calcium, dairy foods, and
risk of incident and fatal Park Y., Mitrou PN., Kipnis V., Hollenbeck A., Calcium, vitamin D, and
dairy product intake and Park SY., Murphy SP., Wilkens LR., Stram DO., Dairy food, calcium, and
risk of cancer in the NIH-Park Y., Leitzmann MF., Subar AF., Hollenbeck A., Effects of a short-term
vitamin D(3) and calcium Pfeifer M., Begerow B., Minne HW., Nachtigall D., Diet and risk of colorectal
cancer in a cohort of Pietinen P., Malila N., Virtanen M., Hartman TJ., Plasma 1,25-dihydroxy-
and 25-hydroxyvitamin D Platz EA., Hankinson SE., Hollis BW., Colditz GA., Effects of calcium
supplementation on body Reid IR., Horne A., Mason B., Ames R., Bava U., Calcium, dairy products,
and risk of prostate cancer Rodriguez C., McCullough ML., Mondul AM., Jacobs Meat and dairy
consumption and Rohrmann S., Platz EA., Kavanaugh CJ., Thuita L., Prospective evaluation of
dietary and other Ross RK., Yuan JM., Henderson BE., Park J., Serum parathyroid
hormone is associated Sambrook PN., Chen JS., March LM., Cameron ID., Animal products, calcium
and protein and prostate Schuurman AG., van den Brandt PA., Dorant E., Effect of winter oral
vitamin D3 Scragg R., Khaw KT., Murphy S.Intake of dairy products,
calcium, and vitamin d and Shin MH., Holmes MD., Hankinson SE., Wu K., Dietary intake of calcium,
fiber and other Shin A., Li H., Shu XO., Yang G., Gao YT., Zheng Vitamin D intake and the
risk for pancreatic cancer Skinner HG., Michaud DS., Giovannucci E., Willett Calcium intake and 28-
year gastro-intestinal Slob IC., Lambregts JL., Schuit AJ., Kok FJ.Supplementation with
cholecalciferol does not Sneve M., Figenschau Y., Jorde R.Serum vitamin D and risk
of pancreatic cancer in the Stolzenberg-Solomon RZ., Hayes RB., Horst RL., A prospective nested case-
control study of vitamin D Stolzenberg-Solomon RZ., Vieth R., Azad A., Pietinen Serum levels of vitamin D
metabolites and the Tangrea J., Helzlsouer K., Pietinen P., Taylor P., Hollis Dietary calcium and
vitamin D intake and risk Terry P., Baron JA., Bergkvist L., Holmberg L., Dietary calcium intake and
blood pressure in Thomsen K., Nilas L., Christiansen C.Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.Dairy, calcium, and
vitamin D intakes and Tseng M., Breslow RA., Graubard BI., Ziegler RG.Dietary intake of calcium
in relation to mortality Umesawa M., Iso H., Date C., Yamamoto A., Dietary calcium intake and
risks of stroke, its Umesawa M., Iso H., Ishihara J., Saito I., Kokubo Oral calcium and blood
pressure: a controlled van Beresteyn EC., Schaafsma G., de Waard Childhood dairy intake and
adult cancer risk: 65-y van der Pols JC., Bain C., Gunnell D., Smith GD., Low serum concentrations
of 25-hydroxyvitamin D in Visser M., Deeg DJ., Puts MT., Seidell JC., Lips P.Calcium plus vitamin D
supplementation and the Wactawski-Wende J., Kotchen JM., Anderson GL., High-dose vitamin D3
supplementation in a Wagner CL., Hulsey TC., Fanning D., Ebeling M., Dietary intake of dairy
products, calcium, and Wang L., Manson JE., Buring JE., Lee IM., Sesso Vitamin D deficiency and
risk of cardiovascular Wang TJ., Pencina MJ., Booth SL., Jacques PF., Effect of longterm placebo
controlled calcium Weisgerber UM., Boeing H., Owen RW., Waldherr
200819971987200220071995199820082008
Is ischemic stroke risk related to folate status or
Weng LC., Yeh WT., Bai CH., Chen HJ., Chuang SY., Efficacy of
nonpharmacologic Whelton PK., Kumanyika SK., Cook NR., Cutler JA., Alcohol, physical activity
and other risk factors for Wu AH., Paganini-Hill A., Ross RK., Henderson BE.Calcium intake and risk of
colon cancer in women Wu K., Willett WC., Fuchs CS., Colditz GA., A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis Lack of blood pressure
effect with calcium and Yamamoto ME., Applegate WB., Klag MJ., Borhani NO., A prospective cohort study
of intake of calcium, Zheng W., Anderson KE., Kushi LH., Sellers TA., Effects of calcium and
vitamin D supplementation Zhu K., Devine A., Dick IM., Wilson SG., Prince RL.Randomized controlled
trial of the effects of Zhu K., Bruce D., Austin N., Devine A., Ebeling PR.,
Calcium Dairy diet0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 10 0 0 0 0 0 00 1 0 0 0 0 0
Ca intake - Quintile
Vit D intake -
Ca intake - Quintile
maternal vit D at
Ca (mg/1000
1 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 1 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 1 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
zero dose0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 1 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 1 1 00 0 0 0 1 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
Ca (mg/1000
Ca (mg/1000
1,25(OH)D - Tertile
Ca intake - Quintile
Ca intake - Quintile
Cholecalciferol 400
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 1 1 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 1 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 1 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 1 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 1 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 1 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 1 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 1 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
2-Q2 2-Q10 0 0 0 0 0 00 0 0 0 0 0 00 1 1 0 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 1 0 1 0 00 1 1 0 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
Training + Ca
Ca intake - Quintile
Ca intake - Quintile
25(OH)D - Quintile
Ca intake - Quintile
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 1 0 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 1 0 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 1 0 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 1 0 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 1 0 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 1 0 1 0 00 0 0 0 0 0 00 0 0 1 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 1 0 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 1 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
Quartile 1: 1,25-D
Ca (mg/1000
Calcium carbonicu
Quartile 1:
Vit D intake -
Cholecalciferol
Quartile 4: highest
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
<32 5000 IU0 0 0 0 0 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
1,25(OH)D - Tertile
Quartile 4: 1,25-D
Quintile 3: 23.5-
Ca intake - Quintile
Serum 25(OH)D -
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 1 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
10000 IU0 0 0 0 0 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
Severe deficiency
Quintile 2: 18.3-
Ca + placebo
Dietary Ca
Ca intake - Quartile
Quintile 3: 51.4-
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 1 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
Control0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 1 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
100 mg of elemental
Ca intake - Quartile
Baseline 25(OH)D -
Quintile 3: 33.5-
Vit D3 + Ca
Calcium placebo
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
>= 30.0 4-Q10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
Ca intake - Quintile
Quartile 4: >75
Urinary Ca 236-
Ca intake - Quintile
Calcium, both
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 1 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
4-Q2 4-Q3 4-Q40 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 1 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
High 25(OH)D,
Ca intake - Quintile
Ca 500 mg/d + vit
Ca Intake - Quartile
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 1 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 1 1 0 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
Baseline 25(OH)D -
Ca intake - Quartile
Ca intake - Quartile
Ca intake - Quartile
Ca intake - Quintile
Vit D + Ca + placebo
Ca intake - Quartile
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 1 0 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 1 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 1 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
Low 25(OH)D,
Quartile 3 + Quartile
1,25(OH)2D -
Baseline 25(OH)D -
1,25(OH)2D -
No training +
1,25(OH)2D -
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 10 0 0 0 0 0 00 0 0 0 0 0 01 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 1 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
1,25(OH)2D -
1,25(OH)2D -
25(OH)D - Quintile
Quartile 1: 25-D
Quartile 2: 1,25-D
Calcium intake -
Medium dairy
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 0
Vit D3 Vit D20 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
Calcium carbonate
Quintile 1: <28.2
1,25(OH)D - Tertile
Quartile 1: lowest
No chemopre
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 1 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
< 30.00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 1 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
No chemopre
Ca suppleme
Baseline 25(OH)D -
Ca Intake - Quartile
Baseline 25(OH)D -
1,25(OH)2D - Tertile
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 10 0 0 0 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
mom 6400
Baseline 25(OH)D -
1,25 OH-D,
Ca intake - Quintile
Ca intake - Tertile 2
Ca intake - Tertile 3
Ca intake - Quintile
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 1 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 1 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 10 0 0 0 0 0 00 0 0 0 1 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
1000 IU0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
Ca intake - Tertile 1
No Calcium
Quintile 2: 28.2-
unsupplemented
25(OH)D - Tertile 2
25(OH)D - Tertile 1
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 1 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 1 0 00 0 0 0 0 0 01 0 0 0 0 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
Vit D0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
Ca intake, per 1
Urinary Ca 169.1-
25(OH)D - Tertile 3
Calcium intake -
1,25(OH)D -
1,25(OH)D -
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 1 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 00 1 0 0 0 0 00 0 0 1 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
6-Q4 6-Q5 6-Q2 6-Q30 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 1 1 1 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
1,25(OH)D -
1,25(OH)D -
Ca intake - Quintile
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
200 IU 6-Q6 100 IU0 0 0 0 0 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
25(OH)D >= 15
Ca intake - Quintile
Baseline 25(OH)D -
Quintile 5: 71.8-
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 1 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
6-Q10 0 0 0 0 0 00 0 0 0 1 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 1 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 0
Dairy free diet
Ca intake - Quintile
Ca + Placebo
25(OH)D - Group 1:
Training + + Ca + Vit
Quartile 2:
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 1 0 0 00 0 0 1 0 0 0
Referent Tertile 2 Tertile 1 Tertile 30 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
>41.1 and <51.1
1,25(OH)D - Tertile
Quartile 2: 25-D
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 1 1 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 1 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
High dairy0 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 10 0 0 1 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 1 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 1 0 0 00 0 0 0 0 0 0
Urinary Ca 20.3-
Baseline 1,25(OH)2
25(OH)D - Quintile 1
Vit D intake -
Quintile 2: 42.5-
Baseline 1,25(OH)2
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 1 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 1 0 0 01 1 1 0 1 1 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 1 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 1 10 0 0 0 0 0 0
25(OH)2D - Quintile
25(OH)D - Quintile 2
25(OH)2D - Quintile
Baseline 1,25(OH)2
25(OH)2D - Quintile
25(OH)D - Quintile 5
25(OH)D - Quintile 3
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 1 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
Usual diet Quintile 5 Ca + Vit D0 0 0 0 0 0 00 0 0 0 0 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 1 0 00 0 0 0 0 0 00 0 0 0 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 0
25(OH)D - Quintile 4
High dairy (high Ca)
>51.1 and <65.5
25(OH)D - Group 2:
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 1 0 00 0 0 0 0 0 00 0 0 0 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 1 0 0 0 00 0 0 0 0 1 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 1 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
Quintile 2 Quintile 1 Quintile 4 Quintile 30 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 1 1 0 10 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 1 1 0 10 0 0 0 0 0 01 0 0 1 1 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 1 1 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
Ca intake Categorie
Ca intake (diet +
1.2 million IU
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 1 1 0 10 0 0 0 0 0 01 0 0 1 1 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 1 1 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 01 0 0 1 1 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
Cases0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
Vit D2 supplmen
Ca intake -
Placebo, both
Ca intake - Quintile
Ca intake - Quintile
1,25(OH)2D -
0 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 1 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 1 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
1,25(OH)2D -
Quintile 1: <18.3
1,25(OH)2D -
Quartile 2: 30-50
Vit D 1000 IU/d
Quartile 4: 25-D
No chemopre
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
Ca 500 mg/d + vit
25(OH)D <15
Quintile 4: 39-
25 OH-D, quartile
Ca intake - Quintile
Ca intake - Quintile
1,25(OH)2D -
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 1 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 10 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
Controls0 0 0 0 0 0 00 0 0 0 0 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
Ca intake - Quartile
25(OH)2D - Quintile
25(OH)2D - Quintile
25(OH)D - Quartile 4
25(OH)D - Quartile 3
Quartile 3:
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 1 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 1 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 1 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 1 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
>65.5 Quartile 3 Quartile 4 Quartile 1 Quartile 20 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 1 1 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 1 1 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
Ca 500 mg/d +
Ca + 10000 D2
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 1 1 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 1 1 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 1 1 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 1 1 1 0 00 1 1 1 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 1 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 1 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
Dairy product
Vit D intake -
High 25(OH)D,
Quartile 3: 1,25-D
Urinary Ca 125.0-
25(OH)D - Quartile 1
25(OH)D - Quartile 2
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 10 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 10 0 0 0 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
3-Q3 calciferol0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 00 0 0 0 0 0 10 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
Ca Intake - Quartile
Quartile 1:<30
Low 25(OH)D,
25(OH)D - Quintile
Quintile 5: >=
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 1 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
3-Q1 3-Q2 High Vit D0 0 0 0 0 0 00 0 0 0 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 1 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
Total daily
Caclium (patients
Quartile cut off
25(OH)D - Quintile
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 1 0 1 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 10 0 0 0 0 0 0
Dairy Ca intake -
Dairy Ca intake -
Ca enriched
Dairy Ca intake -
25(OH)D - Quintile
Dairy Ca intake -
25(OH)D - Group 2
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 01 1 0 1 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
Total0 1 0 0 0 0 10 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 1 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 1 0 1 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 1 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 01 1 0 0 0 0 00 1 0 0 0 0 0
25(OH)D - Group 1
Quintile 5: >=
Caclium (patients
Ca intake - Quintile
Vit D3 10 ug/d
Quintile 4: 60.6-
0 0 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 1 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 0
0 1 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 0
Vit D + Ca0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 01 0 0 0 0 0 01 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 00 0 0 0 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
Ca carbonate
Quartile 3: >50-75
Ca intake - Quintile
Quartile 3: 25-D
Ca intake - Quintile
Vit D3 20 ug/d
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 1 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 0
Deficiency0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
1,25(OH)D - Tertile
infant placebo
Ca intake - Quintile
Vit D 200,000
Ca + 5000 D2
Quintile 4: 28.3-
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 1 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 1 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
Dairy Ca0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
Ca Intake - Quartile
Ca intake - Quintile
1,25(OH)D - Tertile
>32 and <41.1
Control (low Ca)
Ca intake - Quintile
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 1 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
400 IU infant 3000 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 1 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
Vit D2 + Ca
Quartile 4: highest
Calcium intake -
Cholecalciferol 1200
Quintile 2-5
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 01 0 0 0 0 0 01 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 1 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 1 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
Baseline dietary Ca
Baseline dietary Ca
Baseline dietary Ca
No training +
25(OH)D, published
Ca intake - Quintile
Vit D intake -
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
Lactoval mom 4000 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 1 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
Ca suppleme
Baseline 25(OH)D -
Calcium carbonicu
Dairy group
Ca intake - Quartile
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 10 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
Placebo Low Vit D0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
>= 28 nmol/L
Ca intake - Quintile
Quartile 1: lowest
Ca Intake - Quartile
Ca intake - Quintile
0 0 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 1 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 0
0 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 0
Study ID:EF ID Creator Create Date PMID6307:194 admin Aug 18, 2013 Sep 5, 2014 78928826307:194 admin Aug 18, 2013 Sep 5, 2014 78928826309:194 admin Aug 18, 2013 Sep 5, 2014 182086366309:194 admin Aug 18, 2013 Sep 5, 2014 182086366309:194 admin Aug 18, 2013 Sep 5, 2014 182086366314:194 admin Aug 18, 2013 Sep 5, 2014 157673346316:194 admin Aug 18, 2013 Sep 5, 2014 179650376316:194 admin Aug 18, 2013 Sep 5, 2014 179650376316:194 admin Aug 18, 2013 Sep 5, 2014 179650376317:194 admin Aug 18, 2013 Sep 5, 2014 186895596317:194 admin Aug 18, 2013 Sep 5, 2014 186895596319:194 admin Aug 18, 2013 Sep 5, 2014 181983946319:194 admin Aug 18, 2013 Sep 5, 2014 181983946320:194 admin Aug 18, 2013 Sep 5, 2014 172438666320:194 admin Aug 18, 2013 Sep 5, 2014 172438666321:194 admin Aug 18, 2013 Sep 5, 2014 188427716321:194 admin Aug 18, 2013 Sep 5, 2014 188427716326:194 admin Aug 18, 2013 Sep 5, 2014 187553196326:194 admin Aug 18, 2013 Sep 5, 2014 187553196327:194 admin Aug 18, 2013 Sep 5, 2014 167979036327:194 admin Aug 18, 2013 Sep 5, 2014 167979036328:194 admin Aug 18, 2013 Sep 5, 2014 176564206328:194 admin Aug 18, 2013 Sep 5, 2014 176564206329:194 admin Aug 18, 2013 Sep 5, 2014 175025306329:194 admin Aug 18, 2013 Sep 5, 2014 175025306331:194 admin Aug 18, 2013 Sep 5, 2014 190016016333:194 admin Aug 18, 2013 Sep 5, 2014 162804476333:194 admin Aug 18, 2013 Sep 5, 2014 162804476333:194 admin Aug 18, 2013 Sep 5, 2014 162804476333:194 admin Aug 18, 2013 Sep 5, 2014 162804476334:194 admin Aug 18, 2013 Sep 5, 2014 152130386334:194 admin Aug 18, 2013 Sep 5, 2014 152130386336:194 admin Aug 18, 2013 Sep 5, 2014 86824536336:194 admin Aug 18, 2013 Sep 5, 2014 86824536338:194 admin Aug 18, 2013 Sep 5, 2014 171895526338:194 admin Aug 18, 2013 Sep 5, 2014 171895526338:194 admin Aug 18, 2013 Sep 5, 2014 171895526339:194 admin Aug 18, 2013 Sep 5, 2014 162782626339:194 admin Aug 18, 2013 Sep 5, 2014 162782626339:194 admin Aug 18, 2013 Sep 5, 2014 162782626353:194 admin Aug 18, 2013 Sep 5, 2014 74936596353:194 admin Aug 18, 2013 Sep 5, 2014 74936596357:194 admin Aug 18, 2013 Sep 5, 2014 172279966357:194 admin Aug 18, 2013 Sep 5, 2014 172279966358:194 admin Aug 18, 2013 Sep 5, 2014 105113296358:194 admin Aug 18, 2013 Sep 5, 2014 105113296360:194 admin Aug 18, 2013 Sep 5, 2014 16286519
Last Updated
6360:194 admin Aug 18, 2013 Sep 5, 2014 162865196361:194 admin Aug 18, 2013 Sep 5, 2014 145539576361:194 admin Aug 18, 2013 Sep 5, 2014 145539576362:194 admin Aug 18, 2013 Sep 5, 2014 124993436362:194 admin Aug 18, 2013 Sep 5, 2014 124993436362:194 admin Aug 18, 2013 Sep 5, 2014 124993436362:194 admin Aug 18, 2013 Sep 5, 2014 124993436363:194 admin Aug 18, 2013 Sep 5, 2014 94050296363:194 admin Aug 18, 2013 Sep 5, 2014 94050296373:194 admin Aug 18, 2013 Sep 5, 2014 175528806373:194 admin Aug 18, 2013 Sep 5, 2014 175528806373:194 admin Aug 18, 2013 Sep 5, 2014 175528806381:194 admin Aug 18, 2013 Sep 5, 2014 192211906382:194 admin Aug 18, 2013 Sep 5, 2014 153541506382:194 admin Aug 18, 2013 Sep 5, 2014 153541506383:194 admin Aug 18, 2013 Sep 5, 2014 175566976383:194 admin Aug 18, 2013 Sep 5, 2014 175566976383:194 admin Aug 18, 2013 Sep 5, 2014 175566976384:194 admin Aug 18, 2013 Sep 5, 2014 184333056384:194 admin Aug 18, 2013 Sep 5, 2014 184333056390:194 admin Aug 18, 2013 Sep 5, 2014 85579656390:194 admin Aug 18, 2013 Sep 5, 2014 85579656393:194 admin Aug 18, 2013 Sep 5, 2014 164000446393:194 admin Aug 18, 2013 Sep 5, 2014 164000446394:194 admin Aug 18, 2013 Sep 5, 2014 174739116394:194 admin Aug 18, 2013 Sep 5, 2014 174739116395:194 admin Aug 18, 2013 Sep 5, 2014 172091776395:194 admin Aug 18, 2013 Sep 5, 2014 172091776396:194 admin Aug 18, 2013 Sep 5, 2014 37555176396:194 admin Aug 18, 2013 Sep 5, 2014 37555176396:194 admin Aug 18, 2013 Sep 5, 2014 37555176397:194 admin Aug 18, 2013 Sep 5, 2014 188246626397:194 admin Aug 18, 2013 Sep 5, 2014 188246626401:194 admin Aug 18, 2013 Sep 5, 2014 36232606401:194 admin Aug 18, 2013 Sep 5, 2014 36232606402:194 admin Aug 18, 2013 Sep 5, 2014 32436096402:194 admin Aug 18, 2013 Sep 5, 2014 32436096403:194 admin Aug 18, 2013 Sep 5, 2014 163915876403:194 admin Aug 18, 2013 Sep 5, 2014 163915876403:194 admin Aug 18, 2013 Sep 5, 2014 163915876404:194 admin Aug 18, 2013 Sep 5, 2014 67930586404:194 admin Aug 18, 2013 Sep 5, 2014 67930586412:194 admin Aug 18, 2013 Sep 5, 2014 171818906412:194 admin Aug 18, 2013 Sep 5, 2014 171818906412:194 admin Aug 18, 2013 Sep 5, 2014 171818906413:194 admin Aug 18, 2013 Sep 5, 2014 191257566413:194 admin Aug 18, 2013 Sep 5, 2014 191257566414:194 admin Aug 18, 2013 Sep 5, 2014 19158226
6414:194 admin Aug 18, 2013 Sep 5, 2014 191582266423:194 admin Aug 18, 2013 Sep 5, 2014 112975966423:194 admin Aug 18, 2013 Sep 5, 2014 112975966428:194 admin Aug 18, 2013 Sep 5, 2014 158271036428:194 admin Aug 18, 2013 Sep 5, 2014 158271036434:194 admin Aug 18, 2013 Sep 5, 2014 74981006434:194 admin Aug 18, 2013 Sep 5, 2014 74981006439:194 admin Aug 18, 2013 Sep 5, 2014 190569006439:194 admin Aug 18, 2013 Sep 5, 2014 190569006439:194 admin Aug 18, 2013 Sep 5, 2014 190569006445:194 admin Aug 18, 2013 Sep 5, 2014 33073076445:194 admin Aug 18, 2013 Sep 5, 2014 33073076446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406452:194 admin Aug 18, 2013 Sep 5, 2014 37888356452:194 admin Aug 18, 2013 Sep 5, 2014 37888356456:194 admin Aug 18, 2013 Sep 5, 2014 164816366456:194 admin Aug 18, 2013 Sep 5, 2014 164816366460:194 admin Aug 18, 2013 Sep 5, 2014 86750936460:194 admin Aug 18, 2013 Sep 5, 2014 86750936462:194 admin Aug 18, 2013 Sep 5, 2014 90225616462:194 admin Aug 18, 2013 Sep 5, 2014 90225616466:194 admin Aug 18, 2013 Sep 5, 2014 77958376466:194 admin Aug 18, 2013 Sep 5, 2014 77958376468:194 admin Aug 18, 2013 Sep 5, 2014 180897016468:194 admin Aug 18, 2013 Sep 5, 2014 180897016468:194 admin Aug 18, 2013 Sep 5, 2014 180897016469:194 admin Aug 18, 2013 Sep 5, 2014 184102256469:194 admin Aug 18, 2013 Sep 5, 2014 18410225
Alt ID(s) Title Year Author19951995200820082008200520082008200820082008200820082007200720082008200820082006200620072007200720072008200520052005200520042004-- Not Found ---- Not Found --2006200620062006200620061995199520072007199919992005
The influence of menopause and hormonal
Aloia JF., Vaswani A., Russo L., Sheehan M., The influence of
menopause and hormonal Aloia JF., Vaswani A., Russo L., Sheehan M., Effect of vitamin D
supplementation on bone Andersen R., Mølgaard C., Skovgaard LT., Brot C., Effect of vitamin D
supplementation on bone Andersen R., Mølgaard C., Skovgaard LT., Brot C., Effect of vitamin D
supplementation on bone Andersen R., Mølgaard C., Skovgaard LT., Brot C., Risk of prostate cancer in
a randomized clinical trial Baron JA., Beach M., Wallace K., Grau MV., Vitamin D
supplementation has Björkman M., Sorva A., Risteli J., Tilvis R.Vitamin D
supplementation has Björkman M., Sorva A., Risteli J., Tilvis R.Vitamin D
supplementation has Björkman M., Sorva A., Risteli J., Tilvis R.Body size and serum 25
hydroxy vitamin D Blum M., Dallal GE., Dawson-Hughes B.Body size and serum 25
hydroxy vitamin D Blum M., Dallal GE., Dawson-Hughes B.Vascular events in healthy
older women receiving Bolland MJ., Barber PA., Doughty RN., Mason B., Vascular events in healthy
older women receiving Bolland MJ., Barber PA., Doughty RN., Mason B., Two-year randomized
controlled trial of vitamin Bolton-Smith C., McMurdo ME., Paterson CR., Mole Two-year randomized
controlled trial of vitamin Bolton-Smith C., McMurdo ME., Paterson CR., Mole Dairy calcium
supplementation in Bortolotti M., Rudelle S., Schneiter P., Vidal H., Dairy calcium
supplementation in Bortolotti M., Rudelle S., Schneiter P., Vidal H., Calcium, vitamin D
supplementation, and Brunner RL., Cochrane B., Jackson RD., Larson J., Calcium, vitamin D
supplementation, and Brunner RL., Cochrane B., Jackson RD., Larson J., Effects of vitamin D
supplementation and Bunout D., Barrera G., Leiva L., Gattas V., de la Effects of vitamin D
supplementation and Bunout D., Barrera G., Leiva L., Gattas V., de la Does vitamin D stop
inpatients falling? A Burleigh E., McColl J., Potter J.Does vitamin D stop
inpatients falling? A Burleigh E., McColl J., Potter J.Calcium plus vitamin D
supplementation and the Caan B., Neuhouser M., Aragaki A., Lewis CB., Calcium plus vitamin D
supplementation and the Caan B., Neuhouser M., Aragaki A., Lewis CB., Calcium plus vitamin D
supplementation and the Chlebowski RT., Johnson KC., Kooperberg C., Effects of calcium, dairy
product, and vitamin D Cheng S., Lyytikäinen A., Kröger H., Lamberg-Allardt Effects of calcium, dairy
product, and vitamin D Cheng S., Lyytikäinen A., Kröger H., Lamberg-Allardt Effects of calcium, dairy
product, and vitamin D Cheng S., Lyytikäinen A., Kröger H., Lamberg-Allardt Effects of calcium, dairy
product, and vitamin D Cheng S., Lyytikäinen A., Kröger H., Lamberg-Allardt Weight loss and calcium
intake influence calcium Cifuentes M., Riedt CS., Brolin RE., Field MP., Weight loss and calcium
intake influence calcium Cifuentes M., Riedt CS., Brolin RE., Field MP., Calcium chemoprevention
in colorectal cancer.Duris I., Hruby D., Pekarkova B., Huorka M., Calcium chemoprevention
in colorectal cancer.Duris I., Hruby D., Pekarkova B., Huorka M., Effect of 1-year dairy
product intervention on fat Eagan MS., Lyle RM., Gunther CW., Peacock M., Effect of 1-year dairy
product intervention on fat Eagan MS., Lyle RM., Gunther CW., Peacock M., Effect of 1-year dairy
product intervention on fat Eagan MS., Lyle RM., Gunther CW., Peacock M., Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J., Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J., Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J., The influence of dairy
products on plasma uric Ghadirian P., Shatenstein B., Verdy M., Hamet P.The influence of dairy
products on plasma uric Ghadirian P., Shatenstein B., Verdy M., Hamet P.Prolonged effect of
calcium supplementation Grau MV., Baron JA., Sandler RS., Wallace K., Prolonged effect of
calcium supplementation Grau MV., Baron JA., Sandler RS., Wallace K., Plasma 25-hydroxyvitamin
D responses of younger Harris SS., Dawson-Hughes B., Perrone GA.Plasma 25-hydroxyvitamin
D responses of younger Harris SS., Dawson-Hughes B., Perrone GA.The impact of calcium and
dairy product consumption Harvey-Berino J., Gold BC., Lauber R., Starinski A.
200520032003200320032003200319971997200820082008200920042004200720072007200820081995 Lijnen P., Petrov V.1995 Lijnen P., Petrov V.200620062007200720072007198619861986200820081987198719881988200620062006198119812006 Moschonis G., Manios Y.2006 Moschonis G., Manios Y.2006 Moschonis G., Manios Y.200920092009
The impact of calcium and dairy product consumption
Harvey-Berino J., Gold BC., Lauber R., Starinski A.Gestational calcium
supplementation and Hatton DC., Harrison-Hohner J., Coste S., Reller Gestational calcium
supplementation and Hatton DC., Harrison-Hohner J., Coste S., Reller Human serum 25-
hydroxycholecalciferol Heaney RP., Davies KM., Chen TC., Holick MF., Human serum 25-
hydroxycholecalciferol Heaney RP., Davies KM., Chen TC., Holick MF., Human serum 25-
hydroxycholecalciferol Heaney RP., Davies KM., Chen TC., Holick MF., Human serum 25-
hydroxycholecalciferol Heaney RP., Davies KM., Chen TC., Holick MF., Long-term vitamin D3
supplementation may Heikkinen AM., Tuppurainen MT., Long-term vitamin D3
supplementation may Heikkinen AM., Tuppurainen MT., Calcium intake and the
outcome of short-term Kabrnová-Hlavatá K., Hainer V., Gojová M., Calcium intake and the
outcome of short-term Kabrnová-Hlavatá K., Hainer V., Gojová M., Calcium intake and the
outcome of short-term Kabrnová-Hlavatá K., Hainer V., Gojová M., Calcium plus vitamin D
supplementation and LaCroix AZ., Kotchen J., Anderson G., Brzyski R., Girls on a high-calcium
diet gain weight at the Lappe JM., Rafferty KA., Davies KM., Lypaczewski Girls on a high-calcium
diet gain weight at the Lappe JM., Rafferty KA., Davies KM., Lypaczewski Vitamin D and calcium
supplementation reduces Lappe JM., Travers-Gustafson D., Davies KM., Vitamin D and calcium
supplementation reduces Lappe JM., Travers-Gustafson D., Davies KM., Vitamin D and calcium
supplementation reduces Lappe JM., Travers-Gustafson D., Davies KM., Calcium and vitamin d
supplementation Lappe J., Cullen D., Haynatzki G., Recker R., Calcium and vitamin d
supplementation Lappe J., Cullen D., Haynatzki G., Recker R., Dietary calcium, blood
pressure and cell Dietary calcium, blood pressure and cell Calcium supplementation for 1 y does not reduce
Lorenzen JK., Mølgaard C., Michaelsen KF., Astrup A.Calcium supplementation
for 1 y does not reduce Lorenzen JK., Mølgaard C., Michaelsen KF., Astrup A.Preventing fractures
among older people living Lyons RA., Johansen A., Brophy S., Newcombe RG., Preventing fractures
among older people living Lyons RA., Johansen A., Brophy S., Newcombe RG., Supplementation with
calcium + vitamin D Major GC., Alarie F., Doré J., Phouttama S., Tremblay Supplementation with
calcium + vitamin D Major GC., Alarie F., Doré J., Phouttama S., Tremblay Vitamin D
supplementation in Mallet E., Gügi B., Brunelle P., Hénocq A., Basuyau JP., Vitamin D
supplementation in Mallet E., Gügi B., Brunelle P., Hénocq A., Basuyau JP., Vitamin D
supplementation in Mallet E., Gügi B., Brunelle P., Hénocq A., Basuyau JP., Effect of calcium and
vitamin D supplementation Margolis KL., Ray RM., Van Horn L., Manson JE., Allison Effect of calcium and
vitamin D supplementation Margolis KL., Ray RM., Van Horn L., Manson JE., Allison Effect of calcium and
vitamin D supplementation Marya RK., Rathee S., Manrow M.Effect of calcium and
vitamin D supplementation Marya RK., Rathee S., Manrow M.Effect of vitamin D
supplementation during Marya RK., Rathee S., Dua V., Sangwan K.Effect of vitamin D
supplementation during Marya RK., Rathee S., Dua V., Sangwan K.Vitamin D2 dose required
to rapidly increase 25OHD Mastaglia SR., Mautalen CA., Parisi MS., Oliveri B.Vitamin D2 dose required
to rapidly increase 25OHD Mastaglia SR., Mautalen CA., Parisi MS., Oliveri B.Vitamin D2 dose required
to rapidly increase 25OHD Mastaglia SR., Mautalen CA., Parisi MS., Oliveri B.Vitamin D supplements
enhance weight gain and Maxwell JD., Ang L., Brooke OG., Brown IR.Vitamin D supplements
enhance weight gain and Maxwell JD., Ang L., Brooke OG., Brown IR.Skeletal site-dependent
response of bone mineral Skeletal site-dependent response of bone mineral Skeletal site-dependent response of bone mineral A double-blind, randomized, placebo-
Nagpal J., Pande JN., Bhartia A.A double-blind,
randomized, placebo-Nagpal J., Pande JN., Bhartia A.Supplements of 20
microg/d cholecalciferol Nelson ML., Blum JM., Hollis BW., Rosen C.,
20092001200120052005199519952008200820081987198720032003198619862006200619961996199719971995199520082008200820082008
Supplements of 20 microg/d cholecalciferol
Nelson ML., Blum JM., Hollis BW., Rosen C., Effects of a short-term
vitamin D(3) and calcium Pfeifer M., Begerow B., Minne HW., Nachtigall D., Effects of a short-term
vitamin D(3) and calcium Pfeifer M., Begerow B., Minne HW., Nachtigall D., Effects of calcium
supplementation on body Reid IR., Horne A., Mason B., Ames R., Bava U., Effects of calcium
supplementation on body Reid IR., Horne A., Mason B., Ames R., Bava U., Effect of winter oral
vitamin D3 Scragg R., Khaw KT., Murphy S.Effect of winter oral
vitamin D3 Scragg R., Khaw KT., Murphy S.Supplementation with
cholecalciferol does not Sneve M., Figenschau Y., Jorde R.Supplementation with
cholecalciferol does not Sneve M., Figenschau Y., Jorde R.Supplementation with
cholecalciferol does not Sneve M., Figenschau Y., Jorde R.Dietary calcium intake and
blood pressure in Thomsen K., Nilas L., Christiansen C.Dietary calcium intake and
blood pressure in Thomsen K., Nilas L., Christiansen C.Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.Oral calcium and blood
pressure: a controlled van Beresteyn EC., Schaafsma G., de Waard Oral calcium and blood
pressure: a controlled van Beresteyn EC., Schaafsma G., de Waard Calcium plus vitamin D
supplementation and the Wactawski-Wende J., Kotchen JM., Anderson GL., Calcium plus vitamin D
supplementation and the Wactawski-Wende J., Kotchen JM., Anderson GL., Effect of longterm placebo
controlled calcium Weisgerber UM., Boeing H., Owen RW., Waldherr Effect of longterm placebo
controlled calcium Weisgerber UM., Boeing H., Owen RW., Waldherr Efficacy of
nonpharmacologic Whelton PK., Kumanyika SK., Cook NR., Cutler JA., Efficacy of
nonpharmacologic Whelton PK., Kumanyika SK., Cook NR., Cutler JA., Lack of blood pressure
effect with calcium and Yamamoto ME., Applegate WB., Klag MJ., Borhani NO., Lack of blood pressure
effect with calcium and Yamamoto ME., Applegate WB., Klag MJ., Borhani NO., Effects of calcium and
vitamin D supplementation Zhu K., Devine A., Dick IM., Wilson SG., Prince RL.Effects of calcium and
vitamin D supplementation Zhu K., Devine A., Dick IM., Wilson SG., Prince RL.Effects of calcium and
vitamin D supplementation Zhu K., Devine A., Dick IM., Wilson SG., Prince RL.Randomized controlled
trial of the effects of Zhu K., Bruce D., Austin N., Devine A., Ebeling PR., Randomized controlled
trial of the effects of Zhu K., Bruce D., Austin N., Devine A., Ebeling PR.,
Arm Source DoseCa supplement nd about type 1700 mg Ca 2.9 +/- 1.1 yrs. ndCalcium placebo nd nd nd ndVit D3 10 ug/d 10 ug/d 1 yr DailyVit D3 20 ug/d nd 20 ug/d 1 yr DailyPlacebo 0 1 yr Daily
nd nd6 months nd6 months nd
Placebo nd nd nd ndVit D + Ca nd 3 y ndPlacebo nd Placebo 3 y ndCalcium 1 g (elemental) 5 yearsPlacebo nd nd nd nd
2 yearsPlacebo nd nd nd ndCalcium 800 mg/d 5 wksPlacebo - 5 wksPlacebo nd nd nd ndVit D + Ca Average 7.1 yrs two times a dayCalcium nd 800mg of Ca 9 months one time/dayVit D + Ca nd 9 months one time/dayVit D + Ca Once dailyCalcium calcium carbonate Once dailyVit D + Ca 1000 mg 400 IU 7 yearsPlacebo nd nd 7 years 2x/dayVit D3 + Ca GlaxoSmith Kline 7 yearsVit D + Ca 24 moCa + Placebo ndDairy product nd nd ndPlacebo nd ndCalcium 6 weeksPlacebo 6 weeks
2 g ndnd nd
High dairy Foods from dairy 1y ndMedium dairy Foods from dairy 1y ndControl nd 1y ndLow Vit D 200IU/d 1yHigh Vit D 2000IU/d 1yPlacebo Oily solution nd 1yDairy diet Regular food 4 wk 3 mealsDairy free diet nd nd ndCalcium 4y 1 time/dayPlacebo nd nd nd ndPlacebo nd nd nd ndVit D2 supplment 1800 IU/d 3 wk qAM
12 months nd
Arm Description
Intervention Duration
Intervention
Scanphrm A/S (Birkerod,
Cellulosum microcristalliumCa carbonate
supplementCaCO3 3g (= elemental Ca
Mean 44 mo (Compliance >/= Cholecalciferol
400 IU/dayCholecalciferol (Vigantol, Merck
Vitamin D 400 IU/day (group II)Cholecalciferol
1200 IU/dayCholecalciferol (Vigantol, Merck
Vitamin D 1200 IU/day (group III)
vit D3 700 IU + Ca 500 mg/d
Calcium citrate (Citracal)
2 x 200 mg before breakfast; 3 x 200
100 mg of elemental calcium
A chewable tablet form contains
100 mg of elemental calcium
2 tablets per day with breakfast
Dairy Ca supplement
Sachets were taken 2 times a Made of
maltodextrin and Sachets were taken 2 times a
500mg calcium carbonate +
1000mg calcium carbonate +
800mg of Ca + 400 IU of vitDcholecalciferol
+calcium 800iu cholecalciferol
The intervention was continued 1200mg calcium
carbonateContinued until time of patient Ca carbonate
Cholecalciferol500 mg/200 IU 2x/day
400 IU vit D 1000 mg Ca
200 IU vit D x twice daily 500 Tums or Kalcipos
(calcium); 1000 mg calcium carbonate + 200
one tab in am; one tab in pm; drops Tums or Kalcipos
(calcium)1000 mg calcium carbonate + vit D
one tab in am; one tab in pm; drops 1000 mg calcium
equivalentcalcium placebo + vit D placebo
one tab in am; one tab in pm; drops Supplement of
calcium citrate, 1.2 g/d in high calcium group
2 Ca tablets in the morning, 3 in the Supplement of
calcium citrate, 0.4 g/d in normal calcium group
2 tablets in the morning, 3 in the Caclium (patients
with polyps)Calcium carbonicum
Mean: 3.1 yr range 1-6 yr Caclium (patients
with CRC)Calcium carbonicum
~50 mo (based on Kaplan Meier 1300-1400mg
Ca/day from dairy1000-1100mg Ca/day from dairyMaintain current dietary Diluted Vigantol
oil, Merck KGaA, Weekly, usually taken on the Vigantol oil, Merck
KGaA, Darmstadt, Weekly, usually taken on the Weekly, usually taken on the Achieved 1242
mg/d (30 g dairy Achieved 377 mg/dayCa
supplementation1200mg of elemental calcium
Drisdol (Sanofi Winthrop, NY)High dairy (high
Ca)3-4 dairy servings/d (milk,
Goal of 1200 to 1400 mg/d Ca
Control (low Ca) 12 months ndPlacebo nd nd nd nd
Ca carbonate 2 gzero dose nd zero dose ~20 wk nd1000 IU 25 g (1000 IU) ~20 wk 1 tab5000 IU Tishcon, NY 125 g (5000 IU) ~20 wk 1 tab10000 IU Tishcon, NY 250 g (10,000 IU) ~20 wk 2 tabsVit D3 + Ca 30 mo ndCalcium 30 mo ndPlacebo Food/tablets 3 wks
3 wksLactoval 3 wksCa + Vit D nd nd nd ndCa enriched diet 1500 mg/d 24 mo ndUsual diet nd nd nd ndPlacebo nd placebo 4 y(?) ndCalcium nd 4 y(?) ndCa + Vit D nd 4 y(?) ndCa + Vit D nd 8 weeksPlacebo nd nd nd ndCa supplement Ca gluconate 2 g 16 wk 1 g 2x/dayPlacebo nd nd nd ndCalcium calcium carbonate 500 mg 1 yPlacebo nd nd nd ndVit D 822IU/d 3 yearsPlacebo nd nd 3 years Every 4 monthsPlacebo nd nd nd ndVit D + Ca 15 wk 1 capsule 2x/dunsupplemented nd nd nd ndVit D 1000 IU/d nd 1000 IU nd
nd nd ndPlacebo nd nd nd ndVit D + Ca 7y 2 times/dVit D + Ca nd 16-20 wk ndPlacebo nd nd nd nd1.2 million IU vit D nd ndPlacebo nd nd nd nd
calcium carbonate 3 mo 1 tablet qd3 mo3 mo
calciferol nd 1000 IU/d 3rd trimester only ndPlacebo nd nd nd ndControl Not Applicable 12 mo Not ApplicableCa supplement 600 mg 12 mo ndDairy group 12 moVit D 6 wkPlacebo - 6 wkVit D3 Vit D3 supplement Vit D3 20 g/d 6 mo One time/day
One dairy serving/d
Goal of 400-500 mg/d Ca
Ca supplement (prenatal)
~20-30 weeks (during pregnancy
2x500 mg capsules 2x/day
Douglas Laboratory,
D-Calsor, Orion Corporation,
300 IU Vit D3/day, 500 mg/day D-Calsor, Orion
Corporation, 500 mg/day calcium lactate350 mg/d from food
Placebo tablets were taken 3x/dayCa carbonate
supplementCalcium carbonate + food
500 mg/d tablet / 350 mg/d from
Tablets were taken 3x/dayLactoval (70% Ca
phosphate, 20% 500 mg/d tablet / 350 mg/d from
Tablets were taken 3x/day
foods, calcium-fortified foods (but
calcium citrate (1400 mg Ca/d) or calcium citrate (1400 mg Ca/d) or 200 mg calcium and 800 IU
4 supplement pills per day made
two 250 mg chewables with
Supplementation ergo-calciferol
Every 4 months (Two 1.25 mg vit
Supplements (Caltrate 600+D)
Ca: 1200 mg (Ca carbonate per
daily for last 3 mo pregnancyVit D 200,000 IU
1x!x at 7 mo pregnancy
Ca-Tablet as calcium carbonate
Ca 1000mg VitD3 400IUcalcium 375 mg and Vit D 1200 IU
unclear if this is oral or parenteral
600,000 IU once each in 7th and
Ca 500 mg/d + No vit D
calcium 500 mg/d + No vit DCa 500 mg/d + vit
D 125 ug/dcalcium carbonate + vit D2 (Spedrog-
calcium 500 mg/d + 5000 IU/d vit D2
2 drop qd of vit D2 + 1 tablet of Ca 500 mg/d + vit
D 250 ug/dcalcium carbonate + vit D2 (Spedrog-
calcium 500 mg/d + 10000 IU/d vit
4 drop qd of vit D2 + 1 tablet of
No intervention, usual dietSupplementary Ca (87% of Calcium Advised to consume 3
400 mg calcium/portion
Advice to consume dairy Calcirol (brand
name of 8571 IU cholecalciferol
120,000 IU sachets given 3 Identical to vit D
in color, taste, and Placebo sachets given 3 times,
Placebo nd nd nd ndCalcium Ca carbonate 8 wksVit D + Ca 8 wksPlacebo nd nd nd ndCa supplement 1 g (elemental) 5 yearsCholecalciferolPlacebo nd ndVit D + Ca 1 yr
1 yrCa + placebo 500 mg Ca 1 yrCalcium 2,000 mg One year ndPlacebo nd nd nd ndVit D 1 cap q 4 moPlacebo Matching placebo nd nd ndCalcium 1500 mg Ca++ 6 weeks Three times a dayPlacebo 0 mg Ca++ 6 weeks Three times a dayPlacebo Not Applicable 7y Taken twice dailyVit D + Ca 7yCalcium supplement 2000 mg/d 9 monPlacebo nd nd nd ndCa supplement Ca carbonate 1 g 18 mo 500 mg 2x/dayPlacebo nd nd nd ndCalcium Calcium carbonate 1 g Ca 6 mo.Placebo nd N/A 6 mo.Ca + Placebo Ca 1200 mg 5yVit D + Ca 5yPlacebo n/a 5y n/aCa + Placebo 1000 mg/d 1 yrVit D2 + Ca 1 yr
1200 mg elemental Ca
Capsules were taken 2x/day Ca carbonate Vit
D31200 mg elemental Ca and
Capsules were taken 2x/day
Calcium citrate (Citracal)
2 x 200 mg before breakfast; 3 x 200 Prepared in
Arachis oil by a 2.5 mg (100,000 IU)
Follow-up assessment 5 wks
One time drink taken in presence Prepared in
Arachis oil by a One time drink taken in presence Vit D capsules
from Jenapharm, 5714 IU cholecalciferol +
2 capsules each containing 20,000 Vit D + Ca +
placeboVit D capsules from Jenapharm,
2857 IU cholecalciferol +
1 capsule containing 20,000 Ca supplement
Nycoplus Ca, 2 placebo capsules taken Sandoz (calcium
lactate-gluconate,
Vit D3 (cholecalciferol)
100,000 IU q 4 months (~833
5 years (15 total doses)
Calcium powder containing calcium Placebo powder containing citric identical appearing placebo VitD GlaxoSmithKline
VitD 400 IU + Ca 1000 mg
200IU of VitD twice daily 500mg A 1000mg tablet was take with
Pills were taken 2 times a dayPills were taken 2 times a dayCa (Caltrate;
Wyeth Consumer 600 mg of Ca twice/dayCa (Caltrate;
Wyeth Consumer Ca 1200 mg + VitD2 1000 IU
600 mg of Ca twice/day + 1000 Placebo Ca (nd) +
Placebo vitD (nd)Calcium citrate (Citracal; Mission
Consume with evening mealOstelin; Boots
Healthcare, North 1000 IU vit D2 + 1000 mg/d Ca
Consume with evening meal
nd ndnd ndnd ndnd ndnd ndnd ndnd ndnd ndnd ndnd ndnd ndNoneNonend ndnd ndnd ndnd nd
nd ndnd ndnd ndnd ndnd ndnd nd
nd ndnd ndnd ndnd ndnd ndnd ndnd ndnd ndnd ndnd ndnd ndnd ndnd ndnd ndnd ndnd ndNoneNonend ndnd nd
Co-interventio
Compliance/Adherence
Calcium: 396 (54%) alive, Calcium: 396 (54%) alive,
Hormone therapy, dietary
No information on adherence rate Hormone therapy,
dietary No information on adherence rate
Hormone use was similar in both
60%-63% during first 3 years of
50% (no information on 50% (no information on
Calorie restriction in both groups
7 dropped out from not being
nd ndnd ndnd ndnd ndnd ndnd nd
nd ndnd ndnd ndnd ndnd ndnd ndnd ndnd ndnd ndnd ndnd ndnd ndnd ndnd nd
ndnd
nd ndnd ndnd ndNoneNonend ndnd ndnd ndnd ndnd ndnd ndnd ndnd ndnd ndNoneNoneNonend ndnd ndnd nd
Calorie restriction in both groups
7 dropped out from not being All received
prenatal vitamin nd (but all had to meet a All received
prenatal vitamin nd (but all had to meet a
Only those subjects who
All subjects were advised to eat all Only those
subjects who All subjects were advised to eat all Only those
subjects who All subjects were advised to eat all
Energy restriction diet: -700 Kcal/d, Energy restriction diet: -700 Kcal/d,
60% (proportion taking study 60% (proportion taking study
Dairy group 93% (assessed via Dairy group 93% (assessed via Dairy group 93% (assessed via
nd ndndndNoneNonend ndnd ndnd ndnd ndnd ndnd ndnd ndnd ndnd ndnd ndnd nd
nd ndnd ndnd ndnd ndnd ndnd ndNoneNoneNoneNoneNone
Assessed by pill counts, 95 12% Assessed by pill counts, 95 12% Calcium: 396 (54%) alive, Calcium: 396 (54%) alive,
54%of the participants
During year 1, 60% of the 54%of the
participants During year 1, 60% of the
Measured by counting tablets Measured by counting tablets Measured by counting tablets Tablet counting, 86.7% and 86.8% Tablet counting, 86.7% and 86.8%
Study ID:EF ID Creator Create Date PMID6304:194 admin Aug 18, 2013 Sep 5, 2014 185059676305:194 admin Aug 18, 2013 Sep 5, 2014 110758746306:194 admin Aug 18, 2013 Sep 5, 2014 126632776307:194 admin Aug 18, 2013 Sep 5, 2014 78928826308:194 admin Aug 18, 2013 Sep 5, 2014 162804276309:194 admin Aug 18, 2013 Sep 5, 2014 182086366313:194 admin Aug 18, 2013 Sep 5, 2014 97435116314:194 admin Aug 18, 2013 Sep 5, 2014 157673346315:194 admin Aug 18, 2013 Sep 5, 2014 161034506316:194 admin Aug 18, 2013 Sep 5, 2014 179650376317:194 admin Aug 18, 2013 Sep 5, 2014 186895596318:194 admin Aug 18, 2013 Sep 5, 2014 175359856319:194 admin Aug 18, 2013 Sep 5, 2014 181983946320:194 admin Aug 18, 2013 Sep 5, 2014 172438666321:194 admin Aug 18, 2013 Sep 5, 2014 188427716322:194 admin Aug 18, 2013 Sep 5, 2014 83334126323:194 admin Aug 18, 2013 Sep 5, 2014 99219606325:194 admin Aug 18, 2013 Sep 5, 2014 76128036326:194 admin Aug 18, 2013 Sep 5, 2014 187553196327:194 admin Aug 18, 2013 Sep 5, 2014 167979036328:194 admin Aug 18, 2013 Sep 5, 2014 176564206329:194 admin Aug 18, 2013 Sep 5, 2014 175025306330:194 admin Aug 18, 2013 Sep 5, 2014 115666566331:194 admin Aug 18, 2013 Sep 5, 2014 190016016333:194 admin Aug 18, 2013 Sep 5, 2014 162804476334:194 admin Aug 18, 2013 Sep 5, 2014 152130386335:194 admin Aug 18, 2013 Sep 5, 2014 82200926336:194 admin Aug 18, 2013 Sep 5, 2014 86824536337:194 admin Aug 18, 2013 Sep 5, 2014 88906616338:194 admin Aug 18, 2013 Sep 5, 2014 171895526339:194 admin Aug 18, 2013 Sep 5, 2014 162782626340:194 admin Aug 18, 2013 Sep 5, 2014 80781156341:194 admin Aug 18, 2013 Sep 5, 2014 153424526342:194 admin Aug 18, 2013 Sep 5, 2014 156684856344:194 admin Aug 18, 2013 Sep 5, 2014 173720316345:194 admin Aug 18, 2013 Sep 5, 2014 188386236346:194 admin Aug 18, 2013 Sep 5, 2014 179715266347:194 admin Aug 18, 2013 Sep 5, 2014 183814726348:194 admin Aug 18, 2013 Sep 5, 2014 90612756349:194 admin Aug 18, 2013 Sep 5, 2014 173110576350:194 admin Aug 18, 2013 Sep 5, 2014 88502736351:194 admin Aug 18, 2013 Sep 5, 2014 28573646352:194 admin Aug 18, 2013 Sep 5, 2014 25729006353:194 admin Aug 18, 2013 Sep 5, 2014 74936596357:194 admin Aug 18, 2013 Sep 5, 2014 172279966358:194 admin Aug 18, 2013 Sep 5, 2014 105113296359:194 admin Aug 18, 2013 Sep 5, 2014 15671222
Last Updated
6360:194 admin Aug 18, 2013 Sep 5, 2014 162865196361:194 admin Aug 18, 2013 Sep 5, 2014 145539576362:194 admin Aug 18, 2013 Sep 5, 2014 124993436363:194 admin Aug 18, 2013 Sep 5, 2014 94050296364:194 admin Aug 18, 2013 Sep 5, 2014 39462956369:194 admin Aug 18, 2013 Sep 5, 2014 152258336370:194 admin Aug 18, 2013 Sep 5, 2014 116417506372:194 admin Aug 18, 2013 Sep 5, 2014 82014446373:194 admin Aug 18, 2013 Sep 5, 2014 175528806374:194 admin Aug 18, 2013 Sep 5, 2014 82055386375:194 admin Aug 18, 2013 Sep 5, 2014 93438376376:194 admin Aug 18, 2013 Sep 5, 2014 86107046377:194 admin Aug 18, 2013 Sep 5, 2014 158805326378:194 admin Aug 18, 2013 Sep 5, 2014 175361916379:194 admin Aug 18, 2013 Sep 5, 2014 171064376380:194 admin Aug 18, 2013 Sep 5, 2014 183980336382:194 admin Aug 18, 2013 Sep 5, 2014 153541506383:194 admin Aug 18, 2013 Sep 5, 2014 175566976384:194 admin Aug 18, 2013 Sep 5, 2014 184333056385:194 admin Aug 18, 2013 Sep 5, 2014 165229156386:194 admin Aug 18, 2013 Sep 5, 2014 165229156387:194 admin Aug 18, 2013 Sep 5, 2014 183322896388:194 admin Aug 18, 2013 Sep 5, 2014 190565696389:194 admin Aug 18, 2013 Sep 5, 2014 173886676390:194 admin Aug 18, 2013 Sep 5, 2014 85579656391:194 admin Aug 18, 2013 Sep 5, 2014 158002686392:194 admin Aug 18, 2013 Sep 5, 2014 175332086393:194 admin Aug 18, 2013 Sep 5, 2014 164000446394:194 admin Aug 18, 2013 Sep 5, 2014 174739116395:194 admin Aug 18, 2013 Sep 5, 2014 172091776396:194 admin Aug 18, 2013 Sep 5, 2014 37555176397:194 admin Aug 18, 2013 Sep 5, 2014 188246626398:194 admin Aug 18, 2013 Sep 5, 2014 159554676399:194 admin Aug 18, 2013 Sep 5, 2014 120201026401:194 admin Aug 18, 2013 Sep 5, 2014 36232606402:194 admin Aug 18, 2013 Sep 5, 2014 32436096403:194 admin Aug 18, 2013 Sep 5, 2014 163915876404:194 admin Aug 18, 2013 Sep 5, 2014 67930586405:194 admin Aug 18, 2013 Sep 5, 2014 127087196406:194 admin Aug 18, 2013 Sep 5, 2014 163650076407:194 admin Aug 18, 2013 Sep 5, 2014 186950766408:194 admin Aug 18, 2013 Sep 5, 2014 188278116409:194 admin Aug 18, 2013 Sep 5, 2014 171064376410:194 admin Aug 18, 2013 Sep 5, 2014 163526846411:194 admin Aug 18, 2013 Sep 5, 2014 112624666412:194 admin Aug 18, 2013 Sep 5, 2014 171818906413:194 admin Aug 18, 2013 Sep 5, 2014 191257566414:194 admin Aug 18, 2013 Sep 5, 2014 19158226
6415:194 admin Aug 18, 2013 Sep 5, 2014 97941756416:194 admin Aug 18, 2013 Sep 5, 2014 173796166417:194 admin Aug 18, 2013 Sep 5, 2014 175219216418:194 admin Aug 18, 2013 Sep 5, 2014 176222446419:194 admin Aug 18, 2013 Sep 5, 2014 172153806420:194 admin Aug 18, 2013 Sep 5, 2014 180000206421:194 admin Aug 18, 2013 Sep 5, 2014 179252836422:194 admin Aug 18, 2013 Sep 5, 2014 192377246423:194 admin Aug 18, 2013 Sep 5, 2014 112975966424:194 admin Aug 18, 2013 Sep 5, 2014 105306086425:194 admin Aug 18, 2013 Sep 5, 2014 110457886428:194 admin Aug 18, 2013 Sep 5, 2014 158271036429:194 admin Aug 18, 2013 Sep 5, 2014 128693976430:194 admin Aug 18, 2013 Sep 5, 2014 173153196431:194 admin Aug 18, 2013 Sep 5, 2014 92364166432:194 admin Aug 18, 2013 Sep 5, 2014 155315006433:194 admin Aug 18, 2013 Sep 5, 2014 103621256434:194 admin Aug 18, 2013 Sep 5, 2014 74981006435:194 admin Aug 18, 2013 Sep 5, 2014 122088956436:194 admin Aug 18, 2013 Sep 5, 2014 170197166437:194 admin Aug 18, 2013 Sep 5, 2014 169850316438:194 admin Aug 18, 2013 Sep 5, 2014 84781446439:194 admin Aug 18, 2013 Sep 5, 2014 190569006441:194 admin Aug 18, 2013 Sep 5, 2014 192088426442:194 admin Aug 18, 2013 Sep 5, 2014 170470876443:194 admin Aug 18, 2013 Sep 5, 2014 92424786444:194 admin Aug 18, 2013 Nov 6, 2013 124671336445:194 admin Aug 18, 2013 Sep 5, 2014 33073076446:194 admin Aug 18, 2013 Sep 5, 2014 126099406447:194 admin Aug 18, 2013 Sep 5, 2014 158834416450:194 admin Aug 18, 2013 Sep 5, 2014 163394766451:194 admin Aug 18, 2013 Sep 5, 2014 186358556452:194 admin Aug 18, 2013 Sep 5, 2014 37888356453:194 admin Aug 18, 2013 Sep 5, 2014 180655926455:194 admin Aug 18, 2013 Sep 5, 2014 169601776456:194 admin Aug 18, 2013 Sep 5, 2014 164816366457:194 admin Aug 18, 2013 Sep 5, 2014 176615656459:194 admin Aug 18, 2013 Sep 5, 2014 181803956460:194 admin Aug 18, 2013 Sep 5, 2014 86750936461:194 admin Aug 18, 2013 Sep 5, 2014 189889096462:194 admin Aug 18, 2013 Sep 5, 2014 90225616463:194 admin Aug 18, 2013 Sep 5, 2014 36203146464:194 admin Aug 18, 2013 Sep 5, 2014 119043166465:194 admin Aug 18, 2013 Sep 5, 2014 176238016466:194 admin Aug 18, 2013 Sep 5, 2014 77958376467:194 admin Aug 18, 2013 Sep 5, 2014 95214376468:194 admin Aug 18, 2013 Sep 5, 2014 180897016469:194 admin Aug 18, 2013 Sep 5, 2014 18410225
Alt ID(s) Title Year Author20082000200319952005200819982005200520082008200720082007200819931999199520082006200720072001200820052004-- Not Found ---- Not Found --1996200620061994200420052007200820072008199620081996198519891995200719992005
Serum vitamin D concentration and
Ahn J., Peters U., Albanes D., Purdue MP., Abnet CC., Prostate cancer risk and
prediagnostic serum 25-Ahonen MH., Tenkanen L., Teppo L., Hakama M., A prospective study of
calcium intake from diet Al-Delaimy WK., Rimm E., Willett WC., Stampfer MJ., The influence of
menopause and hormonal Aloia JF., Vaswani A., Russo L., Sheehan M., Low-fat dairy consumption
and reduced risk of Alonso A., Beunza JJ., Delgado-Rodríguez M., Effect of vitamin D
supplementation on bone Andersen R., Mølgaard C., Skovgaard LT., Brot C., Intake of potassium,
magnesium, calcium, and Ascherio A., Rimm EB., Hernán MA., Giovannucci Risk of prostate cancer in
a randomized clinical trial Baron JA., Beach M., Wallace K., Grau MV., Plasma 25-hydroxyvitamin
D and 1,25-Bertone-Johnson ER., Chen WY., Holick MF., Hollis BW., Vitamin D
supplementation has Björkman M., Sorva A., Risteli J., Tilvis R.Body size and serum 25
hydroxy vitamin D Blum M., Dallal GE., Dawson-Hughes B.Maternal vitamin D
deficiency increases the Bodnar LM., Catov JM., Simhan HN., Holick MF., Vascular events in healthy
older women receiving Bolland MJ., Barber PA., Doughty RN., Mason B., Two-year randomized
controlled trial of vitamin Bolton-Smith C., McMurdo ME., Paterson CR., Mole Dairy calcium
supplementation in Bortolotti M., Rudelle S., Schneiter P., Vidal H., Relation of calcium,
vitamin D, and dairy food Bostick RM., Potter JD., Sellers TA., McKenzie DR., Relation of calcium,
vitamin D, and dairy food Bostick RM., Kushi LH., Wu Y., Meyer KA., Sellers TA., Prostate cancer and
prediagnostic levels of Braun MM., Helzlsouer KJ., Hollis BW., Comstock GW.Calcium, vitamin D
supplementation, and Brunner RL., Cochrane B., Jackson RD., Larson J., Effects of vitamin D
supplementation and Bunout D., Barrera G., Leiva L., Gattas V., de la Does vitamin D stop
inpatients falling? A Burleigh E., McColl J., Potter J.Calcium plus vitamin D
supplementation and the Caan B., Neuhouser M., Aragaki A., Lewis CB., Dairy products, calcium,
and prostate cancer risk in Chan JM., Stampfer MJ., Ma J., Gann PH., Gaziano JM., Calcium plus vitamin D
supplementation and the Chlebowski RT., Johnson KC., Kooperberg C., Effects of calcium, dairy
product, and vitamin D Cheng S., Lyytikäinen A., Kröger H., Lamberg-Allardt Weight loss and calcium
intake influence calcium Cifuentes M., Riedt CS., Brolin RE., Field MP., Vitamin D and prostate
cancer: a prediagnostic Corder EH., Guess HA., Hulka BS., Friedman GD., Calcium chemoprevention
in colorectal cancer.Duris I., Hruby D., Pekarkova B., Huorka M., Dietary calcium, alcohol,
and incidence of treated Dwyer JH., Li L., Dwyer KM., Curtin LR., Feinleib M.Effect of 1-year dairy
product intervention on fat Eagan MS., Lyle RM., Gunther CW., Peacock M., Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J., Seasonal and geographical
variations in the growth Feliciano ES., Ho ML., Specker BL., Falciglia G., Plasma vitamin D
metabolites and risk of Feskanich D., Ma J., Fuchs CS., Kirkner GJ., Hankinson Calcium from diet and
supplements is associated Flood A., Peters U., Chatterjee N., Lacey JV., Plasma 25-hydroxyvitamin
D levels and risk of Forman JP., Giovannucci E., Holmes MD., Bischoff-Plasma 25-hydroxyvitamin
D levels and risk of Forman JP., Curhan GC., Taylor EN.Prospective study of
serum vitamin D and Freedman DM., Looker AC., Chang SC., Graubard Serum levels of vitamin D
metabolites and breast Freedman DM., Chang SC., Falk RT., Purdue MP., Dietary factors and risk of
colon cancer: a Gaard M., Tretli S., Løken EB.Maternal vitamin D status
during pregnancy and Gale CR., Robinson SM., Harvey NC., Javaid MK., Circulating vitamin D
metabolites in relation to Gann PH., Ma J., Hennekens CH., Hollis Dietary vitamin D and
calcium and risk of Garland C., Shekelle RB., Barrett-Connor E., Criqui Serum 25-hydroxyvitamin
D and colon cancer: eight-Garland CF., Comstock GW., Garland FC., Helsing The influence of dairy
products on plasma uric Ghadirian P., Shatenstein B., Verdy M., Hamet P.Prolonged effect of
calcium supplementation Grau MV., Baron JA., Sandler RS., Wallace K., Plasma 25-hydroxyvitamin
D responses of younger Harris SS., Dawson-Hughes B., Perrone GA.The association of calcium
and vitamin D with risk of Hartman TJ., Albert PS., Snyder K., Slattery ML.,
2005200320031997198620042001199420081994199719962005200720062008200420072008200620062008200920071995 Lijnen P., Petrov V.200520072006200720071986200820052002198719882006198120032005200820082006200620012006 Moschonis G., Manios Y.20092009
The impact of calcium and dairy product consumption
Harvey-Berino J., Gold BC., Lauber R., Starinski A.Gestational calcium
supplementation and Hatton DC., Harrison-Hohner J., Coste S., Reller Human serum 25-
hydroxycholecalciferol Heaney RP., Davies KM., Chen TC., Holick MF., Long-term vitamin D3
supplementation may Heikkinen AM., Tuppurainen MT., Colon cancer and dietary
fat, phosphorus, and Heilbrun LK., Hankin JH., Nomura AM., Plasma levels of 25-
hydroxyvitamin D, 1,25-Jacobs ET., Giuliano AR., Martínez ME., Hollis BW., Prospective study on milk
products, calcium and Järvinen R., Knekt P., Hakulinen T., Aromaa A.Dietary intakes,
anthropometric Johnson AA., Knight EM., Edwards CH., Oyemade Calcium intake and the
outcome of short-term Kabrnová-Hlavatá K., Hainer V., Gojová M., Fermented dairy products,
calcium, and colorectal Kampman E., Goldbohm RA., van den Brandt PA., Prospective study of diet
and female colorectal Kato I., Akhmedkhanov A., Koenig K., Toniolo PG., Calcium, vitamin D, and
dairy foods and the Kearney J., Giovannucci E., Rimm EB., Ascherio A., Dietary calcium,
phosphorus, vitamin D, Kesse E., Boutron-Ruault MC., Norat T., Riboli E., Dairy products, calcium
and the risk of breast Kesse-Guyot E., Bertrais S., Duperray B., Arnault N., Dairy products, calcium
and prostate cancer risk.Koh KA., Sesso HD., Paffenbarger RS., Lee IM.Dairy product, saturated
fatty acid, and calcium Kurahashi N., Inoue M., Iwasaki M., Sasazuki S., Girls on a high-calcium
diet gain weight at the Lappe JM., Rafferty KA., Davies KM., Lypaczewski Vitamin D and calcium
supplementation reduces Lappe JM., Travers-Gustafson D., Davies KM., Calcium and vitamin d
supplementation Lappe J., Cullen D., Haynatzki G., Recker R., Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci Magnesium, calcium,
potassium, and sodium Larsson SC., Virtanen MJ., Mars M., Männistö S., Long-term dietary calcium
intake and breast cancer Larsson SC., Bergkvist L., Wolk A.A prospective study of
plasma vitamin D Li H., Stampfer MJ., Hollis JB., Mucci LA., Gaziano JM., Dietary calcium, blood
pressure and cell Intakes of calcium and vitamin D and risk of
Lin J., Zhang SM., Cook NR., Manson JE., Lee IM., Intakes of calcium and
vitamin D and breast Lin J., Manson JE., Lee IM., Cook NR., Buring JE., Calcium supplementation
for 1 y does not reduce Lorenzen JK., Mølgaard C., Michaelsen KF., Astrup A.Preventing fractures
among older people living Lyons RA., Johansen A., Brophy S., Newcombe RG., Supplementation with
calcium + vitamin D Major GC., Alarie F., Doré J., Phouttama S., Tremblay Vitamin D
supplementation in Mallet E., Gügi B., Brunelle P., Hénocq A., Basuyau JP., Effect of calcium and
vitamin D supplementation Margolis KL., Ray RM., Van Horn L., Manson JE., Allison Dietary and serum
vitamins and minerals as Marniemi J., Alanen E., Impivaara O., Seppänen Calcium, vitamin D, and
risk of adenoma Martínez ME., Marshall JR., Sampliner R., Wilkinson J., Effect of calcium and
vitamin D supplementation Marya RK., Rathee S., Manrow M.Effect of vitamin D
supplementation during Marya RK., Rathee S., Dua V., Sangwan K.Vitamin D2 dose required
to rapidly increase 25OHD Mastaglia SR., Mautalen CA., Parisi MS., Oliveri B.Vitamin D supplements
enhance weight gain and Maxwell JD., Ang L., Brooke OG., Brown IR.Calcium, vitamin D, dairy
products, and risk of McCullough ML., Robertson AS., Rodriguez Dairy, calcium, and
vitamin D intake and McCullough ML., Rodriguez C., Diver WR., Feigelson 25-hydroxyvitamin D
levels and the risk of Melamed ML., Michos ED., Post W., Astor B.Dietary calcium and
vitamin D intakes in Mishra G., McCormack V., Kuh D., Hardy R., Stephen Dairy products, calcium
and prostate cancer risk.Koh KA., Sesso HD., Paffenbarger RS., Lee IM.Maternal 25-
hydroxyvitamin D and Morley R., Carlin JB., Pasco JA., Wark JD.Nutrient intake and
hypertensive disorders of Morris CD., Jacobson SL., Anand R., Ewell MG., Skeletal site-dependent
response of bone mineral A double-blind, randomized, placebo-
Nagpal J., Pande JN., Bhartia A.Supplements of 20
microg/d cholecalciferol Nelson ML., Blum JM., Hollis BW., Rosen C.,
199820072007200720072007200720092001199920002005200320071997200419991995200220062006199320082009200619972002198720032005200620081986200720062006200620081996200819971987200220071995199820082008
Serum vitamin D metabolite levels and the
Nomura AM., Stemmermann GN., Lee J., Calcium and vitamin D
intakes in relation to risk Oh K., Willett WC., Wu K., Fuchs CS., Giovannucci EL.Diet during pregnancy and
risk of preeclampsia or Oken E., Ning Y., Rifas-Shiman SL., Rich-Edwards Plasma vitamin D and risk
of colorectal cancer: the Otani T., Iwasaki M., Sasazuki S., Inoue M., Calcium and vitamin D
intake and risk of Park SY., Murphy SP., Wilkens LR., Nomura AM., Calcium, dairy foods, and
risk of incident and fatal Park Y., Mitrou PN., Kipnis V., Hollenbeck A., Calcium, vitamin D, and
dairy product intake and Park SY., Murphy SP., Wilkens LR., Stram DO., Dairy food, calcium, and
risk of cancer in the NIH-Park Y., Leitzmann MF., Subar AF., Hollenbeck A., Effects of a short-term
vitamin D(3) and calcium Pfeifer M., Begerow B., Minne HW., Nachtigall D., Diet and risk of colorectal
cancer in a cohort of Pietinen P., Malila N., Virtanen M., Hartman TJ., Plasma 1,25-dihydroxy-
and 25-hydroxyvitamin D Platz EA., Hankinson SE., Hollis BW., Colditz GA., Effects of calcium
supplementation on body Reid IR., Horne A., Mason B., Ames R., Bava U., Calcium, dairy products,
and risk of prostate cancer Rodriguez C., McCullough ML., Mondul AM., Jacobs Meat and dairy
consumption and Rohrmann S., Platz EA., Kavanaugh CJ., Thuita L., Prospective evaluation of
dietary and other Ross RK., Yuan JM., Henderson BE., Park J., Serum parathyroid
hormone is associated Sambrook PN., Chen JS., March LM., Cameron ID., Animal products, calcium
and protein and prostate Schuurman AG., van den Brandt PA., Dorant E., Effect of winter oral
vitamin D3 Scragg R., Khaw KT., Murphy S.Intake of dairy products,
calcium, and vitamin d and Shin MH., Holmes MD., Hankinson SE., Wu K., Dietary intake of calcium,
fiber and other Shin A., Li H., Shu XO., Yang G., Gao YT., Zheng Vitamin D intake and the
risk for pancreatic cancer Skinner HG., Michaud DS., Giovannucci E., Willett Calcium intake and 28-
year gastro-intestinal Slob IC., Lambregts JL., Schuit AJ., Kok FJ.Supplementation with
cholecalciferol does not Sneve M., Figenschau Y., Jorde R.Serum vitamin D and risk
of pancreatic cancer in the Stolzenberg-Solomon RZ., Hayes RB., Horst RL., A prospective nested case-
control study of vitamin D Stolzenberg-Solomon RZ., Vieth R., Azad A., Pietinen Serum levels of vitamin D
metabolites and the Tangrea J., Helzlsouer K., Pietinen P., Taylor P., Hollis Dietary calcium and
vitamin D intake and risk Terry P., Baron JA., Bergkvist L., Holmberg L., Dietary calcium intake and
blood pressure in Thomsen K., Nilas L., Christiansen C.Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.Dairy, calcium, and
vitamin D intakes and Tseng M., Breslow RA., Graubard BI., Ziegler RG.Dietary intake of calcium
in relation to mortality Umesawa M., Iso H., Date C., Yamamoto A., Dietary calcium intake and
risks of stroke, its Umesawa M., Iso H., Ishihara J., Saito I., Kokubo Oral calcium and blood
pressure: a controlled van Beresteyn EC., Schaafsma G., de Waard Childhood dairy intake and
adult cancer risk: 65-y van der Pols JC., Bain C., Gunnell D., Smith GD., Low serum concentrations
of 25-hydroxyvitamin D in Visser M., Deeg DJ., Puts MT., Seidell JC., Lips P.Calcium plus vitamin D
supplementation and the Wactawski-Wende J., Kotchen JM., Anderson GL., High-dose vitamin D3
supplementation in a Wagner CL., Hulsey TC., Fanning D., Ebeling M., Vitamin D deficiency and
risk of cardiovascular Wang TJ., Pencina MJ., Booth SL., Jacques PF., Effect of longterm placebo
controlled calcium Weisgerber UM., Boeing H., Owen RW., Waldherr Is ischemic stroke risk
related to folate status or Weng LC., Yeh WT., Bai CH., Chen HJ., Chuang SY., Efficacy of
nonpharmacologic Whelton PK., Kumanyika SK., Cook NR., Cutler JA., Alcohol, physical activity
and other risk factors for Wu AH., Paganini-Hill A., Ross RK., Henderson BE.Calcium intake and risk of
colon cancer in women Wu K., Willett WC., Fuchs CS., Colditz GA., A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis Lack of blood pressure
effect with calcium and Yamamoto ME., Applegate WB., Klag MJ., Borhani NO., A prospective cohort study
of intake of calcium, Zheng W., Anderson KE., Kushi LH., Sellers TA., Effects of calcium and
vitamin D supplementation Zhu K., Devine A., Dick IM., Wilson SG., Prince RL.Randomized controlled
trial of the effects of Zhu K., Bruce D., Austin N., Devine A., Ebeling PR.,
Arm Location N enrolled N analyzedTotal Total 1530Total Total 715 ndTotal Total US, various 39,800 ~54 (~9)Total Total 118Total Total 6686 36 (~11)Total Total 199 147Total Total US, various 43,738 43,738 (implied) ndTotal Total 672 61.8 (8.7)Total Total U.S. 57 (7.0)Total Total 218 218 84.5Total Total Boston, US, 42 N 389 (original trial) 70 (4.9)Total Total Pittsburgh, PA 24 (est.)Total Total 1471 1471 74 (~4.2)Total Total UK 123 106Total Total 10 10 22.2 (1.2)Total Total 41837 35216 61.5 (nd)Total Total Iowa ~42 34,486 34,486 61Total Total 183 Mode 55-64 (51%)Total Total US 40 centers ndTotal Total Chile (32.26 S) 96 92 76 (4)Total Total 205 199 83.0 (7.6)Total Total US 36282 36282 ndTotal Total US 22071 20885 53.3Total Total US 38 N 68.132 36,282 ndTotal Total 195 165 11.2Total Total 73 57 61(5)Total 57 (nd)Total TotalTotal Total US, various 6634 6634 46 (~14)Total Total Indiana 40 N 154 51 19.4 1.6Total Total 179 168 13.2 (no sd)Total Total 255 255 newbornTotal Total 576 60 (no SD)Total Total 61431 61.9 (nd)Total various 1811Total Total US 43 (nd)Total Total 16818 16818 44.0 (nd)Total Total 2010 66.5Total 50535 50535 43 (nd)Total Total Southampton, UK 466 440 26.3 (est.)Total Total 62 yrsTotal Total Chicago, US 41 N 2107 1954 48.7 (4.4)Total Total 101 62.8 (no SD)Total Total 265 158 Maybe ~80Total Total 930 822 60.6 (no sd)Total Total Boston, MA 20 18 Young: 26 Old: 69Total Total 2079 1905 61.1(9.9)
Arm Description
Mean (SD) Age, yrUnited States
(various): 1530 749 cases; 781 controls
Case: 67.8 (5.3); Control: 67.6 (5.3)Finland 62
(various cities)715 cases: 149 control: 566 39,800 (415,965
person years)Mineola, NY, USA, 40
64 (+30 in HRT arm)
-Calcium group: 52(0.6) yrs -Navarra, Spain 42
40~7470 (incl missing data)Copenhagen area,
Denmark (55 N )Median age - Adolescent girls:
Cleveland Clinic Dartmouth
672 542 w/ full PSA data (58% of 1459 735 with
breast cancer 724 1425 (701 breast cancer and 724 Helsinki, Finland
60 10' North 257 (for this study)1198 in the
eligible cohort; 55 49 cases; 216 controlsAuckland, New
Zealand 36 Vit D+Ca: 69.4 (6.4) Placebo: 67.8 Lausanne,
Switzerland Iowa, US (40 23 -40 30 N)
Washington County, MD 39.7
183 (61 cases, 122 controls)36,282 joined at the initial stage of
2928 had objective physical
Scotland (55 57' N)
Jyvaskyla, Finland 62 24'NNew Brunswick, NJ, USA 40.486San Francisco Bay area, US 37 46'
200 cases 200 controls
181 cases 181 controlsBratislava, Slovak
Republic (48 40' Patients with polyps and
Patients with polyps and
Patients with polyps and
Greater Beirut area, Lebanon (33 Beijing (40 N); Jiamusi (47 N); US (various latitudes)
Original cohort (N=121,700), 27 cities across
the US (25 46'-54 45354 (details on the reasons for 1811 (613 men,
1198 women)Men: 65 8 years Women: 57 7 116,671 Female
registered nurses 742 cases and 742 controlsUS Mean
latitude=38.3N10 US centers 38 00 N
1,005 cases and 1,005 noncasesNorway (Finnmark
[69 44 N], Sogn
United States (multiple
22,071 in original cohort, 520 cases
232 cases and 414 controls
Washington county, Maryland
Original Cohort (n=25620) Cases Montreal, Canada
45.7US The Cleveland Clinic Foundation
US 38 N, 8 clinical centers
Total Total 54 44 45.2(6.7)Total Total Portland, OR 45.5 497 62 ndTotal Total 67 67 38.7 (11.2)Total Total 464 320 52.9(0.29)Total 519 477 ndTotal Total 249 68Total Total Finland (64 00 N) 9959 9959 39.1 (nd)Total Washington DC 322 322 21.6Total Total 67 67 49.1 12.1Total Total 3500 (see above) 3111 ~61 (nd)#Total Total 14727 14727 ndTotal Total 47935 47239 ndTotal Total France 46 N 100,000 52.7 (nd)Total Total France 46o N 3836 3627 51 (6.3)Total nd 11014 10011 67Total Japan 36 N 46,036 ndTotal Total Omaha, NE 41 N 63 59 9.5Total Total Nebraska, 41.4 N 1180 1179 67 (7.3)Total Total 5201 3700 Median: 19Total Total 48850 45306 60.3 (nd)Total Total 48850 45306 60.3 (nd)Total Total 26556 26556 ~57 (nd)Total Total Sweden 62 N 61,433 36,664 53.7(9.7)Total Total 2684Total Total 32 32 24 1Total Total 36976 36976 Nd (~54 y)Total Total US 26 - 61 31487 31487 55 yTotal Total 113 110 13.2Total Total 3440 3343 84 (7.5)Total Total 84 63 43 (~5.5)Total Total NW France, 48 N 77 77 25Total Total US 36282 36282 62 (7)Total Total Turku, Finland 60 769 755 79 (nd)Total Total 1429 1304Total Total 400 400 ndTotal Total 200 200 24Total Total 45 45 65 (median, est.)Total Total London, UK 51 N 126 126 ndTotal Total US (21 states) 127749 127749Total US 30 N 97,786 68,567 63 (nd)Total 13331 13331 44.8Total Total 54 N 1471 1161 51.5Total Total Finland 64 N 29133 27028 56.7 (est.)Total Total 475 374 29Total 4314 4157 79% age 17-24Total Total 112 101 61 (nd)Total Total 100 44 (8)Total Total Bangor, ME 112 women 86 women 22.2 (3.7)
Vermont, USA 44 N
Omaha, NE 41.2 NKuopio Province, Eastern Finland Oahu, HI [21 19'N]Eastern United States (25 46 N
1312 in original cohort, 249 with
Prague, Czech Republic. 50 NNetherlands (nd) (52 30 N)New York City, NY (40 47 ) or US (25 46 - 54 40 N) Adenoma study:
5320 CRC: 67484
65,801 men in initial cohort
Great Lakes, IL, USA 41 NorthSweden (Vastmanland [59 Sweden (Vastmanland [59 Southwestern Finland ~60
United States- multiple locations
1156 492 cases 664 control
58.9 8.3 at study onset. 69.3 7.3 Leuven, Belgium
51US (25 46 -54 40 )
Frederiksberg, Copenhagen, South Wales (51.96 N)Quebec City, QC, Canada 47
Phoenix, Arizona, metropolitan area
According to calcium intake, Rohtak, India 28
54 NRohtak, India 28 54 NBuenos Aires, Argentina (34 S)
According to calcium intake per
nd (multiple cities in US)
Geelong, Australia 38 SAlbuquerque, NM; Birmingham, AL; Greece (Nea Smyrni, Kalluthea New Delhi, India (28 N)
71 (ITT analysis) 65 (per protocol
Total Total 272 272 58 (nd)Total Total US (38 N) 121700 48115 ndTotal MA 41 42 N 1718 1718Total Total 1125Total Total 215,000 191,011 ndTotal 339671 293888 ndTotal Total 82,483 ndTotal ndTotal Total 148 145 75 4 yrs.Total Total 27111 27111Total Total 652 652 58.5 6.6Total Total 1471 74 (~4.2)Total Total 65,321 ndTotal Total 5620 3892 53.8 (nd)Total Total 18,244 ndTotal 842 842 85 (nd)TotalTotal Total 191 189 69.6 (nd)Total US 88691 88381 46.7 (nd)Total Total 73314 73314TotalTotal Total 3091 2591Total Total 445 334 47.6 (11.4)Total TotalTotal Total Finland 64 N 58Total Total Median 60Total 61463Total Total 28 28 ndTotal Total 2686 2686 75 (5)Total 14407 3779 57.8(14.6)Total Japan, various 53,387 53,387 56Total Total 41,526 41,526 ~49 (nd)Total Total 58 58 21(1.0)Total 1343 families 4374 children 7.6 (sd, nd)Total 1260 1260 65 yTotal Total US (38 N) ndTotal Total 19 19 29Total Total 1739 59 (9)Total Total 44# 30 62 (nd)Total Total Taiwan 3282 1772Total Total 10 sites 471 445 43~+/-6.6Total 11,888 11,644 ndTotal HPFS: nd NHS: USTotal Total US, various 535 66.2Total Total US, various 471 43 6.5Total Total 34702 34702 ndTotal Total Western Australia 120 120 74.8 (2.6)Total Total 302 256 77 (4.5)
Oahu, Hawaii 21 N
68% age 30 to <40Japan (~ 30 40
N)Original cohort (N=133323),
Men 56.9 (no SD) Women 56.4 (no Hawaii (21 N) Los
Angeles, California CA, FL, LA, NJ, NC, PAHawaii (20 N) and California
Original cohort of 215,000 men and California, Florida,
Louisiana, New N=492,810 (M=293,907,
N=492,810 (M=293,907, Lower Saxony,
Germany 52 NSouthwestern Finland
Median, cases: 60.1; non cases: US, various
locationsAuckland, New Zealand (36.5 S)
1471 (ITT), 153 withdrew prior to United States
(various)86,404 male participants in the Washington
County, MarylandShanghai, China 31 N
245 cases 1225 controlsN. Sydney,
AustraliaNetherlands, 52.30 N
2392 (original cohort size =
2167 (642 cases, 1525 controls)
Cases: 63.9 3.8 Controls: 61.4 4.2Cambridge, UK 52
N
urban Shanghai, China (31 14' N)
Cases: 59 (8.5); non-cases: 52 Multiple cities in
USNHS: 121,701 HPFS: 51,529
NHS: 75,427 HPFS: 46,771
NHS: 51 (nd) HPFS: 55 (nd)Amsterdam (52
18' N)Men 53(7.3) Women 52 (7.2)North Norway
(latitude = 70 N)Multicenters in the US: Birmingham,
Original RCT participants:
Cases: 184 Controls: 368
Cases: 66 Controls: 66200 cases 400
controls200 cases 400 controlsSouthwestern
Finland (~ 60 N)438 (146 cases, 292 controls)
436 (146 cases, 290 controls)Vastmanland
county (59 45'N) 61463 This number is smaller
According to calcium intake Copenhagen,
Denmark 55 40 UK (Oxford [52 N] & Ipswich [52 N])United States various, excluding
4 areas Japan Okinawa (24 ) to Netherlands (52 N)England (54 N) Scotland (55 57' W, NE, S of the Netherlands RCT part: 36282
(Ca+vitD RCT part: 36282 Case-cohort part: Charleston, SC 32
47'NProbably mostly still around
1739 (Originally 5124)Heidelberg and
surrounding Stroke group = 62.6(8.1)
About 50 miles south of Los HPFS: 47344
NHS: 87998HPFS: 47344 NHS: 87998
HPFS: 54.4 (nd) NHS: 46.6 (nd)Original cohort
(N=51,129), 447 at 3 mo. 438 at 6 mo.Iowa, US (40 23
-40 30 N)
Perth, Australia (32 S)
Male %nd 100% nd40-57 100% nd nd nd nd40-75 100% ~25.5 ~3.4 Healthy ndnd 0% White 100% nd nd20-90 39% BMI 23.1 No HTN nd
42 Pakistani Generally healthy No hypercalcimia40-75 100 mostly White nd Healthy ndnd 100 nd ndnd 0% nd65-104.3 18.4 nd nd65-86 47 97% white 45% BMI 25-30 healthy20-29 (est.) 0 nd55 y 0 nd BMI 26.4 healthy60 0 nd Mean BMI: 26 Healthy ndnd 30% nd Overweight/obesend 0% nd nd55-69 0 White ~100% ~27 Healthy nd<45 75+ 100% White 100% nd50-79 yr 0 nd nd nd ndnd 11.6% nd Healthy elderlynd 40% nd nd50-79 0nd 100 nd BMI=24.9 nd nd50-79 010-12 0 nd BMI: 18.252-75 0% nd BMI: 26.9(1.9) nd nd38-81 100 nd nd nd
nd nd nd25-74 63% BMI 25.4 No HTN ndnd 0 nd nd nd10-17y 0% nd Healthy ndnd nd Asians nd nd43-70 (inclusion) 0% nd BMI 25.1 ndnd 0% ndnd 34% BMI ~ 25 4 nd40-46 0 nd BMI 24.1 nd ndnd 45.4 ndnd 0 ~90% Caucasian ~2120-53(invited) nd nd ndnd 0 Caucasians nd
100% nd nd nd ndnd 100 BMI 25.5 nd ndnd 49.5% White: 100% nd nd nd
0% 59.7 Kg Healthy ndnd nd nd nd ndnd 100 nd ndnd 64 Caucasian 90% nd nd nd
Age Range/1QR
Race/Ethnicity
Anthropometry data
Health Status
Specific Nutrition Non-Hispanic
whiteBMI case 27.3 (3.6); BMI control
No prior history of cancer before
White close to 100% -Weight: calcium
group 65.8 (1.5) nd (educated Spaniards)Range
Adolescent girls: Median BMI - Adolescent girls:
African American: 5.4%
From Baron NEJM 1999 paper: Had BMI at age
18=21.1 BMI at Post menopausal 68% Ever smokers
Plasma 25 (OH) D at 1989-1990 31.5 All required
assistance of >2 Frail and chronically Mean Vit D 189 IU/d; Ca 721 mg/d78% white (in
cases); 68% white prepregnancy BMI 25 = 58% of
no preexisting medical conditions 25(OD)D 25
nmol/L
Weight(kg) = 78.1 (9.1) Height(m) =
Ca intakes < 800 mg/dBMI=27.0 kg/m2
Height=64.1 Total energy intake=1801.5
No prostate cancer at baseline
<5% with baseline 25(OH)D <15
BMI 28.8 kg/m2 Weight 65.6 kg
serum vitamin D of 16 ng/ml or lessUnder weight 40%
Normal weight Inpatient with high levels of White 83% Black
9% Hispanic 4% BMI <25 28% 25 to <30 35% 30
Healthy, post-menopausal
Total Ca intake <600 mg/d 20%
CaD: White 82.8% Black 9.3%
CaD <25 26.2% 25-<30 35.8%
CaD : Alcohol use in Non drinker
Baseline vitD supplementation: no serious medical
conditionsdietary calcium: 670 mg/d; vit D
Black 91 pairs White 90 pairsPatients with
polyps and Patients with polyps and
Patients with history of polyps, White 86% Black
14% BMI: 22.31 Weight: 62.4kgHeight 152.7cm Weight 47.3 kg % 6 mo weight: 7.8 Kg; length; 67 cm Aspirin user
(>10y): 10% HRT BMI=24.7 kg/m2 Ht=64.0 (inches)
Some with previous breast
Total energy intake ~1273 - 95% of men and
85% of women Low vit D intake in part of cohort
Non-Hispanic white: 71.2 Non-
BMI=26.7 kg/m2 %body fat=23.4
Vit D: 4.7 mcg/d Ca: 811.8 mg/dEver smoker ~37-
47% History of Total calcium intake 1.1 to 1.7 49% (male and
female were Male Total energy: 2033.7 prepregnancy wt:
59 Kg (est.)vit D intake (food & supplements): 40-84 yrs at
baseline 65% Americans of Germen, Polish, or
50-69: 25% 70: 75%
Probably almost all whiteMale 71.7%
Female 28.3% BMI Young: 26.6 Old: 31
vit D intake Young: 51 IU/d
18-60 7% nd nd ndnd 0 nd nd Healthy ndnd 100 nd BMI 26.2 (2.4)47-56 0% nd 26.4(0.47) nd nd46-68 100% Japanese nd ndnd 100 white 26 nd15- nd nd BMI=24.8 kg/m2 nd16->31 (est.) 0 African American ndnd 0% nd nd nd
~49%# nd nd nd ndnd 0% nd nd40-75 100% nd BMI=25kg/m2nd 0% nd BMI 23.0kg/m2 nd ndnd 0% ndnd 100 nd 43% with BMI>25 nd nd45-74 100% nd nd nd ndnd 0 BMI 17 ndnd 0 white BMI 2917-35 0nd 100% nd BMI=25.8kg/m2nd 100% nd BMI=25.8kg/m250-69 100 ~26.5 Healthy ndnd 0 Swedish BMI 24.8(3.9) nd ndnd 100% nd20-44 y 100 nd Healthy
0% nd BMI=~2655-56 0% nd BMI = 26nd 0 white wt 51 Kg nd62-107 23.7% nd nd nd nd
0 nd BMI 31.9 (~3) nd18-36 0 white nd nd50-79 0% healthy nd65-99 48% nd nd ndnd 57.1 nd nd20-35 0 Indian nd nd22-35 0 Indian weight 54 Kg nd54.5-77 (IQR, est.) 0 nd BMD T-score < -1nd 0 Asians ndnd 48 ndnd 0 nd>=20 46 Mean BMI: 26.85nd 0 nd nd ndnd 100 Caucasians BMI 26.5 (est.)nd 0 99% white Ht 166 cm ndnd 0 nd55-65 0% 100% Greek nd ndnd 100% Indian19-35 y 0 Healthy nd
BMI = 30(2.5), weight = 81(9),
good general health
est. <5 g/d intake of vit D
Total fat: 75 g/d Ca: 575 mg/dsome subjects
were on Se to Total energy=2602.6Kc42% 90-110% of
ideal Calcium 933.4 51.8 (SE) mg/d BMI=32.2 4.1
Weight=84.5 13 55-69 (per inclusion criteria) [Based on only
11573 [based on only 14724 Family history=8.4%
Total energy intake=1958.7
BMI: <18.5 = 4.4% = 75.8%
Post-menopausal status 52% cases;
Energy adjusted calcium intake
95% white 5% black
dietary intake calcium: 819 mentally and
physically fit to baseline 25(OH)-D 71.8 20.3 nmol/LAmerican Indian:
3%, Asian: 4%, Mean BMI = 24 (ranged 15-43)
Assumed healthy (Navy recruits)
Mean dairy servings/wk = 6 Hx of DM=6.1%
Aspirin Vit D=6.4 g/d Saturated fat 33.5 Hx of DM=6.1%
Aspirin Vit D=6.4 g/d Saturated fat 33.5 Mostly white
(implied)
6% not of European descent
Age at study onset: cases =
-Vit D deficiency (<20 ng/ml) in Weight 75.9 1.3
Kg1 month low Ca diet run-in45 or over
(enrollment of the FH of colorectal cancer=~10%
Total energy intake=~1700 Current smokers
= 8% to 20% Current users of multivitamins, dietary calcium: 957 mg/d
nd (premenopausal)
Healthy, overweight/ obese Ca intake 550 to
1000 mg/d in 55% 83% White, 9% Black, 4%
BMI <25 28.0% BMI 25 to <30 White 100%
(probably) Regular aspirin use in the past 10
According to calcium intake diet: calcium 500 mg/d and vit D 40 Vit D 35 IU/d; calcium 429 mg/d BMI 27.4 (median,
est.)25(OH)D level 42 nmol/L (median, weight at 3rd
trimester: 63.7 Kg25(OH)D level at 28-32 wk: 20.1 According to
calcium intake per According to calcium intake per
According to calcium intake per Mean body mass
index in 1992 = Current smoker 5 to 13%
Total calcium (mg/d) = 706-Non-Hispanic
white: 72.9%, non-Diabetes: 7.4% History of CVD:
Use of vitamin D supplement: Intake levels available as smokers at
baselinevit D 5.4 g/d mean intake (est.)25(OH)D in winter: 49.2 nmol/L; 51% white; 46%
African American38% with BMI 26
dietary calcium pre-intervention: Weight - 72.9 kg
Height 157.2 BMI = 26.4 (4) Waist
apparently healthy ,
Most subjects severely vit D Predominantly
white womenBMI 25.9 % body fat 30.1% Height
49-70 100 Hawaiian Japanese nd ndnd 0% nd BMI 24 nd ndnd 0 nd nd40-69 52% nd ndnd 45% nd nd nd50-71 100 92% white (est.) BMI 27.2 (est.) nd45-75 100% nd nd nd50-71 (range) 60%
0% nd ndnd 100 Finishnd 0% nd nd55 y 0 nd BMI 26.4 healthy50-74 100% nd BMI mean = 26.1 nd ndnd 100 99% white BMI 27.2 nd45-64 100% Chinese nd ndnd 22 nd 60 Kg ndRange: 55-69 yrs 100% nd nd nd nd
46% nd Healthy ndnd 0 nd ndnd 0 Chinese
NHS: 0 HPFS: 100 nd40-65y 50.9% nd nd ndnd 36% nd
65.254-62 100% Caucasian BMI 26 kg/m250-69 100 nd nd ndnd 0 Swedish ndnd 0% nd nd nd nd65-85**** 76 nd BMI=24.425-74 100% nd nd nd40-79 39% Japanese Healthy nd40-59 48% Japanese ~23.5 Healthy nd20-23 0% nd nd nd4-11 yr 49.5% nd nd nd65 to 80 y 51 nd BMI <25 to 30 nd50-79y 0% nd ndnd 0 89% white nd ndnd 45% White 100% BMI 28.1 No CVD, CKD46-75 53## nd ndnd 44% nd nd30-54 68% 86% white ~83 Kg BMI ~27 nd
~33% nd nd ndHPFS: nd NHS: nd HPFS: 100 NHS: 0 HPFS: nd NHS: ndnd 100 nd BMI 25.7Age range: 30-54 69% BMI=27.4 3.7 healthy
0 nd ndnd 0% nd nd70 to 90 0 nd Mean BMI = 29
22 pack-years smoked
72% white; 12% black
67% prepregnancy BMI (Japanese or Asian
~100%)BMI Men: 23.4 Women: 23.6African Americans,
Native Hawaiians, calcium from non-dairy food (346-African Americans,
Native Hawaiians, White (non-Hispanic): M=
BMI: M= ~27.2 F= ~26.7
Family history of any cancer: M=
Ca-containing multivitamin user: Age range = 70
86 yrs.Mean weight = 65 kg. Mean height =
25(OH)D < 50 nmol/LMedian BMI
(kg/m2), cases: Physical activity (moderate), cases:
Median daily energy intake BMI 25.0 kg/m2
Mean physical Regular aspirin use: 26.1% 25(OD)D 25
nmol/L
25% used calcium supplementsBMI quartiles:
<20, 20-<22, 22- 7.2% DM; 62% HTN
Age range: 63 76 yrs.
Mean weight = 70.3 kg. Mean BMI Mean BMI at age 18y: 21.4, Mean
History of osteoporosis: BMI, average
(Kg/m2): 24 Waist Menopause: 49% CRC in first degree
Fruits/vegetables intake (g/day), NHS: 30-55 HPFS:
40-75Mean BMI - NHS: 24 HPFS: 25
Diabetic NHS: 3% HPFS: 1%
Residence in northern state BMI Men 24.7
(2.7) Women 26.4 Weight(kg)=100.1 (14.2)
Overweight or obese, 22%
Serum Ca(mmol/L)=2.31(Cases: IQR 59-72
Controls: IQR 58-90.2% White, 3.3% Black, 1.6%
Mean (IQR) BMI Cases: 26.7
DM: 10.5% Gallbladder
Vit D inadequacy (<40 nol/L): 14%Diabetes 9%
Bronchial asthma Vit D food 5 g Supplement 8% Wt=79.1
BMI=26.3According to calcium intake
Calcium intake, median (mg/day):
Hx of CAD: 16% Hx of stroke: 4%
Mean total Ca intake at 4 year White 88%, Black
11%, Other 1% Men 22.7 Women 22.9
Bodyweight = 49-76 kgHeight z score: -0.01 BMI z score: 31-41% with CVD;
44-59% with White 83.1% Black 9.1% Hispanic
Previous polyps: 8% Family Hx: dietary calcium
intake: 1125 Vit D supplement 4% Multivitamin nd (other than
previously Total: 2638 (kcal/d) Fiber: 33 Mean BMI stroke
group=25.3(3.4) 10.5% diabetics, 4.2% self-report Healthy Borderline DBPnd (to adjust for
age, the cohort 100% Caucasian (upper-middle HPFS: Average
BMI (kg/m2): 25.5 HPFS: %current smokers: 9.6;
HPFS: Average total energy Aspirin use in
1994: 40% Vit D: 455.7 IU/d Ca: 939 mg/d86% white 10.5%
blackCa intake= 970mg/d 24-hr 55-59 years old:
107377 person-yr; Pack-yr of smoking: Never
Total energy intake (tertile, nd (some
subjects, unclear living in sunny climatend (based on the
inclusion and Mean 25(OH)D = 44 nM Only 37%
Study ID:EF ID Creator Create Date PMID6304:194 admin Aug 18, 2013 Sep 5, 2014 185059676304:194 admin Aug 18, 2013 Sep 5, 2014 185059676305:194 admin Aug 18, 2013 Sep 5, 2014 110758746305:194 admin Aug 18, 2013 Sep 5, 2014 110758746305:194 admin Aug 18, 2013 Sep 5, 2014 110758746306:194 admin Aug 18, 2013 Sep 5, 2014 126632776306:194 admin Aug 18, 2013 Sep 5, 2014 126632776306:194 admin Aug 18, 2013 Sep 5, 2014 126632776307:194 admin Aug 18, 2013 Sep 5, 2014 78928826308:194 admin Aug 18, 2013 Sep 5, 2014 162804276309:194 admin Aug 18, 2013 Sep 5, 2014 182086366309:194 admin Aug 18, 2013 Sep 5, 2014 182086366309:194 admin Aug 18, 2013 Sep 5, 2014 182086366311:194 admin Aug 18, 2013 Sep 5, 2014 13303606312:194 admin Aug 18, 2013 Sep 5, 2014 86211986313:194 admin Aug 18, 2013 Sep 5, 2014 97435116313:194 admin Aug 18, 2013 Sep 5, 2014 97435116314:194 admin Aug 18, 2013 Sep 5, 2014 157673346314:194 admin Aug 18, 2013 Sep 5, 2014 157673346315:194 admin Aug 18, 2013 Sep 5, 2014 161034506315:194 admin Aug 18, 2013 Sep 5, 2014 161034506316:194 admin Aug 18, 2013 Sep 5, 2014 179650376316:194 admin Aug 18, 2013 Sep 5, 2014 179650376317:194 admin Aug 18, 2013 Sep 5, 2014 186895596318:194 admin Aug 18, 2013 Sep 5, 2014 175359856319:194 admin Aug 18, 2013 Sep 5, 2014 181983946319:194 admin Aug 18, 2013 Sep 5, 2014 181983946319:194 admin Aug 18, 2013 Sep 5, 2014 181983946319:194 admin Aug 18, 2013 Sep 5, 2014 181983946319:194 admin Aug 18, 2013 Sep 5, 2014 181983946320:194 admin Aug 18, 2013 Sep 5, 2014 172438666320:194 admin Aug 18, 2013 Sep 5, 2014 172438666321:194 admin Aug 18, 2013 Sep 5, 2014 188427716322:194 admin Aug 18, 2013 Sep 5, 2014 83334126323:194 admin Aug 18, 2013 Sep 5, 2014 99219606325:194 admin Aug 18, 2013 Sep 5, 2014 76128036326:194 admin Aug 18, 2013 Sep 5, 2014 187553196326:194 admin Aug 18, 2013 Sep 5, 2014 187553196326:194 admin Aug 18, 2013 Sep 5, 2014 187553196327:194 admin Aug 18, 2013 Sep 5, 2014 167979036327:194 admin Aug 18, 2013 Sep 5, 2014 167979036327:194 admin Aug 18, 2013 Sep 5, 2014 167979036327:194 admin Aug 18, 2013 Sep 5, 2014 167979036327:194 admin Aug 18, 2013 Sep 5, 2014 167979036327:194 admin Aug 18, 2013 Sep 5, 2014 167979036328:194 admin Aug 18, 2013 Sep 5, 2014 176564206328:194 admin Aug 18, 2013 Sep 5, 2014 17656420
Last Updated
6329:194 admin Aug 18, 2013 Sep 5, 2014 175025306330:194 admin Aug 18, 2013 Sep 5, 2014 115666566331:194 admin Aug 18, 2013 Sep 5, 2014 190016016333:194 admin Aug 18, 2013 Sep 5, 2014 162804476333:194 admin Aug 18, 2013 Sep 5, 2014 162804476333:194 admin Aug 18, 2013 Sep 5, 2014 162804476334:194 admin Aug 18, 2013 Sep 5, 2014 152130386334:194 admin Aug 18, 2013 Sep 5, 2014 152130386334:194 admin Aug 18, 2013 Sep 5, 2014 152130386335:194 admin Aug 18, 2013 Sep 5, 2014 82200926335:194 admin Aug 18, 2013 Sep 5, 2014 82200926335:194 admin Aug 18, 2013 Sep 5, 2014 82200926336:194 admin Aug 18, 2013 Sep 5, 2014 86824536336:194 admin Aug 18, 2013 Sep 5, 2014 86824536337:194 admin Aug 18, 2013 Sep 5, 2014 88906616337:194 admin Aug 18, 2013 Sep 5, 2014 88906616338:194 admin Aug 18, 2013 Sep 5, 2014 171895526338:194 admin Aug 18, 2013 Sep 5, 2014 171895526339:194 admin Aug 18, 2013 Sep 5, 2014 162782626339:194 admin Aug 18, 2013 Sep 5, 2014 162782626339:194 admin Aug 18, 2013 Sep 5, 2014 162782626339:194 admin Aug 18, 2013 Sep 5, 2014 162782626339:194 admin Aug 18, 2013 Sep 5, 2014 162782626339:194 admin Aug 18, 2013 Sep 5, 2014 162782626339:194 admin Aug 18, 2013 Sep 5, 2014 162782626340:194 admin Aug 18, 2013 Sep 5, 2014 80781156340:194 admin Aug 18, 2013 Sep 5, 2014 80781156341:194 admin Aug 18, 2013 Sep 5, 2014 153424526341:194 admin Aug 18, 2013 Sep 5, 2014 153424526341:194 admin Aug 18, 2013 Sep 5, 2014 153424526341:194 admin Aug 18, 2013 Sep 5, 2014 153424526342:194 admin Aug 18, 2013 Sep 5, 2014 156684856342:194 admin Aug 18, 2013 Sep 5, 2014 156684856342:194 admin Aug 18, 2013 Sep 5, 2014 156684856344:194 admin Aug 18, 2013 Sep 5, 2014 173720316345:194 admin Aug 18, 2013 Sep 5, 2014 188386236346:194 admin Aug 18, 2013 Sep 5, 2014 179715266346:194 admin Aug 18, 2013 Sep 5, 2014 179715266346:194 admin Aug 18, 2013 Sep 5, 2014 179715266346:194 admin Aug 18, 2013 Sep 5, 2014 179715266346:194 admin Aug 18, 2013 Sep 5, 2014 179715266346:194 admin Aug 18, 2013 Sep 5, 2014 179715266346:194 admin Aug 18, 2013 Sep 5, 2014 179715266346:194 admin Aug 18, 2013 Sep 5, 2014 179715266347:194 admin Aug 18, 2013 Sep 5, 2014 183814726348:194 admin Aug 18, 2013 Sep 5, 2014 90612756349:194 admin Aug 18, 2013 Sep 5, 2014 173110576349:194 admin Aug 18, 2013 Sep 5, 2014 17311057
6349:194 admin Aug 18, 2013 Sep 5, 2014 173110576349:194 admin Aug 18, 2013 Sep 5, 2014 173110576349:194 admin Aug 18, 2013 Sep 5, 2014 173110576350:194 admin Aug 18, 2013 Sep 5, 2014 88502736351:194 admin Aug 18, 2013 Sep 5, 2014 28573646352:194 admin Aug 18, 2013 Sep 5, 2014 25729006353:194 admin Aug 18, 2013 Sep 5, 2014 74936596353:194 admin Aug 18, 2013 Sep 5, 2014 74936596353:194 admin Aug 18, 2013 Sep 5, 2014 74936596353:194 admin Aug 18, 2013 Sep 5, 2014 74936596357:194 admin Aug 18, 2013 Sep 5, 2014 172279966357:194 admin Aug 18, 2013 Sep 5, 2014 172279966358:194 admin Aug 18, 2013 Sep 5, 2014 105113296358:194 admin Aug 18, 2013 Sep 5, 2014 105113296358:194 admin Aug 18, 2013 Sep 5, 2014 105113296359:194 admin Aug 18, 2013 Sep 5, 2014 156712226359:194 admin Aug 18, 2013 Sep 5, 2014 156712226360:194 admin Aug 18, 2013 Sep 5, 2014 162865196361:194 admin Aug 18, 2013 Sep 5, 2014 145539576361:194 admin Aug 18, 2013 Sep 5, 2014 145539576361:194 admin Aug 18, 2013 Sep 5, 2014 145539576362:194 admin Aug 18, 2013 Sep 5, 2014 124993436363:194 admin Aug 18, 2013 Sep 5, 2014 94050296364:194 admin Aug 18, 2013 Sep 5, 2014 39462956369:194 admin Aug 18, 2013 Sep 5, 2014 152258336370:194 admin Aug 18, 2013 Sep 5, 2014 116417506370:194 admin Aug 18, 2013 Sep 5, 2014 116417506370:194 admin Aug 18, 2013 Sep 5, 2014 116417506372:194 admin Aug 18, 2013 Sep 5, 2014 82014446372:194 admin Aug 18, 2013 Sep 5, 2014 82014446372:194 admin Aug 18, 2013 Sep 5, 2014 82014446373:194 admin Aug 18, 2013 Sep 5, 2014 175528806373:194 admin Aug 18, 2013 Sep 5, 2014 175528806374:194 admin Aug 18, 2013 Sep 5, 2014 82055386375:194 admin Aug 18, 2013 Sep 5, 2014 93438376376:194 admin Aug 18, 2013 Sep 5, 2014 86107046377:194 admin Aug 18, 2013 Sep 5, 2014 158805326377:194 admin Aug 18, 2013 Sep 5, 2014 158805326378:194 admin Aug 18, 2013 Sep 5, 2014 175361916379:194 admin Aug 18, 2013 Sep 5, 2014 171064376380:194 admin Aug 18, 2013 Sep 5, 2014 183980336382:194 admin Aug 18, 2013 Sep 5, 2014 153541506382:194 admin Aug 18, 2013 Sep 5, 2014 153541506382:194 admin Aug 18, 2013 Sep 5, 2014 153541506383:194 admin Aug 18, 2013 Sep 5, 2014 175566976383:194 admin Aug 18, 2013 Sep 5, 2014 175566976384:194 admin Aug 18, 2013 Sep 5, 2014 184333056385:194 admin Aug 18, 2013 Sep 5, 2014 16522915
6385:194 admin Aug 18, 2013 Sep 5, 2014 165229156385:194 admin Aug 18, 2013 Sep 5, 2014 165229156385:194 admin Aug 18, 2013 Sep 5, 2014 165229156385:194 admin Aug 18, 2013 Sep 5, 2014 165229156386:194 admin Aug 18, 2013 Sep 5, 2014 165229156386:194 admin Aug 18, 2013 Sep 5, 2014 165229156386:194 admin Aug 18, 2013 Sep 5, 2014 165229156386:194 admin Aug 18, 2013 Sep 5, 2014 165229156386:194 admin Aug 18, 2013 Sep 5, 2014 165229156387:194 admin Aug 18, 2013 Sep 5, 2014 183322896387:194 admin Aug 18, 2013 Sep 5, 2014 183322896387:194 admin Aug 18, 2013 Sep 5, 2014 183322896387:194 admin Aug 18, 2013 Sep 5, 2014 183322896388:194 admin Aug 18, 2013 Sep 5, 2014 190565696389:194 admin Aug 18, 2013 Sep 5, 2014 173886676390:194 admin Aug 18, 2013 Sep 5, 2014 85579656390:194 admin Aug 18, 2013 Sep 5, 2014 85579656390:194 admin Aug 18, 2013 Sep 5, 2014 85579656390:194 admin Aug 18, 2013 Sep 5, 2014 85579656390:194 admin Aug 18, 2013 Sep 5, 2014 85579656391:194 admin Aug 18, 2013 Sep 5, 2014 158002686391:194 admin Aug 18, 2013 Sep 5, 2014 158002686391:194 admin Aug 18, 2013 Sep 5, 2014 158002686392:194 admin Aug 18, 2013 Sep 5, 2014 175332086393:194 admin Aug 18, 2013 Sep 5, 2014 164000446393:194 admin Aug 18, 2013 Sep 5, 2014 164000446393:194 admin Aug 18, 2013 Sep 5, 2014 164000446394:194 admin Aug 18, 2013 Sep 5, 2014 174739116394:194 admin Aug 18, 2013 Sep 5, 2014 174739116394:194 admin Aug 18, 2013 Sep 5, 2014 174739116395:194 admin Aug 18, 2013 Sep 5, 2014 172091776395:194 admin Aug 18, 2013 Sep 5, 2014 172091776395:194 admin Aug 18, 2013 Sep 5, 2014 172091776395:194 admin Aug 18, 2013 Sep 5, 2014 172091776396:194 admin Aug 18, 2013 Sep 5, 2014 37555176396:194 admin Aug 18, 2013 Sep 5, 2014 37555176396:194 admin Aug 18, 2013 Sep 5, 2014 37555176396:194 admin Aug 18, 2013 Sep 5, 2014 37555176396:194 admin Aug 18, 2013 Sep 5, 2014 37555176397:194 admin Aug 18, 2013 Sep 5, 2014 188246626397:194 admin Aug 18, 2013 Sep 5, 2014 188246626398:194 admin Aug 18, 2013 Sep 5, 2014 159554676398:194 admin Aug 18, 2013 Sep 5, 2014 159554676399:194 admin Aug 18, 2013 Sep 5, 2014 120201026401:194 admin Aug 18, 2013 Sep 5, 2014 36232606402:194 admin Aug 18, 2013 Sep 5, 2014 32436096402:194 admin Aug 18, 2013 Sep 5, 2014 32436096402:194 admin Aug 18, 2013 Sep 5, 2014 3243609
6403:194 admin Aug 18, 2013 Sep 5, 2014 163915876404:194 admin Aug 18, 2013 Sep 5, 2014 67930586404:194 admin Aug 18, 2013 Sep 5, 2014 67930586405:194 admin Aug 18, 2013 Sep 5, 2014 127087196405:194 admin Aug 18, 2013 Sep 5, 2014 127087196405:194 admin Aug 18, 2013 Sep 5, 2014 127087196405:194 admin Aug 18, 2013 Sep 5, 2014 127087196405:194 admin Aug 18, 2013 Sep 5, 2014 127087196407:194 admin Aug 18, 2013 Sep 5, 2014 186950766407:194 admin Aug 18, 2013 Sep 5, 2014 186950766407:194 admin Aug 18, 2013 Sep 5, 2014 186950766407:194 admin Aug 18, 2013 Sep 5, 2014 186950766408:194 admin Aug 18, 2013 Sep 5, 2014 188278116409:194 admin Aug 18, 2013 Sep 5, 2014 171064376409:194 admin Aug 18, 2013 Sep 5, 2014 171064376410:194 admin Aug 18, 2013 Sep 5, 2014 163526846410:194 admin Aug 18, 2013 Sep 5, 2014 163526846410:194 admin Aug 18, 2013 Sep 5, 2014 163526846411:194 admin Aug 18, 2013 Sep 5, 2014 112624666411:194 admin Aug 18, 2013 Sep 5, 2014 112624666412:194 admin Aug 18, 2013 Sep 5, 2014 171818906413:194 admin Aug 18, 2013 Sep 5, 2014 191257566413:194 admin Aug 18, 2013 Sep 5, 2014 191257566413:194 admin Aug 18, 2013 Sep 5, 2014 191257566413:194 admin Aug 18, 2013 Sep 5, 2014 191257566413:194 admin Aug 18, 2013 Sep 5, 2014 191257566414:194 admin Aug 18, 2013 Sep 5, 2014 191582266415:194 admin Aug 18, 2013 Sep 5, 2014 97941756416:194 admin Aug 18, 2013 Sep 5, 2014 173796166416:194 admin Aug 18, 2013 Sep 5, 2014 173796166417:194 admin Aug 18, 2013 Sep 5, 2014 175219216417:194 admin Aug 18, 2013 Sep 5, 2014 175219216418:194 admin Aug 18, 2013 Sep 5, 2014 176222446418:194 admin Aug 18, 2013 Sep 5, 2014 176222446418:194 admin Aug 18, 2013 Sep 5, 2014 176222446419:194 admin Aug 18, 2013 Sep 5, 2014 172153806420:194 admin Aug 18, 2013 Sep 5, 2014 180000206421:194 admin Aug 18, 2013 Sep 5, 2014 179252836422:194 admin Aug 18, 2013 Sep 5, 2014 192377246422:194 admin Aug 18, 2013 Sep 5, 2014 192377246422:194 admin Aug 18, 2013 Sep 5, 2014 192377246422:194 admin Aug 18, 2013 Sep 5, 2014 192377246422:194 admin Aug 18, 2013 Sep 5, 2014 192377246422:194 admin Aug 18, 2013 Sep 5, 2014 192377246422:194 admin Aug 18, 2013 Sep 5, 2014 192377246422:194 admin Aug 18, 2013 Sep 5, 2014 192377246422:194 admin Aug 18, 2013 Sep 5, 2014 192377246422:194 admin Aug 18, 2013 Sep 5, 2014 19237724
6422:194 admin Aug 18, 2013 Sep 5, 2014 192377246422:194 admin Aug 18, 2013 Sep 5, 2014 192377246422:194 admin Aug 18, 2013 Sep 5, 2014 192377246422:194 admin Aug 18, 2013 Sep 5, 2014 192377246422:194 admin Aug 18, 2013 Sep 5, 2014 192377246422:194 admin Aug 18, 2013 Sep 5, 2014 192377246422:194 admin Aug 18, 2013 Sep 5, 2014 192377246422:194 admin Aug 18, 2013 Sep 5, 2014 192377246422:194 admin Aug 18, 2013 Sep 5, 2014 192377246422:194 admin Aug 18, 2013 Sep 5, 2014 192377246422:194 admin Aug 18, 2013 Sep 5, 2014 192377246422:194 admin Aug 18, 2013 Sep 5, 2014 192377246422:194 admin Aug 18, 2013 Sep 5, 2014 192377246422:194 admin Aug 18, 2013 Sep 5, 2014 192377246422:194 admin Aug 18, 2013 Sep 5, 2014 192377246422:194 admin Aug 18, 2013 Sep 5, 2014 192377246423:194 admin Aug 18, 2013 Sep 5, 2014 112975966423:194 admin Aug 18, 2013 Sep 5, 2014 112975966423:194 admin Aug 18, 2013 Sep 5, 2014 112975966424:194 admin Aug 18, 2013 Sep 5, 2014 105306086425:194 admin Aug 18, 2013 Sep 5, 2014 110457886425:194 admin Aug 18, 2013 Sep 5, 2014 110457886425:194 admin Aug 18, 2013 Sep 5, 2014 110457886425:194 admin Aug 18, 2013 Sep 5, 2014 110457886425:194 admin Aug 18, 2013 Sep 5, 2014 110457886428:194 admin Aug 18, 2013 Sep 5, 2014 158271036428:194 admin Aug 18, 2013 Sep 5, 2014 158271036428:194 admin Aug 18, 2013 Sep 5, 2014 158271036428:194 admin Aug 18, 2013 Sep 5, 2014 158271036428:194 admin Aug 18, 2013 Sep 5, 2014 158271036429:194 admin Aug 18, 2013 Sep 5, 2014 128693976430:194 admin Aug 18, 2013 Sep 5, 2014 173153196431:194 admin Aug 18, 2013 Sep 5, 2014 92364166432:194 admin Aug 18, 2013 Sep 5, 2014 155315006433:194 admin Aug 18, 2013 Sep 5, 2014 103621256434:194 admin Aug 18, 2013 Sep 5, 2014 74981006434:194 admin Aug 18, 2013 Sep 5, 2014 74981006434:194 admin Aug 18, 2013 Sep 5, 2014 74981006435:194 admin Aug 18, 2013 Sep 5, 2014 122088956436:194 admin Aug 18, 2013 Sep 5, 2014 170197166436:194 admin Aug 18, 2013 Sep 5, 2014 170197166436:194 admin Aug 18, 2013 Sep 5, 2014 170197166437:194 admin Aug 18, 2013 Sep 5, 2014 169850316438:194 admin Aug 18, 2013 Sep 5, 2014 84781446438:194 admin Aug 18, 2013 Sep 5, 2014 84781446438:194 admin Aug 18, 2013 Sep 5, 2014 84781446439:194 admin Aug 18, 2013 Sep 5, 2014 190569006439:194 admin Aug 18, 2013 Sep 5, 2014 19056900
6439:194 admin Aug 18, 2013 Sep 5, 2014 190569006441:194 admin Aug 18, 2013 Sep 5, 2014 192088426442:194 admin Aug 18, 2013 Sep 5, 2014 170470876443:194 admin Aug 18, 2013 Sep 5, 2014 92424786443:194 admin Aug 18, 2013 Sep 5, 2014 92424786443:194 admin Aug 18, 2013 Sep 5, 2014 92424786443:194 admin Aug 18, 2013 Sep 5, 2014 92424786443:194 admin Aug 18, 2013 Sep 5, 2014 92424786444:194 admin Aug 18, 2013 Nov 6, 2013 124671336444:194 admin Aug 18, 2013 Nov 6, 2013 124671336444:194 admin Aug 18, 2013 Nov 6, 2013 124671336444:194 admin Aug 18, 2013 Nov 6, 2013 124671336444:194 admin Aug 18, 2013 Nov 6, 2013 124671336445:194 admin Aug 18, 2013 Sep 5, 2014 33073076446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406447:194 admin Aug 18, 2013 Sep 5, 2014 158834416450:194 admin Aug 18, 2013 Sep 5, 2014 163394766450:194 admin Aug 18, 2013 Sep 5, 2014 163394766450:194 admin Aug 18, 2013 Sep 5, 2014 163394766450:194 admin Aug 18, 2013 Sep 5, 2014 163394766451:194 admin Aug 18, 2013 Sep 5, 2014 186358556451:194 admin Aug 18, 2013 Sep 5, 2014 186358556451:194 admin Aug 18, 2013 Sep 5, 2014 186358556451:194 admin Aug 18, 2013 Sep 5, 2014 186358556452:194 admin Aug 18, 2013 Sep 5, 2014 37888356452:194 admin Aug 18, 2013 Sep 5, 2014 37888356453:194 admin Aug 18, 2013 Sep 5, 2014 180655926455:194 admin Aug 18, 2013 Sep 5, 2014 169601776456:194 admin Aug 18, 2013 Sep 5, 2014 164816366456:194 admin Aug 18, 2013 Sep 5, 2014 164816366456:194 admin Aug 18, 2013 Sep 5, 2014 164816366456:194 admin Aug 18, 2013 Sep 5, 2014 16481636
6456:194 admin Aug 18, 2013 Sep 5, 2014 164816366456:194 admin Aug 18, 2013 Sep 5, 2014 164816366456:194 admin Aug 18, 2013 Sep 5, 2014 164816366456:194 admin Aug 18, 2013 Sep 5, 2014 164816366456:194 admin Aug 18, 2013 Sep 5, 2014 164816366457:194 admin Aug 18, 2013 Sep 5, 2014 176615656457:194 admin Aug 18, 2013 Sep 5, 2014 176615656457:194 admin Aug 18, 2013 Sep 5, 2014 176615656457:194 admin Aug 18, 2013 Sep 5, 2014 176615656457:194 admin Aug 18, 2013 Sep 5, 2014 176615656457:194 admin Aug 18, 2013 Sep 5, 2014 176615656459:194 admin Aug 18, 2013 Sep 5, 2014 181803956460:194 admin Aug 18, 2013 Sep 5, 2014 86750936460:194 admin Aug 18, 2013 Sep 5, 2014 86750936460:194 admin Aug 18, 2013 Sep 5, 2014 86750936460:194 admin Aug 18, 2013 Sep 5, 2014 86750936461:194 admin Aug 18, 2013 Sep 5, 2014 189889096462:194 admin Aug 18, 2013 Sep 5, 2014 90225616462:194 admin Aug 18, 2013 Sep 5, 2014 90225616462:194 admin Aug 18, 2013 Sep 5, 2014 90225616463:194 admin Aug 18, 2013 Sep 5, 2014 36203146464:194 admin Aug 18, 2013 Sep 5, 2014 119043166464:194 admin Aug 18, 2013 Sep 5, 2014 119043166464:194 admin Aug 18, 2013 Sep 5, 2014 119043166465:194 admin Aug 18, 2013 Sep 5, 2014 176238016465:194 admin Aug 18, 2013 Sep 5, 2014 176238016465:194 admin Aug 18, 2013 Sep 5, 2014 176238016465:194 admin Aug 18, 2013 Sep 5, 2014 176238016465:194 admin Aug 18, 2013 Sep 5, 2014 176238016466:194 admin Aug 18, 2013 Sep 5, 2014 77958376466:194 admin Aug 18, 2013 Sep 5, 2014 77958376466:194 admin Aug 18, 2013 Sep 5, 2014 77958376467:194 admin Aug 18, 2013 Sep 5, 2014 95214376468:194 admin Aug 18, 2013 Sep 5, 2014 180897016468:194 admin Aug 18, 2013 Sep 5, 2014 180897016469:194 admin Aug 18, 2013 Sep 5, 2014 184102256469:194 admin Aug 18, 2013 Sep 5, 2014 18410225
Alt ID(s) Title Year Author20082008200020002000200320032003199520052008200820081992199619981998200520052005200520082008200820072008200820082008200820072007200819931999199520082008200820062006200620062006200620072007
OutcomeSerum vitamin D
concentration and Ahn J., Peters U., Albanes D., Purdue MP., Abnet CC.,
Aggressive prostate Serum vitamin D
concentration and Ahn J., Peters U., Albanes D., Purdue MP., Abnet CC.,
Prostate cancer Prostate cancer risk and
prediagnostic serum 25-Ahonen MH., Tenkanen L., Teppo L., Hakama M.,
Prostate cancer Prostate cancer risk and
prediagnostic serum 25-Ahonen MH., Tenkanen L., Teppo L., Hakama M.,
Prostate cancer in Prostate cancer risk and
prediagnostic serum 25-Ahonen MH., Tenkanen L., Teppo L., Hakama M.,
Prostate cancer in A prospective study of
calcium intake from diet Al-Delaimy WK., Rimm E., Willett WC., Stampfer MJ.,
Fatal IHD [Including A prospective study of
calcium intake from diet Al-Delaimy WK., Rimm E., Willett WC., Stampfer MJ.,
IHD (fatal + nonfatal) A prospective study of
calcium intake from diet Al-Delaimy WK., Rimm E., Willett WC., Stampfer MJ.,
Nonfatal MI [Self-The influence of
menopause and hormonal Aloia JF., Vaswani A., Russo L., Sheehan M.,
Body weight Low-fat dairy consumption
and reduced risk of Alonso A., Beunza JJ., Delgado-Rodríguez M.,
HTN, incident Effect of vitamin D
supplementation on bone Andersen R., Mølgaard C., Skovgaard LT., Brot C.,
25(OH)D [ContinuouEffect of vitamin D
supplementation on bone Andersen R., Mølgaard C., Skovgaard LT., Brot C.,
BMC - whole body Effect of vitamin D
supplementation on bone Andersen R., Mølgaard C., Skovgaard LT., Brot C.,
BMD - lumbar A prospective study of
nutritional factors and Ascherio A., Rimm EB., Giovannucci EL., Colditz
Incident HTN Prospective study of
nutritional factors, blood Ascherio A., Hennekens C., Willett WC., Sacks F.,
Hypertension Intake of potassium,
magnesium, calcium, and Ascherio A., Rimm EB., Hernán MA., Giovannucci
Incident stroke Intake of potassium,
magnesium, calcium, and Ascherio A., Rimm EB., Hernán MA., Giovannucci
specific stroke Risk of prostate cancer in
a randomized clinical trial Baron JA., Beach M., Wallace K., Grau MV.,
Prostate cancer risk Risk of prostate cancer in
a randomized clinical trial Baron JA., Beach M., Wallace K., Grau MV.,
Total serum PSA Plasma 25-hydroxyvitamin
D and 1,25-Bertone-Johnson ER., Chen WY., Holick MF., Hollis BW.,
Breast cancer risk Plasma 25-hydroxyvitamin
D and 1,25-Bertone-Johnson ER., Chen WY., Holick MF., Hollis BW.,
Breast cancer risk Vitamin D
supplementation has Björkman M., Sorva A., Risteli J., Tilvis R.
25(OH)D level Vitamin D
supplementation has Björkman M., Sorva A., Risteli J., Tilvis R.
Mortality [All Body size and serum 25
hydroxy vitamin D Blum M., Dallal GE., Dawson-Hughes B.
25(OH)D at 1 y Maternal vitamin D
deficiency increases the Bodnar LM., Catov JM., Simhan HN., Holick MF.,
preeclampsia Vascular events in healthy
older women receiving Bolland MJ., Barber PA., Doughty RN., Mason B.,
CVD Composite Vascular events in healthy
older women receiving Bolland MJ., Barber PA., Doughty RN., Mason B.,
Death [Family, Vascular events in healthy
older women receiving Bolland MJ., Barber PA., Doughty RN., Mason B.,
MI [Standard Vascular events in healthy
older women receiving Bolland MJ., Barber PA., Doughty RN., Mason B.,
Stroke [Standard Vascular events in healthy
older women receiving Bolland MJ., Barber PA., Doughty RN., Mason B.,
Sudden death Two-year randomized
controlled trial of vitamin Bolton-Smith C., McMurdo ME., Paterson CR., Mole
25(OH)D [Measured Two-year randomized
controlled trial of vitamin Bolton-Smith C., McMurdo ME., Paterson CR., Mole
Femoral neck BMD Dairy calcium
supplementation in Bortolotti M., Rudelle S., Schneiter P., Vidal H.,
Weight [ContinuouRelation of calcium,
vitamin D, and dairy food Bostick RM., Potter JD., Sellers TA., McKenzie DR.,
Colon cancer Relation of calcium,
vitamin D, and dairy food Bostick RM., Kushi LH., Wu Y., Meyer KA., Sellers TA.,
IHD death [CategoricProstate cancer and
prediagnostic levels of Braun MM., Helzlsouer KJ., Hollis BW., Comstock GW.
Prostate cancer Calcium, vitamin D
supplementation, and Brunner RL., Cochrane B., Jackson RD., Larson J.,
Chair stands Calcium, vitamin D
supplementation, and Brunner RL., Cochrane B., Jackson RD., Larson J.,
Grip strength Calcium, vitamin D
supplementation, and Brunner RL., Cochrane B., Jackson RD., Larson J.,
Timed walk [The timed Effects of vitamin D
supplementation and Bunout D., Barrera G., Leiva L., Gattas V., de la
25(OH)vitD [No assay Effects of vitamin D
supplementation and Bunout D., Barrera G., Leiva L., Gattas V., de la
Fall [Fall free Effects of vitamin D
supplementation and Bunout D., Barrera G., Leiva L., Gattas V., de la
Muscle strength Effects of vitamin D
supplementation and Bunout D., Barrera G., Leiva L., Gattas V., de la
Physical performanEffects of vitamin D
supplementation and Bunout D., Barrera G., Leiva L., Gattas V., de la
Timed up and go Effects of vitamin D
supplementation and Bunout D., Barrera G., Leiva L., Gattas V., de la
Twelve minutes Does vitamin D stop
inpatients falling? A Burleigh E., McColl J., Potter J.
Fall [Defined as Does vitamin D stop
inpatients falling? A Burleigh E., McColl J., Potter J.
fracture [Any
200720012008200520052005200420042004-- Not Found ---- Not Found ---- Not Found ---- Not Found ---- Not Found --1996199620062006200620062006200620062006200619941994200420042004200420052005200520072008200720072007200720072007200720072008199620082008
Calcium plus vitamin D supplementation and the
Caan B., Neuhouser M., Aragaki A., Lewis CB.,
Weight [Kg]Dairy products, calcium,
and prostate cancer risk in Chan JM., Stampfer MJ., Ma J., Gann PH., Gaziano JM.,
Prostate cancer Calcium plus vitamin D
supplementation and the Chlebowski RT., Johnson KC., Kooperberg C.,
Incident invasive Effects of calcium, dairy
product, and vitamin D Cheng S., Lyytikäinen A., Kröger H., Lamberg-Allardt
areal BMD [ContinuouEffects of calcium, dairy
product, and vitamin D Cheng S., Lyytikäinen A., Kröger H., Lamberg-Allardt
bone indexes Effects of calcium, dairy
product, and vitamin D Cheng S., Lyytikäinen A., Kröger H., Lamberg-Allardt
change in BMC (ITT Weight loss and calcium
intake influence calcium Cifuentes M., Riedt CS., Brolin RE., Field MP.,
25(OH)D [ContinuouWeight loss and calcium
intake influence calcium Cifuentes M., Riedt CS., Brolin RE., Field MP.,
Curve 4- Ca Weight loss and calcium
intake influence calcium Cifuentes M., Riedt CS., Brolin RE., Field MP.,
Weight change Vitamin D and prostate
cancer: a prediagnostic Corder EH., Guess HA., Hulka BS., Friedman GD.,
Prostate cancer Vitamin D and prostate
cancer: a prediagnostic Corder EH., Guess HA., Hulka BS., Friedman GD.,
Prostate cancer Vitamin D and prostate
cancer: a prediagnostic Corder EH., Guess HA., Hulka BS., Friedman GD.,
Prostate cancer Calcium chemoprevention
in colorectal cancer.Duris I., Hruby D., Pekarkova B., Huorka M.,
Adenomas recurrence Calcium chemoprevention
in colorectal cancer.Duris I., Hruby D., Pekarkova B., Huorka M.,
Survival [nd (only Dietary calcium, alcohol,
and incidence of treated Dwyer JH., Li L., Dwyer KM., Curtin LR., Feinleib M.
HTN (BP or Rx) [SBP Dietary calcium, alcohol,
and incidence of treated Dwyer JH., Li L., Dwyer KM., Curtin LR., Feinleib M.
HTN (Rx) [HTN Effect of 1-year dairy
product intervention on fat Eagan MS., Lyle RM., Gunther CW., Peacock M.,
BMI [ContinuouEffect of 1-year dairy
product intervention on fat Eagan MS., Lyle RM., Gunther CW., Peacock M.,
Weight [To the nearest Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J.,
25(OH)D [ContinuouEffect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J.,
Weight [ContinuouEffect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J.,
% change in BMC at Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J.,
% change in total hip Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J.,
1,25(OH)D [ContinuouEffect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J.,
Total body BMC Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J.,
height [ContinuouSeasonal and geographical
variations in the growth Feliciano ES., Ho ML., Specker BL., Falciglia G.,
length [ContinuouSeasonal and geographical
variations in the growth Feliciano ES., Ho ML., Specker BL., Falciglia G.,
weight [ContinuouPlasma vitamin D
metabolites and risk of Feskanich D., Ma J., Fuchs CS., Kirkner GJ., Hankinson
Colon cancer [nd]Plasma vitamin D
metabolites and risk of Feskanich D., Ma J., Fuchs CS., Kirkner GJ., Hankinson
Colorectal cancer Plasma vitamin D
metabolites and risk of Feskanich D., Ma J., Fuchs CS., Kirkner GJ., Hankinson
Proximal and distal Plasma vitamin D
metabolites and risk of Feskanich D., Ma J., Fuchs CS., Kirkner GJ., Hankinson
Rectal cancer [nd]Calcium from diet and
supplements is associated Flood A., Peters U., Chatterjee N., Lacey JV.,
Colon cancer vs. Calcium from diet and
supplements is associated Flood A., Peters U., Chatterjee N., Lacey JV.,
Colorectal cancer Calcium from diet and
supplements is associated Flood A., Peters U., Chatterjee N., Lacey JV.,
Proximal vs. distal Plasma 25-hydroxyvitamin
D levels and risk of Forman JP., Giovannucci E., Holmes MD., Bischoff-
Incident HTN Plasma 25-hydroxyvitamin
D levels and risk of Forman JP., Curhan GC., Taylor EN.
Hypertension [Self-Prospective study of
serum vitamin D and Freedman DM., Looker AC., Chang SC., Graubard
Breast cancer Prospective study of
serum vitamin D and Freedman DM., Looker AC., Chang SC., Graubard
Cancer mortality Prospective study of
serum vitamin D and Freedman DM., Looker AC., Chang SC., Graubard
Colorectal cancer Prospective study of
serum vitamin D and Freedman DM., Looker AC., Chang SC., Graubard
Digestive cancer Prospective study of
serum vitamin D and Freedman DM., Looker AC., Chang SC., Graubard
Lung cancer Prospective study of
serum vitamin D and Freedman DM., Looker AC., Chang SC., Graubard
Non-Hodgkin s Prospective study of
serum vitamin D and Freedman DM., Looker AC., Chang SC., Graubard
Other cancers Prospective study of
serum vitamin D and Freedman DM., Looker AC., Chang SC., Graubard
Prostate cancer Serum levels of vitamin D
metabolites and breast Freedman DM., Chang SC., Falk RT., Purdue MP.,
Breast cancer risk Dietary factors and risk of
colon cancer: a Gaard M., Tretli S., Løken EB.
Colon cancer Maternal vitamin D status
during pregnancy and Gale CR., Robinson SM., Harvey NC., Javaid MK.,
9 mo length Maternal vitamin D status
during pregnancy and Gale CR., Robinson SM., Harvey NC., Javaid MK.,
9 mo weight
200820082008199619851989199519951995 SBP/DBP199520072007199919991999200520052005200320032003200319971986200420012001200119941994199420082008199419971996200520052007200620082004200420042007200720082006
Maternal vitamin D status during pregnancy and
Gale CR., Robinson SM., Harvey NC., Javaid MK.,
atopic eczema at Maternal vitamin D status
during pregnancy and Gale CR., Robinson SM., Harvey NC., Javaid MK.,
birth length Maternal vitamin D status
during pregnancy and Gale CR., Robinson SM., Harvey NC., Javaid MK.,
birth weight Circulating vitamin D
metabolites in relation to Gann PH., Ma J., Hennekens CH., Hollis
Prostate cancer Dietary vitamin D and
calcium and risk of Garland C., Shekelle RB., Barrett-Connor E., Criqui
Colorectal cancer Serum 25-hydroxyvitamin
D and colon cancer: eight-Garland CF., Comstock GW., Garland FC., Helsing
Colon cancer The influence of dairy
products on plasma uric Ghadirian P., Shatenstein B., Verdy M., Hamet P.
DBP [ContinuouThe influence of dairy
products on plasma uric Ghadirian P., Shatenstein B., Verdy M., Hamet P.
SBP [ContinuouThe influence of dairy
products on plasma uric Ghadirian P., Shatenstein B., Verdy M., Hamet P.The influence of dairy
products on plasma uric Ghadirian P., Shatenstein B., Verdy M., Hamet P.
Weight [Kg:ContinProlonged effect of
calcium supplementation Grau MV., Baron JA., Sandler RS., Wallace K.,
Advance adenomas Prolonged effect of
calcium supplementation Grau MV., Baron JA., Sandler RS., Wallace K.,
All adenomas Plasma 25-hydroxyvitamin
D responses of younger Harris SS., Dawson-Hughes B., Perrone GA.
25(OH)D total [sum Plasma 25-hydroxyvitamin
D responses of younger Harris SS., Dawson-Hughes B., Perrone GA.
25(OH)D2 [ContinuouPlasma 25-hydroxyvitamin
D responses of younger Harris SS., Dawson-Hughes B., Perrone GA.
25(OH)D3 [ContinuouThe association of calcium
and vitamin D with risk of Hartman TJ., Albert PS., Snyder K., Slattery ML.,
Advanced adenomas The association of calcium
and vitamin D with risk of Hartman TJ., Albert PS., Snyder K., Slattery ML.,
Recurrent adenomas The impact of calcium and
dairy product consumption Harvey-Berino J., Gold BC., Lauber R., Starinski A.
Body weight Gestational calcium
supplementation and Hatton DC., Harrison-Hohner J., Coste S., Reller
DBP [ContinuouGestational calcium
supplementation and Hatton DC., Harrison-Hohner J., Coste S., Reller
SBP [ContinuouGestational calcium
supplementation and Hatton DC., Harrison-Hohner J., Coste S., Reller
BP (post-partum)Human serum 25-
hydroxycholecalciferol Heaney RP., Davies KM., Chen TC., Holick MF.,
slope [ 25(OH)D/ Long-term vitamin D3
supplementation may Heikkinen AM., Tuppurainen MT.,
Body weight Colon cancer and dietary
fat, phosphorus, and Heilbrun LK., Hankin JH., Nomura AM.,
Colon cancer Plasma levels of 25-
hydroxyvitamin D, 1,25-Jacobs ET., Giuliano AR., Martínez ME., Hollis BW.,
Prostate cancer Prospective study on milk
products, calcium and Järvinen R., Knekt P., Hakulinen T., Aromaa A.
Colon cancer Prospective study on milk
products, calcium and Järvinen R., Knekt P., Hakulinen T., Aromaa A.
Colorectal cancer Prospective study on milk
products, calcium and Järvinen R., Knekt P., Hakulinen T., Aromaa A.
Rectal cancer Dietary intakes,
anthropometric Johnson AA., Knight EM., Edwards CH., Oyemade
birth lengthDietary intakes,
anthropometric Johnson AA., Knight EM., Edwards CH., Oyemade
birth weightDietary intakes,
anthropometric Johnson AA., Knight EM., Edwards CH., Oyemade
gestational ageCalcium intake and the
outcome of short-term Kabrnová-Hlavatá K., Hainer V., Gojová M.,
BMI [ContinuouCalcium intake and the
outcome of short-term Kabrnová-Hlavatá K., Hainer V., Gojová M.,
weight [Analyzed Fermented dairy products,
calcium, and colorectal Kampman E., Goldbohm RA., van den Brandt PA.,
Colorectal cancer Prospective study of diet
and female colorectal Kato I., Akhmedkhanov A., Koenig K., Toniolo PG.,
Colorectal Cancer Calcium, vitamin D, and
dairy foods and the Kearney J., Giovannucci E., Rimm EB., Ascherio A.,
Colon caner Dietary calcium,
phosphorus, vitamin D, Kesse E., Boutron-Ruault MC., Norat T., Riboli E.,
Colorectal cancer Dietary calcium,
phosphorus, vitamin D, Kesse E., Boutron-Ruault MC., Norat T., Riboli E.,
adenoma [Complete Dairy products, calcium
and the risk of breast Kesse-Guyot E., Bertrais S., Duperray B., Arnault N.,
Incident breast Dairy products, calcium
and prostate cancer risk.Koh KA., Sesso HD., Paffenbarger RS., Lee IM.
prostate cancer Dairy product, saturated
fatty acid, and calcium Kurahashi N., Inoue M., Iwasaki M., Sasazuki S.,
Prostate cancer Girls on a high-calcium
diet gain weight at the Lappe JM., Rafferty KA., Davies KM., Lypaczewski
change in BMI Girls on a high-calcium
diet gain weight at the Lappe JM., Rafferty KA., Davies KM., Lypaczewski
change in ht Girls on a high-calcium
diet gain weight at the Lappe JM., Rafferty KA., Davies KM., Lypaczewski
change in wt Vitamin D and calcium
supplementation reduces Lappe JM., Travers-Gustafson D., Davies KM.,
change in 25 OH(D) Vitamin D and calcium
supplementation reduces Lappe JM., Travers-Gustafson D., Davies KM.,
incident cancer Calcium and vitamin d
supplementation Lappe J., Cullen D., Haynatzki G., Recker R.,
stress fractures Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci
Colon caner
2006200620062006200620062006200620062008200820082008200920071995 Lijnen P., Petrov V.1995 Lijnen P., Petrov V.1995 Lijnen P., Petrov V.1995 Lijnen P., Petrov V.1995 Lijnen P., Petrov V.2005200520052007200620062006200720072007200720072007200719861986198619861986200820082005200520021987198819881988
Calcium and dairy food intakes are inversely
Larsson SC., Bergkvist L., Rutegård J., Giovannucci
Colorectal caner Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci
Distal colon Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci
Proximal colon Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci
Rectal caner Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci
Colon caner Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci
Colorectal caner Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci
Distal colon Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci
Proximal colon Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci
Rectal caner Magnesium, calcium,
potassium, and sodium Larsson SC., Virtanen MJ., Mars M., Männistö S.,
Also separate Magnesium, calcium,
potassium, and sodium Larsson SC., Virtanen MJ., Mars M., Männistö S.,
Cerebral infarction Magnesium, calcium,
potassium, and sodium Larsson SC., Virtanen MJ., Mars M., Männistö S.,
First stroke (and Magnesium, calcium,
potassium, and sodium Larsson SC., Virtanen MJ., Mars M., Männistö S.,
No analysis of total Long-term dietary calcium
intake and breast cancer Larsson SC., Bergkvist L., Wolk A.
Invasive breast A prospective study of
plasma vitamin D Li H., Stampfer MJ., Hollis JB., Mucci LA., Gaziano JM.,
Prostate cancer Dietary calcium, blood
pressure and cell 1,25(OH)D [RadioreceDietary calcium, blood
pressure and cell 25(OH)D [CompetitiDietary calcium, blood
pressure and cell DBP (supine) Dietary calcium, blood
pressure and cell SBP (standing) Dietary calcium, blood
pressure and cell SBP/DBP [Standing Intakes of calcium and
vitamin D and risk of Lin J., Zhang SM., Cook NR., Manson JE., Lee IM.,
Colorectal cancer Intakes of calcium and
vitamin D and risk of Lin J., Zhang SM., Cook NR., Manson JE., Lee IM.,
Distal colon Intakes of calcium and
vitamin D and risk of Lin J., Zhang SM., Cook NR., Manson JE., Lee IM.,
Proximal colon Intakes of calcium and
vitamin D and breast Lin J., Manson JE., Lee IM., Cook NR., Buring JE.,
Breast cancer Calcium supplementation
for 1 y does not reduce Lorenzen JK., Mølgaard C., Michaelsen KF., Astrup A.
25(OH)D [ContinuouCalcium supplementation
for 1 y does not reduce Lorenzen JK., Mølgaard C., Michaelsen KF., Astrup A.
height [ContinuouCalcium supplementation
for 1 y does not reduce Lorenzen JK., Mølgaard C., Michaelsen KF., Astrup A.
body weight Preventing fractures
among older people living Lyons RA., Johansen A., Brophy S., Newcombe RG.,
First fracture Preventing fractures
among older people living Lyons RA., Johansen A., Brophy S., Newcombe RG.,
Fractures (hip/wrist/fPreventing fractures
among older people living Lyons RA., Johansen A., Brophy S., Newcombe RG.,
Mortality [nd:CategoSupplementation with
calcium + vitamin D Major GC., Alarie F., Doré J., Phouttama S., Tremblay
BMI [ContinuouSupplementation with
calcium + vitamin D Major GC., Alarie F., Doré J., Phouttama S., Tremblay
DBP [ContinuouSupplementation with
calcium + vitamin D Major GC., Alarie F., Doré J., Phouttama S., Tremblay
SBP [ContinuouSupplementation with
calcium + vitamin D Major GC., Alarie F., Doré J., Phouttama S., Tremblay
Weight [Kg:ContinVitamin D
supplementation in Mallet E., Gügi B., Brunelle P., Hénocq A., Basuyau JP.,
birth weight Vitamin D
supplementation in Mallet E., Gügi B., Brunelle P., Hénocq A., Basuyau JP.,
cord blood 1,25 Vitamin D
supplementation in Mallet E., Gügi B., Brunelle P., Hénocq A., Basuyau JP.,
cord blood 25(OH)D at Vitamin D
supplementation in Mallet E., Gügi B., Brunelle P., Hénocq A., Basuyau JP.,
maternal 1,25 Vitamin D
supplementation in Mallet E., Gügi B., Brunelle P., Hénocq A., Basuyau JP.,
maternal 25(OH)D at Effect of calcium and
vitamin D supplementation Margolis KL., Ray RM., Van Horn L., Manson JE., Allison
Hypertension [Self-Effect of calcium and
vitamin D supplementation Margolis KL., Ray RM., Van Horn L., Manson JE., Allison
Systolic BP [ContinuouDietary and serum
vitamins and minerals as Marniemi J., Alanen E., Impivaara O., Seppänen
AMI [ICD 9 codes from Dietary and serum
vitamins and minerals as Marniemi J., Alanen E., Impivaara O., Seppänen
Stroke [Same:CatCalcium, vitamin D, and
risk of adenoma Martínez ME., Marshall JR., Sampliner R., Wilkinson J.,
Adenoma recurrence Effect of calcium and
vitamin D supplementation Marya RK., Rathee S., Manrow M.
toxemia [nd:CategoEffect of vitamin D
supplementation during Marya RK., Rathee S., Dua V., Sangwan K.
crown-heel length Effect of vitamin D
supplementation during Marya RK., Rathee S., Dua V., Sangwan K.
gestational age Effect of vitamin D
supplementation during Marya RK., Rathee S., Dua V., Sangwan K.
newborn birth
200619811981200320032003200320032008200820082008200820062006200620062006200120012006 Moschonis G., Manios Y.200920092009200920092009199820072007200720072007200720072007200720072009200920092009200920092009200920092009
Vitamin D2 dose required to rapidly increase 25OHD
Mastaglia SR., Mautalen CA., Parisi MS., Oliveri B.
25(OH)D [ContinuouVitamin D supplements
enhance weight gain and Maxwell JD., Ang L., Brooke OG., Brown IR.
birth weight Vitamin D supplements
enhance weight gain and Maxwell JD., Ang L., Brooke OG., Brown IR.
weight gain 3rd Calcium, vitamin D, dairy
products, and risk of McCullough ML., Robertson AS., Rodriguez
CRC [CategoricCalcium, vitamin D, dairy
products, and risk of McCullough ML., Robertson AS., Rodriguez
Colorectal cancer Calcium, vitamin D, dairy
products, and risk of McCullough ML., Robertson AS., Rodriguez
Distal colon Calcium, vitamin D, dairy
products, and risk of McCullough ML., Robertson AS., Rodriguez
Proximal colon Calcium, vitamin D, dairy
products, and risk of McCullough ML., Robertson AS., Rodriguez
Rectal cancer 25-hydroxyvitamin D
levels and the risk of Melamed ML., Michos ED., Post W., Astor B.
All-cause mortality 25-hydroxyvitamin D
levels and the risk of Melamed ML., Michos ED., Post W., Astor B.
CVD mortality 25-hydroxyvitamin D
levels and the risk of Melamed ML., Michos ED., Post W., Astor B.
Cancer mortality 25-hydroxyvitamin D
levels and the risk of Melamed ML., Michos ED., Post W., Astor B.
Infectious disease Dietary calcium and
vitamin D intakes in Mishra G., McCormack V., Kuh D., Hardy R., Stephen
Mammography Dairy products, calcium
and prostate cancer risk.Koh KA., Sesso HD., Paffenbarger RS., Lee IM.
fatal prostate Dairy products, calcium
and prostate cancer risk.Koh KA., Sesso HD., Paffenbarger RS., Lee IM.
prostate cancer Maternal 25-
hydroxyvitamin D and Morley R., Carlin JB., Pasco JA., Wark JD.
birth weight Maternal 25-
hydroxyvitamin D and Morley R., Carlin JB., Pasco JA., Wark JD.
crown-heel length Maternal 25-
hydroxyvitamin D and Morley R., Carlin JB., Pasco JA., Wark JD.
gestation lengthNutrient intake and
hypertensive disorders of Morris CD., Jacobson SL., Anand R., Ewell MG.,
Pregnancy-induced Nutrient intake and
hypertensive disorders of Morris CD., Jacobson SL., Anand R., Ewell MG.,
preeclampsia [HTN Skeletal site-dependent
response of bone mineral BMD [DXA:ContiA double-blind,
randomized, placebo-Nagpal J., Pande JN., Bhartia A.
25(OH)D [ContinuouA double-blind,
randomized, placebo-Nagpal J., Pande JN., Bhartia A.
BMI (per protocol) A double-blind,
randomized, placebo-Nagpal J., Pande JN., Bhartia A.
DBP [Same as A double-blind,
randomized, placebo-Nagpal J., Pande JN., Bhartia A.
SBP [AutomateA double-blind,
randomized, placebo-Nagpal J., Pande JN., Bhartia A.
Weight (ITT) Supplements of 20
microg/d cholecalciferol Nelson ML., Blum JM., Hollis BW., Rosen C.,
Serum 25(OH)D Serum vitamin D
metabolite levels and the Nomura AM., Stemmermann GN., Lee J.,
prostate cancer Calcium and vitamin D
intakes in relation to risk Oh K., Willett WC., Wu K., Fuchs CS., Giovannucci EL.
Colorectal adenoma Calcium and vitamin D
intakes in relation to risk Oh K., Willett WC., Wu K., Fuchs CS., Giovannucci EL.
Distal colon Diet during pregnancy and
risk of preeclampsia or Oken E., Ning Y., Rifas-Shiman SL., Rich-Edwards
gestational HTNDiet during pregnancy and
risk of preeclampsia or Oken E., Ning Y., Rifas-Shiman SL., Rich-Edwards
preeclampsia [BP Plasma vitamin D and risk
of colorectal cancer: the Otani T., Iwasaki M., Sasazuki S., Inoue M.,
Colon cancer Plasma vitamin D and risk
of colorectal cancer: the Otani T., Iwasaki M., Sasazuki S., Inoue M.,
Colorectal cancer Plasma vitamin D and risk
of colorectal cancer: the Otani T., Iwasaki M., Sasazuki S., Inoue M.,
Rectal cancer Calcium and vitamin D
intake and risk of Park SY., Murphy SP., Wilkens LR., Nomura AM.,
Colorectal cancer Calcium, dairy foods, and
risk of incident and fatal Park Y., Mitrou PN., Kipnis V., Hollenbeck A.,
incident prostate Calcium, vitamin D, and
dairy product intake and Park SY., Murphy SP., Wilkens LR., Stram DO.,
Prostate cancer Dairy food, calcium, and
risk of cancer in the NIH-Park Y., Leitzmann MF., Subar AF., Hollenbeck A.,
All cancers [Identified Dairy food, calcium, and
risk of cancer in the NIH-Park Y., Leitzmann MF., Subar AF., Hollenbeck A.,
Bladder cancer Dairy food, calcium, and
risk of cancer in the NIH-Park Y., Leitzmann MF., Subar AF., Hollenbeck A.,
Brain and other Dairy food, calcium, and
risk of cancer in the NIH-Park Y., Leitzmann MF., Subar AF., Hollenbeck A.,
Brain cancer Dairy food, calcium, and
risk of cancer in the NIH-Park Y., Leitzmann MF., Subar AF., Hollenbeck A.,
Breast cancer Dairy food, calcium, and
risk of cancer in the NIH-Park Y., Leitzmann MF., Subar AF., Hollenbeck A.,
Colorectal cancer Dairy food, calcium, and
risk of cancer in the NIH-Park Y., Leitzmann MF., Subar AF., Hollenbeck A.,
Digestive system Dairy food, calcium, and
risk of cancer in the NIH-Park Y., Leitzmann MF., Subar AF., Hollenbeck A.,
Endocrine system Dairy food, calcium, and
risk of cancer in the NIH-Park Y., Leitzmann MF., Subar AF., Hollenbeck A.,
Endometrial cancer Dairy food, calcium, and
risk of cancer in the NIH-Park Y., Leitzmann MF., Subar AF., Hollenbeck A.,
Esophageal cancer
200920092009200920092009200920092009200920092009200920092009200920012001200119992000200020002000200020052005200520052005200320071997200419991995199519952002200620062006200619931993199320082008
Dairy food, calcium, and risk of cancer in the NIH-
Park Y., Leitzmann MF., Subar AF., Hollenbeck A.,
Head and neck Dairy food, calcium, and
risk of cancer in the NIH-Park Y., Leitzmann MF., Subar AF., Hollenbeck A.,
Kidney cancer Dairy food, calcium, and
risk of cancer in the NIH-Park Y., Leitzmann MF., Subar AF., Hollenbeck A.,
Leukemia [The same Dairy food, calcium, and
risk of cancer in the NIH-Park Y., Leitzmann MF., Subar AF., Hollenbeck A.,
Liver cancer Dairy food, calcium, and
risk of cancer in the NIH-Park Y., Leitzmann MF., Subar AF., Hollenbeck A.,
Lung cancer Dairy food, calcium, and
risk of cancer in the NIH-Park Y., Leitzmann MF., Subar AF., Hollenbeck A.,
Myeloma [The same Dairy food, calcium, and
risk of cancer in the NIH-Park Y., Leitzmann MF., Subar AF., Hollenbeck A.,
Non-Hodgkin Dairy food, calcium, and
risk of cancer in the NIH-Park Y., Leitzmann MF., Subar AF., Hollenbeck A.,
Others [A combined Dairy food, calcium, and
risk of cancer in the NIH-Park Y., Leitzmann MF., Subar AF., Hollenbeck A.,
Ovarian cancer Dairy food, calcium, and
risk of cancer in the NIH-Park Y., Leitzmann MF., Subar AF., Hollenbeck A.,
Pancreatic cancer Dairy food, calcium, and
risk of cancer in the NIH-Park Y., Leitzmann MF., Subar AF., Hollenbeck A.,
Reproductive system Dairy food, calcium, and
risk of cancer in the NIH-Park Y., Leitzmann MF., Subar AF., Hollenbeck A.,
Respiratory system Dairy food, calcium, and
risk of cancer in the NIH-Park Y., Leitzmann MF., Subar AF., Hollenbeck A.,
Stomach cancer Dairy food, calcium, and
risk of cancer in the NIH-Park Y., Leitzmann MF., Subar AF., Hollenbeck A.,
Thyroid cancer Dairy food, calcium, and
risk of cancer in the NIH-Park Y., Leitzmann MF., Subar AF., Hollenbeck A.,
Urinary system Dairy food, calcium, and
risk of cancer in the NIH-Park Y., Leitzmann MF., Subar AF., Hollenbeck A.,
Women [A Effects of a short-term
vitamin D(3) and calcium Pfeifer M., Begerow B., Minne HW., Nachtigall D.,
25(OH)D [ContinuouEffects of a short-term
vitamin D(3) and calcium Pfeifer M., Begerow B., Minne HW., Nachtigall D.,
DBP [Same as Effects of a short-term
vitamin D(3) and calcium Pfeifer M., Begerow B., Minne HW., Nachtigall D.,
SBP [Measured Diet and risk of colorectal
cancer in a cohort of Pietinen P., Malila N., Virtanen M., Hartman TJ.,
Colon cancer or Plasma 1,25-dihydroxy-
and 25-hydroxyvitamin D Platz EA., Hankinson SE., Hollis BW., Colditz GA.,
Distal colon Plasma 1,25-dihydroxy-
and 25-hydroxyvitamin D Platz EA., Hankinson SE., Hollis BW., Colditz GA.,
Distal colorectal Plasma 1,25-dihydroxy-
and 25-hydroxyvitamin D Platz EA., Hankinson SE., Hollis BW., Colditz GA.,
Rectal adenoma Plasma 1,25-dihydroxy-
and 25-hydroxyvitamin D Platz EA., Hankinson SE., Hollis BW., Colditz GA.,
high-risk distal colon Plasma 1,25-dihydroxy-
and 25-hydroxyvitamin D Platz EA., Hankinson SE., Hollis BW., Colditz GA.,
low-risk (distal) Effects of calcium
supplementation on body Reid IR., Horne A., Mason B., Ames R., Bava U.,
BMI [ContinuouEffects of calcium
supplementation on body Reid IR., Horne A., Mason B., Ames R., Bava U.,
DBP [ContinuouEffects of calcium
supplementation on body Reid IR., Horne A., Mason B., Ames R., Bava U.,
SBP [ContinuouEffects of calcium
supplementation on body Reid IR., Horne A., Mason B., Ames R., Bava U.,
BP [SBP, DBP]Effects of calcium
supplementation on body Reid IR., Horne A., Mason B., Ames R., Bava U.,
Weight [Kg, Calcium, dairy products,
and risk of prostate cancer Rodriguez C., McCullough ML., Mondul AM., Jacobs
Prostate cancer Meat and dairy
consumption and Rohrmann S., Platz EA., Kavanaugh CJ., Thuita L.,
incident prostate Prospective evaluation of
dietary and other Ross RK., Yuan JM., Henderson BE., Park J.,
Fatal stroke Serum parathyroid
hormone is associated Sambrook PN., Chen JS., March LM., Cameron ID.,
Total mortality Animal products, calcium
and protein and prostate Schuurman AG., van den Brandt PA., Dorant E.,
Prostate cancer Effect of winter oral
vitamin D3 Scragg R., Khaw KT., Murphy S.
25(OH)D [As Effect of winter oral
vitamin D3 Scragg R., Khaw KT., Murphy S.
DBP [BP was Effect of winter oral
vitamin D3 Scragg R., Khaw KT., Murphy S.
SBP [BP was Intake of dairy products,
calcium, and vitamin d and Shin MH., Holmes MD., Hankinson SE., Wu K.,
Breast cancer Dietary intake of calcium,
fiber and other Shin A., Li H., Shu XO., Yang G., Gao YT., Zheng
Colon cancerDietary intake of calcium,
fiber and other Shin A., Li H., Shu XO., Yang G., Gao YT., Zheng
Colorectal cancer Dietary intake of calcium,
fiber and other Shin A., Li H., Shu XO., Yang G., Gao YT., Zheng
Rectal cancerVitamin D intake and the
risk for pancreatic cancer Skinner HG., Michaud DS., Giovannucci E., Willett
Pancreatic cancer Calcium intake and 28-
year gastro-intestinal Slob IC., Lambregts JL., Schuit AJ., Kok FJ.
All-cause mortality Calcium intake and 28-
year gastro-intestinal Slob IC., Lambregts JL., Schuit AJ., Kok FJ.
Cancer mortality Calcium intake and 28-
year gastro-intestinal Slob IC., Lambregts JL., Schuit AJ., Kok FJ.
Gastrointestinal Supplementation with
cholecalciferol does not Sneve M., Figenschau Y., Jorde R.
BMI [ContinuouSupplementation with
cholecalciferol does not Sneve M., Figenschau Y., Jorde R.
weight [Continuou
200820092006199719971997199719972002200220022002200219872003200320032003200320032003200320032003200320032003200320032003200320052006200620062006200820082008200819861986200720062006200620062006
Supplementation with cholecalciferol does not
Sneve M., Figenschau Y., Jorde R.
Serum 25(OH)D Serum vitamin D and risk
of pancreatic cancer in the Stolzenberg-Solomon RZ., Hayes RB., Horst RL.,
Pancreatic cancer A prospective nested case-
control study of vitamin D Stolzenberg-Solomon RZ., Vieth R., Azad A., Pietinen
Pancreatic cancer Serum levels of vitamin D
metabolites and the Tangrea J., Helzlsouer K., Pietinen P., Taylor P., Hollis
Colon cancer Serum levels of vitamin D
metabolites and the Tangrea J., Helzlsouer K., Pietinen P., Taylor P., Hollis
Colon cancer Serum levels of vitamin D
metabolites and the Tangrea J., Helzlsouer K., Pietinen P., Taylor P., Hollis
Colorectal cancer Serum levels of vitamin D
metabolites and the Tangrea J., Helzlsouer K., Pietinen P., Taylor P., Hollis
Rectal cancer Serum levels of vitamin D
metabolites and the Tangrea J., Helzlsouer K., Pietinen P., Taylor P., Hollis
Rectal cancer Dietary calcium and
vitamin D intake and risk Terry P., Baron JA., Bergkvist L., Holmberg L.,
Colon cancer Dietary calcium and
vitamin D intake and risk Terry P., Baron JA., Bergkvist L., Holmberg L.,
Colorectal cancer Dietary calcium and
vitamin D intake and risk Terry P., Baron JA., Bergkvist L., Holmberg L.,
Distal colon Dietary calcium and
vitamin D intake and risk Terry P., Baron JA., Bergkvist L., Holmberg L.,
Proximal colon Dietary calcium and
vitamin D intake and risk Terry P., Baron JA., Bergkvist L., Holmberg L.,
Rectal cancer Dietary calcium intake and
blood pressure in Thomsen K., Nilas L., Christiansen C.
Bodyweight [Change Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.
All cancers incidence Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.
All cancers mortality Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.
All cause mortality Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.
Breast cancer Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.
Breast cancer Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.
Cardiovascular Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.
Cardiovascular Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.
Cerebrovascular Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.
Cerebrovascular Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.
Colorectal cancer Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.
Colorectal caner Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.
Falls incidence Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.
Ischemic heart Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.
Ischemic heart Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.
Respira-ry [CategoricEffect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.
Respiratory cancer Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.
Respiratory cancer Dairy, calcium, and
vitamin D intakes and Tseng M., Breslow RA., Graubard BI., Ziegler RG.
Prostate cancer Dietary intake of calcium
in relation to mortality Umesawa M., Iso H., Date C., Yamamoto A.,
Coronary heart Dietary intake of calcium
in relation to mortality Umesawa M., Iso H., Date C., Yamamoto A.,
Total CVD mortality Dietary intake of calcium
in relation to mortality Umesawa M., Iso H., Date C., Yamamoto A.,
Total stroke Dietary intake of calcium
in relation to mortality Umesawa M., Iso H., Date C., Yamamoto A.,
specific stroke data Dietary calcium intake and
risks of stroke, its Umesawa M., Iso H., Ishihara J., Saito I., Kokubo
CHD [CategoricDietary calcium intake and
risks of stroke, its Umesawa M., Iso H., Ishihara J., Saito I., Kokubo
Coronary heart Dietary calcium intake and
risks of stroke, its Umesawa M., Iso H., Ishihara J., Saito I., Kokubo
Fatal stroke Dietary calcium intake and
risks of stroke, its Umesawa M., Iso H., Ishihara J., Saito I., Kokubo
Stroke incidence Oral calcium and blood
pressure: a controlled van Beresteyn EC., Schaafsma G., de Waard
BMI [ContinuouOral calcium and blood
pressure: a controlled van Beresteyn EC., Schaafsma G., de Waard
Body weight Childhood dairy intake and
adult cancer risk: 65-y van der Pols JC., Bain C., Gunnell D., Smith GD.,
Colorectal cancer Low serum concentrations
of 25-hydroxyvitamin D in Visser M., Deeg DJ., Puts MT., Seidell JC., Lips P.
mortality [by death Calcium plus vitamin D
supplementation and the Wactawski-Wende J., Kotchen JM., Anderson GL.,
(Invasive) colon Calcium plus vitamin D
supplementation and the Wactawski-Wende J., Kotchen JM., Anderson GL.,
(Invasive) colorectal Calcium plus vitamin D
supplementation and the Wactawski-Wende J., Kotchen JM., Anderson GL.,
(invasive) rectal Calcium plus vitamin D
supplementation and the Wactawski-Wende J., Kotchen JM., Anderson GL.,
All cause mortality
2006200620062006200620062006200620062006200620081996199619961996200819971997199719872002200220022007200720072007200719951995 in DBP199519982008200820082008
Calcium plus vitamin D supplementation and the
Wactawski-Wende J., Kotchen JM., Anderson GL.,
Cancer related Calcium plus vitamin D
supplementation and the Wactawski-Wende J., Kotchen JM., Anderson GL.,
Death from colorectal Calcium plus vitamin D
supplementation and the Wactawski-Wende J., Kotchen JM., Anderson GL.,
Intestinal polyps Calcium plus vitamin D
supplementation and the Wactawski-Wende J., Kotchen JM., Anderson GL.,
Kidney stone Calcium plus vitamin D
supplementation and the Wactawski-Wende J., Kotchen JM., Anderson GL.,
Total cancer High-dose vitamin D3
supplementation in a Wagner CL., Hulsey TC., Fanning D., Ebeling M.,
25(OH)D level in High-dose vitamin D3
supplementation in a Wagner CL., Hulsey TC., Fanning D., Ebeling M.,
25(OH)D level in High-dose vitamin D3
supplementation in a Wagner CL., Hulsey TC., Fanning D., Ebeling M.,
anti-rachitic High-dose vitamin D3
supplementation in a Wagner CL., Hulsey TC., Fanning D., Ebeling M.,
at 2 mo [ContinuouHigh-dose vitamin D3
supplementation in a Wagner CL., Hulsey TC., Fanning D., Ebeling M.,
infant weight and High-dose vitamin D3
supplementation in a Wagner CL., Hulsey TC., Fanning D., Ebeling M.,
vit D3 level in mom Vitamin D deficiency and
risk of cardiovascular Wang TJ., Pencina MJ., Booth SL., Jacques PF.,
First cardiovascEffect of longterm placebo
controlled calcium Weisgerber UM., Boeing H., Owen RW., Waldherr
Calcium balance Effect of longterm placebo
controlled calcium Weisgerber UM., Boeing H., Owen RW., Waldherr
PI [Change in PI% of Effect of longterm placebo
controlled calcium Weisgerber UM., Boeing H., Owen RW., Waldherr
PI [Change in PI% of Effect of longterm placebo
controlled calcium Weisgerber UM., Boeing H., Owen RW., Waldherr
PI [Change in curve of Is ischemic stroke risk
related to folate status or Weng LC., Yeh WT., Bai CH., Chen HJ., Chuang SY.,
stroke [Self-Efficacy of
nonpharmacologic Whelton PK., Kumanyika SK., Cook NR., Cutler JA.,
DBP [ContinuouEfficacy of
nonpharmacologic Whelton PK., Kumanyika SK., Cook NR., Cutler JA.,
SBP [ContinuouEfficacy of
nonpharmacologic Whelton PK., Kumanyika SK., Cook NR., Cutler JA.,
Change in SBP/DBPAlcohol, physical activity
and other risk factors for Wu AH., Paganini-Hill A., Ross RK., Henderson BE.
Colorectal cancer Calcium intake and risk of
colon cancer in women Wu K., Willett WC., Fuchs CS., Colditz GA.,
Distal (left sided) Calcium intake and risk of
colon cancer in women Wu K., Willett WC., Fuchs CS., Colditz GA.,
Primary adenocarciCalcium intake and risk of
colon cancer in women Wu K., Willett WC., Fuchs CS., Colditz GA.,
Proximal (right A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis
Distal colon A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis
Colon cancer A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis
Colorectal cancer A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis
Proximal colon A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis
Rectal cancer Lack of blood pressure
effect with calcium and Yamamoto ME., Applegate WB., Klag MJ., Borhani NO.,
BMI [ContinuouLack of blood pressure
effect with calcium and Yamamoto ME., Applegate WB., Klag MJ., Borhani NO., Lack of blood pressure
effect with calcium and Yamamoto ME., Applegate WB., Klag MJ., Borhani NO.,
in SBP [ContinuouA prospective cohort study
of intake of calcium, Zheng W., Anderson KE., Kushi LH., Sellers TA.,
Rectal cancer Effects of calcium and
vitamin D supplementation Zhu K., Devine A., Dick IM., Wilson SG., Prince RL.
25(OH)D [Measured Effects of calcium and
vitamin D supplementation Zhu K., Devine A., Dick IM., Wilson SG., Prince RL.
BMD [Measured Randomized controlled
trial of the effects of Zhu K., Bruce D., Austin N., Devine A., Ebeling PR.,
25(OH)D [ContinuouRandomized controlled
trial of the effects of Zhu K., Bruce D., Austin N., Devine A., Ebeling PR.,
BMD [Hip and total
Unit(s) Type NotesN/A (years) Categorical secondary
nd N/A (years) Categorical secondarynd N/A (years) Categorical Nd
N/A (years) CategoricalN/A (years) Categorical12 (years) Categorical 112 (years) Categorical 212 (years) Categorical 1
kg N/A (years) Continuous 22 (years) Categorical
Continuous primaryContinuous primaryContinuous primary
1 CategoricalCategorical
N/A (years) 1N/A (years) Stroke Categorical
Secondary CategoricalSecondary Categorical
N/A (years) Categorical PrimaryN/A (years) Secondary
nmol/l N/A (years) Continuous PrimaryAll cause N/A (years) Continuous secondary
nmol/L N/A (years) Continuous Primary30 (weeks) Categorical primaryN/A (years) CategoricalN/A (years)N/A (years) CategoricalN/A (years) CategoricalN/A (years) Categorical
ug/L N/A (years) Continuous ndmg/cm2 N/A (years) Continuous ndkg N/A (years) Continuous 2
N/A (years) CategoricalN/A (years) CategoricalN/A (years) Categorical
Counts N/A (years) Continuous SecondaryKg N/A (years) Continuous Secondaryseconds N/A (years) Continuous Secondary
N/A (years) secondaryN/A (years) Categorical secondary
kg N/A (years) Continuous primaryN/A (years) secondary
m N/A (years) Continuousm N/A (years) Continuous
N/A (years) Fall Categorical primaryN/A (years) Fracture Categorical primary
Description
Timepoint(s)
Subgroup(s)Gleason
sum >=7 All ParticipantAll ParticipantAll ParticipantAll ParticipantAll ParticipantIncluding
sudden All ParticipantImplied
combinatioAll ParticipantSelf-
reporting All ParticipantChange in
kg/yrAll ParticipantPhysician
diagnosis All ParticipantEnter a
numeric All ParticipantDXA, whole
body, or Enter a numeric
All ParticipantDXA, whole
body, or Enter a numeric
All ParticipantEnter a
numeric All Participant
self-reported Enter a
numeric All ParticipantFatal or
nonfatal All Participantnot
extracted Enter a numeric
All Participant
Incident cases were Enter a
numeric All Participant
Prostate-specific Risk of
developing All ParticipantRisk of
developing All ParticipantChanges
from All ParticipantAll ParticipantAll Participantgestational
HTN & All Participantcomposite
All Participant
1 (this analysis; 2 Family,
hospital, All Participant
1 (this analysis; 2 Standard
criteria All Participant
1 (this analysis; 2 Standard
criteria All Participant
1 (this analysis; 2 Standard
criteria All Participant
1 (this analysis; 2 Measured
at baseline All ParticipantDEXA of
the femur All ParticipantAll ParticipantState
Health All Participant
Not explicitly All
ParticipantDiagnosed 1980-
All Participant
Primary (in post hoc Conducted
if the Chair stands Two
measuremGrip strength The timed
walk Timed walk (year 2), No assay
informatioNo subgroups Fall free
survival Fall free survival Isometric
quadriceps Right quadriceps Endurance
(The No subgroups Timed up and goTwelve minutes Defined as
the patient Any fracture
Kg N/A (years)N/A (years) Categorical SecondaryN/A (years) Categorical
g/cm2 N/A (years) areal BMD ContinuousN/A (years) primary
g N/A (years) Continuouspmol/L N/A (years) Continuous
N/A (years) SecondaryKg N/A (years) Continuous Primary
N/A (years) SecondaryN/A (years) PrimaryN/A (years) SecondaryN/A (years) Categorical ndN/A (years) Categorical ndN/A (years) Categorical 2N/A (years) Categorical 1
Kg/m2 N/A (years) Continuous ndKg N/A (years) Continuous ndng/ml N/A (years) Continuouskg N/A (years) Continuous
N/A (years) PrimaryKg N/A (years) Continuous Primary
N/A (years) ContinuousN/A (years) Continuous
cm N/A (years) ContinuousN/A (years) Continuous primaryN/A (years) Continuous primary
nd N/A (years) ndN/A (years) Categorical nd
nd N/A (years) ndnd N/A (years) nd
N/A (years) ndN/A (years) NdN/A (years) CategoricalN/A (years)N/A (years) Categorical PrimaryN/A (years) Continuous SecondaryN/A (years) Continuous PrimaryN/A (years) Continuous SecondaryN/A (years) Continuous SecondaryN/A (years) Continuous SecondaryN/A (years) Continuous SecondaryN/A (years) Continuous SecondaryN/A (years) Continuous SecondaryN/A (years) CategoricalN/A (years)
cm N/A (years) ContinuousKg N/A (years) Continuous
No subgroups
2 (1 for this article)Requested
permission Prostate cancerConfirmed
by both Invasive breast
Not clear. Most likely
by dual-energy X-
All Participantchange in BMC (ITT 25(OH)D, 1,25(OH)DChange in
25(OH)D No subgroups Change in
weight in Body weightDeath
recordAll ParticipantInvasive
adenocarciAll ParticipantGleason
gradeAll Participantnd (only
for patients Adenomas recurrencend (only
for patients Survival, SurvivalSBP 160
or DBP 95 All ParticipantHTN
medication All ParticipantBMI, BMI, BMITo the
nearest 0.5 Weight, Weight, All ParticipantAll ParticipantAll ParticipantTotal body BMCAll ParticipantAll ParticipantAll ParticipantLength gain in weight gain in All ParticipantReported
by a All ParticipantAll ParticipantAll ParticipantSame as
aboveAll ParticipantSelf
reports, All ParticipantSame as
above (not Colorectal cancer Subject
reporting No subgroups
1 (for this post hoc Self-
reported All ParticipantBased on
ICD-10 All ParticipantBased on
ICD-10 All ParticipantBased on
ICD-10 All ParticipantBased on
ICD-10 All ParticipantBased on
ICD-10 All ParticipantBased on
ICD-10 All ParticipantBased on
ICD-10 All ParticipantBased on
ICD-10 All ParticipantIncident
breast Incident breast
Primary outcomeNorwegian
cancer No subgroups
Primary (only 9 mo
length9 mo weight
N/A (years) Categoricalcm N/A (years) Continuous primaryKg N/A (years) Continuous
N/A (years) Categorical NdN/A (years) Categorical ndN/A (years) Categorical nd
mm Hg N/A (years) DBP Continuousmm Hg N/A (years) SBP Continuous
N/A (years) 2Kg Kg N/A (years) Weight Continuous 2
N/A (years) Categorical ndN/A (years) Categorical Primary
nmol/L N/A (years) Continuous secondarynmol/L N/A (years) Continuous primarynmol/L N/A (years) Continuous primary
N/A (years) Categorical ndN/A (years) Categorical nd
Kg N/A (years) Continuous Primarymm Hg N/A (years) DBP Continuousmm Hg N/A (years) SBP Continuous
N/A (years) 2N/A (years) primary
kg N/A (years) Continuous secondaryN/A (years)
nd N/A (years) Categorical secondaryN/A (years)N/A (years)N/A (years) CategoricalN/A (years)N/A (years) primaryN/A (years)
Kg/m2 N/A (years) BMI Continuous ndkg N/A (years) Weight Continuous nd
N/A (years) Categorical ndN/A (years) CategoricalN/A (years) Categorical ndN/A (years) Categorical ndN/A (years) ndN/A (years) Categorical ndN/A (years) Categorical primaryN/A (years) nd
kg/m2 N/A (years) BMI Continuous secondarycm N/A (years) ht Continuouskg N/A (years) wt Continuous
N/A (years) ContinuousN/A (years) Categorical secondaryN/A (years) Categorical primaryN/A (years) nd
modified UK
atopic eczema at birth lengthbirth weightMedical
records Total prostate Medical
and Colorectal cancerICD-8
153.0-All Participant
No subgroups
Advanced lesions
Advanced adenomas, For each
colonoscopAll adenomas, sum of D2
and D3change in total change in 25(OH)D2 change in 25(OH)D3 Subjects
had Advanced adenomas, Ascertaine
d by Recurrent adenomasChange in
bodyweighBody weight
No subgroups 25(OH)D/
vitD doseNo subgroups Change in
kg over 30 Body weightConfirmed
through No subgroups
Only reported Prostate
cancer, Finish cancer
No subgroups
Not explicitly Finish
cancer No subgroups
Not explicitly Finish
cancer Colorectal cancer
Not explicitly No
subgroups No subgroups No subgroups
Analyzed by a Record linkage to
Colorectal cancer Self
reports (in Colorectal cancer
Not explicitly Response
to the Colon cancer Mostly
diagnosed Colorectal cancerComplete
colonoscopNo subgroups Self
reported Breast cancer, self-
reported of prostate cancer, Active
patient No subgroups
change in 25 OH(D) from
medical incident cancer Stress
fractures Stress fracture National
Swedish No subgroups
N/A (years) Categorical ndN/A (years) Categorical ndN/A (years) ndN/A (years) Categorical ndN/A (years)N/A (years) CategoricalN/A (years) CategoricalN/A (years)N/A (years) CategoricalN/A (years)N/A (years) CategoricalN/A (years) 1N/A (years)N/A (years) Categorical PrimaryN/A (years) Categorical secondary
pg/mL N/A (years) 1,25(OH)D Continuousng/mL N/A (years) 25(OH)D Continuous 2mm Hg N/A (years) Continuousmm Hg N/A (years) Continuous
N/A (years) 2N/A (years) ndN/A (years) Categorical ndN/A (years) ndN/A (years) Categorical Primary
mmol/L N/A (years) Continuous secondarycm N/A (years) ContinuousKg N/A (years) Continuous primary
N/A (years) Categorical PrimaryN/A (years) Secondary
nd N/A (years) mortality Categorical SecondaryKg/m2 N/A (years) BMI Continuous 2mmHg N/A (years) DBP Continuous 2mmHg N/A (years) SBP Continuous 2
Kg Kg N/A (years) Weight Continuous 2g N/A (years) Continuous secondarypmol/L N/A (years) Continuous
N/A (years)N/A (years) primary
nmol/L N/A (years) Continuous primaryN/A (years) Categorical primary
mmHg N/A (years) ContinuousN/A (years) Categorical 1
Same N/A (years) CategoricalN/A (years) Categorical primary
nd N/A (years) toxemia Categorical primarycm N/A (years) Categorical secondarywk N/A (years) ContinuousKg N/A (years) Continuous primary
National Swedish
Colorectal cancer National
Swedish Colon cancer National
Swedish No subgroups National
Swedish Rectal cancer National
Swedish No subgroups
Not explicitly National
Swedish Colorectal cancer
Not explicitly National
Swedish Colon cancer
Not explicitly National
Swedish No subgroups
Not explicitly National
Swedish Rectal cancer
Not explicitly No
subgroups Cerebral infarctionHospital
discharge No subgroups No subgroups Linkage
with Invasive breast Tumor
Gleason Total prostate Radiorecep
tor assay Competitive protein DBP
(supine)SBP (standing), Standing
and supineNo subgroups Follow-up
questionnaNo subgroups Not fully
defined Colorectal cancer Not fully
defined No subgroups Incident
cases of Invasive breast 25(OH)D Δ in medium height Δ in medium weight Δ in medium Confirmed
by First fracture Confirmed
by No subgroups
birth weightcord 25(OH)D, No subgroups No subgroups maternal 25(OH)D at Self-report
of HypertensionSystolic BP, Diastolic ICD 9
codes from AMI, AMI, AMIStroke, Stroke, One or
more Adenoma recurrence,
crown-heel lengthgestational agenewborn birth
nmol/L N/A (years) Continuous primaryg N/A (years) Continuous secondary
N/A (years) primaryN/A (years) CRC CategoricalN/A (years) primaryN/A (years)N/A (years)N/A (years)N/A (years) primaryN/A (years) PrimaryN/A (years) PrimaryN/A (years) primaryN/A (years) Categorical NDN/A (years) CategoricalN/A (years) Categorical primary
g N/A (years) Continuous primarycm N/A (years) Continuous
N/A (years)N/A (years) CategoricalN/A (years) Categorical primary
DXA g/cm2 N/A (years) Continuous primarynmol/L N/A (years) Continuous nd
N/A (years) ContinuousmmHg N/A (years) Continuous 2mmHg N/A (years) Continuous 2kg/m2 N/A (years) Continuousnmol/L N/A (years) 25(OH)D Continuous Primary
N/A (years) Categorical primaryN/A (years) Adenoma Categorical ndN/A (years) CategoricalN/A (years)N/A (years) primaryN/A (years) Categorical ndN/A (years) Categorical ndN/A (years) Categorical ndN/A (years) Categorical ndN/A (years) Categorical primaryN/A (years) Categorical ndN/A (years) Nd***N/A (years) Nd***N/A (years) Nd***N/A (years) Nd***N/A (years) Nd***N/A (years) Nd***N/A (years) Nd***N/A (years) Nd***N/A (years) Nd***N/A (years) Nd***
25(OH)D at 2 mo, maternal weight No subgroups
Confirmed incident
No subgroups Cancer at
descending No subgroups Cancer at
cecum to No subgroups Cancer at
rectum No subgroups Linked
National No subgroups Cause-
specific No subgroups Including
all No subgroups Including
deaths No subgroups Ratio of
the Mammographic All ParticipantFinnish
Cancer All Participantbirth weightcrown-heel lengthNo subgroups Pregnancy-induced HTN (DBP
90 mm) preeclampsiaTotal body BMD, Total 25(OH)D (ITT), BMI (per protocol)Same as
SBPDBP (ITT), DBP (per Automated
OMRON SBP (ITT analysis), Weight (ITT),
biopsy or surgical
prostate cancerReviewed
the Distal colon No subgroups BP
>140/90 & No subgroups See above
(ICD180-Men, WomenAdenocarci
noma Men, WomenSee above
(ICD199 Men, WomenIdentified
by means Colorectal cancer 8 state
cancer total prostate Identified
by linkage Prostate cancer, Identified
thorough a No subgroups The same
as all No subgroups A
combined No subgroups The same
as all No subgroups The same
as all No subgroups The same
as all No subgroups A
combined No subgroups A
combined No subgroups The same
as all No subgroups The same
as all No subgroups
N/A (years) Nd***N/A (years) Nd***N/A (years) Nd***N/A (years) Nd***N/A (years) Nd***N/A (years) Nd***N/A (years) Nd***N/A (years) Nd***N/A (years) Nd***N/A (years) Nd***N/A (years) Nd***N/A (years) Nd***N/A (years) Nd***N/A (years) Nd***N/A (years) Nd***N/A (years) Nd***
nmol/L N/A (years) 25(OH)D ContinuousmmHg N/A (years) DBP Continuous 1mmHg N/A (years) SBP Continuous 1
N/A (years) CategoricalN/A (years) CategoricalN/A (years) Categorical ndN/A (years) CategoricalN/A (years) CategoricalN/A (years) Categorical
kg/m2 N/A (years) BMI Continuousmm Hg N/A (years) DBP Continuousmm Hg N/A (years) SBP Continuous
SBP, DBP N/A (years) 2Kg, BMI Kg N/A (years) Weight Continuous 2
N/A (years) Categorical NdN/A (years) Categorical primaryN/A (years) Categorical 1N/A (years)N/A (years) nd
ng/mL N/A (years) 25(OH)D Continuous 2N/A (years) DBP Continuous 1
mmHg N/A (years) SBP Continuous 1N/A (years) ndN/A (years) secondaryN/A (years) Categorical primaryN/A (years) secondaryN/A (years) Categorical ndN/A (years) Categorical ndN/A (years) Categorical ndN/A (years) nd
Kg/m2 N/A (years) BMI Continuous 2kg N/A (years) weight Continuous 1
The same as all
No subgroups The same
as all No subgroups The same
as NHLNo subgroups The same
as all No subgroups The same
as all No subgroups The same
as NHLNo subgroups Identified
through No subgroups A
combined No subgroups The same
as all No subgroups The same
as all No subgroups A
combined No subgroups A
combined No subgroups The same
as all No subgroups The same
as all No subgroups A
combined No subgroups A
combined No subgroups
Same as SBPMeasured after at Incident cases of
Colorectal cancer
Secondary outcomeAdenomat
ous polyps All ParticipantAdenomat
ous polyps All ParticipantAdenomat
ous polyps All ParticipantLarge (1
cm or All ParticipantSmall (<1
cm), All Participant
No subgroups
Incident cases
Prostate cancerCancer
Registry; incident prostate Fatal strokeMortality
and cause No subgroups
Secondary (assumed Computeri
zed record No subgroups As
measured BP was measured BP was measured Medical records
No subgroups No subgroups Cohort
members Colorectal cancer, No subgroups Self-
reported Pancreatic cancer, The
residence All cause mortality – The
residence Gastrointestinal The
residence No subgroups
nmol/L N/A (years) Continuous 2N/A (years) CategoricalN/A (years) Categorical CancerN/A (years) Categorical ndN/A (years) Categorical ndN/A (years) Categorical ndN/A (years) Categorical ndN/A (years) Categorical ndN/A (years) secondaryN/A (years) primaryN/A (years) secondaryN/A (years) secondaryN/A (years) secondary
Kg N/A (years) Continuous ndN/A (years) Categorical SecondaryN/A (years) SecondaryN/A (years) SecondaryN/A (years) Categorical SecondaryN/A (years) SecondaryN/A (years) SecondaryN/A (years) SecondaryN/A (years) Categorical SecondaryN/A (years) SecondaryN/A (years) Categorical SecondaryN/A (years) SecondaryN/A (years) Categorical SecondaryN/A (years) SecondaryN/A (years) SecondaryN/A (years) Respira-ry CategoricalN/A (years) Categorical SecondaryN/A (years) SecondaryN/A (years) NdN/A (years) 2N/A (years) 2N/A (years) 1N/A (years)N/A (years) CHD CategoricalN/A (years) 2N/A (years) Categorical 1N/A (years) 1
Kg/m2 N/A (years) BMI ContinuousKg N/A (years) Continuous Secondary
N/A (years) ndN/A (years) Categorical primaryN/A (years) ndN/A (years)N/A (years) nd
nd N/A (years) Categorical nd
Serum 25(OH)DVital status
of cohort Pancreatic cancerodds ratios
(OR) for pancreatic cancer, All ParticipantDiagnosis
of primary All ParticipantDiagnosis
of primary All ParticipantAll ParticipantDiagnosis
of primary All ParticipantCancer
occurring No subgroups Matching
two No subgroups Cancer
occurring No subgroups Cancer
occurring No subgroups Cancer
occurring No subgroups Change in
kg/yrBodyweight changesame as
aboveAll Causes, All same as
aboveNo subgroups Death
certificate No subgroups same as
aboveBreast, Cancer same as
aboveNo subgroups Death
certificate No subgroups same as
aboveNo subgroups same as
aboveCardiovascular same as
aboveNo subgroups same as
aboveColorectal, Colorectal, same as
aboveNo subgroups same as
aboveSelf Reported same as
aboveNo subgroups same as
aboveNo subgroups
same as above
Respiratory, same as
aboveNo subgroups Confirmati
on through No subgroups Death
certificates No subgroups Death
certificates No subgroups Death
certificates No subgroups not
extractedNo subgroups
MI, sudden cardiac
No subgroups Death
certificates Total strokeParticipant
reporting No subgroups
Body weight in
Body weightDerived
from the No subgroups by death
certificatemortality, mortality, Excluded
in situ and No subgroups Verified in
a blinded No subgroups
Secondary (primary: Excluded
in situ and No subgroups All cause mortality
N/A (years) Categorical ndN/A (years) Categorical ndN/A (years) Categorical ndN/A (years) Categorical ndN/A (years) ndN/A (years)N/A (years) primaryN/A (years)N/A (years) ContinuousN/A (years)
ng/mL N/A (years) ContinuousN/A (years) Categorical Primary
% change N/A (years) Continuous UnlcearN/A (years) Unlcear
% change N/A (years) Continuous UnlcearN/A (years) UnlcearN/A (years) stroke Categorical nd
mm Hg N/A (years) DBP Continuousmm Hg N/A (years) SBP Continuous
N/A (years) 1N/A (years) ndN/A (years) Categorical primaryN/A (years) Categorical primaryN/A (years) Categorical primaryN/A (years) Categorical ndN/A (years) Categorical ndN/A (years) Categorical ndN/A (years) Categorical ndN/A (years) Categorical nd
kg/m2 N/A (years) Continuous ndN/A (years) 1
mmHg N/A (years) Continuous 1N/A (years) Categorical secondary
nmol/liter Continuous Secondarymg/cm2 Continuous Primarynmol/L N/A (years) Continuous Secondarymg/cm2 N/A (years) Continuous primary
Kidney stone
Invasive colorectal Death from
colorectal Death from colorectal Intestinal
polyps Intestinal PolypKidney
stone Kidney stone (UL)Intestinal
polyps No subgroups No subgroups No subgroups vit D3 and
25 (OH)D No subgroups at 2 mo, at 3 mo, at 4 No subgroups mom 25 (OH)D at 1 MI,
coronary CV event, CV eventTotal fecal
calcium Total fecal calcium, Change in
PI% of all No subgroups Change in
PI% of PI (total), PI (highest Change in
curve of PINo subgroups Self-
reported
No subgroups Pathologic
al No subgroups Colon
cancer All ParticipantReported
as All ParticipantColon
cancer All ParticipantAll ParticipantAll ParticipantThe vast
majority of All ParticipantAll ParticipantAll ParticipantAll ParticipantAll ParticipantSBP in white State
Health All ParticipantMeasured
by 1 (years), 3 (years), 5
All ParticipantMeasured
at the hip 12 (months),
All ParticipantAll ParticipantHip and
total body. All Participant
Study ID:EF ID Creator Create Date PMID6304:194 admin Aug 18, 2013 Sep 5, 2014 185059676305:194 admin Aug 18, 2013 Sep 5, 2014 110758746306:194 admin Aug 18, 2013 Sep 5, 2014 126632776307:194 admin Aug 18, 2013 Sep 5, 2014 78928826308:194 admin Aug 18, 2013 Sep 5, 2014 162804276309:194 admin Aug 18, 2013 Sep 5, 2014 182086366311:194 admin Aug 18, 2013 Sep 5, 2014 13303606312:194 admin Aug 18, 2013 Sep 5, 2014 86211986313:194 admin Aug 18, 2013 Sep 5, 2014 97435116314:194 admin Aug 18, 2013 Sep 5, 2014 157673346315:194 admin Aug 18, 2013 Sep 5, 2014 161034506316:194 admin Aug 18, 2013 Sep 5, 2014 179650376317:194 admin Aug 18, 2013 Sep 5, 2014 186895596318:194 admin Aug 18, 2013 Sep 5, 2014 175359856319:194 admin Aug 18, 2013 Sep 5, 2014 181983946320:194 admin Aug 18, 2013 Sep 5, 2014 172438666321:194 admin Aug 18, 2013 Sep 5, 2014 188427716322:194 admin Aug 18, 2013 Sep 5, 2014 83334126323:194 admin Aug 18, 2013 Sep 5, 2014 99219606325:194 admin Aug 18, 2013 Sep 5, 2014 76128036326:194 admin Aug 18, 2013 Sep 5, 2014 187553196327:194 admin Aug 18, 2013 Sep 5, 2014 167979036328:194 admin Aug 18, 2013 Sep 5, 2014 176564206329:194 admin Aug 18, 2013 Sep 5, 2014 175025306330:194 admin Aug 18, 2013 Sep 5, 2014 115666566331:194 admin Aug 18, 2013 Sep 5, 2014 190016016333:194 admin Aug 18, 2013 Sep 5, 2014 162804476334:194 admin Aug 18, 2013 Sep 5, 2014 152130386335:194 admin Aug 18, 2013 Sep 5, 2014 82200926336:194 admin Aug 18, 2013 Sep 5, 2014 86824536337:194 admin Aug 18, 2013 Sep 5, 2014 88906616338:194 admin Aug 18, 2013 Sep 5, 2014 171895526339:194 admin Aug 18, 2013 Sep 5, 2014 162782626340:194 admin Aug 18, 2013 Sep 5, 2014 80781156341:194 admin Aug 18, 2013 Sep 5, 2014 153424526342:194 admin Aug 18, 2013 Sep 5, 2014 156684856343:194 admin Aug 18, 2013 Nov 6, 2013 19376626344:194 admin Aug 18, 2013 Sep 5, 2014 173720316345:194 admin Aug 18, 2013 Sep 5, 2014 188386236346:194 admin Aug 18, 2013 Sep 5, 2014 179715266347:194 admin Aug 18, 2013 Sep 5, 2014 183814726348:194 admin Aug 18, 2013 Sep 5, 2014 90612756349:194 admin Aug 18, 2013 Sep 5, 2014 173110576350:194 admin Aug 18, 2013 Sep 5, 2014 88502736351:194 admin Aug 18, 2013 Sep 5, 2014 28573646352:194 admin Aug 18, 2013 Sep 5, 2014 25729006353:194 admin Aug 18, 2013 Sep 5, 2014 7493659
Last Updated
6356:194 admin Aug 18, 2013 Sep 5, 2014 146522386357:194 admin Aug 18, 2013 Sep 5, 2014 172279966358:194 admin Aug 18, 2013 Sep 5, 2014 105113296359:194 admin Aug 18, 2013 Sep 5, 2014 156712226360:194 admin Aug 18, 2013 Sep 5, 2014 162865196361:194 admin Aug 18, 2013 Sep 5, 2014 145539576362:194 admin Aug 18, 2013 Sep 5, 2014 124993436363:194 admin Aug 18, 2013 Sep 5, 2014 94050296364:194 admin Aug 18, 2013 Sep 5, 2014 39462956367:194 admin Aug 18, 2013 Nov 6, 2013 104714226368:194 admin Aug 18, 2013 Nov 6, 2013 104714226369:194 admin Aug 18, 2013 Sep 5, 2014 152258336370:194 admin Aug 18, 2013 Sep 5, 2014 116417506371:194 admin Aug 18, 2013 Sep 5, 2014 174421306372:194 admin Aug 18, 2013 Sep 5, 2014 82014446373:194 admin Aug 18, 2013 Sep 5, 2014 175528806374:194 admin Aug 18, 2013 Sep 5, 2014 82055386375:194 admin Aug 18, 2013 Sep 5, 2014 93438376376:194 admin Aug 18, 2013 Sep 5, 2014 86107046377:194 admin Aug 18, 2013 Sep 5, 2014 158805326378:194 admin Aug 18, 2013 Sep 5, 2014 175361916379:194 admin Aug 18, 2013 Sep 5, 2014 171064376380:194 admin Aug 18, 2013 Sep 5, 2014 183980336381:194 admin Aug 18, 2013 Sep 5, 2014 192211906382:194 admin Aug 18, 2013 Sep 5, 2014 153541506383:194 admin Aug 18, 2013 Sep 5, 2014 175566976384:194 admin Aug 18, 2013 Sep 5, 2014 184333056385:194 admin Aug 18, 2013 Sep 5, 2014 165229156386:194 admin Aug 18, 2013 Sep 5, 2014 165229156387:194 admin Aug 18, 2013 Sep 5, 2014 183322896388:194 admin Aug 18, 2013 Sep 5, 2014 190565696389:194 admin Aug 18, 2013 Sep 5, 2014 173886676390:194 admin Aug 18, 2013 Sep 5, 2014 85579656391:194 admin Aug 18, 2013 Sep 5, 2014 158002686392:194 admin Aug 18, 2013 Sep 5, 2014 175332086393:194 admin Aug 18, 2013 Sep 5, 2014 164000446394:194 admin Aug 18, 2013 Sep 5, 2014 174739116395:194 admin Aug 18, 2013 Sep 5, 2014 172091776396:194 admin Aug 18, 2013 Sep 5, 2014 37555176397:194 admin Aug 18, 2013 Sep 5, 2014 188246626398:194 admin Aug 18, 2013 Sep 5, 2014 159554676399:194 admin Aug 18, 2013 Sep 5, 2014 120201026401:194 admin Aug 18, 2013 Sep 5, 2014 36232606402:194 admin Aug 18, 2013 Sep 5, 2014 32436096403:194 admin Aug 18, 2013 Sep 5, 2014 163915876404:194 admin Aug 18, 2013 Sep 5, 2014 67930586405:194 admin Aug 18, 2013 Sep 5, 2014 127087196406:194 admin Aug 18, 2013 Sep 5, 2014 16365007
6407:194 admin Aug 18, 2013 Sep 5, 2014 186950766408:194 admin Aug 18, 2013 Sep 5, 2014 188278116409:194 admin Aug 18, 2013 Sep 5, 2014 171064376410:194 admin Aug 18, 2013 Sep 5, 2014 163526846411:194 admin Aug 18, 2013 Sep 5, 2014 112624666412:194 admin Aug 18, 2013 Sep 5, 2014 171818906413:194 admin Aug 18, 2013 Sep 5, 2014 191257566414:194 admin Aug 18, 2013 Sep 5, 2014 191582266415:194 admin Aug 18, 2013 Sep 5, 2014 97941756416:194 admin Aug 18, 2013 Sep 5, 2014 173796166417:194 admin Aug 18, 2013 Sep 5, 2014 175219216418:194 admin Aug 18, 2013 Sep 5, 2014 176222446419:194 admin Aug 18, 2013 Sep 5, 2014 172153806420:194 admin Aug 18, 2013 Sep 5, 2014 180000206421:194 admin Aug 18, 2013 Sep 5, 2014 179252836422:194 admin Aug 18, 2013 Sep 5, 2014 192377246423:194 admin Aug 18, 2013 Sep 5, 2014 112975966424:194 admin Aug 18, 2013 Sep 5, 2014 105306086425:194 admin Aug 18, 2013 Sep 5, 2014 110457886428:194 admin Aug 18, 2013 Sep 5, 2014 158271036429:194 admin Aug 18, 2013 Sep 5, 2014 128693976430:194 admin Aug 18, 2013 Sep 5, 2014 173153196431:194 admin Aug 18, 2013 Sep 5, 2014 92364166432:194 admin Aug 18, 2013 Sep 5, 2014 155315006433:194 admin Aug 18, 2013 Sep 5, 2014 103621256434:194 admin Aug 18, 2013 Sep 5, 2014 74981006435:194 admin Aug 18, 2013 Sep 5, 2014 122088956436:194 admin Aug 18, 2013 Sep 5, 2014 170197166437:194 admin Aug 18, 2013 Sep 5, 2014 169850316438:194 admin Aug 18, 2013 Sep 5, 2014 84781446439:194 admin Aug 18, 2013 Sep 5, 2014 190569006441:194 admin Aug 18, 2013 Sep 5, 2014 192088426442:194 admin Aug 18, 2013 Sep 5, 2014 170470876443:194 admin Aug 18, 2013 Sep 5, 2014 92424786444:194 admin Aug 18, 2013 Nov 6, 2013 124671336445:194 admin Aug 18, 2013 Sep 5, 2014 33073076446:194 admin Aug 18, 2013 Sep 5, 2014 126099406447:194 admin Aug 18, 2013 Sep 5, 2014 158834416450:194 admin Aug 18, 2013 Sep 5, 2014 163394766451:194 admin Aug 18, 2013 Sep 5, 2014 186358556452:194 admin Aug 18, 2013 Sep 5, 2014 37888356453:194 admin Aug 18, 2013 Sep 5, 2014 180655926455:194 admin Aug 18, 2013 Sep 5, 2014 169601776456:194 admin Aug 18, 2013 Sep 5, 2014 164816366457:194 admin Aug 18, 2013 Sep 5, 2014 176615656458:194 admin Aug 18, 2013 Nov 6, 2013 182590076459:194 admin Aug 18, 2013 Sep 5, 2014 181803956460:194 admin Aug 18, 2013 Sep 5, 2014 8675093
6461:194 admin Aug 18, 2013 Sep 5, 2014 189889096462:194 admin Aug 18, 2013 Sep 5, 2014 90225616463:194 admin Aug 18, 2013 Sep 5, 2014 36203146464:194 admin Aug 18, 2013 Sep 5, 2014 119043166465:194 admin Aug 18, 2013 Sep 5, 2014 176238016466:194 admin Aug 18, 2013 Sep 5, 2014 77958376467:194 admin Aug 18, 2013 Sep 5, 2014 95214376468:194 admin Aug 18, 2013 Sep 5, 2014 180897016469:194 admin Aug 18, 2013 Sep 5, 2014 18410225
Alt ID(s) Title Year Author2008200020031995200520081992199619982005200520082008200720082007200819931999199520082006200720072001200820052004-- Not Found ---- Not Found --1996200620061994200420051991 Ford ES., Cooper RS.2007200820072008199620081996198519891995
Serum vitamin D concentration and
Ahn J., Peters U., Albanes D., Purdue MP., Abnet CC., Prostate cancer risk and
prediagnostic serum 25-Ahonen MH., Tenkanen L., Teppo L., Hakama M., A prospective study of
calcium intake from diet Al-Delaimy WK., Rimm E., Willett WC., Stampfer MJ., The influence of
menopause and hormonal Aloia JF., Vaswani A., Russo L., Sheehan M., Low-fat dairy consumption
and reduced risk of Alonso A., Beunza JJ., Delgado-Rodríguez M., Effect of vitamin D
supplementation on bone Andersen R., Mølgaard C., Skovgaard LT., Brot C., A prospective study of
nutritional factors and Ascherio A., Rimm EB., Giovannucci EL., Colditz Prospective study of
nutritional factors, blood Ascherio A., Hennekens C., Willett WC., Sacks F., Intake of potassium,
magnesium, calcium, and Ascherio A., Rimm EB., Hernán MA., Giovannucci Risk of prostate cancer in
a randomized clinical trial Baron JA., Beach M., Wallace K., Grau MV., Plasma 25-hydroxyvitamin
D and 1,25-Bertone-Johnson ER., Chen WY., Holick MF., Hollis BW., Vitamin D
supplementation has Björkman M., Sorva A., Risteli J., Tilvis R.Body size and serum 25
hydroxy vitamin D Blum M., Dallal GE., Dawson-Hughes B.Maternal vitamin D
deficiency increases the Bodnar LM., Catov JM., Simhan HN., Holick MF., Vascular events in healthy
older women receiving Bolland MJ., Barber PA., Doughty RN., Mason B., Two-year randomized
controlled trial of vitamin Bolton-Smith C., McMurdo ME., Paterson CR., Mole Dairy calcium
supplementation in Bortolotti M., Rudelle S., Schneiter P., Vidal H., Relation of calcium,
vitamin D, and dairy food Bostick RM., Potter JD., Sellers TA., McKenzie DR., Relation of calcium,
vitamin D, and dairy food Bostick RM., Kushi LH., Wu Y., Meyer KA., Sellers TA., Prostate cancer and
prediagnostic levels of Braun MM., Helzlsouer KJ., Hollis BW., Comstock GW.Calcium, vitamin D
supplementation, and Brunner RL., Cochrane B., Jackson RD., Larson J., Effects of vitamin D
supplementation and Bunout D., Barrera G., Leiva L., Gattas V., de la Does vitamin D stop
inpatients falling? A Burleigh E., McColl J., Potter J.Calcium plus vitamin D
supplementation and the Caan B., Neuhouser M., Aragaki A., Lewis CB., Dairy products, calcium,
and prostate cancer risk in Chan JM., Stampfer MJ., Ma J., Gann PH., Gaziano JM., Calcium plus vitamin D
supplementation and the Chlebowski RT., Johnson KC., Kooperberg C., Effects of calcium, dairy
product, and vitamin D Cheng S., Lyytikäinen A., Kröger H., Lamberg-Allardt Weight loss and calcium
intake influence calcium Cifuentes M., Riedt CS., Brolin RE., Field MP., Vitamin D and prostate
cancer: a prediagnostic Corder EH., Guess HA., Hulka BS., Friedman GD., Calcium chemoprevention
in colorectal cancer.Duris I., Hruby D., Pekarkova B., Huorka M., Dietary calcium, alcohol,
and incidence of treated Dwyer JH., Li L., Dwyer KM., Curtin LR., Feinleib M.Effect of 1-year dairy
product intervention on fat Eagan MS., Lyle RM., Gunther CW., Peacock M., Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J., Seasonal and geographical
variations in the growth Feliciano ES., Ho ML., Specker BL., Falciglia G., Plasma vitamin D
metabolites and risk of Feskanich D., Ma J., Fuchs CS., Kirkner GJ., Hankinson Calcium from diet and
supplements is associated Flood A., Peters U., Chatterjee N., Lacey JV., Risk factors for
hypertension in a national Plasma 25-hydroxyvitamin D levels and risk of
Forman JP., Giovannucci E., Holmes MD., Bischoff-Plasma 25-hydroxyvitamin
D levels and risk of Forman JP., Curhan GC., Taylor EN.Prospective study of
serum vitamin D and Freedman DM., Looker AC., Chang SC., Graubard Serum levels of vitamin D
metabolites and breast Freedman DM., Chang SC., Falk RT., Purdue MP., Dietary factors and risk of
colon cancer: a Gaard M., Tretli S., Løken EB.Maternal vitamin D status
during pregnancy and Gale CR., Robinson SM., Harvey NC., Javaid MK., Circulating vitamin D
metabolites in relation to Gann PH., Ma J., Hennekens CH., Hollis Dietary vitamin D and
calcium and risk of Garland C., Shekelle RB., Barrett-Connor E., Criqui Serum 25-hydroxyvitamin
D and colon cancer: eight-Garland CF., Comstock GW., Garland FC., Helsing The influence of dairy
products on plasma uric Ghadirian P., Shatenstein B., Verdy M., Hamet P.
200320071999200520052003200319971986199919992004200120071994200819941997199620052007200620082009200420072008200620062008200920071995 Lijnen P., Petrov V.200520072006200720071986200820052002198719882006198120032005
Vitamin D, calcium supplementation, and
Grau MV., Baron JA., Sandler RS., Haile RW., Prolonged effect of
calcium supplementation Grau MV., Baron JA., Sandler RS., Wallace K., Plasma 25-hydroxyvitamin
D responses of younger Harris SS., Dawson-Hughes B., Perrone GA.The association of calcium
and vitamin D with risk of Hartman TJ., Albert PS., Snyder K., Slattery ML., The impact of calcium and
dairy product consumption Harvey-Berino J., Gold BC., Lauber R., Starinski A.Gestational calcium
supplementation and Hatton DC., Harrison-Hohner J., Coste S., Reller Human serum 25-
hydroxycholecalciferol Heaney RP., Davies KM., Chen TC., Holick MF., Long-term vitamin D3
supplementation may Heikkinen AM., Tuppurainen MT., Colon cancer and dietary
fat, phosphorus, and Heilbrun LK., Hankin JH., Nomura AM., Prospective study of
calcium, potassium, and Iso H., Stampfer MJ., Manson JE., Rexrode K., Prospective study of
calcium, potassium, and Iso H., Stampfer MJ., Manson JE., Rexrode K., Plasma levels of 25-
hydroxyvitamin D, 1,25-Jacobs ET., Giuliano AR., Martínez ME., Hollis BW., Prospective study on milk
products, calcium and Järvinen R., Knekt P., Hakulinen T., Aromaa A.Nutritional status and
subsequent all-cause Jia X., Aucott LS., McNeill G.Dietary intakes,
anthropometric Johnson AA., Knight EM., Edwards CH., Oyemade Calcium intake and the
outcome of short-term Kabrnová-Hlavatá K., Hainer V., Gojová M., Fermented dairy products,
calcium, and colorectal Kampman E., Goldbohm RA., van den Brandt PA., Prospective study of diet
and female colorectal Kato I., Akhmedkhanov A., Koenig K., Toniolo PG., Calcium, vitamin D, and
dairy foods and the Kearney J., Giovannucci E., Rimm EB., Ascherio A., Dietary calcium,
phosphorus, vitamin D, Kesse E., Boutron-Ruault MC., Norat T., Riboli E., Dairy products, calcium
and the risk of breast Kesse-Guyot E., Bertrais S., Duperray B., Arnault N., Dairy products, calcium
and prostate cancer risk.Koh KA., Sesso HD., Paffenbarger RS., Lee IM.Dairy product, saturated
fatty acid, and calcium Kurahashi N., Inoue M., Iwasaki M., Sasazuki S., Calcium plus vitamin D
supplementation and LaCroix AZ., Kotchen J., Anderson G., Brzyski R., Girls on a high-calcium
diet gain weight at the Lappe JM., Rafferty KA., Davies KM., Lypaczewski Vitamin D and calcium
supplementation reduces Lappe JM., Travers-Gustafson D., Davies KM., Calcium and vitamin d
supplementation Lappe J., Cullen D., Haynatzki G., Recker R., Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci Magnesium, calcium,
potassium, and sodium Larsson SC., Virtanen MJ., Mars M., Männistö S., Long-term dietary calcium
intake and breast cancer Larsson SC., Bergkvist L., Wolk A.A prospective study of
plasma vitamin D Li H., Stampfer MJ., Hollis JB., Mucci LA., Gaziano JM., Dietary calcium, blood
pressure and cell Intakes of calcium and vitamin D and risk of
Lin J., Zhang SM., Cook NR., Manson JE., Lee IM., Intakes of calcium and
vitamin D and breast Lin J., Manson JE., Lee IM., Cook NR., Buring JE., Calcium supplementation
for 1 y does not reduce Lorenzen JK., Mølgaard C., Michaelsen KF., Astrup A.Preventing fractures
among older people living Lyons RA., Johansen A., Brophy S., Newcombe RG., Supplementation with
calcium + vitamin D Major GC., Alarie F., Doré J., Phouttama S., Tremblay Vitamin D
supplementation in Mallet E., Gügi B., Brunelle P., Hénocq A., Basuyau JP., Effect of calcium and
vitamin D supplementation Margolis KL., Ray RM., Van Horn L., Manson JE., Allison Dietary and serum
vitamins and minerals as Marniemi J., Alanen E., Impivaara O., Seppänen Calcium, vitamin D, and
risk of adenoma Martínez ME., Marshall JR., Sampliner R., Wilkinson J., Effect of calcium and
vitamin D supplementation Marya RK., Rathee S., Manrow M.Effect of vitamin D
supplementation during Marya RK., Rathee S., Dua V., Sangwan K.Vitamin D2 dose required
to rapidly increase 25OHD Mastaglia SR., Mautalen CA., Parisi MS., Oliveri B.Vitamin D supplements
enhance weight gain and Maxwell JD., Ang L., Brooke OG., Brown IR.Calcium, vitamin D, dairy
products, and risk of McCullough ML., Robertson AS., Rodriguez Dairy, calcium, and
vitamin D intake and McCullough ML., Rodriguez C., Diver WR., Feigelson
200820082006200620012006 Moschonis G., Manios Y.200920091998200720072007200720072007200920011999200020052003200719972004199919952002200620061993200820092006199720021987200320052006200819862007200620062006200820081996
25-hydroxyvitamin D levels and the risk of
Melamed ML., Michos ED., Post W., Astor B.Dietary calcium and
vitamin D intakes in Mishra G., McCormack V., Kuh D., Hardy R., Stephen Dairy products, calcium
and prostate cancer risk.Koh KA., Sesso HD., Paffenbarger RS., Lee IM.Maternal 25-
hydroxyvitamin D and Morley R., Carlin JB., Pasco JA., Wark JD.Nutrient intake and
hypertensive disorders of Morris CD., Jacobson SL., Anand R., Ewell MG., Skeletal site-dependent
response of bone mineral A double-blind, randomized, placebo-
Nagpal J., Pande JN., Bhartia A.Supplements of 20
microg/d cholecalciferol Nelson ML., Blum JM., Hollis BW., Rosen C., Serum vitamin D
metabolite levels and the Nomura AM., Stemmermann GN., Lee J., Calcium and vitamin D
intakes in relation to risk Oh K., Willett WC., Wu K., Fuchs CS., Giovannucci EL.Diet during pregnancy and
risk of preeclampsia or Oken E., Ning Y., Rifas-Shiman SL., Rich-Edwards Plasma vitamin D and risk
of colorectal cancer: the Otani T., Iwasaki M., Sasazuki S., Inoue M., Calcium and vitamin D
intake and risk of Park SY., Murphy SP., Wilkens LR., Nomura AM., Calcium, dairy foods, and
risk of incident and fatal Park Y., Mitrou PN., Kipnis V., Hollenbeck A., Calcium, vitamin D, and
dairy product intake and Park SY., Murphy SP., Wilkens LR., Stram DO., Dairy food, calcium, and
risk of cancer in the NIH-Park Y., Leitzmann MF., Subar AF., Hollenbeck A., Effects of a short-term
vitamin D(3) and calcium Pfeifer M., Begerow B., Minne HW., Nachtigall D., Diet and risk of colorectal
cancer in a cohort of Pietinen P., Malila N., Virtanen M., Hartman TJ., Plasma 1,25-dihydroxy-
and 25-hydroxyvitamin D Platz EA., Hankinson SE., Hollis BW., Colditz GA., Effects of calcium
supplementation on body Reid IR., Horne A., Mason B., Ames R., Bava U., Calcium, dairy products,
and risk of prostate cancer Rodriguez C., McCullough ML., Mondul AM., Jacobs Meat and dairy
consumption and Rohrmann S., Platz EA., Kavanaugh CJ., Thuita L., Prospective evaluation of
dietary and other Ross RK., Yuan JM., Henderson BE., Park J., Serum parathyroid
hormone is associated Sambrook PN., Chen JS., March LM., Cameron ID., Animal products, calcium
and protein and prostate Schuurman AG., van den Brandt PA., Dorant E., Effect of winter oral
vitamin D3 Scragg R., Khaw KT., Murphy S.Intake of dairy products,
calcium, and vitamin d and Shin MH., Holmes MD., Hankinson SE., Wu K., Dietary intake of calcium,
fiber and other Shin A., Li H., Shu XO., Yang G., Gao YT., Zheng Vitamin D intake and the
risk for pancreatic cancer Skinner HG., Michaud DS., Giovannucci E., Willett Calcium intake and 28-
year gastro-intestinal Slob IC., Lambregts JL., Schuit AJ., Kok FJ.Supplementation with
cholecalciferol does not Sneve M., Figenschau Y., Jorde R.Serum vitamin D and risk
of pancreatic cancer in the Stolzenberg-Solomon RZ., Hayes RB., Horst RL., A prospective nested case-
control study of vitamin D Stolzenberg-Solomon RZ., Vieth R., Azad A., Pietinen Serum levels of vitamin D
metabolites and the Tangrea J., Helzlsouer K., Pietinen P., Taylor P., Hollis Dietary calcium and
vitamin D intake and risk Terry P., Baron JA., Bergkvist L., Holmberg L., Dietary calcium intake and
blood pressure in Thomsen K., Nilas L., Christiansen C.Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.Dairy, calcium, and
vitamin D intakes and Tseng M., Breslow RA., Graubard BI., Ziegler RG.Dietary intake of calcium
in relation to mortality Umesawa M., Iso H., Date C., Yamamoto A., Dietary calcium intake and
risks of stroke, its Umesawa M., Iso H., Ishihara J., Saito I., Kokubo Oral calcium and blood
pressure: a controlled van Beresteyn EC., Schaafsma G., de Waard Childhood dairy intake and
adult cancer risk: 65-y van der Pols JC., Bain C., Gunnell D., Smith GD., Low serum concentrations
of 25-hydroxyvitamin D in Visser M., Deeg DJ., Puts MT., Seidell JC., Lips P.Calcium plus vitamin D
supplementation and the Wactawski-Wende J., Kotchen JM., Anderson GL., High-dose vitamin D3
supplementation in a Wagner CL., Hulsey TC., Fanning D., Ebeling M., Dietary intake of dairy
products, calcium, and Wang L., Manson JE., Buring JE., Lee IM., Sesso Vitamin D deficiency and
risk of cardiovascular Wang TJ., Pencina MJ., Booth SL., Jacques PF., Effect of longterm placebo
controlled calcium Weisgerber UM., Boeing H., Owen RW., Waldherr
200819971987200220071995199820082008
Is ischemic stroke risk related to folate status or
Weng LC., Yeh WT., Bai CH., Chen HJ., Chuang SY., Efficacy of
nonpharmacologic Whelton PK., Kumanyika SK., Cook NR., Cutler JA., Alcohol, physical activity
and other risk factors for Wu AH., Paganini-Hill A., Ross RK., Henderson BE.Calcium intake and risk of
colon cancer in women Wu K., Willett WC., Fuchs CS., Colditz GA., A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis Lack of blood pressure
effect with calcium and Yamamoto ME., Applegate WB., Klag MJ., Borhani NO., A prospective cohort study
of intake of calcium, Zheng W., Anderson KE., Kushi LH., Sellers TA., Effects of calcium and
vitamin D supplementation Zhu K., Devine A., Dick IM., Wilson SG., Prince RL.Randomized controlled
trial of the effects of Zhu K., Bruce D., Austin N., Devine A., Ebeling PR.,
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
Coronary heart
All adenomas
Sudden death
Endocrine system
Gastrointestinal
Colorectal caner
Invasive breast
0 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 1 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
slope0 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
IHD (fatal +
Rectal caner
Colorectal adenoma
Change in SBP/DBP
Prostate cancer
Kidney stone
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 1 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
CHD0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
Distal colon
birth length
Recurrent adenomas
Distal colon
Brain and other
BP (post-partum)
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 1 0 0 00 0 0 1 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
areal BMD0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 1 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
Advance adenomas
Colorectal caner
25(OH)D at 1 y
Bladder cancer
Other cancers
First cardiovas
0 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 10 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
Fatal IHD Death0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 1 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
Proximal vs. distal
Weight (ITT)
Hypertension
Brain cancer
Ischemic heart
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
Survival Leukemia0 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
Prostate cancer in
bone indexes
change in 25 OH(D)
Infectious disease
Digestive system
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 1 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 1 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
Stroke0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 1 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
birth weight
Distal colorectal
1,25(OH)D
Lung cancer
Ovarian cancer
All-cause mortality
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 10 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
HTN (Rx) SBP mortality0 0 0 0 0 1 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 1 0 0 0
DBP (supine)
Curve 4- Ca
SBP (standing)
Prostate cancer
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 1 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 1 0 0 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 1 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 1 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 1 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 1 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 1 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 1 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
Cancer mortality
BMI (per protocol)
Intestinal polyps
Total cancer
(Invasive) colon
Colon cancer or
Death from
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
1 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 1 1 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
in DBP Women height0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
Advanced adenomas
cord blood
Fatal stroke
Chair stands
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 10 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 1 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
SBP/DBP0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 1 0 0 0
Body weight
Total mortality
Cerebrovascular
Stroke incidence
All cause mortality
change in BMC (ITT
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 1 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 1 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 10 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
% change in total
Femoral neck BMD
All cancers
gestational age
newborn birth
Breast cancer
Total serum
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 1 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 1 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
CVD Composit
Timed walk
Stomach cancer
(Invasive) colorectal
Total CVD mortality
Ischemic heart
(invasive) rectal
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 1 0 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 1 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
Cancer related
Nonfatal MI
Breast cancer
BMC - whole
anti-rachitic
Respiratory cancer
Distal (left
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
weight0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
Respiratory system
Cardiovascular
Proximal colon
25(OH)D level in
stress fractures
Kidney cancer
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 1 0 0 00 0 0 1 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
BP0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
Twelve minutes
weight gain 3rd
Respiratory cancer
Endometrial cancer
Lung cancer
Weight change
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 1 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 1 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
crown-heel
Colon cancer vs.
atopic eczema at
Coronary heart
25(OH)D level
Incident HTN
Breast cancer
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 1 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
Myeloma0 0 0 0 0 0 00 0 0 0 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 1 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
Colorectal cancer
Non-Hodgkin
specific stroke
Total body BMC
Prostate cancer in
Incident breast
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
fracture in SBP stroke0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 1 0 0 00 0 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
Breast cancer
25(OH)vitD
Muscle strength
infant weight
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
Weight MI0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 1 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 0
9 mo weight
Proximal colon
incident cancer
Rectal cancer
Primary adenocarc
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 1 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 1 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 10 0 1 0 0 1 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
gestational HTN
vit D3 level in
maternal 1,25
Rectal cancer
Pancreatic cancer
cord blood
Cardiovascular
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 1 0 00 0 0 0 1 0 00 0 0 1 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
Calcium balance
Prostate cancer
Physical performa
Distal colon
high-risk distal
Total stroke
Colon cancer
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 1 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
adenoma at 2 mo length BMI0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
Pregnancy-induced
Prostate cancer
preeclampsia
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 1 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
BMD Others 1 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
Aggressive prostate
HTN (BP or Rx)
Systolic BP
Incident invasive
Prostate cancer
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 1 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 1 0 0 0 0 0
PI0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
First stroke
incident prostate
No analysis
Rectal adenoma
low-risk (distal)
gestation length
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 1 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
toxemia Fall0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 1 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 1 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 00 0 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
Colorectal cancer
BMD - lumbar
Timed up and go
change in ht
Adenoma recurrenc
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 11 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 00 0 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 00 0 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
Proximal and distal
HTN, incident
change in wt
change in BMI
Colorectal cancer
Cerebrovascular
Proximal (right
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 1 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 1 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
25(OH)D0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 1 0 0 00 0 0 0 0 0 00 0 0 0 0 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 10 0 0 0 0 0 0
25(OH)D level in
prostate cancer
% change in BMC at
Breast cancer
Esophageal cancer
Colon cancer
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 1 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 10 0 0 0 0 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 1 0
Respira-ry AMI0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 1 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
Falls incidence
Thyroid cancer
Digestive cancer
Urinary system
Serum 25(OH)D
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
CVD mortality
9 mo length
Incident stroke
Breast cancer
All cancers
Grip strength
Liver cancer
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
1 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 1 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 1 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
Non-Hodgkin
Serum 25(OH)D
Colon caner
fatal prostate
Reproductive
Bodyweight
Mammography
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 00 0 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 10 0 0 1 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
Mortality 25(OH)D20 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 1 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
Head and neck
body weight
25(OH)D total
Cerebral infarction
specific stroke
0 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 0 0 1 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
25(OH)D30 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 1 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 1 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 1 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
Prostate cancer
Colorectal Cancer
Adenomas
All cancers
Prostate cancer
Also separate
0 0 0 0 0 0 00 0 0 0 0 0 01 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 1 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 10 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 1 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
0 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 00 0 0 0 0 0 0
DBP CRC IHD death0 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 10 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 1 0 0 0 0
First fracture
maternal 25(OH)D
Fractures (hip/wrist/
0 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 1 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 01 0 0 0 1 00 1 0 0 0 00 0 0 1 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 1 0 0 00 0 0 0 0 0
0 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 1 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 1 0 0 0 00 0 0 0 0 00 0 0 0 0 00 1 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 1 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 0
0 0 0 0 0 00 1 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 0
Study ID:EF ID Creator Create Date PMID6304:194 admin Aug 18, 2013 Sep 5, 2014 185059676304:194 admin Aug 18, 2013 Sep 5, 2014 185059676305:194 admin Aug 18, 2013 Sep 5, 2014 110758746306:194 admin Aug 18, 2013 Sep 5, 2014 126632776306:194 admin Aug 18, 2013 Sep 5, 2014 126632776306:194 admin Aug 18, 2013 Sep 5, 2014 126632776307:194 admin Aug 18, 2013 Sep 5, 2014 78928826308:194 admin Aug 18, 2013 Sep 5, 2014 162804276309:194 admin Aug 18, 2013 Sep 5, 2014 182086366311:194 admin Aug 18, 2013 Sep 5, 2014 13303606312:194 admin Aug 18, 2013 Sep 5, 2014 86211986313:194 admin Aug 18, 2013 Sep 5, 2014 97435116313:194 admin Aug 18, 2013 Sep 5, 2014 97435116314:194 admin Aug 18, 2013 Sep 5, 2014 157673346314:194 admin Aug 18, 2013 Sep 5, 2014 157673346315:194 admin Aug 18, 2013 Sep 5, 2014 161034506315:194 admin Aug 18, 2013 Sep 5, 2014 161034506316:194 admin Aug 18, 2013 Sep 5, 2014 179650376316:194 admin Aug 18, 2013 Sep 5, 2014 179650376317:194 admin Aug 18, 2013 Sep 5, 2014 186895596318:194 admin Aug 18, 2013 Sep 5, 2014 175359856319:194 admin Aug 18, 2013 Sep 5, 2014 181983946319:194 admin Aug 18, 2013 Sep 5, 2014 181983946319:194 admin Aug 18, 2013 Sep 5, 2014 181983946319:194 admin Aug 18, 2013 Sep 5, 2014 181983946319:194 admin Aug 18, 2013 Sep 5, 2014 181983946320:194 admin Aug 18, 2013 Sep 5, 2014 172438666320:194 admin Aug 18, 2013 Sep 5, 2014 172438666321:194 admin Aug 18, 2013 Sep 5, 2014 188427716322:194 admin Aug 18, 2013 Sep 5, 2014 83334126325:194 admin Aug 18, 2013 Sep 5, 2014 76128036326:194 admin Aug 18, 2013 Sep 5, 2014 187553196326:194 admin Aug 18, 2013 Sep 5, 2014 187553196326:194 admin Aug 18, 2013 Sep 5, 2014 187553196327:194 admin Aug 18, 2013 Sep 5, 2014 167979036327:194 admin Aug 18, 2013 Sep 5, 2014 167979036327:194 admin Aug 18, 2013 Sep 5, 2014 167979036327:194 admin Aug 18, 2013 Sep 5, 2014 167979036328:194 admin Aug 18, 2013 Sep 5, 2014 176564206328:194 admin Aug 18, 2013 Sep 5, 2014 176564206329:194 admin Aug 18, 2013 Sep 5, 2014 175025306330:194 admin Aug 18, 2013 Sep 5, 2014 115666566331:194 admin Aug 18, 2013 Sep 5, 2014 190016016333:194 admin Aug 18, 2013 Sep 5, 2014 162804476334:194 admin Aug 18, 2013 Sep 5, 2014 152130386334:194 admin Aug 18, 2013 Sep 5, 2014 152130386335:194 admin Aug 18, 2013 Sep 5, 2014 8220092
Last Updated
6335:194 admin Aug 18, 2013 Sep 5, 2014 82200926335:194 admin Aug 18, 2013 Sep 5, 2014 82200926336:194 admin Aug 18, 2013 Sep 5, 2014 86824536336:194 admin Aug 18, 2013 Sep 5, 2014 86824536337:194 admin Aug 18, 2013 Sep 5, 2014 88906616337:194 admin Aug 18, 2013 Sep 5, 2014 88906616338:194 admin Aug 18, 2013 Sep 5, 2014 171895526338:194 admin Aug 18, 2013 Sep 5, 2014 171895526339:194 admin Aug 18, 2013 Sep 5, 2014 162782626339:194 admin Aug 18, 2013 Sep 5, 2014 162782626339:194 admin Aug 18, 2013 Sep 5, 2014 162782626339:194 admin Aug 18, 2013 Sep 5, 2014 162782626339:194 admin Aug 18, 2013 Sep 5, 2014 162782626340:194 admin Aug 18, 2013 Sep 5, 2014 80781156340:194 admin Aug 18, 2013 Sep 5, 2014 80781156341:194 admin Aug 18, 2013 Sep 5, 2014 153424526341:194 admin Aug 18, 2013 Sep 5, 2014 153424526341:194 admin Aug 18, 2013 Sep 5, 2014 153424526341:194 admin Aug 18, 2013 Sep 5, 2014 153424526342:194 admin Aug 18, 2013 Sep 5, 2014 156684856342:194 admin Aug 18, 2013 Sep 5, 2014 156684856342:194 admin Aug 18, 2013 Sep 5, 2014 156684856344:194 admin Aug 18, 2013 Sep 5, 2014 173720316345:194 admin Aug 18, 2013 Sep 5, 2014 188386236346:194 admin Aug 18, 2013 Sep 5, 2014 179715266346:194 admin Aug 18, 2013 Sep 5, 2014 179715266346:194 admin Aug 18, 2013 Sep 5, 2014 179715266346:194 admin Aug 18, 2013 Sep 5, 2014 179715266346:194 admin Aug 18, 2013 Sep 5, 2014 179715266346:194 admin Aug 18, 2013 Sep 5, 2014 179715266346:194 admin Aug 18, 2013 Sep 5, 2014 179715266346:194 admin Aug 18, 2013 Sep 5, 2014 179715266347:194 admin Aug 18, 2013 Sep 5, 2014 183814726348:194 admin Aug 18, 2013 Sep 5, 2014 90612756349:194 admin Aug 18, 2013 Sep 5, 2014 173110576349:194 admin Aug 18, 2013 Sep 5, 2014 173110576349:194 admin Aug 18, 2013 Sep 5, 2014 173110576349:194 admin Aug 18, 2013 Sep 5, 2014 173110576349:194 admin Aug 18, 2013 Sep 5, 2014 173110576350:194 admin Aug 18, 2013 Sep 5, 2014 88502736351:194 admin Aug 18, 2013 Sep 5, 2014 28573646352:194 admin Aug 18, 2013 Sep 5, 2014 25729006353:194 admin Aug 18, 2013 Sep 5, 2014 74936596353:194 admin Aug 18, 2013 Sep 5, 2014 74936596357:194 admin Aug 18, 2013 Sep 5, 2014 172279966357:194 admin Aug 18, 2013 Sep 5, 2014 172279966358:194 admin Aug 18, 2013 Sep 5, 2014 105113296358:194 admin Aug 18, 2013 Sep 5, 2014 10511329
6358:194 admin Aug 18, 2013 Sep 5, 2014 105113296359:194 admin Aug 18, 2013 Sep 5, 2014 156712226359:194 admin Aug 18, 2013 Sep 5, 2014 156712226360:194 admin Aug 18, 2013 Sep 5, 2014 162865196361:194 admin Aug 18, 2013 Sep 5, 2014 145539576362:194 admin Aug 18, 2013 Sep 5, 2014 124993436363:194 admin Aug 18, 2013 Sep 5, 2014 94050296364:194 admin Aug 18, 2013 Sep 5, 2014 39462956369:194 admin Aug 18, 2013 Sep 5, 2014 152258336370:194 admin Aug 18, 2013 Sep 5, 2014 116417506370:194 admin Aug 18, 2013 Sep 5, 2014 116417506370:194 admin Aug 18, 2013 Sep 5, 2014 116417506372:194 admin Aug 18, 2013 Sep 5, 2014 82014446372:194 admin Aug 18, 2013 Sep 5, 2014 82014446372:194 admin Aug 18, 2013 Sep 5, 2014 82014446373:194 admin Aug 18, 2013 Sep 5, 2014 175528806373:194 admin Aug 18, 2013 Sep 5, 2014 175528806374:194 admin Aug 18, 2013 Sep 5, 2014 82055386375:194 admin Aug 18, 2013 Sep 5, 2014 93438376376:194 admin Aug 18, 2013 Sep 5, 2014 86107046377:194 admin Aug 18, 2013 Sep 5, 2014 158805326377:194 admin Aug 18, 2013 Sep 5, 2014 158805326378:194 admin Aug 18, 2013 Sep 5, 2014 175361916379:194 admin Aug 18, 2013 Sep 5, 2014 171064376380:194 admin Aug 18, 2013 Sep 5, 2014 183980336382:194 admin Aug 18, 2013 Sep 5, 2014 153541506382:194 admin Aug 18, 2013 Sep 5, 2014 153541506382:194 admin Aug 18, 2013 Sep 5, 2014 153541506383:194 admin Aug 18, 2013 Sep 5, 2014 175566976384:194 admin Aug 18, 2013 Sep 5, 2014 184333056385:194 admin Aug 18, 2013 Sep 5, 2014 165229156385:194 admin Aug 18, 2013 Sep 5, 2014 165229156385:194 admin Aug 18, 2013 Sep 5, 2014 165229156385:194 admin Aug 18, 2013 Sep 5, 2014 165229156385:194 admin Aug 18, 2013 Sep 5, 2014 165229156386:194 admin Aug 18, 2013 Sep 5, 2014 165229156386:194 admin Aug 18, 2013 Sep 5, 2014 165229156386:194 admin Aug 18, 2013 Sep 5, 2014 165229156386:194 admin Aug 18, 2013 Sep 5, 2014 165229156386:194 admin Aug 18, 2013 Sep 5, 2014 165229156387:194 admin Aug 18, 2013 Sep 5, 2014 183322896387:194 admin Aug 18, 2013 Sep 5, 2014 183322896387:194 admin Aug 18, 2013 Sep 5, 2014 183322896387:194 admin Aug 18, 2013 Sep 5, 2014 183322896388:194 admin Aug 18, 2013 Sep 5, 2014 190565696389:194 admin Aug 18, 2013 Sep 5, 2014 173886676390:194 admin Aug 18, 2013 Sep 5, 2014 85579656390:194 admin Aug 18, 2013 Sep 5, 2014 8557965
6390:194 admin Aug 18, 2013 Sep 5, 2014 85579656391:194 admin Aug 18, 2013 Sep 5, 2014 158002686391:194 admin Aug 18, 2013 Sep 5, 2014 158002686391:194 admin Aug 18, 2013 Sep 5, 2014 158002686392:194 admin Aug 18, 2013 Sep 5, 2014 175332086393:194 admin Aug 18, 2013 Sep 5, 2014 164000446393:194 admin Aug 18, 2013 Sep 5, 2014 164000446393:194 admin Aug 18, 2013 Sep 5, 2014 164000446394:194 admin Aug 18, 2013 Sep 5, 2014 174739116394:194 admin Aug 18, 2013 Sep 5, 2014 174739116394:194 admin Aug 18, 2013 Sep 5, 2014 174739116395:194 admin Aug 18, 2013 Sep 5, 2014 172091776395:194 admin Aug 18, 2013 Sep 5, 2014 172091776395:194 admin Aug 18, 2013 Sep 5, 2014 172091776395:194 admin Aug 18, 2013 Sep 5, 2014 172091776396:194 admin Aug 18, 2013 Sep 5, 2014 37555176396:194 admin Aug 18, 2013 Sep 5, 2014 37555176396:194 admin Aug 18, 2013 Sep 5, 2014 37555176396:194 admin Aug 18, 2013 Sep 5, 2014 37555176396:194 admin Aug 18, 2013 Sep 5, 2014 37555176397:194 admin Aug 18, 2013 Sep 5, 2014 188246626398:194 admin Aug 18, 2013 Sep 5, 2014 159554676398:194 admin Aug 18, 2013 Sep 5, 2014 159554676399:194 admin Aug 18, 2013 Sep 5, 2014 120201026401:194 admin Aug 18, 2013 Sep 5, 2014 36232606402:194 admin Aug 18, 2013 Sep 5, 2014 32436096402:194 admin Aug 18, 2013 Sep 5, 2014 32436096403:194 admin Aug 18, 2013 Sep 5, 2014 163915876404:194 admin Aug 18, 2013 Sep 5, 2014 67930586404:194 admin Aug 18, 2013 Sep 5, 2014 67930586405:194 admin Aug 18, 2013 Sep 5, 2014 127087196405:194 admin Aug 18, 2013 Sep 5, 2014 127087196405:194 admin Aug 18, 2013 Sep 5, 2014 127087196405:194 admin Aug 18, 2013 Sep 5, 2014 127087196407:194 admin Aug 18, 2013 Sep 5, 2014 186950766407:194 admin Aug 18, 2013 Sep 5, 2014 186950766407:194 admin Aug 18, 2013 Sep 5, 2014 186950766407:194 admin Aug 18, 2013 Sep 5, 2014 186950766408:194 admin Aug 18, 2013 Sep 5, 2014 188278116409:194 admin Aug 18, 2013 Sep 5, 2014 171064376410:194 admin Aug 18, 2013 Sep 5, 2014 163526846410:194 admin Aug 18, 2013 Sep 5, 2014 163526846410:194 admin Aug 18, 2013 Sep 5, 2014 163526846411:194 admin Aug 18, 2013 Sep 5, 2014 112624666412:194 admin Aug 18, 2013 Sep 5, 2014 171818906413:194 admin Aug 18, 2013 Sep 5, 2014 191257566413:194 admin Aug 18, 2013 Sep 5, 2014 191257566413:194 admin Aug 18, 2013 Sep 5, 2014 19125756
6414:194 admin Aug 18, 2013 Sep 5, 2014 191582266415:194 admin Aug 18, 2013 Sep 5, 2014 97941756416:194 admin Aug 18, 2013 Sep 5, 2014 173796166417:194 admin Aug 18, 2013 Sep 5, 2014 175219216417:194 admin Aug 18, 2013 Sep 5, 2014 175219216418:194 admin Aug 18, 2013 Sep 5, 2014 176222446418:194 admin Aug 18, 2013 Sep 5, 2014 176222446418:194 admin Aug 18, 2013 Sep 5, 2014 176222446419:194 admin Aug 18, 2013 Sep 5, 2014 172153806420:194 admin Aug 18, 2013 Sep 5, 2014 180000206421:194 admin Aug 18, 2013 Sep 5, 2014 179252836422:194 admin Aug 18, 2013 Sep 5, 2014 192377246422:194 admin Aug 18, 2013 Sep 5, 2014 192377246422:194 admin Aug 18, 2013 Sep 5, 2014 192377246422:194 admin Aug 18, 2013 Sep 5, 2014 192377246422:194 admin Aug 18, 2013 Sep 5, 2014 192377246422:194 admin Aug 18, 2013 Sep 5, 2014 192377246422:194 admin Aug 18, 2013 Sep 5, 2014 192377246422:194 admin Aug 18, 2013 Sep 5, 2014 192377246422:194 admin Aug 18, 2013 Sep 5, 2014 192377246422:194 admin Aug 18, 2013 Sep 5, 2014 192377246422:194 admin Aug 18, 2013 Sep 5, 2014 192377246422:194 admin Aug 18, 2013 Sep 5, 2014 192377246422:194 admin Aug 18, 2013 Sep 5, 2014 192377246422:194 admin Aug 18, 2013 Sep 5, 2014 192377246422:194 admin Aug 18, 2013 Sep 5, 2014 192377246422:194 admin Aug 18, 2013 Sep 5, 2014 192377246422:194 admin Aug 18, 2013 Sep 5, 2014 192377246422:194 admin Aug 18, 2013 Sep 5, 2014 192377246422:194 admin Aug 18, 2013 Sep 5, 2014 192377246422:194 admin Aug 18, 2013 Sep 5, 2014 192377246422:194 admin Aug 18, 2013 Sep 5, 2014 192377246422:194 admin Aug 18, 2013 Sep 5, 2014 192377246422:194 admin Aug 18, 2013 Sep 5, 2014 192377246422:194 admin Aug 18, 2013 Sep 5, 2014 192377246422:194 admin Aug 18, 2013 Sep 5, 2014 192377246422:194 admin Aug 18, 2013 Sep 5, 2014 192377246423:194 admin Aug 18, 2013 Sep 5, 2014 112975966423:194 admin Aug 18, 2013 Sep 5, 2014 112975966423:194 admin Aug 18, 2013 Sep 5, 2014 112975966424:194 admin Aug 18, 2013 Sep 5, 2014 105306086425:194 admin Aug 18, 2013 Sep 5, 2014 110457886428:194 admin Aug 18, 2013 Sep 5, 2014 158271036428:194 admin Aug 18, 2013 Sep 5, 2014 158271036429:194 admin Aug 18, 2013 Sep 5, 2014 128693976430:194 admin Aug 18, 2013 Sep 5, 2014 173153196431:194 admin Aug 18, 2013 Sep 5, 2014 92364166432:194 admin Aug 18, 2013 Sep 5, 2014 15531500
6433:194 admin Aug 18, 2013 Sep 5, 2014 103621256434:194 admin Aug 18, 2013 Sep 5, 2014 74981006434:194 admin Aug 18, 2013 Sep 5, 2014 74981006434:194 admin Aug 18, 2013 Sep 5, 2014 74981006435:194 admin Aug 18, 2013 Sep 5, 2014 122088956436:194 admin Aug 18, 2013 Sep 5, 2014 170197166436:194 admin Aug 18, 2013 Sep 5, 2014 170197166436:194 admin Aug 18, 2013 Sep 5, 2014 170197166437:194 admin Aug 18, 2013 Sep 5, 2014 169850316438:194 admin Aug 18, 2013 Sep 5, 2014 84781446438:194 admin Aug 18, 2013 Sep 5, 2014 84781446438:194 admin Aug 18, 2013 Sep 5, 2014 84781446439:194 admin Aug 18, 2013 Sep 5, 2014 190569006439:194 admin Aug 18, 2013 Sep 5, 2014 190569006439:194 admin Aug 18, 2013 Sep 5, 2014 190569006441:194 admin Aug 18, 2013 Sep 5, 2014 192088426442:194 admin Aug 18, 2013 Sep 5, 2014 170470876443:194 admin Aug 18, 2013 Sep 5, 2014 92424786443:194 admin Aug 18, 2013 Sep 5, 2014 92424786443:194 admin Aug 18, 2013 Sep 5, 2014 92424786443:194 admin Aug 18, 2013 Sep 5, 2014 92424786443:194 admin Aug 18, 2013 Sep 5, 2014 92424786444:194 admin Aug 18, 2013 Nov 6, 2013 124671336444:194 admin Aug 18, 2013 Nov 6, 2013 124671336444:194 admin Aug 18, 2013 Nov 6, 2013 124671336444:194 admin Aug 18, 2013 Nov 6, 2013 124671336444:194 admin Aug 18, 2013 Nov 6, 2013 124671336445:194 admin Aug 18, 2013 Sep 5, 2014 33073076446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406447:194 admin Aug 18, 2013 Sep 5, 2014 158834416450:194 admin Aug 18, 2013 Sep 5, 2014 163394766450:194 admin Aug 18, 2013 Sep 5, 2014 163394766450:194 admin Aug 18, 2013 Sep 5, 2014 16339476
6450:194 admin Aug 18, 2013 Sep 5, 2014 163394766451:194 admin Aug 18, 2013 Sep 5, 2014 186358556451:194 admin Aug 18, 2013 Sep 5, 2014 186358556451:194 admin Aug 18, 2013 Sep 5, 2014 186358556452:194 admin Aug 18, 2013 Sep 5, 2014 37888356453:194 admin Aug 18, 2013 Sep 5, 2014 180655926455:194 admin Aug 18, 2013 Sep 5, 2014 169601776456:194 admin Aug 18, 2013 Sep 5, 2014 164816366456:194 admin Aug 18, 2013 Sep 5, 2014 164816366456:194 admin Aug 18, 2013 Sep 5, 2014 164816366456:194 admin Aug 18, 2013 Sep 5, 2014 164816366456:194 admin Aug 18, 2013 Sep 5, 2014 164816366456:194 admin Aug 18, 2013 Sep 5, 2014 164816366456:194 admin Aug 18, 2013 Sep 5, 2014 164816366456:194 admin Aug 18, 2013 Sep 5, 2014 164816366456:194 admin Aug 18, 2013 Sep 5, 2014 164816366457:194 admin Aug 18, 2013 Sep 5, 2014 176615656457:194 admin Aug 18, 2013 Sep 5, 2014 176615656457:194 admin Aug 18, 2013 Sep 5, 2014 176615656457:194 admin Aug 18, 2013 Sep 5, 2014 176615656457:194 admin Aug 18, 2013 Sep 5, 2014 176615656459:194 admin Aug 18, 2013 Sep 5, 2014 181803956460:194 admin Aug 18, 2013 Sep 5, 2014 86750936460:194 admin Aug 18, 2013 Sep 5, 2014 86750936460:194 admin Aug 18, 2013 Sep 5, 2014 86750936460:194 admin Aug 18, 2013 Sep 5, 2014 86750936461:194 admin Aug 18, 2013 Sep 5, 2014 189889096462:194 admin Aug 18, 2013 Sep 5, 2014 90225616463:194 admin Aug 18, 2013 Sep 5, 2014 36203146464:194 admin Aug 18, 2013 Sep 5, 2014 119043166464:194 admin Aug 18, 2013 Sep 5, 2014 119043166464:194 admin Aug 18, 2013 Sep 5, 2014 119043166465:194 admin Aug 18, 2013 Sep 5, 2014 176238016465:194 admin Aug 18, 2013 Sep 5, 2014 176238016465:194 admin Aug 18, 2013 Sep 5, 2014 176238016465:194 admin Aug 18, 2013 Sep 5, 2014 176238016465:194 admin Aug 18, 2013 Sep 5, 2014 176238016466:194 admin Aug 18, 2013 Sep 5, 2014 77958376466:194 admin Aug 18, 2013 Sep 5, 2014 77958376466:194 admin Aug 18, 2013 Sep 5, 2014 77958376467:194 admin Aug 18, 2013 Sep 5, 2014 95214376468:194 admin Aug 18, 2013 Sep 5, 2014 180897016468:194 admin Aug 18, 2013 Sep 5, 2014 180897016469:194 admin Aug 18, 2013 Sep 5, 2014 184102256469:194 admin Aug 18, 2013 Sep 5, 2014 18410225
Alt ID(s) Title Year Author2008200820002003200320031995200520081992199619981998200520052005200520082008200820072008200820082008200820072007200819931995200820082008200620062006200620072007200720012008200520042004-- Not Found --
Serum vitamin D concentration and
Ahn J., Peters U., Albanes D., Purdue MP., Abnet CC., Serum vitamin D
concentration and Ahn J., Peters U., Albanes D., Purdue MP., Abnet CC., Prostate cancer risk and
prediagnostic serum 25-Ahonen MH., Tenkanen L., Teppo L., Hakama M., A prospective study of
calcium intake from diet Al-Delaimy WK., Rimm E., Willett WC., Stampfer MJ., A prospective study of
calcium intake from diet Al-Delaimy WK., Rimm E., Willett WC., Stampfer MJ., A prospective study of
calcium intake from diet Al-Delaimy WK., Rimm E., Willett WC., Stampfer MJ., The influence of
menopause and hormonal Aloia JF., Vaswani A., Russo L., Sheehan M., Low-fat dairy consumption
and reduced risk of Alonso A., Beunza JJ., Delgado-Rodríguez M., Effect of vitamin D
supplementation on bone Andersen R., Mølgaard C., Skovgaard LT., Brot C., A prospective study of
nutritional factors and Ascherio A., Rimm EB., Giovannucci EL., Colditz Prospective study of
nutritional factors, blood Ascherio A., Hennekens C., Willett WC., Sacks F., Intake of potassium,
magnesium, calcium, and Ascherio A., Rimm EB., Hernán MA., Giovannucci Intake of potassium,
magnesium, calcium, and Ascherio A., Rimm EB., Hernán MA., Giovannucci Risk of prostate cancer in
a randomized clinical trial Baron JA., Beach M., Wallace K., Grau MV., Risk of prostate cancer in
a randomized clinical trial Baron JA., Beach M., Wallace K., Grau MV., Plasma 25-hydroxyvitamin
D and 1,25-Bertone-Johnson ER., Chen WY., Holick MF., Hollis BW., Plasma 25-hydroxyvitamin
D and 1,25-Bertone-Johnson ER., Chen WY., Holick MF., Hollis BW., Vitamin D
supplementation has Björkman M., Sorva A., Risteli J., Tilvis R.Vitamin D
supplementation has Björkman M., Sorva A., Risteli J., Tilvis R.Body size and serum 25
hydroxy vitamin D Blum M., Dallal GE., Dawson-Hughes B.Maternal vitamin D
deficiency increases the Bodnar LM., Catov JM., Simhan HN., Holick MF., Vascular events in healthy
older women receiving Bolland MJ., Barber PA., Doughty RN., Mason B., Vascular events in healthy
older women receiving Bolland MJ., Barber PA., Doughty RN., Mason B., Vascular events in healthy
older women receiving Bolland MJ., Barber PA., Doughty RN., Mason B., Vascular events in healthy
older women receiving Bolland MJ., Barber PA., Doughty RN., Mason B., Vascular events in healthy
older women receiving Bolland MJ., Barber PA., Doughty RN., Mason B., Two-year randomized
controlled trial of vitamin Bolton-Smith C., McMurdo ME., Paterson CR., Mole Two-year randomized
controlled trial of vitamin Bolton-Smith C., McMurdo ME., Paterson CR., Mole Dairy calcium
supplementation in Bortolotti M., Rudelle S., Schneiter P., Vidal H., Relation of calcium,
vitamin D, and dairy food Bostick RM., Potter JD., Sellers TA., McKenzie DR., Prostate cancer and
prediagnostic levels of Braun MM., Helzlsouer KJ., Hollis BW., Comstock GW.Calcium, vitamin D
supplementation, and Brunner RL., Cochrane B., Jackson RD., Larson J., Calcium, vitamin D
supplementation, and Brunner RL., Cochrane B., Jackson RD., Larson J., Calcium, vitamin D
supplementation, and Brunner RL., Cochrane B., Jackson RD., Larson J., Effects of vitamin D
supplementation and Bunout D., Barrera G., Leiva L., Gattas V., de la Effects of vitamin D
supplementation and Bunout D., Barrera G., Leiva L., Gattas V., de la Effects of vitamin D
supplementation and Bunout D., Barrera G., Leiva L., Gattas V., de la Effects of vitamin D
supplementation and Bunout D., Barrera G., Leiva L., Gattas V., de la Does vitamin D stop
inpatients falling? A Burleigh E., McColl J., Potter J.Does vitamin D stop
inpatients falling? A Burleigh E., McColl J., Potter J.Calcium plus vitamin D
supplementation and the Caan B., Neuhouser M., Aragaki A., Lewis CB., Dairy products, calcium,
and prostate cancer risk in Chan JM., Stampfer MJ., Ma J., Gann PH., Gaziano JM., Calcium plus vitamin D
supplementation and the Chlebowski RT., Johnson KC., Kooperberg C., Effects of calcium, dairy
product, and vitamin D Cheng S., Lyytikäinen A., Kröger H., Lamberg-Allardt Weight loss and calcium
intake influence calcium Cifuentes M., Riedt CS., Brolin RE., Field MP., Weight loss and calcium
intake influence calcium Cifuentes M., Riedt CS., Brolin RE., Field MP., Vitamin D and prostate
cancer: a prediagnostic Corder EH., Guess HA., Hulka BS., Friedman GD.,
-- Not Found ---- Not Found ---- Not Found ---- Not Found --19961996200620062006200620062006200619941994200420042004200420052005200520072008200720072007200720072007200720072008199620082008200820082008199619851989199519952007200719991999
Vitamin D and prostate cancer: a prediagnostic
Corder EH., Guess HA., Hulka BS., Friedman GD., Vitamin D and prostate
cancer: a prediagnostic Corder EH., Guess HA., Hulka BS., Friedman GD., Calcium chemoprevention
in colorectal cancer.Duris I., Hruby D., Pekarkova B., Huorka M., Calcium chemoprevention
in colorectal cancer.Duris I., Hruby D., Pekarkova B., Huorka M., Dietary calcium, alcohol,
and incidence of treated Dwyer JH., Li L., Dwyer KM., Curtin LR., Feinleib M.Dietary calcium, alcohol,
and incidence of treated Dwyer JH., Li L., Dwyer KM., Curtin LR., Feinleib M.Effect of 1-year dairy
product intervention on fat Eagan MS., Lyle RM., Gunther CW., Peacock M., Effect of 1-year dairy
product intervention on fat Eagan MS., Lyle RM., Gunther CW., Peacock M., Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J., Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J., Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J., Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J., Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J., Seasonal and geographical
variations in the growth Feliciano ES., Ho ML., Specker BL., Falciglia G., Seasonal and geographical
variations in the growth Feliciano ES., Ho ML., Specker BL., Falciglia G., Plasma vitamin D
metabolites and risk of Feskanich D., Ma J., Fuchs CS., Kirkner GJ., Hankinson Plasma vitamin D
metabolites and risk of Feskanich D., Ma J., Fuchs CS., Kirkner GJ., Hankinson Plasma vitamin D
metabolites and risk of Feskanich D., Ma J., Fuchs CS., Kirkner GJ., Hankinson Plasma vitamin D
metabolites and risk of Feskanich D., Ma J., Fuchs CS., Kirkner GJ., Hankinson Calcium from diet and
supplements is associated Flood A., Peters U., Chatterjee N., Lacey JV., Calcium from diet and
supplements is associated Flood A., Peters U., Chatterjee N., Lacey JV., Calcium from diet and
supplements is associated Flood A., Peters U., Chatterjee N., Lacey JV., Plasma 25-hydroxyvitamin
D levels and risk of Forman JP., Giovannucci E., Holmes MD., Bischoff-Plasma 25-hydroxyvitamin
D levels and risk of Forman JP., Curhan GC., Taylor EN.Prospective study of
serum vitamin D and Freedman DM., Looker AC., Chang SC., Graubard Prospective study of
serum vitamin D and Freedman DM., Looker AC., Chang SC., Graubard Prospective study of
serum vitamin D and Freedman DM., Looker AC., Chang SC., Graubard Prospective study of
serum vitamin D and Freedman DM., Looker AC., Chang SC., Graubard Prospective study of
serum vitamin D and Freedman DM., Looker AC., Chang SC., Graubard Prospective study of
serum vitamin D and Freedman DM., Looker AC., Chang SC., Graubard Prospective study of
serum vitamin D and Freedman DM., Looker AC., Chang SC., Graubard Prospective study of
serum vitamin D and Freedman DM., Looker AC., Chang SC., Graubard Serum levels of vitamin D
metabolites and breast Freedman DM., Chang SC., Falk RT., Purdue MP., Dietary factors and risk of
colon cancer: a Gaard M., Tretli S., Løken EB.Maternal vitamin D status
during pregnancy and Gale CR., Robinson SM., Harvey NC., Javaid MK., Maternal vitamin D status
during pregnancy and Gale CR., Robinson SM., Harvey NC., Javaid MK., Maternal vitamin D status
during pregnancy and Gale CR., Robinson SM., Harvey NC., Javaid MK., Maternal vitamin D status
during pregnancy and Gale CR., Robinson SM., Harvey NC., Javaid MK., Maternal vitamin D status
during pregnancy and Gale CR., Robinson SM., Harvey NC., Javaid MK., Circulating vitamin D
metabolites in relation to Gann PH., Ma J., Hennekens CH., Hollis Dietary vitamin D and
calcium and risk of Garland C., Shekelle RB., Barrett-Connor E., Criqui Serum 25-hydroxyvitamin
D and colon cancer: eight-Garland CF., Comstock GW., Garland FC., Helsing The influence of dairy
products on plasma uric Ghadirian P., Shatenstein B., Verdy M., Hamet P.The influence of dairy
products on plasma uric Ghadirian P., Shatenstein B., Verdy M., Hamet P.Prolonged effect of
calcium supplementation Grau MV., Baron JA., Sandler RS., Wallace K., Prolonged effect of
calcium supplementation Grau MV., Baron JA., Sandler RS., Wallace K., Plasma 25-hydroxyvitamin
D responses of younger Harris SS., Dawson-Hughes B., Perrone GA.Plasma 25-hydroxyvitamin
D responses of younger Harris SS., Dawson-Hughes B., Perrone GA.
19992005200520052003200319971986200420012001200119941994199420082008199419971996200520052007200620082004200420042007200820062006200620062006200620062006200620062008200820082008200920071995 Lijnen P., Petrov V.1995 Lijnen P., Petrov V.
Plasma 25-hydroxyvitamin D responses of younger
Harris SS., Dawson-Hughes B., Perrone GA.The association of calcium
and vitamin D with risk of Hartman TJ., Albert PS., Snyder K., Slattery ML., The association of calcium
and vitamin D with risk of Hartman TJ., Albert PS., Snyder K., Slattery ML., The impact of calcium and
dairy product consumption Harvey-Berino J., Gold BC., Lauber R., Starinski A.Gestational calcium
supplementation and Hatton DC., Harrison-Hohner J., Coste S., Reller Human serum 25-
hydroxycholecalciferol Heaney RP., Davies KM., Chen TC., Holick MF., Long-term vitamin D3
supplementation may Heikkinen AM., Tuppurainen MT., Colon cancer and dietary
fat, phosphorus, and Heilbrun LK., Hankin JH., Nomura AM., Plasma levels of 25-
hydroxyvitamin D, 1,25-Jacobs ET., Giuliano AR., Martínez ME., Hollis BW., Prospective study on milk
products, calcium and Järvinen R., Knekt P., Hakulinen T., Aromaa A.Prospective study on milk
products, calcium and Järvinen R., Knekt P., Hakulinen T., Aromaa A.Prospective study on milk
products, calcium and Järvinen R., Knekt P., Hakulinen T., Aromaa A.Dietary intakes,
anthropometric Johnson AA., Knight EM., Edwards CH., Oyemade Dietary intakes,
anthropometric Johnson AA., Knight EM., Edwards CH., Oyemade Dietary intakes,
anthropometric Johnson AA., Knight EM., Edwards CH., Oyemade Calcium intake and the
outcome of short-term Kabrnová-Hlavatá K., Hainer V., Gojová M., Calcium intake and the
outcome of short-term Kabrnová-Hlavatá K., Hainer V., Gojová M., Fermented dairy products,
calcium, and colorectal Kampman E., Goldbohm RA., van den Brandt PA., Prospective study of diet
and female colorectal Kato I., Akhmedkhanov A., Koenig K., Toniolo PG., Calcium, vitamin D, and
dairy foods and the Kearney J., Giovannucci E., Rimm EB., Ascherio A., Dietary calcium,
phosphorus, vitamin D, Kesse E., Boutron-Ruault MC., Norat T., Riboli E., Dietary calcium,
phosphorus, vitamin D, Kesse E., Boutron-Ruault MC., Norat T., Riboli E., Dairy products, calcium
and the risk of breast Kesse-Guyot E., Bertrais S., Duperray B., Arnault N., Dairy products, calcium
and prostate cancer risk.Koh KA., Sesso HD., Paffenbarger RS., Lee IM.Dairy product, saturated
fatty acid, and calcium Kurahashi N., Inoue M., Iwasaki M., Sasazuki S., Girls on a high-calcium
diet gain weight at the Lappe JM., Rafferty KA., Davies KM., Lypaczewski Girls on a high-calcium
diet gain weight at the Lappe JM., Rafferty KA., Davies KM., Lypaczewski Girls on a high-calcium
diet gain weight at the Lappe JM., Rafferty KA., Davies KM., Lypaczewski Vitamin D and calcium
supplementation reduces Lappe JM., Travers-Gustafson D., Davies KM., Calcium and vitamin d
supplementation Lappe J., Cullen D., Haynatzki G., Recker R., Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci Magnesium, calcium,
potassium, and sodium Larsson SC., Virtanen MJ., Mars M., Männistö S., Magnesium, calcium,
potassium, and sodium Larsson SC., Virtanen MJ., Mars M., Männistö S., Magnesium, calcium,
potassium, and sodium Larsson SC., Virtanen MJ., Mars M., Männistö S., Magnesium, calcium,
potassium, and sodium Larsson SC., Virtanen MJ., Mars M., Männistö S., Long-term dietary calcium
intake and breast cancer Larsson SC., Bergkvist L., Wolk A.A prospective study of
plasma vitamin D Li H., Stampfer MJ., Hollis JB., Mucci LA., Gaziano JM., Dietary calcium, blood
pressure and cell Dietary calcium, blood pressure and cell
1995 Lijnen P., Petrov V.20052005200520072006200620062007200720072007200720072007198619861986198619862008200520052002198719881988200619811981200320032003200320082008200820082008200620062006200620012006 Moschonis G., Manios Y.200920092009
Dietary calcium, blood pressure and cell Intakes of calcium and vitamin D and risk of
Lin J., Zhang SM., Cook NR., Manson JE., Lee IM., Intakes of calcium and
vitamin D and risk of Lin J., Zhang SM., Cook NR., Manson JE., Lee IM., Intakes of calcium and
vitamin D and risk of Lin J., Zhang SM., Cook NR., Manson JE., Lee IM., Intakes of calcium and
vitamin D and breast Lin J., Manson JE., Lee IM., Cook NR., Buring JE., Calcium supplementation
for 1 y does not reduce Lorenzen JK., Mølgaard C., Michaelsen KF., Astrup A.Calcium supplementation
for 1 y does not reduce Lorenzen JK., Mølgaard C., Michaelsen KF., Astrup A.Calcium supplementation
for 1 y does not reduce Lorenzen JK., Mølgaard C., Michaelsen KF., Astrup A.Preventing fractures
among older people living Lyons RA., Johansen A., Brophy S., Newcombe RG., Preventing fractures
among older people living Lyons RA., Johansen A., Brophy S., Newcombe RG., Preventing fractures
among older people living Lyons RA., Johansen A., Brophy S., Newcombe RG., Supplementation with
calcium + vitamin D Major GC., Alarie F., Doré J., Phouttama S., Tremblay Supplementation with
calcium + vitamin D Major GC., Alarie F., Doré J., Phouttama S., Tremblay Supplementation with
calcium + vitamin D Major GC., Alarie F., Doré J., Phouttama S., Tremblay Supplementation with
calcium + vitamin D Major GC., Alarie F., Doré J., Phouttama S., Tremblay Vitamin D
supplementation in Mallet E., Gügi B., Brunelle P., Hénocq A., Basuyau JP., Vitamin D
supplementation in Mallet E., Gügi B., Brunelle P., Hénocq A., Basuyau JP., Vitamin D
supplementation in Mallet E., Gügi B., Brunelle P., Hénocq A., Basuyau JP., Vitamin D
supplementation in Mallet E., Gügi B., Brunelle P., Hénocq A., Basuyau JP., Vitamin D
supplementation in Mallet E., Gügi B., Brunelle P., Hénocq A., Basuyau JP., Effect of calcium and
vitamin D supplementation Margolis KL., Ray RM., Van Horn L., Manson JE., Allison Dietary and serum
vitamins and minerals as Marniemi J., Alanen E., Impivaara O., Seppänen Dietary and serum
vitamins and minerals as Marniemi J., Alanen E., Impivaara O., Seppänen Calcium, vitamin D, and
risk of adenoma Martínez ME., Marshall JR., Sampliner R., Wilkinson J., Effect of calcium and
vitamin D supplementation Marya RK., Rathee S., Manrow M.Effect of vitamin D
supplementation during Marya RK., Rathee S., Dua V., Sangwan K.Effect of vitamin D
supplementation during Marya RK., Rathee S., Dua V., Sangwan K.Vitamin D2 dose required
to rapidly increase 25OHD Mastaglia SR., Mautalen CA., Parisi MS., Oliveri B.Vitamin D supplements
enhance weight gain and Maxwell JD., Ang L., Brooke OG., Brown IR.Vitamin D supplements
enhance weight gain and Maxwell JD., Ang L., Brooke OG., Brown IR.Calcium, vitamin D, dairy
products, and risk of McCullough ML., Robertson AS., Rodriguez Calcium, vitamin D, dairy
products, and risk of McCullough ML., Robertson AS., Rodriguez Calcium, vitamin D, dairy
products, and risk of McCullough ML., Robertson AS., Rodriguez Calcium, vitamin D, dairy
products, and risk of McCullough ML., Robertson AS., Rodriguez 25-hydroxyvitamin D
levels and the risk of Melamed ML., Michos ED., Post W., Astor B.25-hydroxyvitamin D
levels and the risk of Melamed ML., Michos ED., Post W., Astor B.25-hydroxyvitamin D
levels and the risk of Melamed ML., Michos ED., Post W., Astor B.25-hydroxyvitamin D
levels and the risk of Melamed ML., Michos ED., Post W., Astor B.Dietary calcium and
vitamin D intakes in Mishra G., McCormack V., Kuh D., Hardy R., Stephen Dairy products, calcium
and prostate cancer risk.Koh KA., Sesso HD., Paffenbarger RS., Lee IM.Maternal 25-
hydroxyvitamin D and Morley R., Carlin JB., Pasco JA., Wark JD.Maternal 25-
hydroxyvitamin D and Morley R., Carlin JB., Pasco JA., Wark JD.Maternal 25-
hydroxyvitamin D and Morley R., Carlin JB., Pasco JA., Wark JD.Nutrient intake and
hypertensive disorders of Morris CD., Jacobson SL., Anand R., Ewell MG., Skeletal site-dependent
response of bone mineral A double-blind, randomized, placebo-
Nagpal J., Pande JN., Bhartia A.A double-blind,
randomized, placebo-Nagpal J., Pande JN., Bhartia A.A double-blind,
randomized, placebo-Nagpal J., Pande JN., Bhartia A.
200919982007200720072007200720072007200720072009200920092009200920092009200920092009200920092009200920092009200920092009200920092009200920092009200920012001200119992000200520052003200719972004
Supplements of 20 microg/d cholecalciferol
Nelson ML., Blum JM., Hollis BW., Rosen C., Serum vitamin D
metabolite levels and the Nomura AM., Stemmermann GN., Lee J., Calcium and vitamin D
intakes in relation to risk Oh K., Willett WC., Wu K., Fuchs CS., Giovannucci EL.Diet during pregnancy and
risk of preeclampsia or Oken E., Ning Y., Rifas-Shiman SL., Rich-Edwards Diet during pregnancy and
risk of preeclampsia or Oken E., Ning Y., Rifas-Shiman SL., Rich-Edwards Plasma vitamin D and risk
of colorectal cancer: the Otani T., Iwasaki M., Sasazuki S., Inoue M., Plasma vitamin D and risk
of colorectal cancer: the Otani T., Iwasaki M., Sasazuki S., Inoue M., Plasma vitamin D and risk
of colorectal cancer: the Otani T., Iwasaki M., Sasazuki S., Inoue M., Calcium and vitamin D
intake and risk of Park SY., Murphy SP., Wilkens LR., Nomura AM., Calcium, dairy foods, and
risk of incident and fatal Park Y., Mitrou PN., Kipnis V., Hollenbeck A., Calcium, vitamin D, and
dairy product intake and Park SY., Murphy SP., Wilkens LR., Stram DO., Dairy food, calcium, and
risk of cancer in the NIH-Park Y., Leitzmann MF., Subar AF., Hollenbeck A., Dairy food, calcium, and
risk of cancer in the NIH-Park Y., Leitzmann MF., Subar AF., Hollenbeck A., Dairy food, calcium, and
risk of cancer in the NIH-Park Y., Leitzmann MF., Subar AF., Hollenbeck A., Dairy food, calcium, and
risk of cancer in the NIH-Park Y., Leitzmann MF., Subar AF., Hollenbeck A., Dairy food, calcium, and
risk of cancer in the NIH-Park Y., Leitzmann MF., Subar AF., Hollenbeck A., Dairy food, calcium, and
risk of cancer in the NIH-Park Y., Leitzmann MF., Subar AF., Hollenbeck A., Dairy food, calcium, and
risk of cancer in the NIH-Park Y., Leitzmann MF., Subar AF., Hollenbeck A., Dairy food, calcium, and
risk of cancer in the NIH-Park Y., Leitzmann MF., Subar AF., Hollenbeck A., Dairy food, calcium, and
risk of cancer in the NIH-Park Y., Leitzmann MF., Subar AF., Hollenbeck A., Dairy food, calcium, and
risk of cancer in the NIH-Park Y., Leitzmann MF., Subar AF., Hollenbeck A., Dairy food, calcium, and
risk of cancer in the NIH-Park Y., Leitzmann MF., Subar AF., Hollenbeck A., Dairy food, calcium, and
risk of cancer in the NIH-Park Y., Leitzmann MF., Subar AF., Hollenbeck A., Dairy food, calcium, and
risk of cancer in the NIH-Park Y., Leitzmann MF., Subar AF., Hollenbeck A., Dairy food, calcium, and
risk of cancer in the NIH-Park Y., Leitzmann MF., Subar AF., Hollenbeck A., Dairy food, calcium, and
risk of cancer in the NIH-Park Y., Leitzmann MF., Subar AF., Hollenbeck A., Dairy food, calcium, and
risk of cancer in the NIH-Park Y., Leitzmann MF., Subar AF., Hollenbeck A., Dairy food, calcium, and
risk of cancer in the NIH-Park Y., Leitzmann MF., Subar AF., Hollenbeck A., Dairy food, calcium, and
risk of cancer in the NIH-Park Y., Leitzmann MF., Subar AF., Hollenbeck A., Dairy food, calcium, and
risk of cancer in the NIH-Park Y., Leitzmann MF., Subar AF., Hollenbeck A., Dairy food, calcium, and
risk of cancer in the NIH-Park Y., Leitzmann MF., Subar AF., Hollenbeck A., Dairy food, calcium, and
risk of cancer in the NIH-Park Y., Leitzmann MF., Subar AF., Hollenbeck A., Dairy food, calcium, and
risk of cancer in the NIH-Park Y., Leitzmann MF., Subar AF., Hollenbeck A., Dairy food, calcium, and
risk of cancer in the NIH-Park Y., Leitzmann MF., Subar AF., Hollenbeck A., Dairy food, calcium, and
risk of cancer in the NIH-Park Y., Leitzmann MF., Subar AF., Hollenbeck A., Dairy food, calcium, and
risk of cancer in the NIH-Park Y., Leitzmann MF., Subar AF., Hollenbeck A., Dairy food, calcium, and
risk of cancer in the NIH-Park Y., Leitzmann MF., Subar AF., Hollenbeck A., Effects of a short-term
vitamin D(3) and calcium Pfeifer M., Begerow B., Minne HW., Nachtigall D., Effects of a short-term
vitamin D(3) and calcium Pfeifer M., Begerow B., Minne HW., Nachtigall D., Effects of a short-term
vitamin D(3) and calcium Pfeifer M., Begerow B., Minne HW., Nachtigall D., Diet and risk of colorectal
cancer in a cohort of Pietinen P., Malila N., Virtanen M., Hartman TJ., Plasma 1,25-dihydroxy-
and 25-hydroxyvitamin D Platz EA., Hankinson SE., Hollis BW., Colditz GA., Effects of calcium
supplementation on body Reid IR., Horne A., Mason B., Ames R., Bava U., Effects of calcium
supplementation on body Reid IR., Horne A., Mason B., Ames R., Bava U., Calcium, dairy products,
and risk of prostate cancer Rodriguez C., McCullough ML., Mondul AM., Jacobs Meat and dairy
consumption and Rohrmann S., Platz EA., Kavanaugh CJ., Thuita L., Prospective evaluation of
dietary and other Ross RK., Yuan JM., Henderson BE., Park J., Serum parathyroid
hormone is associated Sambrook PN., Chen JS., March LM., Cameron ID.,
199919951995199520022006200620062006199319931993200820082008200920061997199719971997199720022002200220022002198720032003200320032003200320032003200320032003200320032003200320032005200620062006
Animal products, calcium and protein and prostate
Schuurman AG., van den Brandt PA., Dorant E., Effect of winter oral
vitamin D3 Scragg R., Khaw KT., Murphy S.Effect of winter oral
vitamin D3 Scragg R., Khaw KT., Murphy S.Effect of winter oral
vitamin D3 Scragg R., Khaw KT., Murphy S.Intake of dairy products,
calcium, and vitamin d and Shin MH., Holmes MD., Hankinson SE., Wu K., Dietary intake of calcium,
fiber and other Shin A., Li H., Shu XO., Yang G., Gao YT., Zheng Dietary intake of calcium,
fiber and other Shin A., Li H., Shu XO., Yang G., Gao YT., Zheng Dietary intake of calcium,
fiber and other Shin A., Li H., Shu XO., Yang G., Gao YT., Zheng Vitamin D intake and the
risk for pancreatic cancer Skinner HG., Michaud DS., Giovannucci E., Willett Calcium intake and 28-
year gastro-intestinal Slob IC., Lambregts JL., Schuit AJ., Kok FJ.Calcium intake and 28-
year gastro-intestinal Slob IC., Lambregts JL., Schuit AJ., Kok FJ.Calcium intake and 28-
year gastro-intestinal Slob IC., Lambregts JL., Schuit AJ., Kok FJ.Supplementation with
cholecalciferol does not Sneve M., Figenschau Y., Jorde R.Supplementation with
cholecalciferol does not Sneve M., Figenschau Y., Jorde R.Supplementation with
cholecalciferol does not Sneve M., Figenschau Y., Jorde R.Serum vitamin D and risk
of pancreatic cancer in the Stolzenberg-Solomon RZ., Hayes RB., Horst RL., A prospective nested case-
control study of vitamin D Stolzenberg-Solomon RZ., Vieth R., Azad A., Pietinen Serum levels of vitamin D
metabolites and the Tangrea J., Helzlsouer K., Pietinen P., Taylor P., Hollis Serum levels of vitamin D
metabolites and the Tangrea J., Helzlsouer K., Pietinen P., Taylor P., Hollis Serum levels of vitamin D
metabolites and the Tangrea J., Helzlsouer K., Pietinen P., Taylor P., Hollis Serum levels of vitamin D
metabolites and the Tangrea J., Helzlsouer K., Pietinen P., Taylor P., Hollis Serum levels of vitamin D
metabolites and the Tangrea J., Helzlsouer K., Pietinen P., Taylor P., Hollis Dietary calcium and
vitamin D intake and risk Terry P., Baron JA., Bergkvist L., Holmberg L., Dietary calcium and
vitamin D intake and risk Terry P., Baron JA., Bergkvist L., Holmberg L., Dietary calcium and
vitamin D intake and risk Terry P., Baron JA., Bergkvist L., Holmberg L., Dietary calcium and
vitamin D intake and risk Terry P., Baron JA., Bergkvist L., Holmberg L., Dietary calcium and
vitamin D intake and risk Terry P., Baron JA., Bergkvist L., Holmberg L., Dietary calcium intake and
blood pressure in Thomsen K., Nilas L., Christiansen C.Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.Dairy, calcium, and
vitamin D intakes and Tseng M., Breslow RA., Graubard BI., Ziegler RG.Dietary intake of calcium
in relation to mortality Umesawa M., Iso H., Date C., Yamamoto A., Dietary intake of calcium
in relation to mortality Umesawa M., Iso H., Date C., Yamamoto A., Dietary intake of calcium
in relation to mortality Umesawa M., Iso H., Date C., Yamamoto A.,
200620082008200819862007200620062006200620062006200620062006200620062006200620062006200819961996199619962008199719872002200220022007200720072007200719951995199519982008200820082008
Dietary intake of calcium in relation to mortality
Umesawa M., Iso H., Date C., Yamamoto A., Dietary calcium intake and
risks of stroke, its Umesawa M., Iso H., Ishihara J., Saito I., Kokubo Dietary calcium intake and
risks of stroke, its Umesawa M., Iso H., Ishihara J., Saito I., Kokubo Dietary calcium intake and
risks of stroke, its Umesawa M., Iso H., Ishihara J., Saito I., Kokubo Oral calcium and blood
pressure: a controlled van Beresteyn EC., Schaafsma G., de Waard Childhood dairy intake and
adult cancer risk: 65-y van der Pols JC., Bain C., Gunnell D., Smith GD., Low serum concentrations
of 25-hydroxyvitamin D in Visser M., Deeg DJ., Puts MT., Seidell JC., Lips P.Calcium plus vitamin D
supplementation and the Wactawski-Wende J., Kotchen JM., Anderson GL., Calcium plus vitamin D
supplementation and the Wactawski-Wende J., Kotchen JM., Anderson GL., Calcium plus vitamin D
supplementation and the Wactawski-Wende J., Kotchen JM., Anderson GL., Calcium plus vitamin D
supplementation and the Wactawski-Wende J., Kotchen JM., Anderson GL., Calcium plus vitamin D
supplementation and the Wactawski-Wende J., Kotchen JM., Anderson GL., Calcium plus vitamin D
supplementation and the Wactawski-Wende J., Kotchen JM., Anderson GL., Calcium plus vitamin D
supplementation and the Wactawski-Wende J., Kotchen JM., Anderson GL., Calcium plus vitamin D
supplementation and the Wactawski-Wende J., Kotchen JM., Anderson GL., Calcium plus vitamin D
supplementation and the Wactawski-Wende J., Kotchen JM., Anderson GL., High-dose vitamin D3
supplementation in a Wagner CL., Hulsey TC., Fanning D., Ebeling M., High-dose vitamin D3
supplementation in a Wagner CL., Hulsey TC., Fanning D., Ebeling M., High-dose vitamin D3
supplementation in a Wagner CL., Hulsey TC., Fanning D., Ebeling M., High-dose vitamin D3
supplementation in a Wagner CL., Hulsey TC., Fanning D., Ebeling M., High-dose vitamin D3
supplementation in a Wagner CL., Hulsey TC., Fanning D., Ebeling M., Vitamin D deficiency and
risk of cardiovascular Wang TJ., Pencina MJ., Booth SL., Jacques PF., Effect of longterm placebo
controlled calcium Weisgerber UM., Boeing H., Owen RW., Waldherr Effect of longterm placebo
controlled calcium Weisgerber UM., Boeing H., Owen RW., Waldherr Effect of longterm placebo
controlled calcium Weisgerber UM., Boeing H., Owen RW., Waldherr Effect of longterm placebo
controlled calcium Weisgerber UM., Boeing H., Owen RW., Waldherr Is ischemic stroke risk
related to folate status or Weng LC., Yeh WT., Bai CH., Chen HJ., Chuang SY., Efficacy of
nonpharmacologic Whelton PK., Kumanyika SK., Cook NR., Cutler JA., Alcohol, physical activity
and other risk factors for Wu AH., Paganini-Hill A., Ross RK., Henderson BE.Calcium intake and risk of
colon cancer in women Wu K., Willett WC., Fuchs CS., Colditz GA., Calcium intake and risk of
colon cancer in women Wu K., Willett WC., Fuchs CS., Colditz GA., Calcium intake and risk of
colon cancer in women Wu K., Willett WC., Fuchs CS., Colditz GA., A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis Lack of blood pressure
effect with calcium and Yamamoto ME., Applegate WB., Klag MJ., Borhani NO., Lack of blood pressure
effect with calcium and Yamamoto ME., Applegate WB., Klag MJ., Borhani NO., Lack of blood pressure
effect with calcium and Yamamoto ME., Applegate WB., Klag MJ., Borhani NO., A prospective cohort study
of intake of calcium, Zheng W., Anderson KE., Kushi LH., Sellers TA., Effects of calcium and
vitamin D supplementation Zhu K., Devine A., Dick IM., Wilson SG., Prince RL.Effects of calcium and
vitamin D supplementation Zhu K., Devine A., Dick IM., Wilson SG., Prince RL.Randomized controlled
trial of the effects of Zhu K., Bruce D., Austin N., Devine A., Ebeling PR., Randomized controlled
trial of the effects of Zhu K., Bruce D., Austin N., Devine A., Ebeling PR.,
Outcome Outcome Definition Commentsnd nd SUBVALUE() nd
ndnd nd SUBVALUE() nd SUBVALUE() nd
2 SUBVALUE() -1 SUBVALUE() -1 SUBVALUE() -
Change in kg/yr 2 SUBVALUE() nd1 SUBVALUE()
nd SUBVALUE() nd1 1 SUBVALUE() -
1 SUBVALUE() -1 SUBVALUE() nd
not extracted - - - -Secondary - -Secondary - -
- - - -nd
All cause - - - -nd SUBVALUE() nd
ndnd
- - - -- - - -- - - -- - - -nd SUBVALUE()nd SUBVALUE()2 SUBVALUE() nd SUBVALUE()
nd
ndndndndndnd
Fall SUBVALUE() ndFall SUBVALUE() nd
ndWeight [Kg] Kg Kg SUBVALUE() nd
nd
nd
- - - -
Outcome Description
Primary / Secondary Prostate cancer
[nd:Categorical]secondary SUBVALUE()
Prostate cancer SUBVALUE()Aggressive
prostate cancer Gleason sum >=7 or clinical stage III
secondary SUBVALUE()
Aggressive prostate cancer
Gleason sum >=7 or clinical stage III Prostate cancer
[nd:Categorical]Prostate cancer SUBVALUE()IHD (fatal +
nonfatal) [Implied Implied combination of
Total ischemic heart disease
Implied combination of Nonfatal MI [Self-
reporting with Self-reporting with medical record
Nonfatal MI SUBVALUE()
Self-reporting with medical record Fatal IHD
[Including sudden Including sudden death. Death
Fatal ischemic heart disease
Including sudden death. Death Body weight
[Change in Body weight SUBVALUE()
Change in kg/yr SUBVALUE()HTN, incident
[Physician Physician diagnosis (self-
HTN, incident SUBVALUE()
Physician diagnosis (self-
In a validation study of 127 25(OH)D
[Continuous]primary SUBVALUE()
25(OH)D SUBVALUE()Incident HTN
[1 :Categorical]Incident HTN SUBVALUE()
self-reported diagnosis Hypertension
[Categorical]Incident HTN SUBVALUE()
Self-reported; apparently did not Incident stroke
[Fatal or nonfatal Fatal or nonfatal stroke by report,
Incident stroke SUBVALUE()
Fatal or nonfatal stroke by report, specific stroke
types [not Prostate cancer risk
Secondary SUBVALUE()
Incident cases were sought Total serum PSA
[Secondary:CategSecondary SUBVALUE()
Prostate-specific antigen Breast cancer risk
[Risk of Risk of developing or newly
Primary SUBVALUE()
Breast cancer risk SUBVALUE()
Risk of developing or newly
Blood were withdrawn in 3 Breast cancer risk
by age <60y and Risk of developing or newly 25(OH)D level
[Changes from Changes from baseline to 6-
Primary SUBVALUE()
25(OH)D level SUBVALUE()
Changes from baseline to 6-Mortality [All
cause:Continuous]25(OH)D at 1 y [Continuous]
Primary SUBVALUE()
25(OH)D at 1 y SUBVALUE()preeclampsia
[gestational HTN gestational HTN & proteinuria and
primary SUBVALUE()
preeclampsia SUBVALUE()
gestational HTN & proteinuria and Death [Family,
hospital, and Family, hospital, and national
1 (this analysis; 2 for original RCT)
Death SUBVALUE()
Family, hospital, and national Sudden death
[Standard criteria Standard criteria adjudicated by MI [Standard
criteria Standard criteria adjudicated by Stroke [Standard
criteria Standard criteria adjudicated by CVD Composite
(MI, Stroke, composite Adjudicated Femoral neck BMD
[DEXA of the DEXA of the femur was carried out
Femoral neck BMD SUBVALUE()
DEXA of the femur was carried out
Original RCT had 4 groups: placebo, 25(OH)D
[Measured at Measured at baseline and
25(OH)D SUBVALUE()
Measured at baseline and
Original RCT had 4 groups: placebo, Weight
[Continuous]weight SUBVALUE()
Study was a RCT crossover design Colon cancer
[State Health State Health registry of
Not explicitly described but the
Colon cancer SUBVALUE()
State Health registry of Prostate cancer
[25(OH)D] Diagnosed 1980-1992, 6-18 y after
Primary (in post hoc analysis,
Prostate cancer SUBVALUE()
Diagnosed 1980-1992, 6-18 y after
Blood samples drawn only from Grip strength [Two
measurements Two measurements
Secondary SUBVALUE()
Grip strength SUBVALUE()
Two measurements Chair stands
[Conducted if the Conducted if the subject was able
Secondary SUBVALUE()
Chair stands SUBVALUE()
Conducted if the subject was able Timed walk [The
timed walk utilized The timed walk utilized a course
Secondary SUBVALUE()
Timed walk SUBVALUE()
The timed walk utilized a course Muscle strength
[Isometric Isometric quadriceps
primary SUBVALUE()
Muscle strength SUBVALUE()
Isometric quadriceps Physical
performance Endurance (The distance that
secondary SUBVALUE()
Physical performance
Endurance (The distance that 25(OH)vitD [No
assay information]No assay information
secondary SUBVALUE()
25(OH)vitD SUBVALUE()
No assay information Fall [Fall free
survival Fall free survival curve
secondary SUBVALUE()
Fall free survival curve SUBVALUE()Fall [Defined as
the patient Defined as the patient
primary SUBVALUE()
Defined as the patient fracture [Any
fracture incurred Any fracture incurred during
primary SUBVALUE()
fracture SUBVALUE()
Any fracture incurred during 2 (1 for this
article) Weight SUBVALUE()Prostate cancer
[Requested Requested permission to
Secondary SUBVALUE()
Prostate cancer SUBVALUE()
Requested permission to Incident invasive
breast cancer Confirmed by both local and central
Not clear. Most likely secondary
Incident invasive breast cancer
Confirmed by both local and central
The trial is unable to discern the bone indexes [by
dual-energy X-ray by dual-energy X-ray
primary SUBVALUE()
bone indexes SUBVALUE()
by dual-energy X-ray Weight change
[Change in weight Change in weight in kg
Primary SUBVALUE()
Weight change SUBVALUE()
Change in weight in kg SUBVALUE()
NS but substantial differences (in Curve 4- Ca
25(OH)D [Change Change in 25(OH)D after 6 Prostate cancer
diagnosis Invasive adenocarcinoma
Primary SUBVALUE()
Prostate cancer diagnosis
Invasive adenocarcinoma
To avoid exclusion of all 19 controls
Gleason gradeDeath record
nd SUBVALUE()nd SUBVALUE()1 SUBVALUE() nd- - - -nd SUBVALUE() nd
BMI [Continuous] nd SUBVALUE() BMI SUBVALUE() nd SUBVALUE() ndnd SUBVALUE() ndnd SUBVALUE() nd
nd SUBVALUE() nd SUBVALUE() ndnd SUBVALUE() nd SUBVALUE() ndnd SUBVALUE() nd SUBVALUE() nd
nd SUBVALUE() nd- - - -nd SUBVALUE() nd
Colon cancer [nd] nd nd SUBVALUE() nd SUBVALUE() ndRectal cancer [nd] nd nd SUBVALUE() nd SUBVALUE() nd
nd nd SUBVALUE() nd SUBVALUE() ndnd SUBVALUE() nd
Same as above - - - -- - - -
ndndndndndndndndndnd
nd SUBVALUE()- - - -- - - -- - - -- - - -nd SUBVALUE() ndnd SUBVALUE() ndnd SUBVALUE() -
Kg 2 SUBVALUE() Kg SUBVALUE() ndSBP/DBP - - - -
ndnd SUBVALUE() nd
sum of D2 and D3 nd- - - -
Prostate cancer stage [Gleason
Secondary SUBVALUE()
Prostate cancer stage SUBVALUE()
Gleason grade SUBVALUE()
To avoid exclusion of all 19 controls Prostate cancer
death [Death Secondary SUBVALUE()
Prostate cancer death SUBVALUE()
Death record SUBVALUE()
To avoid exclusion of all 19 controls Adenomas
recurrence [nd nd (only for patients with
Adenomas recurrence
nd (only for patients with
This publication includes two Survival [nd (only
for patients with nd (only for patients with CRC
Survival SUBVALUE()
nd (only for patients with CRC
This publication includes two HTN (Rx) [HTN
medication HTN medication prescribed
Incident HTN SUBVALUE()
HTN medication prescribed HTN (BP or Rx)
[SBP 160 or DBP SBP 160 or DBP 95 or medication Weight [To the
nearest 0.5 pound To the nearest 0.5 pound (1.1 kg),
Weight SUBVALUE()
To the nearest 0.5 pound (1.1 kg),
% change in BMC at the lumber
Primary SUBVALUE()
% change in BMC at the lumber % change in total
hip BMC Primary SUBVALUE()
% change in total hip BMC 25(OH)D
[Continuous]25(OH)D SUBVALUE()height
[Continuous]Height SUBVALUE()Weight
[Continuous]Weight SUBVALUE()weight
[Continuous]primary SUBVALUE()
weight SUBVALUE()length
[Continuous]Colorectal cancer [Reported by a
Reported by a participant on a
Colorectal cancer SUBVALUE()
Reported by a participant on a Colon cancer
SUBVALUE()Rectal cancer SUBVALUE()Proximal and
distal colon cancer Proximal and distal colon cancer Colorectal cancer
[Self reports, Self reports, statewide cancer
Colorectal cancer SUBVALUE()
Self reports, statewide cancer Colon cancer vs.
rectal cancer Proximal vs. distal colon cancer
Same as above (not data Incident HTN
[Subject reporting Subject reporting that their
1 (for this post hoc analysis)
Incident HTN SUBVALUE()
Subject reporting that their Hypertension
[Self-reported by Self-reported by the health
Primary SUBVALUE()
Hypertension SUBVALUE()
Self-reported by the health Cancer mortality
[Based on ICD-10 Based on ICD-10 codes#
Primary SUBVALUE()
Cancer mortality SUBVALUE()
Based on ICD-10 codes# Lung cancer
mortality [Based Based on ICD-10 codes#
Secondary SUBVALUE()
Lung cancer mortality
Based on ICD-10 codes# Digestive cancer
mortality [Based Based on ICD-10 codes#
Secondary SUBVALUE()
Digestive cancer mortality
Based on ICD-10 codes# Breast cancer
mortality [Based Based on ICD-10 codes#
Secondary SUBVALUE()
Breast cancer mortality
Based on ICD-10 codes# Prostate cancer
mortality [Based Based on ICD-10 codes#
Secondary SUBVALUE()
Prostate cancer mortality
Based on ICD-10 codes# Non-Hodgkin s
lymphoma/leukemBased on ICD-10 codes#
Secondary SUBVALUE()
Non-Hodgkin s lymphoma/leukem
Based on ICD-10 codes# Colorectal cancer
mortality [Based Based on ICD-10 codes#
Secondary SUBVALUE()
Colorectal cancer mortality
Based on ICD-10 codes# Other cancers
mortality [Based Based on ICD-10 codes#
Secondary SUBVALUE()
Other cancers mortality
Based on ICD-10 codes# Breast cancer risk
[Incident breast Incident breast cancer classified
Primary outcome SUBVALUE()
Breast cancer risk SUBVALUE()
Incident breast cancer classified
Used quintiles to assess sensitivity Colon cancer
[Norwegian cancer Norwegian cancer registry
Primary (only reported outcome)
Colon cancer SUBVALUE()
Norwegian cancer registry
Rectal cancer not reported in this birth length
[Continuous]primary SUBVALUE()
birth length SUBVALUE()
Data from a longitudinal cohort birth weight
[Continuous]9 mo length [Continuous]9 mo weight [Continuous]atopic eczema at 9 mo [modified UK
modified UK Working Party Prostate cancer
[Medical records Medical records and pathology
Prostate cancer SUBVALUE()
Medical records and pathology Colorectal cancer
[Medical and Medical and hospital records
Colorectal cancer SUBVALUE()
Medical and hospital records Colon cancer [ICD-
8 153.0-153.8 ICD-8 153.0-153.8 (probably registry
Colon cancer SUBVALUE()
ICD-8 153.0-153.8 (probably registry Weight
[Kg:Continuous]Weight SUBVALUE()
All adenomas [For each colonoscopy
For each colonoscopy a
Primary SUBVALUE()
All adenomas SUBVALUE()
For each colonoscopy a Advance
adenomas Advanced lesions were defined as
Advance adenomas
Advanced lesions were defined as 25(OH)D total
[sum of D2 and secondary SUBVALUE()
25(OH)D total SUBVALUE()
sum of D2 and D3 SUBVALUE()25(OH)D2
[Continuous]
- - - -nd SUBVALUE()nd SUBVALUE()
ndBP (post-partum) 2 SUBVALUE() nd SUBVALUE()
slope SUBVALUE() ndndnd
nd nd SUBVALUE() ndnd
- - - -- - - -
birth weight nd SUBVALUE() ndbirth length - - - -gestational age - - - -
nd SUBVALUE() ndBMI [Continuous] - - - -
nd SUBVALUE() ndnd
nd SUBVALUE() ndnd SUBVALUE()nd SUBVALUE()nd SUBVALUE() nd
ndnd SUBVALUE() nd
nd SUBVALUE()- - - -- - - -
ndnd
nd SUBVALUE() nd- - - -- - - -- - - -- - - -
ndndndndnd
1 SUBVALUE() nd- - - -- - - -- - - -
ndnd
2 SUBVALUE() nd- - - -
25(OH)D3 [Continuous]Recurrent adenomas
Ascertained by complete
Recurrent adenomas
Ascertained by complete
This original study (The Polyp Advanced
adenomas Subjects had maximal diameter
Advanced adenomas
Subjects had maximal diameter
This original study (The Polyp Body weight
[Change in Change in bodyweight in kg
Primary SUBVALUE()
Body weight SUBVALUE()
Change in bodyweight in kg BP (post-partum)
SUBVALUE()RCT was conducted during slope [ 25(OH)D/
vitD dose]25(OH)D/ vitD dose
primary SUBVALUE()
25(OH)D/ vitD dose SUBVALUE()Body weight
[Change in kg Change in kg over 30 months
secondary SUBVALUE()
Body weight SUBVALUE()
Change in kg over 30 months Colon cancer
[Confirmed Confirmed through hospital
Only reported outcome but two
Colon cancer SUBVALUE()
Confirmed through hospital Prostate cancer
[nd:Categorical]secondary SUBVALUE()
Prostate cancer SUBVALUE()Colorectal cancer
[Finish cancer Finish cancer registry (ICD153-
Not explicitly described
Colorectal cancer SUBVALUE()
Finish cancer registry (ICD153-Colon cancer
[Finish cancer Finish cancer registry (no clear Rectal cancer
[Finish cancer Finish cancer registry (no clear primary
SUBVALUE()birth weight SUBVALUE()
weight [Analyzed by a bipedal-
Analyzed by a bipedal-bimanual
weight SUBVALUE()
Analyzed by a bipedal-bimanual
Colorectal cancer [Record linkage to
Record linkage to cancer registries
Colorectal cancer SUBVALUE()
Record linkage to cancer registries Colorectal Cancer
[Self reports (in Self reports (in the questionnaires
Not explicitly stated but the
Colorectal Cancer SUBVALUE()
Self reports (in the questionnaires Colon caner
[Response to the Response to the biennial
Colon caner SUBVALUE()
Response to the biennial adenoma
[Complete Complete colonoscopy was
adenoma SUBVALUE()
Complete colonoscopy was
High risk of adenomas was Colorectal cancer
[Mostly diagnosed Mostly diagnosed when
Colorectal cancer SUBVALUE()
Mostly diagnosed when
High risk of adenomas was Incident breast
cancer [Self Self reported and identified through
Incident breast cancer
Self reported and identified through prostate cancer
[self-reported of self-reported of physician-
primary SUBVALUE()
prostate cancer SUBVALUE()
self-reported of physician-Prostate cancer
[Active patient Active patient notification from
Prostate cancer SUBVALUE()
Active patient notification from change in BMI
[Continuous]secondary SUBVALUE()
change in BMI SUBVALUE()
study funded the calcium enriched change in wt
[Continuous]change in ht [Continuous]incident cancer [from medical
from medical record (including
secondary SUBVALUE()
incident cancer SUBVALUE()
from medical record (including stress fractures
[Stress fractures Stress fractures were ascertained
primary SUBVALUE()
stress fractures SUBVALUE()
Stress fractures were ascertained Colorectal caner
[National Swedish National Swedish Cancer Register (-
Colorectal caner SUBVALUE()
National Swedish Cancer Register (-Colon caner
[National Swedish National Swedish Cancer Register (-Rectal caner
[National Swedish National Swedish Cancer Register (-Proximal colon
caner [National National Swedish Cancer Register (-Distal colon caner
[National Swedish National Swedish Cancer Register (-Colorectal caner
[National Swedish National Swedish Cancer Register (-
Not explicitly described
Colorectal caner SUBVALUE()
National Swedish Cancer Register (-Colon caner
[National Swedish National Swedish Cancer Register (-
Not explicitly described
Colon caner SUBVALUE()
National Swedish Cancer Register (-Rectal caner
[National Swedish National Swedish Cancer Register (-
Not explicitly described
Rectal caner SUBVALUE()
National Swedish Cancer Register (-Proximal colon
caner [National National Swedish Cancer Register (-
Not explicitly described
Proximal colon caner SUBVALUE()
National Swedish Cancer Register (-Distal colon caner
[National Swedish National Swedish Cancer Register (-
Not explicitly described
Distal colon caner SUBVALUE()
National Swedish Cancer Register (-First stroke (and
subtypes) Hospital discharge and death
First stroke (and subtypes)
Hospital discharge and death Cerebral infarction
included here Also separate analysis for much No analysis of total stroke.Invasive breast cancer [Linkage
Linkage with national and
Primary SUBVALUE()
Invasive breast cancer
Linkage with national and Prostate cancer
[Tumor Gleason Tumor Gleason score, grade,
secondary SUBVALUE()
Prostate cancer SUBVALUE()
Tumor Gleason score, grade, SBP/DBP
[Standing and Standing and supine
SBP/DBP SUBVALUE()
Standing and supine 25(OH)D
[Competitive Competitive protein binding
- - - -nd SUBVALUE() nd- - - -- - - -
nd SUBVALUE()- - - -- - - -
ndnd
nd nd SUBVALUE() ndKg 2 SUBVALUE() Kg SUBVALUE() nd
BMI [Continuous] - - - -SBP [Continuous] - - - -DBP [Continuous] - - - -
nd SUBVALUE()- - - -- - - -- - - -- - - -
nd1 SUBVALUE() AMI SUBVALUE() nd
Same - - - -nd
nd nd SUBVALUE() ndnd SUBVALUE() nd
- - - -nd SUBVALUE() ndnd SUBVALUE() nd
- - - -
- - - -- - - -- - - -
nd- - - -- - - -- - - -nd SUBVALUE() nd
ndnd SUBVALUE() nd
gestation length - - - -- - - -
ndDXA BMD SUBVALUE() DXA SUBVALUE() nd
2 SUBVALUE() SBP SUBVALUE() ndSame as SBP - - - -
- - - -
1,25(OH)D [Radioreceptor
Radioreceptor assay (Medgenix Colorectal cancer
[Follow-up Follow-up questionnaire
Colorectal cancer SUBVALUE()
Follow-up questionnaire Proximal colon
cancer [Not fully Not fully defined (data not Distal colon
cancer [Not fully Not fully defined (data not Breast cancer
[Incident cases of Incident cases of invasive breast
Primary SUBVALUE()
Breast cancer SUBVALUE()
Incident cases of invasive breast
Vit D sources estimated from body weight
[Continuous]primary SUBVALUE()
body weight SUBVALUE()
enrolled subject stratified by two height
[Continuous]25(OH)D [Continuous]First fracture [Confirmed by
Confirmed by matching every
Primary SUBVALUE()
First fracture SUBVALUE()
Confirmed by matching every Fractures
(hip/wrist/forearm/Confirmed by matching every
Secondary SUBVALUE()
Fractures (hip/wrist/forearm/
Confirmed by matching every Mortality
[nd:Categorical]Secondary SUBVALUE()
Mortality SUBVALUE()Weight
[Kg:Continuous]Weight SUBVALUE()
maternal 25(OH)D at term
primary SUBVALUE()
maternal 25(OH)D at term
unsupplemented group was not cord blood
25(OH)D at termmaternal 1,25 (OH)2D at termcord blood 1,25 (OH02D at term birth weight [Continuous]Hypertension [Self-report of
Self-report of medication
primary SUBVALUE()
Hypertension SUBVALUE()
Self-report of medication AMI [ICD 9 codes
from national ICD 9 codes from national death
ICD 9 codes from national death Stroke
[Same:CategoricalAdenoma recurrence [One
One or more adenomas or
primary SUBVALUE()
Adenoma recurrence
One or more adenomas or toxemia
[nd:Categorical]primary SUBVALUE()
toxemia SUBVALUE()newborn birth
weight primary SUBVALUE()
newborn birth weight crown-heel length
[Categorical]25(OH)D [Continuous]
primary SUBVALUE()
25(OH)D SUBVALUE()weight gain 3rd
trimesterprimary SUBVALUE()
weight gain 3rd trimester birth weight
[Continuous]Colorectal cancer [Confirmed
Confirmed incident cases of
primary SUBVALUE()
Colorectal cancer SUBVALUE()
Confirmed incident cases of
Data on total energy intake are Proximal colon
cancer [Cancer at Cancer at cecum to splenic flexureDistal colon
cancer [Cancer at Cancer at descending to Rectal cancer
[Cancer at rectum Cancer at rectum and rectosigmoid All-cause mortality
[Linked National Linked National Death Index
primary SUBVALUE()
All-cause mortality SUBVALUE()
Linked National Death Index CVD mortality
[Cause-specific Cause-specific death was coded Cancer mortality
[Including all Including all malignant Infectious disease
mortality Including deaths from infectious Mammography
density [Ratio of Ratio of the absolute area of
Mammography density
Ratio of the absolute area of prostate cancer
[Finnish Cancer Finnish Cancer Registry (medical
primary SUBVALUE()
prostate cancer SUBVALUE()
Finnish Cancer Registry (medical birth weight
[Continuous]primary SUBVALUE()
birth weight SUBVALUE()
crown-heel length [Continuous]preeclampsia [HTN (DBP 90
HTN (DBP 90 mm) and
primary SUBVALUE()
preeclampsia SUBVALUE()
HTN (DBP 90 mm) and BMD
[DXA:Continuous]primary SUBVALUE()SBP [Automated
OMRON electronic Automated OMRON electronic
Automated OMRON electronic DBP [Same as
SBP:Continuous]25(OH)D [Continuous]
nd SUBVALUE()nd
nd SUBVALUE() ndnd
gestational HTN - - - -nd SUBVALUE() ndnd SUBVALUE() ndnd SUBVALUE() ndnd SUBVALUE() nd
ndnd SUBVALUE() ndNd*** SUBVALUE() nd- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -
The same as NHL - - - -The same as NHL - - - -
- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -1 SUBVALUE() SBP SUBVALUE()
Same as SBP - - - -- - - -
nd SUBVALUE() ndKg, BMI 2 SUBVALUE() nd
BP [SBP, DBP] SBP, DBP - - - -nd SUBVALUE() nd
nd1 SUBVALUE() nd SUBVALUE() nd
Serum 25(OH)D change
Primary SUBVALUE()
Serum 25(OH)D change
The actual mean D3 content of the prostate cancer
[biopsy or surgical biopsy or surgical specimen;
primary SUBVALUE()
prostate cancer SUBVALUE()
biopsy or surgical specimen; Colorectal
adenoma Reviewed the medical records
Colorectal adenoma
Reviewed the medical records preeclampsia [BP
>140/90 & BP >140/90 & proteinuria
primary SUBVALUE()
preeclampsia SUBVALUE()
BP >140/90 & proteinuria
Colorectal cancer [Adenocarcinoma
Adenocarcinoma (Collected for the
Colorectal cancer SUBVALUE()
Adenocarcinoma (Collected for the Colon cancer [See
above (ICD180-See above (ICD180-189 only)
Colon cancer SUBVALUE()
See above (ICD180-189 only) Rectal cancer [See
above (ICD199 See above (ICD199 and 209
Rectal cancer SUBVALUE()
See above (ICD199 and 209 Colorectal cancer
[Identified by Identified by means of linkage
Colorectal cancer SUBVALUE()
Identified by means of linkage incident prostate
cancer [8 state 8 state cancer registry
primary SUBVALUE()
incident prostate cancer
8 state cancer registry Prostate cancer
[Identified by Identified by linkage of cohort
Prostate cancer SUBVALUE()
Identified by linkage of cohort All cancers
[Identified Identified thorough a cancer
All cancers SUBVALUE()
Identified thorough a cancer Head and neck
cancer [The same The same as all cancerEsophageal
cancer [The same The same as all cancerStomach cancer
[The same as all The same as all cancerColorectal cancer
[The same as all The same as all cancerLiver cancer [The
same as all The same as all cancerPancreatic cancer
[The same as all The same as all cancerLung cancer [The
same as all The same as all cancerBreast cancer
[The same as all The same as all cancerOvarian cancer
[The same as all The same as all cancerEndometrial
cancer [The same The same as all cancerBladder cancer
[The same as all The same as all cancerKidney cancer
[The same as all The same as all cancerThyroid cancer
[The same as all The same as all cancerBrain cancer [The
same as all The same as all cancerNon-Hodgkin
lymphoma (NHL) Identified through Surveillance Leukemia [The
same as NHL]Myeloma [The same as NHL]Digestive system [A combined
A combined category. See the Respiratory
system A combined category. See the Reproductive
system [A A combined category. See the Women [A
combined A combined category. See the Urinary system
[A combined A combined category. See the Brain and other
nervous system A combined category. See the Endocrine system
[A combined A combined category. See the Others [A
combined A combined category SBP [Measured
after at least 5 Measured after at least 5 min of
Measured after at least 5 min of
32 (47%) of the subjects in the Ca DBP [Same as
SBP:Continuous]25(OH)D [Continuous]Colon cancer or rectal cancer
Incident cases of colon or rectal
Secondary outcome
Colon cancer or rectal cancer
Incident cases of colon or rectal
In cases of multiple colorectal Distal colorectal
adenoma Adenomatous polyps by review
(distal) colorectal polyps
Adenomatous polyps by review Weight [Kg,
BMI:Continuous]Weight SUBVALUE()
Kg, BMI SUBVALUE()
Prostate cancer [Incident cases
Incident cases identified through
Prostate cancer SUBVALUE()
Incident cases identified through incident prostate
cancer [Cancer Cancer Registry; death certificates;
primary SUBVALUE()
incident prostate cancer
Cancer Registry; death certificates; Fatal stroke
[Categorical]Fatal stroke SUBVALUE()Total mortality
[Mortality and Mortality and cause of death
Secondary (assumed because
Total mortality SUBVALUE()
Mortality and cause of death
This paper described first 865
nd SUBVALUE() nd1 SUBVALUE() SBP SUBVALUE()1 SUBVALUE() DBP SUBVALUE()2 SUBVALUE()nd SUBVALUE() nd
Colon cancer - - - -Rectal cancer - - - -
nd SUBVALUE()nd SUBVALUE() ndnd SUBVALUE() ndnd SUBVALUE() nd1 SUBVALUE() nd SUBVALUE() nd
BMI [Continuous] - - - -- - - -nd SUBVALUE()
nd SUBVALUE() nd- - - -- - - -- - - -- - - -
- - - -- - - -- - - -- - - -
Change in kg/yr nd SUBVALUE() ndnd
same as above - - - -same as above - - - -same as above - - - -same as above - - - -same as above - - - -same as above - - - -same as above - - - -
- - - -same as above - - - -same as above - - - -same as above - - - -same as above - - - -same as above - - - -same as above - - - -same as above - - - -
nd SUBVALUE() nd1 SUBVALUE() nd
not extracted - - - -- - - -
Prostate cancer [Computerized
Computerized record linkage
Prostate cancer SUBVALUE()
Computerized record linkage SBP [BP was
measured twice BP was measured twice pre and post
BP was measured twice pre and post
Complete trial performed during DBP [BP was
measured twice BP was measured twice pre and post
BP was measured twice pre and post
Complete trial performed during 25(OH)D [As
measured by As measured by competitive
25(OH)D SUBVALUE()
As measured by competitive
Complete trial performed during Breast cancer
[Medical records Medical records were obtained for
Breast cancer SUBVALUE()
Medical records were obtained for Colorectal cancer
[Cohort members Cohort members have been
primary SUBVALUE()
Colorectal cancer SUBVALUE()
Cohort members have been
Subjects were followed until
Pancreatic cancer [Self-reported
Self-reported diagnosis in the 2-
Pancreatic cancer SUBVALUE()
Self-reported diagnosis in the 2-
This article gave a pooled analysis of Gastrointestinal
cancer mortality The residence at death and the
Gastrointestinal cancer mortality
The residence at death and the Cancer mortality
[The residence at The residence at death and the
Cancer mortality SUBVALUE()
The residence at death and the All-cause mortality
[The residence at The residence at death and the
All-cause mortality SUBVALUE()
The residence at death and the weight
[Continuous]weight SUBVALUE()
Serum 25(OH)D [Continuous]Pancreatic cancer [Vital status of
Vital status of cohort
Pancreatic cancer SUBVALUE()
Vital status of cohort
2.5% had family history of Pancreatic cancer
[odds ratios (OR) odds ratios (OR) for pancreatic
Cancer SUBVALUE()
Pancreatic cancer SUBVALUE()
odds ratios (OR) for pancreatic
Data also available Colorectal cancer
[Diagnosis of Diagnosis of primary
Colorectal cancer SUBVALUE()
Diagnosis of primary Colon cancer
[Diagnosis of Diagnosis of primary Colon cancer
(excluding the 2 y Rectal cancer [Diagnosis of
Diagnosis of primary Rectal cancer
(excluding the 2 y Colorectal cancer [Matching two
Matching two independent
primary SUBVALUE()
Colorectal cancer SUBVALUE()
Matching two independent
Average duration of follow up: 11.3 Colon cancer
[Cancer occurring Cancer occurring above the Rectal cancer
[Cancer occurring Cancer occurring below the Proximal colon
cancer [Cancer Cancer occurring from the cecum Distal colon
cancer [Cancer Cancer occurring from the Bodyweight
[Change in Bodyweight SUBVALUE()
Change in kg/yr SUBVALUE()All cause mortality
[Death certificate Death certificate (based on ICD-9*)
Secondary SUBVALUE()
All cause mortality SUBVALUE()
Death certificate (based on ICD-9*) Cardiovascular
disease mortality Ischemic heart disease mortality Cerebrovascular disease mortality All cancers mortality [same as Colorectal caner mortality [same as Respiratory cancer mortality Breast cancer mortality (female) Cardiovascular disease incidence
Death certificate (ICD-9*) and self-Ischemic heart
disease incidence Cerebrovascular disease incidence All cancers incidence [same Colorectal cancer incidence [same Respiratory cancer incidence Breast cancer incidence (female) Falls incidence [same as Prostate cancer [Confirmation
Confirmation through
Prostate cancer SUBVALUE()
Confirmation through Total stroke
mortality [Death Death certificates (ICD-9 & 10)
Total stroke mortality
Death certificates (ICD-9 & 10) specific stroke
data [not Coronary heart disease mortality
Death certificates (ICD-9 & 10)
- - - -1 SUBVALUE() nd1 SUBVALUE() nd2 SUBVALUE() nd
Body weight in kg ndnd SUBVALUE() nd
ndnd
nd SUBVALUE() ndnd SUBVALUE() nd
nd nd SUBVALUE() nd SUBVALUE() ndnd SUBVALUE() ndnd SUBVALUE() ndnd SUBVALUE() ndnd SUBVALUE() ndnd SUBVALUE() nd
nd SUBVALUE()nd SUBVALUE() nd SUBVALUE()nd SUBVALUE() nd SUBVALUE()nd SUBVALUE()nd SUBVALUE() nd SUBVALUE()
ndPI SUBVALUE() nd
- - - -- - - -
ndnd SUBVALUE() nd1 SUBVALUE() nd SUBVALUE() ndnd SUBVALUE()
- - - -- - - -nd SUBVALUE() ndnd SUBVALUE() nd SUBVALUE() ndnd SUBVALUE() nd SUBVALUE() ndnd SUBVALUE() nd SUBVALUE() ndnd SUBVALUE() nd SUBVALUE() nd
in DBP 1 SUBVALUE() nd SUBVALUE()- - - -
BMI [Continuous] - - - -
ndBMD SUBVALUE() ndBMD SUBVALUE() nd
- - - -
Total CVD mortality [Death
Death certificates (ICD-9 & 10), Stroke incidence
(also stroke Participant reporting and
Stroke incidence (also stroke
Participant reporting and Fatal stroke
[Death certificates Death certificates & medical records
Fatal stroke SUBVALUE()
Death certificates & medical records Coronary heart
disease [MI, MI, sudden cardiac death, per
Coronary heart disease
MI, sudden cardiac death, per Body weight [Body
weight in Secondary SUBVALUE()
Body weight SUBVALUE()
Body weight in kg SUBVALUE()Colorectal cancer
[Derived from the Derived from the presence of a
Colorectal cancer SUBVALUE()
Derived from the presence of a mortality [by
death by death certificate
primary SUBVALUE()
mortality SUBVALUE()
by death certificate (Invasive)
colorectal cancer Verified in a blinded fashion
Secondary (primary: hip
(Invasive) colorectal cancer
Verified in a blinded fashion (Invasive) colon
cancer [Excluded Excluded in situ and primary
(Invasive) colon cancer
Excluded in situ and primary (invasive) rectal
cancer [Excluded Excluded in situ and primary
(invasive) rectal cancer
Excluded in situ and primary All cause mortality
[nd:Categorical]All cause mortality SUBVALUE()Death from
colorectal cancer Death from colorectal cancer
Death from colorectal cancer
Death from colorectal cancer Intestinal polyps
[Intestinal polyps Intestinal polyps based on
Intestinal polyps SUBVALUE()
Intestinal polyps based on Kidney stone
[Kidney stone Kidney stone based on
Kidney stone SUBVALUE()
Kidney stone based on Total cancer
incidence Intestinal polyps based on
Total cancer incidence
Intestinal polyps based on Cancer related
mortality [Kidney Kidney stone based on
Cancer related mortality
Kidney stone based on 25(OH)D level in
momprimary SUBVALUE()
25(OH)D level in mom SUBVALUE()
subjects compensated with vit D3 level in
mom [Continuous]vit D3 level in mom SUBVALUE()
subjects compensated with 25(OH)D level in
infant25(OH)D level in infant SUBVALUE()
subjects compensated with anti-rachitic
activity in milk [vit vit D3 and 25 (OH)D in milk
anti-rachitic activity in milk
vit D3 and 25 (OH)D in milk
subjects compensated with infant weight and
lengthinfant weight and length
subjects compensated with First
cardiovascular MI, coronary insufficiency,
Primary SUBVALUE()
First cardiovascular
MI, coronary insufficiency, PI [Change in PI%
of all examined Change in PI% of all examined
Unlcear SUBVALUE()
Change in PI% of all examined PI [Change in
curve of PI% Change in curve of PI% (function of PI [Change in PI%
of each of 5 Change in PI% of each of 5 Calcium balance
[Total fecal Total fecal calcium and urinary
Unlcear SUBVALUE()
Calcium balance SUBVALUE()
Total fecal calcium and urinary stroke [Self-
reported and Self-reported and cross-checked by
stroke SUBVALUE()
Self-reported and cross-checked by Change in
SBP/DBPChange in SBP/DBP Colorectal cancer
[Pathological Pathological diagnosis of
Colorectal cancer SUBVALUE()
Pathological diagnosis of
No main result for calcium and CRC. Primary
adenocarcinoma Reported as diagnosis of colon
primary SUBVALUE()
Primary adenocarcinoma
Reported as diagnosis of colon
86 cases with colorectal cancer Proximal (right
sided) colon Colon cancer located in cecum, Distal (left sided)
colon cancer Colon cancer located in Colorectal cancer
[The vast majority The vast majority of colorectal
Colorectal cancer SUBVALUE()
The vast majority of colorectal Colon cancer
[Categorical]Colon cancer SUBVALUE()Proximal colon
cancer Proximal colon cancer Distal colon
cancer Distal colon cancer Rectal cancer
[Categorical]Rectal cancer SUBVALUE()in DBP SUBVALUE()
Eligibility blood pressures in SBP
[Continuous]
Rectal cancer [State Health
State Health Registry of Iowa,
secondary SUBVALUE()
Rectal cancer SUBVALUE()
State Health Registry of Iowa,
Primary outcome: mortality; cancer 25(OH)D
[Measured by Measured by competitive
Secondary SUBVALUE()
25(OH)D SUBVALUE()
Measured by competitive BMD [Measured at
the hip with an Measured at the hip with an
Primary SUBVALUE()
Measured at the hip with an BMD [Hip and
total body. Hip and total body. DXA
primary SUBVALUE()
Hip and total body. DXA 25(OH)D
[Continuous]
nd nd nd Yes BMInd nd nd Yes BMI
nd nd Yes Yes BMIYes Energy intake Yes Age Yes BMIYes Energy intake Yes Age Yes BMIYes Energy intake Yes Age Yes BMInd nd No nd No ndYes Yes Age, Sex Yes BMInd nd Yes* age Yes/no* nd- - Yes Age Yes BMInd nd Yes Age Yes BMIYes Yes Age Yes BMIYes Yes Age Yes BMILog-calories - Yes - no -Log-calories - Yes - no -
nd nd Yes BMI at age 18 ndnd nd Yes BMI at age 18 nd
nd nd no* nd no* ndnd nd no* nd no* ndnd nd Yes* age, sex Yes* BMInd nd Yes* race, education Yes* prepregnancy BMINo nd Yes But all 55 yo No ndNo nd Yes But all 55 yo No ndNo nd Yes But all 55 yo No ndNo nd Yes But all 55 yo No ndNo nd Yes But all 55 yo No nd
nd Yes* nd Yes* ndnd Yes* nd Yes* nd
No nd no* nd no* ndnd Yes (age, parity) nd Yes (height) nd
None nd Yes No ndYes Yes* Yes* Weight <127 lb**Yes Yes* Yes* Weight <127 lb**Yes Yes* Yes* Weight <127 lb**nd nd no* nd no* ndnd nd no* nd no* ndnd nd no* nd no* ndnd nd no* nd no* ndnd no* nd no* ndnd no* nd no* ndYes Yes Yesnd nd Yes* - Age nd Yes* - BMI nd
nd Yes nd Yes ndnd nd Yes* age Yes* BMI; Tanner stagend nd Yes age Yesnd nd Yes age YesNo nd Yes No nd
Confounder Groups
Confounder Groups
Confounder Groups
Confounder Groups
Confounder Groups
Confounder Groups Total calcium
intakeTotal calcium intake Age (matched),
residence
Na consumption, total energy
Total energy intakeTotal energy intake
Yes; plasma alpha-carotene
Yes (matched by age, menopausal Yes; plasma
alpha-carotene Yes (matched by age, menopausal
total energy intake, calcium total energy intake, calcium
Yes (total energy intake, total Vit E Age (matched &
subgroup Total Ca intake <600mg**
Age (continuous), age 70 years or Total Ca intake
<600mg**Age (continuous), age 70 years or Total Ca intake
<600mg**Age (continuous), age 70 years or
No statistical analysis of No statistical analysis of Total Ca intake Total
Age, race, education
BMI, waist circumference
Both arms liberally used Ca D
Baseline body weightBaseline body weightRace (matched),
age (matched)
No nd Yes No ndNo nd Yes No ndNo nd No nd No ndNo nd No nd No ndYes Calories Yes Age, Sex, Race Yes BMIYes Calories Yes Age, Sex, Race Yes BMI
nd No nd Yes* - BMI ndnd No nd Yes* - BMI nd
nd no* nd no* ndnd no* nd no* ndnd no* nd no* ndnd no* nd no* ndnd no* nd no* ndnd nd no* nd no* ndnd nd no* nd no* nd
nd Yes - BMI ndnd Yes - BMI ndnd Yes - BMI ndnd Yes - BMI nd
nd nd ndnd nd ndnd nd nd
nd nd Yes YesYes Yes* Age**, race** Yes* BMI
nd ndnd ndnd ndnd ndnd ndnd ndnd ndnd nd
nd nd nd Yes - BMI ndEnergy nd Yes (BMI, height) ndnd nd Yes* age no* ndnd nd Yes* age no* ndnd nd Yes* age no* ndnd nd Yes* age no* ndnd nd Yes* age no* ndnd nd Yes Age (match) No nd
nd Yes* - age nd Yes* - BMI nd- Yes - No -nd nd No nd ndnd nd No nd ndnd Yes* - Age, gender nd no* ndnd Yes* - Age, gender nd no* ndnd nd Yes* age Yes* BMInd nd Yes* age Yes* BMI
Race (matched), age (matched)Race (matched), age (matched)
Yes energy intakeYes energy intake Dietary calcium
intake was Dietary calcium intake was Dietary calcium intake was Dietary calcium intake was Dietary calcium intake was
Intakes of calcium, folate, methionine,
Matching factors: year of birth,
Yes matched on ageIntakes of calcium,
folate, methionine, Matching factors: year of birth,
Yes matched on ageIntakes of calcium,
folate, methionine, Matching factors: year of birth,
Yes matched on ageIntakes of calcium,
folate, methionine, Matching factors: year of birth,
Yes matched on agefolate, vitamin D,
fiber, meat, fat, Age, education (through high
body mass index (kg/m2), heightfolate, vitamin D,
fiber, meat, fat, Age, education (through high
body mass index (kg/m2), heightfolate, vitamin D,
fiber, meat, fat, Age, education (through high
body mass index (kg/m2), heightAge and race were
included in all BMI was included in all modelsCa, phosphorus,
uric acidYes (calcium intake and serum
Final model includes: sex,
Yes (sex, race/ethnicity, and
Yes (BMI and total body fat)Yes (calcium
intake and serum Final model includes: sex,
Yes (sex, race/ethnicity, and
Yes (BMI and total body fat)Yes (calcium
intake and serum Final model includes: sex,
Yes (sex, race/ethnicity, and
Yes (BMI and total body fat)Yes (calcium
intake and serum Final model includes: sex,
Yes (sex, race/ethnicity, and
Yes (BMI and total body fat)Yes (calcium
intake and serum Final model includes: sex,
Yes (sex, race/ethnicity, and
Yes (BMI and total body fat)Yes (calcium
intake and serum Final model includes: sex,
Yes (sex, race/ethnicity, and
Yes (BMI and total body fat)Yes (calcium
intake and serum Final model includes: sex,
Yes (sex, race/ethnicity, and
Yes (BMI and total body fat)Yes (calcium
intake and serum Final model includes: sex,
Yes (sex, race/ethnicity, and
Yes (BMI and total body fat)Yes, age at first
birth, raceYes (age [20-44/45-49/55-],
Men and women were separately
Yes (Dietary intake) Matching factors:
race, sex, age, No (NA for weight analysis)No (NA for weight analysis)For analysis of
subjects who did For analysis of subjects who did
nd nd Yes* age Yes* BMIEnergy intake nd nd Yes/no* ndEnergy intake nd nd Yes/no* ndnd nd No nd No ndnd nd No nd No ndnd nd Yes* age, sex Yes*nd nd No nd No ndNo nd Yes (age) nd no* ndnd nd Yes age Yes BMI
Yes (Age, sex) nd Yes (BMI) ndYes (Age, sex) nd Yes (BMI) ndYes (Age, sex) nd Yes (BMI) nd
nd nd no* nd no* ndnd nd no* nd no* ndnd nd no* nd no* ndYes Yes YesYes Yes Yes
nd nd No ndnd nd No ndnd Yes (age) nd Yes (BMI) ndnd Yes - education nd Yes - BMI ndnd Yes - education nd Yes - BMI ndnd nd Yes (BMI) nd
Yes Yes age Yes BMInd Yes age No nd
Yes No nd Yes wt; htYes No nd Yes wt; htYes No nd Yes wt; htnd nd no* nd no* ndnd nd Yes No nd
nd nd Yes (BMI) ndnd nd Yes (BMI) ndnd nd Yes (BMI) ndnd nd Yes (BMI) ndnd nd Yes (BMI) ndnd nd Yes (BMI) ndnd nd Yes (BMI) ndnd nd Yes (BMI) ndnd nd Yes (BMI) ndnd nd Yes (BMI) nd
Yes Yes Age Yes BMIYes Yes Age Yes BMIYes Yes Age Yes BMIYes Yes Age Yes BMI
nd Yes Age, education Yes BMI, heightnd nd Yes No ndnd nd No nd No ndnd nd No nd No nd
Yes/no* - age, genderYes/no* - age, gender
body weight, % body fat
Yes (Dietary energy intake)
Folic acid, fiber taken into account Yes (Dietary
energy intake)Folic acid, fiber taken into account Yes (Dietary
energy intake)Folic acid, fiber taken into account
All three groups on 7 MJ/day diet
All three groups matched on age
Groups matched on BMI and % All three groups
on 7 MJ/day dietAll three groups matched on age
Groups matched on BMI and % Yes (any vitamin
suppl. use, Yes (age, gender, level of education)Yes (total energy
intake)Yes (age, education)Yes (red meat,
saturated fat, Energy and alcohol intakeEnergy and alcohol intakeSupplement use, saturated fatty
Yes (education level, marital red meat intake,
vegetable intakeIntake of green tea and genistein baseline wt,
energy and baseline wt, energy and baseline wt, energy and
Age group (<25 vs. >=25 yr)Yes (multivitamin,
total energy, Yes (age, education)Yes (multivitamin,
total energy, Yes (age, education)Yes (multivitamin,
total energy, Yes (age, education)Yes (multivitamin,
total energy, Yes (age, education)Yes (multivitamin,
total energy, Yes (age, education)Yes (multivitamin,
total energy, Yes (age, education)Yes (multivitamin,
total energy, Yes (age, education)Yes (multivitamin,
total energy, Yes (age, education)Yes (multivitamin,
total energy, Yes (age, education)Yes (multivitamin,
total energy, Yes (age, education)Total energy
intakeTotal energy intakeTotal energy intakeTotal energy intakeTotal energy
intake, fiber Age (matched), race
nd nd No nd No ndnd Yes (age) nd Yes (BMI) ndnd Yes (age) nd Yes (BMI) ndnd Yes (age) nd Yes (BMI) nd
Yes Yes Yes BMIYes calcium intake Yes age YesYes calcium intake Yes age YesYes calcium intake Yes age Yesnd nd Yes -age, gender nd No ndnd nd Yes -age, gender nd No ndnd nd Yes -age, gender nd No ndNo nd No nd No ndNo nd No nd No ndNo nd No nd No ndNo nd No nd No ndnd nd Yes* age, race no* ndnd nd Yes* age, race no* ndnd nd Yes* age, race no* ndnd nd Yes* age, race no* ndnd nd Yes* age, race no* ndnd Yes* Yes* BMIYes (Ca analyses) Yes Age, sex No ndYes (Ca analyses) Yes Age, sex No nd
nd Yes (age; gender) nd No ndnd nd No nd No ndnd nd No nd Yesnd nd No nd Yesnd nd Yes age No ndnd nd No nd No ndnd nd No nd No nd
nd nd Yes (BMI) ndnd nd Yes (BMI) ndnd nd Yes (BMI) ndnd nd Yes (BMI) ndnd Yes Yes BMInd Yes Yes BMInd Yes Yes BMInd Yes Yes BMI
Yes Yes Yes at the age of 53 yYes Yes age, education Yes BMI; Htnd nd Yes infant sex Yes maternal heightnd nd Yes infant sex Yes maternal heightnd nd Yes infant sex Yes maternal heightnd nd Yes race Yes BMInd nd No nd No ndnd nd nd ndnd nd nd ndnd nd nd nd
Yes (multivitamin, saturated fat, red Yes (multivitamin, saturated fat, red Yes (multivitamin, saturated fat, red multivitamin use
and total energy age at menopause and weight, height,
body fatweight, height, body fatweight, height, body fat
Ca intake, VitD intake, sodium
Age, race, education,Weight adjusted
intake of total Weight adjusted intake of total Dietary fiber; total
vitamin D; energy
weight gain in 3rd trimesterweight gain in 3rd trimester
Yes (total energy, %saturated fat
Yes (age; gender; education)Yes (total energy,
%saturated fat Yes (age; gender; education)Yes (total energy,
%saturated fat Yes (age; gender; education)Yes (total energy,
%saturated fat Yes (age; gender; education)Use of vitamin D
supplementationAge, sex, race, low SES statusUse of vitamin D
supplementationAge, sex, race, low SES statusUse of vitamin D
supplementationAge, sex, race, low SES statusUse of vitamin D
supplementationAge, sex, race, low SES statusTotal energy
intakeage at the time of mammogram; age total energy
intake
Yes groups matched on age,
Yes groups matched on BMI, Yes groups
matched on age, Yes groups matched on BMI, Yes groups
matched on age, Yes groups matched on BMI,
Yes Yes* Age Yes*No nd nd No nd
nd Yes - age nd Yes - BMI ndnd nd Yes Yes prepregnancy BMInd nd Yes Yes prepregnancy BMI
Yes - age, gender nd Yes - BMI ndYes - age, gender nd Yes - BMI ndYes - age, gender nd Yes - BMI nd
nd nd Yes - BMI, ndYes Yes Yes BMIEnergy intake nd Yes Yes BMI
nd nd ndnd nd ndnd nd ndnd nd ndnd nd ndnd nd ndnd nd ndnd nd ndnd nd ndnd nd ndnd nd ndnd nd ndnd nd ndnd nd ndnd nd ndnd nd ndnd nd ndnd nd ndnd nd ndnd nd ndnd nd ndnd nd ndnd nd ndnd nd ndnd nd ndnd nd nd
nd nd No nd No ndnd nd No nd No ndnd nd No nd No nd
nd nd Yes [BMI (tertiles)] ndnd Yes - BMI nd
nd nd No nd No ndnd nd No nd No nd
nd Yes No ndnd Yes age Yes BMI at age 21nd nd Yes Age matched Yes BMINo nd Yes age; gender nd No nd
VitD intake, Ca intake
BMI, total body fat %, height, weightYes (age, month &
year of exam, Energy intake, energy-adjusted age; race;
educationage; race; educationEnergy intake,
vitamin Matching factors: sex, age, date of Energy intake,
vitamin Matching factors: sex, age, date of Energy intake,
vitamin Matching factors: sex, age, date of Total energy
intake, dietary Yes - ethnicity, agetomato, red meat,
fish , vit E, -age; race; educationEthnicity, educationYes (intake of
fruits and Yes (race/ethnicity,
Yes (body mass indexYes (intake of
fruits and Yes (race/ethnicity,
Yes (body mass indexYes (intake of
fruits and Yes (race/ethnicity,
Yes (body mass indexYes (intake of
fruits and Yes (race/ethnicity,
Yes (body mass indexYes (intake of
fruits and Yes (race/ethnicity,
Yes (body mass indexYes (intake of
fruits and Yes (race/ethnicity,
Yes (body mass indexYes (intake of
fruits and Yes (race/ethnicity,
Yes (body mass indexYes (intake of
fruits and Yes (race/ethnicity,
Yes (body mass indexYes (intake of
fruits and Yes (race/ethnicity,
Yes (body mass indexYes (intake of
fruits and Yes (race/ethnicity,
Yes (body mass indexYes (intake of
fruits and Yes (race/ethnicity,
Yes (body mass indexYes (intake of
fruits and Yes (race/ethnicity,
Yes (body mass indexYes (intake of
fruits and Yes (race/ethnicity,
Yes (body mass indexYes (intake of
fruits and Yes (race/ethnicity,
Yes (body mass indexYes (intake of
fruits and Yes (race/ethnicity,
Yes (body mass indexYes (intake of
fruits and Yes (race/ethnicity,
Yes (body mass indexYes (intake of
fruits and Yes (race/ethnicity,
Yes (body mass indexYes (intake of
fruits and Yes (race/ethnicity,
Yes (body mass indexYes (intake of
fruits and Yes (race/ethnicity,
Yes (body mass indexYes (intake of
fruits and Yes (race/ethnicity,
Yes (body mass indexYes (intake of
fruits and Yes (race/ethnicity,
Yes (body mass indexYes (intake of
fruits and Yes (race/ethnicity,
Yes (body mass indexYes (intake of
fruits and Yes (race/ethnicity,
Yes (body mass indexYes (intake of
fruits and Yes (race/ethnicity,
Yes (body mass indexYes (intake of
fruits and Yes (race/ethnicity,
Yes (body mass indexYes (intake of
fruits and Yes (race/ethnicity,
Yes (body mass index
Yes (supplement group; calcium
Yes [age (for 5-year categories); Yes: Intake of red
meat and Matching factors: endoscopy during
Yes matched on age
Total energy intake, total fat
Age at entry, education, raceenergy intake;
tomato; saturated
Yes Yes Age-adjusted No ndnd nd No Nond nd No Nond nd No No
nd ndnd nd No ndnd nd No ndnd nd No nd
Yes age Yes BMI, heightnd Yes - age nd No ndnd Yes - age nd No ndnd Yes - age nd No ndnd nd ndnd nd ndnd nd nd
nd nd Yes* nd Yes* BMIYes serum retinol Yes No nd
nd nd Yes (BMI) ndnd nd Yes (BMI) ndnd nd Yes (BMI) ndnd nd Yes (BMI) ndnd nd Yes (BMI) ndnd nd ndnd nd ndnd nd ndnd nd ndnd nd nd
nd nd No nd No ndNo nd nd No ndNo nd nd No ndNo nd nd No ndNo nd nd No ndNo nd nd No ndNo nd nd No ndNo nd nd No ndNo nd nd No ndNo nd nd No ndNo nd nd No ndNo nd nd No ndNo nd nd No ndNo nd nd No ndNo nd nd No ndNo nd nd No ndNo nd nd No nd
nd Yes No ndYes Yes Age Yes BMIYes Yes Age Yes BMIYes Yes Age Yes BMI
Intake of Ca adjusted for NS diff. in age
between groupsNS diff. In BMI and body weight NS diff. in age
between groupsNS diff. In BMI and body weight NS diff. in age
between groupsNS diff. In BMI and body weight Total energy
intake, total fat For the analysis of postmenopausal
Yes - age, BMI at age 18
Yes - height, weight change Yes (vitamin
supplement use Yes (age at recruitment, Yes (vitamin
supplement use Yes (age at recruitment, Yes (vitamin
supplement use Yes (age at recruitment, Use of
multivitamin Two statistical models: with and Energy intake,
dietary fiberEnergy intake, dietary fiberEnergy intake, dietary fiberYes 3 groups matched on vit D
Yes 3 groups matched on age,
Yes 3 groups matched on BMI, Yes 3 groups
matched on vit D Yes 3 groups matched on age,
Yes 3 groups matched on BMI, Yes 3 groups
matched on vit D Yes 3 groups matched on age,
Yes 3 groups matched on BMI,
education, occupational Yes (fat, fiber,
protein, calcium, Yes (matched on age, education)Yes (fat, fiber,
protein, calcium, Yes (matched on age, education)Yes (fat, fiber,
protein, calcium, Yes (matched on age, education)Yes (fat, fiber,
protein, calcium, Yes (matched on age, education)Yes (fat, fiber,
protein, calcium, Yes (matched on age, education)Yes (red meat,
energy adjusted Yes (age: in 5 year age groups;
Yes (BMI in quartiles)Yes (red meat,
energy adjusted Yes (age: in 5 year age groups;
Yes (BMI in quartiles)Yes (red meat,
energy adjusted Yes (age: in 5 year age groups;
Yes (BMI in quartiles)Yes (red meat,
energy adjusted Yes (age: in 5 year age groups;
Yes (BMI in quartiles)Yes (red meat,
energy adjusted Yes (age: in 5 year age groups;
Yes (BMI in quartiles)
Yes (Age, gender [subgroup])Yes (Age, gender [subgroup])Yes (Age, gender [subgroup])Yes (Age, gender [subgroup])Yes (Age, gender [subgroup])Yes (Age, gender [subgroup])Yes (Age, gender [subgroup])Yes (Age, gender [subgroup])Yes (Age, gender [subgroup])Yes (Age, gender [subgroup])Yes (Age, gender [subgroup])Yes (Age, gender [subgroup])Yes (Age, gender [subgroup])Yes (Age, gender [subgroup])Yes (Age, gender [subgroup])Yes (Age, gender [subgroup])Energy intake,
recreational and Age, race, educationK intake, total
energy intakeK intake, total energy intakeK intake, total energy intake
Yes Yes Age Yes BMIYes Yes Age, sex Yes BMIYes Yes Age, sex Yes BMIYes Yes Age, sex Yes BMInd nd No nd No nd
nd Yes* - age, gender nd Yes/no* ndnd nd nd Yes/no* ndnd Yes (age) nd Yes ndnd Yes (age) nd Yes ndnd Yes (age) nd Yes ndnd Yes (age) nd Yes ndnd Yes (age) nd Yes ndnd Yes (age) nd Yes ndnd Yes (age) nd Yes ndnd Yes (age) nd Yes ndnd Yes (age) nd Yes ndnd nd Yes* age, race Yes*nd nd Yes* age, race Yes*nd nd Yes* age, race Yes*nd nd Yes* age, race Yes*nd nd Yes* age, race Yes*Yes Yes Yes BMInd nd Yes/no* nd Yes/no* ndnd nd Yes/no* nd Yes/no* ndnd nd Yes/no* nd Yes/no* ndnd nd Yes/no* nd Yes/no* ndnd nd Yes No ndnd nd No nd No ndnd nd Yes* nd no* nd
nd Yes (Age) nd Yes (BMI) ndnd Yes (Age) nd Yes (BMI) ndnd Yes (Age) nd Yes (BMI) ndnd Yes - age nd Yes - BMI ndnd Yes - age nd Yes - BMI ndnd Yes - age nd Yes - BMI ndnd Yes - age nd Yes - BMI ndnd Yes - age nd Yes - BMI nd
nd nd nd ndnd nd nd ndnd nd nd nd
nd Yes (age) nd in some analysesnd Yes* - Age nd ndnd Yes* - Age nd nd
nd nd Yes/no* nd Yes/no* ndnd nd Yes/no* nd Yes/no* nd
K intake, total energy intakeNa intake, K intake, n-3 fa Na intake, K intake, n-3 fa Na intake, K intake, n-3 fa
Energy, fruit intakes Yes* age, sex,
educationNo significant interactions were No significant interactions were No significant interactions were No significant interactions were No significant interactions were No significant interactions were No significant interactions were No significant interactions were No significant interactions were changes in skin
pigmentationchanges in skin pigmentationchanges in skin pigmentationchanges in skin pigmentationchanges in skin pigmentationUse of Vit D
containing Age, sex, education (<12 y)
Matched on gender, adjusted
Yes (red meat consumption)Yes (red meat consumption)Yes (red meat consumption)Intakes of folate, calcium, retinol, Intakes of folate, calcium, retinol, Intakes of folate, calcium, retinol, Intakes of folate, calcium, retinol, Intakes of folate, calcium, retinol, Ca/placebo groups
similar age, Ca/placebo group similar BMICa/placebo groups
similar age, Ca/placebo group similar BMICa/placebo groups
similar age, Ca/placebo group similar BMIYes (total energy
intake)Yes (body mass index, fat and Baseline calcium
intake and vitamin Yes * - height, body weightBaseline calcium
intake and vitamin Yes * - height, body weight
History of diabetes nd nd nd nd ndHistory of diabetes nd nd nd nd nd
nd nd YesYes Yes Aspirin, Vitamin E nd ndYes Yes Aspirin, Vitamin E nd ndYes Yes Aspirin, Vitamin E nd ndnd nd nd nd nd ndYes nd nd nd ndnd nd nd nd nd nd- - - - - -nd nd nd nd nd ndYes nd nd nd ndYes nd nd nd nd- - - -- - - -
nd nd nd ndnd nd nd nd
nd nd nd nd nd ndnd nd nd nd nd ndnd nd nd nd Yes season of visitnd nd nd Yes seasonYes h/o outcomes No nd No ndYes h/o outcomes No nd No ndYes h/o outcomes No nd No ndYes h/o outcomes No nd No ndYes h/o outcomes No nd No ndnd nd nd nd nd ndnd nd nd nd nd ndNo nd No nd No ndNo nd No nd nd ndNo nd No ndnd nd nd ndnd nd nd ndnd nd nd ndnd nd nd nd nd ndnd nd nd nd nd ndnd nd nd nd nd ndnd nd nd nd nd ndnd nd nd nd nd ndnd nd nd nd nd ndYes DM Yes No ndnd nd nd nd nd ndnd nd nd ndnd nd nd nd nd ndnd nd nd nd ndnd nd nd nd ndNo nd No nd Yes
Confounder Groups
Confounder Groups
Confounder Groups
Confounder Groups
Confounder Groups
Confounder Groups
Systolic blood pressure, HDL
Treatment with gemfibrozil
time of sample retrievalDM,
HypercholesteroleDM, HypercholesteroleDM, Hypercholesterole
Hypercholesterolemia
HTN, hypercholesteroleHTN, hypercholesterole Season of blood
drawFor 25(OH)D analysis onlySeason of blood
drawFor 25(OH)D analysis onlyFamily of breast
cancer; benign Use of post menopausal Family of breast
cancer; benign Use of post menopausal
sample gestational age
Month commented on
Unclear if used in any analysisHistory of two or
more falls in past Never used hormones**History of two or
more falls in past Never used hormones**History of two or
more falls in past Never used hormones**
hormone replacement
Hormonal therapy, estrogen alone or
Latitude of the clinical center
Season of blood sample collectionSeason of blood sample collection Day of year
(matched)
No nd No nd YesNo nd No nd YesNo nd No nd No ndNo nd No nd No ndnd nd nd nd nd ndnd nd nd nd nd ndnd nd nd nd nd ndnd nd nd nd nd ndnd nd nd nd nd ndnd nd nd nd nd ndnd nd nd nd nd ndnd nd nd nd nd ndnd nd nd nd nd ndnd nd nd nd nd ndnd nd nd nd nd ndnd nd nd Physical activity ndnd nd nd Physical activity ndnd nd nd Physical activity ndnd nd nd Physical activity nd
nd nd No ndnd nd No ndnd nd No nd
nd nd nd nd nd ndYes Yes nd nd
nd No nd ndnd No nd ndnd No nd ndnd No nd ndnd No nd ndnd No nd ndnd No nd ndnd No nd ndnd nd nd nd
No nd No nd No ndNo nd nd nd Yes UVB exposureNo nd nd nd Yes UVB exposureNo nd nd nd Yes UVB exposureNo nd nd nd Yes UVB exposureNo nd nd nd Yes UVB exposurend nd nd nd ndnd nd nd nd nd nd- - - - -nd nd nd nd nd ndnd nd nd nd nd ndnd nd nd nd nd ndnd nd nd nd nd ndnd nd nd nd Yesnd nd nd nd Yes
Day of year (matched)Day of year (matched)
Use of HRT, duration of aspirin Use of HRT, duration of aspirin Use of HRT, duration of aspirin Use of HRT, duration of aspirin history of
menopausal or Non-steroidal anti-inflammatory history of
menopausal or Non-steroidal anti-inflammatory history of
menopausal or Non-steroidal anti-inflammatory
Family history of hypertension
Oral contraceptive use, creatinineYes (disease
history)Yes (season and location/latitude)Yes (disease
history)Yes (season and location/latitude)Yes (disease
history)Yes (season and location/latitude)Yes (disease
history)Yes (season and location/latitude)Yes (disease
history)Yes (season and location/latitude)Yes (disease
history)Yes (season and location/latitude)Yes (disease
history)Yes (season and location/latitude)Yes (disease
history)Yes (season and location/latitude)Menopausal
status, age at Hormonal replacement
Season of blood collection (for 25-
Month blood was taken
blood drawn in February in blood drawn in February in
nd nd nd nd Yesnd nd nd nd ndnd nd nd nd ndnd nd nd nd nd ndnd nd nd nd nd ndnd nd nd nd Yesnd nd nd nd nd ndNo nd No nd No ndnd nd nd Clinic site ndNo nd No nd ndNo nd No nd ndNo nd No nd ndnd nd nd nd nd ndnd nd nd nd nd ndnd nd nd nd nd ndNo nd No nd No ndNo nd No nd No nd
nd No nd No ndNo nd No nd nd
nd Yes (aspirin) nd No ndnd nd nd nd nd ndnd nd nd nd nd ndnd nd HRT use nd Physical activity ndnd nd nd nd nd ndnd nd nd nd nd ndnd nd nd nd nd ndnd nd nd nd nd ndnd nd nd nd nd ndnd nd nd nd nd ndnd nd nd nd nd
nd Yes (Aspirin) nd No ndnd Yes (Aspirin) nd No ndnd Yes (Aspirin) nd No ndnd Yes (Aspirin) nd No ndnd Yes (Aspirin) nd No ndnd Yes (Aspirin) nd No ndnd Yes (Aspirin) nd No ndnd Yes (Aspirin) nd No ndnd Yes (Aspirin) nd No ndnd Yes (Aspirin) nd No nd
Yes DM, CHD Yes No ndYes DM, CHD Yes No ndYes DM, CHD Yes No ndYes DM, CHD Yes No nd
nd nd nd ndnd nd nd nd nd ndnd nd nd nd nd ndnd nd nd nd nd nd
blood drawn in February in Use of
nonsteroidal anti-Use of nonsteroidal anti-
UV exposure, location
Original treatment group (selenium Yes (geographical
region)Yes (geographical region)Yes (geographical region)
Yes (Hx of gallbladder Yes (place of
enrollment [i.e., Yes (family history of colon cancer,
Use of depomedroxyprogYes (family Hx, Hx
of DM)Yes (family Hx, Hx of DM)Yes (family Hx, Hx of DM)Yes (family Hx, Hx of DM)Yes (family Hx, Hx of DM)Yes (family Hx, Hx of DM)Yes (family Hx, Hx of DM)Yes (family Hx, Hx of DM)Yes (family Hx, Hx of DM)Yes (family Hx, Hx of DM) Alpha tocopherol
and beta caroteneAlpha tocopherol and beta caroteneAlpha tocopherol and beta caroteneAlpha tocopherol and beta caroteneHistory of benign
breast diseaseUse of oral contraceptives,
nd nd nd nd nd ndnd nd No ndnd nd No ndnd nd No nd
No nd Yes Yes physical activitynd nd nd nd No ndnd nd nd nd No ndnd nd nd nd No ndnd nd nd nd nd ndnd nd nd nd nd ndnd nd nd nd nd ndNo nd No nd No ndNo nd No nd No ndNo nd No nd No ndNo nd No nd No ndnd nd nd nd Yes spent time outsidend nd nd nd Yes spent time outsidend nd nd nd Yes spent time outsidend nd nd nd Yes spent time outsidend nd nd nd Yes spent time outsidend nd nd nd ndNo nd No nd No ndNo nd No nd No nd
nd nd No ndnd nd nd nd nd ndnd nd nd nd nd ndnd nd nd nd nd ndnd nd nd nd Yes seasonnd nd nd nd nd ndnd nd nd nd nd nd
nd nd No ndnd nd No ndnd nd No ndnd nd No ndnd nd Season ndnd nd Season ndnd nd Season ndnd nd Season nd
Yes Yes Hormonal use No ndYes type 2 DM nd nd nd ndnd parity nd nd ndnd parity nd nd ndnd parity nd nd ndnd nd nd nd nd ndnd nd nd nd nd ndnd nd nd nd nd ndnd nd nd nd nd ndnd nd nd nd nd nd
Yes (family history, polyps)
Yes (hormone replacement Yes (family
history, polyps)Yes (hormone replacement Yes (family
history, polyps)Yes (hormone replacement hormone therapy
in
Blood pressure, hypertensive
Self reported history of polyps
Regular use of aspirin in the
Yes (family CRC history)
Yes (for women only: HRT use )Yes (family CRC
history)Yes (for women only: HRT use )Yes (family CRC
history)Yes (for women only: HRT use )Yes (family CRC
history)Yes (for women only: HRT use )HTN, history of
CVD, diabetesUse of cholesterol-lowering HTN, history of
CVD, diabetesUse of cholesterol-lowering HTN, history of
CVD, diabetesUse of cholesterol-lowering HTN, history of
CVD, diabetesUse of cholesterol-lowering Menopausal status
at the time of
season of blood drawnseason of blood drawnseason of blood drawn
nd nd nd nd YesNo nd No nd ndnd nd nd nd ndnd nd nd nd ndnd nd nd nd nd
nd nd nd Physical exercise ndnd nd nd Physical exercise ndnd nd nd Physical exercise nd
nd nd nd nd ndYes DM; PSA screen nd nd nd nd
nd nd nd nd ndnd nd No ndnd nd No ndnd nd No ndnd nd No ndnd nd No ndnd nd No ndnd nd No ndnd nd No ndnd nd No ndnd nd No ndnd nd No ndnd nd No ndnd nd No ndnd nd No ndnd nd No ndnd nd No ndnd nd No ndnd nd No ndnd nd No ndnd nd No ndnd nd No ndnd nd No ndnd nd No ndnd nd No ndnd nd No ndnd nd No nd
nd nd nd nd nd ndnd nd nd nd nd ndnd nd nd nd nd ndNo nd No nd No ndNo nd nd ndnd nd nd nd nd ndnd nd nd nd nd ndnd nd nd nd nd ndnd nd nd nd nd ndYes HTN nd nd nd ndillness severity nd No nd No nd
Summer sun exposureYes, all from
HawaiiPostmenopausal hormone use, 1st trimester SBP;
parity1st trimester SBP; parityFamily Hx of
colorectal cancerFamily Hx of colorectal cancerFamily Hx of colorectal cancer Use of
nonsteroidal anti-
Family history of prostate cancerYes (family history of cancer, history
Yes (antacid use, menopausal Yes (family history
of cancer, history Yes (antacid use, menopausal Yes (family history
of cancer, history Yes (antacid use, menopausal Yes (family history
of cancer, history Yes (antacid use, menopausal Yes (family history
of cancer, history Yes (antacid use, menopausal Yes (family history
of cancer, history Yes (antacid use, menopausal Yes (family history
of cancer, history Yes (antacid use, menopausal Yes (family history
of cancer, history Yes (antacid use, menopausal Yes (family history
of cancer, history Yes (antacid use, menopausal Yes (family history
of cancer, history Yes (antacid use, menopausal Yes (family history
of cancer, history Yes (antacid use, menopausal Yes (family history
of cancer, history Yes (antacid use, menopausal Yes (family history
of cancer, history Yes (antacid use, menopausal Yes (family history
of cancer, history Yes (antacid use, menopausal Yes (family history
of cancer, history Yes (antacid use, menopausal Yes (family history
of cancer, history Yes (antacid use, menopausal Yes (family history
of cancer, history Yes (antacid use, menopausal Yes (family history
of cancer, history Yes (antacid use, menopausal Yes (family history
of cancer, history Yes (antacid use, menopausal Yes (family history
of cancer, history Yes (antacid use, menopausal Yes (family history
of cancer, history Yes (antacid use, menopausal Yes (family history
of cancer, history Yes (antacid use, menopausal Yes (family history
of cancer, history Yes (antacid use, menopausal Yes (family history
of cancer, history Yes (antacid use, menopausal Yes (family history
of cancer, history Yes (antacid use, menopausal Yes (family history
of cancer, history Yes (antacid use, menopausal
Yes: Aspirin use, 1990
Yes: physical activity
No nd No nd No ndnd nd nd nd nd ndnd nd nd nd nd ndnd nd nd nd nd nd
nd nd nd nd ndnd No nd No ndnd No nd No ndnd No nd No nd
History of DM nd nd nd ndnd nd nd nd nd ndnd nd nd nd nd ndnd nd nd nd nd ndnd nd nd nd nd ndnd nd nd nd nd ndnd nd nd nd nd ndnd nd nd ndNo nd No nd NoNo nd No nd Yes (residence) ndNo nd No nd Yes (residence) ndNo nd No nd Yes (residence) ndNo nd No nd Yes (residence) ndNo nd No nd Yes (residence) ndNo nd No nd No ndNo nd No nd No ndNo nd No nd No ndNo nd No nd No ndNo nd No nd No ndnd nd nd nd nd ndNo nd No nd No ndNo nd No nd No ndNo nd No nd No ndNo nd No nd No ndNo nd No nd No ndNo nd No nd No ndNo nd No nd No ndNo nd No nd No ndNo nd No nd No ndNo nd No nd No ndNo nd No nd No ndNo nd No nd No ndNo nd No nd No ndNo nd No nd No ndNo nd No nd No ndNo nd No nd No ndnd nd nd nd ndYes HTN, DM nd nd nd ndYes HTN, DM nd nd nd ndYes HTN, DM nd nd nd nd
History of benign breast disease, Yes (menopausal status, family Yes (menopausal status, family Yes (menopausal status, family Region of
residence (south,
Seasonal variation of 25(OH)D, and
Seasonal variation of 25(OH)D was Subgroup analyses based on
US region, rural/urban/suburb
Yes HTN, DM nd nd nd ndYes DM, HTN Yes nd ndYes DM, HTN Yes nd ndYes DM, HTN Yes nd ndnd nd nd nd nd ndnd nd nd nd nd ndnd nd nd nd nd nd
nd nd nd nd ndnd nd nd nd ndnd nd nd nd ndnd nd nd nd ndnd nd nd nd ndnd nd nd nd ndnd nd nd nd ndnd nd nd nd ndnd nd nd nd nd
nd nd nd nd nd ndnd nd nd nd nd ndnd nd nd nd nd ndnd nd nd nd nd ndnd nd nd nd nd ndYes DM Yes anti-HTNive Yesnd nd nd nd nd ndnd nd nd nd nd ndnd nd nd nd nd ndnd nd nd nd nd ndYes Yes nd ndnd nd nd nd nd ndnd nd nd nd nd nd
nd nd No ndnd nd No ndnd nd No ndnd Aspirin use nd physical activity ndnd Aspirin use nd physical activity ndnd Aspirin use nd physical activity ndnd Aspirin use nd physical activity ndnd Aspirin use nd physical activity nd
nd nd nd nd nd ndnd nd nd nd nd ndnd nd nd nd nd ndNo nd nd No ndnd nd nd nd nd ndnd nd nd nd nd ndnd nd nd nd nd ndnd nd nd nd nd nd
for hypercholesterolefor hypercholesterolefor hypercholesterole
History of colorectal cancerHistory of colorectal cancerHistory of colorectal cancerHistory of colorectal cancerHistory of colorectal cancerHistory of colorectal cancerHistory of colorectal cancerHistory of colorectal cancerHistory of colorectal cancer
Season of blood draw Physical
Adjusted for DM, htn, heart disease,
Adjusted for use of htn meds
Yes (family history CRC; for NHS only:
Yes (aspirin use; for NHS only: post-Yes (family history
CRC; for NHS only: Yes (aspirin use; for NHS only: post-Yes (family history
CRC; for NHS only: Yes (aspirin use; for NHS only: post-Family history of
colorectal cancerFamily history of colorectal cancerFamily history of colorectal cancerFamily history of colorectal cancerFamily history of colorectal cancer
Yes (use of hormone
Yes study center ndYes study center ndYes Smoking ndYes Yes Family Hx of MIYes Yes Family Hx of MIYes Yes Family Hx of MINo nd nd ndYes nd ndYes/no* nd nd ndYes EtOH - -Yes EtOH nd ndYes ndYes ndno* - -no* - -
nd ndnd nd
no* nd nd ndno* nd nd ndno* nd nd ndno* nd nd ndNo nd No ndNo nd No ndNo nd No ndNo nd No ndNo nd No nd
nd ndnd nd
no* nd No ndNo nd nd ndNo nd ndYes* Current smoker** ndYes* Current smoker** ndYes* Current smoker** ndno* nd nd ndno* nd nd ndno* nd nd ndno* nd nd ndno* nd nd ndno* nd nd ndYes Smoking, exercise nd nd
nd ndYes nd nd ndYes* physical activity nd ndNo nd ndNo nd ndNo nd No nd
Confounder Groups
Confounder Groups
Confounder Groups
Confounder Groups Vigorous physical
activityVigorous physical activity Time of sample
retrieval Smoking, EtOH, Physical activitySmoking, EtOH, Physical activitySmoking, EtOH, Physical activity
Physical activity, EtOH, smoking
Smoking, EtOH, physical activity
Parental early MI, professionSmoking, EtOH,
physical activityParental early MI, professionTreatment
(calcium Treatment (calcium Yes (intakes of
alcohol)Parity; age at first birthYes (intakes of
alcohol)Parity; age at first birth
Yes* (physical activity)
bone area; markers of bone Yes* (physical
activity)bone area; markers of bone
Severity of diseaseTreatment arm in the hormone Treatment arm in the hormone Treatment arm in the hormone
Yes* - Smoking, exercise
Randomized treatment in the
Year of recruitment, Year of recruitment,
No nd No ndNo nd No ndNo nd nd ndNo nd nd ndYes EtOH nd ndYes EtOH nd ndNo nd 25(OH)D ndNo nd 25(OH)D ndno* nd nd ndno* nd nd ndno* nd nd ndno* nd nd ndno* nd nd ndno* nd nd ndno* nd nd nd
nd ndnd ndnd ndnd ndnd nd ndnd nd ndnd nd nd
Yes ndYes* Physical activity Yes
ndndndndndndndnd
nd ndnd nd nd
no* nd nd ndno* nd nd ndno* nd nd ndno* nd nd ndno* nd nd ndYes Smoking (match) nd nd
nd nd ndNo - - -No nd nd ndNo nd nd ndno* nd ndno* nd ndYes/no* nd nd ndYes/no* nd nd nd
Yes - pack years of smoking, alcohol
Family history of colorectal cancer, Yes - pack years of
smoking, alcoholFamily history of colorectal cancer, Yes - pack years of
smoking, alcoholFamily history of colorectal cancer, Yes - pack years of
smoking, alcoholFamily history of colorectal cancer, smoking
(ever/never), smoking (ever/never), smoking (ever/never), Physical activity
was included in all Family hx of HTN, smoking status, Date of blood sample Yes (smoking
pattern)Never, former, current (<20pack-
Levels of physical activityYes (smoking
pattern)Never, former, current (<20pack-
Levels of physical activityYes (smoking
pattern)Never, former, current (<20pack-
Levels of physical activityYes (smoking
pattern)Never, former, current (<20pack-
Levels of physical activityYes (smoking
pattern)Never, former, current (<20pack-
Levels of physical activityYes (smoking
pattern)Never, former, current (<20pack-
Levels of physical activityYes (smoking
pattern)Never, former, current (<20pack-
Levels of physical activityYes (smoking
pattern)Never, former, current (<20pack-
Levels of physical activityYes smoking
status, alcohol Months of the blood draw, Yes (smoking
[current/ex-/never
Yes (Cigarette consumption,
Center, follow-up time, number of Center, follow-up time, number of
Yes/no* nd nd ndYes/no* nd ndYes/no* nd ndNo nd nd ndNo nd nd ndno* nd nd ndNo nd nd ndno* nd nd ndYes nd nd
nd ndnd ndnd nd
no* nd nd ndno* nd nd ndno* nd nd ndNo nd ndNo nd ndYes (smoking) nd ndNo nd nd nd
nd nd ndnd ndnd ndnd nd
Yes ndYes ndYes physical activity nd ndYes physical activity nd ndYes physical activity nd ndno* nd nd ndYes nd
nd nd ndnd nd ndnd nd ndnd nd ndnd nd ndnd nd ndnd nd ndnd nd ndnd nd ndnd nd nd
Yes YesYes YesYes YesYes YesYes alcohol ndYes ndNo nd nd ndNo nd nd nd
Intervention assignment, Intervention assignment,
Cigarette smoking- pack Yes (smoking,
occupation)Cancer during the first-year f/u Yes (smoking,
occupation)Cancer during the first-year f/u Yes (smoking,
occupation)Cancer during the first-year f/u
The studied women were The studied women were Family history of colorectal cancer
Yes (smoking, alcohol, physical Yes - smoking, physical activity
Family hx of colon cancerYes - smoking,
physical activity Family hx of colon cancerYes (total alcohol
intake, smoking)Family hx of breast cancersmoking, alcohol,
physical activitypaternal hx of prostate cancerSmoking status,
drinking frequencyArea, marital status
exercise sessions/wk (high
Menses during trainingYes (exercise,
smoking, alcoholYes (exercise, smoking, alcoholYes (exercise, smoking, alcoholYes (exercise, smoking, alcoholYes (exercise, smoking, alcoholYes (exercise, smoking, alcoholYes (exercise, smoking, alcoholYes (exercise, smoking, alcoholYes (exercise, smoking, alcoholYes (exercise, smoking, alcohol # cigarettes,
physical activity, BP, total cholesterol, HDL# cigarettes,
physical activity, BP, total cholesterol, HDL# cigarettes,
physical activity, BP, total cholesterol, HDL# cigarettes,
physical activity, BP, total cholesterol, HDLAge at first birth,
age at menarche, Smoking status (matched),
Follow-up period (matched)
No nd nd ndnd ndnd ndnd nd
Yes YesNo nd nd ndNo nd nd ndNo nd nd ndNo nd ndNo nd ndNo nd ndNo nd nd ndNo nd nd ndNo nd nd ndNo nd nd ndno* nd nd ndno* nd nd ndno* nd nd ndno* nd nd ndno* nd nd ndYes* nd 25(OH)vitDYes Smoking YesYes Smoking YesNo nd ndNo nd nd ndNo nd nd ndNo nd nd ndNo nd nd ndNo nd nd ndNo nd nd nd
nd nd ndnd nd ndnd nd ndnd nd nd
Yes ndYes ndYes ndYes ndYes Smoking status YesYes YesYes smoking nd ndYes smoking nd ndYes smoking nd ndYes smoking ndNo nd nd nd
nd nd ndnd nd ndnd nd nd
Yes (physical activity, smoking,
Yes (RCT arms [aspirin/no, Vit Yes (physical
activity, smoking, Yes (RCT arms [aspirin/no, Vit Yes (physical
activity, smoking, Yes (RCT arms [aspirin/no, Vit smoking status,
alcohol family history of breast cancer in a
Residential home, nursing or dual-Residential home, nursing or dual-Residential home, nursing or dual-
Physical activity, smoking, alcohol Functional
capacity (Vit D Functional capacity (Vit D Number of
colonoscopies
Yes (smoking; exercise METs)Yes (smoking; exercise METs)Yes (smoking; exercise METs)Yes (smoking; exercise METs) Smoking, physical
activity levelHDL, total cholesterol, Smoking, physical
activity levelHDL, total cholesterol, Smoking, physical
activity levelHDL, total cholesterol, Smoking, physical
activity levelHDL, total cholesterol, Mammographic
viewphysical activity; smoke inhalation,
FH of prostate cancer; marital
health insurance coverage
Yes groups matched on Yes groups matched on Yes groups matched on
no* nd Yes Baseline 25(OH)Dnd nd ndnd nd
No nd nd ndNo nd nd nd
nd ndnd ndnd ndnd nd nd
Yes YesYes Smoking nd
nd marital status ndnd marital status ndnd marital status ndnd marital status ndnd marital status ndnd marital status ndnd marital status ndnd marital status ndnd marital status ndnd marital status ndnd marital status ndnd marital status ndnd marital status ndnd marital status ndnd marital status ndnd marital status ndnd marital status ndnd marital status ndnd marital status ndnd marital status ndnd marital status ndnd marital status ndnd marital status ndnd marital status ndnd marital status ndnd marital status nd
No nd ndNo nd ndNo nd nd
nd nd ndnd nd nd
No nd nd ndNo nd nd ndNo nd ndNo nd nd ndYes Cigarettes, alcohol YesNo nd nd
Yes (smoking; alcohol use)Yes - pack years of smoking,
Family history of colorectal cancer,
Yes - smoking, alcohol
Family history of colorectal cancer, Yes - smoking,
alcoholFamily history of colorectal cancer, Yes - smoking,
alcoholFamily history of colorectal cancer, Yes - smoking,
family history of physical activity; smoking; alcohol
marital status; FH prostate cancerTime since cohort
entryYes (vigorous physical activity, Yes (vigorous physical activity, Yes (vigorous physical activity, Yes (vigorous physical activity, Yes (vigorous physical activity, Yes (vigorous physical activity, Yes (vigorous physical activity, Yes (vigorous physical activity, Yes (vigorous physical activity, Yes (vigorous physical activity, Yes (vigorous physical activity, Yes (vigorous physical activity, Yes (vigorous physical activity, Yes (vigorous physical activity, Yes (vigorous physical activity, Yes (vigorous physical activity, Yes (vigorous physical activity, Yes (vigorous physical activity, Yes (vigorous physical activity, Yes (vigorous physical activity, Yes (vigorous physical activity, Yes (vigorous physical activity, Yes (vigorous physical activity, Yes (vigorous physical activity, Yes (vigorous physical activity, Yes (vigorous physical activity, Both tx groups
were comparable Both tx groups were comparable Both tx groups were comparable Yes [smoking
years (<35 vs. Yes - smoking, alcohol
Family history of prostate cancer in
Education, marital statusserum PTH,
albumin,
No nd YesNo nd ndNo nd ndNo nd nd
nd ndnd nd ndnd nd ndnd nd nd
Yes smoking ndNo nd nd ndNo nd nd ndNo nd nd nd
nd nd ndnd nd ndnd nd nd
Yes* smoking nd ndYes/no No nd
nd ndnd ndnd ndnd ndnd ndnd nd ndnd nd ndnd nd ndnd nd ndnd nd nd
No nd nd ndNo nd None ndNo nd None ndNo nd None ndNo nd None ndNo nd None ndNo nd None ndNo nd None ndNo nd None ndNo nd None ndNo nd None ndNo nd None ndNo nd None ndNo nd None ndNo nd None ndNo nd None ndNo nd None ndYes nd ndYes Smoking, EtOH nd ndYes Smoking, EtOH nd ndYes Smoking, EtOH nd nd
Adjusted for family hx of NS diff in %
smokers between NS diff in % smokers between NS diff in % smokers between Yes - physical
activity, alcohol Time period, parity, age at first Yes (cigarette
smoking, alcohol Yes (cigarette smoking, alcohol Yes (cigarette smoking, alcohol Parity (for women
only)
Yes 3 groups matched on % Yes 3 groups matched on % Yes 3 groups matched on %
smoking intensity and duration, Yes (physical
activity, marital Yes (Tx allocation of alpha-Yes (physical
activity, marital Yes (Tx allocation of alpha-Yes (physical
activity, marital Yes (Tx allocation of alpha-Yes (physical
activity, marital Yes (Tx allocation of alpha-Yes (physical
activity, marital Yes (Tx allocation of alpha-Yes (alcohol
consumption)Yes (alcohol consumption)Yes (alcohol consumption)Yes (alcohol consumption)Yes (alcohol consumption)
Smoking status, current alcohol
Yes Smoking, EtOH nd ndYes Smoking, EtOH Yes MenopauseYes Smoking, EtOH Yes MenopauseYes Smoking, EtOH Yes MenopauseNo nd nd ndYes/no* nd nd nd
nd nd ndYes nd Clinical center ndYes nd Clinical center ndYes nd Clinical center ndYes nd Clinical center ndYes nd Clinical center ndYes nd Clinical center ndYes nd Clinical center ndYes nd Clinical center ndYes nd Clinical center ndYes* outdoor activities nd ndYes* outdoor activities nd ndYes* outdoor activities nd ndYes* outdoor activities nd ndYes* outdoor activities nd ndYes Smoking YesYes/no* nd nd ndYes/no* nd nd ndYes/no* nd nd ndYes/no* nd nd ndYes nd ndNo nd nd ndno* nd nd nd
nd nd ndnd nd ndnd nd ndnd ndnd ndnd ndnd ndnd nd
nd nd ndnd nd ndnd nd nd
nd ndYes/no* nd VitD status ndYes/no* nd VitD status ndYes/no* nd nd ndYes/no* nd nd nd
Yes* frailty indicators and
SBP, TC/HDL, SCr, (CRP, analysis not
Matched on smoking hx, EtOH
Yes (physical activity; pack-Yes (physical activity; pack-Yes (physical activity; pack-Yes - smoking, alcohol intake
Fasting status, month of blood Yes - smoking,
alcohol intakeFasting status, month of blood Yes - smoking,
alcohol intakeFasting status, month of blood Yes - smoking,
alcohol intakeFasting status, month of blood Yes - smoking,
alcohol intakeFasting status, month of blood Ca/placebo groups
similar % current Ca/placebo groups similar % current Ca/placebo groups similar % current Yes (smoking
status, pack-years in some analyses also: alcohol
Study ID:EF ID Creator Create Date PMID6304:194 admin Aug 18, 2013 Sep 5, 2014 185059676304:194 admin Aug 18, 2013 Sep 5, 2014 185059676304:194 admin Aug 18, 2013 Sep 5, 2014 185059676304:194 admin Aug 18, 2013 Sep 5, 2014 185059676304:194 admin Aug 18, 2013 Sep 5, 2014 185059676304:194 admin Aug 18, 2013 Sep 5, 2014 185059676304:194 admin Aug 18, 2013 Sep 5, 2014 185059676304:194 admin Aug 18, 2013 Sep 5, 2014 185059676304:194 admin Aug 18, 2013 Sep 5, 2014 185059676304:194 admin Aug 18, 2013 Sep 5, 2014 185059676305:194 admin Aug 18, 2013 Sep 5, 2014 110758746305:194 admin Aug 18, 2013 Sep 5, 2014 110758746305:194 admin Aug 18, 2013 Sep 5, 2014 110758746305:194 admin Aug 18, 2013 Sep 5, 2014 110758746305:194 admin Aug 18, 2013 Sep 5, 2014 110758746305:194 admin Aug 18, 2013 Sep 5, 2014 110758746305:194 admin Aug 18, 2013 Sep 5, 2014 110758746305:194 admin Aug 18, 2013 Sep 5, 2014 110758746306:194 admin Aug 18, 2013 Sep 5, 2014 126632776306:194 admin Aug 18, 2013 Sep 5, 2014 126632776306:194 admin Aug 18, 2013 Sep 5, 2014 126632776306:194 admin Aug 18, 2013 Sep 5, 2014 126632776306:194 admin Aug 18, 2013 Sep 5, 2014 126632776306:194 admin Aug 18, 2013 Sep 5, 2014 126632776306:194 admin Aug 18, 2013 Sep 5, 2014 126632776306:194 admin Aug 18, 2013 Sep 5, 2014 126632776306:194 admin Aug 18, 2013 Sep 5, 2014 126632776306:194 admin Aug 18, 2013 Sep 5, 2014 126632776306:194 admin Aug 18, 2013 Sep 5, 2014 126632776306:194 admin Aug 18, 2013 Sep 5, 2014 126632776306:194 admin Aug 18, 2013 Sep 5, 2014 126632776306:194 admin Aug 18, 2013 Sep 5, 2014 126632776306:194 admin Aug 18, 2013 Sep 5, 2014 126632776307:194 admin Aug 18, 2013 Sep 5, 2014 78928826307:194 admin Aug 18, 2013 Sep 5, 2014 78928826308:194 admin Aug 18, 2013 Sep 5, 2014 162804276308:194 admin Aug 18, 2013 Sep 5, 2014 162804276308:194 admin Aug 18, 2013 Sep 5, 2014 162804276308:194 admin Aug 18, 2013 Sep 5, 2014 162804276308:194 admin Aug 18, 2013 Sep 5, 2014 162804276309:194 admin Aug 18, 2013 Sep 5, 2014 182086366309:194 admin Aug 18, 2013 Sep 5, 2014 182086366309:194 admin Aug 18, 2013 Sep 5, 2014 182086366309:194 admin Aug 18, 2013 Sep 5, 2014 182086366309:194 admin Aug 18, 2013 Sep 5, 2014 182086366309:194 admin Aug 18, 2013 Sep 5, 2014 182086366309:194 admin Aug 18, 2013 Sep 5, 2014 18208636
Last Updated
6309:194 admin Aug 18, 2013 Sep 5, 2014 182086366309:194 admin Aug 18, 2013 Sep 5, 2014 182086366309:194 admin Aug 18, 2013 Sep 5, 2014 182086366309:194 admin Aug 18, 2013 Sep 5, 2014 182086366309:194 admin Aug 18, 2013 Sep 5, 2014 182086366309:194 admin Aug 18, 2013 Sep 5, 2014 182086366309:194 admin Aug 18, 2013 Sep 5, 2014 182086366309:194 admin Aug 18, 2013 Sep 5, 2014 182086366309:194 admin Aug 18, 2013 Sep 5, 2014 182086366309:194 admin Aug 18, 2013 Sep 5, 2014 182086366309:194 admin Aug 18, 2013 Sep 5, 2014 182086366309:194 admin Aug 18, 2013 Sep 5, 2014 182086366309:194 admin Aug 18, 2013 Sep 5, 2014 182086366309:194 admin Aug 18, 2013 Sep 5, 2014 182086366311:194 admin Aug 18, 2013 Sep 5, 2014 13303606311:194 admin Aug 18, 2013 Sep 5, 2014 13303606311:194 admin Aug 18, 2013 Sep 5, 2014 13303606311:194 admin Aug 18, 2013 Sep 5, 2014 13303606311:194 admin Aug 18, 2013 Sep 5, 2014 13303606311:194 admin Aug 18, 2013 Sep 5, 2014 13303606311:194 admin Aug 18, 2013 Sep 5, 2014 13303606311:194 admin Aug 18, 2013 Sep 5, 2014 13303606311:194 admin Aug 18, 2013 Sep 5, 2014 13303606311:194 admin Aug 18, 2013 Sep 5, 2014 13303606311:194 admin Aug 18, 2013 Sep 5, 2014 13303606312:194 admin Aug 18, 2013 Sep 5, 2014 86211986312:194 admin Aug 18, 2013 Sep 5, 2014 86211986312:194 admin Aug 18, 2013 Sep 5, 2014 86211986312:194 admin Aug 18, 2013 Sep 5, 2014 86211986312:194 admin Aug 18, 2013 Sep 5, 2014 86211986313:194 admin Aug 18, 2013 Sep 5, 2014 97435116313:194 admin Aug 18, 2013 Sep 5, 2014 97435116313:194 admin Aug 18, 2013 Sep 5, 2014 97435116313:194 admin Aug 18, 2013 Sep 5, 2014 97435116313:194 admin Aug 18, 2013 Sep 5, 2014 97435116314:194 admin Aug 18, 2013 Sep 5, 2014 157673346314:194 admin Aug 18, 2013 Sep 5, 2014 157673346314:194 admin Aug 18, 2013 Sep 5, 2014 157673346314:194 admin Aug 18, 2013 Sep 5, 2014 157673346314:194 admin Aug 18, 2013 Sep 5, 2014 157673346314:194 admin Aug 18, 2013 Sep 5, 2014 157673346314:194 admin Aug 18, 2013 Sep 5, 2014 157673346314:194 admin Aug 18, 2013 Sep 5, 2014 157673346314:194 admin Aug 18, 2013 Sep 5, 2014 157673346314:194 admin Aug 18, 2013 Sep 5, 2014 157673346314:194 admin Aug 18, 2013 Sep 5, 2014 157673346315:194 admin Aug 18, 2013 Sep 5, 2014 161034506315:194 admin Aug 18, 2013 Sep 5, 2014 16103450
6315:194 admin Aug 18, 2013 Sep 5, 2014 161034506315:194 admin Aug 18, 2013 Sep 5, 2014 161034506315:194 admin Aug 18, 2013 Sep 5, 2014 161034506315:194 admin Aug 18, 2013 Sep 5, 2014 161034506315:194 admin Aug 18, 2013 Sep 5, 2014 161034506315:194 admin Aug 18, 2013 Sep 5, 2014 161034506315:194 admin Aug 18, 2013 Sep 5, 2014 161034506315:194 admin Aug 18, 2013 Sep 5, 2014 161034506316:194 admin Aug 18, 2013 Sep 5, 2014 179650376316:194 admin Aug 18, 2013 Sep 5, 2014 179650376316:194 admin Aug 18, 2013 Sep 5, 2014 179650376316:194 admin Aug 18, 2013 Sep 5, 2014 179650376316:194 admin Aug 18, 2013 Sep 5, 2014 179650376317:194 admin Aug 18, 2013 Sep 5, 2014 186895596317:194 admin Aug 18, 2013 Sep 5, 2014 186895596318:194 admin Aug 18, 2013 Sep 5, 2014 175359856318:194 admin Aug 18, 2013 Sep 5, 2014 175359856319:194 admin Aug 18, 2013 Sep 5, 2014 181983946319:194 admin Aug 18, 2013 Sep 5, 2014 181983946319:194 admin Aug 18, 2013 Sep 5, 2014 181983946319:194 admin Aug 18, 2013 Sep 5, 2014 181983946319:194 admin Aug 18, 2013 Sep 5, 2014 181983946319:194 admin Aug 18, 2013 Sep 5, 2014 181983946319:194 admin Aug 18, 2013 Sep 5, 2014 181983946319:194 admin Aug 18, 2013 Sep 5, 2014 181983946320:194 admin Aug 18, 2013 Sep 5, 2014 172438666320:194 admin Aug 18, 2013 Sep 5, 2014 172438666320:194 admin Aug 18, 2013 Sep 5, 2014 172438666320:194 admin Aug 18, 2013 Sep 5, 2014 172438666321:194 admin Aug 18, 2013 Sep 5, 2014 188427716321:194 admin Aug 18, 2013 Sep 5, 2014 188427716322:194 admin Aug 18, 2013 Sep 5, 2014 83334126322:194 admin Aug 18, 2013 Sep 5, 2014 83334126322:194 admin Aug 18, 2013 Sep 5, 2014 83334126322:194 admin Aug 18, 2013 Sep 5, 2014 83334126322:194 admin Aug 18, 2013 Sep 5, 2014 83334126323:194 admin Aug 18, 2013 Sep 5, 2014 99219606323:194 admin Aug 18, 2013 Sep 5, 2014 99219606323:194 admin Aug 18, 2013 Sep 5, 2014 99219606323:194 admin Aug 18, 2013 Sep 5, 2014 99219606325:194 admin Aug 18, 2013 Sep 5, 2014 76128036325:194 admin Aug 18, 2013 Sep 5, 2014 76128036325:194 admin Aug 18, 2013 Sep 5, 2014 76128036325:194 admin Aug 18, 2013 Sep 5, 2014 76128036325:194 admin Aug 18, 2013 Sep 5, 2014 76128036325:194 admin Aug 18, 2013 Sep 5, 2014 76128036326:194 admin Aug 18, 2013 Sep 5, 2014 187553196326:194 admin Aug 18, 2013 Sep 5, 2014 18755319
6326:194 admin Aug 18, 2013 Sep 5, 2014 187553196326:194 admin Aug 18, 2013 Sep 5, 2014 187553196326:194 admin Aug 18, 2013 Sep 5, 2014 187553196326:194 admin Aug 18, 2013 Sep 5, 2014 187553196326:194 admin Aug 18, 2013 Sep 5, 2014 187553196326:194 admin Aug 18, 2013 Sep 5, 2014 187553196326:194 admin Aug 18, 2013 Sep 5, 2014 187553196326:194 admin Aug 18, 2013 Sep 5, 2014 187553196326:194 admin Aug 18, 2013 Sep 5, 2014 187553196326:194 admin Aug 18, 2013 Sep 5, 2014 187553196327:194 admin Aug 18, 2013 Sep 5, 2014 167979036327:194 admin Aug 18, 2013 Sep 5, 2014 167979036327:194 admin Aug 18, 2013 Sep 5, 2014 167979036327:194 admin Aug 18, 2013 Sep 5, 2014 167979036327:194 admin Aug 18, 2013 Sep 5, 2014 167979036327:194 admin Aug 18, 2013 Sep 5, 2014 167979036327:194 admin Aug 18, 2013 Sep 5, 2014 167979036327:194 admin Aug 18, 2013 Sep 5, 2014 167979036327:194 admin Aug 18, 2013 Sep 5, 2014 167979036327:194 admin Aug 18, 2013 Sep 5, 2014 167979036328:194 admin Aug 18, 2013 Sep 5, 2014 176564206328:194 admin Aug 18, 2013 Sep 5, 2014 176564206328:194 admin Aug 18, 2013 Sep 5, 2014 176564206328:194 admin Aug 18, 2013 Sep 5, 2014 176564206330:194 admin Aug 18, 2013 Sep 5, 2014 115666566330:194 admin Aug 18, 2013 Sep 5, 2014 115666566330:194 admin Aug 18, 2013 Sep 5, 2014 115666566330:194 admin Aug 18, 2013 Sep 5, 2014 115666566331:194 admin Aug 18, 2013 Sep 5, 2014 190016016331:194 admin Aug 18, 2013 Sep 5, 2014 190016016331:194 admin Aug 18, 2013 Sep 5, 2014 190016016331:194 admin Aug 18, 2013 Sep 5, 2014 190016016331:194 admin Aug 18, 2013 Sep 5, 2014 190016016331:194 admin Aug 18, 2013 Sep 5, 2014 190016016331:194 admin Aug 18, 2013 Sep 5, 2014 190016016331:194 admin Aug 18, 2013 Sep 5, 2014 190016016331:194 admin Aug 18, 2013 Sep 5, 2014 190016016333:194 admin Aug 18, 2013 Sep 5, 2014 162804476333:194 admin Aug 18, 2013 Sep 5, 2014 162804476333:194 admin Aug 18, 2013 Sep 5, 2014 162804476333:194 admin Aug 18, 2013 Sep 5, 2014 162804476333:194 admin Aug 18, 2013 Sep 5, 2014 162804476333:194 admin Aug 18, 2013 Sep 5, 2014 162804476333:194 admin Aug 18, 2013 Sep 5, 2014 162804476333:194 admin Aug 18, 2013 Sep 5, 2014 162804476334:194 admin Aug 18, 2013 Sep 5, 2014 152130386334:194 admin Aug 18, 2013 Sep 5, 2014 152130386334:194 admin Aug 18, 2013 Sep 5, 2014 15213038
6334:194 admin Aug 18, 2013 Sep 5, 2014 152130386334:194 admin Aug 18, 2013 Sep 5, 2014 152130386334:194 admin Aug 18, 2013 Sep 5, 2014 152130386336:194 admin Aug 18, 2013 Sep 5, 2014 86824536336:194 admin Aug 18, 2013 Sep 5, 2014 86824536336:194 admin Aug 18, 2013 Sep 5, 2014 86824536336:194 admin Aug 18, 2013 Sep 5, 2014 86824536336:194 admin Aug 18, 2013 Sep 5, 2014 86824536337:194 admin Aug 18, 2013 Sep 5, 2014 88906616337:194 admin Aug 18, 2013 Sep 5, 2014 88906616337:194 admin Aug 18, 2013 Sep 5, 2014 88906616337:194 admin Aug 18, 2013 Sep 5, 2014 88906616337:194 admin Aug 18, 2013 Sep 5, 2014 88906616337:194 admin Aug 18, 2013 Sep 5, 2014 88906616337:194 admin Aug 18, 2013 Sep 5, 2014 88906616337:194 admin Aug 18, 2013 Sep 5, 2014 88906616337:194 admin Aug 18, 2013 Sep 5, 2014 88906616337:194 admin Aug 18, 2013 Sep 5, 2014 88906616337:194 admin Aug 18, 2013 Sep 5, 2014 88906616337:194 admin Aug 18, 2013 Sep 5, 2014 88906616337:194 admin Aug 18, 2013 Sep 5, 2014 88906616337:194 admin Aug 18, 2013 Sep 5, 2014 88906616337:194 admin Aug 18, 2013 Sep 5, 2014 88906616337:194 admin Aug 18, 2013 Sep 5, 2014 88906616337:194 admin Aug 18, 2013 Sep 5, 2014 88906616337:194 admin Aug 18, 2013 Sep 5, 2014 88906616337:194 admin Aug 18, 2013 Sep 5, 2014 88906616337:194 admin Aug 18, 2013 Sep 5, 2014 88906616337:194 admin Aug 18, 2013 Sep 5, 2014 88906616337:194 admin Aug 18, 2013 Sep 5, 2014 88906616337:194 admin Aug 18, 2013 Sep 5, 2014 88906616337:194 admin Aug 18, 2013 Sep 5, 2014 88906616338:194 admin Aug 18, 2013 Sep 5, 2014 171895526338:194 admin Aug 18, 2013 Sep 5, 2014 171895526338:194 admin Aug 18, 2013 Sep 5, 2014 171895526338:194 admin Aug 18, 2013 Sep 5, 2014 171895526338:194 admin Aug 18, 2013 Sep 5, 2014 171895526338:194 admin Aug 18, 2013 Sep 5, 2014 171895526339:194 admin Aug 18, 2013 Sep 5, 2014 162782626339:194 admin Aug 18, 2013 Sep 5, 2014 162782626339:194 admin Aug 18, 2013 Sep 5, 2014 162782626339:194 admin Aug 18, 2013 Sep 5, 2014 162782626339:194 admin Aug 18, 2013 Sep 5, 2014 162782626339:194 admin Aug 18, 2013 Sep 5, 2014 162782626339:194 admin Aug 18, 2013 Sep 5, 2014 162782626339:194 admin Aug 18, 2013 Sep 5, 2014 162782626339:194 admin Aug 18, 2013 Sep 5, 2014 162782626339:194 admin Aug 18, 2013 Sep 5, 2014 16278262
6339:194 admin Aug 18, 2013 Sep 5, 2014 162782626339:194 admin Aug 18, 2013 Sep 5, 2014 162782626339:194 admin Aug 18, 2013 Sep 5, 2014 162782626339:194 admin Aug 18, 2013 Sep 5, 2014 162782626339:194 admin Aug 18, 2013 Sep 5, 2014 162782626339:194 admin Aug 18, 2013 Sep 5, 2014 162782626339:194 admin Aug 18, 2013 Sep 5, 2014 162782626339:194 admin Aug 18, 2013 Sep 5, 2014 162782626339:194 admin Aug 18, 2013 Sep 5, 2014 162782626339:194 admin Aug 18, 2013 Sep 5, 2014 162782626339:194 admin Aug 18, 2013 Sep 5, 2014 162782626339:194 admin Aug 18, 2013 Sep 5, 2014 162782626339:194 admin Aug 18, 2013 Sep 5, 2014 162782626339:194 admin Aug 18, 2013 Sep 5, 2014 162782626339:194 admin Aug 18, 2013 Sep 5, 2014 162782626339:194 admin Aug 18, 2013 Sep 5, 2014 162782626339:194 admin Aug 18, 2013 Sep 5, 2014 162782626340:194 admin Aug 18, 2013 Sep 5, 2014 80781156340:194 admin Aug 18, 2013 Sep 5, 2014 80781156340:194 admin Aug 18, 2013 Sep 5, 2014 80781156340:194 admin Aug 18, 2013 Sep 5, 2014 80781156340:194 admin Aug 18, 2013 Sep 5, 2014 80781156340:194 admin Aug 18, 2013 Sep 5, 2014 80781156340:194 admin Aug 18, 2013 Sep 5, 2014 80781156340:194 admin Aug 18, 2013 Sep 5, 2014 80781156340:194 admin Aug 18, 2013 Sep 5, 2014 80781156340:194 admin Aug 18, 2013 Sep 5, 2014 80781156340:194 admin Aug 18, 2013 Sep 5, 2014 80781156340:194 admin Aug 18, 2013 Sep 5, 2014 80781156340:194 admin Aug 18, 2013 Sep 5, 2014 80781156340:194 admin Aug 18, 2013 Sep 5, 2014 80781156340:194 admin Aug 18, 2013 Sep 5, 2014 80781156340:194 admin Aug 18, 2013 Sep 5, 2014 80781156340:194 admin Aug 18, 2013 Sep 5, 2014 80781156340:194 admin Aug 18, 2013 Sep 5, 2014 80781156340:194 admin Aug 18, 2013 Sep 5, 2014 80781156340:194 admin Aug 18, 2013 Sep 5, 2014 80781156340:194 admin Aug 18, 2013 Sep 5, 2014 80781156340:194 admin Aug 18, 2013 Sep 5, 2014 80781156340:194 admin Aug 18, 2013 Sep 5, 2014 80781156340:194 admin Aug 18, 2013 Sep 5, 2014 80781156341:194 admin Aug 18, 2013 Sep 5, 2014 153424526341:194 admin Aug 18, 2013 Sep 5, 2014 153424526341:194 admin Aug 18, 2013 Sep 5, 2014 153424526341:194 admin Aug 18, 2013 Sep 5, 2014 153424526341:194 admin Aug 18, 2013 Sep 5, 2014 153424526341:194 admin Aug 18, 2013 Sep 5, 2014 153424526341:194 admin Aug 18, 2013 Sep 5, 2014 15342452
6341:194 admin Aug 18, 2013 Sep 5, 2014 153424526341:194 admin Aug 18, 2013 Sep 5, 2014 153424526341:194 admin Aug 18, 2013 Sep 5, 2014 153424526342:194 admin Aug 18, 2013 Sep 5, 2014 156684856342:194 admin Aug 18, 2013 Sep 5, 2014 156684856342:194 admin Aug 18, 2013 Sep 5, 2014 156684856342:194 admin Aug 18, 2013 Sep 5, 2014 156684856342:194 admin Aug 18, 2013 Sep 5, 2014 156684856342:194 admin Aug 18, 2013 Sep 5, 2014 156684856342:194 admin Aug 18, 2013 Sep 5, 2014 156684856342:194 admin Aug 18, 2013 Sep 5, 2014 156684856342:194 admin Aug 18, 2013 Sep 5, 2014 156684856342:194 admin Aug 18, 2013 Sep 5, 2014 156684856342:194 admin Aug 18, 2013 Sep 5, 2014 156684856342:194 admin Aug 18, 2013 Sep 5, 2014 156684856342:194 admin Aug 18, 2013 Sep 5, 2014 156684856342:194 admin Aug 18, 2013 Sep 5, 2014 156684856342:194 admin Aug 18, 2013 Sep 5, 2014 156684856342:194 admin Aug 18, 2013 Sep 5, 2014 156684856342:194 admin Aug 18, 2013 Sep 5, 2014 156684856342:194 admin Aug 18, 2013 Sep 5, 2014 156684856342:194 admin Aug 18, 2013 Sep 5, 2014 156684856342:194 admin Aug 18, 2013 Sep 5, 2014 156684856342:194 admin Aug 18, 2013 Sep 5, 2014 156684856342:194 admin Aug 18, 2013 Sep 5, 2014 156684856342:194 admin Aug 18, 2013 Sep 5, 2014 156684856342:194 admin Aug 18, 2013 Sep 5, 2014 156684856342:194 admin Aug 18, 2013 Sep 5, 2014 156684856345:194 admin Aug 18, 2013 Sep 5, 2014 188386236345:194 admin Aug 18, 2013 Sep 5, 2014 188386236345:194 admin Aug 18, 2013 Sep 5, 2014 188386236345:194 admin Aug 18, 2013 Sep 5, 2014 188386236345:194 admin Aug 18, 2013 Sep 5, 2014 188386236345:194 admin Aug 18, 2013 Sep 5, 2014 188386236346:194 admin Aug 18, 2013 Sep 5, 2014 179715266346:194 admin Aug 18, 2013 Sep 5, 2014 179715266346:194 admin Aug 18, 2013 Sep 5, 2014 179715266346:194 admin Aug 18, 2013 Sep 5, 2014 179715266346:194 admin Aug 18, 2013 Sep 5, 2014 179715266346:194 admin Aug 18, 2013 Sep 5, 2014 179715266346:194 admin Aug 18, 2013 Sep 5, 2014 179715266346:194 admin Aug 18, 2013 Sep 5, 2014 179715266346:194 admin Aug 18, 2013 Sep 5, 2014 179715266346:194 admin Aug 18, 2013 Sep 5, 2014 179715266346:194 admin Aug 18, 2013 Sep 5, 2014 179715266346:194 admin Aug 18, 2013 Sep 5, 2014 179715266346:194 admin Aug 18, 2013 Sep 5, 2014 179715266346:194 admin Aug 18, 2013 Sep 5, 2014 17971526
6346:194 admin Aug 18, 2013 Sep 5, 2014 179715266346:194 admin Aug 18, 2013 Sep 5, 2014 179715266346:194 admin Aug 18, 2013 Sep 5, 2014 179715266346:194 admin Aug 18, 2013 Sep 5, 2014 179715266346:194 admin Aug 18, 2013 Sep 5, 2014 179715266346:194 admin Aug 18, 2013 Sep 5, 2014 179715266346:194 admin Aug 18, 2013 Sep 5, 2014 179715266346:194 admin Aug 18, 2013 Sep 5, 2014 179715266346:194 admin Aug 18, 2013 Sep 5, 2014 179715266346:194 admin Aug 18, 2013 Sep 5, 2014 179715266347:194 admin Aug 18, 2013 Sep 5, 2014 183814726347:194 admin Aug 18, 2013 Sep 5, 2014 183814726347:194 admin Aug 18, 2013 Sep 5, 2014 183814726347:194 admin Aug 18, 2013 Sep 5, 2014 183814726347:194 admin Aug 18, 2013 Sep 5, 2014 183814726347:194 admin Aug 18, 2013 Sep 5, 2014 183814726347:194 admin Aug 18, 2013 Sep 5, 2014 183814726347:194 admin Aug 18, 2013 Sep 5, 2014 183814726347:194 admin Aug 18, 2013 Sep 5, 2014 183814726347:194 admin Aug 18, 2013 Sep 5, 2014 183814726349:194 admin Aug 18, 2013 Sep 5, 2014 173110576349:194 admin Aug 18, 2013 Sep 5, 2014 173110576349:194 admin Aug 18, 2013 Sep 5, 2014 173110576349:194 admin Aug 18, 2013 Sep 5, 2014 173110576349:194 admin Aug 18, 2013 Sep 5, 2014 173110576349:194 admin Aug 18, 2013 Sep 5, 2014 173110576349:194 admin Aug 18, 2013 Sep 5, 2014 173110576349:194 admin Aug 18, 2013 Sep 5, 2014 173110576349:194 admin Aug 18, 2013 Sep 5, 2014 173110576349:194 admin Aug 18, 2013 Sep 5, 2014 173110576349:194 admin Aug 18, 2013 Sep 5, 2014 173110576349:194 admin Aug 18, 2013 Sep 5, 2014 173110576349:194 admin Aug 18, 2013 Sep 5, 2014 173110576349:194 admin Aug 18, 2013 Sep 5, 2014 173110576349:194 admin Aug 18, 2013 Sep 5, 2014 173110576349:194 admin Aug 18, 2013 Sep 5, 2014 173110576349:194 admin Aug 18, 2013 Sep 5, 2014 173110576349:194 admin Aug 18, 2013 Sep 5, 2014 173110576349:194 admin Aug 18, 2013 Sep 5, 2014 173110576349:194 admin Aug 18, 2013 Sep 5, 2014 173110576350:194 admin Aug 18, 2013 Sep 5, 2014 88502736350:194 admin Aug 18, 2013 Sep 5, 2014 88502736350:194 admin Aug 18, 2013 Sep 5, 2014 88502736350:194 admin Aug 18, 2013 Sep 5, 2014 88502736350:194 admin Aug 18, 2013 Sep 5, 2014 88502736350:194 admin Aug 18, 2013 Sep 5, 2014 88502736350:194 admin Aug 18, 2013 Sep 5, 2014 88502736350:194 admin Aug 18, 2013 Sep 5, 2014 8850273
6351:194 admin Aug 18, 2013 Sep 5, 2014 28573646351:194 admin Aug 18, 2013 Sep 5, 2014 28573646351:194 admin Aug 18, 2013 Sep 5, 2014 28573646351:194 admin Aug 18, 2013 Sep 5, 2014 28573646352:194 admin Aug 18, 2013 Sep 5, 2014 25729006352:194 admin Aug 18, 2013 Sep 5, 2014 25729006352:194 admin Aug 18, 2013 Sep 5, 2014 25729006352:194 admin Aug 18, 2013 Sep 5, 2014 25729006352:194 admin Aug 18, 2013 Sep 5, 2014 25729006352:194 admin Aug 18, 2013 Sep 5, 2014 25729006352:194 admin Aug 18, 2013 Sep 5, 2014 25729006352:194 admin Aug 18, 2013 Sep 5, 2014 25729006352:194 admin Aug 18, 2013 Sep 5, 2014 25729006353:194 admin Aug 18, 2013 Sep 5, 2014 74936596353:194 admin Aug 18, 2013 Sep 5, 2014 74936596353:194 admin Aug 18, 2013 Sep 5, 2014 74936596353:194 admin Aug 18, 2013 Sep 5, 2014 74936596353:194 admin Aug 18, 2013 Sep 5, 2014 74936596353:194 admin Aug 18, 2013 Sep 5, 2014 74936596357:194 admin Aug 18, 2013 Sep 5, 2014 172279966357:194 admin Aug 18, 2013 Sep 5, 2014 172279966357:194 admin Aug 18, 2013 Sep 5, 2014 172279966357:194 admin Aug 18, 2013 Sep 5, 2014 172279966357:194 admin Aug 18, 2013 Sep 5, 2014 172279966357:194 admin Aug 18, 2013 Sep 5, 2014 172279966358:194 admin Aug 18, 2013 Sep 5, 2014 105113296358:194 admin Aug 18, 2013 Sep 5, 2014 105113296358:194 admin Aug 18, 2013 Sep 5, 2014 105113296358:194 admin Aug 18, 2013 Sep 5, 2014 105113296358:194 admin Aug 18, 2013 Sep 5, 2014 105113296358:194 admin Aug 18, 2013 Sep 5, 2014 105113296358:194 admin Aug 18, 2013 Sep 5, 2014 105113296358:194 admin Aug 18, 2013 Sep 5, 2014 105113296358:194 admin Aug 18, 2013 Sep 5, 2014 105113296358:194 admin Aug 18, 2013 Sep 5, 2014 105113296358:194 admin Aug 18, 2013 Sep 5, 2014 105113296358:194 admin Aug 18, 2013 Sep 5, 2014 105113296359:194 admin Aug 18, 2013 Sep 5, 2014 156712226359:194 admin Aug 18, 2013 Sep 5, 2014 156712226359:194 admin Aug 18, 2013 Sep 5, 2014 156712226359:194 admin Aug 18, 2013 Sep 5, 2014 156712226359:194 admin Aug 18, 2013 Sep 5, 2014 156712226359:194 admin Aug 18, 2013 Sep 5, 2014 156712226359:194 admin Aug 18, 2013 Sep 5, 2014 156712226359:194 admin Aug 18, 2013 Sep 5, 2014 156712226359:194 admin Aug 18, 2013 Sep 5, 2014 156712226359:194 admin Aug 18, 2013 Sep 5, 2014 156712226359:194 admin Aug 18, 2013 Sep 5, 2014 15671222
6359:194 admin Aug 18, 2013 Sep 5, 2014 156712226359:194 admin Aug 18, 2013 Sep 5, 2014 156712226359:194 admin Aug 18, 2013 Sep 5, 2014 156712226359:194 admin Aug 18, 2013 Sep 5, 2014 156712226360:194 admin Aug 18, 2013 Sep 5, 2014 162865196360:194 admin Aug 18, 2013 Sep 5, 2014 162865196361:194 admin Aug 18, 2013 Sep 5, 2014 145539576361:194 admin Aug 18, 2013 Sep 5, 2014 145539576361:194 admin Aug 18, 2013 Sep 5, 2014 145539576361:194 admin Aug 18, 2013 Sep 5, 2014 145539576363:194 admin Aug 18, 2013 Sep 5, 2014 94050296369:194 admin Aug 18, 2013 Sep 5, 2014 152258336369:194 admin Aug 18, 2013 Sep 5, 2014 152258336369:194 admin Aug 18, 2013 Sep 5, 2014 152258336369:194 admin Aug 18, 2013 Sep 5, 2014 152258336369:194 admin Aug 18, 2013 Sep 5, 2014 152258336369:194 admin Aug 18, 2013 Sep 5, 2014 152258336370:194 admin Aug 18, 2013 Sep 5, 2014 116417506370:194 admin Aug 18, 2013 Sep 5, 2014 116417506370:194 admin Aug 18, 2013 Sep 5, 2014 116417506370:194 admin Aug 18, 2013 Sep 5, 2014 116417506370:194 admin Aug 18, 2013 Sep 5, 2014 116417506370:194 admin Aug 18, 2013 Sep 5, 2014 116417506370:194 admin Aug 18, 2013 Sep 5, 2014 116417506370:194 admin Aug 18, 2013 Sep 5, 2014 116417506370:194 admin Aug 18, 2013 Sep 5, 2014 116417506370:194 admin Aug 18, 2013 Sep 5, 2014 116417506370:194 admin Aug 18, 2013 Sep 5, 2014 116417506370:194 admin Aug 18, 2013 Sep 5, 2014 116417506373:194 admin Aug 18, 2013 Sep 5, 2014 175528806373:194 admin Aug 18, 2013 Sep 5, 2014 175528806373:194 admin Aug 18, 2013 Sep 5, 2014 175528806373:194 admin Aug 18, 2013 Sep 5, 2014 175528806373:194 admin Aug 18, 2013 Sep 5, 2014 175528806373:194 admin Aug 18, 2013 Sep 5, 2014 175528806374:194 admin Aug 18, 2013 Sep 5, 2014 82055386374:194 admin Aug 18, 2013 Sep 5, 2014 82055386374:194 admin Aug 18, 2013 Sep 5, 2014 82055386374:194 admin Aug 18, 2013 Sep 5, 2014 82055386374:194 admin Aug 18, 2013 Sep 5, 2014 82055386375:194 admin Aug 18, 2013 Sep 5, 2014 93438376375:194 admin Aug 18, 2013 Sep 5, 2014 93438376375:194 admin Aug 18, 2013 Sep 5, 2014 93438376375:194 admin Aug 18, 2013 Sep 5, 2014 93438376376:194 admin Aug 18, 2013 Sep 5, 2014 86107046376:194 admin Aug 18, 2013 Sep 5, 2014 86107046376:194 admin Aug 18, 2013 Sep 5, 2014 86107046376:194 admin Aug 18, 2013 Sep 5, 2014 8610704
6376:194 admin Aug 18, 2013 Sep 5, 2014 86107046377:194 admin Aug 18, 2013 Sep 5, 2014 158805326377:194 admin Aug 18, 2013 Sep 5, 2014 158805326377:194 admin Aug 18, 2013 Sep 5, 2014 158805326377:194 admin Aug 18, 2013 Sep 5, 2014 158805326378:194 admin Aug 18, 2013 Sep 5, 2014 175361916378:194 admin Aug 18, 2013 Sep 5, 2014 175361916378:194 admin Aug 18, 2013 Sep 5, 2014 175361916378:194 admin Aug 18, 2013 Sep 5, 2014 175361916378:194 admin Aug 18, 2013 Sep 5, 2014 175361916378:194 admin Aug 18, 2013 Sep 5, 2014 175361916378:194 admin Aug 18, 2013 Sep 5, 2014 175361916378:194 admin Aug 18, 2013 Sep 5, 2014 175361916378:194 admin Aug 18, 2013 Sep 5, 2014 175361916378:194 admin Aug 18, 2013 Sep 5, 2014 175361916378:194 admin Aug 18, 2013 Sep 5, 2014 175361916378:194 admin Aug 18, 2013 Sep 5, 2014 175361916379:194 admin Aug 18, 2013 Sep 5, 2014 171064376379:194 admin Aug 18, 2013 Sep 5, 2014 171064376382:194 admin Aug 18, 2013 Sep 5, 2014 153541506382:194 admin Aug 18, 2013 Sep 5, 2014 153541506382:194 admin Aug 18, 2013 Sep 5, 2014 153541506382:194 admin Aug 18, 2013 Sep 5, 2014 153541506382:194 admin Aug 18, 2013 Sep 5, 2014 153541506382:194 admin Aug 18, 2013 Sep 5, 2014 153541506383:194 admin Aug 18, 2013 Sep 5, 2014 175566976383:194 admin Aug 18, 2013 Sep 5, 2014 175566976383:194 admin Aug 18, 2013 Sep 5, 2014 175566976383:194 admin Aug 18, 2013 Sep 5, 2014 175566976383:194 admin Aug 18, 2013 Sep 5, 2014 175566976383:194 admin Aug 18, 2013 Sep 5, 2014 175566976383:194 admin Aug 18, 2013 Sep 5, 2014 175566976383:194 admin Aug 18, 2013 Sep 5, 2014 175566976383:194 admin Aug 18, 2013 Sep 5, 2014 175566976384:194 admin Aug 18, 2013 Sep 5, 2014 184333056384:194 admin Aug 18, 2013 Sep 5, 2014 184333056384:194 admin Aug 18, 2013 Sep 5, 2014 184333056384:194 admin Aug 18, 2013 Sep 5, 2014 184333056385:194 admin Aug 18, 2013 Sep 5, 2014 165229156385:194 admin Aug 18, 2013 Sep 5, 2014 165229156385:194 admin Aug 18, 2013 Sep 5, 2014 165229156385:194 admin Aug 18, 2013 Sep 5, 2014 165229156385:194 admin Aug 18, 2013 Sep 5, 2014 165229156385:194 admin Aug 18, 2013 Sep 5, 2014 165229156385:194 admin Aug 18, 2013 Sep 5, 2014 165229156385:194 admin Aug 18, 2013 Sep 5, 2014 165229156385:194 admin Aug 18, 2013 Sep 5, 2014 165229156385:194 admin Aug 18, 2013 Sep 5, 2014 16522915
6385:194 admin Aug 18, 2013 Sep 5, 2014 165229156385:194 admin Aug 18, 2013 Sep 5, 2014 165229156386:194 admin Aug 18, 2013 Sep 5, 2014 165229156386:194 admin Aug 18, 2013 Sep 5, 2014 165229156386:194 admin Aug 18, 2013 Sep 5, 2014 165229156386:194 admin Aug 18, 2013 Sep 5, 2014 165229156386:194 admin Aug 18, 2013 Sep 5, 2014 165229156386:194 admin Aug 18, 2013 Sep 5, 2014 165229156386:194 admin Aug 18, 2013 Sep 5, 2014 165229156386:194 admin Aug 18, 2013 Sep 5, 2014 165229156386:194 admin Aug 18, 2013 Sep 5, 2014 165229156386:194 admin Aug 18, 2013 Sep 5, 2014 165229156386:194 admin Aug 18, 2013 Sep 5, 2014 165229156386:194 admin Aug 18, 2013 Sep 5, 2014 165229156387:194 admin Aug 18, 2013 Sep 5, 2014 183322896387:194 admin Aug 18, 2013 Sep 5, 2014 183322896387:194 admin Aug 18, 2013 Sep 5, 2014 183322896387:194 admin Aug 18, 2013 Sep 5, 2014 183322896387:194 admin Aug 18, 2013 Sep 5, 2014 183322896388:194 admin Aug 18, 2013 Sep 5, 2014 190565696388:194 admin Aug 18, 2013 Sep 5, 2014 190565696388:194 admin Aug 18, 2013 Sep 5, 2014 190565696388:194 admin Aug 18, 2013 Sep 5, 2014 190565696388:194 admin Aug 18, 2013 Sep 5, 2014 190565696389:194 admin Aug 18, 2013 Sep 5, 2014 173886676389:194 admin Aug 18, 2013 Sep 5, 2014 173886676389:194 admin Aug 18, 2013 Sep 5, 2014 173886676389:194 admin Aug 18, 2013 Sep 5, 2014 173886676389:194 admin Aug 18, 2013 Sep 5, 2014 173886676389:194 admin Aug 18, 2013 Sep 5, 2014 173886676389:194 admin Aug 18, 2013 Sep 5, 2014 173886676389:194 admin Aug 18, 2013 Sep 5, 2014 173886676389:194 admin Aug 18, 2013 Sep 5, 2014 173886676389:194 admin Aug 18, 2013 Sep 5, 2014 173886676389:194 admin Aug 18, 2013 Sep 5, 2014 173886676389:194 admin Aug 18, 2013 Sep 5, 2014 173886676389:194 admin Aug 18, 2013 Sep 5, 2014 173886676389:194 admin Aug 18, 2013 Sep 5, 2014 173886676389:194 admin Aug 18, 2013 Sep 5, 2014 173886676389:194 admin Aug 18, 2013 Sep 5, 2014 173886676389:194 admin Aug 18, 2013 Sep 5, 2014 173886676389:194 admin Aug 18, 2013 Sep 5, 2014 173886676389:194 admin Aug 18, 2013 Sep 5, 2014 173886676389:194 admin Aug 18, 2013 Sep 5, 2014 173886676389:194 admin Aug 18, 2013 Sep 5, 2014 173886676389:194 admin Aug 18, 2013 Sep 5, 2014 173886676389:194 admin Aug 18, 2013 Sep 5, 2014 173886676389:194 admin Aug 18, 2013 Sep 5, 2014 17388667
6389:194 admin Aug 18, 2013 Sep 5, 2014 173886676389:194 admin Aug 18, 2013 Sep 5, 2014 173886676389:194 admin Aug 18, 2013 Sep 5, 2014 173886676389:194 admin Aug 18, 2013 Sep 5, 2014 173886676389:194 admin Aug 18, 2013 Sep 5, 2014 173886676389:194 admin Aug 18, 2013 Sep 5, 2014 173886676389:194 admin Aug 18, 2013 Sep 5, 2014 173886676389:194 admin Aug 18, 2013 Sep 5, 2014 173886676390:194 admin Aug 18, 2013 Sep 5, 2014 85579656390:194 admin Aug 18, 2013 Sep 5, 2014 85579656390:194 admin Aug 18, 2013 Sep 5, 2014 85579656390:194 admin Aug 18, 2013 Sep 5, 2014 85579656390:194 admin Aug 18, 2013 Sep 5, 2014 85579656390:194 admin Aug 18, 2013 Sep 5, 2014 85579656390:194 admin Aug 18, 2013 Sep 5, 2014 85579656390:194 admin Aug 18, 2013 Sep 5, 2014 85579656390:194 admin Aug 18, 2013 Sep 5, 2014 85579656390:194 admin Aug 18, 2013 Sep 5, 2014 85579656390:194 admin Aug 18, 2013 Sep 5, 2014 85579656390:194 admin Aug 18, 2013 Sep 5, 2014 85579656391:194 admin Aug 18, 2013 Sep 5, 2014 158002686391:194 admin Aug 18, 2013 Sep 5, 2014 158002686391:194 admin Aug 18, 2013 Sep 5, 2014 158002686391:194 admin Aug 18, 2013 Sep 5, 2014 158002686391:194 admin Aug 18, 2013 Sep 5, 2014 158002686392:194 admin Aug 18, 2013 Sep 5, 2014 175332086392:194 admin Aug 18, 2013 Sep 5, 2014 175332086392:194 admin Aug 18, 2013 Sep 5, 2014 175332086392:194 admin Aug 18, 2013 Sep 5, 2014 175332086392:194 admin Aug 18, 2013 Sep 5, 2014 175332086392:194 admin Aug 18, 2013 Sep 5, 2014 175332086392:194 admin Aug 18, 2013 Sep 5, 2014 175332086392:194 admin Aug 18, 2013 Sep 5, 2014 175332086392:194 admin Aug 18, 2013 Sep 5, 2014 175332086392:194 admin Aug 18, 2013 Sep 5, 2014 175332086393:194 admin Aug 18, 2013 Sep 5, 2014 164000446393:194 admin Aug 18, 2013 Sep 5, 2014 164000446393:194 admin Aug 18, 2013 Sep 5, 2014 164000446393:194 admin Aug 18, 2013 Sep 5, 2014 164000446393:194 admin Aug 18, 2013 Sep 5, 2014 164000446393:194 admin Aug 18, 2013 Sep 5, 2014 164000446393:194 admin Aug 18, 2013 Sep 5, 2014 164000446393:194 admin Aug 18, 2013 Sep 5, 2014 164000446393:194 admin Aug 18, 2013 Sep 5, 2014 164000446393:194 admin Aug 18, 2013 Sep 5, 2014 164000446393:194 admin Aug 18, 2013 Sep 5, 2014 164000446393:194 admin Aug 18, 2013 Sep 5, 2014 164000446394:194 admin Aug 18, 2013 Sep 5, 2014 17473911
6394:194 admin Aug 18, 2013 Sep 5, 2014 174739116394:194 admin Aug 18, 2013 Sep 5, 2014 174739116394:194 admin Aug 18, 2013 Sep 5, 2014 174739116395:194 admin Aug 18, 2013 Sep 5, 2014 172091776395:194 admin Aug 18, 2013 Sep 5, 2014 172091776395:194 admin Aug 18, 2013 Sep 5, 2014 172091776395:194 admin Aug 18, 2013 Sep 5, 2014 172091776395:194 admin Aug 18, 2013 Sep 5, 2014 172091776395:194 admin Aug 18, 2013 Sep 5, 2014 172091776395:194 admin Aug 18, 2013 Sep 5, 2014 172091776395:194 admin Aug 18, 2013 Sep 5, 2014 172091776396:194 admin Aug 18, 2013 Sep 5, 2014 37555176396:194 admin Aug 18, 2013 Sep 5, 2014 37555176396:194 admin Aug 18, 2013 Sep 5, 2014 37555176396:194 admin Aug 18, 2013 Sep 5, 2014 37555176396:194 admin Aug 18, 2013 Sep 5, 2014 37555176396:194 admin Aug 18, 2013 Sep 5, 2014 37555176396:194 admin Aug 18, 2013 Sep 5, 2014 37555176396:194 admin Aug 18, 2013 Sep 5, 2014 37555176396:194 admin Aug 18, 2013 Sep 5, 2014 37555176396:194 admin Aug 18, 2013 Sep 5, 2014 37555176396:194 admin Aug 18, 2013 Sep 5, 2014 37555176396:194 admin Aug 18, 2013 Sep 5, 2014 37555176396:194 admin Aug 18, 2013 Sep 5, 2014 37555176396:194 admin Aug 18, 2013 Sep 5, 2014 37555176396:194 admin Aug 18, 2013 Sep 5, 2014 37555176397:194 admin Aug 18, 2013 Sep 5, 2014 188246626397:194 admin Aug 18, 2013 Sep 5, 2014 188246626397:194 admin Aug 18, 2013 Sep 5, 2014 188246626397:194 admin Aug 18, 2013 Sep 5, 2014 188246626397:194 admin Aug 18, 2013 Sep 5, 2014 188246626397:194 admin Aug 18, 2013 Sep 5, 2014 188246626398:194 admin Aug 18, 2013 Sep 5, 2014 159554676398:194 admin Aug 18, 2013 Sep 5, 2014 159554676398:194 admin Aug 18, 2013 Sep 5, 2014 159554676398:194 admin Aug 18, 2013 Sep 5, 2014 159554676398:194 admin Aug 18, 2013 Sep 5, 2014 159554676398:194 admin Aug 18, 2013 Sep 5, 2014 159554676398:194 admin Aug 18, 2013 Sep 5, 2014 159554676398:194 admin Aug 18, 2013 Sep 5, 2014 159554676398:194 admin Aug 18, 2013 Sep 5, 2014 159554676398:194 admin Aug 18, 2013 Sep 5, 2014 159554676399:194 admin Aug 18, 2013 Sep 5, 2014 120201026399:194 admin Aug 18, 2013 Sep 5, 2014 120201026399:194 admin Aug 18, 2013 Sep 5, 2014 120201026399:194 admin Aug 18, 2013 Sep 5, 2014 120201026401:194 admin Aug 18, 2013 Sep 5, 2014 36232606401:194 admin Aug 18, 2013 Sep 5, 2014 3623260
6402:194 admin Aug 18, 2013 Sep 5, 2014 32436096402:194 admin Aug 18, 2013 Sep 5, 2014 32436096402:194 admin Aug 18, 2013 Sep 5, 2014 32436096402:194 admin Aug 18, 2013 Sep 5, 2014 32436096402:194 admin Aug 18, 2013 Sep 5, 2014 32436096402:194 admin Aug 18, 2013 Sep 5, 2014 32436096403:194 admin Aug 18, 2013 Sep 5, 2014 163915876403:194 admin Aug 18, 2013 Sep 5, 2014 163915876403:194 admin Aug 18, 2013 Sep 5, 2014 163915876403:194 admin Aug 18, 2013 Sep 5, 2014 163915876403:194 admin Aug 18, 2013 Sep 5, 2014 163915876403:194 admin Aug 18, 2013 Sep 5, 2014 163915876404:194 admin Aug 18, 2013 Sep 5, 2014 67930586404:194 admin Aug 18, 2013 Sep 5, 2014 67930586404:194 admin Aug 18, 2013 Sep 5, 2014 67930586404:194 admin Aug 18, 2013 Sep 5, 2014 67930586405:194 admin Aug 18, 2013 Sep 5, 2014 127087196405:194 admin Aug 18, 2013 Sep 5, 2014 127087196405:194 admin Aug 18, 2013 Sep 5, 2014 127087196405:194 admin Aug 18, 2013 Sep 5, 2014 127087196405:194 admin Aug 18, 2013 Sep 5, 2014 127087196408:194 admin Aug 18, 2013 Sep 5, 2014 188278116408:194 admin Aug 18, 2013 Sep 5, 2014 188278116408:194 admin Aug 18, 2013 Sep 5, 2014 188278116408:194 admin Aug 18, 2013 Sep 5, 2014 188278116408:194 admin Aug 18, 2013 Sep 5, 2014 188278116408:194 admin Aug 18, 2013 Sep 5, 2014 188278116408:194 admin Aug 18, 2013 Sep 5, 2014 188278116408:194 admin Aug 18, 2013 Sep 5, 2014 188278116408:194 admin Aug 18, 2013 Sep 5, 2014 188278116408:194 admin Aug 18, 2013 Sep 5, 2014 188278116409:194 admin Aug 18, 2013 Sep 5, 2014 171064376409:194 admin Aug 18, 2013 Sep 5, 2014 171064376409:194 admin Aug 18, 2013 Sep 5, 2014 171064376409:194 admin Aug 18, 2013 Sep 5, 2014 171064376409:194 admin Aug 18, 2013 Sep 5, 2014 171064376409:194 admin Aug 18, 2013 Sep 5, 2014 171064376409:194 admin Aug 18, 2013 Sep 5, 2014 171064376409:194 admin Aug 18, 2013 Sep 5, 2014 171064376410:194 admin Aug 18, 2013 Sep 5, 2014 163526846410:194 admin Aug 18, 2013 Sep 5, 2014 163526846410:194 admin Aug 18, 2013 Sep 5, 2014 163526846410:194 admin Aug 18, 2013 Sep 5, 2014 163526846411:194 admin Aug 18, 2013 Sep 5, 2014 112624666411:194 admin Aug 18, 2013 Sep 5, 2014 112624666412:194 admin Aug 18, 2013 Sep 5, 2014 171818906412:194 admin Aug 18, 2013 Sep 5, 2014 171818906412:194 admin Aug 18, 2013 Sep 5, 2014 17181890
6413:194 admin Aug 18, 2013 Sep 5, 2014 191257566413:194 admin Aug 18, 2013 Sep 5, 2014 191257566413:194 admin Aug 18, 2013 Sep 5, 2014 191257566413:194 admin Aug 18, 2013 Sep 5, 2014 191257566413:194 admin Aug 18, 2013 Sep 5, 2014 191257566413:194 admin Aug 18, 2013 Sep 5, 2014 191257566413:194 admin Aug 18, 2013 Sep 5, 2014 191257566413:194 admin Aug 18, 2013 Sep 5, 2014 191257566413:194 admin Aug 18, 2013 Sep 5, 2014 191257566413:194 admin Aug 18, 2013 Sep 5, 2014 191257566413:194 admin Aug 18, 2013 Sep 5, 2014 191257566413:194 admin Aug 18, 2013 Sep 5, 2014 191257566413:194 admin Aug 18, 2013 Sep 5, 2014 191257566413:194 admin Aug 18, 2013 Sep 5, 2014 191257566413:194 admin Aug 18, 2013 Sep 5, 2014 191257566413:194 admin Aug 18, 2013 Sep 5, 2014 191257566413:194 admin Aug 18, 2013 Sep 5, 2014 191257566413:194 admin Aug 18, 2013 Sep 5, 2014 191257566413:194 admin Aug 18, 2013 Sep 5, 2014 191257566413:194 admin Aug 18, 2013 Sep 5, 2014 191257566414:194 admin Aug 18, 2013 Sep 5, 2014 191582266414:194 admin Aug 18, 2013 Sep 5, 2014 191582266415:194 admin Aug 18, 2013 Sep 5, 2014 97941756415:194 admin Aug 18, 2013 Sep 5, 2014 97941756416:194 admin Aug 18, 2013 Sep 5, 2014 173796166416:194 admin Aug 18, 2013 Sep 5, 2014 173796166416:194 admin Aug 18, 2013 Sep 5, 2014 173796166416:194 admin Aug 18, 2013 Sep 5, 2014 173796166416:194 admin Aug 18, 2013 Sep 5, 2014 173796166416:194 admin Aug 18, 2013 Sep 5, 2014 173796166416:194 admin Aug 18, 2013 Sep 5, 2014 173796166416:194 admin Aug 18, 2013 Sep 5, 2014 173796166416:194 admin Aug 18, 2013 Sep 5, 2014 173796166416:194 admin Aug 18, 2013 Sep 5, 2014 173796166416:194 admin Aug 18, 2013 Sep 5, 2014 173796166416:194 admin Aug 18, 2013 Sep 5, 2014 173796166416:194 admin Aug 18, 2013 Sep 5, 2014 173796166416:194 admin Aug 18, 2013 Sep 5, 2014 173796166416:194 admin Aug 18, 2013 Sep 5, 2014 173796166418:194 admin Aug 18, 2013 Sep 5, 2014 176222446418:194 admin Aug 18, 2013 Sep 5, 2014 176222446418:194 admin Aug 18, 2013 Sep 5, 2014 176222446418:194 admin Aug 18, 2013 Sep 5, 2014 176222446418:194 admin Aug 18, 2013 Sep 5, 2014 176222446418:194 admin Aug 18, 2013 Sep 5, 2014 176222446418:194 admin Aug 18, 2013 Sep 5, 2014 176222446418:194 admin Aug 18, 2013 Sep 5, 2014 176222446418:194 admin Aug 18, 2013 Sep 5, 2014 17622244
6418:194 admin Aug 18, 2013 Sep 5, 2014 176222446418:194 admin Aug 18, 2013 Sep 5, 2014 176222446418:194 admin Aug 18, 2013 Sep 5, 2014 176222446418:194 admin Aug 18, 2013 Sep 5, 2014 176222446418:194 admin Aug 18, 2013 Sep 5, 2014 176222446418:194 admin Aug 18, 2013 Sep 5, 2014 176222446418:194 admin Aug 18, 2013 Sep 5, 2014 176222446418:194 admin Aug 18, 2013 Sep 5, 2014 176222446418:194 admin Aug 18, 2013 Sep 5, 2014 176222446418:194 admin Aug 18, 2013 Sep 5, 2014 176222446418:194 admin Aug 18, 2013 Sep 5, 2014 176222446418:194 admin Aug 18, 2013 Sep 5, 2014 176222446418:194 admin Aug 18, 2013 Sep 5, 2014 176222446418:194 admin Aug 18, 2013 Sep 5, 2014 176222446418:194 admin Aug 18, 2013 Sep 5, 2014 176222446419:194 admin Aug 18, 2013 Sep 5, 2014 172153806419:194 admin Aug 18, 2013 Sep 5, 2014 172153806419:194 admin Aug 18, 2013 Sep 5, 2014 172153806419:194 admin Aug 18, 2013 Sep 5, 2014 172153806419:194 admin Aug 18, 2013 Sep 5, 2014 172153806419:194 admin Aug 18, 2013 Sep 5, 2014 172153806419:194 admin Aug 18, 2013 Sep 5, 2014 172153806419:194 admin Aug 18, 2013 Sep 5, 2014 172153806419:194 admin Aug 18, 2013 Sep 5, 2014 172153806419:194 admin Aug 18, 2013 Sep 5, 2014 172153806420:194 admin Aug 18, 2013 Sep 5, 2014 180000206420:194 admin Aug 18, 2013 Sep 5, 2014 180000206421:194 admin Aug 18, 2013 Sep 5, 2014 179252836421:194 admin Aug 18, 2013 Sep 5, 2014 179252836421:194 admin Aug 18, 2013 Sep 5, 2014 179252836421:194 admin Aug 18, 2013 Sep 5, 2014 179252836421:194 admin Aug 18, 2013 Sep 5, 2014 179252836421:194 admin Aug 18, 2013 Sep 5, 2014 179252836421:194 admin Aug 18, 2013 Sep 5, 2014 179252836421:194 admin Aug 18, 2013 Sep 5, 2014 179252836421:194 admin Aug 18, 2013 Sep 5, 2014 179252836421:194 admin Aug 18, 2013 Sep 5, 2014 179252836423:194 admin Aug 18, 2013 Sep 5, 2014 112975966423:194 admin Aug 18, 2013 Sep 5, 2014 112975966423:194 admin Aug 18, 2013 Sep 5, 2014 112975966423:194 admin Aug 18, 2013 Sep 5, 2014 112975966423:194 admin Aug 18, 2013 Sep 5, 2014 112975966423:194 admin Aug 18, 2013 Sep 5, 2014 112975966424:194 admin Aug 18, 2013 Sep 5, 2014 105306086424:194 admin Aug 18, 2013 Sep 5, 2014 105306086424:194 admin Aug 18, 2013 Sep 5, 2014 105306086424:194 admin Aug 18, 2013 Sep 5, 2014 105306086425:194 admin Aug 18, 2013 Sep 5, 2014 11045788
6425:194 admin Aug 18, 2013 Sep 5, 2014 110457886425:194 admin Aug 18, 2013 Sep 5, 2014 110457886425:194 admin Aug 18, 2013 Sep 5, 2014 110457886425:194 admin Aug 18, 2013 Sep 5, 2014 110457886425:194 admin Aug 18, 2013 Sep 5, 2014 110457886425:194 admin Aug 18, 2013 Sep 5, 2014 110457886425:194 admin Aug 18, 2013 Sep 5, 2014 110457886425:194 admin Aug 18, 2013 Sep 5, 2014 110457886425:194 admin Aug 18, 2013 Sep 5, 2014 110457886425:194 admin Aug 18, 2013 Sep 5, 2014 110457886425:194 admin Aug 18, 2013 Sep 5, 2014 110457886425:194 admin Aug 18, 2013 Sep 5, 2014 110457886425:194 admin Aug 18, 2013 Sep 5, 2014 110457886425:194 admin Aug 18, 2013 Sep 5, 2014 110457886425:194 admin Aug 18, 2013 Sep 5, 2014 110457886425:194 admin Aug 18, 2013 Sep 5, 2014 110457886425:194 admin Aug 18, 2013 Sep 5, 2014 110457886425:194 admin Aug 18, 2013 Sep 5, 2014 110457886425:194 admin Aug 18, 2013 Sep 5, 2014 110457886425:194 admin Aug 18, 2013 Sep 5, 2014 110457886425:194 admin Aug 18, 2013 Sep 5, 2014 110457886425:194 admin Aug 18, 2013 Sep 5, 2014 110457886425:194 admin Aug 18, 2013 Sep 5, 2014 110457886425:194 admin Aug 18, 2013 Sep 5, 2014 110457886425:194 admin Aug 18, 2013 Sep 5, 2014 110457886425:194 admin Aug 18, 2013 Sep 5, 2014 110457886425:194 admin Aug 18, 2013 Sep 5, 2014 110457886428:194 admin Aug 18, 2013 Sep 5, 2014 158271036428:194 admin Aug 18, 2013 Sep 5, 2014 158271036428:194 admin Aug 18, 2013 Sep 5, 2014 158271036428:194 admin Aug 18, 2013 Sep 5, 2014 158271036428:194 admin Aug 18, 2013 Sep 5, 2014 158271036428:194 admin Aug 18, 2013 Sep 5, 2014 158271036428:194 admin Aug 18, 2013 Sep 5, 2014 158271036429:194 admin Aug 18, 2013 Sep 5, 2014 128693976429:194 admin Aug 18, 2013 Sep 5, 2014 128693976429:194 admin Aug 18, 2013 Sep 5, 2014 128693976429:194 admin Aug 18, 2013 Sep 5, 2014 128693976429:194 admin Aug 18, 2013 Sep 5, 2014 128693976430:194 admin Aug 18, 2013 Sep 5, 2014 173153196430:194 admin Aug 18, 2013 Sep 5, 2014 173153196430:194 admin Aug 18, 2013 Sep 5, 2014 173153196431:194 admin Aug 18, 2013 Sep 5, 2014 92364166431:194 admin Aug 18, 2013 Sep 5, 2014 92364166431:194 admin Aug 18, 2013 Sep 5, 2014 92364166434:194 admin Aug 18, 2013 Sep 5, 2014 74981006434:194 admin Aug 18, 2013 Sep 5, 2014 74981006434:194 admin Aug 18, 2013 Sep 5, 2014 7498100
6434:194 admin Aug 18, 2013 Sep 5, 2014 74981006434:194 admin Aug 18, 2013 Sep 5, 2014 74981006434:194 admin Aug 18, 2013 Sep 5, 2014 74981006436:194 admin Aug 18, 2013 Sep 5, 2014 170197166436:194 admin Aug 18, 2013 Sep 5, 2014 170197166436:194 admin Aug 18, 2013 Sep 5, 2014 170197166436:194 admin Aug 18, 2013 Sep 5, 2014 170197166436:194 admin Aug 18, 2013 Sep 5, 2014 170197166437:194 admin Aug 18, 2013 Sep 5, 2014 169850316438:194 admin Aug 18, 2013 Sep 5, 2014 84781446438:194 admin Aug 18, 2013 Sep 5, 2014 84781446438:194 admin Aug 18, 2013 Sep 5, 2014 84781446438:194 admin Aug 18, 2013 Sep 5, 2014 84781446438:194 admin Aug 18, 2013 Sep 5, 2014 84781446438:194 admin Aug 18, 2013 Sep 5, 2014 84781446438:194 admin Aug 18, 2013 Sep 5, 2014 84781446438:194 admin Aug 18, 2013 Sep 5, 2014 84781446438:194 admin Aug 18, 2013 Sep 5, 2014 84781446438:194 admin Aug 18, 2013 Sep 5, 2014 84781446438:194 admin Aug 18, 2013 Sep 5, 2014 84781446438:194 admin Aug 18, 2013 Sep 5, 2014 84781446438:194 admin Aug 18, 2013 Sep 5, 2014 84781446438:194 admin Aug 18, 2013 Sep 5, 2014 84781446438:194 admin Aug 18, 2013 Sep 5, 2014 84781446438:194 admin Aug 18, 2013 Sep 5, 2014 84781446438:194 admin Aug 18, 2013 Sep 5, 2014 84781446438:194 admin Aug 18, 2013 Sep 5, 2014 84781446438:194 admin Aug 18, 2013 Sep 5, 2014 84781446438:194 admin Aug 18, 2013 Sep 5, 2014 84781446438:194 admin Aug 18, 2013 Sep 5, 2014 84781446438:194 admin Aug 18, 2013 Sep 5, 2014 84781446438:194 admin Aug 18, 2013 Sep 5, 2014 84781446438:194 admin Aug 18, 2013 Sep 5, 2014 84781446438:194 admin Aug 18, 2013 Sep 5, 2014 84781446438:194 admin Aug 18, 2013 Sep 5, 2014 84781446438:194 admin Aug 18, 2013 Sep 5, 2014 84781446438:194 admin Aug 18, 2013 Sep 5, 2014 84781446438:194 admin Aug 18, 2013 Sep 5, 2014 84781446438:194 admin Aug 18, 2013 Sep 5, 2014 84781446439:194 admin Aug 18, 2013 Sep 5, 2014 190569006439:194 admin Aug 18, 2013 Sep 5, 2014 190569006439:194 admin Aug 18, 2013 Sep 5, 2014 190569006439:194 admin Aug 18, 2013 Sep 5, 2014 190569006439:194 admin Aug 18, 2013 Sep 5, 2014 190569006439:194 admin Aug 18, 2013 Sep 5, 2014 190569006441:194 admin Aug 18, 2013 Sep 5, 2014 192088426441:194 admin Aug 18, 2013 Sep 5, 2014 192088426441:194 admin Aug 18, 2013 Sep 5, 2014 19208842
6441:194 admin Aug 18, 2013 Sep 5, 2014 192088426441:194 admin Aug 18, 2013 Sep 5, 2014 192088426442:194 admin Aug 18, 2013 Sep 5, 2014 170470876442:194 admin Aug 18, 2013 Sep 5, 2014 170470876442:194 admin Aug 18, 2013 Sep 5, 2014 170470876442:194 admin Aug 18, 2013 Sep 5, 2014 170470876442:194 admin Aug 18, 2013 Sep 5, 2014 170470876443:194 admin Aug 18, 2013 Sep 5, 2014 92424786443:194 admin Aug 18, 2013 Sep 5, 2014 92424786443:194 admin Aug 18, 2013 Sep 5, 2014 92424786443:194 admin Aug 18, 2013 Sep 5, 2014 92424786443:194 admin Aug 18, 2013 Sep 5, 2014 92424786443:194 admin Aug 18, 2013 Sep 5, 2014 92424786443:194 admin Aug 18, 2013 Sep 5, 2014 92424786443:194 admin Aug 18, 2013 Sep 5, 2014 92424786443:194 admin Aug 18, 2013 Sep 5, 2014 92424786443:194 admin Aug 18, 2013 Sep 5, 2014 92424786443:194 admin Aug 18, 2013 Sep 5, 2014 92424786443:194 admin Aug 18, 2013 Sep 5, 2014 92424786443:194 admin Aug 18, 2013 Sep 5, 2014 92424786443:194 admin Aug 18, 2013 Sep 5, 2014 92424786443:194 admin Aug 18, 2013 Sep 5, 2014 92424786443:194 admin Aug 18, 2013 Sep 5, 2014 92424786443:194 admin Aug 18, 2013 Sep 5, 2014 92424786443:194 admin Aug 18, 2013 Sep 5, 2014 92424786443:194 admin Aug 18, 2013 Sep 5, 2014 92424786443:194 admin Aug 18, 2013 Sep 5, 2014 92424786443:194 admin Aug 18, 2013 Sep 5, 2014 92424786443:194 admin Aug 18, 2013 Sep 5, 2014 92424786443:194 admin Aug 18, 2013 Sep 5, 2014 92424786443:194 admin Aug 18, 2013 Sep 5, 2014 92424786443:194 admin Aug 18, 2013 Sep 5, 2014 92424786443:194 admin Aug 18, 2013 Sep 5, 2014 92424786443:194 admin Aug 18, 2013 Sep 5, 2014 92424786443:194 admin Aug 18, 2013 Sep 5, 2014 92424786443:194 admin Aug 18, 2013 Sep 5, 2014 92424786443:194 admin Aug 18, 2013 Sep 5, 2014 92424786443:194 admin Aug 18, 2013 Sep 5, 2014 92424786443:194 admin Aug 18, 2013 Sep 5, 2014 92424786445:194 admin Aug 18, 2013 Sep 5, 2014 33073076445:194 admin Aug 18, 2013 Sep 5, 2014 33073076446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 12609940
6446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406451:194 admin Aug 18, 2013 Sep 5, 2014 186358556451:194 admin Aug 18, 2013 Sep 5, 2014 186358556451:194 admin Aug 18, 2013 Sep 5, 2014 186358556451:194 admin Aug 18, 2013 Sep 5, 2014 186358556451:194 admin Aug 18, 2013 Sep 5, 2014 186358556451:194 admin Aug 18, 2013 Sep 5, 2014 186358556451:194 admin Aug 18, 2013 Sep 5, 2014 186358556451:194 admin Aug 18, 2013 Sep 5, 2014 186358556451:194 admin Aug 18, 2013 Sep 5, 2014 186358556451:194 admin Aug 18, 2013 Sep 5, 2014 186358556452:194 admin Aug 18, 2013 Sep 5, 2014 37888356452:194 admin Aug 18, 2013 Sep 5, 2014 37888356452:194 admin Aug 18, 2013 Sep 5, 2014 37888356452:194 admin Aug 18, 2013 Sep 5, 2014 37888356455:194 admin Aug 18, 2013 Sep 5, 2014 169601776456:194 admin Aug 18, 2013 Sep 5, 2014 164816366456:194 admin Aug 18, 2013 Sep 5, 2014 164816366456:194 admin Aug 18, 2013 Sep 5, 2014 164816366456:194 admin Aug 18, 2013 Sep 5, 2014 164816366456:194 admin Aug 18, 2013 Sep 5, 2014 164816366456:194 admin Aug 18, 2013 Sep 5, 2014 164816366456:194 admin Aug 18, 2013 Sep 5, 2014 164816366456:194 admin Aug 18, 2013 Sep 5, 2014 164816366456:194 admin Aug 18, 2013 Sep 5, 2014 164816366456:194 admin Aug 18, 2013 Sep 5, 2014 16481636
6456:194 admin Aug 18, 2013 Sep 5, 2014 164816366456:194 admin Aug 18, 2013 Sep 5, 2014 164816366456:194 admin Aug 18, 2013 Sep 5, 2014 164816366456:194 admin Aug 18, 2013 Sep 5, 2014 164816366456:194 admin Aug 18, 2013 Sep 5, 2014 164816366456:194 admin Aug 18, 2013 Sep 5, 2014 164816366456:194 admin Aug 18, 2013 Sep 5, 2014 164816366456:194 admin Aug 18, 2013 Sep 5, 2014 164816366457:194 admin Aug 18, 2013 Sep 5, 2014 176615656457:194 admin Aug 18, 2013 Sep 5, 2014 176615656457:194 admin Aug 18, 2013 Sep 5, 2014 176615656457:194 admin Aug 18, 2013 Sep 5, 2014 176615656457:194 admin Aug 18, 2013 Sep 5, 2014 176615656457:194 admin Aug 18, 2013 Sep 5, 2014 176615656457:194 admin Aug 18, 2013 Sep 5, 2014 176615656457:194 admin Aug 18, 2013 Sep 5, 2014 176615656457:194 admin Aug 18, 2013 Sep 5, 2014 176615656457:194 admin Aug 18, 2013 Sep 5, 2014 176615656457:194 admin Aug 18, 2013 Sep 5, 2014 176615656457:194 admin Aug 18, 2013 Sep 5, 2014 176615656457:194 admin Aug 18, 2013 Sep 5, 2014 176615656457:194 admin Aug 18, 2013 Sep 5, 2014 176615656457:194 admin Aug 18, 2013 Sep 5, 2014 176615656457:194 admin Aug 18, 2013 Sep 5, 2014 176615656457:194 admin Aug 18, 2013 Sep 5, 2014 176615656457:194 admin Aug 18, 2013 Sep 5, 2014 176615656457:194 admin Aug 18, 2013 Sep 5, 2014 176615656457:194 admin Aug 18, 2013 Sep 5, 2014 176615656457:194 admin Aug 18, 2013 Sep 5, 2014 176615656457:194 admin Aug 18, 2013 Sep 5, 2014 176615656457:194 admin Aug 18, 2013 Sep 5, 2014 176615656457:194 admin Aug 18, 2013 Sep 5, 2014 176615656457:194 admin Aug 18, 2013 Sep 5, 2014 176615656457:194 admin Aug 18, 2013 Sep 5, 2014 176615656457:194 admin Aug 18, 2013 Sep 5, 2014 176615656457:194 admin Aug 18, 2013 Sep 5, 2014 176615656457:194 admin Aug 18, 2013 Sep 5, 2014 176615656457:194 admin Aug 18, 2013 Sep 5, 2014 176615656459:194 admin Aug 18, 2013 Sep 5, 2014 181803956459:194 admin Aug 18, 2013 Sep 5, 2014 181803956459:194 admin Aug 18, 2013 Sep 5, 2014 181803956459:194 admin Aug 18, 2013 Sep 5, 2014 181803956459:194 admin Aug 18, 2013 Sep 5, 2014 181803956460:194 admin Aug 18, 2013 Sep 5, 2014 86750936460:194 admin Aug 18, 2013 Sep 5, 2014 86750936460:194 admin Aug 18, 2013 Sep 5, 2014 86750936460:194 admin Aug 18, 2013 Sep 5, 2014 86750936460:194 admin Aug 18, 2013 Sep 5, 2014 8675093
6460:194 admin Aug 18, 2013 Sep 5, 2014 86750936460:194 admin Aug 18, 2013 Sep 5, 2014 86750936460:194 admin Aug 18, 2013 Sep 5, 2014 86750936460:194 admin Aug 18, 2013 Sep 5, 2014 86750936460:194 admin Aug 18, 2013 Sep 5, 2014 86750936460:194 admin Aug 18, 2013 Sep 5, 2014 86750936460:194 admin Aug 18, 2013 Sep 5, 2014 86750936460:194 admin Aug 18, 2013 Sep 5, 2014 86750936460:194 admin Aug 18, 2013 Sep 5, 2014 86750936461:194 admin Aug 18, 2013 Sep 5, 2014 189889096461:194 admin Aug 18, 2013 Sep 5, 2014 189889096461:194 admin Aug 18, 2013 Sep 5, 2014 189889096462:194 admin Aug 18, 2013 Sep 5, 2014 90225616462:194 admin Aug 18, 2013 Sep 5, 2014 90225616462:194 admin Aug 18, 2013 Sep 5, 2014 90225616462:194 admin Aug 18, 2013 Sep 5, 2014 90225616464:194 admin Aug 18, 2013 Sep 5, 2014 119043166464:194 admin Aug 18, 2013 Sep 5, 2014 119043166464:194 admin Aug 18, 2013 Sep 5, 2014 119043166465:194 admin Aug 18, 2013 Sep 5, 2014 176238016465:194 admin Aug 18, 2013 Sep 5, 2014 176238016465:194 admin Aug 18, 2013 Sep 5, 2014 176238016465:194 admin Aug 18, 2013 Sep 5, 2014 176238016465:194 admin Aug 18, 2013 Sep 5, 2014 176238016465:194 admin Aug 18, 2013 Sep 5, 2014 176238016465:194 admin Aug 18, 2013 Sep 5, 2014 176238016465:194 admin Aug 18, 2013 Sep 5, 2014 176238016465:194 admin Aug 18, 2013 Sep 5, 2014 176238016465:194 admin Aug 18, 2013 Sep 5, 2014 176238016465:194 admin Aug 18, 2013 Sep 5, 2014 176238016465:194 admin Aug 18, 2013 Sep 5, 2014 176238016465:194 admin Aug 18, 2013 Sep 5, 2014 176238016465:194 admin Aug 18, 2013 Sep 5, 2014 176238016465:194 admin Aug 18, 2013 Sep 5, 2014 176238016465:194 admin Aug 18, 2013 Sep 5, 2014 176238016465:194 admin Aug 18, 2013 Sep 5, 2014 176238016465:194 admin Aug 18, 2013 Sep 5, 2014 176238016465:194 admin Aug 18, 2013 Sep 5, 2014 176238016465:194 admin Aug 18, 2013 Sep 5, 2014 176238016465:194 admin Aug 18, 2013 Sep 5, 2014 176238016465:194 admin Aug 18, 2013 Sep 5, 2014 176238016465:194 admin Aug 18, 2013 Sep 5, 2014 176238016465:194 admin Aug 18, 2013 Sep 5, 2014 176238016465:194 admin Aug 18, 2013 Sep 5, 2014 176238016465:194 admin Aug 18, 2013 Sep 5, 2014 176238016465:194 admin Aug 18, 2013 Sep 5, 2014 176238016465:194 admin Aug 18, 2013 Sep 5, 2014 176238016465:194 admin Aug 18, 2013 Sep 5, 2014 17623801
6466:194 admin Aug 18, 2013 Sep 5, 2014 77958376466:194 admin Aug 18, 2013 Sep 5, 2014 77958376466:194 admin Aug 18, 2013 Sep 5, 2014 77958376466:194 admin Aug 18, 2013 Sep 5, 2014 77958376466:194 admin Aug 18, 2013 Sep 5, 2014 77958376466:194 admin Aug 18, 2013 Sep 5, 2014 77958376466:194 admin Aug 18, 2013 Sep 5, 2014 77958376466:194 admin Aug 18, 2013 Sep 5, 2014 77958376466:194 admin Aug 18, 2013 Sep 5, 2014 77958376466:194 admin Aug 18, 2013 Sep 5, 2014 77958376467:194 admin Aug 18, 2013 Sep 5, 2014 95214376467:194 admin Aug 18, 2013 Sep 5, 2014 95214376467:194 admin Aug 18, 2013 Sep 5, 2014 95214376468:194 admin Aug 18, 2013 Sep 5, 2014 180897016468:194 admin Aug 18, 2013 Sep 5, 2014 180897016468:194 admin Aug 18, 2013 Sep 5, 2014 180897016468:194 admin Aug 18, 2013 Sep 5, 2014 180897016468:194 admin Aug 18, 2013 Sep 5, 2014 180897016468:194 admin Aug 18, 2013 Sep 5, 2014 180897016468:194 admin Aug 18, 2013 Sep 5, 2014 180897016468:194 admin Aug 18, 2013 Sep 5, 2014 180897016468:194 admin Aug 18, 2013 Sep 5, 2014 180897016468:194 admin Aug 18, 2013 Sep 5, 2014 180897016468:194 admin Aug 18, 2013 Sep 5, 2014 180897016468:194 admin Aug 18, 2013 Sep 5, 2014 180897016468:194 admin Aug 18, 2013 Sep 5, 2014 180897016468:194 admin Aug 18, 2013 Sep 5, 2014 180897016469:194 admin Aug 18, 2013 Sep 5, 2014 184102256469:194 admin Aug 18, 2013 Sep 5, 2014 184102256469:194 admin Aug 18, 2013 Sep 5, 2014 184102256469:194 admin Aug 18, 2013 Sep 5, 2014 18410225
Alt ID(s) Title Year Author20082008200820082008200820082008200820082000200020002000200020002000200020032003200320032003200320032003200320032003200320032003200319951995200520052005200520052008200820082008200820082008
Serum vitamin D concentration and
Ahn J., Peters U., Albanes D., Purdue MP., Abnet CC., Serum vitamin D
concentration and Ahn J., Peters U., Albanes D., Purdue MP., Abnet CC., Serum vitamin D
concentration and Ahn J., Peters U., Albanes D., Purdue MP., Abnet CC., Serum vitamin D
concentration and Ahn J., Peters U., Albanes D., Purdue MP., Abnet CC., Serum vitamin D
concentration and Ahn J., Peters U., Albanes D., Purdue MP., Abnet CC., Serum vitamin D
concentration and Ahn J., Peters U., Albanes D., Purdue MP., Abnet CC., Serum vitamin D
concentration and Ahn J., Peters U., Albanes D., Purdue MP., Abnet CC., Serum vitamin D
concentration and Ahn J., Peters U., Albanes D., Purdue MP., Abnet CC., Serum vitamin D
concentration and Ahn J., Peters U., Albanes D., Purdue MP., Abnet CC., Serum vitamin D
concentration and Ahn J., Peters U., Albanes D., Purdue MP., Abnet CC., Prostate cancer risk and
prediagnostic serum 25-Ahonen MH., Tenkanen L., Teppo L., Hakama M., Prostate cancer risk and
prediagnostic serum 25-Ahonen MH., Tenkanen L., Teppo L., Hakama M., Prostate cancer risk and
prediagnostic serum 25-Ahonen MH., Tenkanen L., Teppo L., Hakama M., Prostate cancer risk and
prediagnostic serum 25-Ahonen MH., Tenkanen L., Teppo L., Hakama M., Prostate cancer risk and
prediagnostic serum 25-Ahonen MH., Tenkanen L., Teppo L., Hakama M., Prostate cancer risk and
prediagnostic serum 25-Ahonen MH., Tenkanen L., Teppo L., Hakama M., Prostate cancer risk and
prediagnostic serum 25-Ahonen MH., Tenkanen L., Teppo L., Hakama M., Prostate cancer risk and
prediagnostic serum 25-Ahonen MH., Tenkanen L., Teppo L., Hakama M., A prospective study of
calcium intake from diet Al-Delaimy WK., Rimm E., Willett WC., Stampfer MJ., A prospective study of
calcium intake from diet Al-Delaimy WK., Rimm E., Willett WC., Stampfer MJ., A prospective study of
calcium intake from diet Al-Delaimy WK., Rimm E., Willett WC., Stampfer MJ., A prospective study of
calcium intake from diet Al-Delaimy WK., Rimm E., Willett WC., Stampfer MJ., A prospective study of
calcium intake from diet Al-Delaimy WK., Rimm E., Willett WC., Stampfer MJ., A prospective study of
calcium intake from diet Al-Delaimy WK., Rimm E., Willett WC., Stampfer MJ., A prospective study of
calcium intake from diet Al-Delaimy WK., Rimm E., Willett WC., Stampfer MJ., A prospective study of
calcium intake from diet Al-Delaimy WK., Rimm E., Willett WC., Stampfer MJ., A prospective study of
calcium intake from diet Al-Delaimy WK., Rimm E., Willett WC., Stampfer MJ., A prospective study of
calcium intake from diet Al-Delaimy WK., Rimm E., Willett WC., Stampfer MJ., A prospective study of
calcium intake from diet Al-Delaimy WK., Rimm E., Willett WC., Stampfer MJ., A prospective study of
calcium intake from diet Al-Delaimy WK., Rimm E., Willett WC., Stampfer MJ., A prospective study of
calcium intake from diet Al-Delaimy WK., Rimm E., Willett WC., Stampfer MJ., A prospective study of
calcium intake from diet Al-Delaimy WK., Rimm E., Willett WC., Stampfer MJ., A prospective study of
calcium intake from diet Al-Delaimy WK., Rimm E., Willett WC., Stampfer MJ., The influence of
menopause and hormonal Aloia JF., Vaswani A., Russo L., Sheehan M., The influence of
menopause and hormonal Aloia JF., Vaswani A., Russo L., Sheehan M., Low-fat dairy consumption
and reduced risk of Alonso A., Beunza JJ., Delgado-Rodríguez M., Low-fat dairy consumption
and reduced risk of Alonso A., Beunza JJ., Delgado-Rodríguez M., Low-fat dairy consumption
and reduced risk of Alonso A., Beunza JJ., Delgado-Rodríguez M., Low-fat dairy consumption
and reduced risk of Alonso A., Beunza JJ., Delgado-Rodríguez M., Low-fat dairy consumption
and reduced risk of Alonso A., Beunza JJ., Delgado-Rodríguez M., Effect of vitamin D
supplementation on bone Andersen R., Mølgaard C., Skovgaard LT., Brot C., Effect of vitamin D
supplementation on bone Andersen R., Mølgaard C., Skovgaard LT., Brot C., Effect of vitamin D
supplementation on bone Andersen R., Mølgaard C., Skovgaard LT., Brot C., Effect of vitamin D
supplementation on bone Andersen R., Mølgaard C., Skovgaard LT., Brot C., Effect of vitamin D
supplementation on bone Andersen R., Mølgaard C., Skovgaard LT., Brot C., Effect of vitamin D
supplementation on bone Andersen R., Mølgaard C., Skovgaard LT., Brot C., Effect of vitamin D
supplementation on bone Andersen R., Mølgaard C., Skovgaard LT., Brot C.,
200820082008200820082008200820082008200820082008200820081992199219921992199219921992199219921992199219961996199619961996199819981998199819982005200520052005200520052005200520052005200520052005
Effect of vitamin D supplementation on bone
Andersen R., Mølgaard C., Skovgaard LT., Brot C., Effect of vitamin D
supplementation on bone Andersen R., Mølgaard C., Skovgaard LT., Brot C., Effect of vitamin D
supplementation on bone Andersen R., Mølgaard C., Skovgaard LT., Brot C., Effect of vitamin D
supplementation on bone Andersen R., Mølgaard C., Skovgaard LT., Brot C., Effect of vitamin D
supplementation on bone Andersen R., Mølgaard C., Skovgaard LT., Brot C., Effect of vitamin D
supplementation on bone Andersen R., Mølgaard C., Skovgaard LT., Brot C., Effect of vitamin D
supplementation on bone Andersen R., Mølgaard C., Skovgaard LT., Brot C., Effect of vitamin D
supplementation on bone Andersen R., Mølgaard C., Skovgaard LT., Brot C., Effect of vitamin D
supplementation on bone Andersen R., Mølgaard C., Skovgaard LT., Brot C., Effect of vitamin D
supplementation on bone Andersen R., Mølgaard C., Skovgaard LT., Brot C., Effect of vitamin D
supplementation on bone Andersen R., Mølgaard C., Skovgaard LT., Brot C., Effect of vitamin D
supplementation on bone Andersen R., Mølgaard C., Skovgaard LT., Brot C., Effect of vitamin D
supplementation on bone Andersen R., Mølgaard C., Skovgaard LT., Brot C., Effect of vitamin D
supplementation on bone Andersen R., Mølgaard C., Skovgaard LT., Brot C., A prospective study of
nutritional factors and Ascherio A., Rimm EB., Giovannucci EL., Colditz A prospective study of
nutritional factors and Ascherio A., Rimm EB., Giovannucci EL., Colditz A prospective study of
nutritional factors and Ascherio A., Rimm EB., Giovannucci EL., Colditz A prospective study of
nutritional factors and Ascherio A., Rimm EB., Giovannucci EL., Colditz A prospective study of
nutritional factors and Ascherio A., Rimm EB., Giovannucci EL., Colditz A prospective study of
nutritional factors and Ascherio A., Rimm EB., Giovannucci EL., Colditz A prospective study of
nutritional factors and Ascherio A., Rimm EB., Giovannucci EL., Colditz A prospective study of
nutritional factors and Ascherio A., Rimm EB., Giovannucci EL., Colditz A prospective study of
nutritional factors and Ascherio A., Rimm EB., Giovannucci EL., Colditz A prospective study of
nutritional factors and Ascherio A., Rimm EB., Giovannucci EL., Colditz A prospective study of
nutritional factors and Ascherio A., Rimm EB., Giovannucci EL., Colditz Prospective study of
nutritional factors, blood Ascherio A., Hennekens C., Willett WC., Sacks F., Prospective study of
nutritional factors, blood Ascherio A., Hennekens C., Willett WC., Sacks F., Prospective study of
nutritional factors, blood Ascherio A., Hennekens C., Willett WC., Sacks F., Prospective study of
nutritional factors, blood Ascherio A., Hennekens C., Willett WC., Sacks F., Prospective study of
nutritional factors, blood Ascherio A., Hennekens C., Willett WC., Sacks F., Intake of potassium,
magnesium, calcium, and Ascherio A., Rimm EB., Hernán MA., Giovannucci Intake of potassium,
magnesium, calcium, and Ascherio A., Rimm EB., Hernán MA., Giovannucci Intake of potassium,
magnesium, calcium, and Ascherio A., Rimm EB., Hernán MA., Giovannucci Intake of potassium,
magnesium, calcium, and Ascherio A., Rimm EB., Hernán MA., Giovannucci Intake of potassium,
magnesium, calcium, and Ascherio A., Rimm EB., Hernán MA., Giovannucci Risk of prostate cancer in
a randomized clinical trial Baron JA., Beach M., Wallace K., Grau MV., Risk of prostate cancer in
a randomized clinical trial Baron JA., Beach M., Wallace K., Grau MV., Risk of prostate cancer in
a randomized clinical trial Baron JA., Beach M., Wallace K., Grau MV., Risk of prostate cancer in
a randomized clinical trial Baron JA., Beach M., Wallace K., Grau MV., Risk of prostate cancer in
a randomized clinical trial Baron JA., Beach M., Wallace K., Grau MV., Risk of prostate cancer in
a randomized clinical trial Baron JA., Beach M., Wallace K., Grau MV., Risk of prostate cancer in
a randomized clinical trial Baron JA., Beach M., Wallace K., Grau MV., Risk of prostate cancer in
a randomized clinical trial Baron JA., Beach M., Wallace K., Grau MV., Risk of prostate cancer in
a randomized clinical trial Baron JA., Beach M., Wallace K., Grau MV., Risk of prostate cancer in
a randomized clinical trial Baron JA., Beach M., Wallace K., Grau MV., Risk of prostate cancer in
a randomized clinical trial Baron JA., Beach M., Wallace K., Grau MV., Plasma 25-hydroxyvitamin
D and 1,25-Bertone-Johnson ER., Chen WY., Holick MF., Hollis BW., Plasma 25-hydroxyvitamin
D and 1,25-Bertone-Johnson ER., Chen WY., Holick MF., Hollis BW.,
200520052005200520052005200520052008200820082008200820082008200720072008200820082008200820082008200820072007200720072008200819931993199319931993199919991999199919951995199519951995199520082008
Plasma 25-hydroxyvitamin D and 1,25-
Bertone-Johnson ER., Chen WY., Holick MF., Hollis BW., Plasma 25-hydroxyvitamin
D and 1,25-Bertone-Johnson ER., Chen WY., Holick MF., Hollis BW., Plasma 25-hydroxyvitamin
D and 1,25-Bertone-Johnson ER., Chen WY., Holick MF., Hollis BW., Plasma 25-hydroxyvitamin
D and 1,25-Bertone-Johnson ER., Chen WY., Holick MF., Hollis BW., Plasma 25-hydroxyvitamin
D and 1,25-Bertone-Johnson ER., Chen WY., Holick MF., Hollis BW., Plasma 25-hydroxyvitamin
D and 1,25-Bertone-Johnson ER., Chen WY., Holick MF., Hollis BW., Plasma 25-hydroxyvitamin
D and 1,25-Bertone-Johnson ER., Chen WY., Holick MF., Hollis BW., Plasma 25-hydroxyvitamin
D and 1,25-Bertone-Johnson ER., Chen WY., Holick MF., Hollis BW., Vitamin D
supplementation has Björkman M., Sorva A., Risteli J., Tilvis R.Vitamin D
supplementation has Björkman M., Sorva A., Risteli J., Tilvis R.Vitamin D
supplementation has Björkman M., Sorva A., Risteli J., Tilvis R.Vitamin D
supplementation has Björkman M., Sorva A., Risteli J., Tilvis R.Vitamin D
supplementation has Björkman M., Sorva A., Risteli J., Tilvis R.Body size and serum 25
hydroxy vitamin D Blum M., Dallal GE., Dawson-Hughes B.Body size and serum 25
hydroxy vitamin D Blum M., Dallal GE., Dawson-Hughes B.Maternal vitamin D
deficiency increases the Bodnar LM., Catov JM., Simhan HN., Holick MF., Maternal vitamin D
deficiency increases the Bodnar LM., Catov JM., Simhan HN., Holick MF., Vascular events in healthy
older women receiving Bolland MJ., Barber PA., Doughty RN., Mason B., Vascular events in healthy
older women receiving Bolland MJ., Barber PA., Doughty RN., Mason B., Vascular events in healthy
older women receiving Bolland MJ., Barber PA., Doughty RN., Mason B., Vascular events in healthy
older women receiving Bolland MJ., Barber PA., Doughty RN., Mason B., Vascular events in healthy
older women receiving Bolland MJ., Barber PA., Doughty RN., Mason B., Vascular events in healthy
older women receiving Bolland MJ., Barber PA., Doughty RN., Mason B., Vascular events in healthy
older women receiving Bolland MJ., Barber PA., Doughty RN., Mason B., Vascular events in healthy
older women receiving Bolland MJ., Barber PA., Doughty RN., Mason B., Two-year randomized
controlled trial of vitamin Bolton-Smith C., McMurdo ME., Paterson CR., Mole Two-year randomized
controlled trial of vitamin Bolton-Smith C., McMurdo ME., Paterson CR., Mole Two-year randomized
controlled trial of vitamin Bolton-Smith C., McMurdo ME., Paterson CR., Mole Two-year randomized
controlled trial of vitamin Bolton-Smith C., McMurdo ME., Paterson CR., Mole Dairy calcium
supplementation in Bortolotti M., Rudelle S., Schneiter P., Vidal H., Dairy calcium
supplementation in Bortolotti M., Rudelle S., Schneiter P., Vidal H., Relation of calcium,
vitamin D, and dairy food Bostick RM., Potter JD., Sellers TA., McKenzie DR., Relation of calcium,
vitamin D, and dairy food Bostick RM., Potter JD., Sellers TA., McKenzie DR., Relation of calcium,
vitamin D, and dairy food Bostick RM., Potter JD., Sellers TA., McKenzie DR., Relation of calcium,
vitamin D, and dairy food Bostick RM., Potter JD., Sellers TA., McKenzie DR., Relation of calcium,
vitamin D, and dairy food Bostick RM., Potter JD., Sellers TA., McKenzie DR., Relation of calcium,
vitamin D, and dairy food Bostick RM., Kushi LH., Wu Y., Meyer KA., Sellers TA., Relation of calcium,
vitamin D, and dairy food Bostick RM., Kushi LH., Wu Y., Meyer KA., Sellers TA., Relation of calcium,
vitamin D, and dairy food Bostick RM., Kushi LH., Wu Y., Meyer KA., Sellers TA., Relation of calcium,
vitamin D, and dairy food Bostick RM., Kushi LH., Wu Y., Meyer KA., Sellers TA., Prostate cancer and
prediagnostic levels of Braun MM., Helzlsouer KJ., Hollis BW., Comstock GW.Prostate cancer and
prediagnostic levels of Braun MM., Helzlsouer KJ., Hollis BW., Comstock GW.Prostate cancer and
prediagnostic levels of Braun MM., Helzlsouer KJ., Hollis BW., Comstock GW.Prostate cancer and
prediagnostic levels of Braun MM., Helzlsouer KJ., Hollis BW., Comstock GW.Prostate cancer and
prediagnostic levels of Braun MM., Helzlsouer KJ., Hollis BW., Comstock GW.Prostate cancer and
prediagnostic levels of Braun MM., Helzlsouer KJ., Hollis BW., Comstock GW.Calcium, vitamin D
supplementation, and Brunner RL., Cochrane B., Jackson RD., Larson J., Calcium, vitamin D
supplementation, and Brunner RL., Cochrane B., Jackson RD., Larson J.,
200820082008200820082008200820082008200820062006200620062006200620062006200620062007200720072007200120012001200120082008200820082008200820082008200820052005200520052005200520052005200420042004
Calcium, vitamin D supplementation, and
Brunner RL., Cochrane B., Jackson RD., Larson J., Calcium, vitamin D
supplementation, and Brunner RL., Cochrane B., Jackson RD., Larson J., Calcium, vitamin D
supplementation, and Brunner RL., Cochrane B., Jackson RD., Larson J., Calcium, vitamin D
supplementation, and Brunner RL., Cochrane B., Jackson RD., Larson J., Calcium, vitamin D
supplementation, and Brunner RL., Cochrane B., Jackson RD., Larson J., Calcium, vitamin D
supplementation, and Brunner RL., Cochrane B., Jackson RD., Larson J., Calcium, vitamin D
supplementation, and Brunner RL., Cochrane B., Jackson RD., Larson J., Calcium, vitamin D
supplementation, and Brunner RL., Cochrane B., Jackson RD., Larson J., Calcium, vitamin D
supplementation, and Brunner RL., Cochrane B., Jackson RD., Larson J., Calcium, vitamin D
supplementation, and Brunner RL., Cochrane B., Jackson RD., Larson J., Effects of vitamin D
supplementation and Bunout D., Barrera G., Leiva L., Gattas V., de la Effects of vitamin D
supplementation and Bunout D., Barrera G., Leiva L., Gattas V., de la Effects of vitamin D
supplementation and Bunout D., Barrera G., Leiva L., Gattas V., de la Effects of vitamin D
supplementation and Bunout D., Barrera G., Leiva L., Gattas V., de la Effects of vitamin D
supplementation and Bunout D., Barrera G., Leiva L., Gattas V., de la Effects of vitamin D
supplementation and Bunout D., Barrera G., Leiva L., Gattas V., de la Effects of vitamin D
supplementation and Bunout D., Barrera G., Leiva L., Gattas V., de la Effects of vitamin D
supplementation and Bunout D., Barrera G., Leiva L., Gattas V., de la Effects of vitamin D
supplementation and Bunout D., Barrera G., Leiva L., Gattas V., de la Effects of vitamin D
supplementation and Bunout D., Barrera G., Leiva L., Gattas V., de la Does vitamin D stop
inpatients falling? A Burleigh E., McColl J., Potter J.Does vitamin D stop
inpatients falling? A Burleigh E., McColl J., Potter J.Does vitamin D stop
inpatients falling? A Burleigh E., McColl J., Potter J.Does vitamin D stop
inpatients falling? A Burleigh E., McColl J., Potter J.Dairy products, calcium,
and prostate cancer risk in Chan JM., Stampfer MJ., Ma J., Gann PH., Gaziano JM., Dairy products, calcium,
and prostate cancer risk in Chan JM., Stampfer MJ., Ma J., Gann PH., Gaziano JM., Dairy products, calcium,
and prostate cancer risk in Chan JM., Stampfer MJ., Ma J., Gann PH., Gaziano JM., Dairy products, calcium,
and prostate cancer risk in Chan JM., Stampfer MJ., Ma J., Gann PH., Gaziano JM., Calcium plus vitamin D
supplementation and the Chlebowski RT., Johnson KC., Kooperberg C., Calcium plus vitamin D
supplementation and the Chlebowski RT., Johnson KC., Kooperberg C., Calcium plus vitamin D
supplementation and the Chlebowski RT., Johnson KC., Kooperberg C., Calcium plus vitamin D
supplementation and the Chlebowski RT., Johnson KC., Kooperberg C., Calcium plus vitamin D
supplementation and the Chlebowski RT., Johnson KC., Kooperberg C., Calcium plus vitamin D
supplementation and the Chlebowski RT., Johnson KC., Kooperberg C., Calcium plus vitamin D
supplementation and the Chlebowski RT., Johnson KC., Kooperberg C., Calcium plus vitamin D
supplementation and the Chlebowski RT., Johnson KC., Kooperberg C., Calcium plus vitamin D
supplementation and the Chlebowski RT., Johnson KC., Kooperberg C., Effects of calcium, dairy
product, and vitamin D Cheng S., Lyytikäinen A., Kröger H., Lamberg-Allardt Effects of calcium, dairy
product, and vitamin D Cheng S., Lyytikäinen A., Kröger H., Lamberg-Allardt Effects of calcium, dairy
product, and vitamin D Cheng S., Lyytikäinen A., Kröger H., Lamberg-Allardt Effects of calcium, dairy
product, and vitamin D Cheng S., Lyytikäinen A., Kröger H., Lamberg-Allardt Effects of calcium, dairy
product, and vitamin D Cheng S., Lyytikäinen A., Kröger H., Lamberg-Allardt Effects of calcium, dairy
product, and vitamin D Cheng S., Lyytikäinen A., Kröger H., Lamberg-Allardt Effects of calcium, dairy
product, and vitamin D Cheng S., Lyytikäinen A., Kröger H., Lamberg-Allardt Effects of calcium, dairy
product, and vitamin D Cheng S., Lyytikäinen A., Kröger H., Lamberg-Allardt Weight loss and calcium
intake influence calcium Cifuentes M., Riedt CS., Brolin RE., Field MP., Weight loss and calcium
intake influence calcium Cifuentes M., Riedt CS., Brolin RE., Field MP., Weight loss and calcium
intake influence calcium Cifuentes M., Riedt CS., Brolin RE., Field MP.,
200420042004-- Not Found ---- Not Found ---- Not Found ---- Not Found ---- Not Found --1996199619961996199619961996199619961996199619961996199619961996199619961996199619961996199619962006200620062006200620062006200620062006200620062006200620062006
Weight loss and calcium intake influence calcium
Cifuentes M., Riedt CS., Brolin RE., Field MP., Weight loss and calcium
intake influence calcium Cifuentes M., Riedt CS., Brolin RE., Field MP., Weight loss and calcium
intake influence calcium Cifuentes M., Riedt CS., Brolin RE., Field MP., Calcium chemoprevention
in colorectal cancer.Duris I., Hruby D., Pekarkova B., Huorka M., Calcium chemoprevention
in colorectal cancer.Duris I., Hruby D., Pekarkova B., Huorka M., Calcium chemoprevention
in colorectal cancer.Duris I., Hruby D., Pekarkova B., Huorka M., Calcium chemoprevention
in colorectal cancer.Duris I., Hruby D., Pekarkova B., Huorka M., Calcium chemoprevention
in colorectal cancer.Duris I., Hruby D., Pekarkova B., Huorka M., Dietary calcium, alcohol,
and incidence of treated Dwyer JH., Li L., Dwyer KM., Curtin LR., Feinleib M.Dietary calcium, alcohol,
and incidence of treated Dwyer JH., Li L., Dwyer KM., Curtin LR., Feinleib M.Dietary calcium, alcohol,
and incidence of treated Dwyer JH., Li L., Dwyer KM., Curtin LR., Feinleib M.Dietary calcium, alcohol,
and incidence of treated Dwyer JH., Li L., Dwyer KM., Curtin LR., Feinleib M.Dietary calcium, alcohol,
and incidence of treated Dwyer JH., Li L., Dwyer KM., Curtin LR., Feinleib M.Dietary calcium, alcohol,
and incidence of treated Dwyer JH., Li L., Dwyer KM., Curtin LR., Feinleib M.Dietary calcium, alcohol,
and incidence of treated Dwyer JH., Li L., Dwyer KM., Curtin LR., Feinleib M.Dietary calcium, alcohol,
and incidence of treated Dwyer JH., Li L., Dwyer KM., Curtin LR., Feinleib M.Dietary calcium, alcohol,
and incidence of treated Dwyer JH., Li L., Dwyer KM., Curtin LR., Feinleib M.Dietary calcium, alcohol,
and incidence of treated Dwyer JH., Li L., Dwyer KM., Curtin LR., Feinleib M.Dietary calcium, alcohol,
and incidence of treated Dwyer JH., Li L., Dwyer KM., Curtin LR., Feinleib M.Dietary calcium, alcohol,
and incidence of treated Dwyer JH., Li L., Dwyer KM., Curtin LR., Feinleib M.Dietary calcium, alcohol,
and incidence of treated Dwyer JH., Li L., Dwyer KM., Curtin LR., Feinleib M.Dietary calcium, alcohol,
and incidence of treated Dwyer JH., Li L., Dwyer KM., Curtin LR., Feinleib M.Dietary calcium, alcohol,
and incidence of treated Dwyer JH., Li L., Dwyer KM., Curtin LR., Feinleib M.Dietary calcium, alcohol,
and incidence of treated Dwyer JH., Li L., Dwyer KM., Curtin LR., Feinleib M.Dietary calcium, alcohol,
and incidence of treated Dwyer JH., Li L., Dwyer KM., Curtin LR., Feinleib M.Dietary calcium, alcohol,
and incidence of treated Dwyer JH., Li L., Dwyer KM., Curtin LR., Feinleib M.Dietary calcium, alcohol,
and incidence of treated Dwyer JH., Li L., Dwyer KM., Curtin LR., Feinleib M.Dietary calcium, alcohol,
and incidence of treated Dwyer JH., Li L., Dwyer KM., Curtin LR., Feinleib M.Dietary calcium, alcohol,
and incidence of treated Dwyer JH., Li L., Dwyer KM., Curtin LR., Feinleib M.Dietary calcium, alcohol,
and incidence of treated Dwyer JH., Li L., Dwyer KM., Curtin LR., Feinleib M.Dietary calcium, alcohol,
and incidence of treated Dwyer JH., Li L., Dwyer KM., Curtin LR., Feinleib M.Dietary calcium, alcohol,
and incidence of treated Dwyer JH., Li L., Dwyer KM., Curtin LR., Feinleib M.Effect of 1-year dairy
product intervention on fat Eagan MS., Lyle RM., Gunther CW., Peacock M., Effect of 1-year dairy
product intervention on fat Eagan MS., Lyle RM., Gunther CW., Peacock M., Effect of 1-year dairy
product intervention on fat Eagan MS., Lyle RM., Gunther CW., Peacock M., Effect of 1-year dairy
product intervention on fat Eagan MS., Lyle RM., Gunther CW., Peacock M., Effect of 1-year dairy
product intervention on fat Eagan MS., Lyle RM., Gunther CW., Peacock M., Effect of 1-year dairy
product intervention on fat Eagan MS., Lyle RM., Gunther CW., Peacock M., Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J., Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J., Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J., Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J., Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J., Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J., Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J., Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J., Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J., Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J.,
200620062006200620062006200620062006200620062006200620062006200620061994199419941994199419941994199419941994199419941994199419941994199419941994199419941994199419942004200420042004200420042004
Effect of vitamin D replacement on
El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J., Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J., Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J., Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J., Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J., Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J., Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J., Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J., Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J., Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J., Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J., Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J., Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J., Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J., Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J., Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J., Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J., Seasonal and geographical
variations in the growth Feliciano ES., Ho ML., Specker BL., Falciglia G., Seasonal and geographical
variations in the growth Feliciano ES., Ho ML., Specker BL., Falciglia G., Seasonal and geographical
variations in the growth Feliciano ES., Ho ML., Specker BL., Falciglia G., Seasonal and geographical
variations in the growth Feliciano ES., Ho ML., Specker BL., Falciglia G., Seasonal and geographical
variations in the growth Feliciano ES., Ho ML., Specker BL., Falciglia G., Seasonal and geographical
variations in the growth Feliciano ES., Ho ML., Specker BL., Falciglia G., Seasonal and geographical
variations in the growth Feliciano ES., Ho ML., Specker BL., Falciglia G., Seasonal and geographical
variations in the growth Feliciano ES., Ho ML., Specker BL., Falciglia G., Seasonal and geographical
variations in the growth Feliciano ES., Ho ML., Specker BL., Falciglia G., Seasonal and geographical
variations in the growth Feliciano ES., Ho ML., Specker BL., Falciglia G., Seasonal and geographical
variations in the growth Feliciano ES., Ho ML., Specker BL., Falciglia G., Seasonal and geographical
variations in the growth Feliciano ES., Ho ML., Specker BL., Falciglia G., Seasonal and geographical
variations in the growth Feliciano ES., Ho ML., Specker BL., Falciglia G., Seasonal and geographical
variations in the growth Feliciano ES., Ho ML., Specker BL., Falciglia G., Seasonal and geographical
variations in the growth Feliciano ES., Ho ML., Specker BL., Falciglia G., Seasonal and geographical
variations in the growth Feliciano ES., Ho ML., Specker BL., Falciglia G., Seasonal and geographical
variations in the growth Feliciano ES., Ho ML., Specker BL., Falciglia G., Seasonal and geographical
variations in the growth Feliciano ES., Ho ML., Specker BL., Falciglia G., Seasonal and geographical
variations in the growth Feliciano ES., Ho ML., Specker BL., Falciglia G., Seasonal and geographical
variations in the growth Feliciano ES., Ho ML., Specker BL., Falciglia G., Seasonal and geographical
variations in the growth Feliciano ES., Ho ML., Specker BL., Falciglia G., Seasonal and geographical
variations in the growth Feliciano ES., Ho ML., Specker BL., Falciglia G., Seasonal and geographical
variations in the growth Feliciano ES., Ho ML., Specker BL., Falciglia G., Seasonal and geographical
variations in the growth Feliciano ES., Ho ML., Specker BL., Falciglia G., Plasma vitamin D
metabolites and risk of Feskanich D., Ma J., Fuchs CS., Kirkner GJ., Hankinson Plasma vitamin D
metabolites and risk of Feskanich D., Ma J., Fuchs CS., Kirkner GJ., Hankinson Plasma vitamin D
metabolites and risk of Feskanich D., Ma J., Fuchs CS., Kirkner GJ., Hankinson Plasma vitamin D
metabolites and risk of Feskanich D., Ma J., Fuchs CS., Kirkner GJ., Hankinson Plasma vitamin D
metabolites and risk of Feskanich D., Ma J., Fuchs CS., Kirkner GJ., Hankinson Plasma vitamin D
metabolites and risk of Feskanich D., Ma J., Fuchs CS., Kirkner GJ., Hankinson Plasma vitamin D
metabolites and risk of Feskanich D., Ma J., Fuchs CS., Kirkner GJ., Hankinson
200420042004200520052005200520052005200520052005200520052005200520052005200520052005200520052005200520052005200520082008200820082008200820072007200720072007200720072007200720072007200720072007
Plasma vitamin D metabolites and risk of
Feskanich D., Ma J., Fuchs CS., Kirkner GJ., Hankinson Plasma vitamin D
metabolites and risk of Feskanich D., Ma J., Fuchs CS., Kirkner GJ., Hankinson Plasma vitamin D
metabolites and risk of Feskanich D., Ma J., Fuchs CS., Kirkner GJ., Hankinson Calcium from diet and
supplements is associated Flood A., Peters U., Chatterjee N., Lacey JV., Calcium from diet and
supplements is associated Flood A., Peters U., Chatterjee N., Lacey JV., Calcium from diet and
supplements is associated Flood A., Peters U., Chatterjee N., Lacey JV., Calcium from diet and
supplements is associated Flood A., Peters U., Chatterjee N., Lacey JV., Calcium from diet and
supplements is associated Flood A., Peters U., Chatterjee N., Lacey JV., Calcium from diet and
supplements is associated Flood A., Peters U., Chatterjee N., Lacey JV., Calcium from diet and
supplements is associated Flood A., Peters U., Chatterjee N., Lacey JV., Calcium from diet and
supplements is associated Flood A., Peters U., Chatterjee N., Lacey JV., Calcium from diet and
supplements is associated Flood A., Peters U., Chatterjee N., Lacey JV., Calcium from diet and
supplements is associated Flood A., Peters U., Chatterjee N., Lacey JV., Calcium from diet and
supplements is associated Flood A., Peters U., Chatterjee N., Lacey JV., Calcium from diet and
supplements is associated Flood A., Peters U., Chatterjee N., Lacey JV., Calcium from diet and
supplements is associated Flood A., Peters U., Chatterjee N., Lacey JV., Calcium from diet and
supplements is associated Flood A., Peters U., Chatterjee N., Lacey JV., Calcium from diet and
supplements is associated Flood A., Peters U., Chatterjee N., Lacey JV., Calcium from diet and
supplements is associated Flood A., Peters U., Chatterjee N., Lacey JV., Calcium from diet and
supplements is associated Flood A., Peters U., Chatterjee N., Lacey JV., Calcium from diet and
supplements is associated Flood A., Peters U., Chatterjee N., Lacey JV., Calcium from diet and
supplements is associated Flood A., Peters U., Chatterjee N., Lacey JV., Calcium from diet and
supplements is associated Flood A., Peters U., Chatterjee N., Lacey JV., Calcium from diet and
supplements is associated Flood A., Peters U., Chatterjee N., Lacey JV., Calcium from diet and
supplements is associated Flood A., Peters U., Chatterjee N., Lacey JV., Calcium from diet and
supplements is associated Flood A., Peters U., Chatterjee N., Lacey JV., Calcium from diet and
supplements is associated Flood A., Peters U., Chatterjee N., Lacey JV., Calcium from diet and
supplements is associated Flood A., Peters U., Chatterjee N., Lacey JV., Plasma 25-hydroxyvitamin
D levels and risk of Forman JP., Curhan GC., Taylor EN.Plasma 25-hydroxyvitamin
D levels and risk of Forman JP., Curhan GC., Taylor EN.Plasma 25-hydroxyvitamin
D levels and risk of Forman JP., Curhan GC., Taylor EN.Plasma 25-hydroxyvitamin
D levels and risk of Forman JP., Curhan GC., Taylor EN.Plasma 25-hydroxyvitamin
D levels and risk of Forman JP., Curhan GC., Taylor EN.Plasma 25-hydroxyvitamin
D levels and risk of Forman JP., Curhan GC., Taylor EN.Prospective study of
serum vitamin D and Freedman DM., Looker AC., Chang SC., Graubard Prospective study of
serum vitamin D and Freedman DM., Looker AC., Chang SC., Graubard Prospective study of
serum vitamin D and Freedman DM., Looker AC., Chang SC., Graubard Prospective study of
serum vitamin D and Freedman DM., Looker AC., Chang SC., Graubard Prospective study of
serum vitamin D and Freedman DM., Looker AC., Chang SC., Graubard Prospective study of
serum vitamin D and Freedman DM., Looker AC., Chang SC., Graubard Prospective study of
serum vitamin D and Freedman DM., Looker AC., Chang SC., Graubard Prospective study of
serum vitamin D and Freedman DM., Looker AC., Chang SC., Graubard Prospective study of
serum vitamin D and Freedman DM., Looker AC., Chang SC., Graubard Prospective study of
serum vitamin D and Freedman DM., Looker AC., Chang SC., Graubard Prospective study of
serum vitamin D and Freedman DM., Looker AC., Chang SC., Graubard Prospective study of
serum vitamin D and Freedman DM., Looker AC., Chang SC., Graubard Prospective study of
serum vitamin D and Freedman DM., Looker AC., Chang SC., Graubard Prospective study of
serum vitamin D and Freedman DM., Looker AC., Chang SC., Graubard
200720072007200720072007200720072007200720082008200820082008200820082008200820082008200820082008200820082008200820082008200820082008200820082008200820082008200819961996199619961996199619961996
Prospective study of serum vitamin D and
Freedman DM., Looker AC., Chang SC., Graubard Prospective study of
serum vitamin D and Freedman DM., Looker AC., Chang SC., Graubard Prospective study of
serum vitamin D and Freedman DM., Looker AC., Chang SC., Graubard Prospective study of
serum vitamin D and Freedman DM., Looker AC., Chang SC., Graubard Prospective study of
serum vitamin D and Freedman DM., Looker AC., Chang SC., Graubard Prospective study of
serum vitamin D and Freedman DM., Looker AC., Chang SC., Graubard Prospective study of
serum vitamin D and Freedman DM., Looker AC., Chang SC., Graubard Prospective study of
serum vitamin D and Freedman DM., Looker AC., Chang SC., Graubard Prospective study of
serum vitamin D and Freedman DM., Looker AC., Chang SC., Graubard Prospective study of
serum vitamin D and Freedman DM., Looker AC., Chang SC., Graubard Serum levels of vitamin D
metabolites and breast Freedman DM., Chang SC., Falk RT., Purdue MP., Serum levels of vitamin D
metabolites and breast Freedman DM., Chang SC., Falk RT., Purdue MP., Serum levels of vitamin D
metabolites and breast Freedman DM., Chang SC., Falk RT., Purdue MP., Serum levels of vitamin D
metabolites and breast Freedman DM., Chang SC., Falk RT., Purdue MP., Serum levels of vitamin D
metabolites and breast Freedman DM., Chang SC., Falk RT., Purdue MP., Serum levels of vitamin D
metabolites and breast Freedman DM., Chang SC., Falk RT., Purdue MP., Serum levels of vitamin D
metabolites and breast Freedman DM., Chang SC., Falk RT., Purdue MP., Serum levels of vitamin D
metabolites and breast Freedman DM., Chang SC., Falk RT., Purdue MP., Serum levels of vitamin D
metabolites and breast Freedman DM., Chang SC., Falk RT., Purdue MP., Serum levels of vitamin D
metabolites and breast Freedman DM., Chang SC., Falk RT., Purdue MP., Maternal vitamin D status
during pregnancy and Gale CR., Robinson SM., Harvey NC., Javaid MK., Maternal vitamin D status
during pregnancy and Gale CR., Robinson SM., Harvey NC., Javaid MK., Maternal vitamin D status
during pregnancy and Gale CR., Robinson SM., Harvey NC., Javaid MK., Maternal vitamin D status
during pregnancy and Gale CR., Robinson SM., Harvey NC., Javaid MK., Maternal vitamin D status
during pregnancy and Gale CR., Robinson SM., Harvey NC., Javaid MK., Maternal vitamin D status
during pregnancy and Gale CR., Robinson SM., Harvey NC., Javaid MK., Maternal vitamin D status
during pregnancy and Gale CR., Robinson SM., Harvey NC., Javaid MK., Maternal vitamin D status
during pregnancy and Gale CR., Robinson SM., Harvey NC., Javaid MK., Maternal vitamin D status
during pregnancy and Gale CR., Robinson SM., Harvey NC., Javaid MK., Maternal vitamin D status
during pregnancy and Gale CR., Robinson SM., Harvey NC., Javaid MK., Maternal vitamin D status
during pregnancy and Gale CR., Robinson SM., Harvey NC., Javaid MK., Maternal vitamin D status
during pregnancy and Gale CR., Robinson SM., Harvey NC., Javaid MK., Maternal vitamin D status
during pregnancy and Gale CR., Robinson SM., Harvey NC., Javaid MK., Maternal vitamin D status
during pregnancy and Gale CR., Robinson SM., Harvey NC., Javaid MK., Maternal vitamin D status
during pregnancy and Gale CR., Robinson SM., Harvey NC., Javaid MK., Maternal vitamin D status
during pregnancy and Gale CR., Robinson SM., Harvey NC., Javaid MK., Maternal vitamin D status
during pregnancy and Gale CR., Robinson SM., Harvey NC., Javaid MK., Maternal vitamin D status
during pregnancy and Gale CR., Robinson SM., Harvey NC., Javaid MK., Maternal vitamin D status
during pregnancy and Gale CR., Robinson SM., Harvey NC., Javaid MK., Maternal vitamin D status
during pregnancy and Gale CR., Robinson SM., Harvey NC., Javaid MK., Circulating vitamin D
metabolites in relation to Gann PH., Ma J., Hennekens CH., Hollis Circulating vitamin D
metabolites in relation to Gann PH., Ma J., Hennekens CH., Hollis Circulating vitamin D
metabolites in relation to Gann PH., Ma J., Hennekens CH., Hollis Circulating vitamin D
metabolites in relation to Gann PH., Ma J., Hennekens CH., Hollis Circulating vitamin D
metabolites in relation to Gann PH., Ma J., Hennekens CH., Hollis Circulating vitamin D
metabolites in relation to Gann PH., Ma J., Hennekens CH., Hollis Circulating vitamin D
metabolites in relation to Gann PH., Ma J., Hennekens CH., Hollis Circulating vitamin D
metabolites in relation to Gann PH., Ma J., Hennekens CH., Hollis
198519851985198519891989198919891989198919891989198919951995199519951995199520072007200720072007200719991999199919991999199919991999199919991999199920052005200520052005200520052005200520052005
Dietary vitamin D and calcium and risk of
Garland C., Shekelle RB., Barrett-Connor E., Criqui Dietary vitamin D and
calcium and risk of Garland C., Shekelle RB., Barrett-Connor E., Criqui Dietary vitamin D and
calcium and risk of Garland C., Shekelle RB., Barrett-Connor E., Criqui Dietary vitamin D and
calcium and risk of Garland C., Shekelle RB., Barrett-Connor E., Criqui Serum 25-hydroxyvitamin
D and colon cancer: eight-Garland CF., Comstock GW., Garland FC., Helsing Serum 25-hydroxyvitamin
D and colon cancer: eight-Garland CF., Comstock GW., Garland FC., Helsing Serum 25-hydroxyvitamin
D and colon cancer: eight-Garland CF., Comstock GW., Garland FC., Helsing Serum 25-hydroxyvitamin
D and colon cancer: eight-Garland CF., Comstock GW., Garland FC., Helsing Serum 25-hydroxyvitamin
D and colon cancer: eight-Garland CF., Comstock GW., Garland FC., Helsing Serum 25-hydroxyvitamin
D and colon cancer: eight-Garland CF., Comstock GW., Garland FC., Helsing Serum 25-hydroxyvitamin
D and colon cancer: eight-Garland CF., Comstock GW., Garland FC., Helsing Serum 25-hydroxyvitamin
D and colon cancer: eight-Garland CF., Comstock GW., Garland FC., Helsing Serum 25-hydroxyvitamin
D and colon cancer: eight-Garland CF., Comstock GW., Garland FC., Helsing The influence of dairy
products on plasma uric Ghadirian P., Shatenstein B., Verdy M., Hamet P.The influence of dairy
products on plasma uric Ghadirian P., Shatenstein B., Verdy M., Hamet P.The influence of dairy
products on plasma uric Ghadirian P., Shatenstein B., Verdy M., Hamet P.The influence of dairy
products on plasma uric Ghadirian P., Shatenstein B., Verdy M., Hamet P.The influence of dairy
products on plasma uric Ghadirian P., Shatenstein B., Verdy M., Hamet P.The influence of dairy
products on plasma uric Ghadirian P., Shatenstein B., Verdy M., Hamet P.Prolonged effect of
calcium supplementation Grau MV., Baron JA., Sandler RS., Wallace K., Prolonged effect of
calcium supplementation Grau MV., Baron JA., Sandler RS., Wallace K., Prolonged effect of
calcium supplementation Grau MV., Baron JA., Sandler RS., Wallace K., Prolonged effect of
calcium supplementation Grau MV., Baron JA., Sandler RS., Wallace K., Prolonged effect of
calcium supplementation Grau MV., Baron JA., Sandler RS., Wallace K., Prolonged effect of
calcium supplementation Grau MV., Baron JA., Sandler RS., Wallace K., Plasma 25-hydroxyvitamin
D responses of younger Harris SS., Dawson-Hughes B., Perrone GA.Plasma 25-hydroxyvitamin
D responses of younger Harris SS., Dawson-Hughes B., Perrone GA.Plasma 25-hydroxyvitamin
D responses of younger Harris SS., Dawson-Hughes B., Perrone GA.Plasma 25-hydroxyvitamin
D responses of younger Harris SS., Dawson-Hughes B., Perrone GA.Plasma 25-hydroxyvitamin
D responses of younger Harris SS., Dawson-Hughes B., Perrone GA.Plasma 25-hydroxyvitamin
D responses of younger Harris SS., Dawson-Hughes B., Perrone GA.Plasma 25-hydroxyvitamin
D responses of younger Harris SS., Dawson-Hughes B., Perrone GA.Plasma 25-hydroxyvitamin
D responses of younger Harris SS., Dawson-Hughes B., Perrone GA.Plasma 25-hydroxyvitamin
D responses of younger Harris SS., Dawson-Hughes B., Perrone GA.Plasma 25-hydroxyvitamin
D responses of younger Harris SS., Dawson-Hughes B., Perrone GA.Plasma 25-hydroxyvitamin
D responses of younger Harris SS., Dawson-Hughes B., Perrone GA.Plasma 25-hydroxyvitamin
D responses of younger Harris SS., Dawson-Hughes B., Perrone GA.The association of calcium
and vitamin D with risk of Hartman TJ., Albert PS., Snyder K., Slattery ML., The association of calcium
and vitamin D with risk of Hartman TJ., Albert PS., Snyder K., Slattery ML., The association of calcium
and vitamin D with risk of Hartman TJ., Albert PS., Snyder K., Slattery ML., The association of calcium
and vitamin D with risk of Hartman TJ., Albert PS., Snyder K., Slattery ML., The association of calcium
and vitamin D with risk of Hartman TJ., Albert PS., Snyder K., Slattery ML., The association of calcium
and vitamin D with risk of Hartman TJ., Albert PS., Snyder K., Slattery ML., The association of calcium
and vitamin D with risk of Hartman TJ., Albert PS., Snyder K., Slattery ML., The association of calcium
and vitamin D with risk of Hartman TJ., Albert PS., Snyder K., Slattery ML., The association of calcium
and vitamin D with risk of Hartman TJ., Albert PS., Snyder K., Slattery ML., The association of calcium
and vitamin D with risk of Hartman TJ., Albert PS., Snyder K., Slattery ML., The association of calcium
and vitamin D with risk of Hartman TJ., Albert PS., Snyder K., Slattery ML.,
200520052005200520052005200320032003200319972004200420042004200420042001200120012001200120012001200120012001200120012008200820082008200820081994199419941994199419971997199719971996199619961996
The association of calcium and vitamin D with risk of
Hartman TJ., Albert PS., Snyder K., Slattery ML., The association of calcium
and vitamin D with risk of Hartman TJ., Albert PS., Snyder K., Slattery ML., The association of calcium
and vitamin D with risk of Hartman TJ., Albert PS., Snyder K., Slattery ML., The association of calcium
and vitamin D with risk of Hartman TJ., Albert PS., Snyder K., Slattery ML., The impact of calcium and
dairy product consumption Harvey-Berino J., Gold BC., Lauber R., Starinski A.The impact of calcium and
dairy product consumption Harvey-Berino J., Gold BC., Lauber R., Starinski A.Gestational calcium
supplementation and Hatton DC., Harrison-Hohner J., Coste S., Reller Gestational calcium
supplementation and Hatton DC., Harrison-Hohner J., Coste S., Reller Gestational calcium
supplementation and Hatton DC., Harrison-Hohner J., Coste S., Reller Gestational calcium
supplementation and Hatton DC., Harrison-Hohner J., Coste S., Reller Long-term vitamin D3
supplementation may Heikkinen AM., Tuppurainen MT., Plasma levels of 25-
hydroxyvitamin D, 1,25-Jacobs ET., Giuliano AR., Martínez ME., Hollis BW., Plasma levels of 25-
hydroxyvitamin D, 1,25-Jacobs ET., Giuliano AR., Martínez ME., Hollis BW., Plasma levels of 25-
hydroxyvitamin D, 1,25-Jacobs ET., Giuliano AR., Martínez ME., Hollis BW., Plasma levels of 25-
hydroxyvitamin D, 1,25-Jacobs ET., Giuliano AR., Martínez ME., Hollis BW., Plasma levels of 25-
hydroxyvitamin D, 1,25-Jacobs ET., Giuliano AR., Martínez ME., Hollis BW., Plasma levels of 25-
hydroxyvitamin D, 1,25-Jacobs ET., Giuliano AR., Martínez ME., Hollis BW., Prospective study on milk
products, calcium and Järvinen R., Knekt P., Hakulinen T., Aromaa A.Prospective study on milk
products, calcium and Järvinen R., Knekt P., Hakulinen T., Aromaa A.Prospective study on milk
products, calcium and Järvinen R., Knekt P., Hakulinen T., Aromaa A.Prospective study on milk
products, calcium and Järvinen R., Knekt P., Hakulinen T., Aromaa A.Prospective study on milk
products, calcium and Järvinen R., Knekt P., Hakulinen T., Aromaa A.Prospective study on milk
products, calcium and Järvinen R., Knekt P., Hakulinen T., Aromaa A.Prospective study on milk
products, calcium and Järvinen R., Knekt P., Hakulinen T., Aromaa A.Prospective study on milk
products, calcium and Järvinen R., Knekt P., Hakulinen T., Aromaa A.Prospective study on milk
products, calcium and Järvinen R., Knekt P., Hakulinen T., Aromaa A.Prospective study on milk
products, calcium and Järvinen R., Knekt P., Hakulinen T., Aromaa A.Prospective study on milk
products, calcium and Järvinen R., Knekt P., Hakulinen T., Aromaa A.Prospective study on milk
products, calcium and Järvinen R., Knekt P., Hakulinen T., Aromaa A.Calcium intake and the
outcome of short-term Kabrnová-Hlavatá K., Hainer V., Gojová M., Calcium intake and the
outcome of short-term Kabrnová-Hlavatá K., Hainer V., Gojová M., Calcium intake and the
outcome of short-term Kabrnová-Hlavatá K., Hainer V., Gojová M., Calcium intake and the
outcome of short-term Kabrnová-Hlavatá K., Hainer V., Gojová M., Calcium intake and the
outcome of short-term Kabrnová-Hlavatá K., Hainer V., Gojová M., Calcium intake and the
outcome of short-term Kabrnová-Hlavatá K., Hainer V., Gojová M., Fermented dairy products,
calcium, and colorectal Kampman E., Goldbohm RA., van den Brandt PA., Fermented dairy products,
calcium, and colorectal Kampman E., Goldbohm RA., van den Brandt PA., Fermented dairy products,
calcium, and colorectal Kampman E., Goldbohm RA., van den Brandt PA., Fermented dairy products,
calcium, and colorectal Kampman E., Goldbohm RA., van den Brandt PA., Fermented dairy products,
calcium, and colorectal Kampman E., Goldbohm RA., van den Brandt PA., Prospective study of diet
and female colorectal Kato I., Akhmedkhanov A., Koenig K., Toniolo PG., Prospective study of diet
and female colorectal Kato I., Akhmedkhanov A., Koenig K., Toniolo PG., Prospective study of diet
and female colorectal Kato I., Akhmedkhanov A., Koenig K., Toniolo PG., Prospective study of diet
and female colorectal Kato I., Akhmedkhanov A., Koenig K., Toniolo PG., Calcium, vitamin D, and
dairy foods and the Kearney J., Giovannucci E., Rimm EB., Ascherio A., Calcium, vitamin D, and
dairy foods and the Kearney J., Giovannucci E., Rimm EB., Ascherio A., Calcium, vitamin D, and
dairy foods and the Kearney J., Giovannucci E., Rimm EB., Ascherio A., Calcium, vitamin D, and
dairy foods and the Kearney J., Giovannucci E., Rimm EB., Ascherio A.,
199620052005200520052007200720072007200720072007200720072007200720072006200620042004200420042004200420072007200720072007200720072007200720082008200820082006200620062006200620062006200620062006
Calcium, vitamin D, and dairy foods and the
Kearney J., Giovannucci E., Rimm EB., Ascherio A., Dietary calcium,
phosphorus, vitamin D, Kesse E., Boutron-Ruault MC., Norat T., Riboli E., Dietary calcium,
phosphorus, vitamin D, Kesse E., Boutron-Ruault MC., Norat T., Riboli E., Dietary calcium,
phosphorus, vitamin D, Kesse E., Boutron-Ruault MC., Norat T., Riboli E., Dietary calcium,
phosphorus, vitamin D, Kesse E., Boutron-Ruault MC., Norat T., Riboli E., Dairy products, calcium
and the risk of breast Kesse-Guyot E., Bertrais S., Duperray B., Arnault N., Dairy products, calcium
and the risk of breast Kesse-Guyot E., Bertrais S., Duperray B., Arnault N., Dairy products, calcium
and the risk of breast Kesse-Guyot E., Bertrais S., Duperray B., Arnault N., Dairy products, calcium
and the risk of breast Kesse-Guyot E., Bertrais S., Duperray B., Arnault N., Dairy products, calcium
and the risk of breast Kesse-Guyot E., Bertrais S., Duperray B., Arnault N., Dairy products, calcium
and the risk of breast Kesse-Guyot E., Bertrais S., Duperray B., Arnault N., Dairy products, calcium
and the risk of breast Kesse-Guyot E., Bertrais S., Duperray B., Arnault N., Dairy products, calcium
and the risk of breast Kesse-Guyot E., Bertrais S., Duperray B., Arnault N., Dairy products, calcium
and the risk of breast Kesse-Guyot E., Bertrais S., Duperray B., Arnault N., Dairy products, calcium
and the risk of breast Kesse-Guyot E., Bertrais S., Duperray B., Arnault N., Dairy products, calcium
and the risk of breast Kesse-Guyot E., Bertrais S., Duperray B., Arnault N., Dairy products, calcium
and the risk of breast Kesse-Guyot E., Bertrais S., Duperray B., Arnault N., Dairy products, calcium
and prostate cancer risk.Koh KA., Sesso HD., Paffenbarger RS., Lee IM.Dairy products, calcium
and prostate cancer risk.Koh KA., Sesso HD., Paffenbarger RS., Lee IM.Girls on a high-calcium
diet gain weight at the Lappe JM., Rafferty KA., Davies KM., Lypaczewski Girls on a high-calcium
diet gain weight at the Lappe JM., Rafferty KA., Davies KM., Lypaczewski Girls on a high-calcium
diet gain weight at the Lappe JM., Rafferty KA., Davies KM., Lypaczewski Girls on a high-calcium
diet gain weight at the Lappe JM., Rafferty KA., Davies KM., Lypaczewski Girls on a high-calcium
diet gain weight at the Lappe JM., Rafferty KA., Davies KM., Lypaczewski Girls on a high-calcium
diet gain weight at the Lappe JM., Rafferty KA., Davies KM., Lypaczewski Vitamin D and calcium
supplementation reduces Lappe JM., Travers-Gustafson D., Davies KM., Vitamin D and calcium
supplementation reduces Lappe JM., Travers-Gustafson D., Davies KM., Vitamin D and calcium
supplementation reduces Lappe JM., Travers-Gustafson D., Davies KM., Vitamin D and calcium
supplementation reduces Lappe JM., Travers-Gustafson D., Davies KM., Vitamin D and calcium
supplementation reduces Lappe JM., Travers-Gustafson D., Davies KM., Vitamin D and calcium
supplementation reduces Lappe JM., Travers-Gustafson D., Davies KM., Vitamin D and calcium
supplementation reduces Lappe JM., Travers-Gustafson D., Davies KM., Vitamin D and calcium
supplementation reduces Lappe JM., Travers-Gustafson D., Davies KM., Vitamin D and calcium
supplementation reduces Lappe JM., Travers-Gustafson D., Davies KM., Calcium and vitamin d
supplementation Lappe J., Cullen D., Haynatzki G., Recker R., Calcium and vitamin d
supplementation Lappe J., Cullen D., Haynatzki G., Recker R., Calcium and vitamin d
supplementation Lappe J., Cullen D., Haynatzki G., Recker R., Calcium and vitamin d
supplementation Lappe J., Cullen D., Haynatzki G., Recker R., Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci
200620062006200620062006200620062006200620062006200620062008200820082008200820092009200920092009200720072007200720072007200720072007200720072007200720072007200720072007200720072007200720072007
Calcium and dairy food intakes are inversely
Larsson SC., Bergkvist L., Rutegård J., Giovannucci Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci Magnesium, calcium,
potassium, and sodium Larsson SC., Virtanen MJ., Mars M., Männistö S., Magnesium, calcium,
potassium, and sodium Larsson SC., Virtanen MJ., Mars M., Männistö S., Magnesium, calcium,
potassium, and sodium Larsson SC., Virtanen MJ., Mars M., Männistö S., Magnesium, calcium,
potassium, and sodium Larsson SC., Virtanen MJ., Mars M., Männistö S., Magnesium, calcium,
potassium, and sodium Larsson SC., Virtanen MJ., Mars M., Männistö S., Long-term dietary calcium
intake and breast cancer Larsson SC., Bergkvist L., Wolk A.Long-term dietary calcium
intake and breast cancer Larsson SC., Bergkvist L., Wolk A.Long-term dietary calcium
intake and breast cancer Larsson SC., Bergkvist L., Wolk A.Long-term dietary calcium
intake and breast cancer Larsson SC., Bergkvist L., Wolk A.Long-term dietary calcium
intake and breast cancer Larsson SC., Bergkvist L., Wolk A.A prospective study of
plasma vitamin D Li H., Stampfer MJ., Hollis JB., Mucci LA., Gaziano JM., A prospective study of
plasma vitamin D Li H., Stampfer MJ., Hollis JB., Mucci LA., Gaziano JM., A prospective study of
plasma vitamin D Li H., Stampfer MJ., Hollis JB., Mucci LA., Gaziano JM., A prospective study of
plasma vitamin D Li H., Stampfer MJ., Hollis JB., Mucci LA., Gaziano JM., A prospective study of
plasma vitamin D Li H., Stampfer MJ., Hollis JB., Mucci LA., Gaziano JM., A prospective study of
plasma vitamin D Li H., Stampfer MJ., Hollis JB., Mucci LA., Gaziano JM., A prospective study of
plasma vitamin D Li H., Stampfer MJ., Hollis JB., Mucci LA., Gaziano JM., A prospective study of
plasma vitamin D Li H., Stampfer MJ., Hollis JB., Mucci LA., Gaziano JM., A prospective study of
plasma vitamin D Li H., Stampfer MJ., Hollis JB., Mucci LA., Gaziano JM., A prospective study of
plasma vitamin D Li H., Stampfer MJ., Hollis JB., Mucci LA., Gaziano JM., A prospective study of
plasma vitamin D Li H., Stampfer MJ., Hollis JB., Mucci LA., Gaziano JM., A prospective study of
plasma vitamin D Li H., Stampfer MJ., Hollis JB., Mucci LA., Gaziano JM., A prospective study of
plasma vitamin D Li H., Stampfer MJ., Hollis JB., Mucci LA., Gaziano JM., A prospective study of
plasma vitamin D Li H., Stampfer MJ., Hollis JB., Mucci LA., Gaziano JM., A prospective study of
plasma vitamin D Li H., Stampfer MJ., Hollis JB., Mucci LA., Gaziano JM., A prospective study of
plasma vitamin D Li H., Stampfer MJ., Hollis JB., Mucci LA., Gaziano JM., A prospective study of
plasma vitamin D Li H., Stampfer MJ., Hollis JB., Mucci LA., Gaziano JM., A prospective study of
plasma vitamin D Li H., Stampfer MJ., Hollis JB., Mucci LA., Gaziano JM., A prospective study of
plasma vitamin D Li H., Stampfer MJ., Hollis JB., Mucci LA., Gaziano JM., A prospective study of
plasma vitamin D Li H., Stampfer MJ., Hollis JB., Mucci LA., Gaziano JM., A prospective study of
plasma vitamin D Li H., Stampfer MJ., Hollis JB., Mucci LA., Gaziano JM., A prospective study of
plasma vitamin D Li H., Stampfer MJ., Hollis JB., Mucci LA., Gaziano JM., A prospective study of
plasma vitamin D Li H., Stampfer MJ., Hollis JB., Mucci LA., Gaziano JM., A prospective study of
plasma vitamin D Li H., Stampfer MJ., Hollis JB., Mucci LA., Gaziano JM.,
200720072007200720072007200720071995 Lijnen P., Petrov V.1995 Lijnen P., Petrov V.1995 Lijnen P., Petrov V.1995 Lijnen P., Petrov V.1995 Lijnen P., Petrov V.1995 Lijnen P., Petrov V.1995 Lijnen P., Petrov V.1995 Lijnen P., Petrov V.1995 Lijnen P., Petrov V.1995 Lijnen P., Petrov V.1995 Lijnen P., Petrov V.1995 Lijnen P., Petrov V.2005200520052005200520072007200720072007200720072007200720072006200620062006200620062006200620062006200620062007
A prospective study of plasma vitamin D
Li H., Stampfer MJ., Hollis JB., Mucci LA., Gaziano JM., A prospective study of
plasma vitamin D Li H., Stampfer MJ., Hollis JB., Mucci LA., Gaziano JM., A prospective study of
plasma vitamin D Li H., Stampfer MJ., Hollis JB., Mucci LA., Gaziano JM., A prospective study of
plasma vitamin D Li H., Stampfer MJ., Hollis JB., Mucci LA., Gaziano JM., A prospective study of
plasma vitamin D Li H., Stampfer MJ., Hollis JB., Mucci LA., Gaziano JM., A prospective study of
plasma vitamin D Li H., Stampfer MJ., Hollis JB., Mucci LA., Gaziano JM., A prospective study of
plasma vitamin D Li H., Stampfer MJ., Hollis JB., Mucci LA., Gaziano JM., A prospective study of
plasma vitamin D Li H., Stampfer MJ., Hollis JB., Mucci LA., Gaziano JM., Dietary calcium, blood
pressure and cell Dietary calcium, blood pressure and cell Dietary calcium, blood pressure and cell Dietary calcium, blood pressure and cell Dietary calcium, blood pressure and cell Dietary calcium, blood pressure and cell Dietary calcium, blood pressure and cell Dietary calcium, blood pressure and cell Dietary calcium, blood pressure and cell Dietary calcium, blood pressure and cell Dietary calcium, blood pressure and cell Dietary calcium, blood pressure and cell Intakes of calcium and vitamin D and risk of
Lin J., Zhang SM., Cook NR., Manson JE., Lee IM., Intakes of calcium and
vitamin D and risk of Lin J., Zhang SM., Cook NR., Manson JE., Lee IM., Intakes of calcium and
vitamin D and risk of Lin J., Zhang SM., Cook NR., Manson JE., Lee IM., Intakes of calcium and
vitamin D and risk of Lin J., Zhang SM., Cook NR., Manson JE., Lee IM., Intakes of calcium and
vitamin D and risk of Lin J., Zhang SM., Cook NR., Manson JE., Lee IM., Intakes of calcium and
vitamin D and breast Lin J., Manson JE., Lee IM., Cook NR., Buring JE., Intakes of calcium and
vitamin D and breast Lin J., Manson JE., Lee IM., Cook NR., Buring JE., Intakes of calcium and
vitamin D and breast Lin J., Manson JE., Lee IM., Cook NR., Buring JE., Intakes of calcium and
vitamin D and breast Lin J., Manson JE., Lee IM., Cook NR., Buring JE., Intakes of calcium and
vitamin D and breast Lin J., Manson JE., Lee IM., Cook NR., Buring JE., Intakes of calcium and
vitamin D and breast Lin J., Manson JE., Lee IM., Cook NR., Buring JE., Intakes of calcium and
vitamin D and breast Lin J., Manson JE., Lee IM., Cook NR., Buring JE., Intakes of calcium and
vitamin D and breast Lin J., Manson JE., Lee IM., Cook NR., Buring JE., Intakes of calcium and
vitamin D and breast Lin J., Manson JE., Lee IM., Cook NR., Buring JE., Intakes of calcium and
vitamin D and breast Lin J., Manson JE., Lee IM., Cook NR., Buring JE., Calcium supplementation
for 1 y does not reduce Lorenzen JK., Mølgaard C., Michaelsen KF., Astrup A.Calcium supplementation
for 1 y does not reduce Lorenzen JK., Mølgaard C., Michaelsen KF., Astrup A.Calcium supplementation
for 1 y does not reduce Lorenzen JK., Mølgaard C., Michaelsen KF., Astrup A.Calcium supplementation
for 1 y does not reduce Lorenzen JK., Mølgaard C., Michaelsen KF., Astrup A.Calcium supplementation
for 1 y does not reduce Lorenzen JK., Mølgaard C., Michaelsen KF., Astrup A.Calcium supplementation
for 1 y does not reduce Lorenzen JK., Mølgaard C., Michaelsen KF., Astrup A.Calcium supplementation
for 1 y does not reduce Lorenzen JK., Mølgaard C., Michaelsen KF., Astrup A.Calcium supplementation
for 1 y does not reduce Lorenzen JK., Mølgaard C., Michaelsen KF., Astrup A.Calcium supplementation
for 1 y does not reduce Lorenzen JK., Mølgaard C., Michaelsen KF., Astrup A.Calcium supplementation
for 1 y does not reduce Lorenzen JK., Mølgaard C., Michaelsen KF., Astrup A.Calcium supplementation
for 1 y does not reduce Lorenzen JK., Mølgaard C., Michaelsen KF., Astrup A.Calcium supplementation
for 1 y does not reduce Lorenzen JK., Mølgaard C., Michaelsen KF., Astrup A.Preventing fractures
among older people living Lyons RA., Johansen A., Brophy S., Newcombe RG.,
200720072007200720072007200720072007200720071986198619861986198619861986198619861986198619861986198619862008200820082008200820082005200520052005200520052005200520052005200220022002200219871987
Preventing fractures among older people living
Lyons RA., Johansen A., Brophy S., Newcombe RG., Preventing fractures
among older people living Lyons RA., Johansen A., Brophy S., Newcombe RG., Preventing fractures
among older people living Lyons RA., Johansen A., Brophy S., Newcombe RG., Supplementation with
calcium + vitamin D Major GC., Alarie F., Doré J., Phouttama S., Tremblay Supplementation with
calcium + vitamin D Major GC., Alarie F., Doré J., Phouttama S., Tremblay Supplementation with
calcium + vitamin D Major GC., Alarie F., Doré J., Phouttama S., Tremblay Supplementation with
calcium + vitamin D Major GC., Alarie F., Doré J., Phouttama S., Tremblay Supplementation with
calcium + vitamin D Major GC., Alarie F., Doré J., Phouttama S., Tremblay Supplementation with
calcium + vitamin D Major GC., Alarie F., Doré J., Phouttama S., Tremblay Supplementation with
calcium + vitamin D Major GC., Alarie F., Doré J., Phouttama S., Tremblay Supplementation with
calcium + vitamin D Major GC., Alarie F., Doré J., Phouttama S., Tremblay Vitamin D
supplementation in Mallet E., Gügi B., Brunelle P., Hénocq A., Basuyau JP., Vitamin D
supplementation in Mallet E., Gügi B., Brunelle P., Hénocq A., Basuyau JP., Vitamin D
supplementation in Mallet E., Gügi B., Brunelle P., Hénocq A., Basuyau JP., Vitamin D
supplementation in Mallet E., Gügi B., Brunelle P., Hénocq A., Basuyau JP., Vitamin D
supplementation in Mallet E., Gügi B., Brunelle P., Hénocq A., Basuyau JP., Vitamin D
supplementation in Mallet E., Gügi B., Brunelle P., Hénocq A., Basuyau JP., Vitamin D
supplementation in Mallet E., Gügi B., Brunelle P., Hénocq A., Basuyau JP., Vitamin D
supplementation in Mallet E., Gügi B., Brunelle P., Hénocq A., Basuyau JP., Vitamin D
supplementation in Mallet E., Gügi B., Brunelle P., Hénocq A., Basuyau JP., Vitamin D
supplementation in Mallet E., Gügi B., Brunelle P., Hénocq A., Basuyau JP., Vitamin D
supplementation in Mallet E., Gügi B., Brunelle P., Hénocq A., Basuyau JP., Vitamin D
supplementation in Mallet E., Gügi B., Brunelle P., Hénocq A., Basuyau JP., Vitamin D
supplementation in Mallet E., Gügi B., Brunelle P., Hénocq A., Basuyau JP., Vitamin D
supplementation in Mallet E., Gügi B., Brunelle P., Hénocq A., Basuyau JP., Vitamin D
supplementation in Mallet E., Gügi B., Brunelle P., Hénocq A., Basuyau JP., Effect of calcium and
vitamin D supplementation Margolis KL., Ray RM., Van Horn L., Manson JE., Allison Effect of calcium and
vitamin D supplementation Margolis KL., Ray RM., Van Horn L., Manson JE., Allison Effect of calcium and
vitamin D supplementation Margolis KL., Ray RM., Van Horn L., Manson JE., Allison Effect of calcium and
vitamin D supplementation Margolis KL., Ray RM., Van Horn L., Manson JE., Allison Effect of calcium and
vitamin D supplementation Margolis KL., Ray RM., Van Horn L., Manson JE., Allison Effect of calcium and
vitamin D supplementation Margolis KL., Ray RM., Van Horn L., Manson JE., Allison Dietary and serum
vitamins and minerals as Marniemi J., Alanen E., Impivaara O., Seppänen Dietary and serum
vitamins and minerals as Marniemi J., Alanen E., Impivaara O., Seppänen Dietary and serum
vitamins and minerals as Marniemi J., Alanen E., Impivaara O., Seppänen Dietary and serum
vitamins and minerals as Marniemi J., Alanen E., Impivaara O., Seppänen Dietary and serum
vitamins and minerals as Marniemi J., Alanen E., Impivaara O., Seppänen Dietary and serum
vitamins and minerals as Marniemi J., Alanen E., Impivaara O., Seppänen Dietary and serum
vitamins and minerals as Marniemi J., Alanen E., Impivaara O., Seppänen Dietary and serum
vitamins and minerals as Marniemi J., Alanen E., Impivaara O., Seppänen Dietary and serum
vitamins and minerals as Marniemi J., Alanen E., Impivaara O., Seppänen Dietary and serum
vitamins and minerals as Marniemi J., Alanen E., Impivaara O., Seppänen Calcium, vitamin D, and
risk of adenoma Martínez ME., Marshall JR., Sampliner R., Wilkinson J., Calcium, vitamin D, and
risk of adenoma Martínez ME., Marshall JR., Sampliner R., Wilkinson J., Calcium, vitamin D, and
risk of adenoma Martínez ME., Marshall JR., Sampliner R., Wilkinson J., Calcium, vitamin D, and
risk of adenoma Martínez ME., Marshall JR., Sampliner R., Wilkinson J., Effect of calcium and
vitamin D supplementation Marya RK., Rathee S., Manrow M.Effect of calcium and
vitamin D supplementation Marya RK., Rathee S., Manrow M.
1988198819881988198819882006200620062006200620061981198119811981200320032003200320032008200820082008200820082008200820082008200620062006200620062006200620062006200620062006200120012006 Moschonis G., Manios Y.2006 Moschonis G., Manios Y.2006 Moschonis G., Manios Y.
Effect of vitamin D supplementation during
Marya RK., Rathee S., Dua V., Sangwan K.Effect of vitamin D
supplementation during Marya RK., Rathee S., Dua V., Sangwan K.Effect of vitamin D
supplementation during Marya RK., Rathee S., Dua V., Sangwan K.Effect of vitamin D
supplementation during Marya RK., Rathee S., Dua V., Sangwan K.Effect of vitamin D
supplementation during Marya RK., Rathee S., Dua V., Sangwan K.Effect of vitamin D
supplementation during Marya RK., Rathee S., Dua V., Sangwan K.Vitamin D2 dose required
to rapidly increase 25OHD Mastaglia SR., Mautalen CA., Parisi MS., Oliveri B.Vitamin D2 dose required
to rapidly increase 25OHD Mastaglia SR., Mautalen CA., Parisi MS., Oliveri B.Vitamin D2 dose required
to rapidly increase 25OHD Mastaglia SR., Mautalen CA., Parisi MS., Oliveri B.Vitamin D2 dose required
to rapidly increase 25OHD Mastaglia SR., Mautalen CA., Parisi MS., Oliveri B.Vitamin D2 dose required
to rapidly increase 25OHD Mastaglia SR., Mautalen CA., Parisi MS., Oliveri B.Vitamin D2 dose required
to rapidly increase 25OHD Mastaglia SR., Mautalen CA., Parisi MS., Oliveri B.Vitamin D supplements
enhance weight gain and Maxwell JD., Ang L., Brooke OG., Brown IR.Vitamin D supplements
enhance weight gain and Maxwell JD., Ang L., Brooke OG., Brown IR.Vitamin D supplements
enhance weight gain and Maxwell JD., Ang L., Brooke OG., Brown IR.Vitamin D supplements
enhance weight gain and Maxwell JD., Ang L., Brooke OG., Brown IR.Calcium, vitamin D, dairy
products, and risk of McCullough ML., Robertson AS., Rodriguez Calcium, vitamin D, dairy
products, and risk of McCullough ML., Robertson AS., Rodriguez Calcium, vitamin D, dairy
products, and risk of McCullough ML., Robertson AS., Rodriguez Calcium, vitamin D, dairy
products, and risk of McCullough ML., Robertson AS., Rodriguez Calcium, vitamin D, dairy
products, and risk of McCullough ML., Robertson AS., Rodriguez Dietary calcium and
vitamin D intakes in Mishra G., McCormack V., Kuh D., Hardy R., Stephen Dietary calcium and
vitamin D intakes in Mishra G., McCormack V., Kuh D., Hardy R., Stephen Dietary calcium and
vitamin D intakes in Mishra G., McCormack V., Kuh D., Hardy R., Stephen Dietary calcium and
vitamin D intakes in Mishra G., McCormack V., Kuh D., Hardy R., Stephen Dietary calcium and
vitamin D intakes in Mishra G., McCormack V., Kuh D., Hardy R., Stephen Dietary calcium and
vitamin D intakes in Mishra G., McCormack V., Kuh D., Hardy R., Stephen Dietary calcium and
vitamin D intakes in Mishra G., McCormack V., Kuh D., Hardy R., Stephen Dietary calcium and
vitamin D intakes in Mishra G., McCormack V., Kuh D., Hardy R., Stephen Dietary calcium and
vitamin D intakes in Mishra G., McCormack V., Kuh D., Hardy R., Stephen Dietary calcium and
vitamin D intakes in Mishra G., McCormack V., Kuh D., Hardy R., Stephen Dairy products, calcium
and prostate cancer risk.Koh KA., Sesso HD., Paffenbarger RS., Lee IM.Dairy products, calcium
and prostate cancer risk.Koh KA., Sesso HD., Paffenbarger RS., Lee IM.Dairy products, calcium
and prostate cancer risk.Koh KA., Sesso HD., Paffenbarger RS., Lee IM.Dairy products, calcium
and prostate cancer risk.Koh KA., Sesso HD., Paffenbarger RS., Lee IM.Dairy products, calcium
and prostate cancer risk.Koh KA., Sesso HD., Paffenbarger RS., Lee IM.Dairy products, calcium
and prostate cancer risk.Koh KA., Sesso HD., Paffenbarger RS., Lee IM.Dairy products, calcium
and prostate cancer risk.Koh KA., Sesso HD., Paffenbarger RS., Lee IM.Dairy products, calcium
and prostate cancer risk.Koh KA., Sesso HD., Paffenbarger RS., Lee IM.Maternal 25-
hydroxyvitamin D and Morley R., Carlin JB., Pasco JA., Wark JD.Maternal 25-
hydroxyvitamin D and Morley R., Carlin JB., Pasco JA., Wark JD.Maternal 25-
hydroxyvitamin D and Morley R., Carlin JB., Pasco JA., Wark JD.Maternal 25-
hydroxyvitamin D and Morley R., Carlin JB., Pasco JA., Wark JD.Nutrient intake and
hypertensive disorders of Morris CD., Jacobson SL., Anand R., Ewell MG., Nutrient intake and
hypertensive disorders of Morris CD., Jacobson SL., Anand R., Ewell MG., Skeletal site-dependent
response of bone mineral Skeletal site-dependent response of bone mineral Skeletal site-dependent response of bone mineral
200920092009200920092009200920092009200920092009200920092009200920092009200920092009200919981998200720072007200720072007200720072007200720072007200720072007200720072007200720072007200720072007
A double-blind, randomized, placebo-
Nagpal J., Pande JN., Bhartia A.A double-blind,
randomized, placebo-Nagpal J., Pande JN., Bhartia A.A double-blind,
randomized, placebo-Nagpal J., Pande JN., Bhartia A.A double-blind,
randomized, placebo-Nagpal J., Pande JN., Bhartia A.A double-blind,
randomized, placebo-Nagpal J., Pande JN., Bhartia A.A double-blind,
randomized, placebo-Nagpal J., Pande JN., Bhartia A.A double-blind,
randomized, placebo-Nagpal J., Pande JN., Bhartia A.A double-blind,
randomized, placebo-Nagpal J., Pande JN., Bhartia A.A double-blind,
randomized, placebo-Nagpal J., Pande JN., Bhartia A.A double-blind,
randomized, placebo-Nagpal J., Pande JN., Bhartia A.A double-blind,
randomized, placebo-Nagpal J., Pande JN., Bhartia A.A double-blind,
randomized, placebo-Nagpal J., Pande JN., Bhartia A.A double-blind,
randomized, placebo-Nagpal J., Pande JN., Bhartia A.A double-blind,
randomized, placebo-Nagpal J., Pande JN., Bhartia A.A double-blind,
randomized, placebo-Nagpal J., Pande JN., Bhartia A.A double-blind,
randomized, placebo-Nagpal J., Pande JN., Bhartia A.A double-blind,
randomized, placebo-Nagpal J., Pande JN., Bhartia A.A double-blind,
randomized, placebo-Nagpal J., Pande JN., Bhartia A.A double-blind,
randomized, placebo-Nagpal J., Pande JN., Bhartia A.A double-blind,
randomized, placebo-Nagpal J., Pande JN., Bhartia A.Supplements of 20
microg/d cholecalciferol Nelson ML., Blum JM., Hollis BW., Rosen C., Supplements of 20
microg/d cholecalciferol Nelson ML., Blum JM., Hollis BW., Rosen C., Serum vitamin D
metabolite levels and the Nomura AM., Stemmermann GN., Lee J., Serum vitamin D
metabolite levels and the Nomura AM., Stemmermann GN., Lee J., Calcium and vitamin D
intakes in relation to risk Oh K., Willett WC., Wu K., Fuchs CS., Giovannucci EL.Calcium and vitamin D
intakes in relation to risk Oh K., Willett WC., Wu K., Fuchs CS., Giovannucci EL.Calcium and vitamin D
intakes in relation to risk Oh K., Willett WC., Wu K., Fuchs CS., Giovannucci EL.Calcium and vitamin D
intakes in relation to risk Oh K., Willett WC., Wu K., Fuchs CS., Giovannucci EL.Calcium and vitamin D
intakes in relation to risk Oh K., Willett WC., Wu K., Fuchs CS., Giovannucci EL.Calcium and vitamin D
intakes in relation to risk Oh K., Willett WC., Wu K., Fuchs CS., Giovannucci EL.Calcium and vitamin D
intakes in relation to risk Oh K., Willett WC., Wu K., Fuchs CS., Giovannucci EL.Calcium and vitamin D
intakes in relation to risk Oh K., Willett WC., Wu K., Fuchs CS., Giovannucci EL.Calcium and vitamin D
intakes in relation to risk Oh K., Willett WC., Wu K., Fuchs CS., Giovannucci EL.Calcium and vitamin D
intakes in relation to risk Oh K., Willett WC., Wu K., Fuchs CS., Giovannucci EL.Calcium and vitamin D
intakes in relation to risk Oh K., Willett WC., Wu K., Fuchs CS., Giovannucci EL.Calcium and vitamin D
intakes in relation to risk Oh K., Willett WC., Wu K., Fuchs CS., Giovannucci EL.Calcium and vitamin D
intakes in relation to risk Oh K., Willett WC., Wu K., Fuchs CS., Giovannucci EL.Calcium and vitamin D
intakes in relation to risk Oh K., Willett WC., Wu K., Fuchs CS., Giovannucci EL.Calcium and vitamin D
intakes in relation to risk Oh K., Willett WC., Wu K., Fuchs CS., Giovannucci EL.Plasma vitamin D and risk
of colorectal cancer: the Otani T., Iwasaki M., Sasazuki S., Inoue M., Plasma vitamin D and risk
of colorectal cancer: the Otani T., Iwasaki M., Sasazuki S., Inoue M., Plasma vitamin D and risk
of colorectal cancer: the Otani T., Iwasaki M., Sasazuki S., Inoue M., Plasma vitamin D and risk
of colorectal cancer: the Otani T., Iwasaki M., Sasazuki S., Inoue M., Plasma vitamin D and risk
of colorectal cancer: the Otani T., Iwasaki M., Sasazuki S., Inoue M., Plasma vitamin D and risk
of colorectal cancer: the Otani T., Iwasaki M., Sasazuki S., Inoue M., Plasma vitamin D and risk
of colorectal cancer: the Otani T., Iwasaki M., Sasazuki S., Inoue M., Plasma vitamin D and risk
of colorectal cancer: the Otani T., Iwasaki M., Sasazuki S., Inoue M., Plasma vitamin D and risk
of colorectal cancer: the Otani T., Iwasaki M., Sasazuki S., Inoue M.,
200720072007200720072007200720072007200720072007200720072007200720072007200720072007200720072007200720072007200720072007200720072007200720072007200720012001200120012001200119991999199919992000
Plasma vitamin D and risk of colorectal cancer: the
Otani T., Iwasaki M., Sasazuki S., Inoue M., Plasma vitamin D and risk
of colorectal cancer: the Otani T., Iwasaki M., Sasazuki S., Inoue M., Plasma vitamin D and risk
of colorectal cancer: the Otani T., Iwasaki M., Sasazuki S., Inoue M., Plasma vitamin D and risk
of colorectal cancer: the Otani T., Iwasaki M., Sasazuki S., Inoue M., Plasma vitamin D and risk
of colorectal cancer: the Otani T., Iwasaki M., Sasazuki S., Inoue M., Plasma vitamin D and risk
of colorectal cancer: the Otani T., Iwasaki M., Sasazuki S., Inoue M., Plasma vitamin D and risk
of colorectal cancer: the Otani T., Iwasaki M., Sasazuki S., Inoue M., Plasma vitamin D and risk
of colorectal cancer: the Otani T., Iwasaki M., Sasazuki S., Inoue M., Plasma vitamin D and risk
of colorectal cancer: the Otani T., Iwasaki M., Sasazuki S., Inoue M., Plasma vitamin D and risk
of colorectal cancer: the Otani T., Iwasaki M., Sasazuki S., Inoue M., Plasma vitamin D and risk
of colorectal cancer: the Otani T., Iwasaki M., Sasazuki S., Inoue M., Plasma vitamin D and risk
of colorectal cancer: the Otani T., Iwasaki M., Sasazuki S., Inoue M., Plasma vitamin D and risk
of colorectal cancer: the Otani T., Iwasaki M., Sasazuki S., Inoue M., Plasma vitamin D and risk
of colorectal cancer: the Otani T., Iwasaki M., Sasazuki S., Inoue M., Plasma vitamin D and risk
of colorectal cancer: the Otani T., Iwasaki M., Sasazuki S., Inoue M., Calcium and vitamin D
intake and risk of Park SY., Murphy SP., Wilkens LR., Nomura AM., Calcium and vitamin D
intake and risk of Park SY., Murphy SP., Wilkens LR., Nomura AM., Calcium and vitamin D
intake and risk of Park SY., Murphy SP., Wilkens LR., Nomura AM., Calcium and vitamin D
intake and risk of Park SY., Murphy SP., Wilkens LR., Nomura AM., Calcium and vitamin D
intake and risk of Park SY., Murphy SP., Wilkens LR., Nomura AM., Calcium and vitamin D
intake and risk of Park SY., Murphy SP., Wilkens LR., Nomura AM., Calcium and vitamin D
intake and risk of Park SY., Murphy SP., Wilkens LR., Nomura AM., Calcium and vitamin D
intake and risk of Park SY., Murphy SP., Wilkens LR., Nomura AM., Calcium and vitamin D
intake and risk of Park SY., Murphy SP., Wilkens LR., Nomura AM., Calcium and vitamin D
intake and risk of Park SY., Murphy SP., Wilkens LR., Nomura AM., Calcium, dairy foods, and
risk of incident and fatal Park Y., Mitrou PN., Kipnis V., Hollenbeck A., Calcium, dairy foods, and
risk of incident and fatal Park Y., Mitrou PN., Kipnis V., Hollenbeck A., Calcium, vitamin D, and
dairy product intake and Park SY., Murphy SP., Wilkens LR., Stram DO., Calcium, vitamin D, and
dairy product intake and Park SY., Murphy SP., Wilkens LR., Stram DO., Calcium, vitamin D, and
dairy product intake and Park SY., Murphy SP., Wilkens LR., Stram DO., Calcium, vitamin D, and
dairy product intake and Park SY., Murphy SP., Wilkens LR., Stram DO., Calcium, vitamin D, and
dairy product intake and Park SY., Murphy SP., Wilkens LR., Stram DO., Calcium, vitamin D, and
dairy product intake and Park SY., Murphy SP., Wilkens LR., Stram DO., Calcium, vitamin D, and
dairy product intake and Park SY., Murphy SP., Wilkens LR., Stram DO., Calcium, vitamin D, and
dairy product intake and Park SY., Murphy SP., Wilkens LR., Stram DO., Calcium, vitamin D, and
dairy product intake and Park SY., Murphy SP., Wilkens LR., Stram DO., Calcium, vitamin D, and
dairy product intake and Park SY., Murphy SP., Wilkens LR., Stram DO., Effects of a short-term
vitamin D(3) and calcium Pfeifer M., Begerow B., Minne HW., Nachtigall D., Effects of a short-term
vitamin D(3) and calcium Pfeifer M., Begerow B., Minne HW., Nachtigall D., Effects of a short-term
vitamin D(3) and calcium Pfeifer M., Begerow B., Minne HW., Nachtigall D., Effects of a short-term
vitamin D(3) and calcium Pfeifer M., Begerow B., Minne HW., Nachtigall D., Effects of a short-term
vitamin D(3) and calcium Pfeifer M., Begerow B., Minne HW., Nachtigall D., Effects of a short-term
vitamin D(3) and calcium Pfeifer M., Begerow B., Minne HW., Nachtigall D., Diet and risk of colorectal
cancer in a cohort of Pietinen P., Malila N., Virtanen M., Hartman TJ., Diet and risk of colorectal
cancer in a cohort of Pietinen P., Malila N., Virtanen M., Hartman TJ., Diet and risk of colorectal
cancer in a cohort of Pietinen P., Malila N., Virtanen M., Hartman TJ., Diet and risk of colorectal
cancer in a cohort of Pietinen P., Malila N., Virtanen M., Hartman TJ., Plasma 1,25-dihydroxy-
and 25-hydroxyvitamin D Platz EA., Hankinson SE., Hollis BW., Colditz GA.,
200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200520052005200520052005200520032003200320032003200720072007199719971997199519951995
Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D
Platz EA., Hankinson SE., Hollis BW., Colditz GA., Plasma 1,25-dihydroxy-
and 25-hydroxyvitamin D Platz EA., Hankinson SE., Hollis BW., Colditz GA., Plasma 1,25-dihydroxy-
and 25-hydroxyvitamin D Platz EA., Hankinson SE., Hollis BW., Colditz GA., Plasma 1,25-dihydroxy-
and 25-hydroxyvitamin D Platz EA., Hankinson SE., Hollis BW., Colditz GA., Plasma 1,25-dihydroxy-
and 25-hydroxyvitamin D Platz EA., Hankinson SE., Hollis BW., Colditz GA., Plasma 1,25-dihydroxy-
and 25-hydroxyvitamin D Platz EA., Hankinson SE., Hollis BW., Colditz GA., Plasma 1,25-dihydroxy-
and 25-hydroxyvitamin D Platz EA., Hankinson SE., Hollis BW., Colditz GA., Plasma 1,25-dihydroxy-
and 25-hydroxyvitamin D Platz EA., Hankinson SE., Hollis BW., Colditz GA., Plasma 1,25-dihydroxy-
and 25-hydroxyvitamin D Platz EA., Hankinson SE., Hollis BW., Colditz GA., Plasma 1,25-dihydroxy-
and 25-hydroxyvitamin D Platz EA., Hankinson SE., Hollis BW., Colditz GA., Plasma 1,25-dihydroxy-
and 25-hydroxyvitamin D Platz EA., Hankinson SE., Hollis BW., Colditz GA., Plasma 1,25-dihydroxy-
and 25-hydroxyvitamin D Platz EA., Hankinson SE., Hollis BW., Colditz GA., Plasma 1,25-dihydroxy-
and 25-hydroxyvitamin D Platz EA., Hankinson SE., Hollis BW., Colditz GA., Plasma 1,25-dihydroxy-
and 25-hydroxyvitamin D Platz EA., Hankinson SE., Hollis BW., Colditz GA., Plasma 1,25-dihydroxy-
and 25-hydroxyvitamin D Platz EA., Hankinson SE., Hollis BW., Colditz GA., Plasma 1,25-dihydroxy-
and 25-hydroxyvitamin D Platz EA., Hankinson SE., Hollis BW., Colditz GA., Plasma 1,25-dihydroxy-
and 25-hydroxyvitamin D Platz EA., Hankinson SE., Hollis BW., Colditz GA., Plasma 1,25-dihydroxy-
and 25-hydroxyvitamin D Platz EA., Hankinson SE., Hollis BW., Colditz GA., Plasma 1,25-dihydroxy-
and 25-hydroxyvitamin D Platz EA., Hankinson SE., Hollis BW., Colditz GA., Plasma 1,25-dihydroxy-
and 25-hydroxyvitamin D Platz EA., Hankinson SE., Hollis BW., Colditz GA., Plasma 1,25-dihydroxy-
and 25-hydroxyvitamin D Platz EA., Hankinson SE., Hollis BW., Colditz GA., Plasma 1,25-dihydroxy-
and 25-hydroxyvitamin D Platz EA., Hankinson SE., Hollis BW., Colditz GA., Plasma 1,25-dihydroxy-
and 25-hydroxyvitamin D Platz EA., Hankinson SE., Hollis BW., Colditz GA., Plasma 1,25-dihydroxy-
and 25-hydroxyvitamin D Platz EA., Hankinson SE., Hollis BW., Colditz GA., Plasma 1,25-dihydroxy-
and 25-hydroxyvitamin D Platz EA., Hankinson SE., Hollis BW., Colditz GA., Plasma 1,25-dihydroxy-
and 25-hydroxyvitamin D Platz EA., Hankinson SE., Hollis BW., Colditz GA., Plasma 1,25-dihydroxy-
and 25-hydroxyvitamin D Platz EA., Hankinson SE., Hollis BW., Colditz GA., Effects of calcium
supplementation on body Reid IR., Horne A., Mason B., Ames R., Bava U., Effects of calcium
supplementation on body Reid IR., Horne A., Mason B., Ames R., Bava U., Effects of calcium
supplementation on body Reid IR., Horne A., Mason B., Ames R., Bava U., Effects of calcium
supplementation on body Reid IR., Horne A., Mason B., Ames R., Bava U., Effects of calcium
supplementation on body Reid IR., Horne A., Mason B., Ames R., Bava U., Effects of calcium
supplementation on body Reid IR., Horne A., Mason B., Ames R., Bava U., Effects of calcium
supplementation on body Reid IR., Horne A., Mason B., Ames R., Bava U., Calcium, dairy products,
and risk of prostate cancer Rodriguez C., McCullough ML., Mondul AM., Jacobs Calcium, dairy products,
and risk of prostate cancer Rodriguez C., McCullough ML., Mondul AM., Jacobs Calcium, dairy products,
and risk of prostate cancer Rodriguez C., McCullough ML., Mondul AM., Jacobs Calcium, dairy products,
and risk of prostate cancer Rodriguez C., McCullough ML., Mondul AM., Jacobs Calcium, dairy products,
and risk of prostate cancer Rodriguez C., McCullough ML., Mondul AM., Jacobs Meat and dairy
consumption and Rohrmann S., Platz EA., Kavanaugh CJ., Thuita L., Meat and dairy
consumption and Rohrmann S., Platz EA., Kavanaugh CJ., Thuita L., Meat and dairy
consumption and Rohrmann S., Platz EA., Kavanaugh CJ., Thuita L., Prospective evaluation of
dietary and other Ross RK., Yuan JM., Henderson BE., Park J., Prospective evaluation of
dietary and other Ross RK., Yuan JM., Henderson BE., Park J., Prospective evaluation of
dietary and other Ross RK., Yuan JM., Henderson BE., Park J., Effect of winter oral
vitamin D3 Scragg R., Khaw KT., Murphy S.Effect of winter oral
vitamin D3 Scragg R., Khaw KT., Murphy S.Effect of winter oral
vitamin D3 Scragg R., Khaw KT., Murphy S.
199519951995200620062006200620062006199319931993199319931993199319931993199319931993199319931993199319931993199319931993199319931993199319931993199319931993200820082008200820082008200920092009
Effect of winter oral vitamin D3
Scragg R., Khaw KT., Murphy S.Effect of winter oral
vitamin D3 Scragg R., Khaw KT., Murphy S.Effect of winter oral
vitamin D3 Scragg R., Khaw KT., Murphy S.Dietary intake of calcium,
fiber and other Shin A., Li H., Shu XO., Yang G., Gao YT., Zheng Dietary intake of calcium,
fiber and other Shin A., Li H., Shu XO., Yang G., Gao YT., Zheng Dietary intake of calcium,
fiber and other Shin A., Li H., Shu XO., Yang G., Gao YT., Zheng Dietary intake of calcium,
fiber and other Shin A., Li H., Shu XO., Yang G., Gao YT., Zheng Dietary intake of calcium,
fiber and other Shin A., Li H., Shu XO., Yang G., Gao YT., Zheng Vitamin D intake and the
risk for pancreatic cancer Skinner HG., Michaud DS., Giovannucci E., Willett Calcium intake and 28-
year gastro-intestinal Slob IC., Lambregts JL., Schuit AJ., Kok FJ.Calcium intake and 28-
year gastro-intestinal Slob IC., Lambregts JL., Schuit AJ., Kok FJ.Calcium intake and 28-
year gastro-intestinal Slob IC., Lambregts JL., Schuit AJ., Kok FJ.Calcium intake and 28-
year gastro-intestinal Slob IC., Lambregts JL., Schuit AJ., Kok FJ.Calcium intake and 28-
year gastro-intestinal Slob IC., Lambregts JL., Schuit AJ., Kok FJ.Calcium intake and 28-
year gastro-intestinal Slob IC., Lambregts JL., Schuit AJ., Kok FJ.Calcium intake and 28-
year gastro-intestinal Slob IC., Lambregts JL., Schuit AJ., Kok FJ.Calcium intake and 28-
year gastro-intestinal Slob IC., Lambregts JL., Schuit AJ., Kok FJ.Calcium intake and 28-
year gastro-intestinal Slob IC., Lambregts JL., Schuit AJ., Kok FJ.Calcium intake and 28-
year gastro-intestinal Slob IC., Lambregts JL., Schuit AJ., Kok FJ.Calcium intake and 28-
year gastro-intestinal Slob IC., Lambregts JL., Schuit AJ., Kok FJ.Calcium intake and 28-
year gastro-intestinal Slob IC., Lambregts JL., Schuit AJ., Kok FJ.Calcium intake and 28-
year gastro-intestinal Slob IC., Lambregts JL., Schuit AJ., Kok FJ.Calcium intake and 28-
year gastro-intestinal Slob IC., Lambregts JL., Schuit AJ., Kok FJ.Calcium intake and 28-
year gastro-intestinal Slob IC., Lambregts JL., Schuit AJ., Kok FJ.Calcium intake and 28-
year gastro-intestinal Slob IC., Lambregts JL., Schuit AJ., Kok FJ.Calcium intake and 28-
year gastro-intestinal Slob IC., Lambregts JL., Schuit AJ., Kok FJ.Calcium intake and 28-
year gastro-intestinal Slob IC., Lambregts JL., Schuit AJ., Kok FJ.Calcium intake and 28-
year gastro-intestinal Slob IC., Lambregts JL., Schuit AJ., Kok FJ.Calcium intake and 28-
year gastro-intestinal Slob IC., Lambregts JL., Schuit AJ., Kok FJ.Calcium intake and 28-
year gastro-intestinal Slob IC., Lambregts JL., Schuit AJ., Kok FJ.Calcium intake and 28-
year gastro-intestinal Slob IC., Lambregts JL., Schuit AJ., Kok FJ.Calcium intake and 28-
year gastro-intestinal Slob IC., Lambregts JL., Schuit AJ., Kok FJ.Calcium intake and 28-
year gastro-intestinal Slob IC., Lambregts JL., Schuit AJ., Kok FJ.Calcium intake and 28-
year gastro-intestinal Slob IC., Lambregts JL., Schuit AJ., Kok FJ.Calcium intake and 28-
year gastro-intestinal Slob IC., Lambregts JL., Schuit AJ., Kok FJ.Calcium intake and 28-
year gastro-intestinal Slob IC., Lambregts JL., Schuit AJ., Kok FJ.Calcium intake and 28-
year gastro-intestinal Slob IC., Lambregts JL., Schuit AJ., Kok FJ.Calcium intake and 28-
year gastro-intestinal Slob IC., Lambregts JL., Schuit AJ., Kok FJ.Calcium intake and 28-
year gastro-intestinal Slob IC., Lambregts JL., Schuit AJ., Kok FJ.Supplementation with
cholecalciferol does not Sneve M., Figenschau Y., Jorde R.Supplementation with
cholecalciferol does not Sneve M., Figenschau Y., Jorde R.Supplementation with
cholecalciferol does not Sneve M., Figenschau Y., Jorde R.Supplementation with
cholecalciferol does not Sneve M., Figenschau Y., Jorde R.Supplementation with
cholecalciferol does not Sneve M., Figenschau Y., Jorde R.Supplementation with
cholecalciferol does not Sneve M., Figenschau Y., Jorde R.Serum vitamin D and risk
of pancreatic cancer in the Stolzenberg-Solomon RZ., Hayes RB., Horst RL., Serum vitamin D and risk
of pancreatic cancer in the Stolzenberg-Solomon RZ., Hayes RB., Horst RL., Serum vitamin D and risk
of pancreatic cancer in the Stolzenberg-Solomon RZ., Hayes RB., Horst RL.,
200920092006200620062006200619971997199719971997199719971997199719971997199719971997199719971997199719971997199719971997199719971997199719971997199719971997198719872003200320032003200320032003
Serum vitamin D and risk of pancreatic cancer in the
Stolzenberg-Solomon RZ., Hayes RB., Horst RL., Serum vitamin D and risk
of pancreatic cancer in the Stolzenberg-Solomon RZ., Hayes RB., Horst RL., A prospective nested case-
control study of vitamin D Stolzenberg-Solomon RZ., Vieth R., Azad A., Pietinen A prospective nested case-
control study of vitamin D Stolzenberg-Solomon RZ., Vieth R., Azad A., Pietinen A prospective nested case-
control study of vitamin D Stolzenberg-Solomon RZ., Vieth R., Azad A., Pietinen A prospective nested case-
control study of vitamin D Stolzenberg-Solomon RZ., Vieth R., Azad A., Pietinen A prospective nested case-
control study of vitamin D Stolzenberg-Solomon RZ., Vieth R., Azad A., Pietinen Serum levels of vitamin D
metabolites and the Tangrea J., Helzlsouer K., Pietinen P., Taylor P., Hollis Serum levels of vitamin D
metabolites and the Tangrea J., Helzlsouer K., Pietinen P., Taylor P., Hollis Serum levels of vitamin D
metabolites and the Tangrea J., Helzlsouer K., Pietinen P., Taylor P., Hollis Serum levels of vitamin D
metabolites and the Tangrea J., Helzlsouer K., Pietinen P., Taylor P., Hollis Serum levels of vitamin D
metabolites and the Tangrea J., Helzlsouer K., Pietinen P., Taylor P., Hollis Serum levels of vitamin D
metabolites and the Tangrea J., Helzlsouer K., Pietinen P., Taylor P., Hollis Serum levels of vitamin D
metabolites and the Tangrea J., Helzlsouer K., Pietinen P., Taylor P., Hollis Serum levels of vitamin D
metabolites and the Tangrea J., Helzlsouer K., Pietinen P., Taylor P., Hollis Serum levels of vitamin D
metabolites and the Tangrea J., Helzlsouer K., Pietinen P., Taylor P., Hollis Serum levels of vitamin D
metabolites and the Tangrea J., Helzlsouer K., Pietinen P., Taylor P., Hollis Serum levels of vitamin D
metabolites and the Tangrea J., Helzlsouer K., Pietinen P., Taylor P., Hollis Serum levels of vitamin D
metabolites and the Tangrea J., Helzlsouer K., Pietinen P., Taylor P., Hollis Serum levels of vitamin D
metabolites and the Tangrea J., Helzlsouer K., Pietinen P., Taylor P., Hollis Serum levels of vitamin D
metabolites and the Tangrea J., Helzlsouer K., Pietinen P., Taylor P., Hollis Serum levels of vitamin D
metabolites and the Tangrea J., Helzlsouer K., Pietinen P., Taylor P., Hollis Serum levels of vitamin D
metabolites and the Tangrea J., Helzlsouer K., Pietinen P., Taylor P., Hollis Serum levels of vitamin D
metabolites and the Tangrea J., Helzlsouer K., Pietinen P., Taylor P., Hollis Serum levels of vitamin D
metabolites and the Tangrea J., Helzlsouer K., Pietinen P., Taylor P., Hollis Serum levels of vitamin D
metabolites and the Tangrea J., Helzlsouer K., Pietinen P., Taylor P., Hollis Serum levels of vitamin D
metabolites and the Tangrea J., Helzlsouer K., Pietinen P., Taylor P., Hollis Serum levels of vitamin D
metabolites and the Tangrea J., Helzlsouer K., Pietinen P., Taylor P., Hollis Serum levels of vitamin D
metabolites and the Tangrea J., Helzlsouer K., Pietinen P., Taylor P., Hollis Serum levels of vitamin D
metabolites and the Tangrea J., Helzlsouer K., Pietinen P., Taylor P., Hollis Serum levels of vitamin D
metabolites and the Tangrea J., Helzlsouer K., Pietinen P., Taylor P., Hollis Serum levels of vitamin D
metabolites and the Tangrea J., Helzlsouer K., Pietinen P., Taylor P., Hollis Serum levels of vitamin D
metabolites and the Tangrea J., Helzlsouer K., Pietinen P., Taylor P., Hollis Serum levels of vitamin D
metabolites and the Tangrea J., Helzlsouer K., Pietinen P., Taylor P., Hollis Serum levels of vitamin D
metabolites and the Tangrea J., Helzlsouer K., Pietinen P., Taylor P., Hollis Serum levels of vitamin D
metabolites and the Tangrea J., Helzlsouer K., Pietinen P., Taylor P., Hollis Serum levels of vitamin D
metabolites and the Tangrea J., Helzlsouer K., Pietinen P., Taylor P., Hollis Serum levels of vitamin D
metabolites and the Tangrea J., Helzlsouer K., Pietinen P., Taylor P., Hollis Serum levels of vitamin D
metabolites and the Tangrea J., Helzlsouer K., Pietinen P., Taylor P., Hollis Dietary calcium intake and
blood pressure in Thomsen K., Nilas L., Christiansen C.Dietary calcium intake and
blood pressure in Thomsen K., Nilas L., Christiansen C.Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.
200320032003200320032003200320032003200320032003200320032003200320032003200320032003200320032008200820082008200820082008200820082008198619861986198620062006200620062006200620062006200620062006
Effect of four monthly oral vitamin D3
Trivedi DP., Doll R., Khaw KT.Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.Dietary calcium intake and
risks of stroke, its Umesawa M., Iso H., Ishihara J., Saito I., Kokubo Dietary calcium intake and
risks of stroke, its Umesawa M., Iso H., Ishihara J., Saito I., Kokubo Dietary calcium intake and
risks of stroke, its Umesawa M., Iso H., Ishihara J., Saito I., Kokubo Dietary calcium intake and
risks of stroke, its Umesawa M., Iso H., Ishihara J., Saito I., Kokubo Dietary calcium intake and
risks of stroke, its Umesawa M., Iso H., Ishihara J., Saito I., Kokubo Dietary calcium intake and
risks of stroke, its Umesawa M., Iso H., Ishihara J., Saito I., Kokubo Dietary calcium intake and
risks of stroke, its Umesawa M., Iso H., Ishihara J., Saito I., Kokubo Dietary calcium intake and
risks of stroke, its Umesawa M., Iso H., Ishihara J., Saito I., Kokubo Dietary calcium intake and
risks of stroke, its Umesawa M., Iso H., Ishihara J., Saito I., Kokubo Dietary calcium intake and
risks of stroke, its Umesawa M., Iso H., Ishihara J., Saito I., Kokubo Oral calcium and blood
pressure: a controlled van Beresteyn EC., Schaafsma G., de Waard Oral calcium and blood
pressure: a controlled van Beresteyn EC., Schaafsma G., de Waard Oral calcium and blood
pressure: a controlled van Beresteyn EC., Schaafsma G., de Waard Oral calcium and blood
pressure: a controlled van Beresteyn EC., Schaafsma G., de Waard Low serum concentrations
of 25-hydroxyvitamin D in Visser M., Deeg DJ., Puts MT., Seidell JC., Lips P.Calcium plus vitamin D
supplementation and the Wactawski-Wende J., Kotchen JM., Anderson GL., Calcium plus vitamin D
supplementation and the Wactawski-Wende J., Kotchen JM., Anderson GL., Calcium plus vitamin D
supplementation and the Wactawski-Wende J., Kotchen JM., Anderson GL., Calcium plus vitamin D
supplementation and the Wactawski-Wende J., Kotchen JM., Anderson GL., Calcium plus vitamin D
supplementation and the Wactawski-Wende J., Kotchen JM., Anderson GL., Calcium plus vitamin D
supplementation and the Wactawski-Wende J., Kotchen JM., Anderson GL., Calcium plus vitamin D
supplementation and the Wactawski-Wende J., Kotchen JM., Anderson GL., Calcium plus vitamin D
supplementation and the Wactawski-Wende J., Kotchen JM., Anderson GL., Calcium plus vitamin D
supplementation and the Wactawski-Wende J., Kotchen JM., Anderson GL., Calcium plus vitamin D
supplementation and the Wactawski-Wende J., Kotchen JM., Anderson GL.,
200620062006200620062006200620062006200620062006200620062006200620062006200620062006200620062006200620062006200620062006200620062006200620062006200620062008200820082008200819961996199619961996
Calcium plus vitamin D supplementation and the
Wactawski-Wende J., Kotchen JM., Anderson GL., Calcium plus vitamin D
supplementation and the Wactawski-Wende J., Kotchen JM., Anderson GL., Calcium plus vitamin D
supplementation and the Wactawski-Wende J., Kotchen JM., Anderson GL., Calcium plus vitamin D
supplementation and the Wactawski-Wende J., Kotchen JM., Anderson GL., Calcium plus vitamin D
supplementation and the Wactawski-Wende J., Kotchen JM., Anderson GL., Calcium plus vitamin D
supplementation and the Wactawski-Wende J., Kotchen JM., Anderson GL., Calcium plus vitamin D
supplementation and the Wactawski-Wende J., Kotchen JM., Anderson GL., Calcium plus vitamin D
supplementation and the Wactawski-Wende J., Kotchen JM., Anderson GL., High-dose vitamin D3
supplementation in a Wagner CL., Hulsey TC., Fanning D., Ebeling M., High-dose vitamin D3
supplementation in a Wagner CL., Hulsey TC., Fanning D., Ebeling M., High-dose vitamin D3
supplementation in a Wagner CL., Hulsey TC., Fanning D., Ebeling M., High-dose vitamin D3
supplementation in a Wagner CL., Hulsey TC., Fanning D., Ebeling M., High-dose vitamin D3
supplementation in a Wagner CL., Hulsey TC., Fanning D., Ebeling M., High-dose vitamin D3
supplementation in a Wagner CL., Hulsey TC., Fanning D., Ebeling M., High-dose vitamin D3
supplementation in a Wagner CL., Hulsey TC., Fanning D., Ebeling M., High-dose vitamin D3
supplementation in a Wagner CL., Hulsey TC., Fanning D., Ebeling M., High-dose vitamin D3
supplementation in a Wagner CL., Hulsey TC., Fanning D., Ebeling M., High-dose vitamin D3
supplementation in a Wagner CL., Hulsey TC., Fanning D., Ebeling M., High-dose vitamin D3
supplementation in a Wagner CL., Hulsey TC., Fanning D., Ebeling M., High-dose vitamin D3
supplementation in a Wagner CL., Hulsey TC., Fanning D., Ebeling M., High-dose vitamin D3
supplementation in a Wagner CL., Hulsey TC., Fanning D., Ebeling M., High-dose vitamin D3
supplementation in a Wagner CL., Hulsey TC., Fanning D., Ebeling M., High-dose vitamin D3
supplementation in a Wagner CL., Hulsey TC., Fanning D., Ebeling M., High-dose vitamin D3
supplementation in a Wagner CL., Hulsey TC., Fanning D., Ebeling M., High-dose vitamin D3
supplementation in a Wagner CL., Hulsey TC., Fanning D., Ebeling M., High-dose vitamin D3
supplementation in a Wagner CL., Hulsey TC., Fanning D., Ebeling M., High-dose vitamin D3
supplementation in a Wagner CL., Hulsey TC., Fanning D., Ebeling M., High-dose vitamin D3
supplementation in a Wagner CL., Hulsey TC., Fanning D., Ebeling M., High-dose vitamin D3
supplementation in a Wagner CL., Hulsey TC., Fanning D., Ebeling M., High-dose vitamin D3
supplementation in a Wagner CL., Hulsey TC., Fanning D., Ebeling M., High-dose vitamin D3
supplementation in a Wagner CL., Hulsey TC., Fanning D., Ebeling M., High-dose vitamin D3
supplementation in a Wagner CL., Hulsey TC., Fanning D., Ebeling M., High-dose vitamin D3
supplementation in a Wagner CL., Hulsey TC., Fanning D., Ebeling M., High-dose vitamin D3
supplementation in a Wagner CL., Hulsey TC., Fanning D., Ebeling M., High-dose vitamin D3
supplementation in a Wagner CL., Hulsey TC., Fanning D., Ebeling M., High-dose vitamin D3
supplementation in a Wagner CL., Hulsey TC., Fanning D., Ebeling M., High-dose vitamin D3
supplementation in a Wagner CL., Hulsey TC., Fanning D., Ebeling M., High-dose vitamin D3
supplementation in a Wagner CL., Hulsey TC., Fanning D., Ebeling M., Vitamin D deficiency and
risk of cardiovascular Wang TJ., Pencina MJ., Booth SL., Jacques PF., Vitamin D deficiency and
risk of cardiovascular Wang TJ., Pencina MJ., Booth SL., Jacques PF., Vitamin D deficiency and
risk of cardiovascular Wang TJ., Pencina MJ., Booth SL., Jacques PF., Vitamin D deficiency and
risk of cardiovascular Wang TJ., Pencina MJ., Booth SL., Jacques PF., Vitamin D deficiency and
risk of cardiovascular Wang TJ., Pencina MJ., Booth SL., Jacques PF., Effect of longterm placebo
controlled calcium Weisgerber UM., Boeing H., Owen RW., Waldherr Effect of longterm placebo
controlled calcium Weisgerber UM., Boeing H., Owen RW., Waldherr Effect of longterm placebo
controlled calcium Weisgerber UM., Boeing H., Owen RW., Waldherr Effect of longterm placebo
controlled calcium Weisgerber UM., Boeing H., Owen RW., Waldherr Effect of longterm placebo
controlled calcium Weisgerber UM., Boeing H., Owen RW., Waldherr
199619961996199619961996199619961996200820082008199719971997199720022002200220072007200720072007200720072007200720072007200720072007200720072007200720072007200720072007200720072007200720072007
Effect of longterm placebo controlled calcium
Weisgerber UM., Boeing H., Owen RW., Waldherr Effect of longterm placebo
controlled calcium Weisgerber UM., Boeing H., Owen RW., Waldherr Effect of longterm placebo
controlled calcium Weisgerber UM., Boeing H., Owen RW., Waldherr Effect of longterm placebo
controlled calcium Weisgerber UM., Boeing H., Owen RW., Waldherr Effect of longterm placebo
controlled calcium Weisgerber UM., Boeing H., Owen RW., Waldherr Effect of longterm placebo
controlled calcium Weisgerber UM., Boeing H., Owen RW., Waldherr Effect of longterm placebo
controlled calcium Weisgerber UM., Boeing H., Owen RW., Waldherr Effect of longterm placebo
controlled calcium Weisgerber UM., Boeing H., Owen RW., Waldherr Effect of longterm placebo
controlled calcium Weisgerber UM., Boeing H., Owen RW., Waldherr Is ischemic stroke risk
related to folate status or Weng LC., Yeh WT., Bai CH., Chen HJ., Chuang SY., Is ischemic stroke risk
related to folate status or Weng LC., Yeh WT., Bai CH., Chen HJ., Chuang SY., Is ischemic stroke risk
related to folate status or Weng LC., Yeh WT., Bai CH., Chen HJ., Chuang SY., Efficacy of
nonpharmacologic Whelton PK., Kumanyika SK., Cook NR., Cutler JA., Efficacy of
nonpharmacologic Whelton PK., Kumanyika SK., Cook NR., Cutler JA., Efficacy of
nonpharmacologic Whelton PK., Kumanyika SK., Cook NR., Cutler JA., Efficacy of
nonpharmacologic Whelton PK., Kumanyika SK., Cook NR., Cutler JA., Calcium intake and risk of
colon cancer in women Wu K., Willett WC., Fuchs CS., Colditz GA., Calcium intake and risk of
colon cancer in women Wu K., Willett WC., Fuchs CS., Colditz GA., Calcium intake and risk of
colon cancer in women Wu K., Willett WC., Fuchs CS., Colditz GA., A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis
1995199519951995199519951995199519951995199819981998200820082008200820082008200820082008200820082008200820082008200820082008
Lack of blood pressure effect with calcium and
Yamamoto ME., Applegate WB., Klag MJ., Borhani NO., Lack of blood pressure
effect with calcium and Yamamoto ME., Applegate WB., Klag MJ., Borhani NO., Lack of blood pressure
effect with calcium and Yamamoto ME., Applegate WB., Klag MJ., Borhani NO., Lack of blood pressure
effect with calcium and Yamamoto ME., Applegate WB., Klag MJ., Borhani NO., Lack of blood pressure
effect with calcium and Yamamoto ME., Applegate WB., Klag MJ., Borhani NO., Lack of blood pressure
effect with calcium and Yamamoto ME., Applegate WB., Klag MJ., Borhani NO., Lack of blood pressure
effect with calcium and Yamamoto ME., Applegate WB., Klag MJ., Borhani NO., Lack of blood pressure
effect with calcium and Yamamoto ME., Applegate WB., Klag MJ., Borhani NO., Lack of blood pressure
effect with calcium and Yamamoto ME., Applegate WB., Klag MJ., Borhani NO., Lack of blood pressure
effect with calcium and Yamamoto ME., Applegate WB., Klag MJ., Borhani NO., A prospective cohort study
of intake of calcium, Zheng W., Anderson KE., Kushi LH., Sellers TA., A prospective cohort study
of intake of calcium, Zheng W., Anderson KE., Kushi LH., Sellers TA., A prospective cohort study
of intake of calcium, Zheng W., Anderson KE., Kushi LH., Sellers TA., Effects of calcium and
vitamin D supplementation Zhu K., Devine A., Dick IM., Wilson SG., Prince RL.Effects of calcium and
vitamin D supplementation Zhu K., Devine A., Dick IM., Wilson SG., Prince RL.Effects of calcium and
vitamin D supplementation Zhu K., Devine A., Dick IM., Wilson SG., Prince RL.Effects of calcium and
vitamin D supplementation Zhu K., Devine A., Dick IM., Wilson SG., Prince RL.Effects of calcium and
vitamin D supplementation Zhu K., Devine A., Dick IM., Wilson SG., Prince RL.Effects of calcium and
vitamin D supplementation Zhu K., Devine A., Dick IM., Wilson SG., Prince RL.Effects of calcium and
vitamin D supplementation Zhu K., Devine A., Dick IM., Wilson SG., Prince RL.Effects of calcium and
vitamin D supplementation Zhu K., Devine A., Dick IM., Wilson SG., Prince RL.Effects of calcium and
vitamin D supplementation Zhu K., Devine A., Dick IM., Wilson SG., Prince RL.Effects of calcium and
vitamin D supplementation Zhu K., Devine A., Dick IM., Wilson SG., Prince RL.Effects of calcium and
vitamin D supplementation Zhu K., Devine A., Dick IM., Wilson SG., Prince RL.Effects of calcium and
vitamin D supplementation Zhu K., Devine A., Dick IM., Wilson SG., Prince RL.Effects of calcium and
vitamin D supplementation Zhu K., Devine A., Dick IM., Wilson SG., Prince RL.Effects of calcium and
vitamin D supplementation Zhu K., Devine A., Dick IM., Wilson SG., Prince RL.Randomized controlled
trial of the effects of Zhu K., Bruce D., Austin N., Devine A., Ebeling PR., Randomized controlled
trial of the effects of Zhu K., Bruce D., Austin N., Devine A., Ebeling PR., Randomized controlled
trial of the effects of Zhu K., Bruce D., Austin N., Devine A., Ebeling PR., Randomized controlled
trial of the effects of Zhu K., Bruce D., Austin N., Devine A., Ebeling PR.,
Outcome Units Subgroup TimepointCategorical nd N/A (years)Categorical nd N/A (years)Categorical nd N/A (years)Categorical nd N/A (years)Categorical nd N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical nd N/A (years)Categorical nd N/A (years)Categorical nd N/A (years)Categorical nd N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical 12 (years)Categorical 12 (years)Categorical 12 (years)Categorical 12 (years)Categorical 12 (years)Categorical 12 (years)Categorical 12 (years)Categorical 12 (years)Categorical 12 (years)Categorical 12 (years)Categorical 12 (years)Categorical 12 (years)Categorical 12 (years)Categorical 12 (years)Categorical 12 (years)
kg Continuous N/A (years)kg Continuous N/A (years)
Categorical 2 (years)Categorical 2 (years)Categorical 2 (years)Categorical 2 (years)Categorical 2 (years)Continuous GirlsContinuous GirlsContinuous GirlsContinuous WomenContinuous WomenContinuous WomenContinuous Men
Outcome Type
Outcome DescriptionProstate
cancer All Participants Prostate
cancer All Participants Prostate
cancer All Participants Prostate
cancer All Participants Prostate
cancer All Participants Aggressive
prostate Gleason sum >=7 or
All Participants Aggressive
prostate Gleason sum >=7 or
All Participants Aggressive
prostate Gleason sum >=7 or
All Participants Aggressive
prostate Gleason sum >=7 or
All Participants Aggressive
prostate Gleason sum >=7 or
All Participants Prostate
cancer All Participants Prostate
cancer All Participants Prostate
cancer All Participants Prostate
cancer All Participants Prostate
cancer in All Participants Prostate
cancer in All Participants Prostate
cancer in All Participants Prostate
cancer in All Participants IHD (fatal +
nonfatal) Implied combinatio
All Participants IHD (fatal +
nonfatal) Implied combinatio
All Participants IHD (fatal +
nonfatal) Implied combinatio
All Participants IHD (fatal +
nonfatal) Implied combinatio
All Participants IHD (fatal +
nonfatal) Implied combinatio
All Participants Nonfatal MI
[Self-Self-reporting
All Participants Nonfatal MI
[Self-Self-reporting
All Participants Nonfatal MI
[Self-Self-reporting
All Participants Nonfatal MI
[Self-Self-reporting
All Participants Nonfatal MI
[Self-Self-reporting
All Participants Fatal IHD
[Including Including sudden
All Participants Fatal IHD
[Including Including sudden
All Participants Fatal IHD
[Including Including sudden
All Participants Fatal IHD
[Including Including sudden
All Participants Fatal IHD
[Including Including sudden
All Participants Body
weight Change in kg/yr
All ParticipantsBody
weight Change in kg/yr
All ParticipantsHTN,
incident Physician diagnosis
All Participants HTN,
incident Physician diagnosis
All Participants HTN,
incident Physician diagnosis
All Participants HTN,
incident Physician diagnosis
All Participants HTN,
incident Physician diagnosis
All Participants 25(OH)D
[ContinuousEnter a numeric 25(OH)D
[ContinuousEnter a numeric 25(OH)D
[ContinuousEnter a numeric 25(OH)D
[ContinuousEnter a numeric 25(OH)D
[ContinuousEnter a numeric 25(OH)D
[ContinuousEnter a numeric 25(OH)D
[ContinuousEnter a numeric
Continuous MenContinuous MenContinuous WomenContinuous WomenContinuous WomenContinuous MenContinuous MenContinuous MenContinuousContinuousContinuousContinuous GirlsContinuous GirlsContinuous GirlsCategorical 1Categorical 1Categorical 1Categorical 1Categorical 1Categorical 1 Age<=50Categorical 1 Age<=50Categorical 1 Age<=50Categorical 1 Age >50Categorical 1 Age >50Categorical 1 Age >50CategoricalCategoricalCategoricalCategoricalCategoricalCategorical Stroke N/A (years)Categorical Stroke N/A (years)Categorical Stroke N/A (years)Categorical Stroke N/A (years)Categorical Stroke N/A (years)Categorical SecondaryCategorical SecondaryCategorical SecondaryCategorical SecondaryCategorical SecondaryCategorical SecondaryCategorical SecondaryCategorical SecondaryCategorical SecondaryCategorical SecondaryCategorical SecondaryCategorical N/A (years)Categorical N/A (years)
25(OH)D [Continuous
Enter a numeric 25(OH)D
[ContinuousEnter a numeric BMD -
lumbar DXA, whole body, or
Enter a numeric BMD -
lumbar DXA, whole body, or
Enter a numeric BMD -
lumbar DXA, whole body, or
Enter a numeric BMD -
lumbar DXA, whole body, or
Enter a numeric BMD -
lumbar DXA, whole body, or
Enter a numeric BMD -
lumbar DXA, whole body, or
Enter a numeric BMC -
whole body DXA, whole body, or
All Participants
Enter a numeric BMC -
whole body DXA, whole body, or
All Participants
Enter a numeric BMC -
whole body DXA, whole body, or
All Participants
Enter a numeric BMC -
whole body DXA, whole body, or
Enter a numeric BMC -
whole body DXA, whole body, or
Enter a numeric BMC -
whole body DXA, whole body, or
Enter a numeric Incident
HTN All Participants
Enter a numeric Incident
HTN All Participants
Enter a numeric Incident
HTN All Participants
Enter a numeric Incident
HTN All Participants
Enter a numeric Incident
HTN All Participants
Enter a numeric Incident
HTN Enter a numeric Incident
HTN Enter a numeric Incident
HTN Enter a numeric Incident
HTN Enter a numeric Incident
HTN Enter a numeric Incident
HTN Enter a numeric Hypertensi
on All Participants
Enter a numeric Hypertensi
on All Participants
Enter a numeric Hypertensi
on All Participants
Enter a numeric Hypertensi
on All Participants
Enter a numeric Hypertensi
on All Participants
Enter a numeric specific
stroke not extractedspecific
stroke not extractedspecific
stroke not extractedspecific
stroke not extractedspecific
stroke not extractedProstate
cancer risk All Participants
Enter a numeric Prostate
cancer risk All Participants
Enter a numeric Prostate
cancer risk All Participants
Enter a numeric Prostate
cancer risk All Participants
Enter a numeric Prostate
cancer risk All Participants
Enter a numeric Prostate
cancer risk All Participants
Enter a numeric Prostate
cancer risk All Participants
Enter a numeric Prostate
cancer risk All Participants
Enter a numeric Prostate
cancer risk All Participants
Enter a numeric Total serum
PSA All Participants
Enter a numeric Total serum
PSA All Participants
Enter a numeric Breast
cancer risk Risk of developing
All ParticipantsBreast
cancer risk Risk of developing
All Participants
Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)
nmol/l Continuous N/A (years)nmol/l Continuous N/A (years)nmol/l Continuous N/A (years)
Continuous All cause N/A (years)Continuous All cause N/A (years)
nmol/L Continuous N/A (years)nmol/L Continuous N/A (years)
Categorical 30 (weeks)Categorical 30 (weeks)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)
mg/cm2 Continuous N/A (years)mg/cm2 Continuous N/A (years)ug/L Continuous N/A (years)ug/L Continuous N/A (years)kg Continuous N/A (years)kg Continuous N/A (years)
Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)
Kg Continuous N/A (years)Kg Continuous N/A (years)
Breast cancer risk
Risk of developing
All ParticipantsBreast
cancer risk Risk of developing
All ParticipantsBreast
cancer risk Risk of developing
All ParticipantsBreast
cancer risk Risk of developing
All ParticipantsBreast
cancer risk Risk of developing
All ParticipantsBreast
cancer risk Risk of developing
All ParticipantsBreast
cancer risk Risk of developing
All ParticipantsBreast
cancer risk Risk of developing
All Participants25(OH)D
level Changes from
All Participants25(OH)D
level Changes from
All Participants25(OH)D
level Changes from
All ParticipantsMortality
[All All ParticipantsMortality
[All All Participants25(OH)D at
1 y All Participants25(OH)D at
1 y All Participantspreeclamps
ia gestational HTN &
All Participants preeclamps
ia gestational HTN &
All Participants Sudden
death Standard criteria
All ParticipantsSudden
death Standard criteria
All ParticipantsMI
[Standard Standard criteria
All ParticipantsMI
[Standard Standard criteria
All ParticipantsStroke
[Standard Standard criteria
All ParticipantsStroke
[Standard Standard criteria
All ParticipantsCVD
Composite composite Adjudicated
All ParticipantsCVD
Composite composite Adjudicated
All ParticipantsFemoral
neck BMD DEXA of the femur was
All ParticipantsFemoral
neck BMD DEXA of the femur was
All Participants25(OH)D
[Measured Measured at baseline
All Participants25(OH)D
[Measured Measured at baseline
All ParticipantsWeight
[ContinuousAll ParticipantsWeight
[ContinuousAll ParticipantsColon
cancer State Health
All ParticipantsColon
cancer State Health
All ParticipantsColon
cancer State Health
All ParticipantsColon
cancer State Health
All ParticipantsColon
cancer State Health
All ParticipantsIHD death
[CategoricaAll ParticipantsIHD death
[CategoricaAll ParticipantsIHD death
[CategoricaAll ParticipantsIHD death
[CategoricaAll ParticipantsProstate
cancer Diagnosed 1980-1992,
All Participants Prostate
cancer Diagnosed 1980-1992,
All Participants Prostate
cancer Diagnosed 1980-1992,
All Participants Prostate
cancer Diagnosed 1980-1992,
All Participants Prostate
cancer Diagnosed 1980-1992,
All Participants Prostate
cancer Diagnosed 1980-1992,
All Participants Grip
strength Two measureme
Grip strength Grip
strength Two measureme
Grip strength
Kg Continuous N/A (years)Kg Continuous N/A (years)Counts Continuous N/A (years)Counts Continuous N/A (years)Counts Continuous N/A (years)Counts Continuous N/A (years)seconds Continuous N/A (years)seconds Continuous N/A (years)seconds Continuous N/A (years)seconds Continuous N/A (years)kg Continuous N/A (years)kg Continuous N/A (years)kg Continuous N/A (years)kg Continuous N/A (years)
Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)
m Continuous N/A (years)m Continuous N/A (years)
Categorical Fall N/A (years)Categorical Fall N/A (years)Categorical Fracture N/A (years)Categorical Fracture N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)
g Continuous N/A (years)g Continuous N/A (years)g Continuous N/A (years)g Continuous N/A (years)g/cm2 Continuous areal BMD N/A (years)g/cm2 Continuous areal BMD N/A (years)g/cm2 Continuous areal BMD N/A (years)g/cm2 Continuous areal BMD N/A (years)Kg Continuous N/A (years)Kg Continuous N/A (years)pmol/L Continuous 25(OH)D N/A (years)
Grip strength
Two measureme
Grip strength Grip
strength Two measureme
Grip strength Chair
stands Conducted if the
Chair stands Chair
stands Conducted if the
Chair stands Chair
stands Conducted if the
Chair stands Chair
stands Conducted if the
Chair stands Timed walk
[The timed The timed walk
Timed walk (year 2)Timed walk
[The timed The timed walk
Timed walk (year 2)Timed walk
[The timed The timed walk
Timed walk (year 5)Timed walk
[The timed The timed walk
Timed walk (year 5)Muscle
strength Isometric quadriceps
Right quadriceps Muscle
strength Isometric quadriceps
Left quadriceps Muscle
strength Isometric quadriceps
Right hand grip Muscle
strength Isometric quadriceps
Left hand grip Fall [Fall
free Fall free survival
Fall free survival Fall [Fall
free Fall free survival
Fall free survival Fall [Fall
free Fall free survival
Fall free survival Fall [Fall
free Fall free survival
Fall free survival Twelve
minutes Twelve minutes Timed up
and go Timed up and goFall
[Defined as Defined as the patient Fall
[Defined as Defined as the patient fracture
[Any Any fracture fracture
[Any Any fracture Prostate
cancer Requested permission
Prostate cancerProstate
cancer Requested permission
Prostate cancerProstate
cancer Requested permission
Prostate cancerProstate
cancer Requested permission
Prostate cancerIncident
invasive Confirmed by both
Invasive breast Incident
invasive Confirmed by both
Invasive breast Incident
invasive Confirmed by both
Invasive breast Incident
invasive Confirmed by both
Invasive breast Incident
invasive Confirmed by both
Invasive breast Incident
invasive Confirmed by both
Total breast cancerIncident
invasive Confirmed by both
Total breast cancerIncident
invasive Confirmed by both
Death from breast Incident
invasive Confirmed by both
Death from breast change in
BMC (ITT change in BMC (ITT change in
BMC (ITT change in BMC (ITT change in
BMC (ITT change in BMC (ITT change in
BMC (ITT change in BMC (ITT areal BMD
[Continuousareal BMD [Continuousareal BMD [Continuousareal BMD [ContinuousWeight change
Change in weight in
Body weightWeight
change Change in weight in
Body weight25(OH)D
[Continuous
pmol/L Continuous 25(OH)D N/A (years)pmol/L Continuous 1,25(OH)D N/A (years)pmol/L Continuous 1,25(OH)D N/A (years)
Categorical N/A (years)Categorical N/A (years)Categorical Survival N/A (years)Categorical Survival N/A (years)Categorical Survival N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)
Kg Continuous Weight N/A (years)Kg Continuous Weight N/A (years)Kg Continuous Weight N/A (years)Kg/m2 Continuous BMI N/A (years)Kg/m2 Continuous BMI N/A (years)Kg/m2 Continuous BMI N/A (years)ng/ml Continuous N/A (years)ng/ml Continuous N/A (years)ng/ml Continuous N/A (years)ng/ml Continuous N/A (years)ng/ml Continuous N/A (years)ng/ml Continuous N/A (years)cm Continuous N/A (years)cm Continuous N/A (years)cm Continuous N/A (years)cm Continuous N/A (years)
25(OH)D [Continuous25(OH)D [Continuous25(OH)D [ContinuousAdenomas recurrence
nd (only for patients
Adenomas recurrenceAdenomas
recurrence nd (only for patients
Adenomas recurrenceSurvival [nd
(only for nd (only for patients Survival [nd
(only for nd (only for patients Survival [nd
(only for nd (only for patients HTN (Rx)
[HTN HTN medication
All Participants HTN (Rx)
[HTN HTN medication
All Participants HTN (Rx)
[HTN HTN medication
All Participants HTN (Rx)
[HTN HTN medication
All Participants HTN (Rx)
[HTN HTN medication
All Participants HTN (Rx)
[HTN HTN medication
HTN (Rx), Age 40 yHTN (Rx)
[HTN HTN medication
HTN (Rx), Age 40 yHTN (Rx)
[HTN HTN medication
HTN (Rx), Age 40 yHTN (Rx)
[HTN HTN medication
HTN (Rx), Age >40 yHTN (Rx)
[HTN HTN medication
HTN (Rx), Age >40 yHTN (Rx)
[HTN HTN medication
HTN (Rx), Age >40 yHTN (Rx)
[HTN HTN medication
HTN (Rx), MaleHTN (Rx)
[HTN HTN medication
HTN (Rx), MaleHTN (Rx)
[HTN HTN medication
HTN (Rx), MaleHTN (Rx)
[HTN HTN medication
HTN (Rx), FemaleHTN (Rx)
[HTN HTN medication
HTN (Rx), FemaleHTN (Rx)
[HTN HTN medication
HTN (Rx), FemaleHTN (Rx)
[HTN HTN medication
HTN (Rx), BlackHTN (Rx)
[HTN HTN medication
HTN (Rx), BlackHTN (Rx)
[HTN HTN medication
HTN (Rx), BlackHTN (Rx)
[HTN HTN medication
HTN (Rx), WhiteHTN (Rx)
[HTN HTN medication
HTN (Rx), WhiteHTN (Rx)
[HTN HTN medication
HTN (Rx), WhiteHTN (BP or
Rx) [SBP SBP 160 or DBP 95
All Participants Weight [To
the nearest To the nearest 0.5 Weight [To
the nearest To the nearest 0.5 Weight [To
the nearest To the nearest 0.5 BMI
[ContinuousBMI [ContinuousBMI [Continuous25(OH)D [Continuous
All Participants25(OH)D
[ContinuousAll Participants25(OH)D
[ContinuousAll Participants25(OH)D
[ContinuousPremenarcheal girls 25(OH)D
[ContinuousPremenarcheal girls 25(OH)D
[ContinuousPremenarcheal girls height
[ContinuousAll Participantsheight
[ContinuousAll Participantsheight
[ContinuousAll Participantsheight
[ContinuousPremenarcheal girls
cm Continuous N/A (years)cm Continuous N/A (years)kg Continuous N/A (years)kg Continuous N/A (years)kg Continuous N/A (years)kg Continuous N/A (years)kg Continuous N/A (years)kg Continuous N/A (years)
Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)
height [Continuous
Premenarcheal girls height
[ContinuousPremenarcheal girls Weight
[ContinuousAll ParticipantsWeight
[ContinuousAll ParticipantsWeight
[ContinuousAll ParticipantsWeight
[ContinuousPremenarcheal girls Weight
[ContinuousPremenarcheal girls Weight
[ContinuousPremenarcheal girls Total body
BMC All Participants Total body
BMC All Participants Total body
BMC All Participants Total body
BMC Premenarcheal girls Total body
BMC Premenarcheal girls Total body
BMC Premenarcheal girls 1,25(OH)D
[ContinuousAll Participants 1,25(OH)D
[ContinuousAll Participants 1,25(OH)D
[ContinuousAll Participants weight
[Continuousweight gain in North, weight
[Continuousweight gain in North, weight
[Continuousweight gain in North, weight
[Continuousweight gain in North, weight
[Continuousweight gain in North, weight
[Continuousweight gain in North, weight
[Continuousweight gain in South, weight
[Continuousweight gain in south, weight
[Continuousweight gain in south, weight
[Continuousweight gain in South, weight
[Continuousweight gain in south, weight
[Continuousweight gain in south, length
[ContinuousLength gain in North, length
[ContinuousLength gain in North, length
[ContinuousLength gain in North, length
[ContinuousLength gain in North, length
[ContinuousLength gain in North, length
[ContinuousLength gain in North, length
[ContinuousLength gain in South, length
[ContinuousLength gain in South, length
[ContinuousLength gain in South, length
[ContinuousLength gain in South, length
[ContinuousLength gain in South, length
[ContinuousLength gain in South, Colorectal
cancer Reported by a
All ParticipantsColorectal
cancer Reported by a
All ParticipantsColorectal
cancer Reported by a
All ParticipantsColorectal
cancer Reported by a
All ParticipantsColorectal
cancer Reported by a
All ParticipantsColorectal
cancer Reported by a
All ParticipantsColorectal
cancer Reported by a
All Participants
Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)
Colorectal cancer
Reported by a
All ParticipantsColorectal
cancer Reported by a
All ParticipantsColorectal
cancer Reported by a
All ParticipantsProximal
vs. distal Same as above (not
Colorectal cancer Proximal
vs. distal Same as above (not
Colorectal cancer Proximal
vs. distal Same as above (not
Colorectal cancer Proximal
vs. distal Same as above (not
Colorectal cancer Proximal
vs. distal Same as above (not
Colorectal cancer Proximal
vs. distal Same as above (not
Rectal cancer Proximal
vs. distal Same as above (not
Rectal cancer Proximal
vs. distal Same as above (not
Rectal cancer Proximal
vs. distal Same as above (not
Rectal cancer Proximal
vs. distal Same as above (not
Rectal cancer Proximal
vs. distal Same as above (not
Colon cancer Proximal
vs. distal Same as above (not
Colon cancer Proximal
vs. distal Same as above (not
Colon cancer Proximal
vs. distal Same as above (not
Colon cancer Proximal
vs. distal Same as above (not
Colon cancer Proximal
vs. distal Same as above (not
Proximal colon Proximal
vs. distal Same as above (not
Proximal colon Proximal
vs. distal Same as above (not
Proximal colon Proximal
vs. distal Same as above (not
Proximal colon Proximal
vs. distal Same as above (not
Proximal colon Proximal
vs. distal Same as above (not
Distal colon cancer Proximal
vs. distal Same as above (not
Distal colon cancer Proximal
vs. distal Same as above (not
Distal colon cancer Proximal
vs. distal Same as above (not
Distal colon cancer Proximal
vs. distal Same as above (not
Distal colon cancer Hypertensi
on [Self-Self-reported by
All ParticipantsHypertensi
on [Self-Self-reported by
All ParticipantsHypertensi
on [Self-Self-reported by
All ParticipantsHypertensi
on [Self-Self-reported by
All ParticipantsHypertensi
on [Self-Self-reported by
All ParticipantsHypertensi
on [Self-Self-reported by
All ParticipantsCancer
mortality Based on ICD-10
All ParticipantsCancer
mortality Based on ICD-10
All ParticipantsCancer
mortality Based on ICD-10
All ParticipantsCancer
mortality Based on ICD-10
All ParticipantsCancer
mortality Based on ICD-10
All ParticipantsCancer
mortality Based on ICD-10
All ParticipantsLung cancer
mortality Based on ICD-10
All Participants Lung cancer
mortality Based on ICD-10
All Participants Lung cancer
mortality Based on ICD-10
All Participants Lung cancer
mortality Based on ICD-10
All Participants Digestive
cancer Based on ICD-10
All Participants Digestive
cancer Based on ICD-10
All Participants Breast
cancer Based on ICD-10
All Participants Breast
cancer Based on ICD-10
All Participants
Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)
cm Continuous birth length N/A (years)cm Continuous birth length N/A (years)cm Continuous birth length N/A (years)cm Continuous birth length N/A (years)Kg Continuous N/A (years)Kg Continuous N/A (years)Kg Continuous N/A (years)Kg Continuous N/A (years)cm Continuous 9 mo length N/A (years)cm Continuous 9 mo length N/A (years)cm Continuous 9 mo length N/A (years)cm Continuous 9 mo length N/A (years)Kg Continuous N/A (years)Kg Continuous N/A (years)Kg Continuous N/A (years)Kg Continuous N/A (years)
Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)
Prostate cancer
Based on ICD-10
All Participants Prostate
cancer Based on ICD-10
All Participants Non-
Hodgkin s Based on ICD-10
All Participants Non-
Hodgkin s Based on ICD-10
All Participants Colorectal
cancer Based on ICD-10
All Participants Colorectal
cancer Based on ICD-10
All Participants Colorectal
cancer Based on ICD-10
All Participants Other
cancers Based on ICD-10
All Participants Other
cancers Based on ICD-10
All Participants Other
cancers Based on ICD-10
All Participants Breast
cancer risk Incident breast
Incident breast Breast
cancer risk Incident breast
Incident breast Breast
cancer risk Incident breast
Incident breast Breast
cancer risk Incident breast
Incident breast Breast
cancer risk Incident breast
Incident breast Breast
cancer risk Incident breast
Incident breast Breast
cancer risk Incident breast
Incident breast Breast
cancer risk Incident breast
Incident breast Breast
cancer risk Incident breast
Incident breast Breast
cancer risk Incident breast
Incident breast birth length
[Continuousbirth length [Continuousbirth length [Continuousbirth length [Continuousbirth weight
birth weightbirth
weight birth weightbirth
weight birth weightbirth
weight birth weight9 mo length
[Continuous9 mo length [Continuous9 mo length [Continuous9 mo length [Continuous9 mo weight
9 mo weight9 mo
weight 9 mo weight9 mo
weight 9 mo weight9 mo
weight 9 mo weightatopic
eczema at 9 modified UK Working
atopic eczema at 9 atopic
eczema at 9 modified UK Working
atopic eczema at 9 atopic
eczema at 9 modified UK Working
atopic eczema at 9 atopic
eczema at 9 modified UK Working
atopic eczema at 9 Prostate
cancer Medical records and
Total prostate Prostate
cancer Medical records and
Total prostate Prostate
cancer Medical records and
Total prostate Prostate
cancer Medical records and
Total prostate Prostate
cancer Medical records and
Total prostate Prostate
cancer Medical records and
Total prostate Prostate
cancer Medical records and
Total prostate Prostate
cancer Medical records and
Total prostate
Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)
Kg Continuous Kg Weight N/A (years)Kg Continuous Kg Weight N/A (years)mm Hg Continuous SBP N/A (years)mm Hg Continuous SBP N/A (years)mm Hg Continuous DBP N/A (years)mm Hg Continuous DBP N/A (years)
Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)
nmol/L Continuous N/A (years)nmol/L Continuous N/A (years)nmol/L Continuous N/A (years)nmol/L Continuous N/A (years)nmol/L Continuous N/A (years)nmol/L Continuous N/A (years)nmol/L Continuous N/A (years)nmol/L Continuous N/A (years)nmol/L Continuous N/A (years)nmol/L Continuous N/A (years)nmol/L Continuous N/A (years)nmol/L Continuous N/A (years)
Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)
Colorectal cancer
Medical and hospital
Colorectal cancerColorectal
cancer Medical and hospital
Colorectal cancerColorectal
cancer Medical and hospital
Colorectal cancerColorectal
cancer Medical and hospital
Colorectal cancerColon
cancer ICD-8 153.0-153.8
All ParticipantsColon
cancer ICD-8 153.0-153.8
All ParticipantsColon
cancer ICD-8 153.0-153.8
All ParticipantsColon
cancer ICD-8 153.0-153.8
All ParticipantsColon
cancer ICD-8 153.0-153.8
All ParticipantsColon
cancer ICD-8 153.0-153.8
All ParticipantsColon
cancer ICD-8 153.0-153.8
All ParticipantsColon
cancer ICD-8 153.0-153.8
All ParticipantsColon
cancer ICD-8 153.0-153.8
All ParticipantsWeight
[Kg:ContinuWeight [Kg:ContinuSBP [ContinuousSBP [ContinuousDBP [ContinuousDBP [ContinuousAll adenomas
For each colonoscop
All adenomasAll
adenomas For each colonoscop
All adenomasAdvance
adenomas Advanced lesions
Advanced adenomasAdvance
adenomas Advanced lesions
Advanced adenomasAdvance
adenomas Advanced lesions
Advanced AdenomasAdvance
adenomas Advanced lesions
Advanced Adenomas25(OH)D
total [sum sum of D2 and D3
change in total 25(OH)D
total [sum sum of D2 and D3
change in total 25(OH)D
total [sum sum of D2 and D3
change in total 25(OH)D
total [sum sum of D2 and D3
change in total 25(OH)D2
[Continuouschange in 25(OH)D2 25(OH)D2
[Continuouschange in 25(OH)D2 25(OH)D2
[Continuouschange in 25(OH)D2 25(OH)D2
[Continuouschange in 25(OH)D2 25(OH)D3
[Continuouschange in 25(OH)D3 25(OH)D3
[Continuouschange in 25(OH)D3 25(OH)D3
[Continuouschange in 25(OH)D3 25(OH)D3
[Continuouschange in 25(OH)D3 Recurrent
adenomas Ascertained by
Recurrent adenomasRecurrent
adenomas Ascertained by
Recurrent adenomasRecurrent
adenomas Ascertained by
Recurrent adenomasRecurrent
adenomas Ascertained by
Recurrent adenomasRecurrent
adenomas Ascertained by
Recurrent adenomasAdvanced
adenomas Subjects had
Advanced adenomasAdvanced
adenomas Subjects had
Advanced adenomasAdvanced
adenomas Subjects had
Advanced adenomasAdvanced
adenomas Subjects had
Advanced adenomasAdvanced
adenomas Subjects had
Advanced adenomasAdvanced
adenomas Subjects had
Multiple recurrent
Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)
Kg Continuous N/A (years)Kg Continuous N/A (years)mm Hg Continuous SBP N/A (years)mm Hg Continuous SBP N/A (years)mm Hg Continuous DBP N/A (years)mm Hg Continuous DBP N/A (years)kg Continuous N/A (years)
Categorical nd N/A (years)Categorical nd N/A (years)Categorical nd N/A (years)Categorical nd N/A (years)Categorical nd N/A (years)Categorical nd N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)
kg Continuous Weight N/A (years)kg Continuous Weight N/A (years)kg Continuous Weight N/A (years)Kg/m2 Continuous BMI N/A (years)Kg/m2 Continuous BMI N/A (years)Kg/m2 Continuous BMI N/A (years)
Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)
Advanced adenomas
Subjects had
Multiple recurrent Advanced
adenomas Subjects had
Multiple recurrent Advanced
adenomas Subjects had
Multiple recurrent Advanced
adenomas Subjects had
Multiple recurrent Body
weight Change in bodyweight
Body weightBody
weight Change in bodyweight
Body weightSBP
[ContinuousSBP [ContinuousDBP [ContinuousDBP [ContinuousBody weight
Change in kg over 30
Body weightProstate
cancer Prostate cancerProstate
cancer Prostate cancerProstate
cancer Prostate cancerProstate
cancer Prostate cancerProstate
cancer Prostate cancerProstate
cancer Prostate cancerRectal
cancer Finish cancer
Colorectal cancer Rectal
cancer Finish cancer
Colorectal cancer Rectal
cancer Finish cancer
Colorectal cancer Rectal
cancer Finish cancer
Colorectal cancer Rectal
cancer Finish cancer
Colon cancer Rectal
cancer Finish cancer
Colon cancer Rectal
cancer Finish cancer
Colon cancer Rectal
cancer Finish cancer
Colon cancer Rectal
cancer Finish cancer
Rectal cancer Rectal
cancer Finish cancer
Rectal cancer Rectal
cancer Finish cancer
Rectal cancer Rectal
cancer Finish cancer
Rectal cancer weight
[Analyzed Analyzed by a bipedal-weight
[Analyzed Analyzed by a bipedal-weight
[Analyzed Analyzed by a bipedal-BMI
[ContinuousBMI [ContinuousBMI [ContinuousColorectal cancer
Record linkage to
Colorectal cancer Colorectal
cancer Record linkage to
Colorectal cancer Colorectal
cancer Record linkage to
Colorectal cancer Colorectal
cancer Record linkage to
Colorectal cancer Colorectal
cancer Record linkage to
Colorectal cancer Colorectal
Cancer [Self Self reports (in the
Colorectal cancer Colorectal
Cancer [Self Self reports (in the
Colorectal cancer Colorectal
Cancer [Self Self reports (in the
Colorectal cancer Colorectal
Cancer [Self Self reports (in the
Colorectal cancer Colon caner
[Response Response to the
Colon cancer Colon caner
[Response Response to the
Colon cancer Colon caner
[Response Response to the
Colon cancer Colon caner
[Response Response to the
Colon cancer
Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)
kg/m2 Continuous BMI N/A (years)kg/m2 Continuous BMI N/A (years)kg Continuous wt N/A (years)kg Continuous wt N/A (years)cm Continuous ht N/A (years)cm Continuous ht N/A (years)
Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)
Colon caner [Response
Response to the
Colon cancer Colorectal
cancer Mostly diagnosed
Colorectal cancerColorectal
cancer Mostly diagnosed
Colorectal cancerColorectal
cancer Mostly diagnosed
Colorectal cancerColorectal
cancer Mostly diagnosed
Colorectal cancerIncident
breast Self reported
Breast cancerIncident
breast Self reported
Breast cancerIncident
breast Self reported
Breast cancerIncident
breast Self reported
Breast cancerIncident
breast Self reported
Breast cancer in Incident
breast Self reported
Breast cancer in Incident
breast Self reported
Breast cancer in Incident
breast Self reported
Breast cancer in Incident
breast Self reported
Breast cancer in Incident
breast Self reported
Breast cancer in Incident
breast Self reported
Breast cancer in Incident
breast Self reported
Breast cancer in prostate
cancer self-reported of
prostate cancerprostate
cancer self-reported of
fatal prostate change in
BMI change in BMI change in wt change in wt change in ht change in ht incident cancer
from medical
incident cancer incident
cancer from medical
incident cancer incident
cancer from medical
incident cancer incident
cancer from medical
incident cancer incident
cancer from medical
incident cancer incident
cancer from medical
incident cancer change in
25 OH(D) change in 25 OH(D) change in
25 OH(D) change in 25 OH(D) change in
25 OH(D) change in 25 OH(D) stress
fractures Stress fractures
Stress fracture stress
fractures Stress fractures
Stress fracture stress
fractures Stress fractures
Stress fracture stress
fractures Stress fractures
Stress fracture Colorectal
caner National Swedish
Colorectal cancer Colorectal
caner National Swedish
Colorectal cancer Colorectal
caner National Swedish
Colorectal cancer Colorectal
caner National Swedish
Colorectal cancer Rectal
caner National Swedish
Rectal cancer Rectal
caner National Swedish
Rectal cancer Rectal
caner National Swedish
Rectal cancer Rectal
caner National Swedish
Rectal cancer Distal colon
caner National Swedish
Colon cancer Distal colon
caner National Swedish
Colon cancer
Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)
Distal colon caner
National Swedish
Colon cancer Distal colon
caner National Swedish
Colon cancer Colorectal
caner National Swedish
Colorectal cancer Colorectal
caner National Swedish
Colorectal cancer Colorectal
caner National Swedish
Colorectal cancer Colorectal
caner National Swedish
Colorectal cancer Rectal
caner National Swedish
Rectal cancer Rectal
caner National Swedish
Rectal cancer Rectal
caner National Swedish
Rectal cancer Rectal
caner National Swedish
Rectal cancer Distal colon
caner National Swedish
Colon cancer Distal colon
caner National Swedish
Colon cancer Distal colon
caner National Swedish
Colon cancer Distal colon
caner National Swedish
Colon cancer Cerebral
infarction Cerebral infarctionCerebral
infarction Cerebral infarctionCerebral
infarction Cerebral infarctionCerebral
infarction Cerebral infarctionCerebral
infarction Cerebral infarctionInvasive
breast Linkage with
Invasive breast Invasive
breast Linkage with
Invasive breast Invasive
breast Linkage with
Invasive breast Invasive
breast Linkage with
Invasive breast Invasive
breast Linkage with
Invasive breast Prostate
cancer Tumor Gleason
Total prostate Prostate
cancer Tumor Gleason
Total prostate Prostate
cancer Tumor Gleason
Total prostate Prostate
cancer Tumor Gleason
Total prostate Prostate
cancer Tumor Gleason
Total prostate Prostate
cancer Tumor Gleason
Total prostate Prostate
cancer Tumor Gleason
Total prostate Prostate
cancer Tumor Gleason
Total prostate Prostate
cancer Tumor Gleason
Total prostate Prostate
cancer Tumor Gleason
Total prostate Prostate
cancer Tumor Gleason
Aggressive prostate Prostate
cancer Tumor Gleason
Aggressive prostate Prostate
cancer Tumor Gleason
Aggressive prostate Prostate
cancer Tumor Gleason
Aggressive prostate Prostate
cancer Tumor Gleason
Aggressive prostate Prostate
cancer Tumor Gleason
Aggressive prostate Prostate
cancer Tumor Gleason
Aggressive prostate Prostate
cancer Tumor Gleason
Aggressive prostate Prostate
cancer Tumor Gleason
Aggressive prostate Prostate
cancer Tumor Gleason
Aggressive prostate Prostate
cancer Tumor Gleason
Total prostate Prostate
cancer Tumor Gleason
Total prostate Prostate
cancer Tumor Gleason
Total prostate Prostate
cancer Tumor Gleason
Total prostate
Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)
ng/mL Continuous 25(OH)D N/A (years)ng/mL Continuous 25(OH)D N/A (years)pg/mL Continuous 1,25(OH)D N/A (years)pg/mL Continuous 1,25(OH)D N/A (years)mm Hg Continuous N/A (years)mm Hg Continuous N/A (years)mm Hg Continuous N/A (years)mm Hg Continuous N/A (years)mm Hg Continuous N/A (years)mm Hg Continuous N/A (years)mm Hg Continuous N/A (years)mm Hg Continuous N/A (years)
Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)
Kg Continuous N/A (years)Kg Continuous N/A (years)Kg Continuous N/A (years)Kg Continuous N/A (years)cm Continuous N/A (years)cm Continuous N/A (years)cm Continuous N/A (years)cm Continuous N/A (years)mmol/L Continuous N/A (years)mmol/L Continuous N/A (years)mmol/L Continuous N/A (years)mmol/L Continuous N/A (years)
Categorical N/A (years)
Prostate cancer
Tumor Gleason
Total prostate Prostate
cancer Tumor Gleason
Total prostate Prostate
cancer Tumor Gleason
Aggressive prostate Prostate
cancer Tumor Gleason
Aggressive prostate Prostate
cancer Tumor Gleason
Aggressive prostate Prostate
cancer Tumor Gleason
Aggressive prostate Prostate
cancer Tumor Gleason
Aggressive prostate Prostate
cancer Tumor Gleason
Aggressive prostate 25(OH)D
[CompetitivCompetitive protein 25(OH)D
[CompetitivCompetitive protein 1,25(OH)D
[RadiorecepRadioreceptor assay 1,25(OH)D
[RadiorecepRadioreceptor assay SBP
(standing) SBP (standing)SBP
(standing) SBP (standing)SBP
(standing) DBP (standing)SBP
(standing) DBP (standing)SBP
(standing) SBP (supine)SBP
(standing) SBP (supine)DBP
(supine) DBP (supine)DBP
(supine) DBP (supine)Distal colon
cancer [Not Not fully defined
Colorectal cancer Distal colon
cancer [Not Not fully defined
Colorectal cancer Distal colon
cancer [Not Not fully defined
Colorectal cancer Distal colon
cancer [Not Not fully defined
Colorectal cancer Distal colon
cancer [Not Not fully defined
Colorectal cancer Breast
cancer Incident cases of
Invasive breast Breast
cancer Incident cases of
Invasive breast Breast
cancer Incident cases of
Invasive breast Breast
cancer Incident cases of
Invasive breast Breast
cancer Incident cases of
Invasive breast Breast
cancer Incident cases of
Invasive breast Breast
cancer Incident cases of
Invasive breast Breast
cancer Incident cases of
Invasive breast Breast
cancer Incident cases of
Invasive breast Breast
cancer Incident cases of
Invasive breast body
weight weight in medium body
weight weight in medium body
weight weight in low (<713 body
weight weight in low (<713 height
[Continuousheight in medium height
[Continuousheight in medium height
[Continuousheight in low (<713 height
[Continuousheight in low (<713 25(OH)D
[Continuous25(OH)D in medium 25(OH)D
[Continuous25(OH)D in medium 25(OH)D
[Continuous25(OH)D in low 25(OH)D
[Continuous25(OH)D in low First
fracture Confirmed by
First fracture (all
Categorical N/A (years)Categorical nd mortality N/A (years)Categorical nd mortality N/A (years)
Kg Continuous Kg Weight N/A (years)Kg Continuous Kg Weight N/A (years)Kg/m2 Continuous BMI N/A (years)Kg/m2 Continuous BMI N/A (years)mmHg Continuous SBP N/A (years)mmHg Continuous SBP N/A (years)mmHg Continuous DBP N/A (years)mmHg Continuous DBP N/A (years)nmol/L Continuous N/A (years)nmol/L Continuous N/A (years)nmol/L Continuous N/A (years)pmol/L Continuous N/A (years)pmol/L Continuous N/A (years)pmol/L Continuous N/A (years)pmol/L Continuous N/A (years)pmol/L Continuous N/A (years)pmol/L Continuous N/A (years)pmol/L Continuous N/A (years)pmol/L Continuous N/A (years)pmol/L Continuous N/A (years)g Continuous N/A (years)g Continuous N/A (years)g Continuous N/A (years)
Categorical N/A (years)Categorical N/A (years)
mmHg Continuous Systolic BP N/A (years)mmHg Continuous Systolic BP N/A (years)mmHg Continuous Diastolic BP N/A (years)mmHg Continuous Diastolic BP N/A (years)
Categorical AMI N/A (years)Categorical AMI N/A (years)Categorical AMI N/A (years)Categorical AMI N/A (years)Categorical AMI N/A (years)Categorical Same Stroke N/A (years)Categorical Same Stroke N/A (years)Categorical Same Stroke N/A (years)Categorical Same Stroke N/A (years)Categorical Same Stroke N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical nd toxemia N/A (years)Categorical nd toxemia N/A (years)
First fracture
Confirmed by
First fracture (all Mortality
[nd:CategorMortality [nd:CategorWeight [Kg:ContinuWeight [Kg:ContinuBMI [ContinuousBMI [ContinuousSBP [ContinuousSBP [ContinuousDBP [ContinuousDBP [Continuousmaternal 25(OH)D at
maternal 25(OH)D at maternal
25(OH)D at maternal 25(OH)D at maternal
25(OH)D at maternal 25(OH)D at cord blood
1,25 cord 25(OH)Dcord blood
1,25 cord 25(OH)Dcord blood
1,25 cord 25(OH)Dcord blood
1,25 maternal 1,25(OH)2D cord blood
1,25 maternal 1,25(OH)2D cord blood
1,25 maternal 1,25(OH)2D cord blood
1,25 cord 1,25(OH)2D cord blood
1,25 cord 1,25(OH)2D cord blood
1,25 cord 1,25(OH)2D birth
weight birth weightbirth
weight birth weightbirth
weight birth weightHypertensi
on [Self-Self-report of
HypertensionHypertensi
on [Self-Self-report of
HypertensionSystolic BP
[ContinuousSystolic BP [ContinuousSystolic BP [ContinuousSystolic BP [ContinuousAMI [ICD 9 codes from
ICD 9 codes from AMI [ICD 9
codes from ICD 9 codes from AMI [ICD 9
codes from ICD 9 codes from AMI [ICD 9
codes from ICD 9 codes from AMI [ICD 9
codes from ICD 9 codes from Stroke
[Same:CateStroke [Same:CateStroke [Same:CateStroke [Same:CateStroke [Same:CateAdenoma recurrence
One or more
Adenoma recurrenceAdenoma
recurrence One or more
Adenoma recurrenceAdenoma
recurrence One or more
Adenoma recurrenceAdenoma
recurrence One or more
Adenoma recurrencetoxemia
[nd:Categortoxemia [nd:Categor
Kg Continuous N/A (years)Kg Continuous N/A (years)cm Categorical N/A (years)cm Categorical N/A (years)wk Continuous N/A (years)wk Continuous N/A (years)nmol/L Continuous N/A (years)nmol/L Continuous N/A (years)nmol/L Continuous N/A (years)nmol/L Continuous N/A (years)nmol/L Continuous N/A (years)nmol/L Continuous N/A (years)g Continuous N/A (years)g Continuous N/A (years)g Continuous N/A (years)g Continuous N/A (years)
Categorical CRC N/A (years)Categorical CRC N/A (years)Categorical CRC N/A (years)Categorical CRC N/A (years)Categorical CRC N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)
g Continuous N/A (years)g Continuous N/A (years)cm Continuous N/A (years)cm Continuous N/A (years)
Categorical N/A (years)Categorical N/A (years)
g/cm2 Continuous DXA N/A (years)g/cm2 Continuous DXA N/A (years)g/cm2 Continuous DXA N/A (years)
newborn birth
newborn birth newborn
birth newborn birth crown-heel
length crown-heel lengthcrown-heel
length crown-heel lengthgestational
age gestational agegestational
age gestational age25(OH)D
[Continuous25(OH)D at 2 mo25(OH)D
[Continuous25(OH)D at 2 mo25(OH)D
[Continuous25(OH)D at 2 mo25(OH)D
[Continuous25(OH)D at 3 mo25(OH)D
[Continuous25(OH)D at 3 mo25(OH)D
[Continuous25(OH)D at 3 mobirth
weight maternal weight gain birth
weight maternal weight gain birth
weight infant birth weightbirth
weight infant birth weightCRC
[CategoricaCRC [CategoricaCRC [CategoricaCRC [CategoricaCRC [CategoricaMammography density
Ratio of the absolute
Mammographic Mammogra
phy density Ratio of the absolute
Mammographic Mammogra
phy density Ratio of the absolute
Mammographic Mammogra
phy density Ratio of the absolute
Mammographic Mammogra
phy density Ratio of the absolute
Mammographic Mammogra
phy density Ratio of the absolute
Mammographic Mammogra
phy density Ratio of the absolute
Mammographic Mammogra
phy density Ratio of the absolute
Mammographic Mammogra
phy density Ratio of the absolute
Mammographic Mammogra
phy density Ratio of the absolute
Mammographic prostate
cancer Finnish Cancer
All Participantsprostate
cancer Finnish Cancer
All Participantsprostate
cancer Finnish Cancer
All Participantsprostate
cancer Finnish Cancer
All Participantsfatal
prostate All Participants fatal
prostate All Participants fatal
prostate All Participants fatal
prostate All Participants birth
weight birth weightbirth
weight birth weightcrown-heel
length crown-heel lengthcrown-heel
length crown-heel lengthpreeclamps
ia [HTN HTN (DBP 90 mm) and
preeclampsiaPregnancy-
induced Pregnancy-induced BMD
[DXA:ContiTotal body BMDBMD
[DXA:ContiTotal body BMDBMD
[DXA:ContiTotal body BMD
mmHg Continuous N/A (years)mmHg Continuous N/A (years)mmHg Continuous N/A (years)mmHg Continuous N/A (years)mmHg Continuous DBP (ITT) N/A (years)mmHg Continuous DBP (ITT) N/A (years)mmHg Continuous N/A (years)mmHg Continuous N/A (years)nmol/L Continuous N/A (years)nmol/L Continuous N/A (years)nmol/L Continuous N/A (years)nmol/L Continuous N/A (years)kg/m2 Continuous N/A (years)kg/m2 Continuous N/A (years)kg/m2 Continuous N/A (years)kg/m2 Continuous N/A (years)kg/m2 Continuous BMI (ITT) N/A (years)kg/m2 Continuous BMI (ITT) N/A (years)
Continuous N/A (years)Continuous N/A (years)
nmol/L Continuous 25(OH)D N/A (years)nmol/L Continuous 25(OH)D N/A (years)
Categorical N/A (years)Categorical N/A (years)Categorical Adenoma N/A (years)Categorical Adenoma N/A (years)Categorical Adenoma N/A (years)Categorical Adenoma N/A (years)Categorical Adenoma N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical Men N/A (years)Categorical Men N/A (years)Categorical Men N/A (years)Categorical Men N/A (years)Categorical Women N/A (years)Categorical Women N/A (years)Categorical Women N/A (years)Categorical Women N/A (years)Categorical Men N/A (years)
SBP [Automated
Automated OMRON
SBP (ITT analysis)SBP
[Automated Automated OMRON
SBP (ITT analysis)SBP
[Automated Automated OMRON
SBP (per protocol SBP
[Automated Automated OMRON
SBP (per protocol DBP [Same
as Same as SBPDBP [Same
as Same as SBPDBP [Same
as Same as SBP
DBP (per protocol)DBP [Same
as Same as SBP
DBP (per protocol)25(OH)D
[Continuous25(OH)D (ITT)25(OH)D
[Continuous25(OH)D (ITT)25(OH)D
[Continuous25(OH)D (per 25(OH)D
[Continuous25(OH)D (per Weight
(ITT) Weight (ITT)Weight
(ITT) Weight (ITT)Weight
(ITT) Weight (per protocol)Weight
(ITT) Weight (per protocol)Weight
(ITT) Weight (ITT) BMI (per protocol)
BMI (per protocol)BMI (per
protocol) BMI (per protocol)Serum
25(OH)D Serum 25(OH)D prostate cancer
biopsy or surgical
prostate cancerprostate
cancer biopsy or surgical
prostate cancerColorectal
adenoma Reviewed the medical Colorectal
adenoma Reviewed the medical Colorectal
adenoma Reviewed the medical Colorectal
adenoma Reviewed the medical Colorectal
adenoma Reviewed the medical Distal colon
cancer Distal colon cancerDistal colon
cancer Distal colon cancerDistal colon
cancer Distal colon cancerDistal colon
cancer Distal colon cancerDistal colon
cancer Distal colon cancerDistal colon
cancer Rectum cancerDistal colon
cancer Rectum cancerDistal colon
cancer Rectum cancerDistal colon
cancer Rectum cancerDistal colon
cancer Rectum cancerColorectal
cancer Adenocarcinoma Colorectal
cancer Adenocarcinoma Colorectal
cancer Adenocarcinoma Colorectal
cancer Adenocarcinoma Colorectal
cancer Adenocarcinoma Colorectal
cancer Adenocarcinoma Colorectal
cancer Adenocarcinoma Colorectal
cancer Adenocarcinoma Colon
cancer [See See above (ICD180-
Categorical Men N/A (years)Categorical Men N/A (years)Categorical Men N/A (years)Categorical Women N/A (years)Categorical Women N/A (years)Categorical Women N/A (years)Categorical Women N/A (years)Categorical Men N/A (years)Categorical Men N/A (years)Categorical Men N/A (years)Categorical Men N/A (years)Categorical Women N/A (years)Categorical Women N/A (years)Categorical Women N/A (years)Categorical Women N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)
mmHg Continuous SBP N/A (years)mmHg Continuous SBP N/A (years)mmHg Continuous DBP N/A (years)mmHg Continuous DBP N/A (years)nmol/L Continuous 25(OH)D N/A (years)nmol/L Continuous 25(OH)D N/A (years)
Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)
Colon cancer [See
See above (ICD180-Colon
cancer [See See above (ICD180-Colon
cancer [See See above (ICD180-Colon
cancer [See See above (ICD180-Colon
cancer [See See above (ICD180-Colon
cancer [See See above (ICD180-Colon
cancer [See See above (ICD180-Rectal
cancer [See See above (ICD199 Rectal
cancer [See See above (ICD199 Rectal
cancer [See See above (ICD199 Rectal
cancer [See See above (ICD199 Rectal
cancer [See See above (ICD199 Rectal
cancer [See See above (ICD199 Rectal
cancer [See See above (ICD199 Rectal
cancer [See See above (ICD199 Colorectal
cancer Identified by means
Colorectal cancer Colorectal
cancer Identified by means
Colorectal cancer Colorectal
cancer Identified by means
Colorectal cancer Colorectal
cancer Identified by means
Colorectal cancer Colorectal
cancer Identified by means
Colorectal cancer Colorectal
cancer Identified by means
Colorectal cancer Colorectal
cancer Identified by means
Colorectal cancer Colorectal
cancer Identified by means
Colorectal cancer Colorectal
cancer Identified by means
Colorectal cancer Colorectal
cancer Identified by means
Colorectal cancer incident
prostate 8 state cancer
total prostate incident
prostate 8 state cancer
fatal prostate Prostate
cancer Identified by linkage
Prostate cancerProstate
cancer Identified by linkage
Prostate cancerProstate
cancer Identified by linkage
Prostate cancerProstate
cancer Identified by linkage
Prostate cancerProstate
cancer Identified by linkage
Prostate cancerProstate
cancer Identified by linkage
Prostate cancerProstate
cancer Identified by linkage
Prostate cancerProstate
cancer Identified by linkage
Prostate cancerProstate
cancer Identified by linkage
Prostate cancerProstate
cancer Identified by linkage
Prostate cancerSBP
[Measured Measured after at SBP
[Measured Measured after at DBP [Same
as Same as SBPDBP [Same
as Same as SBP25(OH)D
[Continuous25(OH)D [ContinuousColon cancer or
Incident cases of
Colorectal cancerColon
cancer or Incident cases of
Colorectal cancerColon
cancer or Incident cases of
Colorectal cancerColon
cancer or Incident cases of
Colorectal cancerDistal
colorectal Adenomatous polyps
All Participants
Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)
Kg Continuous Kg, BMI Weight N/A (years)Kg Continuous Kg, BMI Weight N/A (years)kg/m2 Continuous BMI N/A (years)kg/m2 Continuous BMI N/A (years)mm Hg Continuous SBP N/A (years)mm Hg Continuous SBP N/A (years)mm Hg Continuous DBP N/A (years)
Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical Fatal stroke N/A (years)Categorical Fatal stroke N/A (years)Categorical Fatal stroke N/A (years)
mmHg Continuous SBP N/A (years)mmHg Continuous SBP N/A (years)
Continuous DBP N/A (years)
Distal colorectal
Adenomatous polyps
All Participants Distal
colorectal Adenomatous polyps
All Participants Distal
colorectal Adenomatous polyps
All Participants Distal
colorectal Adenomatous polyps
All Participants Distal
colorectal Adenomatous polyps
All Participants Distal
colorectal Adenomatous polyps
All Participants Distal
colorectal Adenomatous polyps
All Participants Rectal
adenoma Adenomatous polyps
All Participants Rectal
adenoma Adenomatous polyps
All Participants Rectal
adenoma Adenomatous polyps
All Participants Rectal
adenoma Adenomatous polyps
All Participants Rectal
adenoma Adenomatous polyps
All Participants Rectal
adenoma Adenomatous polyps
All Participants Rectal
adenoma Adenomatous polyps
All Participants Rectal
adenoma Adenomatous polyps
All Participants Distal colon
adenoma Adenomatous polyps
All Participants Distal colon
adenoma Adenomatous polyps
All Participants Distal colon
adenoma Adenomatous polyps
All Participants Distal colon
adenoma Adenomatous polyps
All Participants Distal colon
adenoma Adenomatous polyps
All Participants Distal colon
adenoma Adenomatous polyps
All Participants Distal colon
adenoma Adenomatous polyps
All Participants Distal colon
adenoma Adenomatous polyps
All Participants high-risk
distal colon Large (1 cm or larger),
All Participants high-risk
distal colon Large (1 cm or larger),
All Participants high-risk
distal colon Large (1 cm or larger),
All Participants high-risk
distal colon Large (1 cm or larger),
All Participants Weight [Kg,
BMI:ContinWeight [Kg, BMI:ContinBMI [ContinuousBMI [ContinuousSBP [ContinuousSBP [ContinuousDBP [ContinuousProstate cancer
Incident cases
Prostate cancerProstate
cancer Incident cases
Prostate cancerProstate
cancer Incident cases
Prostate cancerProstate
cancer Incident cases
Prostate cancerProstate
cancer Incident cases
Prostate cancerincident
prostate Cancer Registry;
incident prostate incident
prostate Cancer Registry;
incident prostate incident
prostate Cancer Registry;
incident prostate Fatal stroke
[CategoricaFatal stroke [CategoricaFatal stroke [CategoricaSBP [BP was
BP was measured SBP [BP
was BP was measured DBP [BP
was BP was measured
Continuous DBP N/A (years)ng/mL Continuous 25(OH)D N/A (years)ng/mL Continuous 25(OH)D N/A (years)
Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)
kg Continuous weight N/A (years)kg Continuous weight N/A (years)Kg/m2 Continuous BMI N/A (years)Kg/m2 Continuous BMI N/A (years)nmol/L Continuous N/A (years)nmol/L Continuous N/A (years)
Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)
DBP [BP was
BP was measured 25(OH)D
[As As measured 25(OH)D
[As As measured Colorectal
cancer Cohort members
Colorectal cancerColorectal
cancer Cohort members
Colorectal cancerColorectal
cancer Cohort members
Colorectal cancerColorectal
cancer Cohort members
Colorectal cancerColorectal
cancer Cohort members
Colorectal cancerPancreatic
cancer Self-reported
Pancreatic cancerCancer
mortality The residence
Gastrointestinal cancer Cancer
mortality The residence
Gastrointestinal cancer Cancer
mortality The residence
Gastrointestinal cancer Cancer
mortality The residence
Gastrointestinal cancer Cancer
mortality The residence
Gastrointestinal cancer Cancer
mortality The residence
Gastrointestinal cancer Cancer
mortality The residence
Gastrointestinal cancer Cancer
mortality The residence
Gastrointestinal cancer Cancer
mortality The residence
Gastrointestinal cancer Cancer
mortality The residence
Gastrointestinal cancer All-cause
mortality The residence
All cause mortality All-cause
mortality The residence
All cause mortality All-cause
mortality The residence
All cause mortality All-cause
mortality The residence
All cause mortality All-cause
mortality The residence
All cause mortality All-cause
mortality The residence
Total cancer All-cause
mortality The residence
Total cancer All-cause
mortality The residence
Total cancer All-cause
mortality The residence
Total cancer All-cause
mortality The residence
Total cancer All-cause
mortality The residence
All cause mortality All-cause
mortality The residence
All cause mortality All-cause
mortality The residence
All cause mortality All-cause
mortality The residence
All cause mortality All-cause
mortality The residence
All cause mortality All-cause
mortality The residence
Total cancer All-cause
mortality The residence
Total cancer All-cause
mortality The residence
Total cancer All-cause
mortality The residence
Total cancer All-cause
mortality The residence
Total cancer weight
[Continuousweight [ContinuousBMI [ContinuousBMI [ContinuousSerum 25(OH)D
Serum 25(OH)DSerum
25(OH)D Serum 25(OH)DPancreatic
cancer Vital status of cohort
Pancreatic cancerPancreatic
cancer Vital status of cohort
Pancreatic cancerPancreatic
cancer Vital status of cohort
Pancreatic cancer
Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)
Kg Continuous N/A (years)Kg Continuous N/A (years)
Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)
Pancreatic cancer
Vital status of cohort
Pancreatic cancerPancreatic
cancer Vital status of cohort
Pancreatic cancerPancreatic
cancer odds ratios (OR) for
pancreatic cancerPancreatic
cancer odds ratios (OR) for
Pancreatic cancerPancreatic
cancer odds ratios (OR) for
Pancreatic cancerPancreatic
cancer odds ratios (OR) for
Pancreatic cancerPancreatic
cancer odds ratios (OR) for
Pancreatic cancerColorectal
cancer Diagnosis of primary
All ParticipantsColorectal
cancer Diagnosis of primary
All ParticipantsColorectal
cancer Diagnosis of primary
All ParticipantsColorectal
cancer Diagnosis of primary
All ParticipantsColorectal
cancer Diagnosis of primary
All ParticipantsColorectal
cancer Diagnosis of primary
All ParticipantsColorectal
cancer Diagnosis of primary
All ParticipantsColorectal
cancer Diagnosis of primary
All ParticipantsColon
cancer Diagnosis of primary
All ParticipantsColon
cancer Diagnosis of primary
All ParticipantsColon
cancer Diagnosis of primary
All ParticipantsColon
cancer Diagnosis of primary
All ParticipantsColon
cancer Diagnosis of primary
All ParticipantsColon
cancer Diagnosis of primary
All ParticipantsColon
cancer Diagnosis of primary
All ParticipantsColon
cancer Diagnosis of primary
All ParticipantsColon
cancer All Participants Colon
cancer All Participants Colon
cancer All Participants Colon
cancer All Participants Colon
cancer All Participants Colon
cancer All Participants Colon
cancer All Participants Colon
cancer All Participants Rectal
cancer Diagnosis of primary
All Participants Rectal
cancer Diagnosis of primary
All Participants Rectal
cancer Diagnosis of primary
All Participants Rectal
cancer Diagnosis of primary
All Participants Rectal
cancer All Participants Rectal
cancer All Participants Rectal
cancer All Participants Rectal
cancer All Participants Bodyweight
[Change in Change in kg/yr
Bodyweight changeBodyweight
[Change in Change in kg/yr
Bodyweight changeCerebrovas
cular same as above
Cardiovascular DiseaseCerebrovas
cular same as above
Cardiovascular DiseaseCerebrovas
cular same as above
Ischaemic Heart Cerebrovas
cular same as above
Ischaemic Heart Cerebrovas
cular same as above
Cerebrovascular Cerebrovas
cular same as above
Cerebrovascular Cerebrovas
cular same as above
IschaemicHeart
Categorical N/A (years)Categorical All Causes N/A (years)Categorical All Causes N/A (years)Categorical All Cancers N/A (years)Categorical All Cancers N/A (years)Categorical Colorectal N/A (years)Categorical Colorectal N/A (years)Categorical Respiratory N/A (years)Categorical Respiratory N/A (years)Categorical Breast N/A (years)Categorical Breast N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical Respira-ry N/A (years)Categorical Respira-ry N/A (years)Categorical Total stroke N/A (years)Categorical Total stroke N/A (years)Categorical Total stroke N/A (years)Categorical Total stroke N/A (years)Categorical Total stroke N/A (years)Categorical CHD N/A (years)Categorical CHD N/A (years)Categorical CHD N/A (years)Categorical CHD N/A (years)Categorical CHD N/A (years)
Kg Continuous N/A (years)Kg Continuous N/A (years)Kg/m2 Continuous BMI N/A (years)Kg/m2 Continuous BMI N/A (years)
Categorical mortality N/A (years)Categorical nd N/A (years)Categorical nd N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)
Cerebrovascular
same as above
IschaemicHeart All cancers
incidence same as aboveAll cancers
incidence same as aboveAll cancers
incidence same as aboveAll cancers
incidence same as aboveColorectal
cancer same as aboveColorectal
cancer same as aboveRespiratory
cancer same as aboveRespiratory
cancer same as aboveBreast
cancer same as aboveBreast
cancer same as aboveBreast
cancer same as above
Cancer Excluding Breast
cancer same as above
Cancer Excluding Breast
cancer same as above
Colorectal CancerBreast
cancer same as above
Colorectal CancerBreast
cancer same as above
Respiratory CancerBreast
cancer same as above
Respiratory CancerBreast
cancer same as above
Breast CancerBreast
cancer same as above
Breast CancerFalls
incidence same as above
Self Reported Falls
incidence same as above
Self Reported Respira-ry
[CategoricaRespira-ry [CategoricaFatal stroke [Death
Death certificates Fatal stroke
[Death Death certificates Fatal stroke
[Death Death certificates Fatal stroke
[Death Death certificates Fatal stroke
[Death Death certificates CHD
[CategoricaCHD [CategoricaCHD [CategoricaCHD [CategoricaCHD [CategoricaBody weight
Body weight in
Body weightBody
weight Body weight in
Body weightBMI
[ContinuousBMI [Continuousmortality [by death
by death certificateAll cause
mortality All cause mortalityAll cause
mortality All cause mortalityDeath from
colorectal Death from colorectal
Death from colorectal Death from
colorectal Death from colorectal
Death from colorectal Intestinal
polyps Intestinal polyps
Intestinal PolypIntestinal
polyps Intestinal polyps
Intestinal PolypKidney
stone Kidney stone
Kidney stone (UL)Kidney
stone Kidney stone
Kidney stone (UL)Cancer
related Kidney stone
Invasive colorectal Cancer
related Kidney stone
Invasive colorectal
Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)
ng/mL Continuous N/A (years)ng/mL Continuous N/A (years)
Continuous at 2 mo N/A (years)Continuous at 2 mo N/A (years)Continuous at 2 mo N/A (years)Continuous at 2 mo N/A (years)Continuous at 3 mo N/A (years)Continuous at 3 mo N/A (years)Continuous at 4 mo N/A (years)Continuous at 4 mo N/A (years)Continuous at 4 mo N/A (years)Continuous at 4 mo N/A (years)Continuous at 5 mo N/A (years)Continuous at 5 mo N/A (years)Continuous at 6 mo N/A (years)Continuous at 6 mo N/A (years)Continuous at 7 mo N/A (years)Continuous at 7 mo N/A (years)Continuous at 7 mo N/A (years)Continuous at 7 mo N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Categorical CV event N/A (years)Categorical CV event N/A (years)Categorical CV event N/A (years)Categorical CV event N/A (years)Categorical CV event N/A (years)
% change Continuous PI (total) N/A (years)% change Continuous PI (total) N/A (years)% change Continuous N/A (years)% change Continuous N/A (years)% change Continuous N/A (years)
Cancer related
Kidney stone
Invasive colon Cancer
related Kidney stone
Invasive colon Cancer
related Kidney stone
Invasive rectal Cancer
related Kidney stone
Invasive rectal Cancer
related Kidney stone
Total cancerCancer
related Kidney stone
Total cancerCancer
related Kidney stone
Cancer mortalityCancer
related Kidney stone
Cancer mortalityvit D3 level
in mom mom 25 (OH)D at 1 vit D3 level
in mom mom 25 (OH)D at 1 at 2 mo
[Continuousat 2 mo [Continuousat 2 mo [Continuousat 2 mo [Continuousat 2 mo [Continuousat 2 mo [Continuousat 2 mo [Continuousat 2 mo [Continuousat 2 mo [Continuousat 2 mo [Continuousat 2 mo [Continuousat 2 mo [Continuousat 2 mo [Continuousat 2 mo [Continuousat 2 mo [Continuousat 2 mo [Continuousat 2 mo [Continuousat 2 mo [Continuousat 2 mo [Continuous
mom vit D3 level at 1 at 2 mo
[Continuousmom vit D3 level at 1 at 2 mo
[Continuousantirachitic activity in at 2 mo
[Continuousantirachitic activity in at 2 mo
[Continuousinfant 25 (OH)D at 1 at 2 mo
[Continuousinfant 25 (OH)D at 1 at 2 mo
[Continuousinfant weight at 1 at 2 mo
[Continuousinfant weight at 1 at 2 mo
[Continuousinfant length at 1 at 2 mo
[Continuousinfant length at 1 First
cardiovascuMI, coronary First
cardiovascuMI, coronary First
cardiovascuMI, coronary First
cardiovascuMI, coronary First
cardiovascuMI, coronary PI [Change
in PI% of Change in PI% of each PI [Change
in PI% of Change in PI% of each PI [Change
in PI% of Change in PI% of each
PI (highest compartmePI [Change
in PI% of Change in PI% of each
PI (highest compartmePI [Change
in PI% of Change in PI% of each
PI (lowest compartme
% change Continuous N/A (years)% change Continuous PI (curve) N/A (years)% change Continuous PI (curve) N/A (years)% change Continuous N/A (years)% change Continuous N/A (years)% change Continuous N/A (years)% change Continuous N/A (years)% change Continuous N/A (years)% change Continuous N/A (years)
Categorical stroke N/A (years)Categorical stroke N/A (years)Categorical stroke N/A (years)
mm Hg Continuous SBP N/A (years)mm Hg Continuous SBP N/A (years)mm Hg Continuous DBP N/A (years)mm Hg Continuous DBP N/A (years)
Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)
PI [Change in PI% of
Change in PI% of each
PI (lowest compartmePI [Change
in PI% of Change in PI% of each PI [Change
in PI% of Change in PI% of each Calcium
balance Total fecal calcium and
Total fecal calciumCalcium
balance Total fecal calcium and
Total fecal calciumCalcium
balance Total fecal calcium and
Water soluble Calcium
balance Total fecal calcium and
Water soluble Calcium
balance Total fecal calcium and
Total urine calciumCalcium
balance Total fecal calcium and
Total urine calciumstroke
[Self-Self-reported stroke
[Self-Self-reported stroke
[Self-Self-reported SBP
[ContinuousSBP [ContinuousDBP [ContinuousDBP [ContinuousPrimary adenocarcin
Reported as diagnosis of
All ParticipantsProximal
(right Colon cancer
All ParticipantsDistal (left
sided) Colon cancer
All ParticipantsColorectal
cancer [The The vast majority of
All ParticipantsColorectal
cancer [The The vast majority of
All ParticipantsColorectal
cancer [The The vast majority of
All ParticipantsColorectal
cancer [The The vast majority of
All ParticipantsColorectal
cancer [The The vast majority of
All ParticipantsColon
cancer All ParticipantsColon
cancer All ParticipantsColon
cancer All ParticipantsColon
cancer All ParticipantsProximal
colon All ParticipantsProximal
colon All ParticipantsProximal
colon All ParticipantsProximal
colon All ParticipantsDistal colon
cancer All ParticipantsDistal colon
cancer All ParticipantsDistal colon
cancer All ParticipantsDistal colon
cancer All ParticipantsRectal
cancer All ParticipantsRectal
cancer All ParticipantsRectal
cancer All ParticipantsRectal
cancer Colorectal cancer Rectal
cancer Colorectal cancer Rectal
cancer Colorectal cancer Rectal
cancer Colorectal cancer Rectal
cancer Colorectal cancer Rectal
cancer Colon cancer Rectal
cancer Colon cancer Rectal
cancer Colon cancer Rectal
cancer Colon cancer
mmHg Continuous N/A (years)mmHg Continuous N/A (years)mmHg Continuous N/A (years)mmHg Continuous N/A (years)mmHg Continuous N/A (years)mmHg Continuous N/A (years)mmHg Continuous N/A (years)mmHg Continuous N/A (years)kg/m2 Continuous N/A (years)kg/m2 Continuous N/A (years)
Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)
nmol/liter Continuous 1 (years)nmol/liter Continuous 1 (years)nmol/liter Continuous 1 (years)nmol/liter Continuous 3 (years)nmol/liter Continuous 3 (years)nmol/liter Continuous 3 (years)nmol/liter Continuous 5 (years)nmol/liter Continuous 5 (years)nmol/liter Continuous 5 (years)mg/cm2 Continuousmg/cm2 Continuousmg/cm2 Continuousmg/cm2 Continuousmg/cm2 Continuousmg/cm2 Continuous N/A (years)mg/cm2 Continuous N/A (years)nmol/L Continuous N/A (years)nmol/L Continuous N/A (years)
in SBP [Continuous
SBP in white in SBP
[ContinuousSBP in white in SBP
[ContinuousSBP in white in SBP
[ContinuousSBP in white in SBP
[ContinuousDBP in white in SBP
[ContinuousDBP in white in SBP
[ContinuousDBP in white in SBP
[ContinuousDBP in white BMI
[ContinuousAll ParticipantsBMI
[ContinuousAll ParticipantsRectal
cancer State Health
All ParticipantsRectal
cancer State Health
All ParticipantsRectal
cancer State Health
All Participants25(OH)D
[Measured Measured by
All Participants25(OH)D
[Measured Measured by
All Participants25(OH)D
[Measured Measured by
All Participants25(OH)D
[Measured Measured by
All Participants25(OH)D
[Measured Measured by
All Participants25(OH)D
[Measured Measured by
All Participants25(OH)D
[Measured Measured by
All Participants25(OH)D
[Measured Measured by
All Participants25(OH)D
[Measured Measured by
All ParticipantsBMD
[Measured Measured at the hip
All Participants
12 (months)BMD
[Measured Measured at the hip
All Participants
12 (months)BMD
[Measured Measured at the hip
All Participants
12 (months)BMD
[Measured Measured at the hip
All Participants
60 (months)BMD
[Measured Measured at the hip
All Participants
60 (months)BMD [Hip
and total Hip and total body.
All ParticipantsBMD [Hip
and total Hip and total body.
All Participants25(OH)D
[ContinuousAll Participants25(OH)D
[ContinuousAll Participants
Armnd nd 119 157nd nd 125 156nd nd 190 157nd nd 167 156nd nd 148 155nd nd 73 156nd nd 130 157nd nd 105 156nd nd 90 155nd nd 68 157nd nd 34 144nd nd 26 148nd nd 41 143nd nd 48 131nd nd nd ndnd nd nd ndnd nd nd ndnd nd nd nd- 523 300 7960- 670 296 7960- 803 267 7960- 995 299 7960- 1377 296 7960- 523 212 7960- 670 206 7960- 803 197 7960- 995 220 7960- 1377 195 7960- 523 88 7960- 670 90 7960- 803 70 7960- 995 79 7960- 137 101 7960- - - -- - - -
Quintile 1 - - - -
Quintile 2 - - - -
Quintile 3 - - - -
Quintile 4 - - - -
Quintile 5 - - - -- - - -- - - -
Placebo - - - -- - - -- - - -
Placebo - - - -- - - -
Arm Description
Mean Vit D level/dose
Mean Ca level/dose
No. of Cases
No. of Non-casesquintiles
based on Quintile 2: 42.5-51.3 Quintile 3: 51.4-60.5 Quintile 4: 60.6-71.7 Quintile 5: 71.8-129.5 Quintile 2: 42.5-51.3 Quintile 3: 51.4-60.5 Quintile 4: 60.6-71.7 Quintile 5: 71.8-129.5 Serum 25(OH)D - Quartile cut off based Quartile 3: 25(OH)D = Quartile 2: 25(OH)D = Quartile 1: 25(OH)D = 25(OH)D - Group 1: 25(OH)D - Group 2: 25(OH)D - Group 1: 25(OH)D - Group 2: Ca intake - Quintile 1Ca intake - Quintile 2Ca intake - Quintile 3Ca intake - Quintile 4Ca intake - Quintile 5Ca intake - Quintile 1Ca intake - Quintile 2Ca intake - Quintile 3Ca intake - Quintile 4Ca intake - Quintile 5Ca intake - Quintile 1Ca intake - Quintile 2Ca intake - Quintile 3Ca intake - Quintile 4Ca intake - Quintile 5Ca supplementCalcium placebo
Vit D3 10 ug/dVit D3 20 ug/dVit D3 10 ug/dVit D3 20 ug/dVit D3 10 ug/d
- - - -
Placebo - - - -- - - -- - - -
Placebo - - - -- - - -- - - -
Placebo - - - -- - - -- - - -
Placebo - - - -- - - -- - - -
Placebo - - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -nd 500 75 ~8748 (64,728)nd 700 69 ~8748 (65,534)nd 800 51 ~8748 (64,596)nd 1000 63 ~8748 (64,425)nd 1400 70 ~8748 (64,112)- <675.2 nd nd- 675.2-990.8 nd nd- >990.8 nd nd- <25.2 ng/mL nd nd- 25.2-34 ng/mL nd nd- >34.0 ng/mL nd nd- <36.4 pg/mL nd nd- 36.4-47.08 pg/mL nd nd- >47.08 pg/mL nd nd- - - -
Placebo - - - -nd 159 138nd 149 141
Vit D3 20 ug/dVit D3 10 ug/dVit D3 20 ug/dVit D3 10 ug/dVit D3 20 ug/dVit D3 10 ug/dVit D3 20 ug/dVit D3 10 ug/dVit D3 20 ug/dCa intake Categories Ca intake Categories Ca intake Categories Ca intake Categories Ca intake Categories Ca intake Categories Ca intake Categories Ca intake Categories Ca intake Categories Ca intake Categories Ca intake Categories Ca intake - Quintile 1Ca intake - Quintile 2Ca intake - Quintile 3Ca intake - Quintile 4Ca intake - Quintile 5Ca intake - Quintile 1Ca intake - Quintile 2Ca intake - Quintile 3Ca intake - Quintile 4Ca intake - Quintile 5Baseline dietary Ca Baseline dietary Ca Baseline dietary Ca Baseline 25(OH)D - Baseline 25(OH)D - Baseline 25(OH)D - Baseline 1,25(OH)2D Baseline 1,25(OH)2D Baseline 1,25(OH)2D Ca carbonate 25(OH)D - Quintile 1
20 ng/mL(1st batch) 28 (2nd 25(OH)D -
Quintile 221 to 28 29 to 34 19 to 24
nd 125 129nd 144 152nd 124 141
28.5 ng/mL nd 138 127nd 111 121
31.6 to 34.3 nd 117 12234.4 to 38.1 nd 123 12238.2 nd 129 126- - - -- - - -
Placebo - - - -1200 IU/day nd 10 73
Placebo 0 nd 9 68
Vit D + Ca - - - -
Placebo - - - -
Cases - - - -
Controls - - - -
Calcium - - - -
Placebo - - - -
Calcium - - - -
Placebo - - - -
Calcium - - - -
Placebo - - - -
Calcium - - - -
Placebo - - - -
Placebo - - - -
Vit D + Ca - - - -
Placebo - - - -
Vit D + Ca - - - -
Calcium - - - -
Placebo - - - -
Quintile 1 nd <629 54 -
Quintile 2 nd 629-896 44 -
Quintile 3 nd 897-1188 42 -
Quintile 4 nd 1189-1547 44 -
Quintile 5 nd 1548- 28 -nd <696 127 ~8621.5 (74,224)nd 696-1051 84 ~8621.5 (74,497)nd 1052-1425 94 ~8621.5 (74,588)nd >1425 82 ~8621.5 (74,570)
Quintile 1 <24.1 nd - -
Quintile 2 24.1-29.5 nd - -
Quintile 3 29.6-35.4 nd - -
Quintile 4 35.5-41.3 nd - -
Quintile 5 >41.3 nd - -
Quintile 2-5 >24.1 nd - -
Placebo - - - -
Vit D + Ca - - - -
25(OH)D - Quintile 3
29 to 33 35 to 39 25 to 2925(OH)D -
Quintile 434 to 39 40 to 47 30 to 3625(OH)D -
Quintile 540 ng/mL 48 ng/mL 37 ng/mL25(OH)2D -
Quintile 125(OH)2D - Quintile 2
28.6 to 31.5 ng/mL25(OH)2D -
Quintile 325(OH)2D - Quintile 425(OH)2D - Quintile 5Cholecalciferol 400 Cholecalciferol 1200 Cholecalciferol 1200
Ca intake - Quartile 1Ca intake - Quartile 2Ca intake - Quartile 3Ca intake - Quartile 4
Placebo - - - -
Vit D + Ca - - - -
Placebo - - - -
Vit D + Ca - - - -
Placebo - - - -
Vit D + Ca - - - -
Placebo - - - -
Vit D + Ca - - - -
Placebo - - - -
Vit D + Ca - - - -- - - -- - - -- - - -- - - -0 800 mg nd 240 800 mg nd 22400 IU 800 mg nd 24400 IU 800 mg nd 22- - - -- - - -
Vit D + Ca - - - -
Calcium - - - -
Vit D + Ca - - - -
Calcium - - - -nd 0-150 155 ndnd 151-300 206 ndnd 301-600 377 ndnd > 600 274 nd81.9 (13.2) nd CaD 86 Pl 76 19560.9 (3.5) nd CaD 95 Pl 86 18549.2 (3.3) nd CaD 102 Pl 92 17138.5 (3.3) nd CaD 71 Pl 102 17123.6 (5.9) nd CaD 94 Pl 91 176- - - -
Placebo - - - -- - - -
Placebo - - - -
Vit D + Ca - - - -- - - -- - - -
Placebo - - - -
Vit D + Ca - - - -- - - -- - - -
Placebo - - - -- - - -- - - -- - - -
No training + Ca, vit DNo training + Ca, vit DNo training + Ca, vit DNo training + Ca, vit DNo training + Ca, vit DTraining + CaNo training + Ca + Vit Training + + Ca + Vit No training + Ca, vit DNo training + Ca, vit D
Dairy Ca intake - Dairy Ca intake - Dairy Ca intake - Dairy Ca intake - Baseline 25(OH)D - Baseline 25(OH)D - Baseline 25(OH)D - Baseline 25(OH)D - Baseline 25(OH)D - Calcium carbonate Calcium carbonate
Ca + PlaceboDairy product
Ca + PlaceboDairy productCalcium, both weight Placebo, both weight Calcium, both weight
- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -
Quartile 1 - - - -
Quartile 2 - - - -
Quartile 3 - - - -
Quartile 4 - - - -
Quartile 2 - nd - -
Quartile 3 - nd - -
Quartile 4 - nd - -
Quartile 2 - nd - -
Quartile 3 - nd - -
Quartile 4 - nd - -
Quartile 2 - nd - -
Quartile 3 - nd - -
Quartile 4 - nd - -
Quartile 2 - nd - -
Quartile 3 - nd - -
Quartile 4 - nd - -
Quartile 2 - nd - -
Quartile 3 - nd - -
Quartile 4 - nd - -
Quartile 2 - nd - -
Quartile 3 - nd - -
Quartile 4 - nd - -- - - -
High dairy - - - -- - - -
Control - - - -
High dairy - - - -- - - -
Control - - - -
Low Vit D - - - -
High Vit D - - - -
Placebo - - - -
Low Vit D - - - -
High Vit D - - - -
Placebo - - - -
Low Vit D - - - -
High Vit D - - - -
Placebo - - - -
Low Vit D - - - -
Placebo, both weight Calcium, both weight Placebo, both weight Calcium carbonicumNo chemoprevCalcium carbonicum No chemoprevNo chemoprevCa intake, per 1 g/day
Ca intake, per 1 g/day Medium dairy
Medium dairy
High Vit D - - - -
Placebo - - - -
Low Vit D - - - -
High Vit D - - - -
Placebo - - - -
Low Vit D - - - -
High Vit D - - - -
Placebo - - - -
Low Vit D - - - -
High Vit D - - - -
Placebo - - - -
Low Vit D - - - -
High Vit D - - - -
Placebo - - - -
Low Vit D - - - -
High Vit D - - - -
Placebo - - - -
100 IU - - - -
200 IU - - - -
400 IU - - - -
100 IU - - - -
200 IU - - - -
400 IU - - - -
100 IU - - - -
200 IU - - - -
400 IU - - - -
100 IU - - - -
200 IU - - - -
400 IU - - - -
100 IU - - - -
200 IU - - - -
400 IU - - - -
100 IU - - - -
200 IU - - - -
400 IU - - - -
100 IU - - - -
200 IU - - - -
400 IU - - - -
100 IU - - - -
200 IU - - - -
400 IU - - - -- - - 77- - - 79- - - 75- - - 77- - - 75- - - 77- - - 78
25(OH)D - Quintile 125(OH)D - Quintile 225(OH)D - Quintile 325(OH)D - Quintile 425(OH)D - Quintile 51,25(OH)2D - Quintile 11,25(OH)2D - Quintile 2
- - - 76- - - 76- - - 75
Quintile 1 17 <472 102 nd
Quintile 2 17 472-635 110 nd
Quintile 3 17 636-844 86 nd
Quintile 4 17 845-1270 106 nd
Quintile 5 17 >1270 80 nd
Quintile 1 17 <472 nd nd
Quintile 2 17 472-635 nd nd
Quintile 3 17 636-844 nd nd
Quintile 4 17 845-1270 nd nd
Quintile 5 17 >1270 nd nd
Quintile 1 17 <472 nd nd
Quintile 2 17 472-635 nd nd
Quintile 3 17 636-844 nd nd
Quintile 4 17 845-1270 nd nd
Quintile 5 17 >1270 nd nd
Quintile 1 17 <472 nd nd
Quintile 2 17 472-635 nd nd
Quintile 3 17 636-844 nd nd
Quintile 4 17 845-1270 nd nd
Quintile 5 17 >1270 nd nd
Quintile 1 17 <472 nd nd
Quintile 2 17 472-635 nd nd
Quintile 3 17 636-844 nd nd
Quintile 4 17 845-1270 nd nd
Quintile 5 17 >1270 nd nd
Quartile 1 - - - -
Quartile 2 - - - -
Quartile 3 - - - -
Quartile 4 - - - -
< 30.0 - - - -
>= 30.0 - - - -
6-Q1 - - - -
6-Q2 - - - -
6-Q3 - - - -
6-Q4 - - - -
6-Q5 - - - -
6-Q6 - - - -
4-Q1 - - - -
4-Q2 - - - -
4-Q3 - - - -
4-Q4 - - - -
2-Q1 - - - -
2-Q2 - - - -
2-Q1 - - - -
2-Q2 - - - -
1,25(OH)2D - Quintile 31,25(OH)2D - Quintile 41,25(OH)2D - Quintile 5
2-Q1 - - - -
2-Q2 - - - -
2-Q1 - - - -
2-Q2 - - - -
3-Q1 - - - -
3-Q2 - - - -
3-Q3 - - - -
3-Q1 - - - -
3-Q2 - - - -
3-Q3 - - - -25(OH)D 12 y 172 201025(OH)D 12 y 188 201025(OH)D 12 y 244 201025(OH)D 12 y 205 201025(OH)D 12 y 196 201025(OH)2D 12 y 166 201025(OH)2D 12 y 186 201025(OH)2D 12 y 206 201025(OH)2D 12 y 234 201025(OH)2D 12 y 212 2010- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -nd nd 9 440nd nd 10 440nd nd 15 440nd nd 14 440nd nd nd ndnd nd nd ndnd nd nd ndnd nd nd ndnd nd nd ndnd nd nd ndnd nd nd ndnd nd nd nd
Quintile 1: <18.3 Quintile 2: 18.3-<23.5 Quintile 3: 23.5-<28.3 Quintile 4: 28.3-<33.7 Quintile 5: >= 33.7 Quintile 1: <28.2 Quintile 2: 28.2-<33.5 Quintile 3: 33.5-<39 Quintile 4: 39-<46.3 Quintile 5: >= 46.3 Quartile 1:<30 Quartile 2: 30-50Quartile 3: >50-75Quartile 4: >75Quartile 1:<30 Quartile 2: 30-50Quartile 3: >50-75Quartile 4: >75Quartile 1:<30 Quartile 2: 30-50Quartile 3: >50-75Quartile 4: >75Quartile 1:<30 Quartile 2: 30-50Quartile 3: >50-75Quartile 4: >75Quartile 1:<30 Quartile 2: 30-50Quartile 3: >50-75Quartile 4: >75Quartile 1: 25-D 6.3-Quartile 2: 25-D 21.4-Quartile 3: 25-D 28.5-Quartile 4: 25-D 37.5-Quartile 1: 1,25-D Quartile 2: 1,25-D Quartile 3: 1,25-D Quartile 4: 1,25-D
nd 102-241 19 488nd 242-306 12 489nd 307-383 12 489nd 384-906 6 4584-19 - 9 820-26 - 7 1327-32 - 5 1833-41 - 4 1742-91 - 9 110-29 - - 42*****30 - - 57*****0-19 - - 17*****20 - - 82*****
Dairy diet - - - -- - - -
Dairy diet - - - -- - - -
Dairy diet - - - -- - - -
Calcium - - - -
Placebo - - - -
Calcium - - - -
Placebo - - - -
Calcium - - - -
Placebo - - - -
Placebo - - - -- - - -
Placebo - - - -- - - -
Placebo - - - -- - - -
Placebo - - - -- - - -
Placebo - - - -- - - -
Placebo - - - -- - - -nd < 666 mg/d 156 ndnd 666-814 163 ndnd 815-969 154 ndnd 970-1226 150 ndnd >1226 131 ndnd < 666 mg/d 23 ndnd 666-814 26 ndnd 815-969 22 ndnd 970-1226 23 ndnd >1226 21 ndnd < 666 mg/d 58 nd
Ca (mg/1000kcCa (mg/1000kcCa (mg/1000kcCa (mg/1000kc25(OH)D - Quintile 125(OH)D - Quintile 225(OH)D - Quintile 325(OH)D - Quintile 425(OH)D - Quintile 525(OH)D - Group 1 [0-25(OH)D - Group 2 25(OH)D - Group 1 [0-25(OH)D - Group 2 Dairy free dietDairy free dietDairy free diet
Vit D2 supplmentVit D2 supplmentVit D2 supplmentVit D2 supplmentVit D2 supplmentVit D2 supplmentCa intake - Quintile 1Ca intake - Quintile 2Ca intake - Quintile 3Ca intake - Quintile 4Ca intake - Quintile 5Ca intake - Quintile 1Ca intake - Quintile 2Ca intake - Quintile 3Ca intake - Quintile 4Ca intake - Quintile 5Ca intake - Quintile 1
nd 666-814 73 ndnd 815-969 71 ndnd 970-1226 69 ndnd >1226 47 nd- - - -- - - -
Placebo - - - -- - - -
Placebo - - - -- - - -
Vit D3 + Ca - - - -nd nd 26 58nd nd 33 49nd nd 24 59nd nd 27 56nd nd 29 54nd nd 27 56
Quartile 1 19.6 y 20 nd
Quartile 2 nd 19 nd
Quartile 3 nd 18 nd
Quartile 4 nd 15 nd
Quartile 1 19.6 y 10 nd
Quartile 2 nd 14 nd
Quartile 3 nd 9 nd
Quartile 4 nd 5 nd
Quartile 1 19.6 y 10 nd
Quartile 2 nd 5 nd
Quartile 3 nd 9 nd
Quartile 4 nd 10 nd
Placebo - - - -- - - -
Lactoval - - - -
Placebo - - - -- - - -
Lactoval - - - -
Quintile 1 39.6 596 98 623
Quintile 2 39.6 768 89 619
Quintile 3 39.6 893 87 622
Quintile 4 39.6 1032 81 627
Quintile 5 39.6 1288 88 620
Quartile 1 nd nd nd nd
Quartile 2 nd nd nd nd
Quartile 3 nd nd nd nd
Quartile 4 nd nd nd nd
Quintile 1 6 y <631 59 51343
Quintile 2 nd 631-765 32 51501
Quintile 3 nd 766-921 36 51127
Quintile 4 nd 922-1212 37 52047
Ca intake - Quintile 2Ca intake - Quintile 3Ca intake - Quintile 4Ca intake - Quintile 5High dairy (high Ca)Control (low Ca)Ca supplement Ca supplement 1,25(OH)D - Tertile 1: 1,25(OH)D - Tertile 2: 1,25(OH)D - Tertile 3: 1,25(OH)D - Tertile 1: 1,25(OH)D - Tertile 2: 1,25(OH)D - Tertile 3: M: <1178.2 F:
<862.5M: 1178.2-1557.1 F: 862.5-1110.7M: 1557.2-1953.2 F: 1110.8-1416.6M: 1953.3- F: 1416.7-M: <1178.2 F: <862.5M: 1178.2-1557.1 F: 862.5-1110.7M: 1557.2-1953.2 F: 1110.8-1416.6M: 1953.3- F: 1416.7-M: <1178.2 F: <862.5M: 1178.2-1557.1 F: 862.5-1110.7M: 1557.2-1953.2 F: 1110.8-1416.6M: 1953.3- F: 1416.7-
Ca carbonate
Ca carbonate
Quintile 5 nd 1213- 39 51620nd <766.22 49 ndnd 766.22-962.63 47 ndnd 962.63-1201.81 39 ndnd > 1201.81 37 nd
Quartile 1 7.7 y <807 mg 32 3627
Quartile 2 7.7 y 807-960 mg 24 3627
Quartile 3 7.7 y 961-1144 mg 20 3627
Quartile 4 7.7 y >1144 mg 16 3627
Quartile 1 7.7 y <807 mg 14 nd
Quartile 2 7.7 y 807-960 mg 13 nd
Quartile 3 7.7 y 961-1144 mg 10 nd
Quartile 4 7.7 y >1144 mg 11 nd
Quartile 1 7.7 y <807 mg 18 nd
Quartile 2 7.7 y 807-960 mg 11 nd
Quartile 3 7.7 y 961-1144 mg 10 nd
Quartile 4 7.7 y >1144 mg 5 nd
Dairy Ca nd 0-199 mg/d 209 10011
Dairy Ca nd 0-199 mg/d 30 10011- - - -
Usual diet - - - -- - - -
Usual diet - - - -- - - -
Usual diet - - - -
Placebo nd nd 20 288
Calcium nd nd 17 445
Ca + Vit D nd nd 13 446
Placebo nd nd 16 266
Calcium nd nd 15 416
Ca + Vit D nd nd 6 403
Placebo - - - -
Calcium - - - -
Ca + Vit D - - - -
Ca + Vit D - - - -
Placebo - - - -
Ca + Vit D - - - -
Placebo - - - -
Quartile 1 80.4 <956 127 11348
Quartile 2 80.4 956-1179 111 11341
Quartile 3 80.4 1180-1444 107 11295
Quartile 4 80.4 1445- 104 11322
Quartile 1 80.4 <956 50 11348
Quartile 2 80.4 956-1179 49 11341
Quartile 3 80.4 1180-1444 37 11295
Quartile 4 80.4 1445- 37 11322
Quartile 1 80.4 <956 77 11348
Quartile 2 80.4 956-1179 62 11341
Ca intake - Quartile 1Ca Intake - Quartile 2Ca intake - Quartile 3Ca intake - Quartile 4
Ca enriched dietCa enriched dietCa enriched diet
Quartile 3 80.4 1180-1444 70 11295
Quartile 4 80.4 1445- 67 11322
Quartile 1 80.4 <956 127 11348
Quartile 2 80.4 956-1179 111 11341
Quartile 3 80.4 1180-1444 107 11295
Quartile 4 80.4 1445- 104 11322
Quartile 1 80.4 <956 50 11348
Quartile 2 80.4 956-1179 49 11341
Quartile 3 80.4 1180-1444 37 11295
Quartile 4 80.4 1445- 37 11322
Quartile 1 80.4 <956 77 11348
Quartile 2 80.4 956-1179 62 11341
Quartile 3 80.4 1180-1444 70 11295
Quartile 4 80.4 1445- 67 11322nd 876 518 ~5311nd 1178 541 ~5311nd 1379 542 ~5311nd 1581 546 ~5311nd 1916 555 ~5311nd nd 595 ndnd nd 595 ndnd nd 592 ndnd nd 571 ndnd nd 599 ndnd nd nd nd
Quartile 2 nd nd nd nd
Quartile 3 nd nd nd ndnd nd nd ndnd nd nd ndnd nd nd ndnd nd nd ndnd nd nd ndnd nd nd ndnd nd nd ndnd nd nd nd
Quartile 2 nd nd nd nd
Quartile 3 nd nd nd ndnd nd nd ndnd nd nd ndnd nd nd ndnd nd nd ndnd nd nd ndnd nd nd ndnd nd nd ndnd nd nd nd
Quartile 2 nd nd nd nd
Quartile 3 nd nd nd ndnd nd nd nd
Ca intake - Quintile 1Ca intake - Quintile 2Ca intake - Quintile 3Ca intake - Quintile 4Ca intake - Quintile 5Ca intake - Quintile 1: Ca intake - Quintile 2: Ca intake - Quintile 3: Ca intake - Quintile 4: Ca intake - Quintile 5: Quartile 1: lowest
Quartile 4: highest Quartile 1: lowest Quartile 4: highest Low 25(OH)D, Low 25(OH)D, High 25(OH)D, High 25(OH)D, Quartile 1: lowest
Quartile 4: highest Quartile 1: lowest Quartile 4: highest Low 25(OH)D, Low 25(OH)D, High 25(OH)D, High 25(OH)D, Quartile 1: lowest
Quartile 4: highest
nd nd nd ndnd nd nd ndnd nd nd nd
Quartile 2 nd nd nd nd
Quartile 3 nd nd nd ndnd nd nd ndnd nd nd ndnd nd nd nd- - - -
Placebo - - - -- - - -
Placebo - - - -- - - -
Placebo - - - -- - - -
Placebo - - - -- - - -
Placebo - - - -- - - -
Placebo - - - -
Quintile 1 nd <614 41 7691
Quintile 2 nd 614-<785 31 nd
Quintile 3 nd 785-<1016 52 7690
Quintile 4 nd 1016-<1357 41 nd
Quintile 5 nd 1357- 58 7690nd <617 70nd 617 to <789 65 ? 10578nd 789 to <1026 44 ? 10578nd 1026 to <1366 59 ? 10578nd 1366 38 ? 10578nd <617 104 ?20909nd 617 to <789 116 ?20909nd 789 to <1026 112 ?20909nd 1026 to <1366 119 ?20909nd 1366 151 ?20909
Calcium - - - -
Placebo - - - -
Calcium - - - -
Placebo - - - -
Calcium - - - -
Placebo - - - -
Calcium - - - -
Placebo - - - -
Calcium - - - -
Placebo - - - -
Calcium - - - -
Placebo - - - -
Placebo - - - -
Quartile 1: lowest Quartile 4: highest Quartile 1: lowest
Quartile 4: highest Quartile 1: lowest Quartile 4: highest Ca supplementCa supplementCa supplementCa supplementCa supplementCa supplement
Ca intake - Quintile 1
? unclear what was used in Ca intake -
Quintile 2Ca intake - Quintile 3Ca intake - Quintile 4Ca intake - Quintile 5Ca intake - Quintile 1Ca intake - Quintile 2Ca intake - Quintile 3Ca intake - Quintile 4Ca intake - Quintile 5
Vit D2 - - - -
Placebo - - - -
Vit D2 - - - -
Placebo - - - -
Vit D + Ca - - - -
Placebo - - - -
Vit D + Ca - - - -
Placebo - - - -
Vit D + Ca - - - -
Placebo - - - -
Vit D + Ca - - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -
Placebo - - - -
Vit D + Ca - - - -
Placebo - - - -
Vit D + Ca - - - -
Placebo - - - -
Vit D + Ca - - - -10 y nd nd ~252nd nd nd ~252nd nd nd ~25210 y nd nd ~25210 y nd nd ~25210 y nd nd ~252nd nd nd ~252nd nd nd ~25210 y nd nd ~252nd nd nd ndnd < 778 178 148nd 778-996 175 151nd 997-1279 148 178nd >1279 138 188
Vit D + Ca - - - -
Placebo - - - -
unsupplementedVit D 1000 IU/dVit D 200,000 IU unsupplementedVit D 1000 IU/dVit D 200,000 IU unsupplementedVit D 1000 IU/dVit D 200,000 IU unsupplementedVit D 1000 IU/dVit D 200,000 IU unsupplementedVit D 1000 IU/dVit D 200,000 IU
Ca intake - Tertile 1Ca intake - Tertile 2Ca intake - Tertile 325(OH)D - Tertile 11,25(OH)2D - Tertile 1Ca intake - Tertile 1Ca intake - Tertile 2Ca intake - Tertile 325(OH)D - Tertile 11,25(OH)2D - Tertile 1Ca Intake - Quartile 1 Ca Intake - Quartile 2 Ca Intake - Quartile 3 Ca Intake - Quartile 4
- - - -
Placebo - - - -- - - -
Placebo - - - -- - - -
Placebo - - - -
Calcium - - - -- - - -- - - -
Calcium - - - -- - - -- - - -
calciferol - - - -
Placebo - - - -
calciferol - - - -
Placebo - - - -nd <561 156 ndnd 561-731 165 ndnd 732-925 137 ndnd 926-1255 108 ndnd >1255 117 nd
Quintile 1 nd 523 133 766
Quintile 2 nd 524 648 143 766
Quintile 3 nd 652 784 156 766
Quintile 4 nd 785 940 160 766
Quintile 5 nd 941 174 766
Quintile 1 nd 611 145 755
Quintile 2 nd 612-735 156 755
Quintile 3 nd 736-859 145 755
Quintile 4 nd 860-1020 156 755
Quintile 5 nd 1021 153 755- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -
Dietary Ca nd 579 nd nd
Dietary Ca nd 579 nd nd
Control - - - -- - - -
Dairy group - - - -
1.2 million IU vit D1.2 million IU vit D1.2 million IU vit D
Ca + 5000 D2Ca + 10000 D2Ca + 5000 D2Ca + 10000 D2
Ca intake - Quintile 1 Ca intake - Quintile 2 Ca intake - Quintile 3 Ca intake - Quintile 4 Ca intake - Quintile 5
Dairy Ca intake - Dairy Ca intake - Dairy Ca intake - Dairy Ca intake - Dairy Ca intake - Dairy Ca intake - Dairy Ca intake - Dairy Ca intake - maternal vit D at 28->= 28 nmol/Lmaternal vit D at 28->= 28 nmol/L
Ca supplement
Vit D - - - -
Placebo - - - -
Vit D - - - -
Placebo - - - -
Vit D - - - -
Placebo - - - -
Vit D - - - -
Placebo - - - -
Vit D - - - -
Placebo - - - -
Vit D - - - -
Placebo - - - -
Vit D - - - -
Placebo - - - -
Vit D - - - -
Placebo - - - -
Vit D - - - -
Placebo - - - -
Vit D - - - -
Placebo - - - -
Vit D3 - - - -
Placebo - - - -nd 38 34
<33 pg/mL nd 42 40nd 584 nd ndnd 779 nd ndnd 949 nd ndnd 1139 nd ndnd 1451 nd ndnd 584 nd ndnd 779 nd ndnd 949 nd ndnd 1139 nd ndnd 1451 nd ndnd 584 nd ndnd 779 nd ndnd 949 nd ndnd 1139 nd ndnd 1451 nd nd<22.9 nd 43 7422.9-27.5 nd 40 8527.6-32.0 nd 36 8532.1+ nd 44 80<22.9 nd 41 7722.9-27.5 nd 34 7327.6-32.0 nd 44 7132.1+ nd 41 76<22.9 nd 25 54
25 OH-D, quartile of
<34 ng/mL (based on controls freq)1,25 OH-D,
quartile ofCa intake - Quintile 1Ca intake - Quintile 2Ca intake - Quintile 3Ca intake - Quintile 4Ca intake - Quintile 5Ca intake - Quintile 1Ca intake - Quintile 2Ca intake - Quintile 3Ca intake - Quintile 4Ca intake - Quintile 5Ca intake - Quintile 1Ca intake - Quintile 2Ca intake - Quintile 3Ca intake - Quintile 4Ca intake - Quintile 525(OH)D - Quartile 125(OH)D - Quartile 225(OH)D - Quartile 325(OH)D - Quartile 425(OH)D - Quartile 125(OH)D - Quartile 225(OH)D - Quartile 325(OH)D - Quartile 425(OH)D - Quartile 1
22.9-27.5 nd 27 5527.6-32.0 nd 29 6632.1+ nd 38 62<22.9 nd 21 5322.9-27.5 nd 27 4827.6-32.0 nd 27 4132.1+ nd 31 53<22.9 nd 18 2022.9-27.5 nd 13 3027.6-32.0 nd 7 1932.1+ nd 6 18<22.9 nd 20 2422.9-27.5 nd 7 2527.6-32.0 nd 17 3032.1+ nd 10 23nd 342 ndnd 271 ndnd 258 ndnd 177 ndnd 90 ndnd 172 ndnd 175 ndnd 194 ndnd 197 ndnd 234 ndnd <500 mg/d 767 ndnd <500 mg/d 11 ndnd nd 706 ndnd nd 925 ndnd nd 949 ndnd nd 936 ndnd nd 888 ndnd nd 639 ndnd nd 938 ndnd nd 910 ndnd nd 940 ndnd nd 977 nd
Calcium - - - -
Vit D + Ca - - - -
Calcium - - - -
Vit D + Ca - - - -
Calcium - - - -
Vit D + Ca - - - -nd 856 60 ndnd 1241 41 ndnd 1484 45 ndnd 1789 39 nd22.3 pg/ml - - -
25(OH)D - Quartile 225(OH)D - Quartile 325(OH)D - Quartile 425(OH)D - Quartile 125(OH)D - Quartile 225(OH)D - Quartile 325(OH)D - Quartile 425(OH)D - Quartile 125(OH)D - Quartile 225(OH)D - Quartile 325(OH)D - Quartile 425(OH)D - Quartile 125(OH)D - Quartile 225(OH)D - Quartile 325(OH)D - Quartile 4Ca intake - Quintile 1
<288 mg/1000kcal/dCa intake -
Quintile 2288 -< 369 mg/1000kcal/dCa intake -
Quintile 3369 -< 457 mg/1000kcal/dCa intake -
Quintile 4457 -< 611 mg/1000kcal/dCa intake -
Quintile 5611 mg/1000kcal/dCa intake -
Quintile 1<288 mg/1000kcal/dCa intake -
Quintile 2288 -< 369 mg/1000kcal/dCa intake -
Quintile 3369 -< 457 mg/1000kcal/dCa intake -
Quintile 4457 -< 611 mg/1000kcal/dCa intake -
Quintile 5611 mg/1000kcal/dCa intake
(diet + Ca intake (diet + Ca intake - Quintile 1: Ca intake - Quintile 2: Ca intake - Quintile 3: Ca intake - Quintile 4: Ca intake - Quintile 5: Vit D intake - Quintile 1: Vit D intake - Quintile 2: Vit D intake - Quintile 3: Vit D intake - Quintile 4: Vit D intake - Quintile 5:
Ca intake - Quartile 1, Ca intake - Quartile 2, Ca intake - Quartile 3, Ca intake - Quartile 4, 1,25(OH)2D - Quartile 2
29.0 pg/ml - - -33.9 pg/ml - - -40.9 pg/ml - - -16.3 pg/ml - - -22.6 pg/ml - - -28.3 pg/ml - - -38.0 pg/ml - - -22.3 pg/ml - - -29.0 pg/ml - - -33.9 pg/ml - - -40.9 pg/ml - - -16.3 pg/ml - - -22.6 pg/ml - - -28.3 pg/ml - - -38.0 pg/ml - - -22.3 pg/ml - - -29.0 pg/ml - - -33.9 pg/ml - - -40.9 pg/ml - - -16.3 pg/ml - - -22.6 pg/ml - - -28.3 pg/ml - - -38.0 pg/ml - - -16.3 - - -22.6 - - -28.3 - - -38.0 - - -
Placebo - - - -- - - -
Placebo - - - -- - - -
Placebo - - - -- - - -- - - -nd nd 1323 23,653nd nd 1293 ndnd nd 835 ndnd nd 265 ndnd nd 95 1,330
Tertile 1 nd <685.77 mg/d 58 nd
Tertile 2 nd 65 nd
Tertile 3 nd >957.58 mg/d 76 nd12 years nd 103 460nd nd 68 369nd nd 74 396
Placebo - - - -
Vit D - - - -
Placebo - - - -
1,25(OH)2D - Quartile 31,25(OH)2D - Quartile 41,25(OH)2D - Quartile 125(OH)D - Quartile 125(OH)D - Quartile 225(OH)D - Quartile 325(OH)D - Quartile 41,25(OH)2D - Quartile 21,25(OH)2D - Quartile 31,25(OH)2D - Quartile 41,25(OH)2D - Quartile 125(OH)D - Quartile 125(OH)D - Quartile 225(OH)D - Quartile 325(OH)D - Quartile 41,25(OH)2D - Quartile 21,25(OH)2D - Quartile 31,25(OH)2D - Quartile 41,25(OH)2D - Quartile 125(OH)D - Quartile 125(OH)D - Quartile 225(OH)D - Quartile 325(OH)D - Quartile 425(OH)D - Quartile 125(OH)D - Quartile 225(OH)D - Quartile 325(OH)D - Quartile 4Ca supplementCa supplementCa supplementCa supplementCa intake - Quintile 1: Ca intake - Quintile 2: Ca intake - Quintile 3: Ca intake - Quintile 4: Ca intake - Quintile 5:
685.77 to 957.58 mg/d
Ca intake - Tertile 1Ca intake - Tertile 2Ca intake - Tertile 3
Vit D - - - -
Placebo - - - -
Vit D - - - -nd 291.9 nd ndnd 389.9 nd ndnd 488.2 nd ndnd 610.8 nd ndnd > 610.8 nd ndnd <500 1728 yr 585 nd ndnd 585<, 725 nd ndnd 725<, 935 nd ndnd 935<, 1245 nd ndnd >1245 nd nd28 yr 445 nd ndnd 445<, 540 nd ndnd 540<, 640 nd ndnd 640<, 850 nd ndnd >850 nd nd28 yr 585 nd ndnd 585<, 725 nd ndnd 725<, 935 nd ndnd 935<, 1245 nd ndnd >1245 nd nd28 yr 585 232 (total cases) 1321 (total)nd 585<, 725 nd ndnd 725<, 935 nd ndnd 935<, 1245 nd ndnd >1245 nd nd28 yr 445 nd ndnd 445<, 540 nd ndnd 540<, 640 nd ndnd 640<, 850 nd ndnd >850 nd nd28 yr 445 127 (total cases) 1270 (total)nd 445<, 540 nd ndnd 540<, 640 nd ndnd 640<, 850 nd ndnd >850 nd nd- - - -- - - -- - - -- - - -- - - -- - - ->82.3 nd 42 73>45.9 and 60.3 - 40 74>60.3 and 69.5 - 27 73
Ca intake - Quintile 1, Ca intake - Quintile 2, Ca intake - Quintile 3, Ca intake - Quintile 4, Ca intake - Quintile 5, Total daily calcium
Person-year: 59,963Ca intake -
Quintile 1Ca intake - Quintile 2Ca intake - Quintile 3Ca intake - Quintile 4Ca intake - Quintile 5Ca intake - Quintile 1Ca intake - Quintile 2Ca intake - Quintile 3Ca intake - Quintile 4Ca intake - Quintile 5Ca intake - Quintile 1Ca intake - Quintile 2Ca intake - Quintile 3Ca intake - Quintile 4Ca intake - Quintile 5Ca intake - Quintile 1Ca intake - Quintile 2Ca intake - Quintile 3Ca intake - Quintile 4Ca intake - Quintile 5Ca intake - Quintile 1Ca intake - Quintile 2Ca intake - Quintile 3Ca intake - Quintile 4Ca intake - Quintile 5Ca intake - Quintile 1Ca intake - Quintile 2Ca intake - Quintile 3Ca intake - Quintile 4Ca intake - Quintile 5Vit D + Ca + placeboCa + placeboVit D + Ca + placeboCa + placeboVit D + Ca + placeboCa + placebo25(OH)D - Quintile 1: 25(OH)D - Quintile 2: 25(OH)D - Quintile 3:
>69.5 and 82.3 - 31 74>82.3 - 42 73
<32 Not Applicable Not Applicable 27 80nd nd 34 80nd nd 47 80nd nd 35 81
>65.5 nd nd 57 79-9.8 nd 46 72>9.8-13.9 nd 35 73>13.9-19.3 nd 36 73>19.3 nd 29 72-31.7 nd 32 72>31.7-37.3 nd 43 72>37.3-43.1 nd 41 74>43.1 nd 30 72-9.8 nd 30 47>9.8-13.9 nd 18 47>13.9-19.3 nd 22 45>19.3 nd 21 42-31.7 nd 20 51>31.7-37.3 nd 29 44>37.3-43.1 nd 20 41>43.1 nd 22 45-9.8 nd 19 38>9.8-13.9 nd 13 35>13.9-19.3 nd 19 32>19.3 nd 17 31-31.7 nd 12 21>31.7-37.3 nd 14 28>37.3-43.1 nd 21 33>43.1 nd 8 27-9.8 nd 16 25>9.8-13.9 nd 17 26>13.9-19.3 nd 14 28>19.3 nd 8 30-9.8 nd 12 15>9.8-13.9 nd 13 16>13.9-19.3 nd 7 21>19.3 nd 7 25
Calcium - - - -
Placebo - - - -
Vit D - - - -
Placebo - - - -
Vit D - - - -
Placebo - - - -
Vit D - - - -
Placebo - - - -
Vit D - - - -
25(OH)D - Quintile 4: 25(OH)D - Quintile 5: >32 and <41.1>41.1 and <51.1>51.1 and <65.525(OH)D - Quartile 125(OH)D - Quartile 225(OH)D - Quartile 325(OH)D - Quartile 41,25(OH)2D - Quartile 11,25(OH)2D - Quartile 21,25(OH)2D - Quartile 31,25(OH)2D - Quartile 425(OH)D - Quartile 125(OH)D - Quartile 225(OH)D - Quartile 325(OH)D - Quartile 41,25(OH)2D - Quartile 11,25(OH)2D - Quartile 21,25(OH)2D - Quartile 31,25(OH)2D - Quartile 425(OH)D - Quartile 125(OH)D - Quartile 225(OH)D - Quartile 325(OH)D - Quartile 41,25(OH)2D - Quartile 11,25(OH)2D - Quartile 21,25(OH)2D - Quartile 31,25(OH)2D - Quartile 425(OH)D - Quartile 125(OH)D - Quartile 225(OH)D - Quartile 325(OH)D - Quartile 425(OH)D - Quartile 125(OH)D - Quartile 225(OH)D - Quartile 325(OH)D - Quartile 4
Placebo - - - -
Vit D - - - -
Placebo - - - -
Vit D - - - -
Placebo - - - -
Vit D - - - -
Placebo - - - -
Vit D - - - -
Placebo - - - -
Vit D - - - -
Placebo - - - -
Vit D - - - -
Placebo - - - -
Vit D - - - -
Placebo - - - -
Vit D - - - -
Placebo - - - -
Vit D - - - -
Placebo - - - -
Vit D - - - -
Placebo - - - -
Vit D - - - -
Placebo - - - -nd 233 314 ~8305 (112,018)nd 344 257 ~8305 (106,354)nd 439 252 ~8305 (106,435)nd 603 247 ~8305 (104,697)nd 753 251 ~8305 (104,186)nd 233 72 ~8305 (112,018)nd 344 72 ~8305 (106,354)nd 439 56 ~8305 (106,435)nd 603 58 ~8305 (104,697)nd 753 64 ~8305 (104,186)
Calcium - - - -
Placebo - - - -
Calcium - - - -
Placebo - - - -<25 nmol/L nd 66 127
Placebo - - - -
Vit D + Ca - - - -
Placebo - - - -
Vit D + Ca - - - -
Placebo - - - -
Vit D + Ca - - - -
Placebo - - - -
Vit D + Ca - - - -
Placebo - - - -
Vit D + Ca - - - -
Ca intake - Quintile 1Ca intake - Quintile 2Ca intake - Quintile 3Ca intake - Quintile 4Ca intake - Quintile 5Ca intake - Quintile 1Ca intake - Quintile 2Ca intake - Quintile 3Ca intake - Quintile 4Ca intake - Quintile 5
25(OH)D, published
Placebo - - - -
Vit D + Ca - - - -
Placebo - - - -
Vit D + Ca - - - -
Placebo - - - -
Vit D + Ca - - - -
Placebo - - - -
Vit D + Ca - - - -
mom 400 - - - -
mom 6400 - - - -
mom 400 - - - -
mom 6400 - - - -
infant 300 - - - -- - - -
mom 400 - - - -
mom 6400 - - - -
mom 400 - - - -
mom 6400 - - - -
infant 300 - - - -- - - -
mom 400 - - - -
mom 6400 - - - -
mom 400 - - - -
mom 6400 - - - -
mom 400 - - - -
mom 6400 - - - -
infant 300 - - - -- - - -
mom 400 - - - -
mom 6400 - - - -
mom 400 - - - -
mom 6400 - - - -
infant 300 - - - -- - - -
infant 300 - - - -- - - -
infant 300 - - - -- - - -<10 ng/mL nd nd nd
Deficiency 10-<15 ng/mL nd nd nd
Referent 15 ng/mL nd 70 1258- - - -- - - -
Calcium - - - -
Placebo - - - -
Calcium - - - -
Placebo - - - -
Calcium - - - -
infant placebo
infant placebo
infant placebo
infant placeboinfant placeboinfant placeboSevere deficiency
25(OH)D <15 ng/mL25(OH)D >= 15 ng/mL
Placebo - - - -
Calcium - - - -
Placebo - - - -
Calcium - - - -
Placebo - - - -
Calcium - - - -
Placebo - - - -
Calcium - - - -
Placebo - - - -nd >591.50 mg nd nd
Quartile 2 nd 451.24-591.50 mg nd nd
Quartile 1 nd <451.24 nd nd- - - -
Placebo - - - -- - - -
Placebo - - - -nd 500 47 ndnd 500 12 ndnd 500 22 nd18.4 nd 45 7125.0 nd 44 7129.1 nd 30 6833.3 nd 23 7439.4 nd 37 7219.3 nd 49 6626.7 nd 44 6832.0 nd 17 6838.8 nd 29 7419.3 nd 20 3026.7 nd 21 3632.0 nd 10 3538.8 nd 18 3519.3 nd 19 2726.7 nd 16 2232.0 nd 4 2138.8 nd 8 2421.2 nd 11 3029.3 nd 15 2837.4 nd 14 2218.4 nd 36 5825.0 nd 38 5529.1 nd 22 5633.3 nd 20 6039.4 nd 29 5919.3 nd 40 5526.7 nd 37 5232.0 nd 16 5938.8 nd 20 58
Quartile 3 + Quartile 4
Ca supplementCa supplementCa intake - Cumulative Ca intake - Cumulative Ca intake - Cumulative 25(OH)D - Quintile 125(OH)D - Quintile 225(OH)D - Quintile 325(OH)D - Quintile 425(OH)D - Quintile 525(OH)D - Quartile 125(OH)D - Quartile 225(OH)D - Quartile 325(OH)D - Quartile 425(OH)D - Quartile 125(OH)D - Quartile 225(OH)D - Quartile 325(OH)D - Quartile 425(OH)D - Quartile 125(OH)D - Quartile 225(OH)D - Quartile 325(OH)D - Quartile 425(OH)D - Tertile 125(OH)D - Tertile 225(OH)D - Tertile 325(OH)D - Quintile 125(OH)D - Quintile 225(OH)D - Quintile 325(OH)D - Quintile 425(OH)D - Quintile 525(OH)D - Quartile 125(OH)D - Quartile 225(OH)D - Quartile 325(OH)D - Quartile 4
- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -
Calcium - - - -
Placebo - - - -nd <800.8 56 ndnd 800.8-1278.7 52 ndnd 1278.7 36 nd- - - -
Vit D + Ca - - - -
Placebo - - - -- - - -
Vit D + Ca - - - -
Placebo - - - -- - - -
Vit D + Ca - - - -
Placebo - - - -- - - -
Placebo - - - -
Vit D2 + Ca - - - -
Vit D + Ca - - - -
Placebo - - - -- - - -
Vit D2 + Ca - - - -- - - -
Vit D2 + Ca - - - -
Urinary Ca 20.3-124.9 Urinary Ca 125.0-169.0 Urinary Ca 169.1-235.9 Urinary Ca 236-606.4 Urinary Ca 20.3-124.9 Urinary Ca 125.0-169.0 Urinary Ca 169.1-235.9 Urinary Ca 236-606.4
Calcium intake - Calcium intake - Calcium intake - Ca + Placebo
Ca + Placebo
Ca + Placebo
Ca + Placebo
Ca + PlaceboCa + Placebo
Baseline- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -2.9 yrs 36 65.8 SD = 1.5 Delta = +0.1 nd2.9 yrs 28 65.6 SD = 1.8 Delta = +0.1 nd- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -12 9 / 7 8.8 - - -12 9 / 7 16.9 - - -12 8 / 7 7.3 - - -12 30 / 21 9.95 - - -12 30 / 22 14.0 - - -12 29 / 19 11.7 - - -12 26 / 19 22.9 - - -
Mean Follow-up,
No. Analyzed
Baseline CI / SE / SD*
Final or Delta**
Final or Delta CI /
12 31 / 26 18.9 - - -12 27 / 20 20 - - -12 30 / 21 1.06 - - -12 30 / 21 0.98 - - -12 29 / 18 0.99 - - -12 25 / 19 1.03 - - -12 31 / 26 0.92 - - -12 29 / 19 1.03 - - -nd 9 / 7 1308 - - -nd 8 / 7 1473 - - -12 8 / 7 1666 - - -12 9 / 7 1308 - - -12 9 / 7 1473 - - -12 8 / 7 1666 - - -4 y - - - - -4 y - - - - -4 y - - - - -4 y - - - - -4 y - - - - -4 y - - - - -4 y - - - - -4 y - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -48 263 1.72 2.93 +0.28 0.1948 279 1.88 2.52 +0.53 0.18- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- 60 nd nd - -- 63 nd nd - -- 59 nd nd - -- - - - - -- - - - - -1 y 132 74.7 33.8 +48.5 35.31 y 125 71.2 29.8 +9.3 21.5- 49 - - - -- 216 - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -24 56 nd nd +0.7 -10.2, 11.624 50 nd nd +1.9 -6.5, 10.324 56 22.8 6.1 19.5 5.324 50 25.0 6.2 Final: 29.8 SD: 6.01.25 10 78.1 9.1 80.0 3.21.25 10 78.1 9.1 79.6 3.0- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -24 months 1265 nd nd -1.27 5.3024 months 1334 nd nd -1.20 5.63
60 months 1162 22.96 5.75 -2.64 5.6960 months 1185 22.81 5.78 -2.49 5.8124 months 1188 nd nd -0.12 1.6024 months 1250 nd nd -0.09 1.5560 months 1053 6.63 1.82 -0.43 1.8160 months 1065 6.52 1.87 -0.38 1.8124 months 1238 nd nd +0.23 6.3824 months 1298 nd nd +0.11 7.0860 months 1141 6.19 4.64 +0.81 6.4360 months 1160 6.5 5.51 +0.26 6.289 months 24 21.2 6.7 19.6 6.89 months 24 19.6 4.9 17.4 5.39 months 24 21.7 6.8 20.6 5.39 months 24 20.3 6.5 18.2 5.3- - - - - -- - - - - -- - - - - -- - - - - -9 months 24 739.3 159.8 859.7 110.19 months 24 11.4 2.0 13.8 2.5
- - - - -- - - - -- - - - -- - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -7 y - - - - -nd - - - - -7 y - - - - -nd - - - - -- 46 1328 292 - -- 41 1431 274 - -- 39 1343 235 - -- 39 1383 257 - -- 46 0.934 0.1 - -- 41 0.945 0.1 - -- 39 0.935 0.1 - -- 39 0.939 0.1 - -6 weeks 10 16 70.9 71.5 5.1 5.8 70.9 67.9 5.5 5.76 weeks 15 16 68.0 74.5 7.7 7.3 68.4 71.2 7.5 7.16 weeks 10 16 81.4 74.1 14.6 22.0 80.1 76.9 16.2 18.2
Median 30 days (IQR 14.75 Median 30 days (IQR 14.75 Median 30 days (IQR 14.75 Median 30 days (IQR 14.75
6 weeks 15 16 96.6 85.8 19.9 21.9 98.4 94.6 26.0 27.76 weeks 10 16 117.0 102.3 34.0 32.4 116.9 113.8 29.8 36.26 weeks 15 16 92.9 135.8 42.9 41.4 99.4 145.2 35.0 41.337.2 - - - - -36 - - - - -nd - - - - -nd - - - - -nd - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -10 year - - - - -- 19 61.2 - - -- 14 66.1 - - -- 18 60.8 - - -- 19 21.9 - - -- 14 23.4 - - -- 18 21.9 - - -- 58 14 - 17 -- 55 14 - 38 -- 55 14 - 16 -- 12 15 - 16 -- 14 14 - 28 -- 8 13 - 11 -- 58 152 - 2.7% -- 55 152 - 2.8% -- 55 154 - Delta =2.0% -- 12 141 - 5.0% -
- 14 140 - 5.6% -- 8 142 - Delta=3.8% -- 58 47 - 8.8% -- 55 47 - 9.7% -- 55 48 - Delta =8.6% -- 12 35 - 15.3% -- 14 36 - 18.4% -- 8 37 - Delta=14.9% -- 58 1.1 - 6.1% -- 55 1.1 - 6.2% -- 55 1.2 - Delta = 5.0% -- 12 0.7 - 11.4% -- 14 0.8 - 11.6% -- 8 0.8 - Delta = 7.4% -- 58 78 - 78 -- 55 83 - 105 -- 55 86 - 76 -- 17 nd nd - 1695- 13 nd nd - 1064- 12 nd nd - 2000- 15 nd nd - 927- 13 nd nd - 862- 13 nd nd - 763- 15 nd nd - 873- 20 nd nd - 706- 20 nd nd - 1005- 21 nd nd - 958- 19 nd nd - 585- 23 nd nd - 671- 15 nd nd - 3.6- 13 nd nd - 1.7- 12 nd nd - 2.4- 18 nd nd - 3.0- 15 nd nd - 1.9- 16 nd nd - 3.5- 15 nd nd - 1.7- 20 nd nd - 2.1- 20 nd nd - 1.8- 22 nd nd - 1.8- 10 nd nd - 3.4- 23 nd nd - 3.7- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- nd nd nd - -- nd nd nd - -- nd nd nd - -- nd nd nd - -- nd nd nd - -- nd nd nd - -- nd nd nd - -- nd nd nd - -- nd nd nd - -- nd nd nd - -- nd nd nd - -- nd nd nd - -- nd nd nd - -- nd nd nd - -- nd nd nd - -- nd nd nd - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -1 81 59.84 11.33 59.94 11.37nd 77 59.65 15.34 59.25 14.801 81 140.34 20.55 137.65 22.14nd 77 131.71 23.91 134.46 21.311 81 81.17 9.87 73.39 10.67nd 77 79.09 9.89 73.50 10.425 years - - - - -5 years - - - - -5 years - - - - -5 years - - - - -5 years - - - - -5 years - - - - -nd 3 42.4 13 -9.2 153 wk 6 32.4 10.7 30.4 9.5nd 4 39.9 6.1 -3.7 6.33 wk 5 39.9 9.3 7.5 13nd 3 7.5 13 -7.5 133 wk 6 0 0 37 9.4nd 4 5.0 10.0 0.0 0.03 wk 5 0 0 19.5 12.8nd 3 34.9 0.0 -1.7 6.33 wk 6 32.4 10.7 -6.7 6.8nd 4 34.9 6.1 -3.7 6.33 wk 5 39.9 9.3 -12.0 5.7- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -12 mo. 23 82.7 SD = 10.0 Delta = -10.8 SD = 5.912 mo. 21 80.9 SD = 8.7 Delta = -9.6 SD = 6.5nd 25 nd nd 104.1 9.62 y 37 nd nd 101.9 12.9nd 25 nd nd 67.8 8.22 y 37 nd nd 67.1 7.730 83 71.5 SD = 1.24 Final = 72.8 Final SD = 1.3- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- 21 85.37 - - -- 25 84.95 - - -- 21 83.43 - - -- 21 32.36 - - -- 25 32.39 - - -- 21 32.42 - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -24 mo 27 17 2.0 19 2.8nd 32 17 3.0 19 3.324 mo 27 32.2 4.6 42.9 7.5nd 32 33.2 6.7 44.1 9.924 mo 27 137 6.3 151 7.0nd 32 138 4.6 151 6.0- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- nd 72.1 - 71.1 -- nd 71.6 - 71 -- nd 71.8 - 96.0 -2 - - - - -2 - - - - -2 - - - - -2 - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -4 16 ~24 ~4 ~20 ~2nd 16 ~29 ~3 ~21 ~24 16 ~30 ~3 ~21 ~3nd 16 ~31 ~2 ~31 ~24 16 ~124 (figure) ~2 (figure) -7.8 -16, +4nd 16 ~122 ~2 -2.1 -15, +74 16 ~78 ~2 -2.6 -14, +6nd 16 ~76 ~2 +0.9 -4, +164 16 114 2 ~110 ~2nd 16 114 2 ~112 ~24 16 74 2 ~73 ~1nd 16 72 2 ~72 ~1- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -1 y 30 51.8 1.7 56.9 1.81 y 30 50.7 1.6 55.6 1.61 y 24 52.2 1.7 56.3 1.81 y 26 49.5 1.7 52.5 1.61 y 30 162.5 1.1 166.2 1.01 y 30 161.9 1.2 165.9 1.11 y 24 159.6 1.3 163.2 1.31 y 26 160.1 1.5 163.2 1.41 y 29 37.5 2 35.1 31 y 29 39.2 3 32.2 21 y 24 30.8 2 25.7 31 y 24 29.2 2 28.5 3
- - - - -367 days (IQR: 139 618) in the
- - - - -3 yr - - - - -3 yr - - - - -nd 33 83.6 11.1 80.6 11.715 wk 30 81.5 8.3 77.5 9.0nd 33 32.3 3.54 31.1 3.715 wk 30 31.4 2.5 29.8 2.8nd 33 109.5 8.5 -1.6 7.615 wk 30 112.4 10.8 -4.1 6.8nd 33 75.2 7.0 -3.0 5.915 wk 30 74.9 8.9 -3.0 4.9- 29 nd nd - -- 21 nd nd - -- 27 nd nd - -- 29 nd nd - -- 21 nd nd - -- 27 nd nd - -- 29 nd nd - -- 21 nd nd - -- 27 nd nd - -- 29 nd nd - -- 21 nd nd - -- 27 nd nd - -- nd nd nd - -- nd nd nd - -- nd nd nd - -74 mo - - - - -74 mo - - - - -74 mo nd nd nd nd nd74 mo nd nd nd nd nd74 mo nd nd nd nd nd74 mo nd nd nd nd nd- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -pregnancy - - - - -pregnancy - - - - -
median time to first fracture =
nd 100 nd nd 2.99 0.36nd 100 nd nd 2.80 0.37nd 100 nd nd 50.06 1.79nd 100 nd nd 48.45 2.04nd 100 nd nd 38.65 1.77nd 100 nd nd 38.86 1.69- 13 - - - -- 13 - - - -- 12 - - - -- 13 - - - -- 13 - - - -- 12 - - - -nd 59 nd nd 63.3 20.7nd 67 nd nd 46.4 29.5nd 59 nd nd 3157 469nd 67 nd nd 3034 524- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- 27 nd nd - -- 347 nd nd - -- 27 nd nd - -- 347 nd nd - -- - - - - -- - - - - -- 36 1.12 - - -- 26 1.077 - - -- 39 1.133 - - -
1.5 35 124 11 0.60 9.821.5 36 124 10 -3.35 7.211.5 32 124 11 0.60 9.821.5 33 124 10 -3.09 7.141.5 35 78 8 0.43 7.661.5 36 77 9 -1.26 5.971.5 32 78 8 0.43 7.661.5 33 77 9 -1.11 5.991.5 35 36.5 14.55 35.1 27.281.5 36 30.0 12.50 0.60 11.611.5 32 36.5 14.55 35.1 27.281.5 33 30.0 12.50 0.65 11.781.5 35 nd nd +0.03 1.821.5 36 nd nd -0.38 1.701.5 32 nd nd +0.35 1.601.5 33 nd nd -0.41 1.731.5 35 26.7 4.54 -0.02 0.621.5 36 26.0 3.46 -0.04 0.681.5 32 26.7 4.54 +0.08 0.561.5 33 26.0 3.46 -0.05 0.6912 mo 55 62.1 24.0 35.3 23.212 mo 31 61.9 22.6 10.9 16.9- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -8 wks 72 140.6 14.7 134.9 19.98 wks 73 144.1 20.4 131.0 16.98 wks 72 82.6 6.4 75.7 12.58 wks 73 84.7 7.6 77.5 12.48 wks 72 24.63 12.14 44.36 27.388 wks 73 25.65 13.63 64.84 25.84- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -nd 739 67.1 11.8 -0.369 0.13430 732 66.9 11.5 -0.368 0.132nd 739 26.4 4.2 +0.02 0.0530 732 26.5 4.3 +0.01 0.05nd 739 133.9 22.9 +2.4 0.930 732 134.9 22.6 0.0 0.930 732 70.1 10.7 -0.2 0.4- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -5 wks 94 147 23 -5 165 wks 95 149 22 -5 135 wks 94 82 10 -1 9
5 wks 95 82 12 -1 95 wks 94 12.9 5.4 -1.4 1.15 wks 95 13.8 5.9 +7.2 3.8- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- 116 101 - - -- 112 100.6 - - -- 116 35.0 - - -- 112 35.1 - - -- 116 54.5 - - -- 112 53.2 - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -1 yr 14 60.6 SD = 5.4 61.0 SD = 5.11 yr 14 66.4 SD = 13.8 67.0 SD = 14.060-69 - - - - -nd - - - - -60-69 - - - - -nd - - - - -60-69 - - - - -nd - - - - -60-69 - - - - -
nd - - - - -60-69 - - - - -nd - - - - -60-69 - - - - -nd - - - - -60-69 - - - - -nd - - - - -60-69 - - - - -nd - - - - -60-69 - - - - -nd - - - - -60-69 - - - - -nd - - - - -60-69 - - - - -nd - - - - -60-69 - - - - -nd - - - - -60-69 - - - - -nd - - - - -60-69 - - - - -nd - - - - -60-69 - - - - -nd - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -6 weeks 29 61.8 SD = 6.9 Final = 61.5 Final SD = 6.46 weeks 29 62.5 SD = 6.9 Final = 63.0 Final SD = 6.66 weeks 29 20.8 SD = 2.0 Final = 20.7 Final SD = 1.96 weeks 29 21.0 SD = 1.9 Final = 21.1 Final SD = 1.8- - - - - -84 - - - - -84 - - - - -84 - - - - -84 - - - - -84 - - - - -84 - - - - -84 - - - - -84 - - - - -84 - - - - -84 - - - - -
84 - - - - -84 - - - - -84 - - - - -84 - - - - -84 - - - - -84 - - - - -84 - - - - -84 - - - - -nd 10 nd nd 32.2 ndnd 9 nd nd 34 ndnd 10 nd nd 35.1 ndnd 9 nd nd 47.1 ndnd 10 nd nd 33 ndnd 9 nd nd 36 ndnd 10 nd nd 35.1 ndnd 9 nd nd 48.4 ndnd 10 nd nd 28.9 ndnd 9 nd nd 45 ndnd 10 nd nd 6.7 0.5nd 9 nd nd 6.6 0.8nd 10 nd nd 25.9 ndnd 9 nd nd 50.6 ndnd 10 nd nd 33.5 ndnd 9 nd nd 51.9 ndnd 10 nd nd 38.4 ndnd 9 nd nd 58.8 ndnd 10 nd nd 43 ndnd 9 nd nd 46 ndnd 10 nd nd 2.2 ndnd 9 nd nd 4.1 ndnd 10 nd nd 59.6 ndnd 9 nd nd 82.4 ndnd 10 nd nd 13 ndnd 9 nd nd 14 ndnd 10 nd nd 4.7 0.4nd 9 nd nd 4.6 0.7nd 10 nd nd 54.6 1.1nd 9 nd nd 55.9 2.9- - - - - -- - - - - -- - - - - -5.4 yr - - - - -nd - - - - -9 15 13.5 1.5 11.4 1.215 13.7 0.9 10.7 1.1 nd9 15 28.2 2.8 23.1 2.415 27.3 2.6 21.5 1.8 nd9 15 0.6 0.2 0.5 0.2
15 0.7 0.4 0.7 0.3 nd9 15 nd nd nd nd15 nd nd nd nd nd6 15 1021 170 2828 31615 914 141 723 78 -1926 15 130 28 337 15815 114 23 100 16 -406 15 100 24 109 1215 68 9 74 11 +5- - - - - -- - - - - -- - - - - -18 mo 221 126.0 7.7 nd ndnd 224 125.4 8.8 nd nd18 mo 221 84.1 2.9 nd ndnd 224 83.9 2.8 nd nd- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- nd nd nd - nd- nd nd nd - nd- nd nd nd - nd- nd nd nd - nd- nd nd nd - nd- nd nd nd - nd- nd nd nd - nd- nd nd nd - nd6 mo. 217 27.4 3.7 +0.07 0.956 mo. 218 27.0 3.7 +0.12 1.02108 - - - - -108 - - - - -108 - - - - -- 37 66.6 - - -- 34 70.2 - - -- 38 67.3 - - -36 35 66.6 25.9 74.6 23.836 32 70.2 25.6 118.4 44.3836 32 67.3 34.2 63.6 32.360 34 66.6 25.9 63.7 28.760 29 70.2 25.6 106.4 29.060 30 67.3 34.2 61.5 23.012 40 / 38 833.9 92.9 -0.17 nd12 41 /36 827.8 125.4 1.27 -12 39 / 33 782.9 88.8 0.19 nd- 39 / 33 782.9 - - -- 41 / 36 827.8 - - -12 133 826 129 0.2% 0.212 123 851 127 0.5% 0.312 133 43.7 12.9 0% nd12 123 44.8 12.7 34% nd
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
2734 p-yr (~1337) - - -39 (14.3/1000 p-y 2726 p-yr (~1337) - - -35 (12.9/1000 p-y 2706 p-yr (~1337) - - -30 (11.2/1000 p-y 2668 p-yr (~1337) - - -37 (13.7/1000 p-y 2692 p-yr (~1337) - - -
- - - Crude 5.2, 17.1 29.3- - - Crude 12, 21.1 47.0- - - Crude 5.3, 23.6 5.75- - - Crude 6.9, 14.3 40.9- - - Crude 8.3, 17.5 46.2- - - Crude 7.5, 19.4 10.1- - - Crude 12.6, 28.2 39.4
Mean Ca level / dose
No. of Cases
Person Years (N)
Crude or Adjusted
Baseline IQR
Final (median)
nd (mean 0.9 0.2)
39 (14.3/1000 p-yr)nd (mean 1.0
0.2)nd (mean 1.2 0.2)nd (mean 1.4 0.3)nd (mean 1.7 0.4)
- - - Crude 13.6, 29.2 54.7- - - Crude 15, 25.2 19.1- - - Crude 0.99, 1.06 1.06- - - Crude 0.93, 1.05 0.99- - - Crude 0.91, 1.12 1.00- - - Crude 0.94, 1.07 1.05- - - Crude 0.89, 1.08 1.00- - - Crude 0.96, 1.14 1.06- - - nd 1104, 1726 1595- - - nd 1209, 1887 1625- - - crude 1399, 1767 1923- - - Crude 1104, 1726 1595- - - Crude 1209, 1887 1625- - - Crude 1399, 1767 1923- 85 - - - -- 297 - - - -- 333 - - - -- 195 - - - -- 338 - - - -- nd - - - -- nd - - - -- nd - - - -- nd - - - -- nd - - - -- nd - - - -- 87 5,581 Adjusted - -- 608 36,605 Adjusted - -- 712 42,544 Adjusted - -- 407 24,240 Adjusted - -- 712 41,325 Adjusted - -- - - 8 y - -- - - nd - -- - - nd - -- - - nd - -- - - nd - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - nd - -- - - nd - -- - - Crude - -- - - nd - -- - - Crude - -- - - - - -- - - - - -- - - adj - -- - - adj - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - 8 y - -- - - nd - -- - - nd - -- - - nd - -- 7 - - - -- 17 - - - -- 16 - - - -- 4 - - - -- 17 - - - -- 54 - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - 9 - -- - - 9 - -- - - 9 - -- - - 9 - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - 132 - -- - - 132 - -- - - 132 - -- - - 132 - -- - - 7 y - -- - - 7 y - -- - - 7 y - -- - - 7 y - -- - - 7 y - -- - - - - -- - - - - -- - - - - -- - - - - -- - - adj - -- - - nd - -- - - nd - -- - - nd - -- - - adj - -- - - nd - -- - - nd - -- - - nd - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- 1704 - - - -nd nd - - - -nd nd - - - -nd nd - - - -nd nd - - - -- nd - - - -- nd - - - -- nd - - - -- nd - - - -- nd - - - -- nd - - - -- nd - - - -- nd - - - -- nd - - - -- nd - - - -- nd - - - -- nd - - - -- nd - - - -- nd - - - -- nd - - - -- nd - - - -- nd - - - -- nd - - - -- - - - - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjsuted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -
- - - Adjusted - -- - - Adjusted - -- - - Ajusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - nd - -- - - nd - -- - - nd - -- - - nd - -- - - nd - -- - - nd - -- - - nd - -- - - nd - -- - - nd - -- - - nd - -- - - nd - -- - - nd - -- - - nd - -- - - nd - -- - - nd - -- - - nd - -- - - nd - -- - - nd - -- - - nd - -- - - nd - -- - - nd - -- - - nd - -- - - nd - -- - - nd - -- 53 - - - -- 47 - - - -- 35 - - - -- 29 - - - -- 29 - - - -- 34 - - - -- 42 - - - -
- 33 - - - -- 38 - - - -- 46 - - - -- - - - -- - - - -- - - - -- - - - -- - - - -- - - - -- - - - -- - - - -- - - - -- - - - -- - - - -- - - - -- - - - -- - - - -- - - - -- - - - -- - - - -- - - - -- - - - -- - - - -- - - - -- - - - -- - - - -- - - - -- - - - -- 151 - - - -- 195 - - - -- 188 - - - -- 208 - - - -- 520 - - - -- 222 - - - -nd 175 - - - -nd 103 - - - -nd 117 - - - -nd 80 - - - -nd 41 - - - -nd 20 - - - -nd 57 - - - -nd 51 - - - -nd 23 - - - -nd 22 - - - -nd 34 - - - -nd 37 - - - -nd 20 - - - -nd 8 - - - -
Age and energy onlyAge and energy onlyAge and energy onlyAge and energy onlyAge and energy onlyAge and energy onlyAge and energy onlyAge and energy onlyAge and energy onlyAge and energy onlyAge and energy onlyAge and energy onlyAge and energy onlyAge and energy onlyAge and energy onlyAge and energy onlyAge and energy onlyAge and energy onlyAge and energy onlyAge and energy onlyAge and energy onlyAge and energy onlyAge and energy onlyAge and energy onlyAge and energy only
nd 22 - - - -nd 25 - - - -nd 16 - - - -nd 24 - - - -nd 28 - - - -nd 24 - - - -nd 14 - - - -nd 38 - - - -nd 60 - - - -nd 32 - - - -- - - Yes - -- - - Yes - -- - - Yes - -- - - Yes - -- - - Yes - -- - - Yes - -- - - Yes - -- - - Yes - -- - - Yes - -- - - Yes - -- - - crude - -- - - nd - -- - - nd - -- - - nd - -- - - crude - -- - - nd - -- - - nd - -- - - nd - -- - - crude - -- - - nd - -- - - nd - -- - - nd - -- - - crude - -- - - nd - -- - - nd - -- - - nd - -- - - crude - -- - - nd - -- - - nd - -- - - nd - -- - - adjusted - -- - - nd - -- - - nd - -- - - nd - -- - - adjusted - -- - - nd - -- - - nd - -- - - nd - -
- - - Adjusted for age - -- - - nd - -- - - nd - -- - - nd - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -
- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - adjusted - -- - - nd - -- - - nd - -- - - adjusted - -- - - nd - -- - - nd - -- - - Adjusted - -- - - nd - -- - - nd - -- - - nd - -- - - Adjusted - -- - - nd - -- - - nd - -- - - nd - -- - - Adjusted - -- - - nd - -- - - nd - -- - - nd - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - - -- - - nd - -- - - nd - -- - - nd - -- - - nd - -- - - 85.2 - -- - - 85.2 - -- - - 85.2 - -- - - 85.2 - -- - - - -- - - nd - -- - - nd - -- - - nd - -
Adjusted (age, gender, energy)
Adjusted (age, energy intake)
- - - nd - -- - - Median, 82.8 - -- - - Median, 82.8 - -- - - Median, 82.8 - -- - - Median, 82.8 - -- - - Yes - -- - - Yes - -- - - Yes - -- - - Yes - -- - - Yes - -- - - Yes - -- - - Yes - -- - - Yes - -- - - Yes - -- - - Yes - -- - - Yes - -- - - Yes - -- - - adj - -- - - adj - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - nd - -- - - nd - -- - - nd - -- - - nd - -- - - nd - -- - - nd - -- - - nd - -- - - nd - -- - - nd - -- - - - - -- - - - - -- - - - - -- - - - - -- - - Adj (age) - -- - - nd - -- - - nd - -- - - nd - -- - - Adj (age) - -- - - nd - -- - - nd - -- - - nd - -- - - Adj (age) - -- - - nd - -
- - - nd - -- - - nd - -- - - Adj (age) - -- - - nd - -- - - nd - -- - - nd - -- - - Adj (age) - -- - - nd - -- - - nd - -- - - nd - -- - - Adj (age) - -- - - nd - -- - - nd - -- - - nd - -- - - 13.6 years - -- - - nd - -- - - nd - -- - - nd - -- - - nd - -- - - 9.4 yrs - -- - - 9.4 yrs - -- - - 9.4 yrs - -- - - 9.4 yrs - -- - - 9.4 yrs - -- - - adjusted - -- - - nd - -- - - nd - -- - - nd - -- - - adjusted - -- - - nd - -- - - adjusted - -- - - nd - -- - - nd - -- - - nd - -- - - adjusted - -- - - nd - -- - - nd - -- - - nd - -- - - adjusted - -- - - nd - -- - - adjusted - -- - - nd - -- - - nd - -- - - nd - -- - - adjusted - -- - - nd - -- - - nd - -- - - nd - -
- - - adjusted - -- - - nd - -- - - adjusted - -- - - nd - -- - - nd - -- - - nd - -- - - adjusted - -- - - nd - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - 10 y (120 mo) - -- - - nd - -- - - nd - -- - - nd - -- - - nd - -- - - - -- - - nd - -- - - nd - -- - - nd - -- - - nd - -- - - nd - -- - - nd - -- - - nd - -- - - nd - -- - - nd - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
Age, randomized treatment, BMI,
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - crude - -- - - nd - -- - - nd - -- - - crude - -- - - nd - -- - - nd - -- - - crude - -- - - nd - -- - - nd - -- - - crude - -- - - nd - -- - - nd - -- - - crude - -- - - nd - -- - - nd - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - Adjusted - -- - - nd - -- - - nd - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - nd - -- - - nd - -- - - Adjusted - -- - - nd - -- - - 36.8 - -- - - 36.8 - -- - - 36.8 - -- - - 36.8 - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - crude 31.2-61.2 47.5- - - nd 23.7-45 67.5- - - nd 27.5-37.5 97.7- - - crude 31.2-61.2 55- - - nd 23.7-45 77.5- - - nd 27.5-37.5 97.7- - - - - -- - - - - -- - - - - -- - - - - -- - - nd - -- - - nd - -- - - nd - -- - - nd - -- - - nd - -- - - ~32 y - -- - - ~32 y - -- - - ~32 y - -- - - ~32 y - -- - - ~32 y - -- - - ~39 - -- - - ~39 - -- - - ~39 - -- - - ~39 - -- - - ~39 - -0-199 mg/d - - - - -200-449 - - - - -450-599 - - - - -600 - - - - -0-199 mg/d - - - - -200-449 - - - - -450-599 - - - - -600 - - - - -- - - adj - -- - - nd - -- - - nd - -- - - nd - -- - - adj - -- - - adj - -- - - Crude - -- - - Crude - -- - - Crude - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - -- - - - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -
crude (conditional logistic)crude (conditional logistic)
- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - 87.6 - -- - - 87.6 - -- - - 87.6 - -- - - 87.6 - -- - - 87.6 - -- - - 87.6 - -- - - 87.6 - -- - - 87.6 - -- - - 87.6 - -- - - 87.6 - -- - - adj - -- - - adj - -- - - adjusted - -- - - nd - -- - - nd - -- - - nd - -- - - nd - -- - - adjusted - -- - - nd - -- - - nd - -- - - nd - -- - - nd - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - 96 - -- - - 96 - -- - - 96 - -- - - 96 - -- 97 - - - -
- 71 - - - -- 84 - - - -- 74 - - - -- 103 - - - -- 62 - - - -- 61 - - - -- 100 - - - -- 16 - - - -- 18 - - - -- 13 - - - -- 18 - - - -- 24 - - - -- 7 - - - -- 10 - - - -- 24 - - - -- 81 - - - -- 53 - - - -- 71 - - - -- 56 - - - -- 79 - - - -- 55 - - - -- 51 - - - -- 76 - - - -- 45 - - - -- 24 - - - -- 26 - - - -- 47 - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - -- - - - -- - - - -- - - - -- - - - -- - - adj - -- - - nd - -- - - nd - -- - - Adjusted - -- - - nd - -- - - nd - -- - - - - -- - - - - -- - - - - -
147,858 person-years137,184 person-years88,023 person-years23,174 person-years8,152 person-years
- - - - - -- - - - - -- - - - - -- - - Median, 68.9 - -- - - Median, 68.9 - -- - - Median, 68.9 - -- - - Median, 68.9 - -- - - Median, 68.9 - -- - - - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - crude - -- - - crude - -- - - crude - -- - - crude - -- - - crude - -- - - crude - -- - - - - -- - - - - -- - - - - -
Adjusted (but no dietary vitamin D)
- - - - - -- - - - - -- - - - -- - - nd - -- - - nd - -- - - nd - -- - - nd - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
Age and multivariable
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - 13 y - -- - - nd - -- - - nd - -- - - nd - -- - - nd - -- - - nd - -- - - nd - -- - - nd - -- - - nd - -- - - nd - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
adjusted for sex, age, education
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - 127 - -- - - 127 - -- - - 127 - -- - - - - -- - - - - -- - - - - -- - - - - -- - - nd - -- - - nd - -- - - nd - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -- - - Adjusted - -
- - - Adjusted - -- - - nd - -- - - nd - -- - - nd - -- - - nd - -- - - nd - -- - - nd - -- - - nd - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - Crude - -- - - Crude - -- - - Crude - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
Final (IQR) Total N** Ca intake- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -28.5, 64.0 - - - - -28.7, 61.5 - - - - -4.68, 16.0 - - - - -37.4, 47.7 - - - - -38.6, 53.2 - - - - -8.38, 16.1 - - - - -31, 48.2 - - - - -
Outcome Metric (e.g.
Mean Follow up
Outcome effect size
45.2, 65.1 - - - - -13.1, 22.6 - - - - -1.01, 1.11 - - - - -0.93, 1.06 - - - - -0.89, 1.16 - - - - -0.97, 1.11 - - - - -0.88, 1.12 - - - - -0.90, 1.14 - - - - -1302, 1953 - - - - -1380, 21440 - - - - -1730, 2145 - - - - -1302, 1953 - - - - -1380, 21440 - - - - -1730, 2145 - - - - -- 1677 - - - -- 7504 - - - -- 8576 - - - -- 5038 - - - -- 7890 - - - -- 14354 - - - -- 14354 - - - -- 14354 - - - -- 16314 - - - -- 16314 - - - -- 16314 - - - -- - <400 RR 14 y -- - 400-599 RR 14 y -- - 600-799 RR 14 y -- - 800-1000 RR 14 y -- - 1000 RR 14 y -- - - - RR- - - nd - nd- - - nd - nd- - - nd - nd- - - nd - nd- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
Adjusted multivariate
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - nd - nd- - - nd - nd- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - Adjusted - RR- - - nd - nd- - - nd - nd- - - nd - nd- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - crude - %- - - crude - %- - - crude - %- - - crude - %- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - Adjusted - RR- - - Adjusted - RR- - - Adjusted - RR- - - Adjusted - RR- - - Adj - OR- - - Adj - OR- - - Adj - OR- - - Adj - OR- - - Adj - OR- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- nd - - - -- nd - - - -- nd - - - -- nd - - - -- nd - - - -- nd - - - -- nd - - - -- nd - - - -- nd - - - -- nd - - - -- nd - - - -- nd - - - -- nd - - - -- nd - - - -- nd - - - -- nd - - - -- nd - - - -- nd - - - -- - - - -- - - - 18 months -- - - - 18 months -- - - - 18 months -- - - - 18 months -- - - - 18 months -- - - - 18 months -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
OR (incrase in Ca intake)
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - RR (HR) - 1.00- - - RR (HR) - 1.03- - - RR (HR) - 0.80- - - RR (HR) - 0.96- - - RR (HR) - 0.74- - - RR (HR) - 1.00- - - RR (HR) - 1.19- - - RR (HR) - 1.10- - - RR (HR) - 1.23- - - RR (HR) - 0.93- - - RR (HR) - 0.68- - - RR (HR) - 0.83- - - RR (HR) - 0.54- - - RR (HR) - 0.89- - - RR (HR) - 1.0- - - RR (HR) - 0.71- - - RR (HR) - 0.71- - - RR (HR) - 0.86- - - RR (HR) - 0.76- - - RR (HR) - 1.0- - - RR (HR) - 1.00- - - RR (HR) - 0.84- - - RR (HR) - 0.66- - - RR (HR) - 0.78- - - RR (HR) - 0.69- 369 - - - -- 374 - - - -- 370 - - - -- 371 - - - -- 975 - - - -- 509 - - - -- 5744 - - - -- 3141 - - - -- 3713 - - - -- 4218 - - - -- 4218 - - - -- 4218 - - - -- 5744 - - - -- 6856 - - - -- 4218 - - - -- 4218 - - - -- Nd - - - -- Nd - - - -- Nd - - - -- Nd - - - -
- nd - - - -- nd - - - -- nd - - - -- nd - - - -- nd - - - -- nd - - - -- nd - - - -- nd - - - -- nd - - - -- nd - - - -- - - RR - 1.0- - - RR - 1.02- - - RR - 1.36- - - RR - 1.13- - - RR - 1.04- - - RR - 1.0- - - RR - 1.22- - - RR - 1.28- - - RR - 1.47- - - RR - 1.23- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - OR - 1.0- - - nd - 1.11- - - nd - 1.75- - - nd - 1.62- - - OR - 1.00- - - nd - 1.10- - - nd - 1.16- - - nd - 0.92- - - OR - 1.00- - - nd - 1.13- - - nd - 0.85- - - nd - 0.88
- - - HR - nd- - - HR - nd- - - HR - nd- - - HR - nd- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - OR - 1.0- - - OR - 1.12- - - OR - 1.02- - - OR - 1.00- - - OR - 0.86- - - OR - 1.0- - - OR - 1.19- - - OR - 1.00- - - OR - 1.56- - - OR - 0.93- - - OR - 1.0
- - - OR - 1.33- - - OR - 1.29- - - OR - 1.30- - - OR - 0.88- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - OR - 1.00- - - nd - 1.71- - - nd - 0.75- - - OR - 1.00- - - nd - 1.44- - - nd - 1.06- - - RR (HR) - 1.00- - - nd - 1.17- - - nd - 1.37- - - nd - 1.43- - - RR (HR) - 1.00- - - nd - 1.44- - - nd - 1.04- - - nd - 0.63- - - RR (HR) - 1.00- - - nd - 0.77- - - nd - 1.88- - - nd - 3.01- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - RR - 1.00- - - RR - 0.83- - - RR - 0.96- - - RR - 0.92- - - RR - 0.92- - - adjusted - HR- - - nd - nd- - - nd - nd- - - nd - nd- - - OR - 1.0- - - nd - 0.57- - - nd - 0.60- - - nd - 0.61
- - - nd - 0.58- - - Adjusted - RR- - - Adjusted - RR- - - Adjusted - RR- - - Adjusted - RR- - - RR - 1- - - RR - 0.73- - - RR - 0.65- - - RR - 0.50- - - RR - 1- - - RR - 0.71- - - RR - 0.67- - - RR - 0.76- - - RR - 1- - - RR - 0.77- - - RR - 0.63- - - RR - 0.26- - - RR - 1.00 (ref)- - - RR - 1.00 (ref)- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - % - 6.9%- - - nd - 3.8%- - - nd - 2.9%- - - nd - 6.8%- - - nd - 3.6%- - - nd - 2.0%- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - RR (HR) - 1.0- - - nd - 0.81- - - nd - 0.77- - - nd - 0.73- - - RR (HR) - 1.0- - - nd - 0.91- - - nd - 0.67- - - nd - 0.69- - - RR (HR) - 1.0- - - nd - 0.74
- - - nd - 0.84- - - nd - 0.78- - - RR (HR) - 1.0- - - nd - 0.81- - - nd - 0.77- - - nd - 0.73- - - RR (HR) - 1.0- - - nd - 0.91- - - nd - 0.67- - - nd - 0.69- - - RR (HR) - 1.0- - - nd - 0.74- - - nd - 0.84- - - nd - 0.78- - - - RR- - - nd - nd- - - nd - nd- - - nd - nd- - - nd - nd- - - Adjusted - RR- - - nd - nd- - - nd - nd- - - nd - nd- - - nd - nd- - - OR - 1.01- - - nd - 1.26- - - nd - 1.00- - - nd - Reference- - - OR - 0.91- - - nd - Reference- - - OR - 1.33- - - nd - 1.16- - - nd - nd- - - nd - Reference- - - OR - 1.27- - - nd - 1.33- - - nd - 0.97- - - nd - Reference- - - OR - 1.37- - - nd - Reference- - - OR - 2.06- - - nd - 1.08- - - nd - 1.24- - - nd - Reference- - - OR - 1.03- - - nd - 1.32- - - nd - 1.02- - - nd - Reference
Adjusted ( multivariate )
- - - OR - 1.19- - - nd - Reference- - - OR - 1.34- - - nd - 1.41- - - nd - 0.91- - - nd - Reference- - - OR - 1.93- - - nd - Reference- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - Adj (first model) - RR (HR)- - - nd - nd- - - nd - nd- - - nd - nd- - - nd - nd- - - HR - 1 (Ref)- - - HR - 0.78- - - HR - 0.60- - - HR - 0.78- - - HR - 0.64- - - HR - 1.0 (Ref)- - - HR - 1.12- - - HR - 1.10- - - HR - 1.10- - - HR - 1.23- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - RR - 1- - - nd - 0.866- - - nd - 1.14- - - RR - 1- - - RR - 1- - - RR - 1- - - nd - 0.981- - - nd - 1.34- - - RR - 1- - - nd - nd- - - adjusted - OR- - - adjusted - OR- - - adjusted - OR- - - adjusted - OR- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -38.7-66.2 - - - - -57.5-91.2 - - - - -79.1-111.8 - - - - -72.5-68 - - - - -66.2-156.2 - - - - -79.3-123.1 - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - adjusted - RR- - - adjusted - RR- - - adjusted - RR- - - adjusted - RR- - - adjusted - RR- - - Adj - coefficient- - - Adj - coefficient- - - Adj - coefficient- - - Adj - coefficient- - - Adj - coefficient- - - Adj - coefficient- - - Adj - coefficient- - - Adj - coefficient- - - Adj - coefficient- - - Adj - coefficient- 10011 - - - -- 10011 - - - -- 10011 - - - -- 10011 - - - -- 10011 - - - -- 10011 - - - -- 10011 - - - -- 10011 - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - RR - 1.00 (ref)- - - RR - 1.00 (ref)- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - OR - 1.0 (Ref)- - - nd - 1.0 (Ref)- - - RR - 1- - - RR - 1.05- - - RR - 0.96- - - RR - 0.96- - - RR - 0.88- - - RR - 1- - - RR - 1.04- - - RR - 0.96- - - RR - 0.97- - - RR - 0.90- - - RR - 1- - - RR - 1.02- - - RR - 0.93- - - RR - 0.91- - - RR - 0.85- - - RR - 1.0 (ref)- - - RR - 0.76- - - RR - 0.76- - - RR - 0.73- - - RR - 1.0 (ref)- - - RR - 1.0- - - RR - 1.2- - - RR - 1.1- - - RR - 1.0 (ref)
- - - RR - 0.98- - - RR - 1.0- - - RR - 1.2- - - RR - 1.0 (ref)- - - RR - 1.7- - - RR - 2.1- - - RR - 2.1- - - RR - 1.0 (ref)- - - RR - 0.17- - - RR - 0.25- - - RR - 0.075- - - RR - 1.0 (ref)- - - RR - 0.26- - - RR - 0.46- - - RR - 0.33- - - Adjusted - RR- - - Adjusted - nd- - - Adjusted - nd- - - Adjusted - nd- - - Adjusted - nd- - - Adjusted - nd- - - Adjusted - nd- - - Adjusted - nd- - - Adjusted - nd- - - Adjusted - nd- - - RR - 1.01- - - RR - 0.76- - - RR - 1.00- - - nd - 1.03- - - nd - 1.04- - - nd - 1.05- - - nd - 1.04- - - RR - 1.00- - - nd - 1.15- - - nd - 1.06- - - nd - 1.11- - - nd - 1.09- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - adjusted - RR- - - adjusted - RR- - - adjusted - RR- - - adjusted - RR- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - adjusted - RR- - - nd - nd- - - nd - nd- - - nd - nd- - - nd - nd- - - HR - 1.00- - - nd - 0.98- - - nd - 0.99- - - RR - 1.0- - - nd - 0.8- - - nd - 1.0- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - adjusted - RR- - - adjusted - RR- - - adjusted - RR- - - adjusted - RR- - - adjusted - RR- - - RR - 1- - - OR - 1.5- - - OR - 1.1- - - OR - 1.1- - - OR - 0.6- - - OR - 1.0- - - OR - 3.1- - - OR - 1.6- - - OR - 3.8- - - OR - 1.8- - - OR - 1.0- - - OR - 1.1- - - OR - 1.1- - - OR - 0.8- - - OR - 0.9- - - OR - 1.0- - - OR - 1.0- - - OR - 1.0- - - OR - 1.0- - - OR - 0.8- - - OR - 1.0- - - OR - 1.2- - - OR - 1.1- - - OR - 1.3- - - OR - 1.1- - - OR - 1.0- - - OR - 1.1- - - OR - 0.8- - - OR - 1.6- - - OR - 1.4- - - OR - 1.0- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - OR - 1.00- - - OR - 1.30- - - OR - 2.12- - - OR - 1.50- - - OR - 2.92- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - HR- - - nd - nd- - - nd - nd- - - nd - nd- - - nd - nd- - - - HR- - - nd - nd- - - nd - nd- - - nd - nd- - - nd - nd- - - - - -- - - - - -- - - - - -- - - - - -- - - HR - 1.61- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
Adjusted ( multivariable+
Adjusted ( multivariable+
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - HR - 1.80- - - HR - 1.53- - - nd - nd- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - adjusted - HR- - - adjusted - HR- - - adjusted - HR- - - - - -- - - - - -- - - - - -- - - - - -- - - adjusted - RR- - - adjusted - RR- - - adjusted - RR- - - OR - 1.0 (ref)- - - nd - 0.97- - - nd - 0.66- - - nd - 0.51- - - nd - 0.83- - - OR - 1.0 (ref)- - - nd - 0.74- - - nd - 0.29- - - nd - 0.46- - - OR - 1.0 (ref)- - - nd - 0.84- - - nd - 0.35- - - nd - 0.69- - - OR - 1.0 (ref)- - - nd - 0.93- - - nd - 0.31- - - nd - 0.71- - - OR - 1.0 (ref)- - - nd - 1.74- - - nd - 3.32- - - OR - 1.0 (ref)- - - nd - 1.29- - - nd - 0.63- - - nd - 0.63- - - nd - 0.84- - - OR - 1.0 (ref)- - - nd - 0.91- - - nd - 0.32- - - nd - 0.43
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
CI P between Delta**- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
Net difference
Net difference
Mean Follow up
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -1.0 - - - - -0.95 - - - - -0.72 - - - - -0.84 - - - - -0.88 - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- -0.25 nd 0.34 - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - nd +26.5- - - - nd +49.1- - - - 6 +1.9nd - - - - -nd - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -1.00 - - - - -0.62 - - - - -0.75 - - - - -0.67 - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -45 (estimate) - - - - -75 (estimate) - - - - -63 (estimate) - - - - -65 (estimate) - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -1.00 - - - - -1.21 - - - - -1.35 - - - - -1.29 - - - - -0.89 - - - - -1.25 - - - - -1.07 - - - - -0.69 - - - - -0.91 - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - 24 mo 34.7%- - - - nd 35%- - - - nd 38.1%- - - - nd 35%- - - - 24 mo 9.8%- - - - nd 9.7%- - - - nd 10.4%- - - - nd 8.9%- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - 1y -- - - - 1y -- - - - 1y -- - - - 1y -- - - - 1y -- - - - 1y -- - - - 1y -- - - - 1y -- - - - 1y -- - - - 1y -
- - - - 1y -- - - - 1y -- - - - 1y -- - - - 1y -- - - - 1y -- - - - 1y -- - - - 1y -- - - - 1y -- - - - 1y -- - - - 1y -- - - - 1y -- - - - 1y -- - - - 1y -- - - - 1y -- - - - 1y -- - - - 1y -- - - - 1y -- - - - 6 mo 4208- - - - nd 5296- - - - nd 3745- - - - 6 mo 5190- - - - nd 5046- - - - nd 4846- - - - 6 mo 4810- - - - nd 4536- - - - nd 4609- - - - nd 4563- - - - nd 4342- - - - nd 4572- - - - nd 19.3- - - - nd 19- - - - nd 18.8- - - - nd 17.9- - - - nd 17.5- - - - nd 18.7- - - - nd 16.6- - - - nd 16.6- - - - nd 16.7- - - - nd 15.6- - - - nd 16.5- - - - nd 17.1- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -Ref - - - - -0.79-1.35 - - - - -0.60-1.06 - - - - -0.73-1.26 - - - - -0.55-0.99 - - - - -Ref - - - - -0.57-2.48 - - - - -0.52-2.32 - - - - -0.60-2.53 - - - - -0.43-2.01 - - - - -0.42-1.08 - - - - -0.53-1.29 - - - - -0.33-0.90 - - - - -0.57-1.38 - - - - -Ref - - - - -0.40-1.26 - - - - -0.40-1.26 - - - - -0.49-1.49 - - - - -0.43-1.34 - - - - -Ref - - - - -Ref - - - - -0.59-1.18 - - - - -0.46-0.96 - - - - -0.55-1.11 - - - - -0.48-0.99 - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -nd - - - - -0.75-1.41 - - - - -0.99-1.87 - - - - -0.82-1.55 - - - - -0.75-1.45 - - - - -1.0 - - - - -1.22 - - - - -1.28 - - - - -1.47 - - - - -1.23 - - - - -- - - - nd -- - - - nd -- - - - nd -- - - - nd -- - - - nd -- - - - nd -- - - - nd -- - - - nd -- - - - nd -- - - - nd -- - - - nd -- - - - nd -- - - - nd -- - - - nd -- - - - nd -- - - - nd -nd - - - - -0.43-2.84 - - - - -0.73-4.17 - - - - -0.67-3.89 - - - - -nd - - - - -nd - - - - -nd - - - - -0.56-1.50 - - - - -nd - - - - -nd - - - - -nd - - - - -0.53-1.45 - - - - -
nd - - - - -nd - - - - -nd - - - - -nd - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -nd - - - - -0.83-1.51 - - - - -0.76-1.38 - - - - -0.74-1.36 - - - - -0.62-1.18 - - - - -nd - - - - -0.66-2.16 - - - - -0.54-1.85 - - - - -0.88-2.77 - - - - -0.49-1.79 - - - - -nd - - - - -
0.90-1.96 - - - - -0.87-1.92 - - - - -0.87-1.93 - - - - -0.56-1.36 - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -reference - - - - -0.68-4.34 - - - - -0.29-1.91 - - - - -reference - - - - -0.59-3.52 - - - - -0.42-2.66 - - - - -Ref - - - - -0.60-2.27 - - - - -0.67-2.81 - - - - -0.61-3.39 - - - - -Ref - - - - -0.61-3.39 - - - - -0.38-2.83 - - - - -0.17-2.35 - - - - -ref - - - - -0.25-2.37 - - - - -0.67-5.30 - - - - -0.93-9.73 - - - - -- - - - 3 wks -4.34- - - - 3 wks -3.34- - - - 3 wks -3.87- - - - 3 wks -1.64- - - - 3 wks -1.29- - - - 3 wks -1.51Ref - - - - -nd - - - - -nd - - - - -nd - - - - -nd - - - - -1.0 - - - - -1.15 - - - - -0.90 - - - - -0.71 - - - - -Ref - - - - -0.36-0.85 - - - - -0.39-0.90 - - - - -0.40-0.89 - - - - -
0.39-0.87 - - - - -1.00 - - - - -0.94 - - - - -0.78 - - - - -0.72 - - - - -nd - - - - -(0.42-1.25) - - - - -(0.37-1.14) - - - - -(0.27-0.91) - - - - -nd - - - - -(0.33-1.54) - - - - -(0.30-1.53) - - - - -(0.34-1.70) - - - - -nd - - - - -(0.36-1.66) - - - - -(0.29-1.38) - - - - -(0.10-0.71) - - - - -nd - - - - -nd - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -nd - - - - -nd - - - - -nd - - - - -nd - - - - -nd - - - - -nd - - - - -- - - - 12 mo -- - - - nd -- - - - nd -- - - - - -- - - - - -- - - - - -- - - - - -Ref - - - - -0.63-1.04 - - - - -0.59-0.99 - - - - -0.51-0.91 - - - - -Ref - - - - -0.61-1.36 - - - - -0.44-1.02 - - - - -0.45-1.06 - - - - -Ref - - - - -0.53-1.04 - - - - -
0.60-1.16 - - - - -0.56-1.08 - - - - -Ref - - - - -0.63-1.04 - - - - -0.59-0.99 - - - - -0.51-0.91 - - - - -Ref - - - - -0.61-1.36 - - - - -0.44-1.02 - - - - -0.45-1.06 - - - - -Ref - - - - -0.53-1.04 - - - - -0.60-1.16 - - - - -0.56-1.08 - - - - -1.00 - - - - -1.08 - - - - -1.09 - - - - -1.11 - - - - -1.10 - - - - -1.00 - - - - -0.97 - - - - -0.95 - - - - -0.93 - - - - -0.97 - - - - -0.71-1.44 - - - - -0.89-1.80 - - - - -0.71-1.41 - - - - -Reference - - - - -0.63-1.33 - - - - -Reference - - - - -0.94-1.88 - - - - -0.82-1.64 - - - - -0.85-1.70 - - - - -Reference - - - - -0.76-2.13 - - - - -0.80-2.20 - - - - -0.58-1.60 - - - - -Reference - - - - -0.81-2.33 - - - - -Reference - - - - -1.24-3.43 - - - - -0.66-1.77 - - - - -0.75-2.04 - - - - -Reference - - - - -0.67-1.60 - - - - -0.86-2.03 - - - - -0.68-1.54 - - - - -Reference - - - - -
0.75-1.89 - - - - -Reference - - - - -0.71-2.53 - - - - -0.75-2.62 - - - - -0.49-1.70 - - - - -Reference - - - - -0.99-3.75 - - - - -Reference - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -1.0 - - - - -0.74 - - - - -1.22 - - - - -0.93 - - - - -1.22 - - - - -nd - - - - -0.52 1.17 - - - - -0.38 0.94 - - - - -0.51 1.19 - - - - -0.40 1.03 - - - - -nd - - - - -0.85 1.47 - - - - -0.83 1.44 - - - - -0.84 1.45 - - - - -0.94 1.61 - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - 3 mo -- - - - nd -- - - - nd -- - - - 3 mo -- - - - nd -- - - - nd -- - - - 3 mo -- - - - nd -- - - - nd -- - - - 3 mo -- - - - nd -- - - - nd -- - - - nd -- - - - nd -- - - - nd -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -Ref - - - - -0.57, 1.37 - - - - -0.70, 1.84 - - - - -Ref - - - - -Ref - - - - -Ref - - - - -0.53, 1.81 - - - - -0.70, 2.55 - - - - -Ref - - - - -nd - - - - -1.00 - - - - -0.90 - - - - -0.64 - - - - -0.65 - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - 2 mo -- - - - nd -- - - - nd -- - - - 3 mo -- - - - nd -- - - - nd -- - - - - -- - - - - -- - - - - -- - - - - -1.00 - - - - -1.18 - - - - -0.96 - - - - -0.75 - - - - -0.87 - - - - -Ref=1 - - - - --0.11 - - - - --0.05 - - - - --0.04 - - - - --0.08 - - - - -Ref=1 - - - - --0.13 - - - - --0.06 - - - - --0.11 - - - - --0.16 - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - nd -- - - - nd -- - - - nd -- - - - nd -nd - - - - -nd - - - - -- - - - 12 m -- - - - 12 m -- - - - 12 m -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -nd - - - - -nd - - - - -nd - - - - -0.93-1.20 - - - - -0.84-1.11 - - - - -0.82-1.12 - - - - -0.74-1.04 - - - - -nd - - - - -0.90-1.20 - - - - -0.82-1.13 - - - - -0.82-1.16 - - - - -0.74-1.09 - - - - -nd - - - - -0.81-1.29 - - - - -0.72-1.20 - - - - -0.69-1.21 - - - - -0.62-1.16 - - - - -nd - - - - -0.42-1.4 - - - - -0.39-1.5 - - - - -0.35-1.5 - - - - -nd - - - - -0.55-1.9 - - - - -0.65-2.3 - - - - -0.50-2.3 - - - - -nd - - - - -
0.48-2.0 - - - - -0.48-2.3 - - - - -0.51-2.7 - - - - -nd - - - - -0.78-3.6 - - - - -0.90-4.7 - - - - -0.78-5.6 - - - - -nd - - - - -0.024-1.2 - - - - -0.051-1.3 - - - - -0.0057-0.99 - - - - -nd - - - - -0.069-1.0 - - - - -0.15-1.4 - - - - -0.084-1.3 - - - - -1.00 - - - - -1.02 - - - - -1.08 - - - - -0.85 - - - - -0.70 - - - - -1.00 - - - - -0.77 - - - - -0.76 - - - - -0.74 - - - - -0.64 - - - - -0.93-1.10 - - - - -0.38-1.53 - - - - -Reference - - - - -0.93-1.15 - - - - -0.93-1.17 - - - - -0.93-1.18 - - - - -0.91-1.20 - - - - -Reference - - - - -1.03-1.28 - - - - -0.95-1.19 - - - - -1.00-1.24 - - - - -0.98-1.22 - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -1.0 - - - - -0.7 - - - - -0.7 - - - - -0.6 - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -1 - - - - -1.0 - - - - -1.0 - - - - -1.3 - - - - -1.2 - - - - -nd - - - - -0.72-1.47 - - - - -0.70-1.41 - - - - --- - - - - -0.6, 1.6 - - - - -0.8, 1.4 - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -1.0 - - - - -1.0 - - - - -1.0 - - - - -0.9 - - - - -0.9 - - - - -nd - - - - -0.7-3.2 - - - - -0.5-2.3 - - - - -0.5-2.2 - - - - -0.3-1.4 - - - - -nd - - - - -0.8-12.3 - - - - -0.4-7.2 - - - - -1.0-13.9 - - - - -0.4-7.7 - - - - -nd - - - - -0.7-1.6 - - - - -0.7-1.6 - - - - -0.5-1.2 - - - - -0.6-1.3 - - - - -nd - - - - -0.6-1.6 - - - - -0.6-1.6 - - - - -0.6-1.5 - - - - -0.5-1.3 - - - - -nd - - - - -0.8-1.9 - - - - -0.7-1.7 - - - - -0.9-2.0 - - - - -0.7-1.7 - - - - -nd - - - - -0.6-2.1 - - - - -0.4-1.5 - - - - -0.9-2.8 - - - - -0.7-2.5 - - - - -nd - - - - -- - - - 12 +0.1- - - - 12 +0.5- - - - 12 0.0- - - - 12 +0.2- - - - 12 +59.8- - - - 12 -2.3- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -(reference) - - - - -(0.70-2.40) - - - - -(1.15-3.90) - - - - -(0.81-2.76) - - - - -(1.56-5.48) - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -1.00 - - - - -0.94 - - - - -0.79 - - - - -0.78 - - - - -0.71 - - - - -1.00 - - - - -1.18 - - - - -0.91 - - - - -1.08 - - - - -0.93 - - - - -- - - - - -- - - - - -- - - - - -- - - - - -1.09-2.37 - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -1.05, 3.08 - - - - -1.00, 2.36 - - - - -nd - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -reference - - - - -1.49 - - - - -1.52 - - - - -- - - - - -- - - - - -- - - - - -- - - - - -1.00 - - - - -1.00 - - - - -1.00 - - - - -nd - - - - -0.55-1.70 - - - - -0.35-1.24 - - - - -0.27-0.97 - - - - -0.45-1.52 - - - - -nd - - - - -0.42-1.33 - - - - -0.14-0.59 - - - - -0.24-0.89 - - - - -nd - - - - -0.29-2.41 - - - - -0.11-1.09 - - - - -0.23-2.08 - - - - -nd - - - - -0.34-2.55 - - - - -0.07-1.36 - - - - -0.21-2.39 - - - - -nd - - - - -0.61-5.00 - - - - -0.87-12.69 - - - - -nd - - - - -0.66-2.51 - - - - -0.31-1.28 - - - - -0.30-1.29 - - - - -0.41-1.72 - - - - -nd - - - - -0.46-1.78 - - - - -0.15-0.69 - - - - -0.20-0.94 - - - - -
- - - - 3 mo. -8- - - - 3 mo. nd- - - - 3 mo. nd- - - - nd nd- - - - 6 mo. -5- - - - 6 mo. nd- - - - 6 mo. nd- - - - 6 mo. nd- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - 12 -- - - - 12 -- - - - 12 -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - 60 -- - - - 60 -- - - - - -- - - - - -- - - - - -- - - - - -
Delta SD*- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
Mean 25(OH)D
Vit D level CI / SE / SD*
Mean Follow-up,
N Event [RR Ca/placebo]
N Total [RR Ca/placebo]
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -11.8 - - - - -19.5 - - - - -10.2 - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- 45.4 38.6-53.4 - - -- 53.1 47.4-59.9 - - -- - - 5 yr 3 732- - - 5 yr 6 739- - - 5 yr 31 732- - - 5 yr 21 739- - - 5 yr 34 732- - - 5 yr 25 739- - - 5 yr 60 732- - - 5 yr 50 739- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -1.3% - - - - -1.4% - - - - -1.4% - - - - -1.4% - - - - -0.5% - - - - -0.5% - - - - -0.5% - - - - -0.5% - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -3.8 - - - - -3.9 - - - - -1.3 - - - - -1.4 - - - - -21.1 - - - - -9.5 - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
N Event- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
Mean Follow-up,
N Event [Ratio of
N Total [Ratio of
No. of Total person-
No. of Non-cases
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -5 yr 0.9 nd - - -5 yr 1.8 nd - - -5 yr 11.1 nd - - -5 yr 6.6 nd - - -5 yr 11.4 nd - - -5 yr 7.8 nd - - -5 yr 23.3 nd - - -5 yr 16.3 nd - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - 33473 - -- - - 33477 - -- - - 33465 - -- - - 33565 - -- - - 33466 - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - 24 -- - - - 25 -- - - - 24 -- - - - 25 -- - - - 24 -- - - - 98 -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - 36- - - - - 45- - - - - 1- - - - - 3- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - 668- - - - - 693- - - - - 23- - - - - 23- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - 12- - - - - 5- - - - - nd- - - - - nd- - - - - nd- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - 1222- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - 51- - - - - 80- - - - - 21- - - - - 23- - - - - 10- - - - - 14- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - 5.3%- - - - - 6.6%- - - - - 6.8%- - - - - 8.6%- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - 218
- - - - - 205- - - - - 953- - - - - 947- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - 3315- - - - - 3377- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - 12- - - - - 18
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - 101- - - - - 117- - - - - 42- - - - - 49- - - - - 28- - - - - 26- - - - - 224
- - - - - 233- - - - - 224- - - - - 247- - - - - 63- - - - - 72- - - - - 7- - - - - 11- - - - - 10- - - - - 9- - - - - 0- - - - - 0- - - - - 144- - - - - 130- - - - - 28- - - - - 27- - - - - 17- - - - - 15- - - - - 4- - - - - 4- - - - - 254- - - - - 261- - - - - 10- - - - - 11- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - 807- - - - - 744- - - - - 41- - - - - 34- - - - - 2997- - - - - 2983- - - - - 381- - - - - 449- - - - - 154- - - - - 168
- - - - - 126- - - - - 128- - - - - 30- - - - - 44- - - - - 1655- - - - - 1634- - - - - 382- - - - - 344- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - 50- - - - - 70- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
N Total Total N Final **- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
Outcome Metric (e.g.
Mean Follow-up
Baseline SD*
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -100 RR VitD+Ca / Ca - - - -103 RR VitD+Ca / Ca - - - -100 nd - - - -103 nd - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -18176 HR - - - -18106 HR - - - -18176 HR - - - -18106 HR - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -175 nd - - - -9 nd - - - -50 nd - - - -47 nd - - - -46 nd - - - -- - 10 year 6634 - -- - 10 y ~1658 - -- - - ~1658 - -- - - ~1658 - -- - - ~1658 - -- - 10 y - - -- - - - - -- - - - - -- - 10 y - - -- - - - - -- - - - - -- - 10 y - - -- - - - - -- - - - - -- - 10 y - - -- - - - - -- - - - - -- - 10 y - - -- - - - - -- - - - - -- - 10 y - - -- - - - - -- - - - - -5527 - - - - -- - - - 7.6 61.5- - - - 13.7 66.3- - - - 11.6 61.2- - - - 2.6 22.1- - - - 4.7 23.6- - - - 3.4 22.0- - - - 9 -- - - - 8 -- - - - 7 -- - - - 6 -- - - - 5 -- - - - 7 -- - - - 9 -- - - - 10 -- - - - 10 -- - - - 9 -
- - - - 7 -- - - - 8 -- - - - 11 -- - - - 13 -- - - - 11 -- - - - 8 -- - - - 8 -- - - - 11 -- - - - 0.3 -- - - - 0.3 -- - - - 0.3 -- - - - 0.2 -- - - - 0.2 -- - - - 0.2 -- - - - 29 -- - - - 27 -- - - - 30 -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -162 RR - - - -185 RR - - - -162 RR - - - -185 RR - - - -102 RR - - - -114 RR - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - 14.83 -- - - - 11.75 -- - - - 11.65 -- - - - 4.86 -- - - - 4.35 -- - - - 4.22 -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - 20.7 -- - - - 20.5 -- - - - 20.0 -2626 - - - -2575 - - - -1852 - - - -1848 - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
RR ca+vitD / placeboRR ca+vitD / placeboOR ca+vitD / placeboOR ca+vitD / placebo
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -1673 HR vit d2/placebo - - - -
1670 HR vit d2/placebo - - - -1673 HR vit d2/placebo - - - -1670 HR vit d2/placebo - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - 9.4- - - - - 25.3- - - - - 26- - - - - 5.3- - - - - 15.7- - - - - 18.2- - - - - 66.1- - - - - 49.9- - - - - 69- - - - - 47- - - - - 42.6- - - - - 46.1- - - - - 3460- - - - - 3370- - - - - 32108525 HR - - - -8597 HR - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -200 nd - - - -200 nd - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - 3397- - - - - 3555- - - - - 49.8- - - - - 50.4- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - 14.5 -- - - - 13.9 -- - - - 4.1 -- - - - 3.8 -- - - - 16.7 -- - - - 15.4 -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -1345 HR - - - -1341 HR - - - -1345 HR - - - -1341 HR - - - -1345 HR - - - -1341 HR - - - -1345 HR - - - -
1341 HR - - - -1345 HR - - - -1341 HR - - - -1345 HR - - - -1341 HR - - - -1345 HR - - - -1341 HR - - - -1019 HR - - - -1018 HR - - - -326 HR - - - -323 HR - - - -1345 HR - - - -1341 HR - - - -1345 HR - - - -1341 HR - - - -1345 HR - - - -1341 HR - - - -326 HR - - - -323 HR - - - -1027 HR - - - -1011 HR - - - -1345 HR - - - -1341 HR - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -18106 - - - -18176 - - - -18106 - - - -18176 - - - -18106 - - - -18176 - - - -18106 - - - -18176 - - - -18106 - - - -18176 - - - -
HR Vit D+Ca / placeboHR Vit D+Ca / placeboHR Vit D+Ca / placeboHR Vit D+Ca / placeboHR Vit D+Ca / placeboHR Vit D+Ca / placeboHR Vit D+Ca / placeboHR Vit D+Ca / placeboHR Vit D+Ca / placeboHR Vit D+Ca / placebo
18106 - - - -18176 - - - -18106 - - - -18176 - - - -18106 - - - -18176 - - - -18106 - - - -18176 - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -481 - - - -1258 - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
HR Vit D+Ca / placeboHR Vit D+Ca / placeboHR Vit D+Ca / placeboHR Vit D+Ca / placeboHR Vit D+Ca / placeboHR Vit D+Ca / placeboHR Vit D+Ca / placeboHR Vit D+Ca / placebo
Unadjusted: Rate (age and sex Unadjusted: Rate (age and sex
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - 25.9 64.5- - - - 25.6 97.8- - - - 34.2 59.7- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - 88.8 nd- - - - 125.4 nd- - - - - -- - - - - -- - - - - -- - - - - -
Final SD*- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
Mean Vit D level /
Mean Vit D level /
Exposure Categories(
Mean Vit D level
Mean follow-up
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -7.4 - - - - -14.8 - - - - -10.9 - - - - -2.5 - - - - -5.1 - - - - -3.0 - - - - -6 - - - - -31 - - - - -8 - - - - -5 - - - - -9 - - - - -6 - - - - -2.3 - - - - -2.4 - - - - -1.8 - - - - -1.4 - - - - -
1.3 - - - - -1.5 - - - - -8.3 - - - - -8.5 - - - - -7.8 - - - - -4.7 - - - - -6.2 - - - - -5.2 - - - - -5.7 - - - - -5.8 - - - - -4.7 - - - - -4.0 - - - - -4.2 - - - - -3.9 - - - - -30 - - - - -33 - - - - -30 - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- 14.9 17.4 - - -- 19.6 24.8 - - -- 24.1 29.6 - - -- 27.9 34.5 - - -- 35.3 44.5 - - -- 24.6 18.7 - - -- 29.4 24.2 - - -
- 33.2 29.8 - - -- 36.8 33.8 - - -- 43.7 42.3 - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - ng/mL 37.9***** - -- - - 29.2 - -- - - 23.8 - -- - - 16.7 - -- - - < 30.0 - -- - - 30.0 - -- - - - <50 105- - - - 50 to <62.5 105- - - - 62.5 to <80 105- - - - 80 to <100 105- - - - 100 to <120 105- - - - 120 or over 105- - - - <50 105- - - - 50 to <80 105- - - - 80 to <100 105- - - - 100 or over 105- - - - <62.5 105- - - - 62.5 or over 105- - - - <62.5 105- - - - 62.5 or over 105
- - - - <62.5 105- - - - 62.5 105- - - - <62.5 105- - - - 62.5 or over 105- - - - <50 105- - - - 50 to <80 105- - - - 80 or over 105- - - - <50 105- - - - 50 to <80 105- - - - 80 or over 105- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -1.83 - - - - -2.29 - - - - -2.25 - - - - -2.09 - - - - -0.46 - - - - -0.56 - - - - -1.57 - - - - -0.51 - - - - -2.85 - - - - -2.60 - - - - -2.89 - - - - -2.67 - - - - -1.07 - - - - -1.14 - - - - -1.34 - - - - -1.06 - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -19.8 - - - - -20.3 - - - - -21.4 - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -4.9 - - - - -7.7 - - - - -6.4 - - - - -2.5 - - - - -5.1 - - - - -5.2 - - - - -14 - - - - -16 - - - - -22 - - - - -16 - - - - -12 - - - - -15 - - - - -70 - - - - -80 - - - - -90 - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -57 - - - - -52 - - - - -2.7 - - - - -2.4 - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -26.5 - - - - -31.8 - - - - -28.8 - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
Final Delta SD Delta **- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
Baseline (median)
No. of Event*
Baseline SE*
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -50 - - - - -50 - - - - -50.5 - - - - -50.1 - - - - -3.38 - - - - -3.40 - - - - -3.49 - - - - -3.43 - - - - -71.2 - - - - -71.4 - - - - -71.7 - - - - -71.1 - - - - -9.10 - - - - -9.03 - - - - -9.24 - - - - -9.07 - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- 1.37 - - - -- 1.79 - - - -- 1.62 - - - -- 0.49 - - - -- 0.69 - - - -- 0.65 - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - 45 - - -- - 42 - - -- - 32.5 - - -- - 45 - - -- - 42 - - -- - 32.5 - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - 209 - -- - - 167 - -- - - 238 - -- - - 201 - -- - - 30 - -- - - 21 - -- - - 23 - -- - - 25 - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - 0.014 -0.7 %- - - - 0.022 0.6 %- - - - 0.012 1.5 %
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
Delta CI*- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -
No. of Non-cases**
Mean Follow up,
- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -
- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -
- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -
- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -
- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -
- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -
- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -
- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -
- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -
- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -
- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -
- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -
- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -
- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - --1.4, -0.1 % - --0.4, 1.6 % - -0.9, 2.2 % - -
- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -
- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- 80 -
- 84 -- 80 -- 82 -- 82 -- 80 -- 82 -- 82 -- 17 -- 14 -- 16 -- 18 -- 18 -- 16 -- 13 -- 18 -- 63 -- 70 -- 64 -- 64 -- 64 -- 64 -- 69 -- 64 -- 36 -- 37 -- 35 -- 34 -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -
- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- -- -- -
Median 5.4 y (up to 11.7 y)Median 5.4 y (up to 11.7 y)Median 5.4 y (up to 11.7 y)
- -- -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -
Median 5.4 y (up to 11.7 y)Median 5.4 y (up to 11.7 y)
- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -
- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -
- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -
- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -- - -
Study ID:EF ID Creator Create Date PMIDLast Updated
Alt ID(s) Title Year Author
ArmAdverse Event
Adverse Event
Arm Description
No Advers
Study ID:EF ID Creator Create Date PMID6304:194 admin Aug 18, 2013 Sep 5, 2014 185059676304:194 admin Aug 18, 2013 Sep 5, 2014 185059676304:194 admin Aug 18, 2013 Sep 5, 2014 185059676304:194 admin Aug 18, 2013 Sep 5, 2014 185059676304:194 admin Aug 18, 2013 Sep 5, 2014 185059676304:194 admin Aug 18, 2013 Sep 5, 2014 185059676304:194 admin Aug 18, 2013 Sep 5, 2014 185059676304:194 admin Aug 18, 2013 Sep 5, 2014 185059676304:194 admin Aug 18, 2013 Sep 5, 2014 185059676304:194 admin Aug 18, 2013 Sep 5, 2014 185059676304:194 admin Aug 18, 2013 Sep 5, 2014 185059676304:194 admin Aug 18, 2013 Sep 5, 2014 185059676304:194 admin Aug 18, 2013 Sep 5, 2014 185059676304:194 admin Aug 18, 2013 Sep 5, 2014 185059676304:194 admin Aug 18, 2013 Sep 5, 2014 185059676304:194 admin Aug 18, 2013 Sep 5, 2014 185059676305:194 admin Aug 18, 2013 Sep 5, 2014 110758746305:194 admin Aug 18, 2013 Sep 5, 2014 110758746305:194 admin Aug 18, 2013 Sep 5, 2014 110758746305:194 admin Aug 18, 2013 Sep 5, 2014 110758746305:194 admin Aug 18, 2013 Sep 5, 2014 110758746305:194 admin Aug 18, 2013 Sep 5, 2014 110758746305:194 admin Aug 18, 2013 Sep 5, 2014 110758746305:194 admin Aug 18, 2013 Sep 5, 2014 110758746306:194 admin Aug 18, 2013 Sep 5, 2014 126632776306:194 admin Aug 18, 2013 Sep 5, 2014 126632776306:194 admin Aug 18, 2013 Sep 5, 2014 126632776306:194 admin Aug 18, 2013 Sep 5, 2014 126632776306:194 admin Aug 18, 2013 Sep 5, 2014 126632776306:194 admin Aug 18, 2013 Sep 5, 2014 126632776306:194 admin Aug 18, 2013 Sep 5, 2014 126632776306:194 admin Aug 18, 2013 Sep 5, 2014 126632776306:194 admin Aug 18, 2013 Sep 5, 2014 126632776306:194 admin Aug 18, 2013 Sep 5, 2014 126632776306:194 admin Aug 18, 2013 Sep 5, 2014 126632776306:194 admin Aug 18, 2013 Sep 5, 2014 126632776307:194 admin Aug 18, 2013 Sep 5, 2014 78928826308:194 admin Aug 18, 2013 Sep 5, 2014 162804276308:194 admin Aug 18, 2013 Sep 5, 2014 162804276308:194 admin Aug 18, 2013 Sep 5, 2014 162804276308:194 admin Aug 18, 2013 Sep 5, 2014 162804276309:194 admin Aug 18, 2013 Sep 5, 2014 182086366309:194 admin Aug 18, 2013 Sep 5, 2014 182086366309:194 admin Aug 18, 2013 Sep 5, 2014 182086366309:194 admin Aug 18, 2013 Sep 5, 2014 182086366309:194 admin Aug 18, 2013 Sep 5, 2014 182086366309:194 admin Aug 18, 2013 Sep 5, 2014 18208636
Last Updated
6309:194 admin Aug 18, 2013 Sep 5, 2014 182086366309:194 admin Aug 18, 2013 Sep 5, 2014 182086366309:194 admin Aug 18, 2013 Sep 5, 2014 182086366309:194 admin Aug 18, 2013 Sep 5, 2014 182086366309:194 admin Aug 18, 2013 Sep 5, 2014 182086366309:194 admin Aug 18, 2013 Sep 5, 2014 182086366309:194 admin Aug 18, 2013 Sep 5, 2014 182086366309:194 admin Aug 18, 2013 Sep 5, 2014 182086366309:194 admin Aug 18, 2013 Sep 5, 2014 182086366309:194 admin Aug 18, 2013 Sep 5, 2014 182086366311:194 admin Aug 18, 2013 Sep 5, 2014 13303606311:194 admin Aug 18, 2013 Sep 5, 2014 13303606311:194 admin Aug 18, 2013 Sep 5, 2014 13303606311:194 admin Aug 18, 2013 Sep 5, 2014 13303606311:194 admin Aug 18, 2013 Sep 5, 2014 13303606311:194 admin Aug 18, 2013 Sep 5, 2014 13303606311:194 admin Aug 18, 2013 Sep 5, 2014 13303606311:194 admin Aug 18, 2013 Sep 5, 2014 13303606312:194 admin Aug 18, 2013 Sep 5, 2014 86211986312:194 admin Aug 18, 2013 Sep 5, 2014 86211986312:194 admin Aug 18, 2013 Sep 5, 2014 86211986312:194 admin Aug 18, 2013 Sep 5, 2014 86211986313:194 admin Aug 18, 2013 Sep 5, 2014 97435116313:194 admin Aug 18, 2013 Sep 5, 2014 97435116313:194 admin Aug 18, 2013 Sep 5, 2014 97435116313:194 admin Aug 18, 2013 Sep 5, 2014 97435116314:194 admin Aug 18, 2013 Sep 5, 2014 157673346314:194 admin Aug 18, 2013 Sep 5, 2014 157673346314:194 admin Aug 18, 2013 Sep 5, 2014 157673346314:194 admin Aug 18, 2013 Sep 5, 2014 157673346314:194 admin Aug 18, 2013 Sep 5, 2014 157673346314:194 admin Aug 18, 2013 Sep 5, 2014 157673346315:194 admin Aug 18, 2013 Sep 5, 2014 161034506315:194 admin Aug 18, 2013 Sep 5, 2014 161034506315:194 admin Aug 18, 2013 Sep 5, 2014 161034506315:194 admin Aug 18, 2013 Sep 5, 2014 161034506315:194 admin Aug 18, 2013 Sep 5, 2014 161034506315:194 admin Aug 18, 2013 Sep 5, 2014 161034506315:194 admin Aug 18, 2013 Sep 5, 2014 161034506315:194 admin Aug 18, 2013 Sep 5, 2014 161034506316:194 admin Aug 18, 2013 Sep 5, 2014 179650376316:194 admin Aug 18, 2013 Sep 5, 2014 179650376317:194 admin Aug 18, 2013 Sep 5, 2014 186895596318:194 admin Aug 18, 2013 Sep 5, 2014 175359856319:194 admin Aug 18, 2013 Sep 5, 2014 181983946319:194 admin Aug 18, 2013 Sep 5, 2014 181983946319:194 admin Aug 18, 2013 Sep 5, 2014 181983946319:194 admin Aug 18, 2013 Sep 5, 2014 18198394
6320:194 admin Aug 18, 2013 Sep 5, 2014 172438666320:194 admin Aug 18, 2013 Sep 5, 2014 172438666321:194 admin Aug 18, 2013 Sep 5, 2014 188427716322:194 admin Aug 18, 2013 Sep 5, 2014 83334126322:194 admin Aug 18, 2013 Sep 5, 2014 83334126322:194 admin Aug 18, 2013 Sep 5, 2014 83334126322:194 admin Aug 18, 2013 Sep 5, 2014 83334126322:194 admin Aug 18, 2013 Sep 5, 2014 83334126322:194 admin Aug 18, 2013 Sep 5, 2014 83334126322:194 admin Aug 18, 2013 Sep 5, 2014 83334126322:194 admin Aug 18, 2013 Sep 5, 2014 83334126323:194 admin Aug 18, 2013 Sep 5, 2014 99219606323:194 admin Aug 18, 2013 Sep 5, 2014 99219606323:194 admin Aug 18, 2013 Sep 5, 2014 99219606325:194 admin Aug 18, 2013 Sep 5, 2014 76128036325:194 admin Aug 18, 2013 Sep 5, 2014 76128036325:194 admin Aug 18, 2013 Sep 5, 2014 76128036325:194 admin Aug 18, 2013 Sep 5, 2014 76128036325:194 admin Aug 18, 2013 Sep 5, 2014 76128036326:194 admin Aug 18, 2013 Sep 5, 2014 187553196326:194 admin Aug 18, 2013 Sep 5, 2014 187553196326:194 admin Aug 18, 2013 Sep 5, 2014 187553196326:194 admin Aug 18, 2013 Sep 5, 2014 187553196326:194 admin Aug 18, 2013 Sep 5, 2014 187553196326:194 admin Aug 18, 2013 Sep 5, 2014 187553196327:194 admin Aug 18, 2013 Sep 5, 2014 167979036327:194 admin Aug 18, 2013 Sep 5, 2014 167979036327:194 admin Aug 18, 2013 Sep 5, 2014 167979036327:194 admin Aug 18, 2013 Sep 5, 2014 167979036327:194 admin Aug 18, 2013 Sep 5, 2014 167979036327:194 admin Aug 18, 2013 Sep 5, 2014 167979036327:194 admin Aug 18, 2013 Sep 5, 2014 167979036327:194 admin Aug 18, 2013 Sep 5, 2014 167979036327:194 admin Aug 18, 2013 Sep 5, 2014 167979036327:194 admin Aug 18, 2013 Sep 5, 2014 167979036328:194 admin Aug 18, 2013 Sep 5, 2014 176564206328:194 admin Aug 18, 2013 Sep 5, 2014 176564206330:194 admin Aug 18, 2013 Sep 5, 2014 115666566330:194 admin Aug 18, 2013 Sep 5, 2014 115666566330:194 admin Aug 18, 2013 Sep 5, 2014 115666566330:194 admin Aug 18, 2013 Sep 5, 2014 115666566331:194 admin Aug 18, 2013 Sep 5, 2014 190016016331:194 admin Aug 18, 2013 Sep 5, 2014 190016016331:194 admin Aug 18, 2013 Sep 5, 2014 190016016331:194 admin Aug 18, 2013 Sep 5, 2014 190016016331:194 admin Aug 18, 2013 Sep 5, 2014 190016016331:194 admin Aug 18, 2013 Sep 5, 2014 190016016331:194 admin Aug 18, 2013 Sep 5, 2014 19001601
6334:194 admin Aug 18, 2013 Sep 5, 2014 152130386334:194 admin Aug 18, 2013 Sep 5, 2014 152130386334:194 admin Aug 18, 2013 Sep 5, 2014 152130386336:194 admin Aug 18, 2013 Sep 5, 2014 86824536336:194 admin Aug 18, 2013 Sep 5, 2014 86824536337:194 admin Aug 18, 2013 Sep 5, 2014 88906616337:194 admin Aug 18, 2013 Sep 5, 2014 88906616337:194 admin Aug 18, 2013 Sep 5, 2014 88906616337:194 admin Aug 18, 2013 Sep 5, 2014 88906616337:194 admin Aug 18, 2013 Sep 5, 2014 88906616337:194 admin Aug 18, 2013 Sep 5, 2014 88906616337:194 admin Aug 18, 2013 Sep 5, 2014 88906616337:194 admin Aug 18, 2013 Sep 5, 2014 88906616337:194 admin Aug 18, 2013 Sep 5, 2014 88906616337:194 admin Aug 18, 2013 Sep 5, 2014 88906616337:194 admin Aug 18, 2013 Sep 5, 2014 88906616337:194 admin Aug 18, 2013 Sep 5, 2014 88906616337:194 admin Aug 18, 2013 Sep 5, 2014 88906616337:194 admin Aug 18, 2013 Sep 5, 2014 88906616337:194 admin Aug 18, 2013 Sep 5, 2014 88906616337:194 admin Aug 18, 2013 Sep 5, 2014 88906616337:194 admin Aug 18, 2013 Sep 5, 2014 88906616337:194 admin Aug 18, 2013 Sep 5, 2014 88906616337:194 admin Aug 18, 2013 Sep 5, 2014 88906616337:194 admin Aug 18, 2013 Sep 5, 2014 88906616337:194 admin Aug 18, 2013 Sep 5, 2014 88906616337:194 admin Aug 18, 2013 Sep 5, 2014 88906616337:194 admin Aug 18, 2013 Sep 5, 2014 88906616337:194 admin Aug 18, 2013 Sep 5, 2014 88906616339:194 admin Aug 18, 2013 Sep 5, 2014 162782626339:194 admin Aug 18, 2013 Sep 5, 2014 162782626339:194 admin Aug 18, 2013 Sep 5, 2014 162782626339:194 admin Aug 18, 2013 Sep 5, 2014 162782626339:194 admin Aug 18, 2013 Sep 5, 2014 162782626339:194 admin Aug 18, 2013 Sep 5, 2014 162782626339:194 admin Aug 18, 2013 Sep 5, 2014 162782626339:194 admin Aug 18, 2013 Sep 5, 2014 162782626339:194 admin Aug 18, 2013 Sep 5, 2014 162782626339:194 admin Aug 18, 2013 Sep 5, 2014 162782626339:194 admin Aug 18, 2013 Sep 5, 2014 162782626339:194 admin Aug 18, 2013 Sep 5, 2014 162782626339:194 admin Aug 18, 2013 Sep 5, 2014 162782626339:194 admin Aug 18, 2013 Sep 5, 2014 162782626339:194 admin Aug 18, 2013 Sep 5, 2014 162782626339:194 admin Aug 18, 2013 Sep 5, 2014 162782626339:194 admin Aug 18, 2013 Sep 5, 2014 162782626339:194 admin Aug 18, 2013 Sep 5, 2014 162782626339:194 admin Aug 18, 2013 Sep 5, 2014 16278262
6339:194 admin Aug 18, 2013 Sep 5, 2014 162782626339:194 admin Aug 18, 2013 Sep 5, 2014 162782626339:194 admin Aug 18, 2013 Sep 5, 2014 162782626339:194 admin Aug 18, 2013 Sep 5, 2014 162782626339:194 admin Aug 18, 2013 Sep 5, 2014 162782626339:194 admin Aug 18, 2013 Sep 5, 2014 162782626339:194 admin Aug 18, 2013 Sep 5, 2014 162782626339:194 admin Aug 18, 2013 Sep 5, 2014 162782626339:194 admin Aug 18, 2013 Sep 5, 2014 162782626339:194 admin Aug 18, 2013 Sep 5, 2014 162782626339:194 admin Aug 18, 2013 Sep 5, 2014 162782626339:194 admin Aug 18, 2013 Sep 5, 2014 162782626341:194 admin Aug 18, 2013 Sep 5, 2014 153424526341:194 admin Aug 18, 2013 Sep 5, 2014 153424526341:194 admin Aug 18, 2013 Sep 5, 2014 153424526341:194 admin Aug 18, 2013 Sep 5, 2014 153424526341:194 admin Aug 18, 2013 Sep 5, 2014 153424526341:194 admin Aug 18, 2013 Sep 5, 2014 153424526341:194 admin Aug 18, 2013 Sep 5, 2014 153424526341:194 admin Aug 18, 2013 Sep 5, 2014 153424526341:194 admin Aug 18, 2013 Sep 5, 2014 153424526341:194 admin Aug 18, 2013 Sep 5, 2014 153424526341:194 admin Aug 18, 2013 Sep 5, 2014 153424526341:194 admin Aug 18, 2013 Sep 5, 2014 153424526342:194 admin Aug 18, 2013 Sep 5, 2014 156684856342:194 admin Aug 18, 2013 Sep 5, 2014 156684856342:194 admin Aug 18, 2013 Sep 5, 2014 156684856342:194 admin Aug 18, 2013 Sep 5, 2014 156684856342:194 admin Aug 18, 2013 Sep 5, 2014 156684856342:194 admin Aug 18, 2013 Sep 5, 2014 156684856342:194 admin Aug 18, 2013 Sep 5, 2014 156684856342:194 admin Aug 18, 2013 Sep 5, 2014 156684856342:194 admin Aug 18, 2013 Sep 5, 2014 156684856342:194 admin Aug 18, 2013 Sep 5, 2014 156684856342:194 admin Aug 18, 2013 Sep 5, 2014 156684856342:194 admin Aug 18, 2013 Sep 5, 2014 156684856342:194 admin Aug 18, 2013 Sep 5, 2014 156684856342:194 admin Aug 18, 2013 Sep 5, 2014 156684856342:194 admin Aug 18, 2013 Sep 5, 2014 156684856342:194 admin Aug 18, 2013 Sep 5, 2014 156684856342:194 admin Aug 18, 2013 Sep 5, 2014 156684856342:194 admin Aug 18, 2013 Sep 5, 2014 156684856342:194 admin Aug 18, 2013 Sep 5, 2014 156684856342:194 admin Aug 18, 2013 Sep 5, 2014 156684856342:194 admin Aug 18, 2013 Sep 5, 2014 156684856342:194 admin Aug 18, 2013 Sep 5, 2014 156684856342:194 admin Aug 18, 2013 Sep 5, 2014 156684856342:194 admin Aug 18, 2013 Sep 5, 2014 15668485
6342:194 admin Aug 18, 2013 Sep 5, 2014 156684856345:194 admin Aug 18, 2013 Sep 5, 2014 188386236345:194 admin Aug 18, 2013 Sep 5, 2014 188386236345:194 admin Aug 18, 2013 Sep 5, 2014 188386236345:194 admin Aug 18, 2013 Sep 5, 2014 188386236345:194 admin Aug 18, 2013 Sep 5, 2014 188386236345:194 admin Aug 18, 2013 Sep 5, 2014 188386236345:194 admin Aug 18, 2013 Sep 5, 2014 188386236346:194 admin Aug 18, 2013 Sep 5, 2014 179715266346:194 admin Aug 18, 2013 Sep 5, 2014 179715266346:194 admin Aug 18, 2013 Sep 5, 2014 179715266346:194 admin Aug 18, 2013 Sep 5, 2014 179715266346:194 admin Aug 18, 2013 Sep 5, 2014 179715266346:194 admin Aug 18, 2013 Sep 5, 2014 179715266346:194 admin Aug 18, 2013 Sep 5, 2014 179715266346:194 admin Aug 18, 2013 Sep 5, 2014 179715266346:194 admin Aug 18, 2013 Sep 5, 2014 179715266346:194 admin Aug 18, 2013 Sep 5, 2014 179715266346:194 admin Aug 18, 2013 Sep 5, 2014 179715266346:194 admin Aug 18, 2013 Sep 5, 2014 179715266346:194 admin Aug 18, 2013 Sep 5, 2014 179715266346:194 admin Aug 18, 2013 Sep 5, 2014 179715266346:194 admin Aug 18, 2013 Sep 5, 2014 179715266346:194 admin Aug 18, 2013 Sep 5, 2014 179715266347:194 admin Aug 18, 2013 Sep 5, 2014 183814726347:194 admin Aug 18, 2013 Sep 5, 2014 183814726347:194 admin Aug 18, 2013 Sep 5, 2014 183814726347:194 admin Aug 18, 2013 Sep 5, 2014 183814726347:194 admin Aug 18, 2013 Sep 5, 2014 183814726347:194 admin Aug 18, 2013 Sep 5, 2014 183814726347:194 admin Aug 18, 2013 Sep 5, 2014 183814726347:194 admin Aug 18, 2013 Sep 5, 2014 183814726347:194 admin Aug 18, 2013 Sep 5, 2014 183814726347:194 admin Aug 18, 2013 Sep 5, 2014 183814726349:194 admin Aug 18, 2013 Sep 5, 2014 173110576349:194 admin Aug 18, 2013 Sep 5, 2014 173110576349:194 admin Aug 18, 2013 Sep 5, 2014 173110576349:194 admin Aug 18, 2013 Sep 5, 2014 173110576350:194 admin Aug 18, 2013 Sep 5, 2014 88502736350:194 admin Aug 18, 2013 Sep 5, 2014 88502736350:194 admin Aug 18, 2013 Sep 5, 2014 88502736350:194 admin Aug 18, 2013 Sep 5, 2014 88502736350:194 admin Aug 18, 2013 Sep 5, 2014 88502736350:194 admin Aug 18, 2013 Sep 5, 2014 88502736350:194 admin Aug 18, 2013 Sep 5, 2014 88502736350:194 admin Aug 18, 2013 Sep 5, 2014 88502736351:194 admin Aug 18, 2013 Sep 5, 2014 28573646351:194 admin Aug 18, 2013 Sep 5, 2014 2857364
6351:194 admin Aug 18, 2013 Sep 5, 2014 28573646351:194 admin Aug 18, 2013 Sep 5, 2014 28573646352:194 admin Aug 18, 2013 Sep 5, 2014 25729006352:194 admin Aug 18, 2013 Sep 5, 2014 25729006352:194 admin Aug 18, 2013 Sep 5, 2014 25729006352:194 admin Aug 18, 2013 Sep 5, 2014 25729006352:194 admin Aug 18, 2013 Sep 5, 2014 25729006352:194 admin Aug 18, 2013 Sep 5, 2014 25729006352:194 admin Aug 18, 2013 Sep 5, 2014 25729006352:194 admin Aug 18, 2013 Sep 5, 2014 25729006352:194 admin Aug 18, 2013 Sep 5, 2014 25729006352:194 admin Aug 18, 2013 Sep 5, 2014 25729006353:194 admin Aug 18, 2013 Sep 5, 2014 74936596353:194 admin Aug 18, 2013 Sep 5, 2014 74936596353:194 admin Aug 18, 2013 Sep 5, 2014 74936596357:194 admin Aug 18, 2013 Sep 5, 2014 172279966357:194 admin Aug 18, 2013 Sep 5, 2014 172279966357:194 admin Aug 18, 2013 Sep 5, 2014 172279966358:194 admin Aug 18, 2013 Sep 5, 2014 105113296358:194 admin Aug 18, 2013 Sep 5, 2014 105113296358:194 admin Aug 18, 2013 Sep 5, 2014 105113296358:194 admin Aug 18, 2013 Sep 5, 2014 105113296358:194 admin Aug 18, 2013 Sep 5, 2014 105113296358:194 admin Aug 18, 2013 Sep 5, 2014 105113296359:194 admin Aug 18, 2013 Sep 5, 2014 156712226359:194 admin Aug 18, 2013 Sep 5, 2014 156712226359:194 admin Aug 18, 2013 Sep 5, 2014 156712226359:194 admin Aug 18, 2013 Sep 5, 2014 156712226359:194 admin Aug 18, 2013 Sep 5, 2014 156712226359:194 admin Aug 18, 2013 Sep 5, 2014 156712226359:194 admin Aug 18, 2013 Sep 5, 2014 156712226359:194 admin Aug 18, 2013 Sep 5, 2014 156712226359:194 admin Aug 18, 2013 Sep 5, 2014 156712226359:194 admin Aug 18, 2013 Sep 5, 2014 156712226359:194 admin Aug 18, 2013 Sep 5, 2014 156712226359:194 admin Aug 18, 2013 Sep 5, 2014 156712226359:194 admin Aug 18, 2013 Sep 5, 2014 156712226359:194 admin Aug 18, 2013 Sep 5, 2014 156712226359:194 admin Aug 18, 2013 Sep 5, 2014 156712226360:194 admin Aug 18, 2013 Sep 5, 2014 162865196361:194 admin Aug 18, 2013 Sep 5, 2014 145539576361:194 admin Aug 18, 2013 Sep 5, 2014 145539576363:194 admin Aug 18, 2013 Sep 5, 2014 94050296369:194 admin Aug 18, 2013 Sep 5, 2014 152258336369:194 admin Aug 18, 2013 Sep 5, 2014 152258336369:194 admin Aug 18, 2013 Sep 5, 2014 152258336369:194 admin Aug 18, 2013 Sep 5, 2014 152258336369:194 admin Aug 18, 2013 Sep 5, 2014 15225833
6369:194 admin Aug 18, 2013 Sep 5, 2014 152258336370:194 admin Aug 18, 2013 Sep 5, 2014 116417506370:194 admin Aug 18, 2013 Sep 5, 2014 116417506370:194 admin Aug 18, 2013 Sep 5, 2014 116417506370:194 admin Aug 18, 2013 Sep 5, 2014 116417506370:194 admin Aug 18, 2013 Sep 5, 2014 116417506370:194 admin Aug 18, 2013 Sep 5, 2014 116417506370:194 admin Aug 18, 2013 Sep 5, 2014 116417506370:194 admin Aug 18, 2013 Sep 5, 2014 116417506370:194 admin Aug 18, 2013 Sep 5, 2014 116417506370:194 admin Aug 18, 2013 Sep 5, 2014 116417506370:194 admin Aug 18, 2013 Sep 5, 2014 116417506370:194 admin Aug 18, 2013 Sep 5, 2014 116417506374:194 admin Aug 18, 2013 Sep 5, 2014 82055386374:194 admin Aug 18, 2013 Sep 5, 2014 82055386374:194 admin Aug 18, 2013 Sep 5, 2014 82055386374:194 admin Aug 18, 2013 Sep 5, 2014 82055386374:194 admin Aug 18, 2013 Sep 5, 2014 82055386375:194 admin Aug 18, 2013 Sep 5, 2014 93438376375:194 admin Aug 18, 2013 Sep 5, 2014 93438376375:194 admin Aug 18, 2013 Sep 5, 2014 93438376375:194 admin Aug 18, 2013 Sep 5, 2014 93438376376:194 admin Aug 18, 2013 Sep 5, 2014 86107046376:194 admin Aug 18, 2013 Sep 5, 2014 86107046376:194 admin Aug 18, 2013 Sep 5, 2014 86107046376:194 admin Aug 18, 2013 Sep 5, 2014 86107046376:194 admin Aug 18, 2013 Sep 5, 2014 86107046377:194 admin Aug 18, 2013 Sep 5, 2014 158805326377:194 admin Aug 18, 2013 Sep 5, 2014 158805326377:194 admin Aug 18, 2013 Sep 5, 2014 158805326377:194 admin Aug 18, 2013 Sep 5, 2014 158805326378:194 admin Aug 18, 2013 Sep 5, 2014 175361916378:194 admin Aug 18, 2013 Sep 5, 2014 175361916378:194 admin Aug 18, 2013 Sep 5, 2014 175361916378:194 admin Aug 18, 2013 Sep 5, 2014 175361916378:194 admin Aug 18, 2013 Sep 5, 2014 175361916378:194 admin Aug 18, 2013 Sep 5, 2014 175361916378:194 admin Aug 18, 2013 Sep 5, 2014 175361916378:194 admin Aug 18, 2013 Sep 5, 2014 175361916378:194 admin Aug 18, 2013 Sep 5, 2014 175361916378:194 admin Aug 18, 2013 Sep 5, 2014 175361916378:194 admin Aug 18, 2013 Sep 5, 2014 175361916378:194 admin Aug 18, 2013 Sep 5, 2014 175361916379:194 admin Aug 18, 2013 Sep 5, 2014 171064376379:194 admin Aug 18, 2013 Sep 5, 2014 171064376382:194 admin Aug 18, 2013 Sep 5, 2014 153541506382:194 admin Aug 18, 2013 Sep 5, 2014 153541506382:194 admin Aug 18, 2013 Sep 5, 2014 15354150
6383:194 admin Aug 18, 2013 Sep 5, 2014 175566976383:194 admin Aug 18, 2013 Sep 5, 2014 175566976383:194 admin Aug 18, 2013 Sep 5, 2014 175566976383:194 admin Aug 18, 2013 Sep 5, 2014 175566976383:194 admin Aug 18, 2013 Sep 5, 2014 175566976383:194 admin Aug 18, 2013 Sep 5, 2014 175566976384:194 admin Aug 18, 2013 Sep 5, 2014 184333056384:194 admin Aug 18, 2013 Sep 5, 2014 184333056385:194 admin Aug 18, 2013 Sep 5, 2014 165229156385:194 admin Aug 18, 2013 Sep 5, 2014 165229156385:194 admin Aug 18, 2013 Sep 5, 2014 165229156385:194 admin Aug 18, 2013 Sep 5, 2014 165229156385:194 admin Aug 18, 2013 Sep 5, 2014 165229156385:194 admin Aug 18, 2013 Sep 5, 2014 165229156385:194 admin Aug 18, 2013 Sep 5, 2014 165229156385:194 admin Aug 18, 2013 Sep 5, 2014 165229156385:194 admin Aug 18, 2013 Sep 5, 2014 165229156385:194 admin Aug 18, 2013 Sep 5, 2014 165229156385:194 admin Aug 18, 2013 Sep 5, 2014 165229156385:194 admin Aug 18, 2013 Sep 5, 2014 165229156386:194 admin Aug 18, 2013 Sep 5, 2014 165229156386:194 admin Aug 18, 2013 Sep 5, 2014 165229156386:194 admin Aug 18, 2013 Sep 5, 2014 165229156386:194 admin Aug 18, 2013 Sep 5, 2014 165229156386:194 admin Aug 18, 2013 Sep 5, 2014 165229156386:194 admin Aug 18, 2013 Sep 5, 2014 165229156386:194 admin Aug 18, 2013 Sep 5, 2014 165229156386:194 admin Aug 18, 2013 Sep 5, 2014 165229156386:194 admin Aug 18, 2013 Sep 5, 2014 165229156386:194 admin Aug 18, 2013 Sep 5, 2014 165229156386:194 admin Aug 18, 2013 Sep 5, 2014 165229156386:194 admin Aug 18, 2013 Sep 5, 2014 165229156387:194 admin Aug 18, 2013 Sep 5, 2014 183322896387:194 admin Aug 18, 2013 Sep 5, 2014 183322896387:194 admin Aug 18, 2013 Sep 5, 2014 183322896387:194 admin Aug 18, 2013 Sep 5, 2014 183322896388:194 admin Aug 18, 2013 Sep 5, 2014 190565696388:194 admin Aug 18, 2013 Sep 5, 2014 190565696388:194 admin Aug 18, 2013 Sep 5, 2014 190565696388:194 admin Aug 18, 2013 Sep 5, 2014 190565696388:194 admin Aug 18, 2013 Sep 5, 2014 190565696389:194 admin Aug 18, 2013 Sep 5, 2014 173886676389:194 admin Aug 18, 2013 Sep 5, 2014 173886676389:194 admin Aug 18, 2013 Sep 5, 2014 173886676389:194 admin Aug 18, 2013 Sep 5, 2014 173886676389:194 admin Aug 18, 2013 Sep 5, 2014 173886676389:194 admin Aug 18, 2013 Sep 5, 2014 173886676389:194 admin Aug 18, 2013 Sep 5, 2014 17388667
6389:194 admin Aug 18, 2013 Sep 5, 2014 173886676389:194 admin Aug 18, 2013 Sep 5, 2014 173886676389:194 admin Aug 18, 2013 Sep 5, 2014 173886676389:194 admin Aug 18, 2013 Sep 5, 2014 173886676389:194 admin Aug 18, 2013 Sep 5, 2014 173886676389:194 admin Aug 18, 2013 Sep 5, 2014 173886676389:194 admin Aug 18, 2013 Sep 5, 2014 173886676389:194 admin Aug 18, 2013 Sep 5, 2014 173886676389:194 admin Aug 18, 2013 Sep 5, 2014 173886676389:194 admin Aug 18, 2013 Sep 5, 2014 173886676389:194 admin Aug 18, 2013 Sep 5, 2014 173886676389:194 admin Aug 18, 2013 Sep 5, 2014 173886676389:194 admin Aug 18, 2013 Sep 5, 2014 173886676389:194 admin Aug 18, 2013 Sep 5, 2014 173886676389:194 admin Aug 18, 2013 Sep 5, 2014 173886676389:194 admin Aug 18, 2013 Sep 5, 2014 173886676389:194 admin Aug 18, 2013 Sep 5, 2014 173886676389:194 admin Aug 18, 2013 Sep 5, 2014 173886676389:194 admin Aug 18, 2013 Sep 5, 2014 173886676389:194 admin Aug 18, 2013 Sep 5, 2014 173886676389:194 admin Aug 18, 2013 Sep 5, 2014 173886676389:194 admin Aug 18, 2013 Sep 5, 2014 173886676389:194 admin Aug 18, 2013 Sep 5, 2014 173886676389:194 admin Aug 18, 2013 Sep 5, 2014 173886676389:194 admin Aug 18, 2013 Sep 5, 2014 173886676390:194 admin Aug 18, 2013 Sep 5, 2014 85579656390:194 admin Aug 18, 2013 Sep 5, 2014 85579656390:194 admin Aug 18, 2013 Sep 5, 2014 85579656390:194 admin Aug 18, 2013 Sep 5, 2014 85579656390:194 admin Aug 18, 2013 Sep 5, 2014 85579656390:194 admin Aug 18, 2013 Sep 5, 2014 85579656391:194 admin Aug 18, 2013 Sep 5, 2014 158002686391:194 admin Aug 18, 2013 Sep 5, 2014 158002686391:194 admin Aug 18, 2013 Sep 5, 2014 158002686391:194 admin Aug 18, 2013 Sep 5, 2014 158002686391:194 admin Aug 18, 2013 Sep 5, 2014 158002686392:194 admin Aug 18, 2013 Sep 5, 2014 175332086392:194 admin Aug 18, 2013 Sep 5, 2014 175332086392:194 admin Aug 18, 2013 Sep 5, 2014 175332086392:194 admin Aug 18, 2013 Sep 5, 2014 175332086392:194 admin Aug 18, 2013 Sep 5, 2014 175332086392:194 admin Aug 18, 2013 Sep 5, 2014 175332086392:194 admin Aug 18, 2013 Sep 5, 2014 175332086392:194 admin Aug 18, 2013 Sep 5, 2014 175332086392:194 admin Aug 18, 2013 Sep 5, 2014 175332086392:194 admin Aug 18, 2013 Sep 5, 2014 175332086393:194 admin Aug 18, 2013 Sep 5, 2014 164000446393:194 admin Aug 18, 2013 Sep 5, 2014 16400044
6393:194 admin Aug 18, 2013 Sep 5, 2014 164000446393:194 admin Aug 18, 2013 Sep 5, 2014 164000446393:194 admin Aug 18, 2013 Sep 5, 2014 164000446393:194 admin Aug 18, 2013 Sep 5, 2014 164000446394:194 admin Aug 18, 2013 Sep 5, 2014 174739116394:194 admin Aug 18, 2013 Sep 5, 2014 174739116395:194 admin Aug 18, 2013 Sep 5, 2014 172091776395:194 admin Aug 18, 2013 Sep 5, 2014 172091776395:194 admin Aug 18, 2013 Sep 5, 2014 172091776395:194 admin Aug 18, 2013 Sep 5, 2014 172091776397:194 admin Aug 18, 2013 Sep 5, 2014 188246626397:194 admin Aug 18, 2013 Sep 5, 2014 188246626397:194 admin Aug 18, 2013 Sep 5, 2014 188246626398:194 admin Aug 18, 2013 Sep 5, 2014 159554676398:194 admin Aug 18, 2013 Sep 5, 2014 159554676398:194 admin Aug 18, 2013 Sep 5, 2014 159554676398:194 admin Aug 18, 2013 Sep 5, 2014 159554676398:194 admin Aug 18, 2013 Sep 5, 2014 159554676398:194 admin Aug 18, 2013 Sep 5, 2014 159554676398:194 admin Aug 18, 2013 Sep 5, 2014 159554676398:194 admin Aug 18, 2013 Sep 5, 2014 159554676398:194 admin Aug 18, 2013 Sep 5, 2014 159554676398:194 admin Aug 18, 2013 Sep 5, 2014 159554676399:194 admin Aug 18, 2013 Sep 5, 2014 120201026399:194 admin Aug 18, 2013 Sep 5, 2014 120201026399:194 admin Aug 18, 2013 Sep 5, 2014 120201026399:194 admin Aug 18, 2013 Sep 5, 2014 120201026401:194 admin Aug 18, 2013 Sep 5, 2014 36232606402:194 admin Aug 18, 2013 Sep 5, 2014 32436096402:194 admin Aug 18, 2013 Sep 5, 2014 32436096402:194 admin Aug 18, 2013 Sep 5, 2014 32436096404:194 admin Aug 18, 2013 Sep 5, 2014 67930586404:194 admin Aug 18, 2013 Sep 5, 2014 67930586405:194 admin Aug 18, 2013 Sep 5, 2014 127087196405:194 admin Aug 18, 2013 Sep 5, 2014 127087196405:194 admin Aug 18, 2013 Sep 5, 2014 127087196405:194 admin Aug 18, 2013 Sep 5, 2014 127087196405:194 admin Aug 18, 2013 Sep 5, 2014 127087196408:194 admin Aug 18, 2013 Sep 5, 2014 188278116408:194 admin Aug 18, 2013 Sep 5, 2014 188278116408:194 admin Aug 18, 2013 Sep 5, 2014 188278116408:194 admin Aug 18, 2013 Sep 5, 2014 188278116408:194 admin Aug 18, 2013 Sep 5, 2014 188278116408:194 admin Aug 18, 2013 Sep 5, 2014 188278116408:194 admin Aug 18, 2013 Sep 5, 2014 188278116408:194 admin Aug 18, 2013 Sep 5, 2014 188278116408:194 admin Aug 18, 2013 Sep 5, 2014 188278116408:194 admin Aug 18, 2013 Sep 5, 2014 18827811
6409:194 admin Aug 18, 2013 Sep 5, 2014 171064376409:194 admin Aug 18, 2013 Sep 5, 2014 171064376409:194 admin Aug 18, 2013 Sep 5, 2014 171064376409:194 admin Aug 18, 2013 Sep 5, 2014 171064376409:194 admin Aug 18, 2013 Sep 5, 2014 171064376409:194 admin Aug 18, 2013 Sep 5, 2014 171064376409:194 admin Aug 18, 2013 Sep 5, 2014 171064376409:194 admin Aug 18, 2013 Sep 5, 2014 171064376409:194 admin Aug 18, 2013 Sep 5, 2014 171064376411:194 admin Aug 18, 2013 Sep 5, 2014 112624666411:194 admin Aug 18, 2013 Sep 5, 2014 112624666413:194 admin Aug 18, 2013 Sep 5, 2014 191257566413:194 admin Aug 18, 2013 Sep 5, 2014 191257566413:194 admin Aug 18, 2013 Sep 5, 2014 191257566413:194 admin Aug 18, 2013 Sep 5, 2014 191257566413:194 admin Aug 18, 2013 Sep 5, 2014 191257566413:194 admin Aug 18, 2013 Sep 5, 2014 191257566413:194 admin Aug 18, 2013 Sep 5, 2014 191257566413:194 admin Aug 18, 2013 Sep 5, 2014 191257566413:194 admin Aug 18, 2013 Sep 5, 2014 191257566413:194 admin Aug 18, 2013 Sep 5, 2014 191257566414:194 admin Aug 18, 2013 Sep 5, 2014 191582266415:194 admin Aug 18, 2013 Sep 5, 2014 97941756415:194 admin Aug 18, 2013 Sep 5, 2014 97941756416:194 admin Aug 18, 2013 Sep 5, 2014 173796166416:194 admin Aug 18, 2013 Sep 5, 2014 173796166416:194 admin Aug 18, 2013 Sep 5, 2014 173796166416:194 admin Aug 18, 2013 Sep 5, 2014 173796166416:194 admin Aug 18, 2013 Sep 5, 2014 173796166416:194 admin Aug 18, 2013 Sep 5, 2014 173796166416:194 admin Aug 18, 2013 Sep 5, 2014 173796166416:194 admin Aug 18, 2013 Sep 5, 2014 173796166416:194 admin Aug 18, 2013 Sep 5, 2014 173796166416:194 admin Aug 18, 2013 Sep 5, 2014 173796166416:194 admin Aug 18, 2013 Sep 5, 2014 173796166416:194 admin Aug 18, 2013 Sep 5, 2014 173796166416:194 admin Aug 18, 2013 Sep 5, 2014 173796166416:194 admin Aug 18, 2013 Sep 5, 2014 173796166416:194 admin Aug 18, 2013 Sep 5, 2014 173796166418:194 admin Aug 18, 2013 Sep 5, 2014 176222446418:194 admin Aug 18, 2013 Sep 5, 2014 176222446418:194 admin Aug 18, 2013 Sep 5, 2014 176222446418:194 admin Aug 18, 2013 Sep 5, 2014 176222446418:194 admin Aug 18, 2013 Sep 5, 2014 176222446418:194 admin Aug 18, 2013 Sep 5, 2014 176222446418:194 admin Aug 18, 2013 Sep 5, 2014 176222446418:194 admin Aug 18, 2013 Sep 5, 2014 176222446418:194 admin Aug 18, 2013 Sep 5, 2014 17622244
6418:194 admin Aug 18, 2013 Sep 5, 2014 176222446418:194 admin Aug 18, 2013 Sep 5, 2014 176222446418:194 admin Aug 18, 2013 Sep 5, 2014 176222446418:194 admin Aug 18, 2013 Sep 5, 2014 176222446418:194 admin Aug 18, 2013 Sep 5, 2014 176222446418:194 admin Aug 18, 2013 Sep 5, 2014 176222446418:194 admin Aug 18, 2013 Sep 5, 2014 176222446418:194 admin Aug 18, 2013 Sep 5, 2014 176222446418:194 admin Aug 18, 2013 Sep 5, 2014 176222446418:194 admin Aug 18, 2013 Sep 5, 2014 176222446418:194 admin Aug 18, 2013 Sep 5, 2014 176222446418:194 admin Aug 18, 2013 Sep 5, 2014 176222446418:194 admin Aug 18, 2013 Sep 5, 2014 176222446418:194 admin Aug 18, 2013 Sep 5, 2014 176222446418:194 admin Aug 18, 2013 Sep 5, 2014 176222446419:194 admin Aug 18, 2013 Sep 5, 2014 172153806419:194 admin Aug 18, 2013 Sep 5, 2014 172153806419:194 admin Aug 18, 2013 Sep 5, 2014 172153806419:194 admin Aug 18, 2013 Sep 5, 2014 172153806419:194 admin Aug 18, 2013 Sep 5, 2014 172153806419:194 admin Aug 18, 2013 Sep 5, 2014 172153806419:194 admin Aug 18, 2013 Sep 5, 2014 172153806419:194 admin Aug 18, 2013 Sep 5, 2014 172153806419:194 admin Aug 18, 2013 Sep 5, 2014 172153806419:194 admin Aug 18, 2013 Sep 5, 2014 172153806420:194 admin Aug 18, 2013 Sep 5, 2014 180000206420:194 admin Aug 18, 2013 Sep 5, 2014 180000206421:194 admin Aug 18, 2013 Sep 5, 2014 179252836421:194 admin Aug 18, 2013 Sep 5, 2014 179252836421:194 admin Aug 18, 2013 Sep 5, 2014 179252836421:194 admin Aug 18, 2013 Sep 5, 2014 179252836421:194 admin Aug 18, 2013 Sep 5, 2014 179252836421:194 admin Aug 18, 2013 Sep 5, 2014 179252836421:194 admin Aug 18, 2013 Sep 5, 2014 179252836421:194 admin Aug 18, 2013 Sep 5, 2014 179252836421:194 admin Aug 18, 2013 Sep 5, 2014 179252836421:194 admin Aug 18, 2013 Sep 5, 2014 179252836423:194 admin Aug 18, 2013 Sep 5, 2014 112975966423:194 admin Aug 18, 2013 Sep 5, 2014 112975966423:194 admin Aug 18, 2013 Sep 5, 2014 112975966424:194 admin Aug 18, 2013 Sep 5, 2014 105306086424:194 admin Aug 18, 2013 Sep 5, 2014 105306086424:194 admin Aug 18, 2013 Sep 5, 2014 105306086424:194 admin Aug 18, 2013 Sep 5, 2014 105306086425:194 admin Aug 18, 2013 Sep 5, 2014 110457886425:194 admin Aug 18, 2013 Sep 5, 2014 110457886425:194 admin Aug 18, 2013 Sep 5, 2014 110457886425:194 admin Aug 18, 2013 Sep 5, 2014 11045788
6425:194 admin Aug 18, 2013 Sep 5, 2014 110457886425:194 admin Aug 18, 2013 Sep 5, 2014 110457886425:194 admin Aug 18, 2013 Sep 5, 2014 110457886425:194 admin Aug 18, 2013 Sep 5, 2014 110457886425:194 admin Aug 18, 2013 Sep 5, 2014 110457886425:194 admin Aug 18, 2013 Sep 5, 2014 110457886425:194 admin Aug 18, 2013 Sep 5, 2014 110457886425:194 admin Aug 18, 2013 Sep 5, 2014 110457886425:194 admin Aug 18, 2013 Sep 5, 2014 110457886425:194 admin Aug 18, 2013 Sep 5, 2014 110457886425:194 admin Aug 18, 2013 Sep 5, 2014 110457886425:194 admin Aug 18, 2013 Sep 5, 2014 110457886425:194 admin Aug 18, 2013 Sep 5, 2014 110457886425:194 admin Aug 18, 2013 Sep 5, 2014 110457886425:194 admin Aug 18, 2013 Sep 5, 2014 110457886425:194 admin Aug 18, 2013 Sep 5, 2014 110457886425:194 admin Aug 18, 2013 Sep 5, 2014 110457886425:194 admin Aug 18, 2013 Sep 5, 2014 110457886425:194 admin Aug 18, 2013 Sep 5, 2014 110457886425:194 admin Aug 18, 2013 Sep 5, 2014 110457886428:194 admin Aug 18, 2013 Sep 5, 2014 158271036428:194 admin Aug 18, 2013 Sep 5, 2014 158271036428:194 admin Aug 18, 2013 Sep 5, 2014 158271036428:194 admin Aug 18, 2013 Sep 5, 2014 158271036429:194 admin Aug 18, 2013 Sep 5, 2014 128693976429:194 admin Aug 18, 2013 Sep 5, 2014 128693976429:194 admin Aug 18, 2013 Sep 5, 2014 128693976429:194 admin Aug 18, 2013 Sep 5, 2014 128693976429:194 admin Aug 18, 2013 Sep 5, 2014 128693976430:194 admin Aug 18, 2013 Sep 5, 2014 173153196430:194 admin Aug 18, 2013 Sep 5, 2014 173153196430:194 admin Aug 18, 2013 Sep 5, 2014 173153196431:194 admin Aug 18, 2013 Sep 5, 2014 92364166431:194 admin Aug 18, 2013 Sep 5, 2014 92364166431:194 admin Aug 18, 2013 Sep 5, 2014 92364166434:194 admin Aug 18, 2013 Sep 5, 2014 74981006434:194 admin Aug 18, 2013 Sep 5, 2014 74981006434:194 admin Aug 18, 2013 Sep 5, 2014 74981006436:194 admin Aug 18, 2013 Sep 5, 2014 170197166436:194 admin Aug 18, 2013 Sep 5, 2014 170197166436:194 admin Aug 18, 2013 Sep 5, 2014 170197166436:194 admin Aug 18, 2013 Sep 5, 2014 170197166436:194 admin Aug 18, 2013 Sep 5, 2014 170197166437:194 admin Aug 18, 2013 Sep 5, 2014 169850316438:194 admin Aug 18, 2013 Sep 5, 2014 84781446438:194 admin Aug 18, 2013 Sep 5, 2014 84781446438:194 admin Aug 18, 2013 Sep 5, 2014 84781446438:194 admin Aug 18, 2013 Sep 5, 2014 8478144
6438:194 admin Aug 18, 2013 Sep 5, 2014 84781446438:194 admin Aug 18, 2013 Sep 5, 2014 84781446438:194 admin Aug 18, 2013 Sep 5, 2014 84781446438:194 admin Aug 18, 2013 Sep 5, 2014 84781446438:194 admin Aug 18, 2013 Sep 5, 2014 84781446438:194 admin Aug 18, 2013 Sep 5, 2014 84781446438:194 admin Aug 18, 2013 Sep 5, 2014 84781446438:194 admin Aug 18, 2013 Sep 5, 2014 84781446438:194 admin Aug 18, 2013 Sep 5, 2014 84781446438:194 admin Aug 18, 2013 Sep 5, 2014 84781446438:194 admin Aug 18, 2013 Sep 5, 2014 84781446438:194 admin Aug 18, 2013 Sep 5, 2014 84781446438:194 admin Aug 18, 2013 Sep 5, 2014 84781446438:194 admin Aug 18, 2013 Sep 5, 2014 84781446438:194 admin Aug 18, 2013 Sep 5, 2014 84781446438:194 admin Aug 18, 2013 Sep 5, 2014 84781446438:194 admin Aug 18, 2013 Sep 5, 2014 84781446438:194 admin Aug 18, 2013 Sep 5, 2014 84781446438:194 admin Aug 18, 2013 Sep 5, 2014 84781446438:194 admin Aug 18, 2013 Sep 5, 2014 84781446438:194 admin Aug 18, 2013 Sep 5, 2014 84781446438:194 admin Aug 18, 2013 Sep 5, 2014 84781446438:194 admin Aug 18, 2013 Sep 5, 2014 84781446438:194 admin Aug 18, 2013 Sep 5, 2014 84781446438:194 admin Aug 18, 2013 Sep 5, 2014 84781446438:194 admin Aug 18, 2013 Sep 5, 2014 84781446441:194 admin Aug 18, 2013 Sep 5, 2014 192088426441:194 admin Aug 18, 2013 Sep 5, 2014 192088426441:194 admin Aug 18, 2013 Sep 5, 2014 192088426441:194 admin Aug 18, 2013 Sep 5, 2014 192088426441:194 admin Aug 18, 2013 Sep 5, 2014 192088426442:194 admin Aug 18, 2013 Sep 5, 2014 170470876442:194 admin Aug 18, 2013 Sep 5, 2014 170470876442:194 admin Aug 18, 2013 Sep 5, 2014 170470876442:194 admin Aug 18, 2013 Sep 5, 2014 170470876442:194 admin Aug 18, 2013 Sep 5, 2014 170470876443:194 admin Aug 18, 2013 Sep 5, 2014 92424786443:194 admin Aug 18, 2013 Sep 5, 2014 92424786443:194 admin Aug 18, 2013 Sep 5, 2014 92424786443:194 admin Aug 18, 2013 Sep 5, 2014 92424786443:194 admin Aug 18, 2013 Sep 5, 2014 92424786443:194 admin Aug 18, 2013 Sep 5, 2014 92424786443:194 admin Aug 18, 2013 Sep 5, 2014 92424786443:194 admin Aug 18, 2013 Sep 5, 2014 92424786443:194 admin Aug 18, 2013 Sep 5, 2014 92424786443:194 admin Aug 18, 2013 Sep 5, 2014 92424786443:194 admin Aug 18, 2013 Sep 5, 2014 92424786443:194 admin Aug 18, 2013 Sep 5, 2014 9242478
6443:194 admin Aug 18, 2013 Sep 5, 2014 92424786443:194 admin Aug 18, 2013 Sep 5, 2014 92424786443:194 admin Aug 18, 2013 Sep 5, 2014 92424786443:194 admin Aug 18, 2013 Sep 5, 2014 92424786443:194 admin Aug 18, 2013 Sep 5, 2014 92424786443:194 admin Aug 18, 2013 Sep 5, 2014 92424786443:194 admin Aug 18, 2013 Sep 5, 2014 92424786443:194 admin Aug 18, 2013 Sep 5, 2014 92424786443:194 admin Aug 18, 2013 Sep 5, 2014 92424786443:194 admin Aug 18, 2013 Sep 5, 2014 92424786445:194 admin Aug 18, 2013 Sep 5, 2014 33073076446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406446:194 admin Aug 18, 2013 Sep 5, 2014 126099406451:194 admin Aug 18, 2013 Sep 5, 2014 186358556451:194 admin Aug 18, 2013 Sep 5, 2014 186358556451:194 admin Aug 18, 2013 Sep 5, 2014 186358556451:194 admin Aug 18, 2013 Sep 5, 2014 186358556451:194 admin Aug 18, 2013 Sep 5, 2014 186358556451:194 admin Aug 18, 2013 Sep 5, 2014 186358556451:194 admin Aug 18, 2013 Sep 5, 2014 186358556451:194 admin Aug 18, 2013 Sep 5, 2014 186358556452:194 admin Aug 18, 2013 Sep 5, 2014 37888356452:194 admin Aug 18, 2013 Sep 5, 2014 37888356455:194 admin Aug 18, 2013 Sep 5, 2014 169601776456:194 admin Aug 18, 2013 Sep 5, 2014 164816366456:194 admin Aug 18, 2013 Sep 5, 2014 164816366456:194 admin Aug 18, 2013 Sep 5, 2014 164816366456:194 admin Aug 18, 2013 Sep 5, 2014 164816366456:194 admin Aug 18, 2013 Sep 5, 2014 164816366456:194 admin Aug 18, 2013 Sep 5, 2014 164816366456:194 admin Aug 18, 2013 Sep 5, 2014 164816366456:194 admin Aug 18, 2013 Sep 5, 2014 164816366456:194 admin Aug 18, 2013 Sep 5, 2014 164816366457:194 admin Aug 18, 2013 Sep 5, 2014 176615656457:194 admin Aug 18, 2013 Sep 5, 2014 17661565
6457:194 admin Aug 18, 2013 Sep 5, 2014 176615656457:194 admin Aug 18, 2013 Sep 5, 2014 176615656457:194 admin Aug 18, 2013 Sep 5, 2014 176615656457:194 admin Aug 18, 2013 Sep 5, 2014 176615656457:194 admin Aug 18, 2013 Sep 5, 2014 176615656457:194 admin Aug 18, 2013 Sep 5, 2014 176615656457:194 admin Aug 18, 2013 Sep 5, 2014 176615656457:194 admin Aug 18, 2013 Sep 5, 2014 176615656457:194 admin Aug 18, 2013 Sep 5, 2014 176615656457:194 admin Aug 18, 2013 Sep 5, 2014 176615656457:194 admin Aug 18, 2013 Sep 5, 2014 176615656457:194 admin Aug 18, 2013 Sep 5, 2014 176615656457:194 admin Aug 18, 2013 Sep 5, 2014 176615656459:194 admin Aug 18, 2013 Sep 5, 2014 181803956459:194 admin Aug 18, 2013 Sep 5, 2014 181803956459:194 admin Aug 18, 2013 Sep 5, 2014 181803956459:194 admin Aug 18, 2013 Sep 5, 2014 181803956460:194 admin Aug 18, 2013 Sep 5, 2014 86750936460:194 admin Aug 18, 2013 Sep 5, 2014 86750936460:194 admin Aug 18, 2013 Sep 5, 2014 86750936460:194 admin Aug 18, 2013 Sep 5, 2014 86750936460:194 admin Aug 18, 2013 Sep 5, 2014 86750936460:194 admin Aug 18, 2013 Sep 5, 2014 86750936460:194 admin Aug 18, 2013 Sep 5, 2014 86750936461:194 admin Aug 18, 2013 Sep 5, 2014 189889096461:194 admin Aug 18, 2013 Sep 5, 2014 189889096461:194 admin Aug 18, 2013 Sep 5, 2014 189889096462:194 admin Aug 18, 2013 Sep 5, 2014 90225616462:194 admin Aug 18, 2013 Sep 5, 2014 90225616464:194 admin Aug 18, 2013 Sep 5, 2014 119043166464:194 admin Aug 18, 2013 Sep 5, 2014 119043166464:194 admin Aug 18, 2013 Sep 5, 2014 119043166465:194 admin Aug 18, 2013 Sep 5, 2014 176238016465:194 admin Aug 18, 2013 Sep 5, 2014 176238016465:194 admin Aug 18, 2013 Sep 5, 2014 176238016465:194 admin Aug 18, 2013 Sep 5, 2014 176238016465:194 admin Aug 18, 2013 Sep 5, 2014 176238016465:194 admin Aug 18, 2013 Sep 5, 2014 176238016465:194 admin Aug 18, 2013 Sep 5, 2014 176238016465:194 admin Aug 18, 2013 Sep 5, 2014 176238016465:194 admin Aug 18, 2013 Sep 5, 2014 176238016465:194 admin Aug 18, 2013 Sep 5, 2014 176238016465:194 admin Aug 18, 2013 Sep 5, 2014 176238016465:194 admin Aug 18, 2013 Sep 5, 2014 176238016465:194 admin Aug 18, 2013 Sep 5, 2014 176238016465:194 admin Aug 18, 2013 Sep 5, 2014 176238016465:194 admin Aug 18, 2013 Sep 5, 2014 176238016465:194 admin Aug 18, 2013 Sep 5, 2014 17623801
6465:194 admin Aug 18, 2013 Sep 5, 2014 176238016465:194 admin Aug 18, 2013 Sep 5, 2014 176238016465:194 admin Aug 18, 2013 Sep 5, 2014 176238016465:194 admin Aug 18, 2013 Sep 5, 2014 176238016465:194 admin Aug 18, 2013 Sep 5, 2014 176238016465:194 admin Aug 18, 2013 Sep 5, 2014 176238016465:194 admin Aug 18, 2013 Sep 5, 2014 176238016465:194 admin Aug 18, 2013 Sep 5, 2014 176238016465:194 admin Aug 18, 2013 Sep 5, 2014 176238016465:194 admin Aug 18, 2013 Sep 5, 2014 176238016465:194 admin Aug 18, 2013 Sep 5, 2014 176238016465:194 admin Aug 18, 2013 Sep 5, 2014 176238016465:194 admin Aug 18, 2013 Sep 5, 2014 176238016466:194 admin Aug 18, 2013 Sep 5, 2014 77958376466:194 admin Aug 18, 2013 Sep 5, 2014 77958376467:194 admin Aug 18, 2013 Sep 5, 2014 95214376467:194 admin Aug 18, 2013 Sep 5, 2014 95214376468:194 admin Aug 18, 2013 Sep 5, 2014 180897016468:194 admin Aug 18, 2013 Sep 5, 2014 180897016468:194 admin Aug 18, 2013 Sep 5, 2014 180897016469:194 admin Aug 18, 2013 Sep 5, 2014 184102256469:194 admin Aug 18, 2013 Sep 5, 2014 18410225
Alt ID(s) Title Year Author20082008200820082008200820082008200820082008200820082008200820082000200020002000200020002000200020032003200320032003200320032003200320032003200319952005200520052005200820082008200820082008
Serum vitamin D concentration and
Ahn J., Peters U., Albanes D., Purdue MP., Abnet CC., Serum vitamin D
concentration and Ahn J., Peters U., Albanes D., Purdue MP., Abnet CC., Serum vitamin D
concentration and Ahn J., Peters U., Albanes D., Purdue MP., Abnet CC., Serum vitamin D
concentration and Ahn J., Peters U., Albanes D., Purdue MP., Abnet CC., Serum vitamin D
concentration and Ahn J., Peters U., Albanes D., Purdue MP., Abnet CC., Serum vitamin D
concentration and Ahn J., Peters U., Albanes D., Purdue MP., Abnet CC., Serum vitamin D
concentration and Ahn J., Peters U., Albanes D., Purdue MP., Abnet CC., Serum vitamin D
concentration and Ahn J., Peters U., Albanes D., Purdue MP., Abnet CC., Serum vitamin D
concentration and Ahn J., Peters U., Albanes D., Purdue MP., Abnet CC., Serum vitamin D
concentration and Ahn J., Peters U., Albanes D., Purdue MP., Abnet CC., Serum vitamin D
concentration and Ahn J., Peters U., Albanes D., Purdue MP., Abnet CC., Serum vitamin D
concentration and Ahn J., Peters U., Albanes D., Purdue MP., Abnet CC., Serum vitamin D
concentration and Ahn J., Peters U., Albanes D., Purdue MP., Abnet CC., Serum vitamin D
concentration and Ahn J., Peters U., Albanes D., Purdue MP., Abnet CC., Serum vitamin D
concentration and Ahn J., Peters U., Albanes D., Purdue MP., Abnet CC., Serum vitamin D
concentration and Ahn J., Peters U., Albanes D., Purdue MP., Abnet CC., Prostate cancer risk and
prediagnostic serum 25-Ahonen MH., Tenkanen L., Teppo L., Hakama M., Prostate cancer risk and
prediagnostic serum 25-Ahonen MH., Tenkanen L., Teppo L., Hakama M., Prostate cancer risk and
prediagnostic serum 25-Ahonen MH., Tenkanen L., Teppo L., Hakama M., Prostate cancer risk and
prediagnostic serum 25-Ahonen MH., Tenkanen L., Teppo L., Hakama M., Prostate cancer risk and
prediagnostic serum 25-Ahonen MH., Tenkanen L., Teppo L., Hakama M., Prostate cancer risk and
prediagnostic serum 25-Ahonen MH., Tenkanen L., Teppo L., Hakama M., Prostate cancer risk and
prediagnostic serum 25-Ahonen MH., Tenkanen L., Teppo L., Hakama M., Prostate cancer risk and
prediagnostic serum 25-Ahonen MH., Tenkanen L., Teppo L., Hakama M., A prospective study of
calcium intake from diet Al-Delaimy WK., Rimm E., Willett WC., Stampfer MJ., A prospective study of
calcium intake from diet Al-Delaimy WK., Rimm E., Willett WC., Stampfer MJ., A prospective study of
calcium intake from diet Al-Delaimy WK., Rimm E., Willett WC., Stampfer MJ., A prospective study of
calcium intake from diet Al-Delaimy WK., Rimm E., Willett WC., Stampfer MJ., A prospective study of
calcium intake from diet Al-Delaimy WK., Rimm E., Willett WC., Stampfer MJ., A prospective study of
calcium intake from diet Al-Delaimy WK., Rimm E., Willett WC., Stampfer MJ., A prospective study of
calcium intake from diet Al-Delaimy WK., Rimm E., Willett WC., Stampfer MJ., A prospective study of
calcium intake from diet Al-Delaimy WK., Rimm E., Willett WC., Stampfer MJ., A prospective study of
calcium intake from diet Al-Delaimy WK., Rimm E., Willett WC., Stampfer MJ., A prospective study of
calcium intake from diet Al-Delaimy WK., Rimm E., Willett WC., Stampfer MJ., A prospective study of
calcium intake from diet Al-Delaimy WK., Rimm E., Willett WC., Stampfer MJ., A prospective study of
calcium intake from diet Al-Delaimy WK., Rimm E., Willett WC., Stampfer MJ., The influence of
menopause and hormonal Aloia JF., Vaswani A., Russo L., Sheehan M., Low-fat dairy consumption
and reduced risk of Alonso A., Beunza JJ., Delgado-Rodríguez M., Low-fat dairy consumption
and reduced risk of Alonso A., Beunza JJ., Delgado-Rodríguez M., Low-fat dairy consumption
and reduced risk of Alonso A., Beunza JJ., Delgado-Rodríguez M., Low-fat dairy consumption
and reduced risk of Alonso A., Beunza JJ., Delgado-Rodríguez M., Effect of vitamin D
supplementation on bone Andersen R., Mølgaard C., Skovgaard LT., Brot C., Effect of vitamin D
supplementation on bone Andersen R., Mølgaard C., Skovgaard LT., Brot C., Effect of vitamin D
supplementation on bone Andersen R., Mølgaard C., Skovgaard LT., Brot C., Effect of vitamin D
supplementation on bone Andersen R., Mølgaard C., Skovgaard LT., Brot C., Effect of vitamin D
supplementation on bone Andersen R., Mølgaard C., Skovgaard LT., Brot C., Effect of vitamin D
supplementation on bone Andersen R., Mølgaard C., Skovgaard LT., Brot C.,
200820082008200820082008200820082008200819921992199219921992199219921992199619961996199619981998199819982005200520052005200520052005200520052005200520052005200520082008200820072008200820082008
Effect of vitamin D supplementation on bone
Andersen R., Mølgaard C., Skovgaard LT., Brot C., Effect of vitamin D
supplementation on bone Andersen R., Mølgaard C., Skovgaard LT., Brot C., Effect of vitamin D
supplementation on bone Andersen R., Mølgaard C., Skovgaard LT., Brot C., Effect of vitamin D
supplementation on bone Andersen R., Mølgaard C., Skovgaard LT., Brot C., Effect of vitamin D
supplementation on bone Andersen R., Mølgaard C., Skovgaard LT., Brot C., Effect of vitamin D
supplementation on bone Andersen R., Mølgaard C., Skovgaard LT., Brot C., Effect of vitamin D
supplementation on bone Andersen R., Mølgaard C., Skovgaard LT., Brot C., Effect of vitamin D
supplementation on bone Andersen R., Mølgaard C., Skovgaard LT., Brot C., Effect of vitamin D
supplementation on bone Andersen R., Mølgaard C., Skovgaard LT., Brot C., Effect of vitamin D
supplementation on bone Andersen R., Mølgaard C., Skovgaard LT., Brot C., A prospective study of
nutritional factors and Ascherio A., Rimm EB., Giovannucci EL., Colditz A prospective study of
nutritional factors and Ascherio A., Rimm EB., Giovannucci EL., Colditz A prospective study of
nutritional factors and Ascherio A., Rimm EB., Giovannucci EL., Colditz A prospective study of
nutritional factors and Ascherio A., Rimm EB., Giovannucci EL., Colditz A prospective study of
nutritional factors and Ascherio A., Rimm EB., Giovannucci EL., Colditz A prospective study of
nutritional factors and Ascherio A., Rimm EB., Giovannucci EL., Colditz A prospective study of
nutritional factors and Ascherio A., Rimm EB., Giovannucci EL., Colditz A prospective study of
nutritional factors and Ascherio A., Rimm EB., Giovannucci EL., Colditz Prospective study of
nutritional factors, blood Ascherio A., Hennekens C., Willett WC., Sacks F., Prospective study of
nutritional factors, blood Ascherio A., Hennekens C., Willett WC., Sacks F., Prospective study of
nutritional factors, blood Ascherio A., Hennekens C., Willett WC., Sacks F., Prospective study of
nutritional factors, blood Ascherio A., Hennekens C., Willett WC., Sacks F., Intake of potassium,
magnesium, calcium, and Ascherio A., Rimm EB., Hernán MA., Giovannucci Intake of potassium,
magnesium, calcium, and Ascherio A., Rimm EB., Hernán MA., Giovannucci Intake of potassium,
magnesium, calcium, and Ascherio A., Rimm EB., Hernán MA., Giovannucci Intake of potassium,
magnesium, calcium, and Ascherio A., Rimm EB., Hernán MA., Giovannucci Risk of prostate cancer in
a randomized clinical trial Baron JA., Beach M., Wallace K., Grau MV., Risk of prostate cancer in
a randomized clinical trial Baron JA., Beach M., Wallace K., Grau MV., Risk of prostate cancer in
a randomized clinical trial Baron JA., Beach M., Wallace K., Grau MV., Risk of prostate cancer in
a randomized clinical trial Baron JA., Beach M., Wallace K., Grau MV., Risk of prostate cancer in
a randomized clinical trial Baron JA., Beach M., Wallace K., Grau MV., Risk of prostate cancer in
a randomized clinical trial Baron JA., Beach M., Wallace K., Grau MV., Plasma 25-hydroxyvitamin
D and 1,25-Bertone-Johnson ER., Chen WY., Holick MF., Hollis BW., Plasma 25-hydroxyvitamin
D and 1,25-Bertone-Johnson ER., Chen WY., Holick MF., Hollis BW., Plasma 25-hydroxyvitamin
D and 1,25-Bertone-Johnson ER., Chen WY., Holick MF., Hollis BW., Plasma 25-hydroxyvitamin
D and 1,25-Bertone-Johnson ER., Chen WY., Holick MF., Hollis BW., Plasma 25-hydroxyvitamin
D and 1,25-Bertone-Johnson ER., Chen WY., Holick MF., Hollis BW., Plasma 25-hydroxyvitamin
D and 1,25-Bertone-Johnson ER., Chen WY., Holick MF., Hollis BW., Plasma 25-hydroxyvitamin
D and 1,25-Bertone-Johnson ER., Chen WY., Holick MF., Hollis BW., Plasma 25-hydroxyvitamin
D and 1,25-Bertone-Johnson ER., Chen WY., Holick MF., Hollis BW., Vitamin D
supplementation has Björkman M., Sorva A., Risteli J., Tilvis R.Vitamin D
supplementation has Björkman M., Sorva A., Risteli J., Tilvis R.Body size and serum 25
hydroxy vitamin D Blum M., Dallal GE., Dawson-Hughes B.Maternal vitamin D
deficiency increases the Bodnar LM., Catov JM., Simhan HN., Holick MF., Vascular events in healthy
older women receiving Bolland MJ., Barber PA., Doughty RN., Mason B., Vascular events in healthy
older women receiving Bolland MJ., Barber PA., Doughty RN., Mason B., Vascular events in healthy
older women receiving Bolland MJ., Barber PA., Doughty RN., Mason B., Vascular events in healthy
older women receiving Bolland MJ., Barber PA., Doughty RN., Mason B.,
200720072008199319931993199319931993199319931999199919991995199519951995199520082008200820082008200820062006200620062006200620062006200620062007200720012001200120012008200820082008200820082008
Two-year randomized controlled trial of vitamin
Bolton-Smith C., McMurdo ME., Paterson CR., Mole Two-year randomized
controlled trial of vitamin Bolton-Smith C., McMurdo ME., Paterson CR., Mole Dairy calcium
supplementation in Bortolotti M., Rudelle S., Schneiter P., Vidal H., Relation of calcium,
vitamin D, and dairy food Bostick RM., Potter JD., Sellers TA., McKenzie DR., Relation of calcium,
vitamin D, and dairy food Bostick RM., Potter JD., Sellers TA., McKenzie DR., Relation of calcium,
vitamin D, and dairy food Bostick RM., Potter JD., Sellers TA., McKenzie DR., Relation of calcium,
vitamin D, and dairy food Bostick RM., Potter JD., Sellers TA., McKenzie DR., Relation of calcium,
vitamin D, and dairy food Bostick RM., Potter JD., Sellers TA., McKenzie DR., Relation of calcium,
vitamin D, and dairy food Bostick RM., Potter JD., Sellers TA., McKenzie DR., Relation of calcium,
vitamin D, and dairy food Bostick RM., Potter JD., Sellers TA., McKenzie DR., Relation of calcium,
vitamin D, and dairy food Bostick RM., Potter JD., Sellers TA., McKenzie DR., Relation of calcium,
vitamin D, and dairy food Bostick RM., Kushi LH., Wu Y., Meyer KA., Sellers TA., Relation of calcium,
vitamin D, and dairy food Bostick RM., Kushi LH., Wu Y., Meyer KA., Sellers TA., Relation of calcium,
vitamin D, and dairy food Bostick RM., Kushi LH., Wu Y., Meyer KA., Sellers TA., Prostate cancer and
prediagnostic levels of Braun MM., Helzlsouer KJ., Hollis BW., Comstock GW.Prostate cancer and
prediagnostic levels of Braun MM., Helzlsouer KJ., Hollis BW., Comstock GW.Prostate cancer and
prediagnostic levels of Braun MM., Helzlsouer KJ., Hollis BW., Comstock GW.Prostate cancer and
prediagnostic levels of Braun MM., Helzlsouer KJ., Hollis BW., Comstock GW.Prostate cancer and
prediagnostic levels of Braun MM., Helzlsouer KJ., Hollis BW., Comstock GW.Calcium, vitamin D
supplementation, and Brunner RL., Cochrane B., Jackson RD., Larson J., Calcium, vitamin D
supplementation, and Brunner RL., Cochrane B., Jackson RD., Larson J., Calcium, vitamin D
supplementation, and Brunner RL., Cochrane B., Jackson RD., Larson J., Calcium, vitamin D
supplementation, and Brunner RL., Cochrane B., Jackson RD., Larson J., Calcium, vitamin D
supplementation, and Brunner RL., Cochrane B., Jackson RD., Larson J., Calcium, vitamin D
supplementation, and Brunner RL., Cochrane B., Jackson RD., Larson J., Effects of vitamin D
supplementation and Bunout D., Barrera G., Leiva L., Gattas V., de la Effects of vitamin D
supplementation and Bunout D., Barrera G., Leiva L., Gattas V., de la Effects of vitamin D
supplementation and Bunout D., Barrera G., Leiva L., Gattas V., de la Effects of vitamin D
supplementation and Bunout D., Barrera G., Leiva L., Gattas V., de la Effects of vitamin D
supplementation and Bunout D., Barrera G., Leiva L., Gattas V., de la Effects of vitamin D
supplementation and Bunout D., Barrera G., Leiva L., Gattas V., de la Effects of vitamin D
supplementation and Bunout D., Barrera G., Leiva L., Gattas V., de la Effects of vitamin D
supplementation and Bunout D., Barrera G., Leiva L., Gattas V., de la Effects of vitamin D
supplementation and Bunout D., Barrera G., Leiva L., Gattas V., de la Effects of vitamin D
supplementation and Bunout D., Barrera G., Leiva L., Gattas V., de la Does vitamin D stop
inpatients falling? A Burleigh E., McColl J., Potter J.Does vitamin D stop
inpatients falling? A Burleigh E., McColl J., Potter J.Dairy products, calcium,
and prostate cancer risk in Chan JM., Stampfer MJ., Ma J., Gann PH., Gaziano JM., Dairy products, calcium,
and prostate cancer risk in Chan JM., Stampfer MJ., Ma J., Gann PH., Gaziano JM., Dairy products, calcium,
and prostate cancer risk in Chan JM., Stampfer MJ., Ma J., Gann PH., Gaziano JM., Dairy products, calcium,
and prostate cancer risk in Chan JM., Stampfer MJ., Ma J., Gann PH., Gaziano JM., Calcium plus vitamin D
supplementation and the Chlebowski RT., Johnson KC., Kooperberg C., Calcium plus vitamin D
supplementation and the Chlebowski RT., Johnson KC., Kooperberg C., Calcium plus vitamin D
supplementation and the Chlebowski RT., Johnson KC., Kooperberg C., Calcium plus vitamin D
supplementation and the Chlebowski RT., Johnson KC., Kooperberg C., Calcium plus vitamin D
supplementation and the Chlebowski RT., Johnson KC., Kooperberg C., Calcium plus vitamin D
supplementation and the Chlebowski RT., Johnson KC., Kooperberg C., Calcium plus vitamin D
supplementation and the Chlebowski RT., Johnson KC., Kooperberg C.,
200420042004-- Not Found ---- Not Found --1996199619961996199619961996199619961996199619961996199619961996199619961996199619961996199619962006200620062006200620062006200620062006200620062006200620062006200620062006
Weight loss and calcium intake influence calcium
Cifuentes M., Riedt CS., Brolin RE., Field MP., Weight loss and calcium
intake influence calcium Cifuentes M., Riedt CS., Brolin RE., Field MP., Weight loss and calcium
intake influence calcium Cifuentes M., Riedt CS., Brolin RE., Field MP., Calcium chemoprevention
in colorectal cancer.Duris I., Hruby D., Pekarkova B., Huorka M., Calcium chemoprevention
in colorectal cancer.Duris I., Hruby D., Pekarkova B., Huorka M., Dietary calcium, alcohol,
and incidence of treated Dwyer JH., Li L., Dwyer KM., Curtin LR., Feinleib M.Dietary calcium, alcohol,
and incidence of treated Dwyer JH., Li L., Dwyer KM., Curtin LR., Feinleib M.Dietary calcium, alcohol,
and incidence of treated Dwyer JH., Li L., Dwyer KM., Curtin LR., Feinleib M.Dietary calcium, alcohol,
and incidence of treated Dwyer JH., Li L., Dwyer KM., Curtin LR., Feinleib M.Dietary calcium, alcohol,
and incidence of treated Dwyer JH., Li L., Dwyer KM., Curtin LR., Feinleib M.Dietary calcium, alcohol,
and incidence of treated Dwyer JH., Li L., Dwyer KM., Curtin LR., Feinleib M.Dietary calcium, alcohol,
and incidence of treated Dwyer JH., Li L., Dwyer KM., Curtin LR., Feinleib M.Dietary calcium, alcohol,
and incidence of treated Dwyer JH., Li L., Dwyer KM., Curtin LR., Feinleib M.Dietary calcium, alcohol,
and incidence of treated Dwyer JH., Li L., Dwyer KM., Curtin LR., Feinleib M.Dietary calcium, alcohol,
and incidence of treated Dwyer JH., Li L., Dwyer KM., Curtin LR., Feinleib M.Dietary calcium, alcohol,
and incidence of treated Dwyer JH., Li L., Dwyer KM., Curtin LR., Feinleib M.Dietary calcium, alcohol,
and incidence of treated Dwyer JH., Li L., Dwyer KM., Curtin LR., Feinleib M.Dietary calcium, alcohol,
and incidence of treated Dwyer JH., Li L., Dwyer KM., Curtin LR., Feinleib M.Dietary calcium, alcohol,
and incidence of treated Dwyer JH., Li L., Dwyer KM., Curtin LR., Feinleib M.Dietary calcium, alcohol,
and incidence of treated Dwyer JH., Li L., Dwyer KM., Curtin LR., Feinleib M.Dietary calcium, alcohol,
and incidence of treated Dwyer JH., Li L., Dwyer KM., Curtin LR., Feinleib M.Dietary calcium, alcohol,
and incidence of treated Dwyer JH., Li L., Dwyer KM., Curtin LR., Feinleib M.Dietary calcium, alcohol,
and incidence of treated Dwyer JH., Li L., Dwyer KM., Curtin LR., Feinleib M.Dietary calcium, alcohol,
and incidence of treated Dwyer JH., Li L., Dwyer KM., Curtin LR., Feinleib M.Dietary calcium, alcohol,
and incidence of treated Dwyer JH., Li L., Dwyer KM., Curtin LR., Feinleib M.Dietary calcium, alcohol,
and incidence of treated Dwyer JH., Li L., Dwyer KM., Curtin LR., Feinleib M.Dietary calcium, alcohol,
and incidence of treated Dwyer JH., Li L., Dwyer KM., Curtin LR., Feinleib M.Dietary calcium, alcohol,
and incidence of treated Dwyer JH., Li L., Dwyer KM., Curtin LR., Feinleib M.Dietary calcium, alcohol,
and incidence of treated Dwyer JH., Li L., Dwyer KM., Curtin LR., Feinleib M.Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J., Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J., Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J., Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J., Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J., Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J., Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J., Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J., Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J., Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J., Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J., Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J., Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J., Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J., Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J., Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J., Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J., Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J., Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J.,
200620062006200620062006200620062006200620062006200420042004200420042004200420042004200420042004200520052005200520052005200520052005200520052005200520052005200520052005200520052005200520052005
Effect of vitamin D replacement on
El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J., Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J., Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J., Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J., Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J., Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J., Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J., Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J., Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J., Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J., Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J., Effect of vitamin D
replacement on El-Hajj Fuleihan G., Nabulsi M., Tamim H., Maalouf J., Plasma vitamin D
metabolites and risk of Feskanich D., Ma J., Fuchs CS., Kirkner GJ., Hankinson Plasma vitamin D
metabolites and risk of Feskanich D., Ma J., Fuchs CS., Kirkner GJ., Hankinson Plasma vitamin D
metabolites and risk of Feskanich D., Ma J., Fuchs CS., Kirkner GJ., Hankinson Plasma vitamin D
metabolites and risk of Feskanich D., Ma J., Fuchs CS., Kirkner GJ., Hankinson Plasma vitamin D
metabolites and risk of Feskanich D., Ma J., Fuchs CS., Kirkner GJ., Hankinson Plasma vitamin D
metabolites and risk of Feskanich D., Ma J., Fuchs CS., Kirkner GJ., Hankinson Plasma vitamin D
metabolites and risk of Feskanich D., Ma J., Fuchs CS., Kirkner GJ., Hankinson Plasma vitamin D
metabolites and risk of Feskanich D., Ma J., Fuchs CS., Kirkner GJ., Hankinson Plasma vitamin D
metabolites and risk of Feskanich D., Ma J., Fuchs CS., Kirkner GJ., Hankinson Plasma vitamin D
metabolites and risk of Feskanich D., Ma J., Fuchs CS., Kirkner GJ., Hankinson Plasma vitamin D
metabolites and risk of Feskanich D., Ma J., Fuchs CS., Kirkner GJ., Hankinson Plasma vitamin D
metabolites and risk of Feskanich D., Ma J., Fuchs CS., Kirkner GJ., Hankinson Calcium from diet and
supplements is associated Flood A., Peters U., Chatterjee N., Lacey JV., Calcium from diet and
supplements is associated Flood A., Peters U., Chatterjee N., Lacey JV., Calcium from diet and
supplements is associated Flood A., Peters U., Chatterjee N., Lacey JV., Calcium from diet and
supplements is associated Flood A., Peters U., Chatterjee N., Lacey JV., Calcium from diet and
supplements is associated Flood A., Peters U., Chatterjee N., Lacey JV., Calcium from diet and
supplements is associated Flood A., Peters U., Chatterjee N., Lacey JV., Calcium from diet and
supplements is associated Flood A., Peters U., Chatterjee N., Lacey JV., Calcium from diet and
supplements is associated Flood A., Peters U., Chatterjee N., Lacey JV., Calcium from diet and
supplements is associated Flood A., Peters U., Chatterjee N., Lacey JV., Calcium from diet and
supplements is associated Flood A., Peters U., Chatterjee N., Lacey JV., Calcium from diet and
supplements is associated Flood A., Peters U., Chatterjee N., Lacey JV., Calcium from diet and
supplements is associated Flood A., Peters U., Chatterjee N., Lacey JV., Calcium from diet and
supplements is associated Flood A., Peters U., Chatterjee N., Lacey JV., Calcium from diet and
supplements is associated Flood A., Peters U., Chatterjee N., Lacey JV., Calcium from diet and
supplements is associated Flood A., Peters U., Chatterjee N., Lacey JV., Calcium from diet and
supplements is associated Flood A., Peters U., Chatterjee N., Lacey JV., Calcium from diet and
supplements is associated Flood A., Peters U., Chatterjee N., Lacey JV., Calcium from diet and
supplements is associated Flood A., Peters U., Chatterjee N., Lacey JV., Calcium from diet and
supplements is associated Flood A., Peters U., Chatterjee N., Lacey JV., Calcium from diet and
supplements is associated Flood A., Peters U., Chatterjee N., Lacey JV., Calcium from diet and
supplements is associated Flood A., Peters U., Chatterjee N., Lacey JV., Calcium from diet and
supplements is associated Flood A., Peters U., Chatterjee N., Lacey JV., Calcium from diet and
supplements is associated Flood A., Peters U., Chatterjee N., Lacey JV., Calcium from diet and
supplements is associated Flood A., Peters U., Chatterjee N., Lacey JV.,
200520082008200820082008200820082007200720072007200720072007200720072007200720072007200720072007200820082008200820082008200820082008200820082008200820081996199619961996199619961996199619851985
Calcium from diet and supplements is associated
Flood A., Peters U., Chatterjee N., Lacey JV., Plasma 25-hydroxyvitamin
D levels and risk of Forman JP., Curhan GC., Taylor EN.Plasma 25-hydroxyvitamin
D levels and risk of Forman JP., Curhan GC., Taylor EN.Plasma 25-hydroxyvitamin
D levels and risk of Forman JP., Curhan GC., Taylor EN.Plasma 25-hydroxyvitamin
D levels and risk of Forman JP., Curhan GC., Taylor EN.Plasma 25-hydroxyvitamin
D levels and risk of Forman JP., Curhan GC., Taylor EN.Plasma 25-hydroxyvitamin
D levels and risk of Forman JP., Curhan GC., Taylor EN.Plasma 25-hydroxyvitamin
D levels and risk of Forman JP., Curhan GC., Taylor EN.Prospective study of
serum vitamin D and Freedman DM., Looker AC., Chang SC., Graubard Prospective study of
serum vitamin D and Freedman DM., Looker AC., Chang SC., Graubard Prospective study of
serum vitamin D and Freedman DM., Looker AC., Chang SC., Graubard Prospective study of
serum vitamin D and Freedman DM., Looker AC., Chang SC., Graubard Prospective study of
serum vitamin D and Freedman DM., Looker AC., Chang SC., Graubard Prospective study of
serum vitamin D and Freedman DM., Looker AC., Chang SC., Graubard Prospective study of
serum vitamin D and Freedman DM., Looker AC., Chang SC., Graubard Prospective study of
serum vitamin D and Freedman DM., Looker AC., Chang SC., Graubard Prospective study of
serum vitamin D and Freedman DM., Looker AC., Chang SC., Graubard Prospective study of
serum vitamin D and Freedman DM., Looker AC., Chang SC., Graubard Prospective study of
serum vitamin D and Freedman DM., Looker AC., Chang SC., Graubard Prospective study of
serum vitamin D and Freedman DM., Looker AC., Chang SC., Graubard Prospective study of
serum vitamin D and Freedman DM., Looker AC., Chang SC., Graubard Prospective study of
serum vitamin D and Freedman DM., Looker AC., Chang SC., Graubard Prospective study of
serum vitamin D and Freedman DM., Looker AC., Chang SC., Graubard Prospective study of
serum vitamin D and Freedman DM., Looker AC., Chang SC., Graubard Serum levels of vitamin D
metabolites and breast Freedman DM., Chang SC., Falk RT., Purdue MP., Serum levels of vitamin D
metabolites and breast Freedman DM., Chang SC., Falk RT., Purdue MP., Serum levels of vitamin D
metabolites and breast Freedman DM., Chang SC., Falk RT., Purdue MP., Serum levels of vitamin D
metabolites and breast Freedman DM., Chang SC., Falk RT., Purdue MP., Serum levels of vitamin D
metabolites and breast Freedman DM., Chang SC., Falk RT., Purdue MP., Serum levels of vitamin D
metabolites and breast Freedman DM., Chang SC., Falk RT., Purdue MP., Serum levels of vitamin D
metabolites and breast Freedman DM., Chang SC., Falk RT., Purdue MP., Serum levels of vitamin D
metabolites and breast Freedman DM., Chang SC., Falk RT., Purdue MP., Serum levels of vitamin D
metabolites and breast Freedman DM., Chang SC., Falk RT., Purdue MP., Serum levels of vitamin D
metabolites and breast Freedman DM., Chang SC., Falk RT., Purdue MP., Maternal vitamin D status
during pregnancy and Gale CR., Robinson SM., Harvey NC., Javaid MK., Maternal vitamin D status
during pregnancy and Gale CR., Robinson SM., Harvey NC., Javaid MK., Maternal vitamin D status
during pregnancy and Gale CR., Robinson SM., Harvey NC., Javaid MK., Maternal vitamin D status
during pregnancy and Gale CR., Robinson SM., Harvey NC., Javaid MK., Circulating vitamin D
metabolites in relation to Gann PH., Ma J., Hennekens CH., Hollis Circulating vitamin D
metabolites in relation to Gann PH., Ma J., Hennekens CH., Hollis Circulating vitamin D
metabolites in relation to Gann PH., Ma J., Hennekens CH., Hollis Circulating vitamin D
metabolites in relation to Gann PH., Ma J., Hennekens CH., Hollis Circulating vitamin D
metabolites in relation to Gann PH., Ma J., Hennekens CH., Hollis Circulating vitamin D
metabolites in relation to Gann PH., Ma J., Hennekens CH., Hollis Circulating vitamin D
metabolites in relation to Gann PH., Ma J., Hennekens CH., Hollis Circulating vitamin D
metabolites in relation to Gann PH., Ma J., Hennekens CH., Hollis Dietary vitamin D and
calcium and risk of Garland C., Shekelle RB., Barrett-Connor E., Criqui Dietary vitamin D and
calcium and risk of Garland C., Shekelle RB., Barrett-Connor E., Criqui
198519851989198919891989198919891989198919891989199519951995200720072007199919991999199919991999200520052005200520052005200520052005200520052005200520052005200520032003199720042004200420042004
Dietary vitamin D and calcium and risk of
Garland C., Shekelle RB., Barrett-Connor E., Criqui Dietary vitamin D and
calcium and risk of Garland C., Shekelle RB., Barrett-Connor E., Criqui Serum 25-hydroxyvitamin
D and colon cancer: eight-Garland CF., Comstock GW., Garland FC., Helsing Serum 25-hydroxyvitamin
D and colon cancer: eight-Garland CF., Comstock GW., Garland FC., Helsing Serum 25-hydroxyvitamin
D and colon cancer: eight-Garland CF., Comstock GW., Garland FC., Helsing Serum 25-hydroxyvitamin
D and colon cancer: eight-Garland CF., Comstock GW., Garland FC., Helsing Serum 25-hydroxyvitamin
D and colon cancer: eight-Garland CF., Comstock GW., Garland FC., Helsing Serum 25-hydroxyvitamin
D and colon cancer: eight-Garland CF., Comstock GW., Garland FC., Helsing Serum 25-hydroxyvitamin
D and colon cancer: eight-Garland CF., Comstock GW., Garland FC., Helsing Serum 25-hydroxyvitamin
D and colon cancer: eight-Garland CF., Comstock GW., Garland FC., Helsing Serum 25-hydroxyvitamin
D and colon cancer: eight-Garland CF., Comstock GW., Garland FC., Helsing Serum 25-hydroxyvitamin
D and colon cancer: eight-Garland CF., Comstock GW., Garland FC., Helsing The influence of dairy
products on plasma uric Ghadirian P., Shatenstein B., Verdy M., Hamet P.The influence of dairy
products on plasma uric Ghadirian P., Shatenstein B., Verdy M., Hamet P.The influence of dairy
products on plasma uric Ghadirian P., Shatenstein B., Verdy M., Hamet P.Prolonged effect of
calcium supplementation Grau MV., Baron JA., Sandler RS., Wallace K., Prolonged effect of
calcium supplementation Grau MV., Baron JA., Sandler RS., Wallace K., Prolonged effect of
calcium supplementation Grau MV., Baron JA., Sandler RS., Wallace K., Plasma 25-hydroxyvitamin
D responses of younger Harris SS., Dawson-Hughes B., Perrone GA.Plasma 25-hydroxyvitamin
D responses of younger Harris SS., Dawson-Hughes B., Perrone GA.Plasma 25-hydroxyvitamin
D responses of younger Harris SS., Dawson-Hughes B., Perrone GA.Plasma 25-hydroxyvitamin
D responses of younger Harris SS., Dawson-Hughes B., Perrone GA.Plasma 25-hydroxyvitamin
D responses of younger Harris SS., Dawson-Hughes B., Perrone GA.Plasma 25-hydroxyvitamin
D responses of younger Harris SS., Dawson-Hughes B., Perrone GA.The association of calcium
and vitamin D with risk of Hartman TJ., Albert PS., Snyder K., Slattery ML., The association of calcium
and vitamin D with risk of Hartman TJ., Albert PS., Snyder K., Slattery ML., The association of calcium
and vitamin D with risk of Hartman TJ., Albert PS., Snyder K., Slattery ML., The association of calcium
and vitamin D with risk of Hartman TJ., Albert PS., Snyder K., Slattery ML., The association of calcium
and vitamin D with risk of Hartman TJ., Albert PS., Snyder K., Slattery ML., The association of calcium
and vitamin D with risk of Hartman TJ., Albert PS., Snyder K., Slattery ML., The association of calcium
and vitamin D with risk of Hartman TJ., Albert PS., Snyder K., Slattery ML., The association of calcium
and vitamin D with risk of Hartman TJ., Albert PS., Snyder K., Slattery ML., The association of calcium
and vitamin D with risk of Hartman TJ., Albert PS., Snyder K., Slattery ML., The association of calcium
and vitamin D with risk of Hartman TJ., Albert PS., Snyder K., Slattery ML., The association of calcium
and vitamin D with risk of Hartman TJ., Albert PS., Snyder K., Slattery ML., The association of calcium
and vitamin D with risk of Hartman TJ., Albert PS., Snyder K., Slattery ML., The association of calcium
and vitamin D with risk of Hartman TJ., Albert PS., Snyder K., Slattery ML., The association of calcium
and vitamin D with risk of Hartman TJ., Albert PS., Snyder K., Slattery ML., The association of calcium
and vitamin D with risk of Hartman TJ., Albert PS., Snyder K., Slattery ML., The impact of calcium and
dairy product consumption Harvey-Berino J., Gold BC., Lauber R., Starinski A.Gestational calcium
supplementation and Hatton DC., Harrison-Hohner J., Coste S., Reller Gestational calcium
supplementation and Hatton DC., Harrison-Hohner J., Coste S., Reller Long-term vitamin D3
supplementation may Heikkinen AM., Tuppurainen MT., Plasma levels of 25-
hydroxyvitamin D, 1,25-Jacobs ET., Giuliano AR., Martínez ME., Hollis BW., Plasma levels of 25-
hydroxyvitamin D, 1,25-Jacobs ET., Giuliano AR., Martínez ME., Hollis BW., Plasma levels of 25-
hydroxyvitamin D, 1,25-Jacobs ET., Giuliano AR., Martínez ME., Hollis BW., Plasma levels of 25-
hydroxyvitamin D, 1,25-Jacobs ET., Giuliano AR., Martínez ME., Hollis BW., Plasma levels of 25-
hydroxyvitamin D, 1,25-Jacobs ET., Giuliano AR., Martínez ME., Hollis BW.,
200420012001200120012001200120012001200120012001200119941994199419941994199719971997199719961996199619961996200520052005200520072007200720072007200720072007200720072007200720062006200420042004
Plasma levels of 25-hydroxyvitamin D, 1,25-
Jacobs ET., Giuliano AR., Martínez ME., Hollis BW., Prospective study on milk
products, calcium and Järvinen R., Knekt P., Hakulinen T., Aromaa A.Prospective study on milk
products, calcium and Järvinen R., Knekt P., Hakulinen T., Aromaa A.Prospective study on milk
products, calcium and Järvinen R., Knekt P., Hakulinen T., Aromaa A.Prospective study on milk
products, calcium and Järvinen R., Knekt P., Hakulinen T., Aromaa A.Prospective study on milk
products, calcium and Järvinen R., Knekt P., Hakulinen T., Aromaa A.Prospective study on milk
products, calcium and Järvinen R., Knekt P., Hakulinen T., Aromaa A.Prospective study on milk
products, calcium and Järvinen R., Knekt P., Hakulinen T., Aromaa A.Prospective study on milk
products, calcium and Järvinen R., Knekt P., Hakulinen T., Aromaa A.Prospective study on milk
products, calcium and Järvinen R., Knekt P., Hakulinen T., Aromaa A.Prospective study on milk
products, calcium and Järvinen R., Knekt P., Hakulinen T., Aromaa A.Prospective study on milk
products, calcium and Järvinen R., Knekt P., Hakulinen T., Aromaa A.Prospective study on milk
products, calcium and Järvinen R., Knekt P., Hakulinen T., Aromaa A.Fermented dairy products,
calcium, and colorectal Kampman E., Goldbohm RA., van den Brandt PA., Fermented dairy products,
calcium, and colorectal Kampman E., Goldbohm RA., van den Brandt PA., Fermented dairy products,
calcium, and colorectal Kampman E., Goldbohm RA., van den Brandt PA., Fermented dairy products,
calcium, and colorectal Kampman E., Goldbohm RA., van den Brandt PA., Fermented dairy products,
calcium, and colorectal Kampman E., Goldbohm RA., van den Brandt PA., Prospective study of diet
and female colorectal Kato I., Akhmedkhanov A., Koenig K., Toniolo PG., Prospective study of diet
and female colorectal Kato I., Akhmedkhanov A., Koenig K., Toniolo PG., Prospective study of diet
and female colorectal Kato I., Akhmedkhanov A., Koenig K., Toniolo PG., Prospective study of diet
and female colorectal Kato I., Akhmedkhanov A., Koenig K., Toniolo PG., Calcium, vitamin D, and
dairy foods and the Kearney J., Giovannucci E., Rimm EB., Ascherio A., Calcium, vitamin D, and
dairy foods and the Kearney J., Giovannucci E., Rimm EB., Ascherio A., Calcium, vitamin D, and
dairy foods and the Kearney J., Giovannucci E., Rimm EB., Ascherio A., Calcium, vitamin D, and
dairy foods and the Kearney J., Giovannucci E., Rimm EB., Ascherio A., Calcium, vitamin D, and
dairy foods and the Kearney J., Giovannucci E., Rimm EB., Ascherio A., Dietary calcium,
phosphorus, vitamin D, Kesse E., Boutron-Ruault MC., Norat T., Riboli E., Dietary calcium,
phosphorus, vitamin D, Kesse E., Boutron-Ruault MC., Norat T., Riboli E., Dietary calcium,
phosphorus, vitamin D, Kesse E., Boutron-Ruault MC., Norat T., Riboli E., Dietary calcium,
phosphorus, vitamin D, Kesse E., Boutron-Ruault MC., Norat T., Riboli E., Dairy products, calcium
and the risk of breast Kesse-Guyot E., Bertrais S., Duperray B., Arnault N., Dairy products, calcium
and the risk of breast Kesse-Guyot E., Bertrais S., Duperray B., Arnault N., Dairy products, calcium
and the risk of breast Kesse-Guyot E., Bertrais S., Duperray B., Arnault N., Dairy products, calcium
and the risk of breast Kesse-Guyot E., Bertrais S., Duperray B., Arnault N., Dairy products, calcium
and the risk of breast Kesse-Guyot E., Bertrais S., Duperray B., Arnault N., Dairy products, calcium
and the risk of breast Kesse-Guyot E., Bertrais S., Duperray B., Arnault N., Dairy products, calcium
and the risk of breast Kesse-Guyot E., Bertrais S., Duperray B., Arnault N., Dairy products, calcium
and the risk of breast Kesse-Guyot E., Bertrais S., Duperray B., Arnault N., Dairy products, calcium
and the risk of breast Kesse-Guyot E., Bertrais S., Duperray B., Arnault N., Dairy products, calcium
and the risk of breast Kesse-Guyot E., Bertrais S., Duperray B., Arnault N., Dairy products, calcium
and the risk of breast Kesse-Guyot E., Bertrais S., Duperray B., Arnault N., Dairy products, calcium
and the risk of breast Kesse-Guyot E., Bertrais S., Duperray B., Arnault N., Dairy products, calcium
and prostate cancer risk.Koh KA., Sesso HD., Paffenbarger RS., Lee IM.Dairy products, calcium
and prostate cancer risk.Koh KA., Sesso HD., Paffenbarger RS., Lee IM.Girls on a high-calcium
diet gain weight at the Lappe JM., Rafferty KA., Davies KM., Lypaczewski Girls on a high-calcium
diet gain weight at the Lappe JM., Rafferty KA., Davies KM., Lypaczewski Girls on a high-calcium
diet gain weight at the Lappe JM., Rafferty KA., Davies KM., Lypaczewski
200720072007200720072007200820082006200620062006200620062006200620062006200620062006200620062006200620062006200620062006200620062008200820082008200920092009200920092007200720072007200720072007
Vitamin D and calcium supplementation reduces
Lappe JM., Travers-Gustafson D., Davies KM., Vitamin D and calcium
supplementation reduces Lappe JM., Travers-Gustafson D., Davies KM., Vitamin D and calcium
supplementation reduces Lappe JM., Travers-Gustafson D., Davies KM., Vitamin D and calcium
supplementation reduces Lappe JM., Travers-Gustafson D., Davies KM., Vitamin D and calcium
supplementation reduces Lappe JM., Travers-Gustafson D., Davies KM., Vitamin D and calcium
supplementation reduces Lappe JM., Travers-Gustafson D., Davies KM., Calcium and vitamin d
supplementation Lappe J., Cullen D., Haynatzki G., Recker R., Calcium and vitamin d
supplementation Lappe J., Cullen D., Haynatzki G., Recker R., Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci Calcium and dairy food
intakes are inversely Larsson SC., Bergkvist L., Rutegård J., Giovannucci Magnesium, calcium,
potassium, and sodium Larsson SC., Virtanen MJ., Mars M., Männistö S., Magnesium, calcium,
potassium, and sodium Larsson SC., Virtanen MJ., Mars M., Männistö S., Magnesium, calcium,
potassium, and sodium Larsson SC., Virtanen MJ., Mars M., Männistö S., Magnesium, calcium,
potassium, and sodium Larsson SC., Virtanen MJ., Mars M., Männistö S., Long-term dietary calcium
intake and breast cancer Larsson SC., Bergkvist L., Wolk A.Long-term dietary calcium
intake and breast cancer Larsson SC., Bergkvist L., Wolk A.Long-term dietary calcium
intake and breast cancer Larsson SC., Bergkvist L., Wolk A.Long-term dietary calcium
intake and breast cancer Larsson SC., Bergkvist L., Wolk A.Long-term dietary calcium
intake and breast cancer Larsson SC., Bergkvist L., Wolk A.A prospective study of
plasma vitamin D Li H., Stampfer MJ., Hollis JB., Mucci LA., Gaziano JM., A prospective study of
plasma vitamin D Li H., Stampfer MJ., Hollis JB., Mucci LA., Gaziano JM., A prospective study of
plasma vitamin D Li H., Stampfer MJ., Hollis JB., Mucci LA., Gaziano JM., A prospective study of
plasma vitamin D Li H., Stampfer MJ., Hollis JB., Mucci LA., Gaziano JM., A prospective study of
plasma vitamin D Li H., Stampfer MJ., Hollis JB., Mucci LA., Gaziano JM., A prospective study of
plasma vitamin D Li H., Stampfer MJ., Hollis JB., Mucci LA., Gaziano JM., A prospective study of
plasma vitamin D Li H., Stampfer MJ., Hollis JB., Mucci LA., Gaziano JM.,
20072007200720072007200720072007200720072007200720072007200720072007200720072007200720072007200720071995 Lijnen P., Petrov V.1995 Lijnen P., Petrov V.1995 Lijnen P., Petrov V.1995 Lijnen P., Petrov V.1995 Lijnen P., Petrov V.1995 Lijnen P., Petrov V.20052005200520052005200720072007200720072007200720072007200720062006
A prospective study of plasma vitamin D
Li H., Stampfer MJ., Hollis JB., Mucci LA., Gaziano JM., A prospective study of
plasma vitamin D Li H., Stampfer MJ., Hollis JB., Mucci LA., Gaziano JM., A prospective study of
plasma vitamin D Li H., Stampfer MJ., Hollis JB., Mucci LA., Gaziano JM., A prospective study of
plasma vitamin D Li H., Stampfer MJ., Hollis JB., Mucci LA., Gaziano JM., A prospective study of
plasma vitamin D Li H., Stampfer MJ., Hollis JB., Mucci LA., Gaziano JM., A prospective study of
plasma vitamin D Li H., Stampfer MJ., Hollis JB., Mucci LA., Gaziano JM., A prospective study of
plasma vitamin D Li H., Stampfer MJ., Hollis JB., Mucci LA., Gaziano JM., A prospective study of
plasma vitamin D Li H., Stampfer MJ., Hollis JB., Mucci LA., Gaziano JM., A prospective study of
plasma vitamin D Li H., Stampfer MJ., Hollis JB., Mucci LA., Gaziano JM., A prospective study of
plasma vitamin D Li H., Stampfer MJ., Hollis JB., Mucci LA., Gaziano JM., A prospective study of
plasma vitamin D Li H., Stampfer MJ., Hollis JB., Mucci LA., Gaziano JM., A prospective study of
plasma vitamin D Li H., Stampfer MJ., Hollis JB., Mucci LA., Gaziano JM., A prospective study of
plasma vitamin D Li H., Stampfer MJ., Hollis JB., Mucci LA., Gaziano JM., A prospective study of
plasma vitamin D Li H., Stampfer MJ., Hollis JB., Mucci LA., Gaziano JM., A prospective study of
plasma vitamin D Li H., Stampfer MJ., Hollis JB., Mucci LA., Gaziano JM., A prospective study of
plasma vitamin D Li H., Stampfer MJ., Hollis JB., Mucci LA., Gaziano JM., A prospective study of
plasma vitamin D Li H., Stampfer MJ., Hollis JB., Mucci LA., Gaziano JM., A prospective study of
plasma vitamin D Li H., Stampfer MJ., Hollis JB., Mucci LA., Gaziano JM., A prospective study of
plasma vitamin D Li H., Stampfer MJ., Hollis JB., Mucci LA., Gaziano JM., A prospective study of
plasma vitamin D Li H., Stampfer MJ., Hollis JB., Mucci LA., Gaziano JM., A prospective study of
plasma vitamin D Li H., Stampfer MJ., Hollis JB., Mucci LA., Gaziano JM., A prospective study of
plasma vitamin D Li H., Stampfer MJ., Hollis JB., Mucci LA., Gaziano JM., A prospective study of
plasma vitamin D Li H., Stampfer MJ., Hollis JB., Mucci LA., Gaziano JM., A prospective study of
plasma vitamin D Li H., Stampfer MJ., Hollis JB., Mucci LA., Gaziano JM., A prospective study of
plasma vitamin D Li H., Stampfer MJ., Hollis JB., Mucci LA., Gaziano JM., Dietary calcium, blood
pressure and cell Dietary calcium, blood pressure and cell Dietary calcium, blood pressure and cell Dietary calcium, blood pressure and cell Dietary calcium, blood pressure and cell Dietary calcium, blood pressure and cell Intakes of calcium and vitamin D and risk of
Lin J., Zhang SM., Cook NR., Manson JE., Lee IM., Intakes of calcium and
vitamin D and risk of Lin J., Zhang SM., Cook NR., Manson JE., Lee IM., Intakes of calcium and
vitamin D and risk of Lin J., Zhang SM., Cook NR., Manson JE., Lee IM., Intakes of calcium and
vitamin D and risk of Lin J., Zhang SM., Cook NR., Manson JE., Lee IM., Intakes of calcium and
vitamin D and risk of Lin J., Zhang SM., Cook NR., Manson JE., Lee IM., Intakes of calcium and
vitamin D and breast Lin J., Manson JE., Lee IM., Cook NR., Buring JE., Intakes of calcium and
vitamin D and breast Lin J., Manson JE., Lee IM., Cook NR., Buring JE., Intakes of calcium and
vitamin D and breast Lin J., Manson JE., Lee IM., Cook NR., Buring JE., Intakes of calcium and
vitamin D and breast Lin J., Manson JE., Lee IM., Cook NR., Buring JE., Intakes of calcium and
vitamin D and breast Lin J., Manson JE., Lee IM., Cook NR., Buring JE., Intakes of calcium and
vitamin D and breast Lin J., Manson JE., Lee IM., Cook NR., Buring JE., Intakes of calcium and
vitamin D and breast Lin J., Manson JE., Lee IM., Cook NR., Buring JE., Intakes of calcium and
vitamin D and breast Lin J., Manson JE., Lee IM., Cook NR., Buring JE., Intakes of calcium and
vitamin D and breast Lin J., Manson JE., Lee IM., Cook NR., Buring JE., Intakes of calcium and
vitamin D and breast Lin J., Manson JE., Lee IM., Cook NR., Buring JE., Calcium supplementation
for 1 y does not reduce Lorenzen JK., Mølgaard C., Michaelsen KF., Astrup A.Calcium supplementation
for 1 y does not reduce Lorenzen JK., Mølgaard C., Michaelsen KF., Astrup A.
200620062006200620072007200720072007200720082008200820052005200520052005200520052005200520052002200220022002198719881988198819811981200320032003200320032008200820082008200820082008200820082008
Calcium supplementation for 1 y does not reduce
Lorenzen JK., Mølgaard C., Michaelsen KF., Astrup A.Calcium supplementation
for 1 y does not reduce Lorenzen JK., Mølgaard C., Michaelsen KF., Astrup A.Calcium supplementation
for 1 y does not reduce Lorenzen JK., Mølgaard C., Michaelsen KF., Astrup A.Calcium supplementation
for 1 y does not reduce Lorenzen JK., Mølgaard C., Michaelsen KF., Astrup A.Preventing fractures
among older people living Lyons RA., Johansen A., Brophy S., Newcombe RG., Preventing fractures
among older people living Lyons RA., Johansen A., Brophy S., Newcombe RG., Supplementation with
calcium + vitamin D Major GC., Alarie F., Doré J., Phouttama S., Tremblay Supplementation with
calcium + vitamin D Major GC., Alarie F., Doré J., Phouttama S., Tremblay Supplementation with
calcium + vitamin D Major GC., Alarie F., Doré J., Phouttama S., Tremblay Supplementation with
calcium + vitamin D Major GC., Alarie F., Doré J., Phouttama S., Tremblay Effect of calcium and
vitamin D supplementation Margolis KL., Ray RM., Van Horn L., Manson JE., Allison Effect of calcium and
vitamin D supplementation Margolis KL., Ray RM., Van Horn L., Manson JE., Allison Effect of calcium and
vitamin D supplementation Margolis KL., Ray RM., Van Horn L., Manson JE., Allison Dietary and serum
vitamins and minerals as Marniemi J., Alanen E., Impivaara O., Seppänen Dietary and serum
vitamins and minerals as Marniemi J., Alanen E., Impivaara O., Seppänen Dietary and serum
vitamins and minerals as Marniemi J., Alanen E., Impivaara O., Seppänen Dietary and serum
vitamins and minerals as Marniemi J., Alanen E., Impivaara O., Seppänen Dietary and serum
vitamins and minerals as Marniemi J., Alanen E., Impivaara O., Seppänen Dietary and serum
vitamins and minerals as Marniemi J., Alanen E., Impivaara O., Seppänen Dietary and serum
vitamins and minerals as Marniemi J., Alanen E., Impivaara O., Seppänen Dietary and serum
vitamins and minerals as Marniemi J., Alanen E., Impivaara O., Seppänen Dietary and serum
vitamins and minerals as Marniemi J., Alanen E., Impivaara O., Seppänen Dietary and serum
vitamins and minerals as Marniemi J., Alanen E., Impivaara O., Seppänen Calcium, vitamin D, and
risk of adenoma Martínez ME., Marshall JR., Sampliner R., Wilkinson J., Calcium, vitamin D, and
risk of adenoma Martínez ME., Marshall JR., Sampliner R., Wilkinson J., Calcium, vitamin D, and
risk of adenoma Martínez ME., Marshall JR., Sampliner R., Wilkinson J., Calcium, vitamin D, and
risk of adenoma Martínez ME., Marshall JR., Sampliner R., Wilkinson J., Effect of calcium and
vitamin D supplementation Marya RK., Rathee S., Manrow M.Effect of vitamin D
supplementation during Marya RK., Rathee S., Dua V., Sangwan K.Effect of vitamin D
supplementation during Marya RK., Rathee S., Dua V., Sangwan K.Effect of vitamin D
supplementation during Marya RK., Rathee S., Dua V., Sangwan K.Vitamin D supplements
enhance weight gain and Maxwell JD., Ang L., Brooke OG., Brown IR.Vitamin D supplements
enhance weight gain and Maxwell JD., Ang L., Brooke OG., Brown IR.Calcium, vitamin D, dairy
products, and risk of McCullough ML., Robertson AS., Rodriguez Calcium, vitamin D, dairy
products, and risk of McCullough ML., Robertson AS., Rodriguez Calcium, vitamin D, dairy
products, and risk of McCullough ML., Robertson AS., Rodriguez Calcium, vitamin D, dairy
products, and risk of McCullough ML., Robertson AS., Rodriguez Calcium, vitamin D, dairy
products, and risk of McCullough ML., Robertson AS., Rodriguez Dietary calcium and
vitamin D intakes in Mishra G., McCormack V., Kuh D., Hardy R., Stephen Dietary calcium and
vitamin D intakes in Mishra G., McCormack V., Kuh D., Hardy R., Stephen Dietary calcium and
vitamin D intakes in Mishra G., McCormack V., Kuh D., Hardy R., Stephen Dietary calcium and
vitamin D intakes in Mishra G., McCormack V., Kuh D., Hardy R., Stephen Dietary calcium and
vitamin D intakes in Mishra G., McCormack V., Kuh D., Hardy R., Stephen Dietary calcium and
vitamin D intakes in Mishra G., McCormack V., Kuh D., Hardy R., Stephen Dietary calcium and
vitamin D intakes in Mishra G., McCormack V., Kuh D., Hardy R., Stephen Dietary calcium and
vitamin D intakes in Mishra G., McCormack V., Kuh D., Hardy R., Stephen Dietary calcium and
vitamin D intakes in Mishra G., McCormack V., Kuh D., Hardy R., Stephen Dietary calcium and
vitamin D intakes in Mishra G., McCormack V., Kuh D., Hardy R., Stephen
200620062006200620062006200620062006200120012009200920092009200920092009200920092009200919981998200720072007200720072007200720072007200720072007200720072007200720072007200720072007200720072007
Dairy products, calcium and prostate cancer risk.
Koh KA., Sesso HD., Paffenbarger RS., Lee IM.Dairy products, calcium
and prostate cancer risk.Koh KA., Sesso HD., Paffenbarger RS., Lee IM.Dairy products, calcium
and prostate cancer risk.Koh KA., Sesso HD., Paffenbarger RS., Lee IM.Dairy products, calcium
and prostate cancer risk.Koh KA., Sesso HD., Paffenbarger RS., Lee IM.Dairy products, calcium
and prostate cancer risk.Koh KA., Sesso HD., Paffenbarger RS., Lee IM.Dairy products, calcium
and prostate cancer risk.Koh KA., Sesso HD., Paffenbarger RS., Lee IM.Dairy products, calcium
and prostate cancer risk.Koh KA., Sesso HD., Paffenbarger RS., Lee IM.Dairy products, calcium
and prostate cancer risk.Koh KA., Sesso HD., Paffenbarger RS., Lee IM.Dairy products, calcium
and prostate cancer risk.Koh KA., Sesso HD., Paffenbarger RS., Lee IM.Nutrient intake and
hypertensive disorders of Morris CD., Jacobson SL., Anand R., Ewell MG., Nutrient intake and
hypertensive disorders of Morris CD., Jacobson SL., Anand R., Ewell MG., A double-blind,
randomized, placebo-Nagpal J., Pande JN., Bhartia A.A double-blind,
randomized, placebo-Nagpal J., Pande JN., Bhartia A.A double-blind,
randomized, placebo-Nagpal J., Pande JN., Bhartia A.A double-blind,
randomized, placebo-Nagpal J., Pande JN., Bhartia A.A double-blind,
randomized, placebo-Nagpal J., Pande JN., Bhartia A.A double-blind,
randomized, placebo-Nagpal J., Pande JN., Bhartia A.A double-blind,
randomized, placebo-Nagpal J., Pande JN., Bhartia A.A double-blind,
randomized, placebo-Nagpal J., Pande JN., Bhartia A.A double-blind,
randomized, placebo-Nagpal J., Pande JN., Bhartia A.A double-blind,
randomized, placebo-Nagpal J., Pande JN., Bhartia A.Supplements of 20
microg/d cholecalciferol Nelson ML., Blum JM., Hollis BW., Rosen C., Serum vitamin D
metabolite levels and the Nomura AM., Stemmermann GN., Lee J., Serum vitamin D
metabolite levels and the Nomura AM., Stemmermann GN., Lee J., Calcium and vitamin D
intakes in relation to risk Oh K., Willett WC., Wu K., Fuchs CS., Giovannucci EL.Calcium and vitamin D
intakes in relation to risk Oh K., Willett WC., Wu K., Fuchs CS., Giovannucci EL.Calcium and vitamin D
intakes in relation to risk Oh K., Willett WC., Wu K., Fuchs CS., Giovannucci EL.Calcium and vitamin D
intakes in relation to risk Oh K., Willett WC., Wu K., Fuchs CS., Giovannucci EL.Calcium and vitamin D
intakes in relation to risk Oh K., Willett WC., Wu K., Fuchs CS., Giovannucci EL.Calcium and vitamin D
intakes in relation to risk Oh K., Willett WC., Wu K., Fuchs CS., Giovannucci EL.Calcium and vitamin D
intakes in relation to risk Oh K., Willett WC., Wu K., Fuchs CS., Giovannucci EL.Calcium and vitamin D
intakes in relation to risk Oh K., Willett WC., Wu K., Fuchs CS., Giovannucci EL.Calcium and vitamin D
intakes in relation to risk Oh K., Willett WC., Wu K., Fuchs CS., Giovannucci EL.Calcium and vitamin D
intakes in relation to risk Oh K., Willett WC., Wu K., Fuchs CS., Giovannucci EL.Calcium and vitamin D
intakes in relation to risk Oh K., Willett WC., Wu K., Fuchs CS., Giovannucci EL.Calcium and vitamin D
intakes in relation to risk Oh K., Willett WC., Wu K., Fuchs CS., Giovannucci EL.Calcium and vitamin D
intakes in relation to risk Oh K., Willett WC., Wu K., Fuchs CS., Giovannucci EL.Calcium and vitamin D
intakes in relation to risk Oh K., Willett WC., Wu K., Fuchs CS., Giovannucci EL.Calcium and vitamin D
intakes in relation to risk Oh K., Willett WC., Wu K., Fuchs CS., Giovannucci EL.Plasma vitamin D and risk
of colorectal cancer: the Otani T., Iwasaki M., Sasazuki S., Inoue M., Plasma vitamin D and risk
of colorectal cancer: the Otani T., Iwasaki M., Sasazuki S., Inoue M., Plasma vitamin D and risk
of colorectal cancer: the Otani T., Iwasaki M., Sasazuki S., Inoue M., Plasma vitamin D and risk
of colorectal cancer: the Otani T., Iwasaki M., Sasazuki S., Inoue M., Plasma vitamin D and risk
of colorectal cancer: the Otani T., Iwasaki M., Sasazuki S., Inoue M., Plasma vitamin D and risk
of colorectal cancer: the Otani T., Iwasaki M., Sasazuki S., Inoue M., Plasma vitamin D and risk
of colorectal cancer: the Otani T., Iwasaki M., Sasazuki S., Inoue M., Plasma vitamin D and risk
of colorectal cancer: the Otani T., Iwasaki M., Sasazuki S., Inoue M., Plasma vitamin D and risk
of colorectal cancer: the Otani T., Iwasaki M., Sasazuki S., Inoue M.,
200720072007200720072007200720072007200720072007200720072007200720072007200720072007200720072007200720072007200720072007200720072007200720072007200720012001200119991999199919992000200020002000
Plasma vitamin D and risk of colorectal cancer: the
Otani T., Iwasaki M., Sasazuki S., Inoue M., Plasma vitamin D and risk
of colorectal cancer: the Otani T., Iwasaki M., Sasazuki S., Inoue M., Plasma vitamin D and risk
of colorectal cancer: the Otani T., Iwasaki M., Sasazuki S., Inoue M., Plasma vitamin D and risk
of colorectal cancer: the Otani T., Iwasaki M., Sasazuki S., Inoue M., Plasma vitamin D and risk
of colorectal cancer: the Otani T., Iwasaki M., Sasazuki S., Inoue M., Plasma vitamin D and risk
of colorectal cancer: the Otani T., Iwasaki M., Sasazuki S., Inoue M., Plasma vitamin D and risk
of colorectal cancer: the Otani T., Iwasaki M., Sasazuki S., Inoue M., Plasma vitamin D and risk
of colorectal cancer: the Otani T., Iwasaki M., Sasazuki S., Inoue M., Plasma vitamin D and risk
of colorectal cancer: the Otani T., Iwasaki M., Sasazuki S., Inoue M., Plasma vitamin D and risk
of colorectal cancer: the Otani T., Iwasaki M., Sasazuki S., Inoue M., Plasma vitamin D and risk
of colorectal cancer: the Otani T., Iwasaki M., Sasazuki S., Inoue M., Plasma vitamin D and risk
of colorectal cancer: the Otani T., Iwasaki M., Sasazuki S., Inoue M., Plasma vitamin D and risk
of colorectal cancer: the Otani T., Iwasaki M., Sasazuki S., Inoue M., Plasma vitamin D and risk
of colorectal cancer: the Otani T., Iwasaki M., Sasazuki S., Inoue M., Plasma vitamin D and risk
of colorectal cancer: the Otani T., Iwasaki M., Sasazuki S., Inoue M., Calcium and vitamin D
intake and risk of Park SY., Murphy SP., Wilkens LR., Nomura AM., Calcium and vitamin D
intake and risk of Park SY., Murphy SP., Wilkens LR., Nomura AM., Calcium and vitamin D
intake and risk of Park SY., Murphy SP., Wilkens LR., Nomura AM., Calcium and vitamin D
intake and risk of Park SY., Murphy SP., Wilkens LR., Nomura AM., Calcium and vitamin D
intake and risk of Park SY., Murphy SP., Wilkens LR., Nomura AM., Calcium and vitamin D
intake and risk of Park SY., Murphy SP., Wilkens LR., Nomura AM., Calcium and vitamin D
intake and risk of Park SY., Murphy SP., Wilkens LR., Nomura AM., Calcium and vitamin D
intake and risk of Park SY., Murphy SP., Wilkens LR., Nomura AM., Calcium and vitamin D
intake and risk of Park SY., Murphy SP., Wilkens LR., Nomura AM., Calcium and vitamin D
intake and risk of Park SY., Murphy SP., Wilkens LR., Nomura AM., Calcium, dairy foods, and
risk of incident and fatal Park Y., Mitrou PN., Kipnis V., Hollenbeck A., Calcium, dairy foods, and
risk of incident and fatal Park Y., Mitrou PN., Kipnis V., Hollenbeck A., Calcium, vitamin D, and
dairy product intake and Park SY., Murphy SP., Wilkens LR., Stram DO., Calcium, vitamin D, and
dairy product intake and Park SY., Murphy SP., Wilkens LR., Stram DO., Calcium, vitamin D, and
dairy product intake and Park SY., Murphy SP., Wilkens LR., Stram DO., Calcium, vitamin D, and
dairy product intake and Park SY., Murphy SP., Wilkens LR., Stram DO., Calcium, vitamin D, and
dairy product intake and Park SY., Murphy SP., Wilkens LR., Stram DO., Calcium, vitamin D, and
dairy product intake and Park SY., Murphy SP., Wilkens LR., Stram DO., Calcium, vitamin D, and
dairy product intake and Park SY., Murphy SP., Wilkens LR., Stram DO., Calcium, vitamin D, and
dairy product intake and Park SY., Murphy SP., Wilkens LR., Stram DO., Calcium, vitamin D, and
dairy product intake and Park SY., Murphy SP., Wilkens LR., Stram DO., Calcium, vitamin D, and
dairy product intake and Park SY., Murphy SP., Wilkens LR., Stram DO., Effects of a short-term
vitamin D(3) and calcium Pfeifer M., Begerow B., Minne HW., Nachtigall D., Effects of a short-term
vitamin D(3) and calcium Pfeifer M., Begerow B., Minne HW., Nachtigall D., Effects of a short-term
vitamin D(3) and calcium Pfeifer M., Begerow B., Minne HW., Nachtigall D., Diet and risk of colorectal
cancer in a cohort of Pietinen P., Malila N., Virtanen M., Hartman TJ., Diet and risk of colorectal
cancer in a cohort of Pietinen P., Malila N., Virtanen M., Hartman TJ., Diet and risk of colorectal
cancer in a cohort of Pietinen P., Malila N., Virtanen M., Hartman TJ., Diet and risk of colorectal
cancer in a cohort of Pietinen P., Malila N., Virtanen M., Hartman TJ., Plasma 1,25-dihydroxy-
and 25-hydroxyvitamin D Platz EA., Hankinson SE., Hollis BW., Colditz GA., Plasma 1,25-dihydroxy-
and 25-hydroxyvitamin D Platz EA., Hankinson SE., Hollis BW., Colditz GA., Plasma 1,25-dihydroxy-
and 25-hydroxyvitamin D Platz EA., Hankinson SE., Hollis BW., Colditz GA., Plasma 1,25-dihydroxy-
and 25-hydroxyvitamin D Platz EA., Hankinson SE., Hollis BW., Colditz GA.,
200020002000200020002000200020002000200020002000200020002000200020002000200020002005200520052005200320032003200320032007200720071997199719971995199519952006200620062006200620061993199319931993
Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D
Platz EA., Hankinson SE., Hollis BW., Colditz GA., Plasma 1,25-dihydroxy-
and 25-hydroxyvitamin D Platz EA., Hankinson SE., Hollis BW., Colditz GA., Plasma 1,25-dihydroxy-
and 25-hydroxyvitamin D Platz EA., Hankinson SE., Hollis BW., Colditz GA., Plasma 1,25-dihydroxy-
and 25-hydroxyvitamin D Platz EA., Hankinson SE., Hollis BW., Colditz GA., Plasma 1,25-dihydroxy-
and 25-hydroxyvitamin D Platz EA., Hankinson SE., Hollis BW., Colditz GA., Plasma 1,25-dihydroxy-
and 25-hydroxyvitamin D Platz EA., Hankinson SE., Hollis BW., Colditz GA., Plasma 1,25-dihydroxy-
and 25-hydroxyvitamin D Platz EA., Hankinson SE., Hollis BW., Colditz GA., Plasma 1,25-dihydroxy-
and 25-hydroxyvitamin D Platz EA., Hankinson SE., Hollis BW., Colditz GA., Plasma 1,25-dihydroxy-
and 25-hydroxyvitamin D Platz EA., Hankinson SE., Hollis BW., Colditz GA., Plasma 1,25-dihydroxy-
and 25-hydroxyvitamin D Platz EA., Hankinson SE., Hollis BW., Colditz GA., Plasma 1,25-dihydroxy-
and 25-hydroxyvitamin D Platz EA., Hankinson SE., Hollis BW., Colditz GA., Plasma 1,25-dihydroxy-
and 25-hydroxyvitamin D Platz EA., Hankinson SE., Hollis BW., Colditz GA., Plasma 1,25-dihydroxy-
and 25-hydroxyvitamin D Platz EA., Hankinson SE., Hollis BW., Colditz GA., Plasma 1,25-dihydroxy-
and 25-hydroxyvitamin D Platz EA., Hankinson SE., Hollis BW., Colditz GA., Plasma 1,25-dihydroxy-
and 25-hydroxyvitamin D Platz EA., Hankinson SE., Hollis BW., Colditz GA., Plasma 1,25-dihydroxy-
and 25-hydroxyvitamin D Platz EA., Hankinson SE., Hollis BW., Colditz GA., Plasma 1,25-dihydroxy-
and 25-hydroxyvitamin D Platz EA., Hankinson SE., Hollis BW., Colditz GA., Plasma 1,25-dihydroxy-
and 25-hydroxyvitamin D Platz EA., Hankinson SE., Hollis BW., Colditz GA., Plasma 1,25-dihydroxy-
and 25-hydroxyvitamin D Platz EA., Hankinson SE., Hollis BW., Colditz GA., Plasma 1,25-dihydroxy-
and 25-hydroxyvitamin D Platz EA., Hankinson SE., Hollis BW., Colditz GA., Effects of calcium
supplementation on body Reid IR., Horne A., Mason B., Ames R., Bava U., Effects of calcium
supplementation on body Reid IR., Horne A., Mason B., Ames R., Bava U., Effects of calcium
supplementation on body Reid IR., Horne A., Mason B., Ames R., Bava U., Effects of calcium
supplementation on body Reid IR., Horne A., Mason B., Ames R., Bava U., Calcium, dairy products,
and risk of prostate cancer Rodriguez C., McCullough ML., Mondul AM., Jacobs Calcium, dairy products,
and risk of prostate cancer Rodriguez C., McCullough ML., Mondul AM., Jacobs Calcium, dairy products,
and risk of prostate cancer Rodriguez C., McCullough ML., Mondul AM., Jacobs Calcium, dairy products,
and risk of prostate cancer Rodriguez C., McCullough ML., Mondul AM., Jacobs Calcium, dairy products,
and risk of prostate cancer Rodriguez C., McCullough ML., Mondul AM., Jacobs Meat and dairy
consumption and Rohrmann S., Platz EA., Kavanaugh CJ., Thuita L., Meat and dairy
consumption and Rohrmann S., Platz EA., Kavanaugh CJ., Thuita L., Meat and dairy
consumption and Rohrmann S., Platz EA., Kavanaugh CJ., Thuita L., Prospective evaluation of
dietary and other Ross RK., Yuan JM., Henderson BE., Park J., Prospective evaluation of
dietary and other Ross RK., Yuan JM., Henderson BE., Park J., Prospective evaluation of
dietary and other Ross RK., Yuan JM., Henderson BE., Park J., Effect of winter oral
vitamin D3 Scragg R., Khaw KT., Murphy S.Effect of winter oral
vitamin D3 Scragg R., Khaw KT., Murphy S.Effect of winter oral
vitamin D3 Scragg R., Khaw KT., Murphy S.Dietary intake of calcium,
fiber and other Shin A., Li H., Shu XO., Yang G., Gao YT., Zheng Dietary intake of calcium,
fiber and other Shin A., Li H., Shu XO., Yang G., Gao YT., Zheng Dietary intake of calcium,
fiber and other Shin A., Li H., Shu XO., Yang G., Gao YT., Zheng Dietary intake of calcium,
fiber and other Shin A., Li H., Shu XO., Yang G., Gao YT., Zheng Dietary intake of calcium,
fiber and other Shin A., Li H., Shu XO., Yang G., Gao YT., Zheng Vitamin D intake and the
risk for pancreatic cancer Skinner HG., Michaud DS., Giovannucci E., Willett Calcium intake and 28-
year gastro-intestinal Slob IC., Lambregts JL., Schuit AJ., Kok FJ.Calcium intake and 28-
year gastro-intestinal Slob IC., Lambregts JL., Schuit AJ., Kok FJ.Calcium intake and 28-
year gastro-intestinal Slob IC., Lambregts JL., Schuit AJ., Kok FJ.Calcium intake and 28-
year gastro-intestinal Slob IC., Lambregts JL., Schuit AJ., Kok FJ.
199319931993199319931993199319931993199319931993199319931993199319931993199319931993199319931993199319932009200920092009200920062006200620062006199719971997199719971997199719971997199719971997
Calcium intake and 28-year gastro-intestinal
Slob IC., Lambregts JL., Schuit AJ., Kok FJ.Calcium intake and 28-
year gastro-intestinal Slob IC., Lambregts JL., Schuit AJ., Kok FJ.Calcium intake and 28-
year gastro-intestinal Slob IC., Lambregts JL., Schuit AJ., Kok FJ.Calcium intake and 28-
year gastro-intestinal Slob IC., Lambregts JL., Schuit AJ., Kok FJ.Calcium intake and 28-
year gastro-intestinal Slob IC., Lambregts JL., Schuit AJ., Kok FJ.Calcium intake and 28-
year gastro-intestinal Slob IC., Lambregts JL., Schuit AJ., Kok FJ.Calcium intake and 28-
year gastro-intestinal Slob IC., Lambregts JL., Schuit AJ., Kok FJ.Calcium intake and 28-
year gastro-intestinal Slob IC., Lambregts JL., Schuit AJ., Kok FJ.Calcium intake and 28-
year gastro-intestinal Slob IC., Lambregts JL., Schuit AJ., Kok FJ.Calcium intake and 28-
year gastro-intestinal Slob IC., Lambregts JL., Schuit AJ., Kok FJ.Calcium intake and 28-
year gastro-intestinal Slob IC., Lambregts JL., Schuit AJ., Kok FJ.Calcium intake and 28-
year gastro-intestinal Slob IC., Lambregts JL., Schuit AJ., Kok FJ.Calcium intake and 28-
year gastro-intestinal Slob IC., Lambregts JL., Schuit AJ., Kok FJ.Calcium intake and 28-
year gastro-intestinal Slob IC., Lambregts JL., Schuit AJ., Kok FJ.Calcium intake and 28-
year gastro-intestinal Slob IC., Lambregts JL., Schuit AJ., Kok FJ.Calcium intake and 28-
year gastro-intestinal Slob IC., Lambregts JL., Schuit AJ., Kok FJ.Calcium intake and 28-
year gastro-intestinal Slob IC., Lambregts JL., Schuit AJ., Kok FJ.Calcium intake and 28-
year gastro-intestinal Slob IC., Lambregts JL., Schuit AJ., Kok FJ.Calcium intake and 28-
year gastro-intestinal Slob IC., Lambregts JL., Schuit AJ., Kok FJ.Calcium intake and 28-
year gastro-intestinal Slob IC., Lambregts JL., Schuit AJ., Kok FJ.Calcium intake and 28-
year gastro-intestinal Slob IC., Lambregts JL., Schuit AJ., Kok FJ.Calcium intake and 28-
year gastro-intestinal Slob IC., Lambregts JL., Schuit AJ., Kok FJ.Calcium intake and 28-
year gastro-intestinal Slob IC., Lambregts JL., Schuit AJ., Kok FJ.Calcium intake and 28-
year gastro-intestinal Slob IC., Lambregts JL., Schuit AJ., Kok FJ.Calcium intake and 28-
year gastro-intestinal Slob IC., Lambregts JL., Schuit AJ., Kok FJ.Calcium intake and 28-
year gastro-intestinal Slob IC., Lambregts JL., Schuit AJ., Kok FJ.Serum vitamin D and risk
of pancreatic cancer in the Stolzenberg-Solomon RZ., Hayes RB., Horst RL., Serum vitamin D and risk
of pancreatic cancer in the Stolzenberg-Solomon RZ., Hayes RB., Horst RL., Serum vitamin D and risk
of pancreatic cancer in the Stolzenberg-Solomon RZ., Hayes RB., Horst RL., Serum vitamin D and risk
of pancreatic cancer in the Stolzenberg-Solomon RZ., Hayes RB., Horst RL., Serum vitamin D and risk
of pancreatic cancer in the Stolzenberg-Solomon RZ., Hayes RB., Horst RL., A prospective nested case-
control study of vitamin D Stolzenberg-Solomon RZ., Vieth R., Azad A., Pietinen A prospective nested case-
control study of vitamin D Stolzenberg-Solomon RZ., Vieth R., Azad A., Pietinen A prospective nested case-
control study of vitamin D Stolzenberg-Solomon RZ., Vieth R., Azad A., Pietinen A prospective nested case-
control study of vitamin D Stolzenberg-Solomon RZ., Vieth R., Azad A., Pietinen A prospective nested case-
control study of vitamin D Stolzenberg-Solomon RZ., Vieth R., Azad A., Pietinen Serum levels of vitamin D
metabolites and the Tangrea J., Helzlsouer K., Pietinen P., Taylor P., Hollis Serum levels of vitamin D
metabolites and the Tangrea J., Helzlsouer K., Pietinen P., Taylor P., Hollis Serum levels of vitamin D
metabolites and the Tangrea J., Helzlsouer K., Pietinen P., Taylor P., Hollis Serum levels of vitamin D
metabolites and the Tangrea J., Helzlsouer K., Pietinen P., Taylor P., Hollis Serum levels of vitamin D
metabolites and the Tangrea J., Helzlsouer K., Pietinen P., Taylor P., Hollis Serum levels of vitamin D
metabolites and the Tangrea J., Helzlsouer K., Pietinen P., Taylor P., Hollis Serum levels of vitamin D
metabolites and the Tangrea J., Helzlsouer K., Pietinen P., Taylor P., Hollis Serum levels of vitamin D
metabolites and the Tangrea J., Helzlsouer K., Pietinen P., Taylor P., Hollis Serum levels of vitamin D
metabolites and the Tangrea J., Helzlsouer K., Pietinen P., Taylor P., Hollis Serum levels of vitamin D
metabolites and the Tangrea J., Helzlsouer K., Pietinen P., Taylor P., Hollis Serum levels of vitamin D
metabolites and the Tangrea J., Helzlsouer K., Pietinen P., Taylor P., Hollis Serum levels of vitamin D
metabolites and the Tangrea J., Helzlsouer K., Pietinen P., Taylor P., Hollis
199719971997199719971997199719971997199719872003200320032003200320032003200320032003200320032003200320032008200820082008200820082008200819861986200620062006200620062006200620062006200620062006
Serum levels of vitamin D metabolites and the
Tangrea J., Helzlsouer K., Pietinen P., Taylor P., Hollis Serum levels of vitamin D
metabolites and the Tangrea J., Helzlsouer K., Pietinen P., Taylor P., Hollis Serum levels of vitamin D
metabolites and the Tangrea J., Helzlsouer K., Pietinen P., Taylor P., Hollis Serum levels of vitamin D
metabolites and the Tangrea J., Helzlsouer K., Pietinen P., Taylor P., Hollis Serum levels of vitamin D
metabolites and the Tangrea J., Helzlsouer K., Pietinen P., Taylor P., Hollis Serum levels of vitamin D
metabolites and the Tangrea J., Helzlsouer K., Pietinen P., Taylor P., Hollis Serum levels of vitamin D
metabolites and the Tangrea J., Helzlsouer K., Pietinen P., Taylor P., Hollis Serum levels of vitamin D
metabolites and the Tangrea J., Helzlsouer K., Pietinen P., Taylor P., Hollis Serum levels of vitamin D
metabolites and the Tangrea J., Helzlsouer K., Pietinen P., Taylor P., Hollis Serum levels of vitamin D
metabolites and the Tangrea J., Helzlsouer K., Pietinen P., Taylor P., Hollis Dietary calcium intake and
blood pressure in Thomsen K., Nilas L., Christiansen C.Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.Effect of four monthly oral
vitamin D3 Trivedi DP., Doll R., Khaw KT.Dietary calcium intake and
risks of stroke, its Umesawa M., Iso H., Ishihara J., Saito I., Kokubo Dietary calcium intake and
risks of stroke, its Umesawa M., Iso H., Ishihara J., Saito I., Kokubo Dietary calcium intake and
risks of stroke, its Umesawa M., Iso H., Ishihara J., Saito I., Kokubo Dietary calcium intake and
risks of stroke, its Umesawa M., Iso H., Ishihara J., Saito I., Kokubo Dietary calcium intake and
risks of stroke, its Umesawa M., Iso H., Ishihara J., Saito I., Kokubo Dietary calcium intake and
risks of stroke, its Umesawa M., Iso H., Ishihara J., Saito I., Kokubo Dietary calcium intake and
risks of stroke, its Umesawa M., Iso H., Ishihara J., Saito I., Kokubo Dietary calcium intake and
risks of stroke, its Umesawa M., Iso H., Ishihara J., Saito I., Kokubo Oral calcium and blood
pressure: a controlled van Beresteyn EC., Schaafsma G., de Waard Oral calcium and blood
pressure: a controlled van Beresteyn EC., Schaafsma G., de Waard Low serum concentrations
of 25-hydroxyvitamin D in Visser M., Deeg DJ., Puts MT., Seidell JC., Lips P.Calcium plus vitamin D
supplementation and the Wactawski-Wende J., Kotchen JM., Anderson GL., Calcium plus vitamin D
supplementation and the Wactawski-Wende J., Kotchen JM., Anderson GL., Calcium plus vitamin D
supplementation and the Wactawski-Wende J., Kotchen JM., Anderson GL., Calcium plus vitamin D
supplementation and the Wactawski-Wende J., Kotchen JM., Anderson GL., Calcium plus vitamin D
supplementation and the Wactawski-Wende J., Kotchen JM., Anderson GL., Calcium plus vitamin D
supplementation and the Wactawski-Wende J., Kotchen JM., Anderson GL., Calcium plus vitamin D
supplementation and the Wactawski-Wende J., Kotchen JM., Anderson GL., Calcium plus vitamin D
supplementation and the Wactawski-Wende J., Kotchen JM., Anderson GL., Calcium plus vitamin D
supplementation and the Wactawski-Wende J., Kotchen JM., Anderson GL., High-dose vitamin D3
supplementation in a Wagner CL., Hulsey TC., Fanning D., Ebeling M., High-dose vitamin D3
supplementation in a Wagner CL., Hulsey TC., Fanning D., Ebeling M.,
200620062006200620062006200620062006200620062006200620082008200820081996199619961996199619961996200820082008199719972002200220022007200720072007200720072007200720072007200720072007200720072007
High-dose vitamin D3 supplementation in a
Wagner CL., Hulsey TC., Fanning D., Ebeling M., High-dose vitamin D3
supplementation in a Wagner CL., Hulsey TC., Fanning D., Ebeling M., High-dose vitamin D3
supplementation in a Wagner CL., Hulsey TC., Fanning D., Ebeling M., High-dose vitamin D3
supplementation in a Wagner CL., Hulsey TC., Fanning D., Ebeling M., High-dose vitamin D3
supplementation in a Wagner CL., Hulsey TC., Fanning D., Ebeling M., High-dose vitamin D3
supplementation in a Wagner CL., Hulsey TC., Fanning D., Ebeling M., High-dose vitamin D3
supplementation in a Wagner CL., Hulsey TC., Fanning D., Ebeling M., High-dose vitamin D3
supplementation in a Wagner CL., Hulsey TC., Fanning D., Ebeling M., High-dose vitamin D3
supplementation in a Wagner CL., Hulsey TC., Fanning D., Ebeling M., High-dose vitamin D3
supplementation in a Wagner CL., Hulsey TC., Fanning D., Ebeling M., High-dose vitamin D3
supplementation in a Wagner CL., Hulsey TC., Fanning D., Ebeling M., High-dose vitamin D3
supplementation in a Wagner CL., Hulsey TC., Fanning D., Ebeling M., High-dose vitamin D3
supplementation in a Wagner CL., Hulsey TC., Fanning D., Ebeling M., Vitamin D deficiency and
risk of cardiovascular Wang TJ., Pencina MJ., Booth SL., Jacques PF., Vitamin D deficiency and
risk of cardiovascular Wang TJ., Pencina MJ., Booth SL., Jacques PF., Vitamin D deficiency and
risk of cardiovascular Wang TJ., Pencina MJ., Booth SL., Jacques PF., Vitamin D deficiency and
risk of cardiovascular Wang TJ., Pencina MJ., Booth SL., Jacques PF., Effect of longterm placebo
controlled calcium Weisgerber UM., Boeing H., Owen RW., Waldherr Effect of longterm placebo
controlled calcium Weisgerber UM., Boeing H., Owen RW., Waldherr Effect of longterm placebo
controlled calcium Weisgerber UM., Boeing H., Owen RW., Waldherr Effect of longterm placebo
controlled calcium Weisgerber UM., Boeing H., Owen RW., Waldherr Effect of longterm placebo
controlled calcium Weisgerber UM., Boeing H., Owen RW., Waldherr Effect of longterm placebo
controlled calcium Weisgerber UM., Boeing H., Owen RW., Waldherr Effect of longterm placebo
controlled calcium Weisgerber UM., Boeing H., Owen RW., Waldherr Is ischemic stroke risk
related to folate status or Weng LC., Yeh WT., Bai CH., Chen HJ., Chuang SY., Is ischemic stroke risk
related to folate status or Weng LC., Yeh WT., Bai CH., Chen HJ., Chuang SY., Is ischemic stroke risk
related to folate status or Weng LC., Yeh WT., Bai CH., Chen HJ., Chuang SY., Efficacy of
nonpharmacologic Whelton PK., Kumanyika SK., Cook NR., Cutler JA., Efficacy of
nonpharmacologic Whelton PK., Kumanyika SK., Cook NR., Cutler JA., Calcium intake and risk of
colon cancer in women Wu K., Willett WC., Fuchs CS., Colditz GA., Calcium intake and risk of
colon cancer in women Wu K., Willett WC., Fuchs CS., Colditz GA., Calcium intake and risk of
colon cancer in women Wu K., Willett WC., Fuchs CS., Colditz GA., A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis
2007200720072007200720072007200720072007200720072007199519951998199820082008200820082008
A nested case control study of plasma 25-
Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis A nested case control
study of plasma 25-Wu K., Feskanich D., Fuchs CS., Willett WC., Hollis Lack of blood pressure
effect with calcium and Yamamoto ME., Applegate WB., Klag MJ., Borhani NO., Lack of blood pressure
effect with calcium and Yamamoto ME., Applegate WB., Klag MJ., Borhani NO., A prospective cohort study
of intake of calcium, Zheng W., Anderson KE., Kushi LH., Sellers TA., A prospective cohort study
of intake of calcium, Zheng W., Anderson KE., Kushi LH., Sellers TA., Effects of calcium and
vitamin D supplementation Zhu K., Devine A., Dick IM., Wilson SG., Prince RL.Effects of calcium and
vitamin D supplementation Zhu K., Devine A., Dick IM., Wilson SG., Prince RL.Effects of calcium and
vitamin D supplementation Zhu K., Devine A., Dick IM., Wilson SG., Prince RL.Randomized controlled
trial of the effects of Zhu K., Bruce D., Austin N., Devine A., Ebeling PR., Randomized controlled
trial of the effects of Zhu K., Bruce D., Austin N., Devine A., Ebeling PR.,
Outcome Units Subgroup TimepointCategorical nd N/A (years)Categorical nd N/A (years)Categorical nd N/A (years)Categorical nd N/A (years)Categorical nd N/A (years)Categorical nd N/A (years)Categorical nd N/A (years)Categorical nd N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical nd N/A (years)Categorical nd N/A (years)Categorical nd N/A (years)Categorical nd N/A (years)Categorical nd N/A (years)Categorical nd N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical 12 (years)Categorical 12 (years)Categorical 12 (years)Categorical 12 (years)Categorical 12 (years)Categorical 12 (years)Categorical 12 (years)Categorical 12 (years)Categorical 12 (years)Categorical 12 (years)Categorical 12 (years)Categorical 12 (years)
kg Continuous Change in kg/yr All Participants N/A (years)Categorical 2 (years)Categorical 2 (years)Categorical 2 (years)Categorical 2 (years)ContinuousContinuous GirlsContinuous GirlsContinuous WomenContinuous WomenContinuous Men
Outcome Type
Outcome DescriptionProstate cancer
[nd:Categorical]All Participants [All participants Prostate cancer
[nd:Categorical]All Participants [All participants Prostate cancer
[nd:Categorical]All Participants [All participants Prostate cancer
[nd:Categorical]All Participants [All participants Prostate cancer
[nd:Categorical]All Participants [All participants Prostate cancer
[nd:Categorical]All Participants [All participants Prostate cancer
[nd:Categorical]All Participants [All participants Prostate cancer
[nd:Categorical]All Participants [All participants Aggressive
prostate cancer Gleason sum >=7 or clinical stage III
All Participants [All participants Aggressive
prostate cancer Gleason sum >=7 or clinical stage III
All Participants [All participants Aggressive
prostate cancer Gleason sum >=7 or clinical stage III
All Participants [All participants Aggressive
prostate cancer Gleason sum >=7 or clinical stage III
All Participants [All participants Aggressive
prostate cancer Gleason sum >=7 or clinical stage III
All Participants [All participants Aggressive
prostate cancer Gleason sum >=7 or clinical stage III
All Participants [All participants Aggressive
prostate cancer Gleason sum >=7 or clinical stage III
All Participants [All participants Aggressive
prostate cancer Gleason sum >=7 or clinical stage III
All Participants [All participants Prostate cancer
[nd:Categorical]All Participants [All articipants Prostate cancer
[nd:Categorical]All Participants [All articipants Prostate cancer
[nd:Categorical]All Participants [All articipants Prostate cancer
[nd:Categorical]All Participants [All articipants Prostate cancer
[nd:Categorical]All Participants [All articipants Prostate cancer
[nd:Categorical]All Participants [All articipants Prostate cancer in
those <52 years All Participants [All articipants Prostate cancer in
those >51 years All Participants [All articipants IHD (fatal +
nonfatal) [Implied Implied combination of
All Participants [All articipants IHD (fatal +
nonfatal) [Implied Implied combination of
All Participants [All articipants IHD (fatal +
nonfatal) [Implied Implied combination of
All Participants [All articipants IHD (fatal +
nonfatal) [Implied Implied combination of
All Participants [All articipants Nonfatal MI [Self-
reporting with Self-reporting with medical record
All Participants [All articipants Nonfatal MI [Self-
reporting with Self-reporting with medical record
All Participants [All articipants Nonfatal MI [Self-
reporting with Self-reporting with medical record
All Participants [All articipants Nonfatal MI [Self-
reporting with Self-reporting with medical record
All Participants [All articipants Fatal IHD
[Including sudden Including sudden death. Death
All Participants [All articipants Fatal IHD
[Including sudden Including sudden death. Death
All Participants [All articipants Fatal IHD
[Including sudden Including sudden death. Death
All Participants [All articipants Fatal IHD
[Including sudden Including sudden death. Death
All Participants [All articipants Body weight
[Change in HTN, incident [Physician
Physician diagnosis (self-
All Participants [All articipants HTN, incident
[Physician Physician diagnosis (self-
All Participants [All articipants HTN, incident
[Physician Physician diagnosis (self-
All Participants [All articipants HTN, incident
[Physician Physician diagnosis (self-
All Participants [All articipants 25(OH)D
[Continuous]All Participants [All articipants
Enter a numeric value or title 25(OH)D
[Continuous]Enter a numeric value or title 25(OH)D
[Continuous]Enter a numeric value or title 25(OH)D
[Continuous]Enter a numeric value or title 25(OH)D
[Continuous]Enter a numeric value or title 25(OH)D
[Continuous]Enter a numeric value or title
Continuous MenContinuousContinuous WomenContinuous WomenContinuous MenContinuous MenContinuousContinuousContinuous GirlsContinuous GirlsCategorical 1Categorical 1Categorical 1Categorical 1Categorical 1 Age<=50Categorical 1 Age<=50Categorical 1 Age >50Categorical 1 Age >50CategoricalCategoricalCategoricalCategoricalCategorical not extracted Stroke N/A (years)Categorical not extracted Stroke N/A (years)Categorical not extracted Stroke N/A (years)Categorical not extracted Stroke N/A (years)Categorical SecondaryCategorical SecondaryCategorical SecondaryCategorical SecondaryCategorical SecondaryCategorical SecondaryCategorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Continuous All cause All Participants N/A (years)Continuous All cause All Participants N/A (years)
nmol/L Continuous All Participants N/A (years)Categorical 30 (weeks)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)
25(OH)D [Continuous]
Enter a numeric value or title BMD - lumbar
spine [DXA, whole DXA, whole body, or lumbar spine
All Participants [All articipants
Enter a numeric value or title BMD - lumbar
spine [DXA, whole DXA, whole body, or lumbar spine
Enter a numeric value or title BMD - lumbar
spine [DXA, whole DXA, whole body, or lumbar spine
Enter a numeric value or title BMD - lumbar
spine [DXA, whole DXA, whole body, or lumbar spine
Enter a numeric value or title BMD - lumbar
spine [DXA, whole DXA, whole body, or lumbar spine
Enter a numeric value or title BMC - whole body
[DXA, whole body, DXA, whole body, or lumbar spine
All Participants [All articipants
Enter a numeric value or title BMC - whole body
[DXA, whole body, DXA, whole body, or lumbar spine
All Participants [All articipants
Enter a numeric value or title BMC - whole body
[DXA, whole body, DXA, whole body, or lumbar spine
Enter a numeric value or title BMC - whole body
[DXA, whole body, DXA, whole body, or lumbar spine
Enter a numeric value or title Incident HTN
[1 :Categorical]All Participants [All articipants
Enter a numeric value or title Incident HTN
[1 :Categorical]All Participants [All articipants
Enter a numeric value or title Incident HTN
[1 :Categorical]All Participants [All articipants
Enter a numeric value or title Incident HTN
[1 :Categorical]All Participants [All articipants
Enter a numeric value or title Incident HTN
[1 :Categorical]Enter a numeric value or title Incident HTN
[1 :Categorical]Enter a numeric value or title Incident HTN
[1 :Categorical]Enter a numeric value or title Incident HTN
[1 :Categorical]Enter a numeric value or title Hypertension
[Categorical]All Participants [All articipants
Enter a numeric value or title Hypertension
[Categorical]All Participants [All articipants
Enter a numeric value or title Hypertension
[Categorical]All Participants [All articipants
Enter a numeric value or title Hypertension
[Categorical]All Participants [All articipants
Enter a numeric value or title specific stroke
types [not specific stroke types [not specific stroke types [not specific stroke types [not Prostate cancer risk
All Participants [All articipants
Enter a numeric value or title Prostate cancer
risk All Participants [All articipants
Enter a numeric value or title Prostate cancer
risk All Participants [All articipants
Enter a numeric value or title Prostate cancer
risk All Participants [All articipants
Enter a numeric value or title Prostate cancer
risk All Participants [All articipants
Enter a numeric value or title Prostate cancer
risk All Participants [All articipants
Enter a numeric value or title Breast cancer risk
[Risk of Risk of developing or newly Breast cancer risk
[Risk of Risk of developing or newly Breast cancer risk
[Risk of Risk of developing or newly Breast cancer risk
[Risk of Risk of developing or newly Breast cancer risk
[Risk of Risk of developing or newly Breast cancer risk
[Risk of Risk of developing or newly Breast cancer risk
[Risk of Risk of developing or newly Breast cancer risk
[Risk of Risk of developing or newly Mortality [All
cause:Continuous]Mortality [All cause:Continuous]25(OH)D at 1 y [Continuous]preeclampsia [gestational HTN
gestational HTN & proteinuria and
All Participants [All articipants Sudden death
[Standard criteria Standard criteria adjudicated by MI [Standard
criteria Standard criteria adjudicated by Stroke [Standard
criteria Standard criteria adjudicated by CVD Composite
(MI, Stroke, composite Adjudicated
mg/cm2 Continuous All Participants N/A (years)ug/L Continuous All Participants N/A (years)kg Continuous All Participants N/A (years)
Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)
Kg Continuous N/A (years)Kg Continuous N/A (years)Counts Continuous N/A (years)Counts Continuous N/A (years)seconds Continuous N/A (years)seconds Continuous N/A (years)kg Continuous N/A (years)kg Continuous N/A (years)kg Continuous N/A (years)kg Continuous N/A (years)
Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)
m Continuous N/A (years)m Continuous Timed up and go N/A (years)
Categorical Fall N/A (years)Categorical Fracture N/A (years)Categorical Prostate cancer N/A (years)Categorical Prostate cancer N/A (years)Categorical Prostate cancer N/A (years)Categorical Prostate cancer N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)
Femoral neck BMD [DEXA of the
DEXA of the femur was carried out 25(OH)D
[Measured at Measured at baseline and Weight
[Continuous]Colon cancer [State Health
State Health registry of Colon cancer
[State Health State Health registry of Colon cancer
[State Health State Health registry of Colon cancer
[State Health State Health registry of Colon cancer
[State Health State Health registry of Colon cancer
[State Health State Health registry of Colon cancer
[State Health State Health registry of Colon cancer
[State Health State Health registry of IHD death
[Categorical]IHD death [Categorical]IHD death [Categorical]Prostate cancer [25(OH)D]
Diagnosed 1980-1992, 6-18 y after
All Participants [All Participants]Prostate cancer
[25(OH)D] Diagnosed 1980-1992, 6-18 y after
All Participants [All Participants]Prostate cancer
[25(OH)D] Diagnosed 1980-1992, 6-18 y after
All Participants [All Participants]Prostate cancer
[25(OH)D] Diagnosed 1980-1992, 6-18 y after
All Participants [All Participants]Prostate cancer
[25(OH)D] Diagnosed 1980-1992, 6-18 y after
All Participants [All Participants]Grip strength [Two
measurements Two measurements
Grip strength (year 2)Grip strength [Two
measurements Two measurements
Grip strength (year 5)Chair stands
[Conducted if the Conducted if the subject was able
Chair stands (year 2)Chair stands
[Conducted if the Conducted if the subject was able
Chair stands (year 5)Timed walk [The
timed walk utilized The timed walk utilized a course
Timed walk (year 2)Timed walk [The
timed walk utilized The timed walk utilized a course
Timed walk (year 5)Muscle strength
[Isometric Isometric quadriceps
Right quadriceps strength basalMuscle strength
[Isometric Isometric quadriceps
Left quadriceps strength basalMuscle strength
[Isometric Isometric quadriceps
Right hand grip strengthMuscle strength
[Isometric Isometric quadriceps
Left hand grip strengthFall [Fall free
survival Fall free survival curve
Fall free survival curveFall [Fall free
survival Fall free survival curve
Fall free survival curveFall [Fall free
survival Fall free survival curve
Fall free survival curveFall [Fall free
survival Fall free survival curve
Fall free survival curveTwelve minutes
walk [Continuous]Twelve minutes walkTimed up and go
[Continuous]Fall [Defined as the patient
Defined as the patient fracture [Any
fracture incurred Any fracture incurred during Prostate cancer
[Requested Requested permission to Prostate cancer
[Requested Requested permission to Prostate cancer
[Requested Requested permission to Prostate cancer
[Requested Requested permission to Incident invasive
breast cancer Confirmed by both local and central
Invasive breast cancerIncident invasive
breast cancer Confirmed by both local and central
Invasive breast cancerIncident invasive
breast cancer Confirmed by both local and central
Invasive breast cancerIncident invasive
breast cancer Confirmed by both local and central
Invasive breast cancerIncident invasive
breast cancer Confirmed by both local and central
Invasive breast cancerIncident invasive
breast cancer Confirmed by both local and central
Total breast cancerIncident invasive
breast cancer Confirmed by both local and central
Death from breast cancer
Kg Continuous Body weight N/A (years)pmol/L Continuous 25(OH)D N/A (years)pmol/L Continuous 1,25(OH)D N/A (years)
Categorical N/A (years)Categorical Survival N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical HTN (Rx), Male N/A (years)Categorical HTN (Rx), Male N/A (years)Categorical HTN (Rx), Male N/A (years)Categorical HTN (Rx), Female N/A (years)Categorical HTN (Rx), Female N/A (years)Categorical HTN (Rx), Female N/A (years)Categorical HTN (Rx), Black N/A (years)Categorical HTN (Rx), Black N/A (years)Categorical HTN (Rx), Black N/A (years)Categorical HTN (Rx), White N/A (years)Categorical HTN (Rx), White N/A (years)Categorical HTN (Rx), White N/A (years)Categorical N/A (years)
ng/ml Continuous All Participants N/A (years)ng/ml Continuous All Participants N/A (years)ng/ml Continuous All Participants N/A (years)ng/ml Continuous N/A (years)ng/ml Continuous N/A (years)ng/ml Continuous N/A (years)ng/ml Continuous N/A (years)cm Continuous All Participants N/A (years)cm Continuous All Participants N/A (years)cm Continuous All Participants N/A (years)cm Continuous N/A (years)cm Continuous N/A (years)cm Continuous N/A (years)cm Continuous N/A (years)kg Continuous All Participants N/A (years)kg Continuous All Participants N/A (years)kg Continuous All Participants N/A (years)kg Continuous N/A (years)kg Continuous N/A (years)
Weight change [Change in weight
Change in weight in kg25(OH)D
[Continuous]25(OH)D [Continuous]Adenomas recurrence [nd
nd (only for patients with
Adenomas recurrenceSurvival [nd (only
for patients with nd (only for patients with CRC HTN (Rx) [HTN
medication HTN medication prescribed
All Participants [All Participants]HTN (Rx) [HTN
medication HTN medication prescribed
All Participants [All Participants]HTN (Rx) [HTN
medication HTN medication prescribed
All Participants [All Participants]HTN (Rx) [HTN
medication HTN medication prescribed
All Participants [All Participants]HTN (Rx) [HTN
medication HTN medication prescribed
All Participants [All Participants]HTN (Rx) [HTN
medication HTN medication prescribed
HTN (Rx), Age 40 yHTN (Rx) [HTN
medication HTN medication prescribed
HTN (Rx), Age 40 yHTN (Rx) [HTN
medication HTN medication prescribed
HTN (Rx), Age 40 yHTN (Rx) [HTN
medication HTN medication prescribed
HTN (Rx), Age >40 yHTN (Rx) [HTN
medication HTN medication prescribed
HTN (Rx), Age >40 yHTN (Rx) [HTN
medication HTN medication prescribed
HTN (Rx), Age >40 yHTN (Rx) [HTN
medication HTN medication prescribedHTN (Rx) [HTN
medication HTN medication prescribedHTN (Rx) [HTN
medication HTN medication prescribedHTN (Rx) [HTN
medication HTN medication prescribedHTN (Rx) [HTN
medication HTN medication prescribedHTN (Rx) [HTN
medication HTN medication prescribedHTN (Rx) [HTN
medication HTN medication prescribedHTN (Rx) [HTN
medication HTN medication prescribedHTN (Rx) [HTN
medication HTN medication prescribedHTN (Rx) [HTN
medication HTN medication prescribedHTN (Rx) [HTN
medication HTN medication prescribedHTN (Rx) [HTN
medication HTN medication prescribedHTN (BP or Rx)
[SBP 160 or DBP SBP 160 or DBP 95 or medication
All Participants [All Participants]25(OH)D
[Continuous]25(OH)D [Continuous]25(OH)D [Continuous]25(OH)D [Continuous]
Premenarcheal girls (mean age = 25(OH)D
[Continuous]Premenarcheal girls (mean age = 25(OH)D
[Continuous]Premenarcheal girls (mean age = 25(OH)D
[Continuous]Premenarcheal girls (mean age = height
[Continuous]height [Continuous]height [Continuous]height [Continuous]
Premenarcheal girls (mean age = height
[Continuous]Premenarcheal girls (mean age = height
[Continuous]Premenarcheal girls (mean age = height
[Continuous]Premenarcheal girls (mean age = Weight
[Continuous]Weight [Continuous]Weight [Continuous]Weight [Continuous]
Premenarcheal girls (mean age = Weight
[Continuous]Premenarcheal girls (mean age =
kg Continuous N/A (years)kg Continuous N/A (years)
Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)
Weight [Continuous]
Premenarcheal girls (mean age = Weight
[Continuous]Premenarcheal girls (mean age = Total body BMC
[Continuous]All Participants [All articipants Total body BMC
[Continuous]All Participants [All articipants Total body BMC
[Continuous]All Participants [All articipants Total body BMC
[Continuous]Premenarcheal girls (mean age = Total body BMC
[Continuous]Premenarcheal girls (mean age = Total body BMC
[Continuous]Premenarcheal girls (mean age = Total body BMC
[Continuous]Premenarcheal girls (mean age = 1,25(OH)D
[Continuous]All Participants [All articipants 1,25(OH)D
[Continuous]All Participants [All articipants 1,25(OH)D
[Continuous]All Participants [All articipants Colorectal cancer
[Reported by a Reported by a participant on a Colorectal cancer
[Reported by a Reported by a participant on a Colorectal cancer
[Reported by a Reported by a participant on a Colorectal cancer
[Reported by a Reported by a participant on a Colorectal cancer
[Reported by a Reported by a participant on a Colorectal cancer
[Reported by a Reported by a participant on a Colorectal cancer
[Reported by a Reported by a participant on a Colorectal cancer
[Reported by a Reported by a participant on a Colorectal cancer
[Reported by a Reported by a participant on a Colorectal cancer
[Reported by a Reported by a participant on a Colorectal cancer
[Reported by a Reported by a participant on a Colorectal cancer
[Reported by a Reported by a participant on a Proximal vs. distal
colon cancer Same as above (not data
Colorectal cancer (Total calcium Proximal vs. distal
colon cancer Same as above (not data
Colorectal cancer (Total calcium Proximal vs. distal
colon cancer Same as above (not data
Colorectal cancer (Total calcium Proximal vs. distal
colon cancer Same as above (not data
Colorectal cancer (Total calcium Proximal vs. distal
colon cancer Same as above (not data
Colorectal cancer (Total calcium Proximal vs. distal
colon cancer Same as above (not data
Rectal cancer (Total calcium Proximal vs. distal
colon cancer Same as above (not data
Rectal cancer (Total calcium Proximal vs. distal
colon cancer Same as above (not data
Rectal cancer (Total calcium Proximal vs. distal
colon cancer Same as above (not data
Rectal cancer (Total calcium Proximal vs. distal
colon cancer Same as above (not data
Rectal cancer (Total calcium Proximal vs. distal
colon cancer Same as above (not data
Colon cancer (Total calcium Proximal vs. distal
colon cancer Same as above (not data
Colon cancer (Total calcium Proximal vs. distal
colon cancer Same as above (not data
Colon cancer (Total calcium Proximal vs. distal
colon cancer Same as above (not data
Colon cancer (Total calcium Proximal vs. distal
colon cancer Same as above (not data
Colon cancer (Total calcium Proximal vs. distal
colon cancer Same as above (not data
Proximal colon cancer (Total Proximal vs. distal
colon cancer Same as above (not data
Proximal colon cancer (Total Proximal vs. distal
colon cancer Same as above (not data
Proximal colon cancer (Total Proximal vs. distal
colon cancer Same as above (not data
Proximal colon cancer (Total Proximal vs. distal
colon cancer Same as above (not data
Proximal colon cancer (Total Proximal vs. distal
colon cancer Same as above (not data
Distal colon cancer (Total Proximal vs. distal
colon cancer Same as above (not data
Distal colon cancer (Total Proximal vs. distal
colon cancer Same as above (not data
Distal colon cancer (Total Proximal vs. distal
colon cancer Same as above (not data
Distal colon cancer (Total
Categorical N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Continuous All Participants N/A (years)Continuous All Participants N/A (years)Continuous All Participants N/A (years)Continuous All Participants N/A (years)Continuous All Participants N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical Colorectal cancer N/A (years)Categorical Colorectal cancer N/A (years)
Proximal vs. distal colon cancer
Same as above (not data
Distal colon cancer (Total Hypertension
[Self-reported by Self-reported by the health Hypertension
[Self-reported by Self-reported by the health Hypertension
[Self-reported by Self-reported by the health Hypertension
[Self-reported by Self-reported by the health Hypertension
[Self-reported by Self-reported by the health Hypertension
[Self-reported by Self-reported by the health Hypertension
[Self-reported by Self-reported by the health Cancer mortality
[Based on ICD-10 Based on ICD-10 codes#Cancer mortality
[Based on ICD-10 Based on ICD-10 codes#Cancer mortality
[Based on ICD-10 Based on ICD-10 codes#Cancer mortality
[Based on ICD-10 Based on ICD-10 codes#Cancer mortality
[Based on ICD-10 Based on ICD-10 codes#Lung cancer
mortality [Based Based on ICD-10 codes#
All Participants [All Participants]Lung cancer
mortality [Based Based on ICD-10 codes#
All Participants [All Participants]Lung cancer
mortality [Based Based on ICD-10 codes#
All Participants [All Participants]Digestive cancer
mortality [Based Based on ICD-10 codes#
All Participants [All Participants]Breast cancer
mortality [Based Based on ICD-10 codes#
All Participants [All Participants]Prostate cancer
mortality [Based Based on ICD-10 codes#
All Participants [All Participants]Non-Hodgkin s
lymphoma/leukemBased on ICD-10 codes#
All Participants [All Participants]Colorectal cancer
mortality [Based Based on ICD-10 codes#
All Participants [All Participants]Colorectal cancer
mortality [Based Based on ICD-10 codes#
All Participants [All Participants]Other cancers
mortality [Based Based on ICD-10 codes#
All Participants [All Participants]Other cancers
mortality [Based Based on ICD-10 codes#
All Participants [All Participants]Breast cancer risk
[Incident breast Incident breast cancer classified
Incident breast cancerBreast cancer risk
[Incident breast Incident breast cancer classified
Incident breast cancerBreast cancer risk
[Incident breast Incident breast cancer classified
Incident breast cancerBreast cancer risk
[Incident breast Incident breast cancer classified
Incident breast cancerBreast cancer risk
[Incident breast Incident breast cancer classified
Incident breast cancerBreast cancer risk
[Incident breast Incident breast cancer classified
Incident breast cancerBreast cancer risk
[Incident breast Incident breast cancer classified
Incident breast cancerBreast cancer risk
[Incident breast Incident breast cancer classified
Incident breast cancerBreast cancer risk
[Incident breast Incident breast cancer classified
Incident breast cancerBreast cancer risk
[Incident breast Incident breast cancer classified
Incident breast canceratopic eczema at
9 mo [modified UK modified UK Working Party
atopic eczema at 9 moatopic eczema at
9 mo [modified UK modified UK Working Party
atopic eczema at 9 moatopic eczema at
9 mo [modified UK modified UK Working Party
atopic eczema at 9 moatopic eczema at
9 mo [modified UK modified UK Working Party
atopic eczema at 9 moProstate cancer
[Medical records Medical records and pathology
Total prostate cancerProstate cancer
[Medical records Medical records and pathology
Total prostate cancerProstate cancer
[Medical records Medical records and pathology
Total prostate cancerProstate cancer
[Medical records Medical records and pathology
Total prostate cancerProstate cancer
[Medical records Medical records and pathology
Total prostate cancerProstate cancer
[Medical records Medical records and pathology
Total prostate cancerProstate cancer
[Medical records Medical records and pathology
Total prostate cancerProstate cancer
[Medical records Medical records and pathology
Total prostate cancerColorectal cancer
[Medical and Medical and hospital recordsColorectal cancer
[Medical and Medical and hospital records
Categorical Colorectal cancer N/A (years)Categorical Colorectal cancer N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)
Kg Continuous Kg Weight N/A (years)SBP [Continuous] mm Hg Continuous SBP N/A (years)DBP [Continuous] mm Hg Continuous DBP N/A (years)
Categorical All adenomas N/A (years)Categorical N/A (years)Categorical N/A (years)
nmol/L Continuous sum of D2 and D3 N/A (years)nmol/L Continuous sum of D2 and D3 N/A (years)nmol/L Continuous N/A (years)nmol/L Continuous N/A (years)nmol/L Continuous N/A (years)nmol/L Continuous N/A (years)
Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)
Kg Continuous Body weight N/A (years)SBP [Continuous] mm Hg Continuous SBP N/A (years)DBP [Continuous] mm Hg Continuous DBP N/A (years)
kg Continuous Body weight N/A (years)Categorical nd Prostate cancer N/A (years)Categorical nd Prostate cancer N/A (years)Categorical nd Prostate cancer N/A (years)Categorical nd Prostate cancer N/A (years)Categorical nd Prostate cancer N/A (years)
Colorectal cancer [Medical and
Medical and hospital recordsColorectal cancer
[Medical and Medical and hospital recordsColon cancer [ICD-
8 153.0-153.8 ICD-8 153.0-153.8 (probably registry Colon cancer [ICD-
8 153.0-153.8 ICD-8 153.0-153.8 (probably registry Colon cancer [ICD-
8 153.0-153.8 ICD-8 153.0-153.8 (probably registry Colon cancer [ICD-
8 153.0-153.8 ICD-8 153.0-153.8 (probably registry Colon cancer [ICD-
8 153.0-153.8 ICD-8 153.0-153.8 (probably registry Colon cancer [ICD-
8 153.0-153.8 ICD-8 153.0-153.8 (probably registry Colon cancer [ICD-
8 153.0-153.8 ICD-8 153.0-153.8 (probably registry Colon cancer [ICD-
8 153.0-153.8 ICD-8 153.0-153.8 (probably registry Colon cancer [ICD-
8 153.0-153.8 ICD-8 153.0-153.8 (probably registry Colon cancer [ICD-
8 153.0-153.8 ICD-8 153.0-153.8 (probably registry Weight
[Kg:Continuous]
All adenomas [For each colonoscopy
For each colonoscopy a Advance
adenomas Advanced lesions were defined as
Advanced adenomasAdvance
adenomas Advanced lesions were defined as
Advanced Adenomas25(OH)D total
[sum of D2 and change in total 25(OH)D in young25(OH)D total
[sum of D2 and change in total 25(OH)D in old25(OH)D2
[Continuous]change in 25(OH)D2 in 25(OH)D2
[Continuous]change in 25(OH)D2 in old25(OH)D3
[Continuous]change in 25(OH)D3 in 25(OH)D3
[Continuous]change in 25(OH)D3 in oldRecurrent
adenomas Ascertained by complete
Recurrent adenomasRecurrent
adenomas Ascertained by complete
Recurrent adenomasRecurrent
adenomas Ascertained by complete
Recurrent adenomasRecurrent
adenomas Ascertained by complete
Recurrent adenomasRecurrent
adenomas Ascertained by complete
Recurrent adenomasAdvanced
adenomas Subjects had maximal diameter
Advanced adenomasAdvanced
adenomas Subjects had maximal diameter
Advanced adenomasAdvanced
adenomas Subjects had maximal diameter
Advanced adenomasAdvanced
adenomas Subjects had maximal diameter
Advanced adenomasAdvanced
adenomas Subjects had maximal diameter
Advanced adenomasAdvanced
adenomas Subjects had maximal diameter
Multiple recurrent adenomasAdvanced
adenomas Subjects had maximal diameter
Multiple recurrent adenomasAdvanced
adenomas Subjects had maximal diameter
Multiple recurrent adenomasAdvanced
adenomas Subjects had maximal diameter
Multiple recurrent adenomasAdvanced
adenomas Subjects had maximal diameter
Multiple recurrent adenomasBody weight
[Change in Change in bodyweight in kg
Body weight [Change in kg
Change in kg over 30 monthsProstate cancer
[nd:Categorical]Prostate cancer [nd:Categorical]Prostate cancer [nd:Categorical]Prostate cancer [nd:Categorical]Prostate cancer [nd:Categorical]
Categorical nd Prostate cancer N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical Colorectal cancer N/A (years)Categorical Colorectal cancer N/A (years)Categorical Colorectal cancer N/A (years)Categorical Colorectal cancer N/A (years)Categorical Breast cancer N/A (years)Categorical Breast cancer N/A (years)Categorical Breast cancer N/A (years)Categorical Breast cancer N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical prostate cancer N/A (years)Categorical N/A (years)
kg/m2 Continuous BMI N/A (years)kg Continuous wt N/A (years)cm Continuous ht N/A (years)
Prostate cancer [nd:Categorical]Rectal cancer [Finish cancer
Finish cancer registry (no clear
Colorectal cancer (total Ca [mg])Rectal cancer
[Finish cancer Finish cancer registry (no clear
Colorectal cancer (total Ca [mg])Rectal cancer
[Finish cancer Finish cancer registry (no clear
Colorectal cancer (total Ca [mg])Rectal cancer
[Finish cancer Finish cancer registry (no clear
Colorectal cancer (total Ca [mg])Rectal cancer
[Finish cancer Finish cancer registry (no clear
Colon cancer (total Ca [mg])Rectal cancer
[Finish cancer Finish cancer registry (no clear
Colon cancer (total Ca [mg])Rectal cancer
[Finish cancer Finish cancer registry (no clear
Colon cancer (total Ca [mg])Rectal cancer
[Finish cancer Finish cancer registry (no clear
Colon cancer (total Ca [mg])Rectal cancer
[Finish cancer Finish cancer registry (no clear
Rectal cancer (total Ca [mg])Rectal cancer
[Finish cancer Finish cancer registry (no clear
Rectal cancer (total Ca [mg])Rectal cancer
[Finish cancer Finish cancer registry (no clear
Rectal cancer (total Ca [mg])Rectal cancer
[Finish cancer Finish cancer registry (no clear
Rectal cancer (total Ca [mg])Colorectal cancer
[Record linkage to Record linkage to cancer registries
Colorectal cancer (Total Ca [mg])Colorectal cancer
[Record linkage to Record linkage to cancer registries
Colorectal cancer (Total Ca [mg])Colorectal cancer
[Record linkage to Record linkage to cancer registries
Colorectal cancer (Total Ca [mg])Colorectal cancer
[Record linkage to Record linkage to cancer registries
Colorectal cancer (Total Ca [mg])Colorectal cancer
[Record linkage to Record linkage to cancer registries
Colorectal cancer (Total Ca [mg])Colorectal Cancer
[Self reports (in Self reports (in the questionnaires
Colorectal cancer (total Ca [mg])Colorectal Cancer
[Self reports (in Self reports (in the questionnaires
Colorectal cancer (total Ca [mg])Colorectal Cancer
[Self reports (in Self reports (in the questionnaires
Colorectal cancer (total Ca [mg])Colorectal Cancer
[Self reports (in Self reports (in the questionnaires
Colorectal cancer (total Ca [mg])Colon caner
[Response to the Response to the biennial
Colon cancer (total Ca intake Colon caner
[Response to the Response to the biennial
Colon cancer (total Ca intake Colon caner
[Response to the Response to the biennial
Colon cancer (total Ca intake Colon caner
[Response to the Response to the biennial
Colon cancer (total Ca intake Colon caner
[Response to the Response to the biennial
Colon cancer (total Ca intake Colorectal cancer
[Mostly diagnosed Mostly diagnosed when Colorectal cancer
[Mostly diagnosed Mostly diagnosed when Colorectal cancer
[Mostly diagnosed Mostly diagnosed when Colorectal cancer
[Mostly diagnosed Mostly diagnosed when Incident breast
cancer [Self Self reported and identified through Incident breast
cancer [Self Self reported and identified through Incident breast
cancer [Self Self reported and identified through Incident breast
cancer [Self Self reported and identified through Incident breast
cancer [Self Self reported and identified through
Breast cancer in post menopausal Incident breast
cancer [Self Self reported and identified through
Breast cancer in post menopausal Incident breast
cancer [Self Self reported and identified through
Breast cancer in post menopausal Incident breast
cancer [Self Self reported and identified through
Breast cancer in post menopausal Incident breast
cancer [Self Self reported and identified through
Breast cancer in pre-menopausal Incident breast
cancer [Self Self reported and identified through
Breast cancer in pre-menopausal Incident breast
cancer [Self Self reported and identified through
Breast cancer in pre-menopausal Incident breast
cancer [Self Self reported and identified through
Breast cancer in pre-menopausal prostate cancer
[self-reported of self-reported of physician-prostate cancer
[self-reported of self-reported of physician-
fatal prostate cancerchange in BMI
[Continuous]change in wt [Continuous]change in ht [Continuous]
Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical Cerebral infarction N/A (years)Categorical Cerebral infarction N/A (years)Categorical Cerebral infarction N/A (years)Categorical Cerebral infarction N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)
incident cancer [from medical
from medical record (including
incident cancer (years 1-4)incident cancer
[from medical from medical record (including
incident cancer (years 1-4)incident cancer
[from medical from medical record (including
incident cancer (years 1-4)incident cancer
[from medical from medical record (including
incident cancer (years 2-4)incident cancer
[from medical from medical record (including
incident cancer (years 2-4)incident cancer
[from medical from medical record (including
incident cancer (years 2-4)stress fractures
[Stress fractures Stress fractures were ascertained
Stress fracture (ITT analysis)stress fractures
[Stress fractures Stress fractures were ascertained
Stress fracture (per protocol Colorectal caner
[National Swedish National Swedish Cancer Register (-
Colorectal cancer (total Ca intake Colorectal caner
[National Swedish National Swedish Cancer Register (-
Colorectal cancer (total Ca intake Colorectal caner
[National Swedish National Swedish Cancer Register (-
Colorectal cancer (total Ca intake Colorectal caner
[National Swedish National Swedish Cancer Register (-
Colorectal cancer (total Ca intake Rectal caner
[National Swedish National Swedish Cancer Register (-
Rectal cancer (total Ca intake Rectal caner
[National Swedish National Swedish Cancer Register (-
Rectal cancer (total Ca intake Rectal caner
[National Swedish National Swedish Cancer Register (-
Rectal cancer (total Ca intake Rectal caner
[National Swedish National Swedish Cancer Register (-
Rectal cancer (total Ca intake Distal colon caner
[National Swedish National Swedish Cancer Register (-
Colon cancer (total Ca intake Distal colon caner
[National Swedish National Swedish Cancer Register (-
Colon cancer (total Ca intake Distal colon caner
[National Swedish National Swedish Cancer Register (-
Colon cancer (total Ca intake Distal colon caner
[National Swedish National Swedish Cancer Register (-
Colon cancer (total Ca intake Colorectal caner
[National Swedish National Swedish Cancer Register (-
Colorectal cancer (total Ca intake Colorectal caner
[National Swedish National Swedish Cancer Register (-
Colorectal cancer (total Ca intake Colorectal caner
[National Swedish National Swedish Cancer Register (-
Colorectal cancer (total Ca intake Colorectal caner
[National Swedish National Swedish Cancer Register (-
Colorectal cancer (total Ca intake Rectal caner
[National Swedish National Swedish Cancer Register (-
Rectal cancer (total Ca intake Rectal caner
[National Swedish National Swedish Cancer Register (-
Rectal cancer (total Ca intake Rectal caner
[National Swedish National Swedish Cancer Register (-
Rectal cancer (total Ca intake Rectal caner
[National Swedish National Swedish Cancer Register (-
Rectal cancer (total Ca intake Distal colon caner
[National Swedish National Swedish Cancer Register (-
Colon cancer (total Ca intake Distal colon caner
[National Swedish National Swedish Cancer Register (-
Colon cancer (total Ca intake Distal colon caner
[National Swedish National Swedish Cancer Register (-
Colon cancer (total Ca intake Distal colon caner
[National Swedish National Swedish Cancer Register (-
Colon cancer (total Ca intake Cerebral infarction
included here Cerebral infarction included here Cerebral infarction included here Cerebral infarction included here Invasive breast cancer [Linkage
Linkage with national and
Invasive breast cancerInvasive breast
cancer [Linkage Linkage with national and
Invasive breast cancerInvasive breast
cancer [Linkage Linkage with national and
Invasive breast cancerInvasive breast
cancer [Linkage Linkage with national and
Invasive breast cancerInvasive breast
cancer [Linkage Linkage with national and
Invasive breast cancerProstate cancer
[Tumor Gleason Tumor Gleason score, grade,
Total prostate cancerProstate cancer
[Tumor Gleason Tumor Gleason score, grade,
Total prostate cancerProstate cancer
[Tumor Gleason Tumor Gleason score, grade,
Total prostate cancerProstate cancer
[Tumor Gleason Tumor Gleason score, grade,
Total prostate cancerProstate cancer
[Tumor Gleason Tumor Gleason score, grade,
Total prostate cancerProstate cancer
[Tumor Gleason Tumor Gleason score, grade,
Total prostate cancerProstate cancer
[Tumor Gleason Tumor Gleason score, grade,
Total prostate cancer
Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)
ng/mL Continuous 25(OH)D N/A (years)pg/mL Continuous 1,25(OH)D N/A (years)mm Hg Continuous SBP (standing) N/A (years)mm Hg Continuous DBP (standing) N/A (years)mm Hg Continuous SBP (supine) N/A (years)mm Hg Continuous DBP (supine) N/A (years)
Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)
Kg Continuous N/A (years)Kg Continuous N/A (years)
Prostate cancer [Tumor Gleason
Tumor Gleason score, grade,
Total prostate cancerProstate cancer
[Tumor Gleason Tumor Gleason score, grade,
Total prostate cancerProstate cancer
[Tumor Gleason Tumor Gleason score, grade,
Total prostate cancerProstate cancer
[Tumor Gleason Tumor Gleason score, grade,
Aggressive prostate cancerProstate cancer
[Tumor Gleason Tumor Gleason score, grade,
Aggressive prostate cancerProstate cancer
[Tumor Gleason Tumor Gleason score, grade,
Aggressive prostate cancerProstate cancer
[Tumor Gleason Tumor Gleason score, grade,
Aggressive prostate cancerProstate cancer
[Tumor Gleason Tumor Gleason score, grade,
Aggressive prostate cancerProstate cancer
[Tumor Gleason Tumor Gleason score, grade,
Aggressive prostate cancerProstate cancer
[Tumor Gleason Tumor Gleason score, grade,
Aggressive prostate cancerProstate cancer
[Tumor Gleason Tumor Gleason score, grade,
Aggressive prostate cancerProstate cancer
[Tumor Gleason Tumor Gleason score, grade,
Aggressive prostate cancerProstate cancer
[Tumor Gleason Tumor Gleason score, grade,
Aggressive prostate cancerProstate cancer
[Tumor Gleason Tumor Gleason score, grade,
Total prostate cancer age >= 65 Prostate cancer
[Tumor Gleason Tumor Gleason score, grade,
Total prostate cancer age >= 65 Prostate cancer
[Tumor Gleason Tumor Gleason score, grade,
Total prostate cancer age >= 65 Prostate cancer
[Tumor Gleason Tumor Gleason score, grade,
Total prostate cancer age >= 65 Prostate cancer
[Tumor Gleason Tumor Gleason score, grade,
Total prostate cancer age >= 65 Prostate cancer
[Tumor Gleason Tumor Gleason score, grade,
Total prostate cancer age >= 65 Prostate cancer
[Tumor Gleason Tumor Gleason score, grade,
Aggressive prostate cancer Prostate cancer
[Tumor Gleason Tumor Gleason score, grade,
Aggressive prostate cancer Prostate cancer
[Tumor Gleason Tumor Gleason score, grade,
Aggressive prostate cancer Prostate cancer
[Tumor Gleason Tumor Gleason score, grade,
Aggressive prostate cancer Prostate cancer
[Tumor Gleason Tumor Gleason score, grade,
Aggressive prostate cancer Prostate cancer
[Tumor Gleason Tumor Gleason score, grade,
Aggressive prostate cancer 25(OH)D
[Competitive Competitive protein binding 1,25(OH)D
[Radioreceptor Radioreceptor assay (Medgenix SBP (standing)
[Continuous]SBP (standing) [Continuous]SBP (standing) [Continuous]DBP (supine) [Continuous]Distal colon cancer [Not fully
Not fully defined (data not
Colorectal cancer (total Ca [mg])Distal colon
cancer [Not fully Not fully defined (data not
Colorectal cancer (total Ca [mg])Distal colon
cancer [Not fully Not fully defined (data not
Colorectal cancer (total Ca [mg])Distal colon
cancer [Not fully Not fully defined (data not
Colorectal cancer (total Ca [mg])Distal colon
cancer [Not fully Not fully defined (data not
Colorectal cancer (total Ca [mg])Breast cancer
[Incident cases of Incident cases of invasive breast
Invasive breast cancer-Breast cancer
[Incident cases of Incident cases of invasive breast
Invasive breast cancer-Breast cancer
[Incident cases of Incident cases of invasive breast
Invasive breast cancer-Breast cancer
[Incident cases of Incident cases of invasive breast
Invasive breast cancer-Breast cancer
[Incident cases of Incident cases of invasive breast
Invasive breast cancer-Breast cancer
[Incident cases of Incident cases of invasive breast
Invasive breast cancer-Breast cancer
[Incident cases of Incident cases of invasive breast
Invasive breast cancer-Breast cancer
[Incident cases of Incident cases of invasive breast
Invasive breast cancer-Breast cancer
[Incident cases of Incident cases of invasive breast
Invasive breast cancer-Breast cancer
[Incident cases of Incident cases of invasive breast
Invasive breast cancer-body weight
[Continuous]weight in medium (1000-body weight
[Continuous]weight in low (<713 mg/d)
cm Continuous N/A (years)cm Continuous N/A (years)mmol/L Continuous N/A (years)mmol/L Continuous N/A (years)
Categorical N/A (years)Categorical nd mortality N/A (years)
Kg Continuous Kg Weight N/A (years)BMI [Continuous] Kg/m2 Continuous BMI N/A (years)SBP [Continuous] mmHg Continuous SBP N/A (years)DBP [Continuous] mmHg Continuous DBP N/A (years)
Categorical Hypertension N/A (years)mmHg Continuous Systolic BP N/A (years)mmHg Continuous Diastolic BP N/A (years)
Categorical AMI N/A (years)Categorical AMI N/A (years)Categorical AMI N/A (years)Categorical AMI N/A (years)Categorical AMI N/A (years)Categorical Same Stroke N/A (years)Categorical Same Stroke N/A (years)Categorical Same Stroke N/A (years)Categorical Same Stroke N/A (years)Categorical Same Stroke N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical nd toxemia N/A (years)
Kg Continuous N/A (years)cm Categorical crown-heel length N/A (years)wk Continuous gestational age N/A (years)g Continuous N/A (years)g Continuous infant birth weight N/A (years)
CRC [Categorical] Categorical CRC N/A (years)CRC [Categorical] Categorical CRC N/A (years)CRC [Categorical] Categorical CRC N/A (years)CRC [Categorical] Categorical CRC N/A (years)CRC [Categorical] Categorical CRC N/A (years)
Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)
height [Continuous]
height in medium (1000-height
[Continuous]height in low (<713 mg/d) 25(OH)D
[Continuous]25(OH)D in medium (1000-25(OH)D
[Continuous]25(OH)D in low (<713 mg/d) First fracture
[Confirmed by Confirmed by matching every
First fracture (all sites)Mortality
[nd:Categorical]Weight [Kg:Continuous]
Hypertension [Self-report of
Self-report of medication Systolic BP
[Continuous]Systolic BP [Continuous]AMI [ICD 9 codes from national
ICD 9 codes from national death AMI [ICD 9 codes
from national ICD 9 codes from national death AMI [ICD 9 codes
from national ICD 9 codes from national death AMI [ICD 9 codes
from national ICD 9 codes from national death AMI [ICD 9 codes
from national ICD 9 codes from national death Stroke
[Same:CategoricalStroke [Same:CategoricalStroke [Same:CategoricalStroke [Same:CategoricalStroke [Same:CategoricalAdenoma recurrence [One
One or more adenomas or
Adenoma recurrenceAdenoma
recurrence [One One or more adenomas or
Adenoma recurrenceAdenoma
recurrence [One One or more adenomas or
Adenoma recurrenceAdenoma
recurrence [One One or more adenomas or
Adenoma recurrencetoxemia
[nd:Categorical]newborn birth weight
newborn birth weightcrown-heel length
[Categorical]gestational age [Continuous]birth weight [Continuous]
maternal weight gain 3rd trimesterbirth weight
[Continuous]
Mammography density [Ratio of
Ratio of the absolute area of
Mammographic density at age 36 Mammography
density [Ratio of Ratio of the absolute area of
Mammographic density at age 36 Mammography
density [Ratio of Ratio of the absolute area of
Mammographic density at age 36 Mammography
density [Ratio of Ratio of the absolute area of
Mammographic density at age 36 Mammography
density [Ratio of Ratio of the absolute area of
Mammographic density at age 36 Mammography
density [Ratio of Ratio of the absolute area of
Mammographic density at age 43 Mammography
density [Ratio of Ratio of the absolute area of
Mammographic density at age 43 Mammography
density [Ratio of Ratio of the absolute area of
Mammographic density at age 43 Mammography
density [Ratio of Ratio of the absolute area of
Mammographic density at age 43 Mammography
density [Ratio of Ratio of the absolute area of
Mammographic density at age 43
Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical preeclampsia N/A (years)Categorical N/A (years)
mmHg Continuous SBP (ITT analysis) N/A (years)mmHg Continuous N/A (years)mmHg Continuous Same as SBP DBP (ITT) N/A (years)mmHg Continuous Same as SBP DBP (per protocol) N/A (years)nmol/L Continuous 25(OH)D (ITT) N/A (years)nmol/L Continuous N/A (years)kg/m2 Continuous Weight (ITT) N/A (years)kg/m2 Continuous N/A (years)kg/m2 Continuous BMI (ITT) N/A (years)
Continuous BMI (per protocol) N/A (years)nmol/L Continuous 25(OH)D N/A (years)
Categorical prostate cancer N/A (years)Categorical prostate cancer N/A (years)Categorical Adenoma N/A (years)Categorical Adenoma N/A (years)Categorical Adenoma N/A (years)Categorical Adenoma N/A (years)Categorical Adenoma N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical Rectum cancer N/A (years)Categorical Rectum cancer N/A (years)Categorical Rectum cancer N/A (years)Categorical Rectum cancer N/A (years)Categorical Rectum cancer N/A (years)Categorical Men N/A (years)Categorical Men N/A (years)Categorical Men N/A (years)Categorical Men N/A (years)Categorical Women N/A (years)Categorical Women N/A (years)Categorical Women N/A (years)Categorical Women N/A (years)Categorical Men N/A (years)
prostate cancer [Finnish Cancer
Finnish Cancer Registry (medical prostate cancer
[Finnish Cancer Finnish Cancer Registry (medical prostate cancer
[Finnish Cancer Finnish Cancer Registry (medical prostate cancer
[Finnish Cancer Finnish Cancer Registry (medical prostate cancer
[Finnish Cancer Finnish Cancer Registry (medical prostate cancer
[Finnish Cancer Finnish Cancer Registry (medical fatal prostate
cancer All Participants [All articipants fatal prostate
cancer All Participants [All articipants fatal prostate
cancer All Participants [All articipants preeclampsia
[HTN (DBP 90 HTN (DBP 90 mm) and Pregnancy-
induced Pregnancy-induced SBP [Automated
OMRON electronic Automated OMRON electronic SBP [Automated
OMRON electronic Automated OMRON electronic
SBP (per protocol analysis)DBP [Same as
SBP:Continuous]DBP [Same as SBP:Continuous]25(OH)D [Continuous]25(OH)D [Continuous]
25(OH)D (per protocol)Weight (ITT)
[Continuous]Weight (ITT) [Continuous]
Weight (per protocol)Weight (ITT)
[Continuous]BMI (per protocol) [Continuous]Serum 25(OH)D change prostate cancer [biopsy or surgical
biopsy or surgical specimen; prostate cancer
[biopsy or surgical biopsy or surgical specimen; Colorectal
adenoma Reviewed the medical records Colorectal
adenoma Reviewed the medical records Colorectal
adenoma Reviewed the medical records Colorectal
adenoma Reviewed the medical records Colorectal
adenoma Reviewed the medical records Distal colon
cancer Distal colon cancerDistal colon
cancer Distal colon cancerDistal colon
cancer Distal colon cancerDistal colon
cancer Distal colon cancerDistal colon
cancer Distal colon cancerDistal colon
cancer Distal colon cancer Distal colon cancer Distal colon cancer Distal colon cancer Colorectal cancer [Adenocarcinoma
Adenocarcinoma (Collected for the Colorectal cancer
[Adenocarcinoma Adenocarcinoma (Collected for the Colorectal cancer
[Adenocarcinoma Adenocarcinoma (Collected for the Colorectal cancer
[Adenocarcinoma Adenocarcinoma (Collected for the Colorectal cancer
[Adenocarcinoma Adenocarcinoma (Collected for the Colorectal cancer
[Adenocarcinoma Adenocarcinoma (Collected for the Colorectal cancer
[Adenocarcinoma Adenocarcinoma (Collected for the Colorectal cancer
[Adenocarcinoma Adenocarcinoma (Collected for the Colon cancer [See
above (ICD180-See above (ICD180-189 only)
Categorical Men N/A (years)Categorical Men N/A (years)Categorical Men N/A (years)Categorical Women N/A (years)Categorical Women N/A (years)Categorical Women N/A (years)Categorical Women N/A (years)Categorical Men N/A (years)Categorical Men N/A (years)Categorical Men N/A (years)Categorical Men N/A (years)Categorical Women N/A (years)Categorical Women N/A (years)Categorical Women N/A (years)Categorical Women N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical Prostate cancer N/A (years)Categorical Prostate cancer N/A (years)Categorical Prostate cancer N/A (years)Categorical Prostate cancer N/A (years)Categorical Prostate cancer N/A (years)Categorical Prostate cancer N/A (years)Categorical Prostate cancer N/A (years)Categorical Prostate cancer N/A (years)Categorical Prostate cancer N/A (years)Categorical Prostate cancer N/A (years)
mmHg Continuous SBP N/A (years)mmHg Continuous Same as SBP DBP N/A (years)nmol/L Continuous 25(OH)D N/A (years)
Categorical Colorectal cancer N/A (years)Categorical Colorectal cancer N/A (years)Categorical Colorectal cancer N/A (years)Categorical Colorectal cancer N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)
Colon cancer [See above (ICD180-
See above (ICD180-189 only)Colon cancer [See
above (ICD180-See above (ICD180-189 only)Colon cancer [See
above (ICD180-See above (ICD180-189 only)Colon cancer [See
above (ICD180-See above (ICD180-189 only)Colon cancer [See
above (ICD180-See above (ICD180-189 only)Colon cancer [See
above (ICD180-See above (ICD180-189 only)Colon cancer [See
above (ICD180-See above (ICD180-189 only)Rectal cancer [See
above (ICD199 See above (ICD199 and 209 Rectal cancer [See
above (ICD199 See above (ICD199 and 209 Rectal cancer [See
above (ICD199 See above (ICD199 and 209 Rectal cancer [See
above (ICD199 See above (ICD199 and 209 Rectal cancer [See
above (ICD199 See above (ICD199 and 209 Rectal cancer [See
above (ICD199 See above (ICD199 and 209 Rectal cancer [See
above (ICD199 See above (ICD199 and 209 Rectal cancer [See
above (ICD199 See above (ICD199 and 209 Colorectal cancer
[Identified by Identified by means of linkage
Colorectal cancer (Men)Colorectal cancer
[Identified by Identified by means of linkage
Colorectal cancer (Men)Colorectal cancer
[Identified by Identified by means of linkage
Colorectal cancer (Men)Colorectal cancer
[Identified by Identified by means of linkage
Colorectal cancer (Men)Colorectal cancer
[Identified by Identified by means of linkage
Colorectal cancer (Men)Colorectal cancer
[Identified by Identified by means of linkage
Colorectal cancer (Women)Colorectal cancer
[Identified by Identified by means of linkage
Colorectal cancer (Women)Colorectal cancer
[Identified by Identified by means of linkage
Colorectal cancer (Women)Colorectal cancer
[Identified by Identified by means of linkage
Colorectal cancer (Women)Colorectal cancer
[Identified by Identified by means of linkage
Colorectal cancer (Women)incident prostate
cancer [8 state 8 state cancer registry
total prostate cancerincident prostate
cancer [8 state 8 state cancer registry
fatal prostate cancerProstate cancer
[Identified by Identified by linkage of cohort Prostate cancer
[Identified by Identified by linkage of cohort Prostate cancer
[Identified by Identified by linkage of cohort Prostate cancer
[Identified by Identified by linkage of cohort Prostate cancer
[Identified by Identified by linkage of cohort Prostate cancer
[Identified by Identified by linkage of cohort Prostate cancer
[Identified by Identified by linkage of cohort Prostate cancer
[Identified by Identified by linkage of cohort Prostate cancer
[Identified by Identified by linkage of cohort Prostate cancer
[Identified by Identified by linkage of cohort SBP [Measured
after at least 5 Measured after at least 5 min of DBP [Same as
SBP:Continuous]25(OH)D [Continuous]Colon cancer or rectal cancer
Incident cases of colon or rectal Colon cancer or
rectal cancer Incident cases of colon or rectal Colon cancer or
rectal cancer Incident cases of colon or rectal Colon cancer or
rectal cancer Incident cases of colon or rectal Distal colorectal
adenoma Adenomatous polyps by review
All Participants [All Participants]Distal colorectal
adenoma Adenomatous polyps by review
All Participants [All Participants]Distal colorectal
adenoma Adenomatous polyps by review
All Participants [All Participants]Distal colorectal
adenoma Adenomatous polyps by review
All Participants [All Participants]
Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)
Kg Continuous Kg, BMI Weight N/A (years)BMI [Continuous] kg/m2 Continuous BMI N/A (years)SBP [Continuous] mm Hg Continuous SBP N/A (years)DBP [Continuous] mm Hg Continuous DBP N/A (years)
Categorical Prostate cancer N/A (years)Categorical Prostate cancer N/A (years)Categorical Prostate cancer N/A (years)Categorical Prostate cancer N/A (years)Categorical Prostate cancer N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical Fatal stroke N/A (years)Categorical Fatal stroke N/A (years)Categorical Fatal stroke N/A (years)
mmHg Continuous SBP N/A (years)Continuous DBP N/A (years)
ng/mL Continuous 25(OH)D N/A (years)Categorical Colorectal cancer N/A (years)Categorical Colorectal cancer N/A (years)Categorical Colorectal cancer N/A (years)Categorical Colorectal cancer N/A (years)Categorical Colorectal cancer N/A (years)Categorical Pancreatic cancer N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)
Distal colorectal adenoma
Adenomatous polyps by review
All Participants [All Participants]Distal colorectal
adenoma Adenomatous polyps by review
All Participants [All Participants]Distal colorectal
adenoma Adenomatous polyps by review
All Participants [All Participants]Distal colorectal
adenoma Adenomatous polyps by review
All Participants [All Participants]Distal colorectal
adenoma Adenomatous polyps by review
All Participants [All Participants]Rectal adenoma
[Adenomatous Adenomatous polyps by review
All Participants [All articipants Rectal adenoma
[Adenomatous Adenomatous polyps by review
All Participants [All articipants Rectal adenoma
[Adenomatous Adenomatous polyps by review
All Participants [All articipants Rectal adenoma
[Adenomatous Adenomatous polyps by review
All Participants [All articipants Rectal adenoma
[Adenomatous Adenomatous polyps by review
All Participants [All articipants Rectal adenoma
[Adenomatous Adenomatous polyps by review
All Participants [All articipants Distal colon
adenoma Adenomatous polyps by review
All Participants [All articipants Distal colon
adenoma Adenomatous polyps by review
All Participants [All articipants Distal colon
adenoma Adenomatous polyps by review
All Participants [All articipants Distal colon
adenoma Adenomatous polyps by review
All Participants [All articipants Distal colon
adenoma Adenomatous polyps by review
All Participants [All articipants Distal colon
adenoma Adenomatous polyps by review
All Participants [All articipants high-risk distal
colon cancer Large (1 cm or larger), villous or
All Participants [All articipants high-risk distal
colon cancer Large (1 cm or larger), villous or
All Participants [All articipants high-risk distal
colon cancer Large (1 cm or larger), villous or
All Participants [All articipants Weight [Kg,
BMI:Continuous]
Prostate cancer [Incident cases
Incident cases identified through Prostate cancer
[Incident cases Incident cases identified through Prostate cancer
[Incident cases Incident cases identified through Prostate cancer
[Incident cases Incident cases identified through Prostate cancer
[Incident cases Incident cases identified through incident prostate
cancer [Cancer Cancer Registry; death certificates;
incident prostate cancerincident prostate
cancer [Cancer Cancer Registry; death certificates;
incident prostate cancerincident prostate
cancer [Cancer Cancer Registry; death certificates;
incident prostate cancerFatal stroke
[Categorical]Fatal stroke [Categorical]Fatal stroke [Categorical]SBP [BP was measured twice
BP was measured twice pre and post DBP [BP was
measured twice BP was measured twice pre and post 25(OH)D [As
measured by As measured by competitive Colorectal cancer
[Cohort members Cohort members have been Colorectal cancer
[Cohort members Cohort members have been Colorectal cancer
[Cohort members Cohort members have been Colorectal cancer
[Cohort members Cohort members have been Colorectal cancer
[Cohort members Cohort members have been Pancreatic cancer
[Self-reported Self-reported diagnosis in the 2-Cancer mortality
[The residence at The residence at death and the
Gastrointestinal cancer mortality Cancer mortality
[The residence at The residence at death and the
Gastrointestinal cancer mortality Cancer mortality
[The residence at The residence at death and the
Gastrointestinal cancer mortality Cancer mortality
[The residence at The residence at death and the
Gastrointestinal cancer mortality
Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical Pancreatic cancer N/A (years)Categorical Pancreatic cancer N/A (years)Categorical Pancreatic cancer N/A (years)Categorical Pancreatic cancer N/A (years)Categorical Pancreatic cancer N/A (years)Categorical pancreatic cancer N/A (years)Categorical Pancreatic cancer N/A (years)Categorical Pancreatic cancer N/A (years)Categorical Pancreatic cancer N/A (years)Categorical Pancreatic cancer N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical N/A (years)Categorical N/A (years)
Cancer mortality [The residence at
The residence at death and the
Gastrointestinal cancer mortality Cancer mortality
[The residence at The residence at death and the
Gastrointestinal cancer mortality Cancer mortality
[The residence at The residence at death and the
Gastrointestinal cancer mortality Cancer mortality
[The residence at The residence at death and the
Gastrointestinal cancer mortality Cancer mortality
[The residence at The residence at death and the
Gastrointestinal cancer mortality Cancer mortality
[The residence at The residence at death and the
Gastrointestinal cancer mortality All-cause mortality
[The residence at The residence at death and the
All cause mortality MenAll-cause mortality
[The residence at The residence at death and the
All cause mortality MenAll-cause mortality
[The residence at The residence at death and the
All cause mortality MenAll-cause mortality
[The residence at The residence at death and the
All cause mortality MenAll-cause mortality
[The residence at The residence at death and the
All cause mortality MenAll-cause mortality
[The residence at The residence at death and the
Total cancer mortality MenAll-cause mortality
[The residence at The residence at death and the
Total cancer mortality MenAll-cause mortality
[The residence at The residence at death and the
Total cancer mortality MenAll-cause mortality
[The residence at The residence at death and the
Total cancer mortality MenAll-cause mortality
[The residence at The residence at death and the
Total cancer mortality MenAll-cause mortality
[The residence at The residence at death and the
All cause mortality WomenAll-cause mortality
[The residence at The residence at death and the
All cause mortality WomenAll-cause mortality
[The residence at The residence at death and the
All cause mortality WomenAll-cause mortality
[The residence at The residence at death and the
All cause mortality WomenAll-cause mortality
[The residence at The residence at death and the
All cause mortality WomenAll-cause mortality
[The residence at The residence at death and the
Total cancer mortality All-cause mortality
[The residence at The residence at death and the
Total cancer mortality All-cause mortality
[The residence at The residence at death and the
Total cancer mortality All-cause mortality
[The residence at The residence at death and the
Total cancer mortality All-cause mortality
[The residence at The residence at death and the
Total cancer mortality Pancreatic cancer
[Vital status of Vital status of cohort Pancreatic cancer
[Vital status of Vital status of cohort Pancreatic cancer
[Vital status of Vital status of cohort Pancreatic cancer
[Vital status of Vital status of cohort Pancreatic cancer
[Vital status of Vital status of cohort Pancreatic cancer
[odds ratios (OR) odds ratios (OR) for pancreatic Pancreatic cancer
[odds ratios (OR) odds ratios (OR) for pancreatic Pancreatic cancer
[odds ratios (OR) odds ratios (OR) for pancreatic Pancreatic cancer
[odds ratios (OR) odds ratios (OR) for pancreatic Pancreatic cancer
[odds ratios (OR) odds ratios (OR) for pancreatic Colorectal cancer
[Diagnosis of Diagnosis of primary Colorectal cancer
[Diagnosis of Diagnosis of primary Colorectal cancer
[Diagnosis of Diagnosis of primary Colorectal cancer
[Diagnosis of Diagnosis of primary Colorectal cancer
[Diagnosis of Diagnosis of primary Colorectal cancer
[Diagnosis of Diagnosis of primary Colon cancer
[Diagnosis of Diagnosis of primary Colon cancer
[Diagnosis of Diagnosis of primary Colon cancer
[Diagnosis of Diagnosis of primary Colon cancer
[Diagnosis of Diagnosis of primary Colon cancer
(excluding the 2 y All Participants [All articipants Colon cancer
(excluding the 2 y All Participants [All articipants
Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)
Kg Continuous Change in kg/yr N/A (years)Categorical same as above N/A (years)Categorical same as above N/A (years)Categorical same as above N/A (years)Categorical same as above N/A (years)Categorical same as above All Causes N/A (years)Categorical same as above All Cancers N/A (years)Categorical same as above Colorectal N/A (years)Categorical same as above Respiratory N/A (years)Categorical same as above Breast N/A (years)Categorical same as above N/A (years)Categorical same as above Colorectal Cancer N/A (years)Categorical same as above N/A (years)Categorical same as above Breast Cancer N/A (years)Categorical same as above Self Reported Falls N/A (years)Categorical Respira-ry N/A (years)Categorical Total stroke N/A (years)Categorical Total stroke N/A (years)Categorical Total stroke N/A (years)Categorical Total stroke N/A (years)
CHD [Categorical] Categorical CHD N/A (years)CHD [Categorical] Categorical CHD N/A (years)CHD [Categorical] Categorical CHD N/A (years)CHD [Categorical] Categorical CHD N/A (years)
Kg Continuous Body weight in kg Body weight N/A (years)BMI [Continuous] Kg/m2 Continuous BMI N/A (years)
Categorical mortality N/A (years)Categorical nd All cause mortality N/A (years)Categorical N/A (years)Categorical Intestinal Polyp N/A (years)Categorical Kidney stone (UL) N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical Total cancer N/A (years)Categorical Cancer mortality N/A (years)
ng/mL Continuous N/A (years)Continuous at 2 mo N/A (years)
Colon cancer (excluding the 2 y
All Participants [All articipants Colon cancer
(excluding the 2 y All Participants [All articipants Colon cancer
(excluding the 2 y All Participants [All articipants Colon cancer
(excluding the 2 y All Participants [All articipants Rectal cancer
[Diagnosis of Diagnosis of primary
All Participants [All articipants Rectal cancer
[Diagnosis of Diagnosis of primary
All Participants [All articipants Rectal cancer
[Diagnosis of Diagnosis of primary
All Participants [All articipants Rectal cancer
(excluding the 2 y All Participants [All articipants Rectal cancer
(excluding the 2 y All Participants [All articipants Rectal cancer
(excluding the 2 y All Participants [All articipants Bodyweight
[Change in Bodyweight changeCerebrovascular
disease incidence Cardiovascular DiseaseCerebrovascular
disease incidence Ischaemic Heart DiseaseCerebrovascular
disease incidence Cerebrovascular DiseaseCerebrovascular
disease incidence IschaemicHeart DiseaseAll cancers
incidence [same All cancers incidence [same Colorectal cancer incidence [same Respiratory cancer incidence Breast cancer incidence (female) Breast cancer incidence (female)
Cancer Excluding SkinBreast cancer
incidence (female) Breast cancer incidence (female)
Respiratory CancerBreast cancer
incidence (female) Falls incidence [same as Respira-ry [Categorical]Fatal stroke [Death certificates
Death certificates & medical recordsFatal stroke
[Death certificates Death certificates & medical recordsFatal stroke
[Death certificates Death certificates & medical recordsFatal stroke
[Death certificates Death certificates & medical records
Body weight [Body weight in
mortality [by death
by death certificateAll cause mortality
[nd:Categorical]Death from colorectal cancer
Death from colorectal cancer
Death from colorectal cancerIntestinal polyps
[Intestinal polyps Intestinal polyps based on Kidney stone
[Kidney stone Kidney stone based on Cancer related
mortality [Kidney Kidney stone based on
Invasive colorectal cancerCancer related
mortality [Kidney Kidney stone based on
Invasive colon cancerCancer related
mortality [Kidney Kidney stone based on
Invasive rectal cancerCancer related
mortality [Kidney Kidney stone based on Cancer related
mortality [Kidney Kidney stone based on vit D3 level in
mom [Continuous]mom 25 (OH)D at 1 moat 2 mo
[Continuous]
Continuous at 2 mo N/A (years)Continuous at 3 mo N/A (years)Continuous at 4 mo N/A (years)Continuous at 4 mo N/A (years)Continuous at 5 mo N/A (years)Continuous at 6 mo N/A (years)Continuous at 7 mo N/A (years)Continuous at 7 mo N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Continuous N/A (years)Categorical CV event N/A (years)Categorical CV event N/A (years)Categorical CV event N/A (years)Categorical CV event N/A (years)
% change Continuous PI (total) N/A (years)% change Continuous N/A (years)% change Continuous N/A (years)% change Continuous PI (curve) N/A (years)% change Continuous Total fecal calcium N/A (years)% change Continuous N/A (years)% change Continuous N/A (years)
Categorical stroke N/A (years)Categorical stroke N/A (years)Categorical stroke N/A (years)
SBP [Continuous] mm Hg Continuous SBP N/A (years)DBP [Continuous] mm Hg Continuous DBP N/A (years)
Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)
at 2 mo [Continuous]at 2 mo [Continuous]at 2 mo [Continuous]at 2 mo [Continuous]at 2 mo [Continuous]at 2 mo [Continuous]at 2 mo [Continuous]at 2 mo [Continuous]at 2 mo [Continuous]
mom vit D3 level at 1 moat 2 mo
[Continuous]antirachitic activity in milk at at 2 mo
[Continuous]infant 25 (OH)D at 1 moat 2 mo
[Continuous]infant weight at 1 moat 2 mo
[Continuous]infant length at 1 moFirst
cardiovascular MI, coronary insufficiency, First
cardiovascular MI, coronary insufficiency, First
cardiovascular MI, coronary insufficiency, First
cardiovascular MI, coronary insufficiency, PI [Change in PI%
of each of 5 Change in PI% of each of 5 PI [Change in PI%
of each of 5 Change in PI% of each of 5
PI (highest compartment)#PI [Change in PI%
of each of 5 Change in PI% of each of 5
PI (lowest compartment)#PI [Change in PI%
of each of 5 Change in PI% of each of 5 Calcium balance
[Total fecal Total fecal calcium and urinary Calcium balance
[Total fecal Total fecal calcium and urinary
Water soluble fecal calciumCalcium balance
[Total fecal Total fecal calcium and urinary
Total urine calciumstroke [Self-
reported and Self-reported and cross-checked by stroke [Self-
reported and Self-reported and cross-checked by stroke [Self-
reported and Self-reported and cross-checked by
Primary adenocarcinoma
Reported as diagnosis of colon Proximal (right
sided) colon Colon cancer located in cecum, Distal (left sided)
colon cancer Colon cancer located in Colorectal cancer
[The vast majority The vast majority of colorectal Colorectal cancer
[The vast majority The vast majority of colorectal Colorectal cancer
[The vast majority The vast majority of colorectal Colorectal cancer
[The vast majority The vast majority of colorectal Colorectal cancer
[The vast majority The vast majority of colorectal Colon cancer
[Categorical]Colon cancer [Categorical]Colon cancer [Categorical]Colon cancer [Categorical]Proximal colon cancer Proximal colon cancer Proximal colon cancer Proximal colon cancer Distal colon cancer Distal colon cancer Distal colon cancer
Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical All Participants N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)Categorical N/A (years)
mmHg Continuous N/A (years)BMI [Continuous] kg/m2 Continuous All Participants N/A (years)
Categorical All Participants N/A (years)Categorical All Participants N/A (years)
mg/cm2 Continuous All Participants 12 (months)mg/cm2 Continuous All Participants 12 (months)mg/cm2 Continuous All Participants 60 (months)mg/cm2 Continuous All Participants N/A (years)nmol/L Continuous All Participants N/A (years)
Distal colon cancer Rectal cancer [Categorical]Rectal cancer [Categorical]Rectal cancer [Categorical]Rectal cancer [Categorical]
Colorectal cancer (only >2y since Rectal cancer
[Categorical]Colorectal cancer (only >2y since Rectal cancer
[Categorical]Colorectal cancer (only >2y since Rectal cancer
[Categorical]Colorectal cancer (only >2y since Rectal cancer
[Categorical]Colorectal cancer (only >2y since Rectal cancer
[Categorical]Colon cancer (only >2y since blood Rectal cancer
[Categorical]Colon cancer (only >2y since blood Rectal cancer
[Categorical]Colon cancer (only >2y since blood Rectal cancer
[Categorical]Colon cancer (only >2y since blood in SBP
[Continuous]SBP in white women
Rectal cancer [State Health
State Health Registry of Iowa, Rectal cancer
[State Health State Health Registry of Iowa, BMD [Measured at
the hip with an Measured at the hip with an BMD [Measured at
the hip with an Measured at the hip with an BMD [Measured at
the hip with an Measured at the hip with an BMD [Hip and
total body. Hip and total body. DXA25(OH)D
[Continuous]
Comparatornd nd - - -nd nd - - -nd nd - - -nd nd - - -- - OR 1.12- - OR 1.61- - OR 1.42- - OR 1.32nd nd - - -nd nd - - -nd nd - - -nd nd - - -- - - -- - - -- - - -- - - -nd nd - - -nd nd - - -nd nd - - -- - - -- - - -- - - -- - - -- - - -- 0.43 - -- 0.43 - -- 0.43 - -- 0.43 - -- 0.43 - -- 0.43 - -- 0.43 - -- 0.43 - -- 0.72 - -- 0.72 - -- 0.72 - -- 0.72 - -- - - - -NS 0.67 Adjusted - -NS 0.67 Adjusted - -NS 0.67 Adjusted - -NS 0.67 Adjusted - -
Total vs. Total - - - -0.03 - - - -NS - - - -<0.0001 - - - -<0.0001 - - - -<0.0001 - - - -
P between groups***
P for trend****
Crude or Adjusted
Outcome Metric (e.g.
Outcome effect size Quintile 2: 42.5-
51.3 nmol/L vs. Quintile 3: 51.4-60.5 nmol/L vs. Quintile 4: 60.6-71.7 nmol/L vs. Quintile 5: 71.8-129.5 nmol/L vs. quintiles based on season of
[Adjusted for age at cohort entry; quintiles based on
season of [Adjusted for age at cohort entry; quintiles based on
season of [Adjusted for age at cohort entry; quintiles based on
season of [Adjusted for age at cohort entry; Quintile 2: 42.5-
51.3 nmol/L vs. Quintile 3: 51.4-60.5 nmol/L vs. Quintile 4: 60.6-71.7 nmol/L vs. Quintile 5: 71.8-129.5 nmol/L vs. Serum 25(OH)D - Quintile 1: 12.8-
[Adjusted for age at cohort entry; Serum 25(OH)D -
Quintile 1: 12.8-[Adjusted for age at cohort entry; Serum 25(OH)D -
Quintile 1: 12.8-[Adjusted for age at cohort entry; Serum 25(OH)D -
Quintile 1: 12.8-[Adjusted for age at cohort entry; Quartile 3:
25(OH)D = 41-54 Quartile 2: 25(OH)D = 31-40 Quartile 1: 25(OH)D = < 30 Quartile cut off based on total
[crude][adjusted for HDL; SBP; BMI]Quartile cut off
based on total [crude][adjusted for HDL; SBP; BMI]Quartile cut off
based on total [crude][adjusted for HDL; SBP; BMI]25(OH)D - Group
1: >40 vs. [adjusted HDL; SBP; BMI]25(OH)D - Group
1: >40 vs. [adjusted HDL; SBP; BMI]Ca intake -
Quintile 1 vs. Ca Adjusted ( multivariate )Ca intake -
Quintile 1 vs. Ca Adjusted ( multivariate )Ca intake -
Quintile 1 vs. Ca Adjusted ( multivariate )Ca intake -
Quintile 1 vs. Ca Adjusted ( multivariate )Ca intake -
Quintile 1 vs. Ca Adjusted ( multivariate )Ca intake -
Quintile 1 vs. Ca Adjusted ( multivariate )Ca intake -
Quintile 1 vs. Ca Adjusted ( multivariate )Ca intake -
Quintile 1 vs. Ca Adjusted ( multivariate )Ca intake -
Quintile 1 vs. Ca Adjusted ( multivariate )Ca intake -
Quintile 1 vs. Ca Adjusted ( multivariate )Ca intake -
Quintile 1 vs. Ca Adjusted ( multivariate )Ca intake -
Quintile 1 vs. Ca Adjusted ( multivariate )Ca supplement vs.
Calcium placeboQuintile 1 vs. Quintile 2Quintile 1 vs. Quintile 3Quintile 1 vs. Quintile 4Quintile 1 vs. Quintile 5
Placebo vs. Vit D3 10 ug/dPlacebo vs. Vit D3 20 ug/dPlacebo vs. Vit D3 10 ug/dPlacebo vs. Vit D3 20 ug/dPlacebo vs. Vit D3 10 ug/d
<0.0001 - - - -Total vs. Total - - - -
NS - - - -NS - - - -NS - - - -NS - - - -NS - - - -NS - - - -NS - - - -NS - - - -NS 0.53 Adjusted - -NS 0.53 Adjusted - -NS 0.53 Adjusted - -NS 0.53 Adjusted - -<.05 nd Adjusted - -NS nd Adjusted - -NS nd - - -NS nd - - -NS 0.76 - - -NS 0.76 - - -NS 0.76 - - -NS 0.76 - - -0.68, 1.32 NS - - -0.50, 1.03 NS - - -0.60, 1.19 NS - - -0.63, 1.23 NS - - -nd 0.51 adjusted - -nd 0.51 adjusted - -nd 0.70 adjusted - -nd 0.70 adjusted - -nd 0.92 adjusted - -nd 0.92 adjusted - -nd 0.39 Adjusted - -nd - -nd Adjusted - -nd Adjusted - -nd Adjusted - -nd 0.39 Adjusted - -nd 0.39 Adjusted - -nd 0.39 Adjusted - -0.262 nd - - -nd nd - - -- - - - -
Cases vs. Controls 0.01 - - - -- - - - -- - - - -- - - - -- - - - -
Placebo vs. Vit D3 20 ug/d
Placebo vs. Vit D3 10 ug/dPlacebo vs. Vit D3 20 ug/dPlacebo vs. Vit D3 10 ug/dPlacebo vs. Vit D3 20 ug/dPlacebo vs. Vit D3 10 ug/dPlacebo vs. Vit D3 20 ug/dPlacebo vs. Vit D3 10 ug/dPlacebo vs. Vit D3 20 ug/dCa intake Categories Ca intake Categories Ca intake Categories Ca intake Categories Ca intake Categories Ca intake Categories Ca intake Categories Ca intake Categories Ca intake - Quintile 1 vs. Ca Ca intake - Quintile 1 vs. Ca Ca intake - Quintile 1 vs. Ca Ca intake - Quintile 1 vs. Ca Ca intake - Quintile 2 vs. Ca Ca intake - Quintile 3 vs. Ca Ca intake - Quintile 4 vs. Ca Ca intake - Quintile 5 vs. 8851Baseline dietary Ca intake - Tertile Baseline dietary Ca intake - Tertile Baseline 25(OH)D - Tertile 1 vs. Baseline 25(OH)D - Tertile 1 vs. Baseline 1,25(OH)2D - Baseline 1,25(OH)2D - 25(OH)2D - Quintile 1 vs. 25(OH)D - Quintile 1 vs. 25(OH)D -
.04 (only data available for
Adjusted (both analyses 25(OH)D - Quintile
1 vs. 25(OH)D - .04 (only data available for 25(OH)D - Quintile
1 vs. 25(OH)D - .04 (only data available for 25(OH)D - Quintile
1 vs. 25(OH)D - .04 (only data available for 25(OH)2D -
Quintile 1 vs. 25(OH)2D - Quintile 1 vs. 25(OH)2D - Quintile 1 vs. Placebo vs. Cholecalciferol Cholecalciferol 1200 IU/day vs. Vit D + Ca vs. Placebo
Calcium vs. PlaceboCalcium vs. PlaceboCalcium vs. PlaceboCalcium vs. Placebo
- - - - -- - - - -- - - - -- - - - -- - - - -- - - - -- - - - -0.55-1.22 nd - - -0.52-1.16 nd - - -0.55-1.23 nd - - -
Quintile 5 vs. 8886 0.33-0.82 nd - - -0.45, 0.85 <.05 - - -0.55, 1.03 >.05 - - -0.47, 0.94 <.05 - - -nd 0.60 crude - -nd 0.60 crude - -nd 0.60 crude - -nd 0.60 crude - -nd NS crude - -- - - - -- - - - -- - - - -- - - - -- - - - -- - - - -- - - - -- - - - -- - - - -- - - - -nd NS - - -nd nd - - -nd nd - - -nd nd - - -- - - - -- - - - -- - - - -- - - - -nd nd - - -0.96-1.53 nd - - -1.09-1.66 nd - - -1.04-1.62 nd - - -0.58 to 1.36 nd - - -0.83 to 1.90 nd - - -0.70 to 1.62 nd - - -0.45 to 1.06 nd - - -0.60 to 1.39 nd - - -- - - - -- - - - -
Vit D + Ca vs. PlaceboVit D + Ca vs. PlaceboCalcium vs. PlaceboQuintile 1 vs. Quintile 2Quintile 1 vs. Quintile 3Quintile 1 vs. Quintile 4Quintile 1 vs. Quintile 5Quintile 2 vs. Quintile 3Quintile 3 vs. Quintile 4Quintile 4 vs. Quintile 5
Ca intake - Quartile 2 vs. Ca Ca intake - Quartile 3 vs. Ca Ca intake - Quartile 4 vs. Quintile 1 vs. Quintile 2Quintile 1 vs. Quintile 3Quintile 1 vs. Quintile 4Quintile 1 vs. Quintile 5Quintile 1 vs. Quintile 2-5Vit D + Ca vs. CalciumVit D + Ca vs. CalciumVit D + Ca vs. CalciumVit D + Ca vs. CalciumVit D + Ca vs. CalciumVit D + Ca vs. CalciumNo training + Ca, vit D vs. Training No training + Ca, vit D vs. Training No training + Ca, vit D vs. Training No training + Ca, vit D vs. Training No training + Ca, vit D vs. Training Training + Ca vs. No training + Ca No training + Ca + Vit D vs. Training + + Ca + Vit D vs. Vit D + No training + Ca, vit D vs. Training No training + Ca, vit D vs. Training Vit D + Ca vs. CalciumVit D + Ca vs. CalciumDairy Ca intake - Quartile 1 vs. Dairy Ca intake - Quartile 2 vs. Dairy Ca intake - Quartile 3 vs. Dairy Ca intake - Quartile 4 vs. Baseline 25(OH)D - Quintile 1: >= Baseline 25(OH)D - Quintile 2: 55.4 Baseline 25(OH)D - Quintile 3: 43.9 Baseline 25(OH)D - Quintile 4: 32.4 Baseline 25(OH)D - Quintile 5: < Calcium carbonate 400 IU Vit D3 Calcium carbonate 400 IU Vit D3
- - - - -- - - - -- - - - -- - - - -- - - - -
000 - nd Adjusted (age) - -- - Unadjusted - -- - Unadjusted - -- - Adjusted (age) - -- - - - -<.05 Adjusted - -<.05 - - - -<.05 - - - -NS - Adjusted - -NS - - - -NS - - - -NS NS male vs female Adjusted - -NS - - - -NS - - - -NS - Adjusted - -NS - - - -NS - - - -NS NS black vs white Adjusted - -NS - - - -NS - - - -NS - Adjusted - -NS - - - -NS - - - -- - - - -- - - - -- - - - -- - - - -
000 - - - - -- - - - -- - - - -- - - - -- - - - -- - - - -- - - - -
000 - - - - -- - - - -- - - - -- - - - -- - - - -- - - - -- - - - -
000 - - - - -- - - - -
Calcium, both weight Calcium, both weight Calcium, both weight Calcium carbonicum, Calcium carbonicum
Quartile 1 vs. Quartile 2Quartile 1 vs. Quartile 3Quartile 1 vs. Quartile 4Ca intake, per 1 g/day increase vs. Quartile 1 vs. Quartile 2
<.05 younger vs olderQuartile 1 vs.
Quartile 3Quartile 1 vs. Quartile 4Quartile 1 vs. Quartile 2Quartile 1 vs. Quartile 3Quartile 1 vs. Quartile 4Quartile 1 vs. Quartile 2Quartile 1 vs. Quartile 3Quartile 1 vs. Quartile 4Quartile 1 vs. Quartile 2Quartile 1 vs. Quartile 3Quartile 1 vs. Quartile 4Quartile 1 vs. Quartile 2Quartile 1 vs. Quartile 3Quartile 1 vs. Quartile 4Quartile 1 vs. Quartile 2Quartile 1 vs. Quartile 3Quartile 1 vs. Quartile 4Ca intake, per 1 g/day increase vs. Placebo vs. Low Vit DPlacebo vs. High Vit DLow Vit D vs. High Vit D
Placebo vs. Low Vit DPlacebo vs. High Vit DLow Vit D vs. High Vit DPlacebo vs. Low Vit DPlacebo vs. High Vit DLow Vit D vs. High Vit D
Placebo vs. Low Vit DPlacebo vs. High Vit DLow Vit D vs. High Vit DPlacebo vs. Low Vit DPlacebo vs. High Vit DLow Vit D vs. High Vit D
Placebo vs. Low Vit D
- - - - -- - - - -- - - - -- - - - -- - - - -
000 - - - - -- - - - -- - - - -- - - - -- - - - -- - - - -- - - - -0.53-1.63 nd - - -0.44-1.40 nd - - -0.31-1.07 nd - - -- 0.02 Adjusted - -- 0.02 Adjusted - -- 0.02 Adjusted - -- 0.02 Adjusted - -0.27-1.04 nd - - -- 0.51 Adjusted - -- 0.51 Adjusted - -- 0.51 Adjusted - -- 0.51 Adjusted - -nd 0.02 - - -nd nd - - -nd nd - - -nd nd - - -
Quintile 5 vs. 8984 nd nd - - -nd 0.30 - - -nd nd - - -nd nd - - -nd nd - - -
Quintile 5 vs. 8984 nd nd - - -nd 0.10 - - -nd nd - - -nd nd - - -nd nd - - -
Quintile 5 vs. 8984 nd nd - - -nd 0.24 - - -nd nd - - -nd nd - - -nd nd - - -
Quintile 5 vs. 8984 nd nd - - -nd 0.26 - - -nd nd - - -nd nd - - -nd nd - - -
Placebo vs. High Vit DLow Vit D vs. High Vit DPlacebo vs. Low Vit DPlacebo vs. High Vit DLow Vit D vs. High Vit D
Placebo vs. Low Vit DPlacebo vs. High Vit DLow Vit D vs. High Vit DPlacebo vs. Low Vit DPlacebo vs. High Vit DLow Vit D vs. High Vit D25(OH)D - Quintile 2 vs. 25(OH)D - 25(OH)D - Quintile 3 vs. 25(OH)D - 25(OH)D - Quintile 4 vs. 25(OH)D - 25(OH)D - Quintile 1 vs. 25(OH)D - 25(OH)D - Quintile 1 vs. 25(OH)D - 25(OH)D - Quintile 1 vs. 25(OH)D - 25(OH)D - Quintile 1 vs. 25(OH)D - 25(OH)D - Quintile 5 vs. 1,25(OH)2D - 1,25(OH)2D - Quintile 1 vs. 1,25(OH)2D - Quintile 1 vs. 1,25(OH)2D - Quintile 1 vs. 1,25(OH)2D - Quintile 1 vs. Quintile 1 vs. Quintile 2Quintile 2 vs. Quintile 3Quintile 3 vs. Quintile 4Quintile 4 vs. Quintile 5
Quintile 1 vs. Quintile 2Quintile 2 vs. Quintile 3Quintile 3 vs. Quintile 4Quintile 4 vs. Quintile 5
Quintile 1 vs. Quintile 2Quintile 2 vs. Quintile 3Quintile 3 vs. Quintile 4Quintile 4 vs. Quintile 5
Quintile 1 vs. Quintile 2Quintile 2 vs. Quintile 3Quintile 3 vs. Quintile 4Quintile 4 vs. Quintile 5
Quintile 1 vs. Quintile 2Quintile 2 vs. Quintile 3Quintile 3 vs. Quintile 4Quintile 4 vs. Quintile 5
Quintile 5 vs. 8984 nd nd - - -- 0.01 Adjusted - -- 0.01 Adjusted - -- 0.01 Adjusted - -1.06, 2.18 nd - - -1.07, 2.23 nd - - -1.11, 2.48 nd - - -- - - - -
6-Q1 vs. 6-Q2 nd 0.65 Adjusted - -6-Q1 vs. 6-Q3 nd 0.65 Adjusted - -6-Q1 vs. 6-Q4 nd 0.65 Adjusted - -6-Q1 vs. 6-Q5 nd 0.65 Adjusted - -6-Q1 vs. 6-Q6 nd 0.65 Adjusted - -4-Q1 vs. 4-Q2 nd 0.41 Adjusted - -4-Q1 vs. 4-Q3 nd 0.41 Adjusted - -4-Q1 vs. 4-Q4 nd 0.41 Adjusted - -2-Q1 vs. 2-Q2 nd 0.18 Adjusted - -2-Q1 vs. 2-Q2 nd 0.76 Adjusted - -2-Q1 vs. 2-Q2 nd 0.95 Adjusted - -2-Q1 vs. 2-Q2 nd 0.96 Adjusted - -3-Q1 vs. 3-Q2 nd 0.02 Adjusted - -3-Q1 vs. 3-Q3 nd 0.02 Adjusted - -3-Q1 vs. 3-Q2 nd 0.84 Adjusted - -3-Q1 vs. 3-Q3 nd 0.84 Adjusted - -
nd 0.81 - - -nd nd - - -nd nd - - -nd nd - - -nd nd - - -nd 0.14 - - -nd nd - - -nd nd - - -nd nd - - -nd nd - - -nd nd - - -nd nd - - -nd nd - - -nd nd - - -nd 0.82 - - -nd nd - - -nd nd - - -nd nd - - -nd 0.50 - - -nd nd - - -nd nd - - -nd nd - - -nd nd - - -nd nd - - -
Quartile 1 vs. Quartile 2Quartile 1 vs. Quartile 3Quartile 1 vs. Quartile 4Quartile 2 vs. Quartile 3Quartile 3 vs. Quartile 4Quartile 4 vs. 8990< 30.0 vs. >= 30.0
Quintile 1: <18.3 ng/mL vs. Quintile Quintile 2: 18.3-<23.5 ng/mL vs. Quintile 3: 23.5-<28.3 ng/mL vs. Quintile 4: 28.3-<33.7 ng/mL vs. Quintile 5: >= 33.7 ng/mL vs. Quintile 1: <28.2 pg/mL vs. Quintile Quintile 2: 28.2-<33.5 pg/mL vs. Quintile 3: 33.5-<39 pg/mL vs. Quintile 4: 39-<46.3 pg/mL vs. Quintile 5: >= 46.3 pg/mL vs. Quartile 1:<30 nmol/L vs. Quartile Quartile 2: 30-50 vs. Quartile 3: Quartile 3: >50-75 vs. Quartile 4: >75Quartile 4: >75 vs. 9012Quartile 1: 25-D 6.3-21.3 ng/mL vs. Quartile 2: 25-D 21.4-28.4 vs. Quartile 3: 25-D 28.5-37.4 vs. Quartile 4: 25-D 37.5-77.8 vs. Quartile 1: 1,25-D 13.8-28.5 pg/mL Quartile 2: 1,25-D 28.6-33.8 vs. Quartile 3: 1,25-D 33.9-40.1 vs. Quartile 4: 1,25-D 40.2-129.1 vs. Ca (mg/1000kcal) - Quartile 1 vs. Ca Ca (mg/1000kcal) - Quartile 2 vs. Ca
nd nd - - -nd nd - - -- - - -0.05 (vs. Q1) - - -0.05 (vs. Q1) - - -- - - -
9028 vs. 9029 nd nd - - -9029 vs. 9030 nd nd - - -9030 vs. 9031 nd nd - - -9031 vs. 9032 nd nd - - -
0.13 - - -0.05 (1-sided) - - -- - - - -- - - - -- - - - -- - - - -- - - - -- - - - -- - - - -- - - - -- - - - -- - - - -- - - - -- - - - -nd 0.20 - - -nd nd - - -nd nd - - -nd nd - - -nd nd - - -nd 0.98 - - -nd nd - - -nd nd - - -nd nd - - -nd nd - - -nd 0.36 - - -nd nd - - -nd nd - - -nd nd - - -nd nd - - -- - - - -- - - - -- - - - -- - - - -nd 0.51 - - -nd nd - - -nd nd - - -nd 0.90 - - -nd nd - - -
Ca (mg/1000kcal) - Quartile 3 vs. Ca Ca (mg/1000kcal) - Quartile 4 vs. 25(OH)D - Quintile 1 vs. 25(OH)D -
Adjusted (matching)25(OH)D - Quintile
1 vs. 25(OH)D - Adjusted (matching)25(OH)D - Quintile
1 vs. 25(OH)D - Adjusted (matching)25(OH)D - Quintile
1 vs. 25(OH)D - Adjusted (matching)
25(OH)D - Group 1 [0-29] vs.
Adjusted (matching)25(OH)D - Group 1
[0-19] vs. Adjusted (matching)Dairy diet vs.
Dairy free dietDairy diet vs. Dairy free dietDairy diet vs. Dairy free dietCalcium vs. PlaceboCalcium vs. PlaceboCalcium vs. PlaceboVit D2 supplment vs. 9051Vit D2 supplment vs. 9051Vit D2 supplment vs. 9051Vit D2 supplment vs. 9051Vit D2 supplment vs. 9051Vit D2 supplment vs. 9051Ca intake - Quintile 1 vs. Ca Ca intake - Quintile 3 vs. Ca Ca intake - Quintile 4 vs. Ca Ca intake - Quintile 2 vs. Ca Ca intake - Quintile 5 vs. 9057Ca intake - Quintile 1 vs. Ca Ca intake - Quintile 3 vs. Ca Ca intake - Quintile 4 vs. Ca Ca intake - Quintile 2 vs. Ca Ca intake - Quintile 5 vs. 9057Ca intake - Quintile 1 vs. Ca Ca intake - Quintile 3 vs. Ca Ca intake - Quintile 4 vs. Ca Ca intake - Quintile 2 vs. Ca Ca intake - Quintile 5 vs. 9057High dairy (high Ca) vs. Control Ca supplement (prenatal) vs. zero Ca supplement (prenatal) vs. zero Vit D3 + Ca vs. Calcium1,25(OH)D - Tertile 1: 8.1-25.3 1,25(OH)D - Tertile 2: 25.4-1,25(OH)D - Tertile 3: 32.8-1,25(OH)D - Tertile 1: 13.7-1,25(OH)D - Tertile 2: 27.6-
nd nd - - -nd 0.97 - - -nd nd - - -nd nd - - -nd nd - - -nd 0.17 - - -nd nd - - -nd nd - - -nd nd - - -nd 0.19 - - -nd nd - - -nd nd - - -nd nd - - -nd 0.87 - - -nd nd - - -nd nd - - -nd nd - - -
Quintile 5 vs. 9101 nd nd - - -Ref nd - - -0.67-1.95 nd - - -0.52-1.57 nd - - -0.39-1.28 nd - - -nd 0.01 - - -nd nd - - -nd nd - - -nd nd - - -
Quintile 5 vs. 9112 nd nd - - -0.51-1.19 nd - - -nd nd - - -0.63-1.41 nd - - -0.47-1.10 nd - - -nd 0.04 - - -nd nd - - -nd nd - - -nd nd - - -nd 0.64 - - -nd nd - - -nd nd - - -nd nd - - -nd 0.01 - - -nd nd - - -nd nd - - -nd nd - - -
Dairy Ca vs. 9124 nd 0.64 - - -Dairy Ca vs. 9124 nd 0.52 - - -
- - - - -- - - - -- - - - -
1,25(OH)D - Tertile 3: 33.0-Quartile 1 vs. Quartile 2Quartile 2 vs. Quartile 3Quartile 3 vs. Quartile 4Quartile 4 vs. 9088Quartile 1 vs. Quartile 2Quartile 2 vs. Quartile 3Quartile 3 vs. Quartile 4Quartile 4 vs. 9088Quartile 1 vs. Quartile 2Quartile 2 vs. Quartile 3Quartile 3 vs. Quartile 4Quartile 4 vs. 9088Quintile 1 vs. Quintile 2Quintile 2 vs. Quintile 3Quintile 3 vs. Quintile 4Quintile 4 vs. Quintile 5
Quartile 1 vs. Quartile 2Quartile 2 vs. Quartile 3Quartile 3 vs. Quartile 4Quartile 4 vs. 9106Quintile 1 vs. Quintile 2Quintile 2 vs. Quintile 3Quintile 3 vs. Quintile 4Quintile 4 vs. Quintile 5
Ca intake - Quartile 3 vs. Ca Ca intake - Quartile 1 vs. Ca Ca Intake - Quartile 2 vs. Ca Ca intake - Quartile 4 vs. Quartile 1 vs. Quartile 2Quartile 2 vs. Quartile 3Quartile 3 vs. Quartile 4Quartile 4 vs. 9122Quartile 1 vs. Quartile 2Quartile 2 vs. Quartile 3Quartile 3 vs. Quartile 4Quartile 4 vs. 9122Quartile 1 vs. Quartile 2Quartile 2 vs. Quartile 3Quartile 3 vs. Quartile 4Quartile 4 vs. 9122
Ca enriched diet vs. Usual dietCa enriched diet vs. Usual dietCa enriched diet vs. Usual diet
nd - - -nd nd - - -nd nd - - -nd nd - - -nd nd - - -nd nd - - -- - - - -- - - - -nd 0.03 - - -nd nd - - -nd nd - - -nd nd - - -nd 0.05 - - -nd nd - - -nd nd - - -nd nd - - -nd 0.24 - - -nd nd - - -nd nd - - -nd nd - - -nd 0.03 - - -nd nd - - -nd nd - - -nd nd - - -nd 0.05 - - -nd nd - - -nd nd - - -nd nd - - -nd 0.24 - - -nd nd - - -nd nd - - -nd nd - - -0.95, 1.22 NS - - -0.96, 1.23 NS - - -0.98, 1.26 NS - - -0.98, 1.26 NS - - -Reference nd - - -0.87-1.09 nd - - -0.84-1.06 nd - - -0.83-1.04 nd - - -0.87-1.09 nd - - -nd nd - - -nd 0.91 - - -nd nd - - -nd nd - - -nd 0.74 - - -nd nd - - -nd - - -
Placebo vs. Calcium
chi2=7.3 with df 2; P<0.03 Calcium vs. Ca +
Vit DCa + Vit D vs. Ca + Vit DPlacebo vs. CalciumCalcium vs. Ca + Vit DCa + Vit D vs. Ca + Vit DCa + Vit D vs. PlaceboCa + Vit D vs. PlaceboQuartile 1 vs. Quartile 2Quartile 2 vs. Quartile 3Quartile 3 vs. Quartile 4Quartile 4 vs. 9140Quartile 1 vs. Quartile 2Quartile 2 vs. Quartile 3Quartile 3 vs. Quartile 4Quartile 4 vs. 9140Quartile 1 vs. Quartile 2Quartile 2 vs. Quartile 3Quartile 3 vs. Quartile 4Quartile 4 vs. 9140Quartile 1 vs. Quartile 2Quartile 2 vs. Quartile 3Quartile 3 vs. Quartile 4Quartile 4 vs. 9145Quartile 1 vs. Quartile 2Quartile 2 vs. Quartile 3Quartile 3 vs. Quartile 4Quartile 4 vs. 9145Quartile 1 vs. Quartile 2Quartile 2 vs. Quartile 3Quartile 3 vs. Quartile 4Quartile 4 vs. 9145Ca intake - Quintile 2 vs. Ca Ca intake - Quintile 3 vs. Ca Ca intake - Quintile 4 vs. Ca Ca intake - Quintile 5 vs. 9151Ca intake - Quintile 1: <727 Ca intake - Quintile 2: 727-Ca intake - Quintile 3: 863-Ca intake - Quintile 4: 980-Ca intake - Quintile 5: >= Quartile 2 vs. Quartile 3Quartile 1: lowest 25(OH)D vs. Quartile 3 vs. Quartile 4: highest Quartile 4: highest 25(OH)D vs. Quartile 1: lowest 1,25(OH)D vs. Quartile 4: highest 1,25(OH)D vs. Low Low 25(OH)D, Low 1,25(OH)D vs. Low
0.85 (p-value for interaction)
nd nd - - -nd nd - - -nd nd - - -nd nd - - -nd 0.74 - - -nd nd - - -nd nd - - -nd 0.07 - - -nd nd - - -nd - - -nd nd - - -nd nd - - -nd nd - - -nd nd - - -nd 0.95 - - -nd nd - - -nd nd - - -nd 0.26 - - -nd nd - - -nd nd - - -nd 0.68 - - -nd nd - - -nd nd - - -nd 0.03 - - -nd nd - - -- - - - -- - - - -- - - - -- - - - -- - - - -- - - - -Ref nd - - -0.46-1.18 nd - - -0.81-1.84 nd - - -0.60-1.43 nd - - -
Quintile 5 vs. 9176 0.81-1.82 nd - - -nd 0.14 - - -nd nd - - -nd nd - - -nd nd - - -nd nd - - -nd 0.17 - - -nd nd - - -nd nd - - -nd nd - - -nd nd - - -- - - - -- - - - -
Low 25(OH)D, High 1,25(OH)D High 25(OH)D, Low 1,25(OH)D vs. High 25(OH)D, High 1,25(OH)D Quartile 2 vs. Quartile 3Quartile 1: lowest 25(OH)D vs. Quartile 3 vs. Quartile 4: highest Quartile 4: highest 25(OH)D vs. Quartile 1: lowest 1,25(OH)D vs. Quartile 4: highest 1,25(OH)D vs. Low Low 25(OH)D, Low 1,25(OH)D vs. Low
0.23 (p-value for interaction)Low 25(OH)D,
High 1,25(OH)D High 25(OH)D, Low 1,25(OH)D vs. High 25(OH)D, High 1,25(OH)D Quartile 2 vs. Quartile 3Quartile 1: lowest 25(OH)D vs. Quartile 3 vs. Quartile 4: highest Quartile 4: highest 25(OH)D vs. Quartile 1: lowest 1,25(OH)D vs. Quartile 4: highest 1,25(OH)D vs. Low Quartile 2 vs. Quartile 3Quartile 1: lowest 25(OH)D vs. Quartile 3 vs. Quartile 4: highest Quartile 4: highest 25(OH)D vs. Quartile 1: lowest 1,25(OH)D vs. Quartile 4: highest 1,25(OH)D vs. Low Ca supplement vs. PlaceboCa supplement vs. PlaceboCa supplement vs. PlaceboCa supplement vs. PlaceboCa supplement vs. PlaceboCa supplement vs. PlaceboQuintile 1 vs. Quintile 2Quintile 2 vs. Quintile 3Quintile 3 vs. Quintile 4Quintile 4 vs. Quintile 5
Ca intake - Quintile 1 vs. Ca Ca intake - Quintile 2 vs. Ca Ca intake - Quintile 3 vs. Ca Ca intake - Quintile 4 vs. Ca Ca intake - Quintile 5 vs. Ca intake - Quintile 1 vs. Ca Ca intake - Quintile 2 vs. Ca Ca intake - Quintile 3 vs. Ca Ca intake - Quintile 4 vs. Ca Ca intake - Quintile 5 vs. Calcium vs. PlaceboCalcium vs. Placebo
- - - - -- - - - -- - - - -- - - - -
Vit D2 vs. 9187 - - - - -Vit D2 vs. 9187 - - - - -
- - - - -- - - - -- - - - -- - - - -- - - - -- - - - -- - - - -nd nd - - -nd nd - - -nd nd - - -nd nd - - -nd nd - - -nd nd - - -nd nd - - -nd nd - - -nd nd - - -nd nd - - -nd nd - - -0.66-1.23 nd - - -0.47-0.88 nd - - -0.47-0.90 nd - - -- - - - -- - - - -- - - - -- - - - -
calciferol vs. 9227 - - - - -calciferol vs. 9227 - - - - -
nd nd - - -nd nd - - -nd nd - - -nd nd - - -nd nd - - -Ref=1 nd - - --0.33, 0.10 nd - - --0.27, 0.17 nd - - --0.27, 0.19 nd - - -
Quintile 5 vs. 9243 -0.32, 0.17 nd - - -Ref=1 nd - - --0.35, 0.09 nd - - --0.29, 0.17 nd - - --0.34, 0.12 nd - - -
Quintile 5 vs. 9243 -0.42, 0.09 nd - - -
Calcium vs. PlaceboCalcium vs. PlaceboCalcium vs. PlaceboCalcium vs. Placebo
Vit D + Ca vs. unsupplementedVit D + Ca vs. unsupplementedVit D + Ca vs. unsupplementedVit D + Ca vs. unsupplementedVit D + Ca vs. 9198Vit D + Ca vs. 9198Vit D + Ca vs. 9198Ca intake - Tertile 1 vs. Ca intake - Ca intake - Tertile 2 vs. Ca intake - Ca intake - Tertile 3 vs. 25(OH)D - 25(OH)D - Tertile 1 vs. 1,25(OH)2D - 1,25(OH)2D - Tertile 1 vs. 9204Ca intake - Tertile 1 vs. Ca intake - Ca intake - Tertile 2 vs. Ca intake - Ca intake - Tertile 3 vs. 25(OH)D - 25(OH)D - Tertile 1 vs. 1,25(OH)2D - 1,25(OH)2D - Tertile 1 vs. 9204Ca Intake - Quartile 1 Ca Intake - Quartile 2 Ca Intake - Quartile 3 Ca Intake - Quartile 4 Vit D + Ca vs. Placebo1.2 million IU vit D vs. Placebo1.2 million IU vit D vs. Placebo1.2 million IU vit D vs. Placebo
Ca intake - Quintile 1 Ca intake - Quintile 2 Ca intake - Quintile 3 Ca intake - Quintile 4 Ca intake - Quintile 5 Quintile 1 vs. Quintile 2Quintile 2 vs. Quintile 3Quintile 3 vs. Quintile 4Quintile 4 vs. Quintile 5
Quintile 1 vs. Quintile 2Quintile 2 vs. Quintile 3Quintile 3 vs. Quintile 4Quintile 4 vs. Quintile 5
- 0.64 adj - -nd nd - - -nd nd - - -nd nd - - -- 0.64 adj - -- 0.64 adj - -- 0.52 adj - -- 0.52 adj - -- 0.52 adj - -NS nd - - -NS nd - - -
Vit D vs. Placebo - - - - -Vit D vs. Placebo - - - - -Vit D vs. Placebo - - - - -Vit D vs. Placebo - - - - -Vit D vs. Placebo - - - - -Vit D vs. Placebo - - - - -Vit D vs. Placebo - - - - -Vit D vs. Placebo - - - - -Vit D vs. Placebo - - - - -Vit D vs. Placebo - - - - -Vit D3 vs. Placebo - - - - -
nd 0.68 - - -nd 0.87 - - -nd 0.06 - - -nd nd - - -nd nd - - -nd nd - - -nd nd - - -nd 0.20 - - -nd nd - - -nd nd - - -nd nd - - -nd nd - - -nd 0.24 - - -nd nd - - -nd nd - - -nd nd - - -nd nd - - -
000 nd 0.39 - - -9274 vs. 9275 nd nd - - -9275 vs. 9276 nd nd - - -9276 vs. 9277 nd nd - - -000 nd 0.74 - - -9278 vs. 9279 nd nd - - -9279 vs. 9280 nd nd - - -9280 vs. 9281 nd nd - - -000 nd 0.70 - - -
Dairy Ca intake - Quartile 1 vs. Dairy Ca intake - Quartile 2 vs. Dairy Ca intake - Quartile 3 vs. Dairy Ca intake - Quartile 4 vs. Dairy Ca intake - Quartile 1 vs. Dairy Ca intake - Quartile 1 vs. Dairy Ca intake - Quartile 1 vs. Dairy Ca intake - Quartile 1 vs. Dairy Ca intake - Quartile 1 vs. Dietary Ca vs. 9253Dietary Ca vs. 9253
25 OH-D, quartile of vs. 1,25 OH-D, 1,25 OH-D, quartile of vs. Ca intake - Quintile 1 vs. Ca Ca intake - Quintile 3 vs. Ca Ca intake - Quintile 4 vs. Ca Ca intake - Quintile 2 vs. Ca Ca intake - Quintile 5 vs. 9271Ca intake - Quintile 1 vs. Ca Ca intake - Quintile 3 vs. Ca Ca intake - Quintile 4 vs. Ca Ca intake - Quintile 2 vs. Ca Ca intake - Quintile 5 vs. 9271Ca intake - Quintile 1 vs. Ca Ca intake - Quintile 3 vs. Ca Ca intake - Quintile 4 vs. Ca Ca intake - Quintile 2 vs. Ca Ca intake - Quintile 5 vs. 9271
9274 vs. 9275 nd nd - - -9275 vs. 9276 nd nd - - -9276 vs. 9277 nd nd - - -000 nd 0.12 - - -9278 vs. 9279 nd nd - - -9279 vs. 9280 nd nd - - -9280 vs. 9281 nd nd - - -000 nd 0.06 - - -9274 vs. 9275 nd nd - - -9275 vs. 9276 nd nd - - -9276 vs. 9277 nd nd - - -000 0.22 0.17 - - -9278 vs. 9279 nd nd - - -9279 vs. 9280 nd nd - - -9280 vs. 9281 nd nd - - -
nd nd - - -0.86-1.22 nd - - -0.89-1.31 nd - - -0.68-1.07 nd - - -0.52-0.93 nd - - -nd nd - - -0.60-0.97 nd - - -0.60-0.97 nd - - -0.57-0.94 nd - - -0.50-0.83 nd - - -nd 0.41 - - -nd 0.99 - - -nd 0.69 - - -nd nd - - -nd nd - - -nd nd - - -nd nd - - -nd 0.64 - - -nd nd - - -nd nd - - -nd nd - - -nd nd - - -- - - - -- - - - -- - - - -nd nd - - -0.4-1.0 nd - - -0.5-1.1 nd - - -0.6-0.9 nd - - -- 0.4 Adjusted - -- 0.4 Adjusted - -- 0.4 Adjusted - -- 1.0 Adjusted - -
Ca intake - Quintile 1 vs. Ca Ca intake - Quintile 2 vs. Ca Ca intake - Quintile 3 vs. Ca Ca intake - Quintile 4 vs. Ca Ca intake - Quintile 5 vs. 9287Ca intake - Quintile 1 vs. Ca Ca intake - Quintile 2 vs. Ca Ca intake - Quintile 3 vs. Ca Ca intake - Quintile 4 vs. Ca Ca intake - Quintile 5 vs. 9287Ca intake (diet + supplement) vs. Ca intake (diet + supplement) vs. Ca intake - Quintile 1: =< Ca intake - Quintile 2: 470 to Ca intake - Quintile 3: 692 to Ca intake - Quintile 4: 935 to Ca intake - Quintile 5: >= Vit D intake - Quintile 1: =< 66 Vit D intake - Quintile 2: 66 to Vit D intake - Quintile 3: 136 to Vit D intake - Quintile 4: 256 to Vit D intake - Quintile 5: >= Vit D + Ca vs. CalciumVit D + Ca vs. CalciumVit D + Ca vs. CalciumCa intake - Quartile 1, median Ca intake - Quartile 2, median Ca intake - Quartile 3, median Ca intake - Quartile 4, median 1,25(OH)2D - Quartile 2 vs. 1,25(OH)2D - Quartile 2 vs. 1,25(OH)2D - Quartile 2 vs. 25(OH)D - Quartile 1 vs. 25(OH)D -
- 1.0 Adjusted - -- 1.0 Adjusted - -- - - - -- - - - -- - - - -- 0.9 Adjusted - -- 0.9 Adjusted - -- 0.9 Adjusted - -- 0.9 Adjusted - -- 0.9 Adjusted - -- 0.9 Adjusted - -- 0.2 Adjusted - -- 0.2 Adjusted - -- 0.2 Adjusted - -- 1.0 Adjusted - -- 1.0 Adjusted - -- 1.0 Adjusted - -- 0.9 Adjusted - -- 0.9 Adjusted - -- 0.9 Adjusted - -- - - - -- - - - -- - - - -- - - - -Reference nd - - -0.9-1.1 nd - - -0.9-1.1 nd - - -1.1-1.5 nd - - -1.0-1.6 nd - - -nd 0.99 - - -nd nd - - -
Tertile 3 vs. 9336 nd nd - - -nd NS - - -NS nd - - -NS nd - - -
Vit D vs. 9345 - - - - -Vit D vs. 9345 - - - - -Vit D vs. 9345 - - - - -
nd nd - - -0.7 1.4 nd - - -0.7 1.4 nd - - -0.6 1.3 nd - - -0.6 1.3 nd - - -nd 0.19 - - -nd nd - - -nd nd - - -nd nd - - -nd nd - - -
25(OH)D - Quartile 1 vs. 25(OH)D - 25(OH)D - Quartile 1 vs. 25(OH)D - 1,25(OH)D - Quartile 1 vs. 1,25(OH)D - Quartile 1 vs. 1,25(OH)D - Quartile 1 vs. 1,25(OH)2D - Quartile 2 vs. 1,25(OH)2D - Quartile 2 vs. 1,25(OH)2D - Quartile 2 vs. 25(OH)D - Quartile 1 vs. 25(OH)D - 25(OH)D - Quartile 1 vs. 25(OH)D - 25(OH)D - Quartile 1 vs. 25(OH)D - 1,25(OH)2D - Quartile 2 vs. 1,25(OH)2D - Quartile 2 vs. 1,25(OH)2D - Quartile 2 vs. 25(OH)D - Quartile 1 vs. 25(OH)D - 25(OH)D - Quartile 1 vs. 25(OH)D - 25(OH)D - Quartile 1 vs. 25(OH)D - 25(OH)D - Quartile 1 vs. 25(OH)D - 25(OH)D - Quartile 1 vs. 25(OH)D - 25(OH)D - Quartile 1 vs. 1,25(OH)2D Ca supplement vs. 9326Ca supplement vs. 9326Ca supplement vs. 9326Ca supplement vs. 9326Ca intake - Quintile 1: =< 700 Ca intake - Quintile 2: 700 to Ca intake - Quintile 3: 1000 to Ca intake - Quintile 4: 1500 to Ca intake - Quintile 5: >= Tertile 1 vs. Tertile 2Tertile 2 vs. Tertile 3
Ca intake - Tertile 1 vs. Ca intake - Ca intake - Tertile 2 vs. Ca intake - Ca intake - Tertile 3 vs. 9340
Ca intake - Quintile 1, median Ca intake - Quintile 2, median Ca intake - Quintile 3, median Ca intake - Quintile 4, median Ca intake - Quintile 5, median Total daily calcium intake (mg) in Ca intake - Quintile 1 vs. Ca Ca intake - Quintile 2 vs. Ca Ca intake - Quintile 3 vs. Ca Ca intake - Quintile 4 vs. Ca
nd nd - - -nd nd - - -nd nd - - -nd nd - - -nd nd - - -nd nd - - -nd nd - - -nd nd - - -nd nd - - -nd nd - - -nd nd - - -nd nd - - -nd nd - - -nd nd - - -nd nd - - -nd nd - - -nd nd - - -nd nd - - -nd nd - - -nd nd - - -nd nd - - -nd nd - - -nd nd - - -nd nd - - -nd nd - - -nd nd - - -0.47-1.98 nd - - -nd 0.49 Adjusted - -nd 0.49 Adjusted - -nd 0.49 Adjusted - -nd 0.49 Adjusted - -nd 0.001 - - -nd 0.001 - - -nd 0.001 - - -nd 0.001 - - -
>65.5 vs. 9373 nd 0.001 - - -nd 0.13 crude - -nd 0.13 crude - -nd 0.13 crude - -nd 0.76 crude - -nd 0.76 crude - -nd 0.76 crude - -nd 0.69 crude - -nd 0.69 crude - -nd 0.69 crude - -nd 0.76 crude - -nd 0.58 crude - -nd 0.58 crude - -
Ca intake - Quintile 5 vs. Vit D Ca intake - Quintile 1 vs. Ca Ca intake - Quintile 2 vs. Ca Ca intake - Quintile 3 vs. Ca Ca intake - Quintile 4 vs. Ca Ca intake - Quintile 5 vs. Vit D Ca intake - Quintile 1 vs. Ca Ca intake - Quintile 2 vs. Ca Ca intake - Quintile 3 vs. Ca Ca intake - Quintile 4 vs. Ca Ca intake - Quintile 5 vs. Vit D Ca intake - Quintile 1 vs. Ca Ca intake - Quintile 2 vs. Ca Ca intake - Quintile 3 vs. Ca Ca intake - Quintile 4 vs. Ca Ca intake - Quintile 5 vs. Vit D Ca intake - Quintile 1 vs. Ca Ca intake - Quintile 2 vs. Ca Ca intake - Quintile 3 vs. Ca Ca intake - Quintile 4 vs. Ca Ca intake - Quintile 5 vs. Vit D Ca intake - Quintile 1 vs. Ca Ca intake - Quintile 2 vs. Ca Ca intake - Quintile 3 vs. Ca Ca intake - Quintile 4 vs. Ca Ca intake - Quintile 5 vs. Vit D 25(OH)D - Quintile 1: =< 45.9 nmol/L 25(OH)D - Quintile 1: =< 45.9 nmol/L 25(OH)D - Quintile 1: =< 45.9 nmol/L 25(OH)D - Quintile 1: =< 45.9 nmol/L 25(OH)D - Quintile 1: =< 45.9 nmol/L <32 vs. >32 and <41.1>32 and <41.1 vs. >41.1 and <51.1>41.1 and <51.1 vs. >51.1 and >51.1 and <65.5 vs. >65.5
25(OH)D - Quartile 1 vs. 25(OH)D - 25(OH)D - Quartile 1 vs. 25(OH)D - 25(OH)D - Quartile 1 vs. 25(OH)D - 1,25(OH)2D - Quartile 1 vs. 1,25(OH)2D - Quartile 1 vs. 1,25(OH)2D - Quartile 1 vs. 25(OH)D - Quartile 1 vs. 25(OH)D - 25(OH)D - Quartile 1 vs. 25(OH)D - 25(OH)D - Quartile 1 vs. 25(OH)D - 1,25(OH)2D - Quartile 1 vs. 25(OH)D - Quartile 1 vs. 25(OH)D - 25(OH)D - Quartile 1 vs. 25(OH)D -
nd 0.58 crude - -nd 0.39 crude - -nd 0.39 crude - -nd 0.39 crude - -nd 0.06 crude - -nd 0.06 crude - -nd 0.06 crude - -nd 0.04 crude - -nd 0.04 crude - -nd 0.04 crude - -- - - - -
Vit D vs. Placebo - - - - -Vit D vs. Placebo - - - - -Vit D vs. Placebo - - - - -Vit D vs. Placebo - - - - -Vit D vs. Placebo - - - - -Vit D vs. Placebo - - - - -Vit D vs. Placebo - - - - -Vit D vs. Placebo - - - - -Vit D vs. Placebo - - - - -Vit D vs. Placebo - - - - -Vit D vs. Placebo - - - - -Vit D vs. Placebo - - - - -Vit D vs. Placebo - - - - -Vit D vs. Placebo - - - - -Vit D vs. Placebo - - - - -
0.79, 1.13 NS - - -0.65, 0.97 <0.05 - - -0.63, 0.96 <0.05 - - -0.56, 0.89 <0.05 - - -0.83, 1.68 NS - - -0.60, 1.37 NS - - -0.71, 1.65 NS - - -0.58, 1.50 NS - - -- - - - -- - - - -nd 0.0058 - - -- - - - -- - - - -- - - - -- - - - -- - - - -- - - - -- - - - -- - - - -- - - - -- - - - -- - - - -
25(OH)D - Quartile 1 vs. 25(OH)D - 1,25(OH)2D - Quartile 1 vs. 1,25(OH)2D - Quartile 1 vs. 1,25(OH)2D - Quartile 1 vs. 25(OH)D - Quartile 1 vs. 25(OH)D - 25(OH)D - Quartile 1 vs. 25(OH)D - 25(OH)D - Quartile 1 vs. 25(OH)D - 25(OH)D - Quartile 1 vs. 25(OH)D - 25(OH)D - Quartile 1 vs. 25(OH)D - 25(OH)D - Quartile 1 vs. 25(OH)D - Calcium vs. Placebo
Ca intake - Quintile 2 vs. Ca Ca intake - Quintile 3 vs. Ca Ca intake - Quintile 4 vs. Ca Ca intake - Quintile 5 vs. Ca intake - Quintile 2 vs. Ca Ca intake - Quintile 3 vs. Ca Ca intake - Quintile 4 vs. Ca Ca intake - Quintile 5 vs. Calcium vs. PlaceboCalcium vs. Placebo25(OH)D, published cutoffs Vit D + Ca vs. mom 400Vit D + Ca vs. mom 400Vit D + Ca vs. mom 400Vit D + Ca vs. mom 400Vit D + Ca vs. mom 400Vit D + Ca vs. mom 400Vit D + Ca vs. mom 400Vit D + Ca vs. mom 400Vit D + Ca vs. mom 400mom 400 vs. mom 6400mom 400 vs. mom 6400
- - - - -- - - - -- - - - -- - - - -- - - - -- - - - -- - - - -- - - - -- - - - -- - - - -- - - - -- - - - -- - - - -<.05 .01 - - -P=.05 nd - - -nd nd - - -- - - - -
Calcium vs. 9427 - - - - -Calcium vs. 9427 - - - - -Calcium vs. 9427 - - - - -Calcium vs. 9427 - - - - -Calcium vs. 9427 - - - - -Calcium vs. 9427 - - - - -Calcium vs. 9427 - - - - -
nd nd - - -0.99-2.24 nd - - -0.98-2.35 nd - - -- - - - -- - - - -nd nd - - -nd nd - - -nd nd - - -nd nd - - -nd nd - - -nd nd - - -nd 0.24 - - -nd nd - - -nd 0.005 - - -nd nd - - -nd nd - - -nd nd - - -nd 0.36 - - -nd nd - - -nd nd - - -nd nd - - -nd 0.29 - - -nd nd - - -nd nd - - -
infant 300 vs. infant placebomom 400 vs. mom 6400mom 400 vs. mom 6400infant 300 vs. infant placebomom 400 vs. mom 6400mom 400 vs. mom 6400mom 400 vs. mom 6400infant 300 vs. infant placebomom 400 vs. mom 6400mom 400 vs. mom 6400infant 300 vs. infant placeboinfant 300 vs. infant placeboinfant 300 vs. infant placeboSevere deficiency vs. DeficiencyDeficiency vs. ReferentReferent vs. 25(OH)D <15 25(OH)D <15 ng/mL vs.
Quartile 3 + Quartile 4 vs. Quartile 2 vs. Quartile 1Quartile 1 vs. Ca supplementCa supplement vs. PlaceboCa supplement vs. PlaceboCa intake - Cumulative Ca intake - Cumulative Ca intake - Cumulative 25(OH)D - Quintile 2 vs. 25(OH)D - 25(OH)D - Quintile 3 vs. 25(OH)D - 25(OH)D - Quintile 4 vs. 25(OH)D - 25(OH)D - Quintile 1 vs. 25(OH)D - 25(OH)D - Quintile 5 vs. 25(OH)D - 25(OH)D - Quartile 1 vs. 25(OH)D - 25(OH)D - Quartile 2 vs. 25(OH)D - 25(OH)D - Quartile 3 vs. 25(OH)D - 25(OH)D - Quartile 4 vs. 25(OH)D - 25(OH)D - Quartile 1 vs. 25(OH)D - 25(OH)D - Quartile 2 vs. 25(OH)D - 25(OH)D - Quartile 3 vs. 25(OH)D - 25(OH)D - Quartile 4 vs. 25(OH)D - 25(OH)D - Quartile 1 vs. 25(OH)D - 25(OH)D - Quartile 2 vs. 25(OH)D - 25(OH)D - Quartile 3 vs. 25(OH)D -
nd nd - - -nd 0.08 - - -nd nd - - -nd nd - - -nd nd - - -nd nd - - -nd nd - - -nd 0.31 - - -nd nd - - -nd 0.008 - - -nd nd - - -nd nd - - -nd nd - - -
Total vs. Total - - - - -- - - - -nd 0.02 adjusted - -nd 0.02 adjusted - -- - - - -- - - - -- - - - -- - - - -- - - - -
25(OH)D - Quartile 4 vs. 25(OH)D - 25(OH)D - Tertile 1 vs. 25(OH)D - 25(OH)D - Tertile 2 vs. 25(OH)D - 25(OH)D - Tertile 3 vs. Calcium25(OH)D - Quintile 2 vs. 25(OH)D - 25(OH)D - Quintile 3 vs. 25(OH)D - 25(OH)D - Quintile 4 vs. 25(OH)D - 25(OH)D - Quintile 1 vs. 25(OH)D - 25(OH)D - Quintile 5 vs. 25(OH)D - 25(OH)D - Quartile 1 vs. 25(OH)D - 25(OH)D - Quartile 2 vs. 25(OH)D - 25(OH)D - Quartile 3 vs. 25(OH)D - 25(OH)D - Quartile 4 vs. 25(OH)D -
Calcium vs. PlaceboCalcium intake - Tertile 1 (mg/day) Calcium intake - Tertile 1 (mg/day) Vit D + Ca vs. PlaceboVit D2 + Ca vs. PlaceboVit D + Ca vs. PlaceboVit D2 + Ca vs. Ca + PlaceboVit D2 + Ca vs. Ca + Placebo
- - - - - -- - - - - -- - - - - -- - - - - -0.79-1.57 OR 1.10 0.78-1.56 - -1.16-2.22 OR 1.53 1.10-2.13 - -1.02-1.96 OR 1.33 0.95-1.86 - -0.94-1.84 OR 1.18 0.83-1.68 - -- - - - - -- - - - - -- - - - - -- - - - - -- OR 1.18 0.78-1.79 OR 1.20- OR 1.92 1.31-2.82 OR 1.96- OR 1.56 1.05-2.31 OR 1.61- OR 1.34 0.87-1.98 OR 1.37- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
CI [Adjusted
Outcome Metric (e.g.
Outcome effect size
CI [Adjusted
Outcome Metric (e.g.
Outcome effect size
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- 0.04 0.20 - - -- 0.04 0.20 - - -- 0.04 0.20 - - -- 0.04 0.20 - - -- - - - - -- - - - - -- - - - - -- - - - - -0.80-1.81 - 0.09 0.05 - -1.34-2.87 - 0.09 0.05 - -1.09-2.38 - 0.09 0.05 - -0.92-2.05 - 0.09 0.05 - -- - - - - -- - - - - -- - - - - -- - - - OR 0.8- - - - OR 1.3- - - - OR 1.7- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
CI [Adjusted
P for trend****
P for trend****
P for trend****
Outcome Metric (e.g.
Outcome effect size
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
CI [crude]- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -0.4-1.4 0.01 OR 0.8 0.5-1.5 0.010.8-2.3 0.01 OR 1.4 0.8-2.4 0.011.0-3.0 0.01 OR 1.8 1.0-3.2 0.01- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
P for trend****
Outcome Metric (e.g.
Outcome effect size
CI [adjusted for HDL;
P for trend****
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -OR 3.5 1.7-7.0 - -- - - - OR 1.2- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
Outcome Metric (e.g.
Outcome effect size
CI [adjusted HDL; SBP;
P between groups***
Outcome Metric (e.g.
Outcome effect size
Group 2 vs. 1 = 0.0006
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
CI- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -0.7-2.1 - - - -- - RR 1.03 0.88,1.22 -- - RR 0.92 0.78,1.09 -- - RR 1.01 0.85,1.19 -- - RR 0.94 0.79,1.11 -- - RR 1.01 0.83,1.23 -- - RR 0.96 0.78,1.17 -- - RR 1.04 0.85,1.28 -- - RR 0.92 0.74,1.14 -- - RR 1.17 0.87,1.50 -- - RR 0.93 0.67,1.29 -- - RR 1.06 0.77,1.47 -- - RR 1.10 0.79,1.51 -- - - - - 0.0- - HR 0.98 0.62,1.54 -- - HR 0.82 0.51,1.30 -- - HR 0.73 0.45,1.19 -- - HR 0.97 0.61,1.54 -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
CI [Adjusted]
P between groups***
Outcome Metric (e.g.
Outcome effect size
Net difference
Group 2 vs. 1 = NS
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - RR 1.17 0.91, 1.50 -- - RR 0.91 0.77, 1.07 -- - RR 0.89 0.76, 1.04 -- - RR 0.91 0.76, 1.09 -- - RR 1.52 nd -- - RR 0.86 nd -- - - 0.98 nd -- - - 0.91 nd -- - - 1.07 0.85,1.35 -- - - 1.05 0.83, 1.31 -- - - 1.03 0.82, 1.31 -- - - 1.04 0.83, 1.31 -- - - - - -- - - - - -- - - - - -- - - - - -- - RR 1.48 - -- - RR 1.20 - -- - RR 1.22 - -- - RR 1.32 - -- - RR 1.10 - -- - RR 1.02 - -- - RR 0.68 0.46-1.02 -- - RR 0.95 0.66-1.36 -- - RR 0.74 0.51-1.06 -- - RR 0.80 0.58-1.11 -- - RR 0.73 0.49-1.07 -- - RR 0.73 0.50-1.07 -- - RR 0.78 0.53-1.14 -- - RR 0.76 0.52-1.11 -- - - - - -- - - - - -- - - - - 39.2- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - +1.2- - - - - nd- - - - - +0.4- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - OR 2.3 0.7-7.8 -- - OR 2.3 0.7-7.7 -- - OR 0.6 0.1-2.5 -- - OR 2.4 0.8-8.2 -- - OR 1.9 0.7-5.5 -- - - - - 0.06- - - - - 0.15- - - - - 0.03- - - - - 0.04- - - - - -0.12- - - - - -0.54- - - - -- - - - -- - - - -- - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - -- - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - 0.9- - - - - 1.5- - - - - 11.4- - - - - -- - - - - -- - - 29.8% - -- - - ~27% (figure) - -- - - ~25% (figure) - -- - - 21.3% - -- - - - - -- - - 0.89 0.81,0.97 -- - - 0.79 0.66,094 -- - - 0.70 0.54,0.91 -- - - 1.01 0.94,1.08 -- - - 1.02 0.89,1.18 -- - - 1.04 0.84,1.28 -- - - 0.98 0.89, 1.08 -- - - 0.96 0.79, 1.17 -- - - 0.95 0.70, 1.28 -- - - 0.96 0.89, 1.03 -- - - 0.92 0.80, 1.07 -- - - 0.87 0.71, 1.11 -- - - 0.94 0.82, 1.09 -- - - 0.86 0.67, 1.19 -- - - 0.84 0.55, 1.29 -- - - 0.97 0.91, 1.04 -- - - 0.94 0.83, 1.08 -- - - 0.92 0.75, 1.12 -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - OR 0.93 - -- - - 0.79 - -- - - 0.58 - -- - - 0.53 - -- - - - - -- - OR - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - 1.52 1.06, 2.18 -- - - 1.55 1.07, 2.23 -- - - 1.66 1.11, 2.48 -- - - - - -- - - - - -- - - - - -- - - - - -- - HR 1.22 - -- - HR 1.02 - -- - HR 1.00 - -- - HR 0.92 - -- - HR 1.49 - -- - HR 0.78 - -- - HR 0.65 - -- - HR 1.14 - -- - HR 1.42 - -- - HR 0.28 - -- - RR 0.91 - -- - HR 1.34 - -- - HR 0.44 - -- - HR 0.28 - -- - HR 1.83 - -- - HR 1.86 - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - OR 0.48 - -- - OR 0.25 - -- - OR 0.21 - -- - OR 0.73 - -- - - - - -- - - - - -- - - - - -- - - - - -- - OR 0.5 - -- - OR 0.3 - -- - - - - +0.5- - - - - -5.44- - - - - -2.19- - - - - -- - - - - -- - - - - -- - - - -- - - - -- - - - -- - - - -- - - - -- - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -1.2- - - - -- - - - -- - - - - 0.9- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - -- - - - -- - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - ~+5- - - - - ~-9- - - - - -5.7- - - - - -3.5- - - - - ~-2- - - - - ~-1- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - -- - - - -
- - - - -- - - - -- - - - -- - - - -- - - - - -- - - - - -- - - - - -1.0- - - - - -0.4- - - - - -2.5- - - - - 0- - - - - -- - - - - +0.22- - - - - +0.11- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - -- - - - -- - - - -- - - - -- - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - RR 0.81 - -- - - - - -- - - - - -- - - - - -- - RR 0.91 - -- - RR 0.91 - -- - RR 0.57 - -- - RR 0.60 - -- - RR 0.81 - -- - - - - -- - - - - -- - - - - +3.95- - - - - +3.68- - - - - +1.69- - - - - +1.55- - - - - +34.52- - - - - +34.44- - - - - +0.42- - - - - +0.76- - - - - +0.02- - - - - +0.13- - - - - 24.4- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -7.4- - - - - -0.3- - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - OR 0.64 - -- - OR 0.80 - -- - OR 0.71 - -- - OR 0.64 - -
- - OR 0.58 - -- - OR 1.04 - -- - - - - -- - - - - -- - - - - -- - OR 1.35 - -- - OR 0.58 - -- - OR 1.06 - -- - OR 0.38 - -- - OR 0.34 - -- - OR 1.59 - -- - OR 0.51 - -- - OR 0.78 - -- - OR 0.60 - -- - OR 0.71 - -- - OR 0.60 - -- - OR 1.02 - -- - OR 0.67 - -- - OR 1.30 - -- - OR 0.54 - -- - - - - 0- - - - - -0.01- - - - - -2.4- - - - - -1.0- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - 0- - - - - 0- - - - - 8.6- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - OR 0.97 0.47-1.98 -- - OR 0.86 0.40-1.84 -- - OR 0.84 0.39-1.80 -- - OR 1.45 0.66-3.15 -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - RR 0.7 - -- - RR 0.8 - -- - RR 0.6 - -- - RR 1.3 - -- - RR 1.2 - -- - RR 0.9 - -- - RR 0.6 - -- - RR 0.8 - -- - RR 0.8 - -- - RR 1.7 - -- - RR 0.8 - -- - RR 1.2 - -
- - RR 1.2 - -- - RR 0.7 - -- - RR 1.0 - -- - RR 0.5 - -- - RR 0.9 - -- - RR 0.8 - -- - RR 0.4 - -- - RR 0.8 - -- - RR 0.4 - -- - RR 0.3 - -- - - - - -0.2- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - 0.8- - - - - 0.2- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - -- - - - -
- - - - -- - - - -- - - - -- - - - -- - - - -- - - - -- - - - -- - - - -- - - - -- - - - -- - - - -- - - - -- - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - nd- - - - - nd- - - - - nd- - - - - nd- - - - - +1807- - - - - +206- - - - - +10- - - - - -- - - - - -- - - - - -- - - - - ~-0.5 (figure)- - - - - ~+0.3 (figure)- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - 9- - - - - -0.05- - RR 0.90 0.61-1.33 -- - RR 0.59 0.37-0.94 -- - - - -- - - - - 1.2%- - - - - 2.2%- - - - - 0.3%- - - - - 34%
P between CI/SE/SD **- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -ND Not significant - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - -- - - - - -- - - - - -- - - - - -- - - - - -
Net difference
Net difference**
Unadjusted - Result
Unadjusted - 95% CI
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - 0.81-2.70 - -- - - 0.64-2.23 - -- - - 0.66-2.26 - -- - - 0.72-2.43 - -- - - 0.55-1.83 - -- - - 0.57-1.82 - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
<0.01 - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
nd NS - - - -nd <0.001 - - - -
NS - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -0.21 0.790 - - - -0.24 0.524 - - - -0.06 0.623 - - - -0.08 0.603 - - - -0.27 0.580 - - - -0.26 0.030 - - - -
- - - -- - - -- - - -- - - -
- - - - - -- - - - - -- - - - - -- - - - - -
- - - -- - - -
- - - - 0.82 0.59-1.16- - - - nd nd- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - 0.96 0.86 to 1.07- - - - 0.99 0.55 to 1.76
nd 0.3227 - - - -Nd 0.1639 - - - -nd 0.9663 - - - -- - - - nd nd- - - - nd nd- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - 0.53-1.63 - -- - - 0.44-1.40 - -- - - 0.31-1.07 - -- - - 0.27-1.04 - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - Nd - -- - - Nd - -- - - Nd - -- - - Nd - -- - - - - -- - - - - -- - - - - -- - - - - -- - - Nd - -- - - Nd - -
NS (implied) - - - -NS (implied) - - - -NS (implied) - - - -
- - - - nd nd- - - - nd nd- - - - nd nd
nd - - - -nd - - - -nd - - - -nd - - - -nd - - - -nd - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -Nd 0.56 - - - -
NS - - - -NS - - - -
Nd Not significant - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
NS - - - -NS - - - -NS - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - 0.8 0.64-0.99- - - - nd nd- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
NS - - - -<0.05 - - - -0.01 - - - -0.06 - - - -NS - - - -NS - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
NS - - - -NS - - - -
NS - - - -NS - - - -NS - - - -NS - - - -
- - - - 0.95 0.79-1.15- - - - 1.0 0.9-1.0
0.19 - - - -0.23 - - - -0.18 - - - -1.0 - - - -
- - - - nd nd-0.05 to 0.49 0.11 - - - --0.04 to 0.27 0.14 - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - 6% vs. 9% nd
<0.05 - - - -<0.001 - - - ->0.05 - - - -<0.001 - - - -NS - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - 0.64-1.02 - -- - - - - -- - - - - -- - - - - -- - - 0.73-1.14 - -- - - 0.70-1.18 - -- - - 0.27-1.19 - -- - - 0.29-1.22 - -- - - 0.38-1.71 - -- - - - - -- - - - - -2.05 0.058 - - - -2.06 0.079 - - - -1.64 0.305 - - - -1.65 0.353 - - - -4.94 <0.0005 - - - -5.02 <0.0005 - - - -0.42 0.42 - - - -0.41 0.07 - - - -0.15 0.90 - - - -0.16 0.40 - - - -nd <0.0005 - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
0.02 - - - -0.10 - - - -<0.01 - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - 0.41-1.02 - -- - - 0.50-1.30 - -- - - 0.43-1.15 - -- - - 0.41-1.00 - -
- - - 0.36-0.95 - -- - - 0.66-1.66 - -- - - - - -- - - - - -- - - - - -- - - 0.41-4.43 - -- - - 0.16-2.09 - -- - - 0.30-3.73 - -- - - 0.12-0.19 - -- - - 0.08-1.42 - -- - - 0.50-5.03 - -- - - 0.30-0.86 - -- - - 0.45-1.34 - -- - - 0.34-1.04 - -- - - 0.43-1.18 - -- - - 0.35-1.02 - -- - - 0.60-1.73 - -- - - 0.31-1.44 - -- - - 0.59-2.86 - -- - - 0.25-1.16 - -
0.93 - - - -0.83 - - - -0.14 - - - -0.13 - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
0.81 - - - -0.92 - - - -0.0001 - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - 0.4-1.3 - -- - - 0.4-1.3 - -- - - 0.3-1.1 - -- - - 0.8-2.4 - -- - - 0.7-2.2 - -- - - 0.5-1.7 - -- - - 0.3-1.2 - -- - - 0.4-1.6 - -- - - 0.4-1.6 - -- - - 0.8-3.4 - -- - - 0.3-1.8 - -- - - 0.5-2.8 - -
- - - 0.5-2.8 - -- - - 0.3-2.2 - -- - - 0.4-2.5 - -- - - 0.2-1.5 - -- - - 0.4-2.4 - -- - - 0.3-2.0 - -- - - 0.1-1.1 - -- - - 0.2-2.4 - -- - - 0.1-1.3 - -- - - 0.1-1.1 - -ND Not significant - - - -- - - - nd nd- - - - nd nd- - - - nd nd- - - - nd nd- - - - nd nd- - - - nd nd- - - - nd nd- - - - nd nd- - - - nd nd- - - - nd nd- - - - nd nd- - - - nd nd- - - - nd nd- - - - nd nd- - - - nd nd- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -Nd Not significant - - - -Nd Not significant - - - -- - - - - -- - - - nd nd- - - - nd nd- - - - nd nd- - - - nd nd- - - - nd nd- - - - nd nd- - - - nd nd- - - - nd nd- - - - nd nd
nd - - - -- - - -
- - - -- - - -- - - -
0.91 - - - -- - - -- - - -- - - -- - - -
nd - - - -nd - - - -nd - - - -0.80 - - - -0.29 - - - -
- - - - - -- - - - - -- - - - - -- - - - 8.9% 5.5, 12.2nd 0.7 (MW)## - - - -nd 0.4 (MW)## - - - -nd 0.8 (MW)## - - - -nd NS (unclear) - - - -357 <0.001## - - - -37 <0.01## - - - -24 0.6## - - - -- - - - - -- - - - - -- - - - - -~0.75 NS - - - -~0.5 NS - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -9 - - - - -
NS - - - -- - - - - -- - - - - -- - - - -- 0.04 - - - -- 0.05 - - - -nd NS - - - -nd <0.001 - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
Unadjusted - P btw
Adjusted - Result
Adjusted - 95% CI
Adjusted - P btw
Result [Unadjuste
95% CI [Unadjuste
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - 0.51 0.13,2.01- - - - 1.49 0.86,2.57- - - - 1.37 0.83,2.28- - - - 1.21 0.84,29.2
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -0.263 nd nd nd - -NS nd nd nd - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -NS nd nd nd - -NS nd nd nd - -
- - - - - -- - - - - -- - - - - -nd nd nd nd - -0.048 nd nd nd - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -nd 0.63 0.46-0.87 nd - -nd 0.85 0.43-1.69 nd - -nd 0.62 0.29-1.33 nd - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -0.026 nd nd nd - -0.02 0.789 0.616-1.01 0.0589 - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -NS nd nd nd - -NS nd nd nd - -- - - - - -- - - - - -- - - - - -- - - - - -nd 1.01 0.96, to 1.06 0.69 - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - ->0.05 per chi2 nd nd nd - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -nd 0.84 0.65-1.1 0.2 - -nd 0.84 0.56-1.27 0.41 - -nd 1.04 0.61-1.77 0.89 - -nd 0.94 0.77-1.15 0.57 - -nd 0.88 0.74-1.06 0.18 - -nd 0.86 0.61-1.2 0.37 - -nd 0.62 0.24-1.6 0.33 - -nd 1.08 0.44-2.65 0.87 - -nd Not Applicable nd Not Applicable - -nd 1.11 0.86-1.42 0.43 - -nd 1.02 0.60-1.74 0.94 - -nd 1.12 0.56-2.25 0.75 - -nd 0.99 0.25-3.99 0.99 - -nd 0.93 0.76-1.14 0.5 - -nd 0.89 0.38-2.09 0.78 - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -nd 0.91 0.83-1.01 0.07 - -nd 0.82 0.52-1.29 0.39 - -nd 0.99 0.94-1.04 0.71 - -nd 1.17 1.02-1.34 0.02 - -nd 1.08 0.86-1.34 0.51 - -nd 1.00 0.78-1.28 0.99 - -nd 1.46 0.92-2.32 0.11 - -nd 0.98 0.91-1.05 0.53 - -nd 0.89 0.77-1.03 0.12 - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -nd 1.70 1.08, 2.67 .02 - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
P btw [Unadjuste
Result [Unadjuste
95% CI [Unadjuste
P btw [Unadjuste
Outcome Metric (e.g.
Outcome effect size
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -NS 0.51 0.10,2.04 NS - -NS 1.67 0.98,2.87 0.06 - -NS 1.45 0.88,2.49 NS - -NS 1.43 1.01,2.04 .04 - -
- - - - - -- - - - - -- - - - - -- - - - RR (HR) 0.82- - - - RR (HR) 0.78- - - - RR (HR) 0.82- - - - RR (HR) 0.52- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
CI** [Adj (age)]
P between groups***
P for trend****
Outcome Metric (e.g.
Outcome effect size
CI ** [Adj (full
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -0.55-1.22 Nd 0.01 RR (HR) 0.89 0.59-1.330.55-1.22 Nd 0.01 RR (HR) 0.88 0.58-1.330.55-1.23 Nd 0.01 RR (HR) 0.97 0.63-1.500.33-0.82 Nd 0.01 RR (HR) 0.68 0.41-1.11- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
P between groups***
P for trend****
Metric (e.g. OR, RR, HR,
Result - Adjusted
95% CI - Adjusted
P btw - Adjusted
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -Nd 0.22 - - - -Nd 0.22 - - - -Nd 0.22 - - - -Nd 0.22 - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - % - - -- - % - - -- - % - - -- - % - - -- - - 0.90 0.77,1.04 NS- - OR - - -- - - - - -- - - - - -- - OR - - -- - - - - -- - - - - -- - OR - - -- - - - - -- - - - - -- - OR - - -- - - - - -- - - - - -- - OR - - -- - - - - -- - - - - -- - OR - - -- - - - - -- - - - - -- - - 0.99 0.85,1.172 NS- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
P between groups***
Outcome Metric (e.g.
Result [Unadjuste
95% CI [Unadjuste
P btw [Unadjuste
Result [Adjusted]
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -NS - - - - -p<0.001 - - - - -p<0.001 - - - - -<0.001 - - - - -NS - - - - -<0.001 - - - - -<0.001 - - - - -NS - - - - -NS - - - - -NS - - - - -0.07 - - - - -NS - - - - -NS - - - - -NS - - - - -NS - - - - -NS - - - - -NS - - - - -0.25 - - - - -NS - - - - -
NS - - - - -NS - - - - -NS - - - - -NS - - - - -NS - - - - -0.06 - - - - -NS - - - - -NS - - - - -NS - - - - -NS - - - - -p<0.001 - - - - -p<0.001 - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- OR - - - -- OR - - - -- OR - - - -- - - - - -- - - - - -- - - - - -- OR 1.64 1.29, 2.10 nd 1.47- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
CI / **- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
95% CI [Adjusted]
P btw [Adjusted]
Outcome effect size
CI / SE / SD ** [Adjusted
P for trend****
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -1.10, 1.97 nd - - - -- - 0.91-1.64 - - -- - 0.69-1.50 - - -- - 0.71-1.40 - - -- - 0.58-1.46 - - -- - 0.85-2.64 - - -- - 0.50-1.22 - - -- - 0.36-1.18 - - -- - 0.60-2.18 - - -- - 0.73-1.76 - - -- - 0.08-0.93 - - -- - 0.39-2.14 - - -- - 0.62-2.91 - - -- - 0.20-0.95 - - -- - 0.11-0.68 - - -- - 0.93-3.61 - - -- - 0.75-4.63 - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - 0.73 nd Nd comparable
to main analysis
- - - 0.85 nd- - - 0.96 nd- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
Nd comparable to main analysisNd comparable to main analysis
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -- - - - - -
- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -
Outcome effect size
CI / SE / SD ** [Adjusted
P for trend****
Net difference
- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -
- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -
- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -
- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -
- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -
- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -
- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -
- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -
- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -
- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -
- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -
- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -
- - - -- - - -0.64 nd -0.75 nd -0.68 nd -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -
Nd comparable to main analysisNd comparable to main analysisNd comparable to main analysis
- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -
- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -
- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -
- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - -- - - 0.5%- - - 0.6%- - - 1.1%- - - -- - - -
Study ID:EF ID Creator Create Date PMIDLast Updated
Alt ID(s) Title Year Author
Outcome Units Subgroup ArmOutcome Type
Outcome Description
Comparator No results
Recommended